ID   ARHGA_HUMAN             Reviewed;        1369 AA.
AC   O15013; O14665; Q2KHR8; Q68D55; Q8IWD9; Q8IY77;
DT   05-JUL-2004, integrated into UniProtKB/Swiss-Prot.
DT   27-JUN-2006, sequence version 4.
DT   13-FEB-2019, entry version 161.
DE   RecName: Full=Rho guanine nucleotide exchange factor 10;
GN   Name=ARHGEF10; Synonyms=KIAA0294;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5).
RC   TISSUE=Brain;
RX   PubMed=9205841; DOI=10.1093/dnares/4.2.141;
RA   Nagase T., Ishikawa K., Nakajima D., Ohira M., Seki N., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. VII.
RT   The complete sequences of 100 new cDNA clones from brain which can
RT   code for large proteins in vitro.";
RL   DNA Res. 4:141-150(1997).
RN   [3]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S.,
RA   Garber M., Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A.,
RA   Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X.,
RA   Allen N.R., Anderson S., Asakawa T., Blechschmidt K., Bloom T.,
RA   Borowsky M.L., Butler J., Cook A., Corum B., DeArellano K.,
RA   DeCaprio D., Dooley K.T., Dorris L. III, Engels R., Gloeckner G.,
RA   Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K., Jaffe D.B.,
RA   Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C.,
RA   O'Leary S.B., O'Neill K., Parker S.C.J., Polley A., Raymond C.K.,
RA   Reichwald K., Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R.,
RA   Smith C.L., Sneddon T.P., Talamas J.A., Tenzin P., Topham K.,
RA   Venkataraman V., Wen G., Yamazaki S., Young S.K., Zeng Q.,
RA   Zimmer A.R., Rosenthal A., Birren B.W., Platzer M., Shimizu N.,
RA   Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Duodenum, Prostate, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 353-1369 (ISOFORM 4).
RC   TISSUE=Brain;
RX   PubMed=9314494;
RA   Ranta S., Lehesjoki A.-E., de Fatima Bonaldo M., Knowles J.A.,
RA   Hirvasniemi A., Ross B., de Jong P.J., Soares M.B., de la Chapelle A.,
RA   Gilliam T.C.;
RT   "High-resolution mapping and transcript identification at the
RT   progressive epilepsy with mental retardation locus on chromosome 8p.";
RL   Genome Res. 7:887-896(1997).
RN   [7]
RP   FUNCTION, AND VARIANT SNCV ILE-357.
RX   PubMed=14508709; DOI=10.1086/378159;
RA   Verhoeven K., De Jonghe P., Van de Putte T., Nelis E., Zwijsen A.,
RA   Verpoorten N., De Vriendt E., Jacobs A., Van Gerwen V., Francis A.,
RA   Ceuterick C., Huylebroeck D., Timmerman V.;
RT   "Slowed conduction and thin myelination of peripheral nerves
RT   associated with mutant rho Guanine-nucleotide exchange factor 10.";
RL   Am. J. Hum. Genet. 73:926-932(2003).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1287, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-379, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-379, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11]
RP   METHYLATION AT GLN-1338, AND MUTAGENESIS OF GLN-1338.
RX   PubMed=26797129; DOI=10.1074/jbc.M115.711952;
RA   Kusevic D., Kudithipudi S., Jeltsch A.;
RT   "Substrate specificity of the HEMK2 protein glutamine
RT   methyltransferase and identification of novel substrates.";
RL   J. Biol. Chem. 291:6124-6133(2016).
RN   [12]
RP   VARIANT HIS-227.
RX   PubMed=24627108; DOI=10.1007/s00415-014-7289-8;
RA   Schabhuettl M., Wieland T., Senderek J., Baets J., Timmerman V.,
RA   De Jonghe P., Reilly M.M., Stieglbauer K., Laich E., Windhager R.,
RA   Erwa W., Trajanoski S., Strom T.M., Auer-Grumbach M.;
RT   "Whole-exome sequencing in patients with inherited neuropathies:
RT   outcome and challenges.";
RL   J. Neurol. 261:970-982(2014).
CC   -!- FUNCTION: May play a role in developmental myelination of
CC       peripheral nerves. {ECO:0000269|PubMed:14508709}.
CC   -!- INTERACTION:
CC       O15066:KIF3B; NbExp=3; IntAct=EBI-2515636, EBI-3931791;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=O15013-1; Sequence=Displayed;
CC         Note=No experimental confirmation available.;
CC       Name=2;
CC         IsoId=O15013-6; Sequence=VSP_040757;
CC       Name=3;
CC         IsoId=O15013-7; Sequence=VSP_040754, VSP_040756;
CC       Name=4;
CC         IsoId=O15013-4; Sequence=VSP_010704;
CC         Note=No experimental confirmation available.;
CC       Name=5;
CC         IsoId=O15013-5; Sequence=VSP_040754, VSP_040755;
CC   -!- PTM: Methylated at Gln-1338 by N6AMT1.
CC       {ECO:0000269|PubMed:26797129}.
CC   -!- DISEASE: Slowed nerve conduction velocity (SNCV) [MIM:608236]:
CC       Affected individuals present a reduction in nerve conduction
CC       velocities without any clinical signs of peripheral or central
CC       nervous system dysfunction. SNCV inheritance is autosomal
CC       dominant. {ECO:0000269|PubMed:14508709}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH36809.1; Type=Miscellaneous discrepancy; Note=Probable cloning artifact.; Evidence={ECO:0000305};
CC       Sequence=AAH40474.1; Type=Miscellaneous discrepancy; Note=Probable cloning artifact.; Evidence={ECO:0000305};
CC       Sequence=BAA20754.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=CAH18365.1; Type=Erroneous termination; Positions=895; Note=Translated as Lys.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; CR749570; CAH18365.1; ALT_TERM; mRNA.
DR   EMBL; AB002292; BAA20754.2; ALT_INIT; mRNA.
DR   EMBL; AC019257; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC036809; AAH36809.1; ALT_SEQ; mRNA.
DR   EMBL; BC040474; AAH40474.1; ALT_SEQ; mRNA.
DR   EMBL; BC112926; AAI12927.1; -; mRNA.
DR   EMBL; AF009205; AAB71662.1; -; mRNA.
DR   CCDS; CCDS34794.1; -. [O15013-5]
DR   CCDS; CCDS78296.1; -. [O15013-6]
DR   CCDS; CCDS78297.1; -. [O15013-7]
DR   PIR; T03307; T03307.
DR   RefSeq; NP_001295081.1; NM_001308152.1. [O15013-7]
DR   RefSeq; NP_001295082.1; NM_001308153.1. [O15013-6]
DR   RefSeq; NP_055444.2; NM_014629.3. [O15013-5]
DR   RefSeq; XP_016869492.1; XM_017014003.1. [O15013-1]
DR   UniGene; Hs.98594; -.
DR   ProteinModelPortal; O15013; -.
DR   SMR; O15013; -.
DR   BioGrid; 114998; 14.
DR   IntAct; O15013; 6.
DR   STRING; 9606.ENSP00000340297; -.
DR   iPTMnet; O15013; -.
DR   PhosphoSitePlus; O15013; -.
DR   BioMuta; ARHGEF10; -.
DR   EPD; O15013; -.
DR   jPOST; O15013; -.
DR   MaxQB; O15013; -.
DR   PaxDb; O15013; -.
DR   PeptideAtlas; O15013; -.
DR   PRIDE; O15013; -.
DR   ProteomicsDB; 48364; -.
DR   ProteomicsDB; 48365; -. [O15013-4]
DR   ProteomicsDB; 48366; -. [O15013-5]
DR   ProteomicsDB; 48367; -. [O15013-6]
DR   ProteomicsDB; 48368; -. [O15013-7]
DR   Ensembl; ENST00000349830; ENSP00000340297; ENSG00000104728. [O15013-5]
DR   Ensembl; ENST00000398564; ENSP00000381571; ENSG00000104728. [O15013-1]
DR   Ensembl; ENST00000518288; ENSP00000431012; ENSG00000104728. [O15013-6]
DR   Ensembl; ENST00000520359; ENSP00000427909; ENSG00000104728. [O15013-7]
DR   Ensembl; ENST00000610399; ENSP00000481974; ENSG00000274726. [O15013-1]
DR   Ensembl; ENST00000619613; ENSP00000477988; ENSG00000274726. [O15013-5]
DR   Ensembl; ENST00000631758; ENSP00000488343; ENSG00000274726. [O15013-7]
DR   Ensembl; ENST00000633616; ENSP00000488463; ENSG00000274726. [O15013-6]
DR   GeneID; 9639; -.
DR   KEGG; hsa:9639; -.
DR   UCSC; uc003wpr.4; human. [O15013-1]
DR   CTD; 9639; -.
DR   DisGeNET; 9639; -.
DR   EuPathDB; HostDB:ENSG00000104728.15; -.
DR   GeneCards; ARHGEF10; -.
DR   GeneReviews; ARHGEF10; -.
DR   HGNC; HGNC:14103; ARHGEF10.
DR   HPA; HPA024649; -.
DR   MalaCards; ARHGEF10; -.
DR   MIM; 608136; gene.
DR   MIM; 608236; phenotype.
DR   neXtProt; NX_O15013; -.
DR   OpenTargets; ENSG00000104728; -.
DR   Orphanet; 140481; Autosomal dominant slowed nerve conduction velocity.
DR   PharmGKB; PA24967; -.
DR   eggNOG; KOG3522; Eukaryota.
DR   eggNOG; ENOG410ZJK1; LUCA.
DR   GeneTree; ENSGT00940000153798; -.
DR   HOGENOM; HOG000232060; -.
DR   HOVERGEN; HBG050570; -.
DR   InParanoid; O15013; -.
DR   KO; K16727; -.
DR   OMA; MCATVSA; -.
DR   OrthoDB; 67600at2759; -.
DR   PhylomeDB; O15013; -.
DR   TreeFam; TF331430; -.
DR   Reactome; R-HSA-193648; NRAGE signals death through JNK.
DR   Reactome; R-HSA-194840; Rho GTPase cycle.
DR   Reactome; R-HSA-416482; G alpha (12/13) signalling events.
DR   ChiTaRS; ARHGEF10; human.
DR   GeneWiki; ARHGEF10; -.
DR   GenomeRNAi; 9639; -.
DR   PRO; PR:O15013; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000104728; Expressed in 227 organ(s), highest expression level in tibial nerve.
DR   ExpressionAtlas; O15013; baseline and differential.
DR   Genevisible; O15013; HS.
DR   GO; GO:0005813; C:centrosome; IDA:BHF-UCL.
DR   GO; GO:0005829; C:cytosol; NAS:BHF-UCL.
DR   GO; GO:0005085; F:guanyl-nucleotide exchange factor activity; IBA:GO_Central.
DR   GO; GO:0019894; F:kinesin binding; IPI:BHF-UCL.
DR   GO; GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IDA:BHF-UCL.
DR   GO; GO:0030036; P:actin cytoskeleton organization; IBA:GO_Central.
DR   GO; GO:0090630; P:activation of GTPase activity; IDA:BHF-UCL.
DR   GO; GO:0051298; P:centrosome duplication; IMP:BHF-UCL.
DR   GO; GO:0090307; P:mitotic spindle assembly; IMP:BHF-UCL.
DR   GO; GO:0022011; P:myelination in peripheral nervous system; IMP:BHF-UCL.
DR   GO; GO:0051496; P:positive regulation of stress fiber assembly; IMP:BHF-UCL.
DR   GO; GO:0035023; P:regulation of Rho protein signal transduction; IEA:InterPro.
DR   CDD; cd00160; RhoGEF; 1.
DR   Gene3D; 1.20.900.10; -; 1.
DR   Gene3D; 2.130.10.10; -; 1.
DR   InterPro; IPR030632; ARHGEF10.
DR   InterPro; IPR039919; ARHGEF10/ARHGEF17.
DR   InterPro; IPR035899; DBL_dom_sf.
DR   InterPro; IPR000219; DH-domain.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom_sf.
DR   InterPro; IPR036322; WD40_repeat_dom_sf.
DR   PANTHER; PTHR12877; PTHR12877; 1.
DR   PANTHER; PTHR12877:SF14; PTHR12877:SF14; 1.
DR   Pfam; PF00621; RhoGEF; 1.
DR   SMART; SM00325; RhoGEF; 1.
DR   SUPFAM; SSF48065; SSF48065; 1.
DR   SUPFAM; SSF50978; SSF50978; 1.
DR   PROSITE; PS50010; DH_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Coiled coil; Complete proteome;
KW   Disease mutation; Guanine-nucleotide releasing factor; Methylation;
KW   Phosphoprotein; Polymorphism; Reference proteome.
FT   CHAIN         1   1369       Rho guanine nucleotide exchange factor
FT                                10.
FT                                /FTId=PRO_0000080926.
FT   DOMAIN      421    608       DH. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00062}.
FT   COILED      304    355       {ECO:0000255}.
FT   COMPBIAS   1271   1304       Ser-rich.
FT   MOD_RES     180    180       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8C033}.
FT   MOD_RES     379    379       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1287   1287       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES    1338   1338       N5-methylglutamine.
FT                                {ECO:0000269|PubMed:26797129}.
FT   VAR_SEQ       1     24       Missing (in isoform 3 and isoform 5).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:9205841}.
FT                                /FTId=VSP_040754.
FT   VAR_SEQ     185    185       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:9205841}.
FT                                /FTId=VSP_040755.
FT   VAR_SEQ     307    345       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_040756.
FT   VAR_SEQ     545    545       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_040757.
FT   VAR_SEQ     897    925       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:9314494}.
FT                                /FTId=VSP_010704.
FT   VARIANT     227    227       N -> H (found in a patient with
FT                                hereditary motor and sensory neuropathy;
FT                                unknown pathological significance;
FT                                dbSNP:rs767902219).
FT                                {ECO:0000269|PubMed:24627108}.
FT                                /FTId=VAR_073288.
FT   VARIANT     357    357       T -> I (in SNCV; dbSNP:rs28940281).
FT                                {ECO:0000269|PubMed:14508709}.
FT                                /FTId=VAR_019118.
FT   VARIANT     700    700       V -> I (in dbSNP:rs2294039).
FT                                /FTId=VAR_038603.
FT   VARIANT     725    725       V -> I (in dbSNP:rs2294039).
FT                                /FTId=VAR_057188.
FT   MUTAGEN    1338   1338       Q->R: Abolishes methylation by N6AMT1.
FT                                {ECO:0000269|PubMed:26797129}.
FT   CONFLICT    395    395       L -> F (in Ref. 5; AAI12927).
FT                                {ECO:0000305}.
FT   CONFLICT    500    500       D -> V (in Ref. 5; AAH40474).
FT                                {ECO:0000305}.
FT   CONFLICT   1024   1024       T -> S (in Ref. 6; AAB71662).
FT                                {ECO:0000305}.
FT   CONFLICT   1046   1046       S -> T (in Ref. 6; AAB71662).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1369 AA;  151612 MW;  6F87869C7C6A5759 CRC64;
     MRPPGFLSRA PSLNRAERGI WSCSMDQREP LPPAPAENEM KYDTNNNEEE EGEQFDFDSG
     DEIPEADRQA PSAPETGGAG ASEAPAPTGG EDGAGAETTP VAEPTKLVLP MKVNPYSVID
     ITPFQEDQPP TPVPSAEEEN VGLHVPCGYL VPVPCGYAVP SNLPLLLPAY SSPVIICATS
     LDEEAETPEV TEDRQPNSLS SEEPPTSEDQ VGREDSALAR WAADPANTAW MENPEEAIYD
     DVPRENSDSE PDEMIYDDVE NGDEGGNSSL EYGWSSSEFE SYEEQSDSEC KNGIPRSFLR
     SNHKKQLSHD LTRLKEHYEK KMRDLMASTV GVVEIQQLRQ KHELKMQKLV KAAKDGTKDG
     LERTRAAVKR GRSFIRTKSL IAQDHRSSLE EEQNLFIDVD CKHPEAILTP MPEGLSQQQV
     VRRYILGSVV DSEKNYVDAL KRILEQYEKP LSEMEPKVLS ERKLKTVFYR VKEILQCHSL
     FQIALASRVS EWDSVEMIGD VFVASFSKSM VLDAYSEYVN NFSTAVAVLK KTCATKPAFL
     EFLKQEQEAS PDRTTLYSLM MKPIQRFPQF ILLLQDMLKN TSKGHPDRLP LQMALTELET
     LAEKLNERKR DADQRCEVKQ IAKAINERYL NKLLSSGSRY LIRSDDMIET VYNDRGEIVK
     TKERRVFMLN DVLMCATVSS RPSHDSRVMS SQRYLLKWSV PLGHVDAIEY GSSAGTGEHS
     RHLAVHPPES LAVVANAKPN KVYMGPGQLY QDLQNLLHDL NVIGQITQLI GNLKGNYQNL
     NQSVAHDWTS GLQRLILKKE DEIRAADCCR IQLQLPGKQD KSGRPTFFTA VFNTFTPAIK
     ESWVNSLQMA KLALEEENHM GWFCVEDDGN HIKKEKHPLL VGHMPVMVAK QQEFKIECAA
     YNPEPYLNNE SQPDSFSTAH GFLWIGSCTH QMGQIAIVSF QNSTPKVIEC FNVESRILCM
     LYVPVEEKRR EPGAPPDPET PAVRASDVPT ICVGTEEGSI SIYKSSQGSK KVRLQHFFTP
     EKSTVMSLAC TSQSLYAGLV NGAVASYARA PDGSWDSEPQ KVIKLGVLPV RSLLMMEDTL
     WAASGGQVFI ISVETHAVEG QLEAHQEEGM VISHMAVSGV GIWIAFTSGS TLRLFHTETL
     KHLQDINIAT PVHNMLPGHQ RLSVTSLLVC HGLLMVGTSL GVLVALPVPR LQGIPKVTGR
     GMVSYHAHNS PVKFIVLATA LHEKDKDKSR DSLAPGPEPQ DEDQKDALPS GGAGSSLSQG
     DPDAAIWLGD SLGSMTQKSD LSSSSGSLSL SHGSSSLEHR SEDSTIYDLL KDPVSLRSKA
     RRAKKAKASS ALVVCGGQGH RRVHRKARQP HQEELAPTVM VWQIPLLNI
//
ID   B4DTL3_HUMAN            Unreviewed;      1042 AA.
AC   B4DTL3;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   16-JAN-2019, entry version 58.
DE   SubName: Full=cDNA FLJ53192, highly similar to Homo sapiens Rho guanine nucleotide exchange factor (GEF) 10-like, transcript variant 1, mRNA {ECO:0000313|EMBL:BAG62025.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG62025.1};
RN   [1] {ECO:0000313|EMBL:BAG62025.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Placenta {ECO:0000313|EMBL:BAG62025.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AK300264; BAG62025.1; -; mRNA.
DR   RefSeq; NP_001315053.1; NM_001328124.1.
DR   UniGene; Hs.443460; -.
DR   MaxQB; B4DTL3; -.
DR   PeptideAtlas; B4DTL3; -.
DR   PRIDE; B4DTL3; -.
DR   GeneID; 55160; -.
DR   CTD; 55160; -.
DR   eggNOG; KOG3522; Eukaryota.
DR   eggNOG; KOG3524; Eukaryota.
DR   eggNOG; ENOG410ZJK1; LUCA.
DR   HOGENOM; HOG000232060; -.
DR   HOVERGEN; HBG050570; -.
DR   OrthoDB; 67600at2759; -.
DR   GenomeRNAi; 55160; -.
DR   GO; GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro.
DR   GO; GO:0035023; P:regulation of Rho protein signal transduction; IEA:InterPro.
DR   CDD; cd00160; RhoGEF; 1.
DR   Gene3D; 1.20.900.10; -; 1.
DR   Gene3D; 2.130.10.10; -; 1.
DR   Gene3D; 2.30.29.30; -; 1.
DR   InterPro; IPR039919; ARHGEF10/ARHGEF17.
DR   InterPro; IPR035899; DBL_dom_sf.
DR   InterPro; IPR000219; DH-domain.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom_sf.
DR   InterPro; IPR036322; WD40_repeat_dom_sf.
DR   PANTHER; PTHR12877; PTHR12877; 1.
DR   Pfam; PF00621; RhoGEF; 1.
DR   SMART; SM00325; RhoGEF; 1.
DR   SUPFAM; SSF48065; SSF48065; 1.
DR   SUPFAM; SSF50978; SSF50978; 1.
DR   PROSITE; PS50010; DH_2; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   DOMAIN       94    281       DH. {ECO:0000259|PROSITE:PS50010}.
FT   COILED      261    294       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   1042 AA;  114497 MW;  56DFD28E48C65344 CRC64;
     MLPSSSWGKR KLRGRLGWVR SDARGVMWAR QEGLHHPHPH AVIRCPSSSS SSVSCSGDSE
     EEDMGLLEVS VSDIKPPAPE LGPMPEGLSP QQVVRRHILG SIVQSEGSYV ESLKRILQDY
     RNPLMEMEPK ALSARKCQVV FFRVKEILHC HSMFQIALSS RVAEWDSTEK IGDLFVASFS
     KSMVLDVYSD YVNNFTSAMS IIKKACLTKP AFLEFLKRRQ VCSPDRVTLY GLMVKPIQRF
     PQFILLLQDM LKNTPRGHPD RLSLQLALTE LETLAEKLNE QKRLADQVAE IQQLTKSVSD
     RSSLNKLLTS GQRQLLLCET LTETVYGDRG QLIKSKERRV FLLNDMLVCA NINFKGQLEI
     SSLVPLGPKY VVKWNTALPQ VQVVEVGQDG GTYDKDNVLI QHSGAKKASA SGQAQNKVYL
     GPPRLFQELQ DLQKDLAVVE QITLLISTLH GTYQNLNMTV AQDWCLALQR LMRVKEEEIH
     SANKCRLRLL LPGKPDKSGR PISFMVVFIT PNPLSKISWV NRLHLAKIGL REENQPGWLC
     PDEDKKSKAP FWCPILACCI PAFSSRALSL QLGALVHSPV NCPLLGFSAV STSLPQGYLW
     VGGGQEGAGG QVEIFSLNRP SPRTVKSFPL AAPVLCMEYI PELEEEAESR DESPTVADPS
     ATVHPTICLG LQDGSILLYS SVDTGTQCLV SCRSPGLQPV LCLRHSPFHL LAGLQDGTLA
     AYPRTSGGVL WDLESPPVCL TVGPGPVRTL LSLEDAVWAS CGPRVTVLEA TTLQPQQSFE
     AHQDEAVSVT HMVKAGSGVW MAFSSGTSIR LFHTETLEHL QEINIATRTT FLLPGQKHLC
     VTSLLICQGL LWVGTDQGVI VLLPVPRLEG IPKITGKGMV SLNGHCGPVA FLAVATSILA
     PDILRSDQEE AEGPRAEEDK PDGQAHEPMP DSHVGRELTR KKGILLQYRL RSTAHLPGPL
     LSMREPAPAD GAALEHSEED GSIYEMAFFL KAKNTKPHNC LASPVSLVWA LAGLQGSHTP
     LLEGCVRVSV CECVGWCVNI YK
//
ID   Q5VXI4_HUMAN            Unreviewed;      1052 AA.
AC   Q5VXI4;
DT   07-DEC-2004, integrated into UniProtKB/TrEMBL.
DT   29-OCT-2014, sequence version 2.
DT   16-JAN-2019, entry version 113.
DE   SubName: Full=Rho guanine nucleotide exchange factor 10-like protein {ECO:0000313|Ensembl:ENSP00000364557};
GN   Name=ARHGEF10L {ECO:0000313|Ensembl:ENSP00000364557};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000364557, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000364557, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S., Hart E., Haugen E., Heath P.D., Holmes S.,
RA   Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J.,
RA   James R., Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K.,
RA   Kibukawa M., Kimberley A.M., King A., Knights A.J., Lad H., Laird G.,
RA   Lawlor S., Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J.,
RA   Lush M.J., Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L.,
RA   Matthews N.S., McLaren S., Milne S., Mistry S., Moore M.J.,
RA   Nickerson T., O'Dell C.N., Oliver K., Palmeiri A., Palmer S.A.,
RA   Parker A., Patel D., Pearce A.V., Peck A.I., Pelan S., Phelps K.,
RA   Phillimore B.J., Plumb R., Rajan J., Raymond C., Rouse G.,
RA   Saenphimmachak C., Sehra H.K., Sheridan E., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M., Steward C., Subramanian S., Sycamore N.,
RA   Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M., White S.,
RA   Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H., Wilming L.,
RA   Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E., Durbin R.,
RA   Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G., Ross M.T.,
RA   Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R., Banerjee R.,
RA   Bryant S.P., Burford D.C., Burrill W.D., Clegg S.M., Dhami P.,
RA   Dovey O., Faulkner L.M., Gribble S.M., Langford C.F., Pandian R.D.,
RA   Porter K.M., Prigmore E.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [2] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [3] {ECO:0000313|Ensembl:ENSP00000364557}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (FEB-2012) to UniProtKB.
RN   [4] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AL139250; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL358593; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL390994; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF495877; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; XP_005245986.2; XM_005245929.2.
DR   UniGene; Hs.443460; -.
DR   ProteinModelPortal; Q5VXI4; -.
DR   EPD; Q5VXI4; -.
DR   jPOST; Q5VXI4; -.
DR   PeptideAtlas; Q5VXI4; -.
DR   PRIDE; Q5VXI4; -.
DR   Ensembl; ENST00000375408; ENSP00000364557; ENSG00000074964.
DR   GeneID; 55160; -.
DR   UCSC; uc010ocs.3; human.
DR   CTD; 55160; -.
DR   EuPathDB; HostDB:ENSG00000074964.16; -.
DR   HGNC; HGNC:25540; ARHGEF10L.
DR   OpenTargets; ENSG00000074964; -.
DR   eggNOG; KOG3522; Eukaryota.
DR   eggNOG; KOG3524; Eukaryota.
DR   eggNOG; ENOG410ZJK1; LUCA.
DR   GeneTree; ENSGT00940000153798; -.
DR   HOGENOM; HOG000232060; -.
DR   HOVERGEN; HBG050570; -.
DR   OrthoDB; 67600at2759; -.
DR   ChiTaRS; ARHGEF10L; human.
DR   GenomeRNAi; 55160; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000074964; Expressed in 227 organ(s), highest expression level in right lobe of liver.
DR   ExpressionAtlas; Q5VXI4; baseline and differential.
DR   GO; GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro.
DR   GO; GO:0035023; P:regulation of Rho protein signal transduction; IEA:InterPro.
DR   CDD; cd00160; RhoGEF; 1.
DR   Gene3D; 1.20.900.10; -; 1.
DR   Gene3D; 2.130.10.10; -; 1.
DR   Gene3D; 2.30.29.30; -; 1.
DR   InterPro; IPR039919; ARHGEF10/ARHGEF17.
DR   InterPro; IPR035899; DBL_dom_sf.
DR   InterPro; IPR000219; DH-domain.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom_sf.
DR   InterPro; IPR036322; WD40_repeat_dom_sf.
DR   PANTHER; PTHR12877; PTHR12877; 1.
DR   Pfam; PF00621; RhoGEF; 1.
DR   SMART; SM00325; RhoGEF; 1.
DR   SUPFAM; SSF48065; SSF48065; 1.
DR   SUPFAM; SSF50978; SSF50978; 1.
DR   PROSITE; PS50010; DH_2; 1.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|MaxQB:Q5VXI4,
KW   ECO:0000213|PeptideAtlas:Q5VXI4};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN       94    281       DH. {ECO:0000259|PROSITE:PS50010}.
FT   COILED      261    294       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   1052 AA;  115568 MW;  38BF19D3CBD9B8B9 CRC64;
     MLPSSSWGKR KLRGRLGWVR SDARGVMWAR QEGLHHPHPH AVIRCPSSSS SSVSCSGDSE
     EEDMGLLEVS VSDIKPPAPE LGPMPEGLSP QQVVRRHILG SIVQSEGSYV ESLKRILQDY
     RNPLMEMEPK ALSARKCQVV FFRVKEILHC HSMFQIALSS RVAEWDSTEK IGDLFVASFS
     KSMVLDVYSD YVNNFTSAMS IIKKACLTKP AFLEFLKRRQ VCSPDRVTLY GLMVKPIQRF
     PQFILLLQDM LKNTPRGHPD RLSLQLALTE LETLAEKLNE QKRLADQVAE IQQLTKSVSD
     RSSLNKLLTS GQRQLLLCET LTETVYGDRG QLIKSKERRV FLLNDMLVCA NINFKGQLEI
     SSLVPLGPKY VVKWNTALPQ VQVVEVGQDG GTYDKDNVLI QHSGAKKASA SGQAQNKVYL
     GPPRLFQELQ DLQKDLAVVE QITLLISTLH GTYQNLNMTV AQDWCLALQR LMRVKEEEIH
     SANKCRLRLL LPGKPDKSGR PISFMVVFIT PNPLSKISWV NRLHLAKIGL REENQPGWLC
     PDEDKKSKAP FWCPILACCI PAFSSRALSL QLGALVHSPV NCPLLGFSAV STSLPQGYLW
     VGGGQEGAGG QVEIFSLNRP SPRTVKSFPL AAPVLCMEYI PELEEEAESR DESPTVADPS
     ATVHPTICLG LQDGSILLYS SVDTGTQCLV SCRSPGLQPV LCLRHSPFHL LAGLQDGTLA
     AYPRTSGGVL WDLESPPVCL TVGPGPVRTL LSLEDAVWAS CGPRVTVLEA TTLQPQQSFE
     AHQDEAVSVT HMVKAGSGVW MAFSSGTSIR LFHTETLEHL QEINIATRTT FLLPGQKHLC
     VTSLLICQGL LWVGTDQGVI VLLPVPRLEG IPKITGKGMV SLNGHCGPVA FLAVATSILA
     PDILRSDQEE AEGPRAEEDK PDGQAHEPMP DSHVGRELTR KKGILLQYRL RSTAHLPGPL
     LSMREPAPAD GAALEHSEED GSIYEMADDP DIWVRSRPCA RDAHRKEICS VAIISGGQGY
     RNFGSALGSS GRQAPCGETD STLLIWQVPL ML
//
ID   ARGAL_HUMAN             Reviewed;        1279 AA.
AC   Q9HCE6; B7ZKS1; Q17RW1; Q3YFJ4; Q5VXI5; Q5VXI6; Q66K51; Q6P0L7;
AC   Q8NAV5; Q9NVT3;
DT   01-JUL-2008, integrated into UniProtKB/Swiss-Prot.
DT   12-SEP-2018, sequence version 4.
DT   13-FEB-2019, entry version 126.
DE   RecName: Full=Rho guanine nucleotide exchange factor 10-like protein;
DE   AltName: Full=GrinchGEF;
GN   Name=ARHGEF10L; Synonyms=GRINCHGEF, KIAA1626;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), FUNCTION, INTERACTION WITH
RP   RHOA; RHOB AND RHOC, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND
RP   VARIANT VAL-1219.
RC   TISSUE=Embryonic kidney;
RX   PubMed=16112081; DOI=10.1016/j.bbrc.2005.08.025;
RA   Winkler S., Mohl M., Wieland T., Lutz S.;
RT   "GrinchGEF -- a novel Rho-specific guanine nucleotide exchange
RT   factor.";
RL   Biochem. Biophys. Res. Commun. 335:1280-1286(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   VAL-1219.
RC   TISSUE=Brain;
RX   PubMed=10997877; DOI=10.1093/dnares/7.4.271;
RA   Nagase T., Kikuno R., Nakayama M., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes.
RT   XVIII. The complete sequences of 100 new cDNA clones from brain which
RT   code for large proteins in vitro.";
RL   DNA Res. 7:273-281(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 457-1279 (ISOFORM 5).
RC   TISSUE=Mesangial cell, and Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3), AND VARIANT
RP   VAL-1219.
RC   TISSUE=Colon, Eye, and Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-40 AND SER-281, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [8]
RP   VARIANT [LARGE SCALE ANALYSIS] VAL-96.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Acts as guanine nucleotide exchange factor (GEF) for
CC       RHOA, RHOB and RHOC. {ECO:0000269|PubMed:16112081}.
CC   -!- SUBUNIT: Interacts with RHOA, RHOB and RHOC.
CC       {ECO:0000269|PubMed:16112081}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16112081}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=Q9HCE6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9HCE6-2; Sequence=VSP_034421;
CC       Name=3;
CC         IsoId=Q9HCE6-3; Sequence=VSP_034421, VSP_034424;
CC       Name=4;
CC         IsoId=Q9HCE6-4; Sequence=VSP_034420, VSP_034422, VSP_034423,
CC                                  VSP_034424;
CC       Name=5;
CC         IsoId=Q9HCE6-5; Sequence=VSP_034424, VSP_034425, VSP_034426;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Detected in heart, liver, skeletal muscle,
CC       kidney and pancreas. {ECO:0000269|PubMed:16112081}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA91663.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=BAB13452.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=BAC03792.1; Type=Erroneous termination; Positions=931; Note=Translated as Arg.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; DQ139833; AAZ73162.1; -; mRNA.
DR   EMBL; AB046846; BAB13452.1; ALT_INIT; mRNA.
DR   EMBL; AK001383; BAA91663.1; ALT_INIT; mRNA.
DR   EMBL; AK092020; BAC03792.1; ALT_SEQ; mRNA.
DR   EMBL; AL139250; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL358593; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC065561; AAH65561.1; -; mRNA.
DR   EMBL; BC080596; AAH80596.1; -; mRNA.
DR   EMBL; BC117171; AAI17172.1; -; mRNA.
DR   EMBL; BC143347; AAI43348.1; -; mRNA.
DR   CCDS; CCDS182.1; -. [Q9HCE6-1]
DR   CCDS; CCDS30617.1; -. [Q9HCE6-2]
DR   RefSeq; NP_001011722.2; NM_001011722.2. [Q9HCE6-2]
DR   RefSeq; NP_001306766.1; NM_001319837.1. [Q9HCE6-3]
DR   RefSeq; NP_001306767.1; NM_001319838.1. [Q9HCE6-4]
DR   RefSeq; NP_001315053.1; NM_001328124.1.
DR   RefSeq; NP_060595.3; NM_018125.3. [Q9HCE6-1]
DR   RefSeq; XP_005245982.2; XM_005245925.2. [Q9HCE6-2]
DR   RefSeq; XP_016857106.1; XM_017001617.1. [Q9HCE6-3]
DR   RefSeq; XP_016857110.1; XM_017001621.1. [Q9HCE6-1]
DR   UniGene; Hs.443460; -.
DR   ProteinModelPortal; Q9HCE6; -.
DR   IntAct; Q9HCE6; 5.
DR   STRING; 9606.ENSP00000355060; -.
DR   iPTMnet; Q9HCE6; -.
DR   PhosphoSitePlus; Q9HCE6; -.
DR   BioMuta; ARHGEF10L; -.
DR   DMDM; 317373481; -.
DR   EPD; Q9HCE6; -.
DR   jPOST; Q9HCE6; -.
DR   PaxDb; Q9HCE6; -.
DR   PeptideAtlas; Q9HCE6; -.
DR   PRIDE; Q9HCE6; -.
DR   ProteomicsDB; 81688; -.
DR   ProteomicsDB; 81689; -. [Q9HCE6-2]
DR   ProteomicsDB; 81690; -. [Q9HCE6-3]
DR   ProteomicsDB; 81691; -. [Q9HCE6-4]
DR   ProteomicsDB; 81692; -. [Q9HCE6-5]
DR   Ensembl; ENST00000361221; ENSP00000355060; ENSG00000074964. [Q9HCE6-1]
DR   Ensembl; ENST00000375415; ENSP00000364564; ENSG00000074964. [Q9HCE6-2]
DR   GeneID; 55160; -.
DR   KEGG; hsa:55160; -.
DR   UCSC; uc001ban.4; human. [Q9HCE6-1]
DR   CTD; 55160; -.
DR   DisGeNET; 55160; -.
DR   EuPathDB; HostDB:ENSG00000074964.16; -.
DR   GeneCards; ARHGEF10L; -.
DR   HGNC; HGNC:25540; ARHGEF10L.
DR   HPA; HPA026426; -.
DR   HPA; HPA026440; -.
DR   HPA; HPA028115; -.
DR   MIM; 612494; gene.
DR   neXtProt; NX_Q9HCE6; -.
DR   OpenTargets; ENSG00000074964; -.
DR   PharmGKB; PA142672586; -.
DR   eggNOG; KOG3522; Eukaryota.
DR   eggNOG; KOG3524; Eukaryota.
DR   eggNOG; ENOG410ZJK1; LUCA.
DR   GeneTree; ENSGT00940000153798; -.
DR   HOVERGEN; HBG050570; -.
DR   InParanoid; Q9HCE6; -.
DR   KO; K16727; -.
DR   OrthoDB; 67600at2759; -.
DR   PhylomeDB; Q9HCE6; -.
DR   TreeFam; TF331430; -.
DR   Reactome; R-HSA-193648; NRAGE signals death through JNK.
DR   Reactome; R-HSA-194840; Rho GTPase cycle.
DR   Reactome; R-HSA-416482; G alpha (12/13) signalling events.
DR   ChiTaRS; ARHGEF10L; human.
DR   GenomeRNAi; 55160; -.
DR   PRO; PR:Q9HCE6; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000074964; Expressed in 227 organ(s), highest expression level in right lobe of liver.
DR   ExpressionAtlas; Q9HCE6; baseline and differential.
DR   Genevisible; Q9HCE6; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HGNC.
DR   GO; GO:0005096; F:GTPase activator activity; IDA:HGNC.
DR   GO; GO:0005085; F:guanyl-nucleotide exchange factor activity; IBA:GO_Central.
DR   GO; GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IBA:GO_Central.
DR   GO; GO:0030036; P:actin cytoskeleton organization; IBA:GO_Central.
DR   GO; GO:0051496; P:positive regulation of stress fiber assembly; IDA:HGNC.
DR   GO; GO:0035023; P:regulation of Rho protein signal transduction; IEA:InterPro.
DR   GO; GO:0032933; P:SREBP signaling pathway; IDA:HGNC.
DR   CDD; cd00160; RhoGEF; 1.
DR   Gene3D; 1.20.900.10; -; 1.
DR   Gene3D; 2.130.10.10; -; 1.
DR   Gene3D; 2.30.29.30; -; 1.
DR   InterPro; IPR039919; ARHGEF10/ARHGEF17.
DR   InterPro; IPR035899; DBL_dom_sf.
DR   InterPro; IPR000219; DH-domain.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom_sf.
DR   InterPro; IPR036322; WD40_repeat_dom_sf.
DR   PANTHER; PTHR12877; PTHR12877; 1.
DR   Pfam; PF00621; RhoGEF; 1.
DR   SMART; SM00325; RhoGEF; 1.
DR   SUPFAM; SSF48065; SSF48065; 1.
DR   SUPFAM; SSF50978; SSF50978; 1.
DR   PROSITE; PS50010; DH_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Cytoplasm;
KW   Guanine-nucleotide releasing factor; Phosphoprotein; Polymorphism;
KW   Reference proteome.
FT   CHAIN         1   1279       Rho guanine nucleotide exchange factor
FT                                10-like protein.
FT                                /FTId=PRO_0000342361.
FT   DOMAIN      316    503       DH. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00062}.
FT   MOD_RES      40     40       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     131    131       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:A2AWP8}.
FT   MOD_RES     152    152       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:A2AWP8}.
FT   MOD_RES     281    281       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   VAR_SEQ       1    221       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_034420.
FT   VAR_SEQ     203    241       Missing (in isoform 2 and isoform 3).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:16112081}.
FT                                /FTId=VSP_034421.
FT   VAR_SEQ     222    278       ILALRVGGRDMQELKHKYDCKMTQLMKAAKSGTKDGLEKTR
FT                                MAVMRKVSFLHRKDVL -> MLPSSSWGKRKLRGRLGWVRS
FT                                DARGVMWARQEGLHHPHPHAVIRCPSSSSSSVSCS (in
FT                                isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_034422.
FT   VAR_SEQ     401    470       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_034423.
FT   VAR_SEQ     578    582       Missing (in isoform 3, isoform 4 and
FT                                isoform 5). {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:16112081}.
FT                                /FTId=VSP_034424.
FT   VAR_SEQ    1062   1072       GQKHLCVTSLL -> DRSLIKCSPRA (in isoform
FT                                5). {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_034425.
FT   VAR_SEQ    1073   1279       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_034426.
FT   VARIANT      47     47       S -> N (in dbSNP:rs34417109).
FT                                /FTId=VAR_061794.
FT   VARIANT      69     69       D -> N (in dbSNP:rs35497285).
FT                                /FTId=VAR_044183.
FT   VARIANT      96     96       A -> V (in a colorectal cancer sample;
FT                                somatic mutation; dbSNP:rs1421731181).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_044184.
FT   VARIANT     991    991       R -> W (in dbSNP:rs6695710).
FT                                /FTId=VAR_044185.
FT   VARIANT    1219   1219       I -> V (in dbSNP:rs2270976).
FT                                {ECO:0000269|PubMed:10997877,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:16112081}.
FT                                /FTId=VAR_044186.
FT   CONFLICT     24     24       S -> P (in Ref. 1; AAZ73162).
FT                                {ECO:0000305}.
FT   CONFLICT    924    924       L -> P (in Ref. 3; BAA91663).
FT                                {ECO:0000305}.
FT   CONFLICT   1006   1006       F -> S (in Ref. 3; BAA91663).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1279 AA;  140379 MW;  1ED000F0C8864CD7 CRC64;
     MASSNPPPQP AIGDQLVPGV PGPSSEAEDD PGEAFEFDDS DDEEDTSAAL GVPSLAPERD
     TDPPLIHLDS IPVTDPDPAA APPGTGVPAW VSNGDAADAA FSGARHSSWK RKSSRRIDRF
     TFPALEEDVI YDDVPCESPD AHQPGAERNL LYEDAHRAGA PRQAEDLGWS SSEFESYSED
     SGEEAKPEVE VEPAKHRVSF QPKLSPDLTR LKERYARTKR DILALRVGGR DMQELKHKYD
     CKMTQLMKAA KSGTKDGLEK TRMAVMRKVS FLHRKDVLGD SEEEDMGLLE VSVSDIKPPA
     PELGPMPEGL SPQQVVRRHI LGSIVQSEGS YVESLKRILQ DYRNPLMEME PKALSARKCQ
     VVFFRVKEIL HCHSMFQIAL SSRVAEWDST EKIGDLFVAS FSKSMVLDVY SDYVNNFTSA
     MSIIKKACLT KPAFLEFLKR RQVCSPDRVT LYGLMVKPIQ RFPQFILLLQ DMLKNTPRGH
     PDRLSLQLAL TELETLAEKL NEQKRLADQV AEIQQLTKSV SDRSSLNKLL TSGQRQLLLC
     ETLTETVYGD RGQLIKSKER RVFLLNDMLV CANINFKPAN HRGQLEISSL VPLGPKYVVK
     WNTALPQVQV VEVGQDGGTY DKDNVLIQHS GAKKASASGQ AQNKVYLGPP RLFQELQDLQ
     KDLAVVEQIT LLISTLHGTY QNLNMTVAQD WCLALQRLMR VKEEEIHSAN KCRLRLLLPG
     KPDKSGRPIS FMVVFITPNP LSKISWVNRL HLAKIGLREE NQPGWLCPDE DKKSKAPFWC
     PILACCIPAF SSRALSLQLG ALVHSPVNCP LLGFSAVSTS LPQGYLWVGG GQEGAGGQVE
     IFSLNRPSPR TVKSFPLAAP VLCMEYIPEL EEEAESRDES PTVADPSATV HPTICLGLQD
     GSILLYSSVD TGTQCLVSCR SPGLQPVLCL RHSPFHLLAG LQDGTLAAYP RTSGGVLWDL
     ESPPVCLTVG PGPVRTLLSL EDAVWASCGP RVTVLEATTL QPQQSFEAHQ DEAVSVTHMV
     KAGSGVWMAF SSGTSIRLFH TETLEHLQEI NIATRTTFLL PGQKHLCVTS LLICQGLLWV
     GTDQGVIVLL PVPRLEGIPK ITGKGMVSLN GHCGPVAFLA VATSILAPDI LRSDQEEAEG
     PRAEEDKPDG QAHEPMPDSH VGRELTRKKG ILLQYRLRST AHLPGPLLSM REPAPADGAA
     LEHSEEDGSI YEMADDPDIW VRSRPCARDA HRKEICSVAI ISGGQGYRNF GSALGSSGRQ
     APCGETDSTL LIWQVPLML
//
ID   ASXL2_HUMAN             Reviewed;        1435 AA.
AC   Q76L83; Q53TC9; Q5H9U4; Q76L81; Q86XM1; Q9C0H8; Q9NV67;
DT   15-JAN-2008, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   13-FEB-2019, entry version 121.
DE   RecName: Full=Putative Polycomb group protein ASXL2;
DE   AltName: Full=Additional sex combs-like protein 2;
GN   Name=ASXL2; Synonyms=ASXH2, KIAA1685;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND CHROMOSOMAL TRANSLOCATION
RP   WITH KAT6A.
RC   TISSUE=Bone marrow;
RA   Hosoda F., Kitabayashi I., Kakazu N., Fukushima M., Aikawa Y., Abe T.,
RA   Hibi S., Yagi T., Ohki M.;
RT   "MOZ is fused to a novel Polycomb group gene in a therapy-related
RT   myelodysplastic syndrome with t(2;8)(p23;p11.2).";
RL   Submitted (APR-2002) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=11214970; DOI=10.1093/dnares/7.6.347;
RA   Nagase T., Kikuno R., Hattori A., Kondo Y., Okumura K., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XIX.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 7:347-355(2000).
RN   [3]
RP   SEQUENCE REVISION.
RA   Ohara O., Nagase T., Kikuno R.;
RL   Submitted (JAN-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT
RP   VAL-796.
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 890-1435 (ISOFORM 1).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-146, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [12]
RP   FUNCTION, AND INTERACTION WITH PPARA AND PPARG.
RX   PubMed=21047783; DOI=10.1074/jbc.M110.177816;
RA   Park U.H., Yoon S.K., Park T., Kim E.J., Um S.J.;
RT   "Additional sex comb-like (ASXL) proteins 1 and 2 play opposite roles
RT   in adipogenesis via reciprocal regulation of peroxisome proliferator-
RT   activated receptor {gamma}.";
RL   J. Biol. Chem. 286:1354-1363(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-524; SER-562; SER-571;
RP   SER-600; SER-637; SER-648 AND SER-1319, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   INVOLVEMENT IN SHAPNS.
RX   PubMed=27693232; DOI=10.1016/j.ajhg.2016.08.017;
RG   Undiagnosed Diseases Network;
RA   Shashi V., Pena L.D., Kim K., Burton B., Hempel M., Schoch K.,
RA   Walkiewicz M., McLaughlin H.M., Cho M., Stong N., Hickey S.E.,
RA   Shuss C.M., Freemark M.S., Bellet J.S., Keels M.A., Bonner M.J.,
RA   El-Dairi M., Butler M., Kranz P.G., Stumpel C.T., Klinkenberg S.,
RA   Oberndorff K., Alawi M., Santer R., Petrovski S., Kuismin O.,
RA   Korpi-Heikkilae S., Pietilainen O., Aarno P., Kurki M.I., Hoischen A.,
RA   Need A.C., Goldstein D.B., Kortuem F.;
RT   "De novo truncating variants in ASXL2 are associated with a unique and
RT   recognizable clinical phenotype.";
RL   Am. J. Hum. Genet. 99:991-999(2016).
CC   -!- FUNCTION: Putative Polycomb group (PcG) protein. PcG proteins act
CC       by forming multiprotein complexes, which are required to maintain
CC       the transcriptionally repressive state of homeotic genes
CC       throughout development. PcG proteins are not required to initiate
CC       repression, but to maintain it during later stages of development.
CC       They probably act via methylation of histones, rendering chromatin
CC       heritably changed in its expressibility (By similarity). Involved
CC       in transcriptional regulation mediated by ligand-bound nuclear
CC       hormone receptors, such as peroxisome proliferator-activated
CC       receptor gamma (PPARG). Acts as coactivator for PPARG and enhances
CC       its adipocyte differentiation-inducing activity; the function
CC       seems to involve differential recruitment of acetylated and
CC       methylated histone H3. {ECO:0000250, ECO:0000269|PubMed:21047783}.
CC   -!- SUBUNIT: Interacts with PPARA and PPARG.
CC       {ECO:0000269|PubMed:21047783}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q76L83-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q76L83-2; Sequence=VSP_030163, VSP_030164;
CC         Note=No experimental confirmation available.;
CC   -!- DOMAIN: Contains two Leu-Xaa-Xaa-Leu-Leu (LXXLL) motifs, which may
CC       be required for an association with nuclear receptors.
CC       {ECO:0000250}.
CC   -!- DISEASE: Shashi-Pena syndrome (SHAPNS) [MIM:617190]: An autosomal
CC       dominant syndrome characterized by delayed psychomotor
CC       development, intellectual disability of variable severity,
CC       macrocephaly, prominent eyes, arched eyebrows, hypertelorism, a
CC       glabellar nevus flammeus, neonatal feeding difficulties, and
CC       hypotonia. Some patients may also have atrial septal defect,
CC       episodic hypoglycemia, changes in bone mineral density, and/or
CC       seizures. {ECO:0000269|PubMed:27693232}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Note=A chromosomal aberration involving ASXL2 is a cause
CC       of therapy-related myelodysplastic syndrome. Translocation
CC       t(2;8)(p23;p11.2) with KAT6A generates a KAT6A-ASXL2 fusion
CC       protein.
CC   -!- SIMILARITY: Belongs to the Asx family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA91889.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAB21776.2; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAD00088.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AB084279; BAD00086.1; -; mRNA.
DR   EMBL; AB084281; BAD00088.1; ALT_INIT; mRNA.
DR   EMBL; AB051472; BAB21776.2; ALT_INIT; mRNA.
DR   EMBL; CR933613; CAI45930.1; -; mRNA.
DR   EMBL; AC010150; AAY14841.1; -; Genomic_DNA.
DR   EMBL; BC042999; AAH42999.1; -; mRNA.
DR   EMBL; AK001760; BAA91889.1; ALT_INIT; mRNA.
DR   RefSeq; NP_060733.4; NM_018263.4. [Q76L83-1]
DR   UniGene; Hs.119815; -.
DR   UniGene; Hs.229304; -.
DR   ProteinModelPortal; Q76L83; -.
DR   SMR; Q76L83; -.
DR   BioGrid; 120543; 22.
DR   IntAct; Q76L83; 12.
DR   MINT; Q76L83; -.
DR   STRING; 9606.ENSP00000391447; -.
DR   CarbonylDB; Q76L83; -.
DR   iPTMnet; Q76L83; -.
DR   PhosphoSitePlus; Q76L83; -.
DR   BioMuta; ASXL2; -.
DR   DMDM; 74712929; -.
DR   EPD; Q76L83; -.
DR   jPOST; Q76L83; -.
DR   MaxQB; Q76L83; -.
DR   PaxDb; Q76L83; -.
DR   PeptideAtlas; Q76L83; -.
DR   PRIDE; Q76L83; -.
DR   ProteomicsDB; 68680; -.
DR   ProteomicsDB; 68681; -. [Q76L83-2]
DR   DNASU; 55252; -.
DR   Ensembl; ENST00000404843; ENSP00000383920; ENSG00000143970. [Q76L83-2]
DR   Ensembl; ENST00000435504; ENSP00000391447; ENSG00000143970. [Q76L83-1]
DR   GeneID; 55252; -.
DR   KEGG; hsa:55252; -.
DR   UCSC; uc002rgt.2; human. [Q76L83-1]
DR   CTD; 55252; -.
DR   DisGeNET; 55252; -.
DR   EuPathDB; HostDB:ENSG00000143970.16; -.
DR   GeneCards; ASXL2; -.
DR   HGNC; HGNC:23805; ASXL2.
DR   HPA; HPA034646; -.
DR   HPA; HPA058040; -.
DR   MalaCards; ASXL2; -.
DR   MIM; 612991; gene.
DR   MIM; 617190; phenotype.
DR   neXtProt; NX_Q76L83; -.
DR   OpenTargets; ENSG00000143970; -.
DR   PharmGKB; PA134884863; -.
DR   eggNOG; ENOG410IIF3; Eukaryota.
DR   eggNOG; ENOG4111F3G; LUCA.
DR   GeneTree; ENSGT00520000055578; -.
DR   HOVERGEN; HBG106941; -.
DR   InParanoid; Q76L83; -.
DR   KO; K11471; -.
DR   OMA; FNFTHSG; -.
DR   OrthoDB; 123355at2759; -.
DR   PhylomeDB; Q76L83; -.
DR   TreeFam; TF328464; -.
DR   Reactome; R-HSA-5689603; UCH proteinases.
DR   ChiTaRS; ASXL2; human.
DR   GenomeRNAi; 55252; -.
DR   PRO; PR:Q76L83; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000143970; Expressed in 238 organ(s), highest expression level in colon.
DR   ExpressionAtlas; Q76L83; baseline and differential.
DR   Genevisible; Q76L83; HS.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0035517; C:PR-DUB complex; IBA:GO_Central.
DR   GO; GO:0003682; F:chromatin binding; IBA:GO_Central.
DR   GO; GO:0003677; F:DNA binding; IEA:InterPro.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0042975; F:peroxisome proliferator activated receptor binding; IDA:UniProtKB.
DR   GO; GO:0009887; P:animal organ morphogenesis; IBA:GO_Central.
DR   GO; GO:0045600; P:positive regulation of fat cell differentiation; IDA:UniProtKB.
DR   GO; GO:0035360; P:positive regulation of peroxisome proliferator activated receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:UniProtKB.
DR   GO; GO:0016579; P:protein deubiquitination; TAS:Reactome.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:InterPro.
DR   InterPro; IPR026905; ASX-like_PHD.
DR   InterPro; IPR024811; ASX/ASX-like.
DR   InterPro; IPR028020; ASXH.
DR   InterPro; IPR024817; ASXL2.
DR   InterPro; IPR007759; HB1/Asxl_HTH.
DR   PANTHER; PTHR13578; PTHR13578; 1.
DR   PANTHER; PTHR13578:SF11; PTHR13578:SF11; 1.
DR   Pfam; PF13919; ASXH; 1.
DR   Pfam; PF05066; HARE-HTH; 1.
DR   Pfam; PF13922; PHD_3; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Chromosomal rearrangement; Complete proteome;
KW   Mental retardation; Metal-binding; Methylation; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome; Repeat; Repressor;
KW   Transcription; Transcription regulation; Zinc; Zinc-finger.
FT   CHAIN         1   1435       Putative Polycomb group protein ASXL2.
FT                                /FTId=PRO_0000313826.
FT   ZN_FING    1397   1434       PHD-type; atypical.
FT   MOTIF       174    178       Nuclear localization signal.
FT                                {ECO:0000255}.
FT   MOTIF       303    307       LXXLL motif 1.
FT   MOTIF       887    891       LXXLL motif 2.
FT   COMPBIAS     95    235       Ser-rich.
FT   COMPBIAS    303    307       Poly-Leu.
FT   COMPBIAS    654    684       Ala-rich.
FT   COMPBIAS    687    739       Gly-rich.
FT   COMPBIAS   1173   1176       Poly-Ser.
FT   SITE         20     21       Breakpoint for translocation to form
FT                                KAT6A-ASXL2 protein.
FT   MOD_RES     146    146       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     524    524       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     562    562       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     571    571       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     600    600       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     637    637       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     641    641       Asymmetric dimethylarginine.
FT                                {ECO:0000250|UniProtKB:Q8BZ32}.
FT   MOD_RES     648    648       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1319   1319       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1    260       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_030163.
FT   VAR_SEQ     838   1094       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_030164.
FT   VARIANT     731    731       L -> P (in dbSNP:rs13385963).
FT                                /FTId=VAR_037773.
FT   VARIANT     796    796       A -> V (in dbSNP:rs17854251).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_037774.
FT   VARIANT    1210   1210       T -> P (in dbSNP:rs12991178).
FT                                /FTId=VAR_037775.
FT   VARIANT    1242   1242       T -> P (in dbSNP:rs12990978).
FT                                /FTId=VAR_037776.
FT   CONFLICT    473    473       E -> G (in Ref. 3; CAI45930).
FT                                {ECO:0000305}.
FT   CONFLICT    651    651       R -> K (in Ref. 3; CAI45930).
FT                                {ECO:0000305}.
FT   CONFLICT   1334   1334       S -> P (in Ref. 7; BAA91889).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1435 AA;  153820 MW;  A01026E3C2D1035D CRC64;
     MREKGRRKKG RTWAEAAKTV LEKYPNTPMS HKEILQVIQR EGLKEIRSGT SPLACLNAML
     HTNSRGEEGI FYKVPGRMGV YTLKKDVPDG VKELSEGSEE SSDGQSDSQS SENSSSSSDG
     GSNKEGKKSR WKRKVSSSSP QSGCPSPTIP AGKVISPSQK HSKKALKQAL KQQQQKKQQQ
     QCRPSISISS NQHLSLKTVK AASDSVPAKP ATWEGKQSDG QTGSPQNSNS SFSSSVKVEN
     TLLGLGKKSF QRSERLHTRQ MKRTKCADID VETPDSILVN TNLRALINKH TFSVLPGDCQ
     QRLLLLLPEV DRQVGPDGLM KLNGSALNNE FFTSAAQGWK ERLSEGEFTP EMQVRIRQEI
     EKEKKVEPWK EQFFESYYGQ SSGLSLEDSK KLTASPSDPK VKKTPAEQPK SMPVSEASLI
     RIVPVVSQSE CKEEALQMSS PGRKEECESQ GEVQPNFSTS SEPLLSSALN THELSSILPI
     KCPKDEDLLE QKPVTSAEQE SEKNHLTTAS NYNKSESQES LVTSPSKPKS PGVEKPIVKP
     TAGAGPQETN MKEPLATLVD QSPESLKRKS SLTQEEAPVS WEKRPRVTEN RQHQQPFQVS
     PQPFLNRGDR IQVRKVPPLK IPVSRISPMP FHPSQVSPRA RFPVSITSPN RTGARTLADI
     KAKAQLVKAQ RAAAAAAAAA AAAASVGGTI PGPGPGGGQG PGEGGEGQTA RGGSPGSDRV
     SETGKGPTLE LAGTGSRGGT RELLPCGPET QPQSETKTTP SQAQPHSVSG AQLQQTPPVP
     PTPAVSGACT SVPSPAHIEK LDNEKLNPTR ATATVASVSH PQGPSSCRQE KAPSPTGPAL
     ISGASPVHCA ADGTVELKAG PSKNIPNPSA SSKTDASVPV AVTPSPLTSL LTTATLEKLP
     VPQVSATTAP AGSAPPSSTL PAASSLKTPG TSLNMNGPTL RPTSSIPANN PLVTQLLQGK
     DVPMEQILPK PLTKVEMKTV PLTAKEERGM GALIATNTTE NSTREEVNER QSHPATQQQL
     GKTLQSKQLP QVPRPLQLFS AKELRDSSID THQYHEGLSK ATQDQILQTL IQRVRRQNLL
     SVVPPSQFNF AHSGFQLEDI STSQRFMLGF AGRRTSKPAM AGHYLLNIST YGRGSESFRR
     THSVNPEDRF CLSSPTEALK MGYTDCKNAT GESSSSKEDD TDEESTGDEQ ESVTVKEEPQ
     VSQSAGKGDT SSGPHSRETL STSDCLASKN VKAEIPLNEQ TTLSKENYLF TRGQTFDEKT
     LARDLIQAAQ KQMAHAVRGK AIRSSPELFS STVLPLPADS PTHQPLLLPP LQTPKLYGSP
     TQIGPSYRGM INVSTSSDMD HNSAVPGSQV SSNVGDVMSF SVTVTTIPAS QAMNPSSHGQ
     TIPVQAFSEE NSIEGTPSKC YCRLKAMIMC KGCGAFCHDD CIGPSKLCVS CLVVR
//
ID   BAZ1A_HUMAN             Reviewed;        1556 AA.
AC   Q9NRL2; Q9NZ15; Q9P065; Q9UIG1; Q9Y3V3;
DT   30-AUG-2002, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 2.
DT   13-FEB-2019, entry version 188.
DE   RecName: Full=Bromodomain adjacent to zinc finger domain protein 1A;
DE   AltName: Full=ATP-dependent chromatin-remodeling protein;
DE   AltName: Full=ATP-utilizing chromatin assembly and remodeling factor 1;
DE            Short=hACF1;
DE   AltName: Full=CHRAC subunit ACF1;
DE   AltName: Full=Williams syndrome transcription factor-related chromatin-remodeling factor 180;
DE            Short=WCRF180;
DE   AltName: Full=hWALp1;
GN   Name=BAZ1A; Synonyms=ACF1, WCRF180; ORFNames=HSPC317;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), IDENTIFICATION BY MASS
RP   SPECTROMETRY, IDENTIFICATION IN THE CHRAC COMPLEX, AND VARIANT
RP   LYS-1366.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=10880450; DOI=10.1093/emboj/19.13.3377;
RA   Poot R.A., Dellaire G., Huelsmann B.B., Grimaldi M.A., Corona D.F.V.,
RA   Becker P.B., Bickmore W.A., Varga-Weisz P.D.;
RT   "HuCHRAC, a human ISWI chromatin remodelling complex contains hACF1
RT   and two novel histone-fold proteins.";
RL   EMBO J. 19:3377-3387(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=10655480; DOI=10.1073/pnas.97.3.1038;
RA   Bochar D.A., Savard J., Wang W., Lafleur D.W., Moore P., Cote J.,
RA   Shiekhattar R.;
RT   "A family of chromatin remodeling factors related to Williams syndrome
RT   transcription factor.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:1038-1043(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=10662543; DOI=10.1006/geno.1999.6071;
RA   Jones M.H., Hamana N., Nezu J., Shimane M.;
RT   "A novel family of bromodomain genes.";
RL   Genomics 63:40-45(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S.,
RA   Sun H., Du H., Pepin K., Artiguenave F., Robert C., Cruaud C.,
RA   Bruels T., Jaillon O., Friedlander L., Samson G., Brottier P.,
RA   Cure S., Segurens B., Aniere F., Samain S., Crespeau H., Abbasi N.,
RA   Aiach N., Boscus D., Dickhoff R., Dors M., Dubois I., Friedman C.,
RA   Gouyvenoux M., James R., Madan A., Mairey-Estrada B., Mangenot S.,
RA   Martins N., Menard M., Oztas S., Ratcliffe A., Shaffer T., Trask B.,
RA   Vacherie B., Bellemere C., Belser C., Besnard-Gonnet M.,
RA   Bartol-Mavel D., Boutard M., Briez-Silla S., Combette S.,
RA   Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C., Muselet D.,
RA   Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P., Trybou A.,
RA   Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L.,
RA   Verdier J., Verdier-Discala C., Hillier L.W., Fulton L., McPherson J.,
RA   Matsuda F., Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W.,
RA   Quetier F., Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-540 (ISOFORM 1).
RC   TISSUE=Umbilical cord blood;
RA   Ye M., Zhang Q.-H., Zhou J., Shen Y., Wu X.-Y., Guan Z.Q., Wang L.,
RA   Fan H.-Y., Mao Y.-F., Dai M., Huang Q.-H., Chen S.-J., Chen Z.;
RT   "Human partial CDS from CD34+ stem cells.";
RL   Submitted (MAY-1999) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 746-1556 (ISOFORM 1), AND
RP   VARIANT LYS-1366.
RC   TISSUE=Uterus;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [8]
RP   FUNCTION, AND INTERACTION WITH SMARCA5 IN THE AFC COMPLEX.
RX   PubMed=12434153; DOI=10.1038/ng1046;
RA   Collins N., Poot R.A., Kukimoto I., Garcia-Jimenez C., Dellaire G.,
RA   Varga-Weisz P.D.;
RT   "An ACF1-ISWI chromatin-remodeling complex is required for DNA
RT   replication through heterochromatin.";
RL   Nat. Genet. 32:627-632(2002).
RN   [9]
RP   ASSOCIATION WITH THE CHRAC1/POLE3 COMPLEX, AND FUNCTION OF THE CHRAC
RP   COMPLEX.
RX   PubMed=14759371; DOI=10.1016/S1097-2765(03)00523-9;
RA   Kukimoto I., Elderkin S., Grimaldi M., Oelgeschlager T.,
RA   Varga-Weisz P.D.;
RT   "The histone-fold protein complex CHRAC-15/17 enhances nucleosome
RT   sliding and assembly mediated by ACF.";
RL   Mol. Cell 13:265-277(2004).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1413 AND SER-1417, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [11]
RP   FUNCTION OF ACF COMPLEX.
RX   PubMed=17099699; DOI=10.1038/nsmb1170;
RA   Yang J.G., Madrid T.S., Sevastopoulos E., Narlikar G.J.;
RT   "The chromatin-remodeling enzyme ACF is an ATP-dependent DNA length
RT   sensor that regulates nucleosome spacing.";
RL   Nat. Struct. Mol. Biol. 13:1078-1083(2006).
RN   [12]
RP   INTERACTION WITH NCOR1, AND POSSIBLE FUNCTION.
RX   PubMed=17519354; DOI=10.1210/me.2007-0095;
RA   Ewing A.K., Attner M., Chakravarti D.;
RT   "Novel regulatory role for human Acf1 in transcriptional repression of
RT   vitamin D3 receptor-regulated genes.";
RL   Mol. Endocrinol. 21:1791-1806(2007).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1402; SER-1413 AND
RP   SER-1417, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-270 AND SER-702, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-270; SER-1371 AND
RP   SER-1402, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-731; SER-1281 AND
RP   SER-1413, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-731; SER-961; SER-1281;
RP   SER-1320; SER-1363; SER-1413; SER-1417 AND THR-1547, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [19]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-952, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: Component of the ACF complex, an ATP-dependent chromatin
CC       remodeling complex, that regulates spacing of nucleosomes using
CC       ATP to generate evenly spaced nucleosomes along the chromatin. The
CC       ATPase activity of the complex is regulated by the length of
CC       flanking DNA. Also involved in facilitating the DNA replication
CC       process. BAZ1A is the accessory, non-catalytic subunit of the
CC       complex which can enhance and direct the process provided by the
CC       ATPase subunit, SMARCA5, probably through targeting
CC       pericentromeric heterochromatin in late S phase. Moves end-
CC       positioned nucleosomes to a predominantly central position. May
CC       have a role in nuclear receptor-mediated transcription repression.
CC   -!- FUNCTION: Component of the histone-fold protein complex CHRAC
CC       complex which facilitates nucleosome sliding by the ACF complex
CC       and enhances ACF-mediated chromatin assembly. The C-terminal
CC       regions of both CHRAC1 and POLE1 are required for these functions.
CC   -!- SUBUNIT: Component of the ACF chromatin remodeling complex that
CC       includes BAZ1A and SMARCA5. Additional this complex can form,
CC       together with CHRAC1 and POLE1, the histone-fold protein complex,
CC       CHRAC. Interacts with NCOR1 (via its RD1 domain); the interaction
CC       corepresses a number of NCOR1-regulated genes.
CC       {ECO:0000269|PubMed:10880450, ECO:0000269|PubMed:12434153,
CC       ECO:0000269|PubMed:17519354}.
CC   -!- INTERACTION:
CC       P42858:HTT; NbExp=4; IntAct=EBI-927511, EBI-466029;
CC       O60264:SMARCA5; NbExp=3; IntAct=EBI-927511, EBI-352588;
CC       O95365:ZBTB7A; NbExp=2; IntAct=EBI-927511, EBI-2795384;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Note=May target the CHRAC complex
CC       to heterochromatin.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9NRL2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NRL2-2; Sequence=VSP_000551;
CC   -!- TISSUE SPECIFICITY: Highly expressed in testis and at low or
CC       undetectable levels in other tissues analyzed.
CC   -!- MISCELLANEOUS: Stimulated by double-stranded DNA and nucleosomal
CC       DNA.
CC   -!- SIMILARITY: Belongs to the WAL family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAF28995.1; Type=Frameshift; Positions=Several; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AF213467; AAF70601.1; -; mRNA.
DR   EMBL; AF221130; AAF32366.1; -; mRNA.
DR   EMBL; AB032252; BAA89209.1; -; mRNA.
DR   EMBL; AL121603; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL355885; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471078; EAW65900.1; -; Genomic_DNA.
DR   EMBL; AF161435; AAF28995.1; ALT_FRAME; mRNA.
DR   EMBL; AL050089; CAB43261.1; -; mRNA.
DR   CCDS; CCDS41943.1; -. [Q9NRL2-2]
DR   CCDS; CCDS9651.1; -. [Q9NRL2-1]
DR   PIR; T08738; T08738.
DR   RefSeq; NP_038476.2; NM_013448.2. [Q9NRL2-1]
DR   RefSeq; NP_872589.1; NM_182648.1. [Q9NRL2-2]
DR   UniGene; Hs.509140; -.
DR   PDB; 5UIY; X-ray; 1.69 A; A/B/C/D=1425-1538.
DR   PDBsum; 5UIY; -.
DR   ProteinModelPortal; Q9NRL2; -.
DR   SMR; Q9NRL2; -.
DR   BioGrid; 116347; 38.
DR   ComplexPortal; CPX-434; ACF complex.
DR   ComplexPortal; CPX-785; CHRAC chromatin remodeling complex.
DR   CORUM; Q9NRL2; -.
DR   DIP; DIP-36071N; -.
DR   IntAct; Q9NRL2; 32.
DR   MINT; Q9NRL2; -.
DR   STRING; 9606.ENSP00000353458; -.
DR   iPTMnet; Q9NRL2; -.
DR   PhosphoSitePlus; Q9NRL2; -.
DR   BioMuta; BAZ1A; -.
DR   DMDM; 116241266; -.
DR   EPD; Q9NRL2; -.
DR   jPOST; Q9NRL2; -.
DR   MaxQB; Q9NRL2; -.
DR   PaxDb; Q9NRL2; -.
DR   PeptideAtlas; Q9NRL2; -.
DR   PRIDE; Q9NRL2; -.
DR   ProteomicsDB; 82383; -.
DR   ProteomicsDB; 82384; -. [Q9NRL2-2]
DR   Ensembl; ENST00000358716; ENSP00000351555; ENSG00000198604. [Q9NRL2-2]
DR   Ensembl; ENST00000360310; ENSP00000353458; ENSG00000198604. [Q9NRL2-1]
DR   Ensembl; ENST00000382422; ENSP00000371859; ENSG00000198604. [Q9NRL2-1]
DR   GeneID; 11177; -.
DR   KEGG; hsa:11177; -.
DR   UCSC; uc001wsk.4; human. [Q9NRL2-1]
DR   CTD; 11177; -.
DR   DisGeNET; 11177; -.
DR   EuPathDB; HostDB:ENSG00000198604.10; -.
DR   GeneCards; BAZ1A; -.
DR   H-InvDB; HIX0037904; -.
DR   HGNC; HGNC:960; BAZ1A.
DR   HPA; HPA002730; -.
DR   MIM; 605680; gene.
DR   neXtProt; NX_Q9NRL2; -.
DR   OpenTargets; ENSG00000198604; -.
DR   PharmGKB; PA25270; -.
DR   eggNOG; KOG1245; Eukaryota.
DR   eggNOG; COG5076; LUCA.
DR   GeneTree; ENSGT00940000158135; -.
DR   HOGENOM; HOG000095179; -.
DR   HOVERGEN; HBG080889; -.
DR   InParanoid; Q9NRL2; -.
DR   KO; K11655; -.
DR   OMA; YYVLESM; -.
DR   OrthoDB; 858930at2759; -.
DR   PhylomeDB; Q9NRL2; -.
DR   TreeFam; TF316326; -.
DR   ChiTaRS; BAZ1A; human.
DR   GenomeRNAi; 11177; -.
DR   PRO; PR:Q9NRL2; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; ENSG00000198604; Expressed in 222 organ(s), highest expression level in oocyte.
DR   ExpressionAtlas; Q9NRL2; baseline and differential.
DR   Genevisible; Q9NRL2; HS.
DR   GO; GO:0016590; C:ACF complex; TAS:BHF-UCL.
DR   GO; GO:0008623; C:CHRAC; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006338; P:chromatin remodeling; TAS:BHF-UCL.
DR   GO; GO:0006261; P:DNA-dependent DNA replication; IDA:UniProtKB.
DR   GO; GO:0016573; P:histone acetylation; IEA:GOC.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; NAS:BHF-UCL.
DR   CDD; cd05504; Bromo_Acf1_like; 1.
DR   Gene3D; 1.20.920.10; -; 1.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR037325; Acf1_Bromo.
DR   InterPro; IPR001487; Bromodomain.
DR   InterPro; IPR036427; Bromodomain-like_sf.
DR   InterPro; IPR018359; Bromodomain_CS.
DR   InterPro; IPR018501; DDT_dom.
DR   InterPro; IPR028942; WHIM1_dom.
DR   InterPro; IPR028941; WHIM2_dom.
DR   InterPro; IPR013136; WSTF_Acf1_Cbp146.
DR   InterPro; IPR019786; Zinc_finger_PHD-type_CS.
DR   InterPro; IPR011011; Znf_FYVE_PHD.
DR   InterPro; IPR001965; Znf_PHD.
DR   InterPro; IPR019787; Znf_PHD-finger.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   Pfam; PF00439; Bromodomain; 1.
DR   Pfam; PF02791; DDT; 1.
DR   Pfam; PF00628; PHD; 1.
DR   Pfam; PF10537; WAC_Acf1_DNA_bd; 1.
DR   Pfam; PF15612; WHIM1; 1.
DR   Pfam; PF15613; WSD; 1.
DR   PRINTS; PR00503; BROMODOMAIN.
DR   SMART; SM00297; BROMO; 1.
DR   SMART; SM00571; DDT; 1.
DR   SMART; SM00249; PHD; 1.
DR   SUPFAM; SSF47370; SSF47370; 1.
DR   SUPFAM; SSF57903; SSF57903; 1.
DR   PROSITE; PS00633; BROMODOMAIN_1; 1.
DR   PROSITE; PS50014; BROMODOMAIN_2; 1.
DR   PROSITE; PS50827; DDT; 1.
DR   PROSITE; PS51136; WAC; 1.
DR   PROSITE; PS01359; ZF_PHD_1; 1.
DR   PROSITE; PS50016; ZF_PHD_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Bromodomain; Coiled coil;
KW   Complete proteome; Isopeptide bond; Metal-binding; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome; Transcription;
KW   Transcription regulation; Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN         1   1556       Bromodomain adjacent to zinc finger
FT                                domain protein 1A.
FT                                /FTId=PRO_0000211167.
FT   DOMAIN       22    128       WAC. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00475}.
FT   DOMAIN      422    487       DDT. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00063}.
FT   DOMAIN     1446   1516       Bromo. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00035}.
FT   ZN_FING    1148   1198       PHD-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00146}.
FT   REGION        1    133       Required for interaction with NCOR1.
FT                                {ECO:0000269|PubMed:17519354}.
FT   REGION        1    128       Required for association with the
FT                                CHRAC1/POLE3 complex.
FT   REGION      667    933       Interaction with SMARCA5.
FT   COILED      306    397       {ECO:0000255}.
FT   COILED      634    709       {ECO:0000255}.
FT   COMPBIAS    487    491       Poly-Glu.
FT   COMPBIAS   1239   1257       Glu-rich.
FT   MOD_RES     270    270       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES     702    702       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     731    731       Phosphothreonine.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     960    960       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O88379}.
FT   MOD_RES     961    961       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1281   1281       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1320   1320       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1339   1339       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O88379}.
FT   MOD_RES    1353   1353       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O88379}.
FT   MOD_RES    1363   1363       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1371   1371       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES    1402   1402       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES    1413   1413       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1417   1417       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1547   1547       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   CROSSLNK    952    952       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   VAR_SEQ     504    535       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:10655480}.
FT                                /FTId=VSP_000551.
FT   VARIANT     344    344       D -> E (in dbSNP:rs1133285).
FT                                /FTId=VAR_028049.
FT   VARIANT    1366   1366       N -> K (in dbSNP:rs1044140).
FT                                {ECO:0000269|PubMed:10880450,
FT                                ECO:0000269|PubMed:17974005}.
FT                                /FTId=VAR_048423.
FT   CONFLICT    135    135       R -> T (in Ref. 3; BAA89209).
FT                                {ECO:0000305}.
FT   CONFLICT    236    236       D -> E (in Ref. 3; BAA89209).
FT                                {ECO:0000305}.
FT   CONFLICT    494    494       K -> Q (in Ref. 6; AAF28995).
FT                                {ECO:0000305}.
FT   CONFLICT    503    508       KDLTEA -> QDFTEP (in Ref. 6; AAF28995).
FT                                {ECO:0000305}.
FT   CONFLICT    525    525       S -> P (in Ref. 6; AAF28995).
FT                                {ECO:0000305}.
FT   CONFLICT    536    540       GCSLK -> AALKF (in Ref. 6; AAF28995).
FT                                {ECO:0000305}.
FT   CONFLICT    551    551       E -> D (in Ref. 1; AAF70601).
FT                                {ECO:0000305}.
FT   CONFLICT    730    730       V -> F (in Ref. 3; BAA89209).
FT                                {ECO:0000305}.
FT   CONFLICT    769    769       P -> L (in Ref. 3; BAA89209).
FT                                {ECO:0000305}.
FT   CONFLICT   1201   1201       S -> C (in Ref. 3; BAA89209).
FT                                {ECO:0000305}.
FT   CONFLICT   1206   1206       S -> F (in Ref. 3; BAA89209).
FT                                {ECO:0000305}.
FT   CONFLICT   1409   1409       R -> K (in Ref. 1; AAF70601 and 7;
FT                                CAB43261). {ECO:0000305}.
FT   HELIX      1436   1447       {ECO:0000244|PDB:5UIY}.
FT   HELIX      1449   1454       {ECO:0000244|PDB:5UIY}.
FT   TURN       1460   1462       {ECO:0000244|PDB:5UIY}.
FT   HELIX      1466   1469       {ECO:0000244|PDB:5UIY}.
FT   HELIX      1476   1484       {ECO:0000244|PDB:5UIY}.
FT   HELIX      1491   1508       {ECO:0000244|PDB:5UIY}.
FT   HELIX      1514   1532       {ECO:0000244|PDB:5UIY}.
SQ   SEQUENCE   1556 AA;  178702 MW;  4D78B9A8ADBF715B CRC64;
     MPLLHRKPFV RQKPPADLRP DEEVFYCKVT NEIFRHYDDF FERTILCNSL VWSCAVTGRP
     GLTYQEALES EKKARQNLQS FPEPLIIPVL YLTSLTHRSR LHEICDDIFA YVKDRYFVEE
     TVEVIRNNGA RLQCRILEVL PPSHQNGFAN GHVNSVDGET IIISDSDDSE TQSCSFQNGK
     KKDAIDPLLF KYKVQPTKKE LHESAIVKAT QISRRKHLFS RDKLKLFLKQ HCEPQDGVIK
     IKASSLSTYK IAEQDFSYFF PDDPPTFIFS PANRRRGRPP KRIHISQEDN VANKQTLASY
     RSKATKERDK LLKQEEMKSL AFEKAKLKRE KADALEAKKK EKEDKEKKRE ELKKIVEEER
     LKKKEEKERL KVEREKEREK LREEKRKYVE YLKQWSKPRE DMECDDLKEL PEPTPVKTRL
     PPEIFGDALM VLEFLNAFGE LFDLQDEFPD GVTLEVLEEA LVGNDSEGPL CELLFFFLTA
     IFQAIAEEEE EVAKEQLTDA DTKDLTEALD EDADPTKSAL SAVASLAAAW PQLHQGCSLK
     SLDLDSCTLS EILRLHILAS GADVTSANAK YRYQKRGGFD ATDDACMELR LSNPSLVKKL
     SSTSVYDLTP GEKMKILHAL CGKLLTLVST RDFIEDYVDI LRQAKQEFRE LKAEQHRKER
     EEAAARIRKR KEEKLKEQEQ KMKEKQEKLK EDEQRNSTAD ISIGEEERED FDTSIESKDT
     EQKELDQDMV TEDEDDPGSH KRGRRGKRGQ NGFKEFTRQE QINCVTREPL TADEEEALKQ
     EHQRKEKELL EKIQSAIACT NIFPLGRDRM YRRYWIFPSI PGLFIEEDYS GLTEDMLLPR
     PSSFQNNVQS QDPQVSTKTG EPLMSESTSN IDQGPRDHSV QLPKPVHKPN RWCFYSSCEQ
     LDQLIEALNS RGHRESALKE TLLQEKSRIC AQLARFSEEK FHFSDKPQPD SKPTYSRGRS
     SNAYDPSQMC AEKQLELRLR DFLLDIEDRI YQGTLGAIKV TDRHIWRSAL ESGRYELLSE
     ENKENGIIKT VNEDVEEMEI DEQTKVIVKD RLLGIKTETP STVSTNASTP QSVSSVVHYL
     AMALFQIEQG IERRFLKAPL DASDSGRSYK TVLDRWRESL LSSASLSQVF LHLSTLDRSV
     IWSKSILNAR CKICRKKGDA ENMVLCDGCD RGHHTYCVRP KLKTVPEGDW FCPECRPKQR
     SRRLSSRQRP SLESDEDVED SMGGEDDEVD GDEEEGQSEE EEYEVEQDED DSQEEEEVSL
     PKRGRPQVRL PVKTRGKLSS SFSSRGQQQE PGRYPSRSQQ STPKTTVSSK TGRSLRKINS
     APPTETKSLR IASRSTRHSH GPLQADVFVE LLSPRRKRRG RKSANNTPEN SPNFPNFRVI
     ATKSSEQSRS VNIASKLSLQ ESESKRRCRK RQSPEPSPVT LGRRSSGRQG GVHELSAFEQ
     LVVELVRHDD SWPFLKLVSK IQVPDYYDII KKPIALNIIR EKVNKCEYKL ASEFIDDIEL
     MFSNCFEYNP RNTSEAKAGT RLQAFFHIQA QKLGLHVTPS NVDQVSTPPA AKKSRI
//
ID   CASP3_HUMAN             Reviewed;         277 AA.
AC   P42574; A8K5M2; D3DP53; Q96AN1; Q96KP2;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   11-OCT-2005, sequence version 2.
DT   13-FEB-2019, entry version 219.
DE   RecName: Full=Caspase-3;
DE            Short=CASP-3;
DE            EC=3.4.22.56;
DE   AltName: Full=Apopain;
DE   AltName: Full=Cysteine protease CPP32;
DE            Short=CPP-32;
DE   AltName: Full=Protein Yama;
DE   AltName: Full=SREBP cleavage activity 1;
DE            Short=SCA-1;
DE   Contains:
DE     RecName: Full=Caspase-3 subunit p17;
DE   Contains:
DE     RecName: Full=Caspase-3 subunit p12;
DE   Flags: Precursor;
GN   Name=CASP3; Synonyms=CPP32;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT ASP-190.
RC   TISSUE=T-cell;
RX   PubMed=7983002;
RA   Fernandes-Alnemri T., Litwack G., Alnemri E.S.;
RT   "CPP32, a novel human apoptotic protein with homology to
RT   Caenorhabditis elegans cell death protein Ced-3 and mammalian
RT   interleukin-1 beta-converting enzyme.";
RL   J. Biol. Chem. 269:30761-30764(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=7774019; DOI=10.1016/0092-8674(95)90541-3;
RA   Tewari M., Quan L.T., O'Rourke K., Desnoyers S., Zeng Z.,
RA   Beidler D.R., Poirier G.G., Salvesen G.S., Dixit V.M.;
RT   "Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable
RT   protease that cleaves the death substrate poly(ADP-ribose)
RT   polymerase.";
RL   Cell 81:801-809(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT ASP-190.
RX   PubMed=15003516; DOI=10.1016/j.bbrc.2004.02.021;
RA   Pelletier M., Cartron P.F., Delaval F., Meflah K., Vallette F.M.,
RA   Oliver L.;
RT   "Caspase 3 activation is controlled by a sequence located in the N-
RT   terminus of its large subunit.";
RL   Biochem. Biophys. Res. Commun. 316:93-99(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NIEHS SNPs program;
RL   Submitted (JAN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PROTEIN SEQUENCE OF 29-46 AND 176-193, FUNCTION, AND VARIANT ASP-190.
RX   PubMed=7596430; DOI=10.1038/376037a0;
RA   Nicholson D.W., Ali A., Thornberry N.A., Vaillancourt J.P., Ding C.K.,
RA   Gallant M., Gareau Y., Griffin P.R., Labelle M., Lazebnik Y.A.,
RA   Munday N.A., Raju S.M., Smulson M.E., Yamin T.-T., Li V.L.,
RA   Miller D.K.;
RT   "Identification and inhibition of the ICE/CED-3 protease necessary for
RT   mammalian apoptosis.";
RL   Nature 376:37-43(1995).
RN   [9]
RP   PROTEOLYTIC PROCESSING.
RX   PubMed=8755496; DOI=10.1073/pnas.93.15.7464;
RA   Fernandes-Alnemri T., Armstrong R.C., Krebs J.F., Srinivasula S.M.,
RA   Wang L., Bullrich F., Fritz L.C., Trapani J.A., Tomaselli K.J.,
RA   Litwack G., Alnemri E.S.;
RT   "In vitro activation of CPP32 and Mch3 by Mch4, a novel human
RT   apoptotic cysteine protease containing two FADD-like domains.";
RL   Proc. Natl. Acad. Sci. U.S.A. 93:7464-7469(1996).
RN   [10]
RP   CLEAVAGE OF HUNTINGTIN.
RX   PubMed=8696339; DOI=10.1038/ng0896-442;
RA   Goldberg Y.P., Nicholson D.W., Rasper D.M., Kalchman M.A., Koide H.B.,
RA   Graham R.K., Bromm M., Kazemi-Esfarjani P., Thornberry N.A.,
RA   Vaillancourt J.P., Hayden M.R.;
RT   "Cleavage of huntingtin by apopain, a proapoptotic cysteine protease,
RT   is modulated by the polyglutamine tract.";
RL   Nat. Genet. 13:442-449(1996).
RN   [11]
RP   S-NITROSYLATION AT CYS-163.
RX   PubMed=10213689; DOI=10.1126/science.284.5414.651;
RA   Mannick J.B., Hausladen A., Liu L., Hess D.T., Zeng M., Miao Q.X.,
RA   Kane L.S., Gow A.J., Stamler J.S.;
RT   "Fas-induced caspase denitrosylation.";
RL   Science 284:651-654(1999).
RN   [12]
RP   INTERACTION WITH BIRC6/BRUCE.
RX   PubMed=15200957; DOI=10.1016/j.molcel.2004.05.018;
RA   Bartke T., Pohl C., Pyrowolakis G., Jentsch S.;
RT   "Dual role of BRUCE as an antiapoptotic IAP and a chimeric E2/E3
RT   ubiquitin ligase.";
RL   Mol. Cell 14:801-811(2004).
RN   [13]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   FUNCTION IN CELL ADHESION.
RX   PubMed=21357690; DOI=10.1074/jbc.M110.195461;
RA   Cabrera J.R., Bouzas-Rodriguez J., Tauszig-Delamasure S., Mehlen P.;
RT   "RET modulates cell adhesion via its cleavage by caspase in
RT   sympathetic neurons.";
RL   J. Biol. Chem. 286:14628-14638(2011).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-26, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 28-277.
RX   PubMed=8673606; DOI=10.1038/nsb0796-619;
RA   Rotonda J., Nicholson D.W., Fazil K.M., Gallant M., Gareau Y.,
RA   Labelle M., Peterson E.P., Rasper D.M., Ruel R., Vaillancourt J.P.,
RA   Thornberry N.A., Becker J.W.;
RT   "The three-dimensional structure of apopain/CPP32, a key mediator of
RT   apoptosis.";
RL   Nat. Struct. Biol. 3:619-625(1996).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 35-173 AND 185-277.
RX   PubMed=9045680; DOI=10.1074/jbc.272.10.6539;
RA   Mittl P.R.E., di Marco S., Krebs J.F., Bai X., Karanewsky D.S.,
RA   Priestle J.P., Tomaselli K.J., Gruetter M.G.;
RT   "Structure of recombinant human CPP32 in complex with the tetrapeptide
RT   acetyl-Asp-Val-Ala-Asp fluoromethyl ketone.";
RL   J. Biol. Chem. 272:6539-6547(1997).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS).
RX   PubMed=10821855; DOI=10.1074/jbc.275.21.16007;
RA   Lee D., Long S.A., Adams J.L., Chan G., Vaidya K.S., Francis T.A.,
RA   Kikly K., Winkler J.D., Sung C.-M., Debouck C., Richardson S.,
RA   Levy M.A., DeWolf W.E. Jr., Keller P.M., Tomaszek T., Head M.S.,
RA   Ryan M.D., Haltiwanger R.C., Liang P.-H., Janson C.A., McDevitt P.J.,
RA   Johanson K., Concha N.O., Chan W., Abdel-Meguid S.S., Badger A.M.,
RA   Lark M.W., Nadeau D.P., Suva L.J., Gowen M., Nuttall M.E.;
RT   "Potent and selective nonpeptide inhibitors of caspases 3 and 7
RT   inhibit apoptosis and maintain cell functionality.";
RL   J. Biol. Chem. 275:16007-16014(2000).
CC   -!- FUNCTION: Involved in the activation cascade of caspases
CC       responsible for apoptosis execution. At the onset of apoptosis it
CC       proteolytically cleaves poly(ADP-ribose) polymerase (PARP) at a
CC       '216-Asp-|-Gly-217' bond. Cleaves and activates sterol regulatory
CC       element binding proteins (SREBPs) between the basic helix-loop-
CC       helix leucine zipper domain and the membrane attachment domain.
CC       Cleaves and activates caspase-6, -7 and -9. Involved in the
CC       cleavage of huntingtin. Triggers cell adhesion in sympathetic
CC       neurons through RET cleavage. {ECO:0000269|PubMed:21357690,
CC       ECO:0000269|PubMed:7596430}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Strict requirement for an Asp residue at positions P1 and
CC         P4. It has a preferred cleavage sequence of Asp-Xaa-Xaa-
CC         Asp-|- with a hydrophobic amino-acid residue at P2 and a
CC         hydrophilic amino-acid residue at P3, although Val or Ala are
CC         also accepted at this position.; EC=3.4.22.56;
CC   -!- ACTIVITY REGULATION: Inhibited by isatin sulfonamides.
CC   -!- SUBUNIT: Heterotetramer that consists of two anti-parallel
CC       arranged heterodimers, each one formed by a 17 kDa (p17) and a 12
CC       kDa (p12) subunit. Interacts with BIRC6/bruce.
CC       {ECO:0000269|PubMed:15200957}.
CC   -!- INTERACTION:
CC       O43823:AKAP8; NbExp=5; IntAct=EBI-524064, EBI-1237481;
CC       Q9Y243:AKT3; NbExp=2; IntAct=EBI-524064, EBI-296115;
CC       P55212:CASP6; NbExp=2; IntAct=EBI-524064, EBI-718729;
CC       P55211:CASP9; NbExp=2; IntAct=EBI-524064, EBI-516799;
CC       Q00987:MDM2; NbExp=2; IntAct=EBI-524064, EBI-389668;
CC       P09874:PARP1; NbExp=2; IntAct=EBI-524064, EBI-355676;
CC       P10599:TXN; NbExp=6; IntAct=EBI-524064, EBI-594644;
CC       Q9BYP7:WNK3; NbExp=2; IntAct=EBI-524064, EBI-1182602;
CC       P98170:XIAP; NbExp=3; IntAct=EBI-524064, EBI-517127;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- TISSUE SPECIFICITY: Highly expressed in lung, spleen, heart, liver
CC       and kidney. Moderate levels in brain and skeletal muscle, and low
CC       in testis. Also found in many cell lines, highest expression in
CC       cells of the immune system.
CC   -!- PTM: Cleavage by granzyme B, caspase-6, caspase-8 and caspase-10
CC       generates the two active subunits. Additional processing of the
CC       propeptides is likely due to the autocatalytic activity of the
CC       activated protease. Active heterodimers between the small subunit
CC       of caspase-7 protease and the large subunit of caspase-3 also
CC       occur and vice versa.
CC   -!- PTM: S-nitrosylated on its catalytic site cysteine in unstimulated
CC       human cell lines and denitrosylated upon activation of the Fas
CC       apoptotic pathway, associated with an increase in intracellular
CC       caspase activity. Fas therefore activates caspase-3 not only by
CC       inducing the cleavage of the caspase zymogen to its active
CC       subunits, but also by stimulating the denitrosylation of its
CC       active site thiol. {ECO:0000269|PubMed:10213689}.
CC   -!- SIMILARITY: Belongs to the peptidase C14A family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/casp3/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; U13737; AAA65015.1; -; mRNA.
DR   EMBL; U13738; AAB60355.1; -; mRNA.
DR   EMBL; U26943; AAA74929.1; -; mRNA.
DR   EMBL; AJ413269; CAC88866.1; -; mRNA.
DR   EMBL; AK291337; BAF84026.1; -; mRNA.
DR   EMBL; AY219866; AAO25654.1; -; Genomic_DNA.
DR   EMBL; CH471056; EAX04673.1; -; Genomic_DNA.
DR   EMBL; CH471056; EAX04674.1; -; Genomic_DNA.
DR   EMBL; CH471056; EAX04675.1; -; Genomic_DNA.
DR   EMBL; BC016926; AAH16926.1; -; mRNA.
DR   CCDS; CCDS3836.1; -.
DR   PIR; A55315; A55315.
DR   RefSeq; NP_004337.2; NM_004346.3.
DR   RefSeq; NP_116786.1; NM_032991.2.
DR   RefSeq; XP_011530603.1; XM_011532301.1.
DR   UniGene; Hs.141125; -.
DR   PDB; 1CP3; X-ray; 2.30 A; A/B=1-277.
DR   PDB; 1GFW; X-ray; 2.80 A; A=29-175, B=181-277.
DR   PDB; 1I3O; X-ray; 2.70 A; A/C=1-175, B/D=176-277.
DR   PDB; 1NME; X-ray; 1.60 A; A=29-174, B=186-277.
DR   PDB; 1NMQ; X-ray; 2.40 A; A/B=29-277.
DR   PDB; 1NMS; X-ray; 1.70 A; A/B=29-277.
DR   PDB; 1PAU; X-ray; 2.50 A; A=29-175, B=176-277.
DR   PDB; 1QX3; X-ray; 1.90 A; A=29-277.
DR   PDB; 1RE1; X-ray; 2.50 A; A=29-175, B=176-277.
DR   PDB; 1RHJ; X-ray; 2.20 A; A/C=29-175, B/D=176-277.
DR   PDB; 1RHK; X-ray; 2.50 A; A=29-175, B=176-277.
DR   PDB; 1RHM; X-ray; 2.50 A; A/C=29-175, B/D=176-277.
DR   PDB; 1RHQ; X-ray; 3.00 A; A/D=29-175, B/E=176-277.
DR   PDB; 1RHR; X-ray; 3.00 A; A=29-175, B=176-277.
DR   PDB; 1RHU; X-ray; 2.51 A; A=29-175, B=176-277.
DR   PDB; 2C1E; X-ray; 1.77 A; A=29-175, B=176-277.
DR   PDB; 2C2K; X-ray; 1.87 A; A=29-175, B=176-277.
DR   PDB; 2C2M; X-ray; 1.94 A; A=29-175, B=176-277.
DR   PDB; 2C2O; X-ray; 2.45 A; A=29-175, B=176-277.
DR   PDB; 2CDR; X-ray; 1.70 A; A=29-175, B=176-277.
DR   PDB; 2CJX; X-ray; 1.70 A; A=29-175, B=176-277.
DR   PDB; 2CJY; X-ray; 1.67 A; A=29-175, B=176-277.
DR   PDB; 2CNK; X-ray; 1.75 A; A=29-175, B=176-277.
DR   PDB; 2CNL; X-ray; 1.67 A; A=29-175, B=176-277.
DR   PDB; 2CNN; X-ray; 1.70 A; A=29-175, B=176-277.
DR   PDB; 2CNO; X-ray; 1.95 A; A=29-175, B=176-277.
DR   PDB; 2DKO; X-ray; 1.06 A; A=29-174, B=175-277.
DR   PDB; 2H5I; X-ray; 1.69 A; A=29-174, B=184-277.
DR   PDB; 2H5J; X-ray; 2.00 A; A/C=29-174, B/D=184-277.
DR   PDB; 2H65; X-ray; 2.30 A; A/C=29-174, B/D=184-277.
DR   PDB; 2J30; X-ray; 1.40 A; A=29-277.
DR   PDB; 2J31; X-ray; 1.50 A; A=29-277.
DR   PDB; 2J32; X-ray; 1.30 A; A=29-277.
DR   PDB; 2J33; X-ray; 2.00 A; A=29-277.
DR   PDB; 2XYG; X-ray; 1.54 A; A=29-174, B=185-277.
DR   PDB; 2XYH; X-ray; 1.89 A; A=29-174, B=185-277.
DR   PDB; 2XYP; X-ray; 1.86 A; A=29-174, B=185-277.
DR   PDB; 2XZD; X-ray; 2.10 A; A/C=27-175, B/D=176-277.
DR   PDB; 2XZT; X-ray; 2.70 A; A/C=29-175, B/D=176-277.
DR   PDB; 2Y0B; X-ray; 2.10 A; A/C=29-175, B/D=176-277.
DR   PDB; 3DEH; X-ray; 2.50 A; A/B/C/D=29-277.
DR   PDB; 3DEI; X-ray; 2.80 A; A/B/C/D=29-277.
DR   PDB; 3DEJ; X-ray; 2.60 A; A/B/C/D=29-277.
DR   PDB; 3DEK; X-ray; 2.40 A; A/B/C/D=29-277.
DR   PDB; 3EDQ; X-ray; 1.61 A; A/C=29-175, B/D=176-277.
DR   PDB; 3GJQ; X-ray; 2.60 A; A/C=29-175, B/D=176-277.
DR   PDB; 3GJR; X-ray; 2.20 A; A/C=29-175, B/D=176-277.
DR   PDB; 3GJS; X-ray; 1.90 A; A/C=29-175, B/D=176-277.
DR   PDB; 3GJT; X-ray; 2.20 A; A/C=29-175, B/D=176-277.
DR   PDB; 3H0E; X-ray; 2.00 A; A/B=29-277.
DR   PDB; 3ITN; X-ray; 1.63 A; A=29-277.
DR   PDB; 3KJF; X-ray; 2.00 A; A=29-175, B=176-277.
DR   PDB; 3PCX; X-ray; 1.50 A; A=29-277.
DR   PDB; 3PD0; X-ray; 2.00 A; A=29-277.
DR   PDB; 3PD1; X-ray; 1.62 A; A=29-277.
DR   PDB; 4DCJ; X-ray; 1.70 A; A/D=29-175, B/E=176-277.
DR   PDB; 4DCO; X-ray; 1.70 A; A/D=29-175, B/E=176-277.
DR   PDB; 4DCP; X-ray; 1.70 A; A/D=29-175, B/E=176-277.
DR   PDB; 4EHA; X-ray; 1.70 A; A/C=1-277.
DR   PDB; 4EHD; X-ray; 1.58 A; A=1-277.
DR   PDB; 4EHF; X-ray; 1.66 A; A=1-277.
DR   PDB; 4EHH; X-ray; 1.78 A; A=1-277.
DR   PDB; 4EHK; X-ray; 1.67 A; A/C=1-277.
DR   PDB; 4EHL; X-ray; 1.80 A; A/C=1-277.
DR   PDB; 4EHN; X-ray; 1.69 A; A=1-277.
DR   PDB; 4JJE; X-ray; 1.48 A; A=29-277.
DR   PDB; 4JQY; X-ray; 2.50 A; A/B=34-277.
DR   PDB; 4JQZ; X-ray; 2.89 A; A/B=34-277.
DR   PDB; 4JR0; X-ray; 1.80 A; A/B=34-277.
DR   PDB; 4PRY; X-ray; 1.70 A; A=1-277.
DR   PDB; 4PS0; X-ray; 1.63 A; A/B=1-277.
DR   PDB; 4QTX; X-ray; 1.97 A; A=1-277.
DR   PDB; 4QTY; X-ray; 1.60 A; A=29-277.
DR   PDB; 4QU0; X-ray; 1.95 A; A=1-277.
DR   PDB; 4QU5; X-ray; 1.91 A; A=1-277.
DR   PDB; 4QU8; X-ray; 1.72 A; A=1-277.
DR   PDB; 4QU9; X-ray; 1.56 A; A=1-277.
DR   PDB; 4QUA; X-ray; 1.89 A; A=1-277.
DR   PDB; 4QUB; X-ray; 1.69 A; A=1-277.
DR   PDB; 4QUD; X-ray; 2.00 A; A/B=1-277.
DR   PDB; 4QUE; X-ray; 1.84 A; A/C=1-277.
DR   PDB; 4QUG; X-ray; 1.92 A; A/C=1-277.
DR   PDB; 4QUH; X-ray; 1.76 A; A/C=1-277.
DR   PDB; 4QUI; X-ray; 1.76 A; A/B=1-277.
DR   PDB; 4QUJ; X-ray; 1.50 A; A=1-277.
DR   PDB; 4QUL; X-ray; 1.90 A; A/C=1-277.
DR   PDB; 5I9B; X-ray; 1.80 A; A=1-277.
DR   PDB; 5I9T; X-ray; 1.95 A; A/C=1-277.
DR   PDB; 5IAB; X-ray; 1.79 A; A/C=1-277.
DR   PDB; 5IAE; X-ray; 1.55 A; A/C=1-277.
DR   PDB; 5IAG; X-ray; 1.98 A; A=1-277.
DR   PDB; 5IAJ; X-ray; 1.58 A; A=1-277.
DR   PDB; 5IAK; X-ray; 1.82 A; A=1-277.
DR   PDB; 5IAN; X-ray; 2.70 A; A=1-277.
DR   PDB; 5IAR; X-ray; 1.76 A; A=1-277.
DR   PDB; 5IAS; X-ray; 1.54 A; A=1-277.
DR   PDB; 5IBC; X-ray; 1.66 A; A=1-277.
DR   PDB; 5IBP; X-ray; 1.38 A; A=1-277.
DR   PDB; 5IBR; X-ray; 1.74 A; A/C=1-277.
DR   PDB; 5IC4; X-ray; 2.65 A; A/C/E/G=1-175, B/D/F/H=176-276.
DR   PDBsum; 1CP3; -.
DR   PDBsum; 1GFW; -.
DR   PDBsum; 1I3O; -.
DR   PDBsum; 1NME; -.
DR   PDBsum; 1NMQ; -.
DR   PDBsum; 1NMS; -.
DR   PDBsum; 1PAU; -.
DR   PDBsum; 1QX3; -.
DR   PDBsum; 1RE1; -.
DR   PDBsum; 1RHJ; -.
DR   PDBsum; 1RHK; -.
DR   PDBsum; 1RHM; -.
DR   PDBsum; 1RHQ; -.
DR   PDBsum; 1RHR; -.
DR   PDBsum; 1RHU; -.
DR   PDBsum; 2C1E; -.
DR   PDBsum; 2C2K; -.
DR   PDBsum; 2C2M; -.
DR   PDBsum; 2C2O; -.
DR   PDBsum; 2CDR; -.
DR   PDBsum; 2CJX; -.
DR   PDBsum; 2CJY; -.
DR   PDBsum; 2CNK; -.
DR   PDBsum; 2CNL; -.
DR   PDBsum; 2CNN; -.
DR   PDBsum; 2CNO; -.
DR   PDBsum; 2DKO; -.
DR   PDBsum; 2H5I; -.
DR   PDBsum; 2H5J; -.
DR   PDBsum; 2H65; -.
DR   PDBsum; 2J30; -.
DR   PDBsum; 2J31; -.
DR   PDBsum; 2J32; -.
DR   PDBsum; 2J33; -.
DR   PDBsum; 2XYG; -.
DR   PDBsum; 2XYH; -.
DR   PDBsum; 2XYP; -.
DR   PDBsum; 2XZD; -.
DR   PDBsum; 2XZT; -.
DR   PDBsum; 2Y0B; -.
DR   PDBsum; 3DEH; -.
DR   PDBsum; 3DEI; -.
DR   PDBsum; 3DEJ; -.
DR   PDBsum; 3DEK; -.
DR   PDBsum; 3EDQ; -.
DR   PDBsum; 3GJQ; -.
DR   PDBsum; 3GJR; -.
DR   PDBsum; 3GJS; -.
DR   PDBsum; 3GJT; -.
DR   PDBsum; 3H0E; -.
DR   PDBsum; 3ITN; -.
DR   PDBsum; 3KJF; -.
DR   PDBsum; 3PCX; -.
DR   PDBsum; 3PD0; -.
DR   PDBsum; 3PD1; -.
DR   PDBsum; 4DCJ; -.
DR   PDBsum; 4DCO; -.
DR   PDBsum; 4DCP; -.
DR   PDBsum; 4EHA; -.
DR   PDBsum; 4EHD; -.
DR   PDBsum; 4EHF; -.
DR   PDBsum; 4EHH; -.
DR   PDBsum; 4EHK; -.
DR   PDBsum; 4EHL; -.
DR   PDBsum; 4EHN; -.
DR   PDBsum; 4JJE; -.
DR   PDBsum; 4JQY; -.
DR   PDBsum; 4JQZ; -.
DR   PDBsum; 4JR0; -.
DR   PDBsum; 4PRY; -.
DR   PDBsum; 4PS0; -.
DR   PDBsum; 4QTX; -.
DR   PDBsum; 4QTY; -.
DR   PDBsum; 4QU0; -.
DR   PDBsum; 4QU5; -.
DR   PDBsum; 4QU8; -.
DR   PDBsum; 4QU9; -.
DR   PDBsum; 4QUA; -.
DR   PDBsum; 4QUB; -.
DR   PDBsum; 4QUD; -.
DR   PDBsum; 4QUE; -.
DR   PDBsum; 4QUG; -.
DR   PDBsum; 4QUH; -.
DR   PDBsum; 4QUI; -.
DR   PDBsum; 4QUJ; -.
DR   PDBsum; 4QUL; -.
DR   PDBsum; 5I9B; -.
DR   PDBsum; 5I9T; -.
DR   PDBsum; 5IAB; -.
DR   PDBsum; 5IAE; -.
DR   PDBsum; 5IAG; -.
DR   PDBsum; 5IAJ; -.
DR   PDBsum; 5IAK; -.
DR   PDBsum; 5IAN; -.
DR   PDBsum; 5IAR; -.
DR   PDBsum; 5IAS; -.
DR   PDBsum; 5IBC; -.
DR   PDBsum; 5IBP; -.
DR   PDBsum; 5IBR; -.
DR   PDBsum; 5IC4; -.
DR   ProteinModelPortal; P42574; -.
DR   SMR; P42574; -.
DR   BioGrid; 107286; 102.
DR   ComplexPortal; CPX-970; Caspase-3 complex.
DR   DIP; DIP-268N; -.
DR   ELM; P42574; -.
DR   IntAct; P42574; 54.
DR   MINT; P42574; -.
DR   STRING; 9606.ENSP00000311032; -.
DR   BindingDB; P42574; -.
DR   ChEMBL; CHEMBL2334; -.
DR   DrugBank; DB06862; 2-HYDROXY-5-(2-MERCAPTO-ETHYLSULFAMOYL)-BENZOIC ACID.
DR   DrugBank; DB08251; 4-[5-(2-CARBOXY-1-FORMYL-ETHYLCARBAMOYL)-PYRIDIN-3-YL]-BENZOIC ACID.
DR   DrugBank; DB03124; 5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid.
DR   DrugBank; DB08229; [N-(3-DIBENZYLCARBAMOYL-OXIRANECARBONYL)-HYDRAZINO]-ACETIC ACID.
DR   DrugBank; DB05408; IDN-6556.
DR   DrugBank; DB07696; methyl (3S)-3-[(tert-butoxycarbonyl)amino]-4-oxopentanoate.
DR   DrugBank; DB01017; Minocycline.
DR   GuidetoPHARMACOLOGY; 1619; -.
DR   MEROPS; C14.003; -.
DR   iPTMnet; P42574; -.
DR   PhosphoSitePlus; P42574; -.
DR   BioMuta; CASP3; -.
DR   DMDM; 77416852; -.
DR   OGP; P42574; -.
DR   EPD; P42574; -.
DR   jPOST; P42574; -.
DR   MaxQB; P42574; -.
DR   PaxDb; P42574; -.
DR   PeptideAtlas; P42574; -.
DR   PRIDE; P42574; -.
DR   ProteomicsDB; 55518; -.
DR   DNASU; 836; -.
DR   Ensembl; ENST00000308394; ENSP00000311032; ENSG00000164305.
DR   Ensembl; ENST00000523916; ENSP00000428929; ENSG00000164305.
DR   GeneID; 836; -.
DR   KEGG; hsa:836; -.
DR   UCSC; uc003iwh.3; human.
DR   CTD; 836; -.
DR   DisGeNET; 836; -.
DR   EuPathDB; HostDB:ENSG00000164305.17; -.
DR   GeneCards; CASP3; -.
DR   HGNC; HGNC:1504; CASP3.
DR   HPA; CAB000091; -.
DR   HPA; CAB008381; -.
DR   HPA; HPA002643; -.
DR   MIM; 600636; gene.
DR   neXtProt; NX_P42574; -.
DR   OpenTargets; ENSG00000164305; -.
DR   PharmGKB; PA26087; -.
DR   eggNOG; KOG3573; Eukaryota.
DR   eggNOG; ENOG410ZQIE; LUCA.
DR   GeneTree; ENSGT00940000153232; -.
DR   HOGENOM; HOG000231878; -.
DR   HOVERGEN; HBG050802; -.
DR   InParanoid; P42574; -.
DR   KO; K02187; -.
DR   OMA; SAFHAKK; -.
DR   OrthoDB; 984395at2759; -.
DR   PhylomeDB; P42574; -.
DR   TreeFam; TF102023; -.
DR   BRENDA; 3.4.22.56; 2681.
DR   Reactome; R-HSA-111459; Activation of caspases through apoptosome-mediated cleavage.
DR   Reactome; R-HSA-111463; SMAC (DIABLO) binds to IAPs.
DR   Reactome; R-HSA-111464; SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes.
DR   Reactome; R-HSA-111465; Apoptotic cleavage of cellular proteins.
DR   Reactome; R-HSA-111469; SMAC, XIAP-regulated apoptotic response.
DR   Reactome; R-HSA-1474228; Degradation of the extracellular matrix.
DR   Reactome; R-HSA-2028269; Signaling by Hippo.
DR   Reactome; R-HSA-205025; NADE modulates death signalling.
DR   Reactome; R-HSA-211227; Activation of DNA fragmentation factor.
DR   Reactome; R-HSA-211736; Stimulation of the cell death response by PAK-2p34.
DR   Reactome; R-HSA-264870; Caspase-mediated cleavage of cytoskeletal proteins.
DR   Reactome; R-HSA-351906; Apoptotic cleavage of cell adhesion proteins.
DR   Reactome; R-HSA-418889; Caspase activation via Dependence Receptors in the absence of ligand.
DR   Reactome; R-HSA-449836; Other interleukin signaling.
DR   SABIO-RK; P42574; -.
DR   SIGNOR; P42574; -.
DR   ChiTaRS; CASP3; human.
DR   EvolutionaryTrace; P42574; -.
DR   GeneWiki; Caspase_3; -.
DR   GenomeRNAi; 836; -.
DR   PMAP-CutDB; P42574; -.
DR   PRO; PR:P42574; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000164305; Expressed in 194 organ(s), highest expression level in jejunal mucosa.
DR   ExpressionAtlas; P42574; baseline and differential.
DR   Genevisible; P42574; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0031264; C:death-inducing signaling complex; IEA:Ensembl.
DR   GO; GO:0045121; C:membrane raft; IEA:Ensembl.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0004190; F:aspartic-type endopeptidase activity; EXP:Reactome.
DR   GO; GO:0004861; F:cyclin-dependent protein serine/threonine kinase inhibitor activity; IEA:Ensembl.
DR   GO; GO:0008656; F:cysteine-type endopeptidase activator activity involved in apoptotic process; TAS:Reactome.
DR   GO; GO:0004197; F:cysteine-type endopeptidase activity; IDA:UniProtKB.
DR   GO; GO:0097153; F:cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB.
DR   GO; GO:0097199; F:cysteine-type endopeptidase activity involved in apoptotic signaling pathway; IMP:UniProtKB.
DR   GO; GO:0097200; F:cysteine-type endopeptidase activity involved in execution phase of apoptosis; IMP:UniProtKB.
DR   GO; GO:0005123; F:death receptor binding; IEA:Ensembl.
DR   GO; GO:0008233; F:peptidase activity; IDA:UniProtKB.
DR   GO; GO:0016005; F:phospholipase A2 activator activity; IEA:Ensembl.
DR   GO; GO:0002020; F:protease binding; IEA:Ensembl.
DR   GO; GO:0044877; F:protein-containing complex binding; IEA:Ensembl.
DR   GO; GO:0006309; P:apoptotic DNA fragmentation; TAS:Reactome.
DR   GO; GO:0006915; P:apoptotic process; IMP:UniProtKB.
DR   GO; GO:0097190; P:apoptotic signaling pathway; TAS:BHF-UCL.
DR   GO; GO:0007413; P:axonal fasciculation; IEA:Ensembl.
DR   GO; GO:0001782; P:B cell homeostasis; IEA:Ensembl.
DR   GO; GO:0045165; P:cell fate commitment; IEA:Ensembl.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; IEA:Ensembl.
DR   GO; GO:0072734; P:cellular response to staurosporine; IMP:CAFA.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0030218; P:erythrocyte differentiation; IDA:UniProtKB.
DR   GO; GO:0097194; P:execution phase of apoptosis; IDA:UniProtKB.
DR   GO; GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; TAS:Reactome.
DR   GO; GO:0034349; P:glial cell apoptotic process; IEA:Ensembl.
DR   GO; GO:0007507; P:heart development; IEA:Ensembl.
DR   GO; GO:0035329; P:hippo signaling; TAS:Reactome.
DR   GO; GO:0021766; P:hippocampus development; IEA:Ensembl.
DR   GO; GO:0008627; P:intrinsic apoptotic signaling pathway in response to osmotic stress; IEA:Ensembl.
DR   GO; GO:0030216; P:keratinocyte differentiation; IBA:GO_Central.
DR   GO; GO:0007611; P:learning or memory; IEA:Ensembl.
DR   GO; GO:0071887; P:leukocyte apoptotic process; IEA:Ensembl.
DR   GO; GO:0001554; P:luteolysis; IEA:Ensembl.
DR   GO; GO:0046007; P:negative regulation of activated T cell proliferation; IEA:Ensembl.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IGI:MGI.
DR   GO; GO:0030889; P:negative regulation of B cell proliferation; IEA:Ensembl.
DR   GO; GO:0051402; P:neuron apoptotic process; IEA:Ensembl.
DR   GO; GO:0030182; P:neuron differentiation; IBA:GO_Central.
DR   GO; GO:0048011; P:neurotrophin TRK receptor signaling pathway; IDA:MGI.
DR   GO; GO:0030220; P:platelet formation; TAS:UniProtKB.
DR   GO; GO:1902004; P:positive regulation of amyloid-beta formation; IDA:UniProtKB.
DR   GO; GO:0043525; P:positive regulation of neuron apoptotic process; IEA:Ensembl.
DR   GO; GO:0016485; P:protein processing; IEA:Ensembl.
DR   GO; GO:0006508; P:proteolysis; IDA:UniProtKB.
DR   GO; GO:0016241; P:regulation of macroautophagy; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0031647; P:regulation of protein stability; IDA:UniProtKB.
DR   GO; GO:0043200; P:response to amino acid; IEA:Ensembl.
DR   GO; GO:0032025; P:response to cobalt ion; IEA:Ensembl.
DR   GO; GO:0032355; P:response to estradiol; IEA:Ensembl.
DR   GO; GO:0051384; P:response to glucocorticoid; IEA:Ensembl.
DR   GO; GO:0009749; P:response to glucose; IEA:Ensembl.
DR   GO; GO:0042542; P:response to hydrogen peroxide; IEA:Ensembl.
DR   GO; GO:0001666; P:response to hypoxia; IEA:Ensembl.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl.
DR   GO; GO:0035094; P:response to nicotine; IEA:Ensembl.
DR   GO; GO:0034612; P:response to tumor necrosis factor; TAS:BHF-UCL.
DR   GO; GO:0009411; P:response to UV; IEA:Ensembl.
DR   GO; GO:0010165; P:response to X-ray; IEA:Ensembl.
DR   GO; GO:0007605; P:sensory perception of sound; IEA:Ensembl.
DR   GO; GO:0051146; P:striated muscle cell differentiation; IEA:Ensembl.
DR   GO; GO:0043029; P:T cell homeostasis; IEA:Ensembl.
DR   GO; GO:0042060; P:wound healing; IEA:Ensembl.
DR   CDD; cd00032; CASc; 1.
DR   InterPro; IPR015471; Casp3/7.
DR   InterPro; IPR029030; Caspase-like_dom_sf.
DR   InterPro; IPR033139; Caspase_cys_AS.
DR   InterPro; IPR016129; Caspase_his_AS.
DR   InterPro; IPR002398; Pept_C14.
DR   InterPro; IPR002138; Pept_C14_p10.
DR   InterPro; IPR001309; Pept_C14_p20.
DR   InterPro; IPR015917; Pept_C14A.
DR   PANTHER; PTHR10454; PTHR10454; 1.
DR   PANTHER; PTHR10454:SF31; PTHR10454:SF31; 1.
DR   PRINTS; PR00376; IL1BCENZYME.
DR   SMART; SM00115; CASc; 1.
DR   SUPFAM; SSF52129; SSF52129; 1.
DR   PROSITE; PS01122; CASPASE_CYS; 1.
DR   PROSITE; PS01121; CASPASE_HIS; 1.
DR   PROSITE; PS50207; CASPASE_P10; 1.
DR   PROSITE; PS50208; CASPASE_P20; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Apoptosis; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Hydrolase; Phosphoprotein; Polymorphism;
KW   Protease; Reference proteome; S-nitrosylation; Thiol protease;
KW   Zymogen.
FT   PROPEP        1      9
FT                                /FTId=PRO_0000004569.
FT   PROPEP       10     28       {ECO:0000269|PubMed:7596430}.
FT                                /FTId=PRO_0000004570.
FT   CHAIN        29    175       Caspase-3 subunit p17.
FT                                /FTId=PRO_0000004571.
FT   CHAIN       176    277       Caspase-3 subunit p12.
FT                                /FTId=PRO_0000004572.
FT   ACT_SITE    121    121       {ECO:0000250}.
FT   ACT_SITE    163    163       {ECO:0000250}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895}.
FT   MOD_RES      11     11       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P70677}.
FT   MOD_RES      26     26       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     163    163       S-nitrosocysteine; in inhibited form.
FT                                {ECO:0000269|PubMed:10213689}.
FT   VARIANT      22     22       H -> R (in dbSNP:rs35578277).
FT                                /FTId=VAR_048616.
FT   VARIANT     190    190       E -> D (in dbSNP:rs1049210).
FT                                {ECO:0000269|PubMed:15003516,
FT                                ECO:0000269|PubMed:7596430,
FT                                ECO:0000269|PubMed:7983002}.
FT                                /FTId=VAR_001401.
FT   CONFLICT     31     36       ISLDNS -> MSWDTG (in Ref. 3; CAC88866).
FT                                {ECO:0000305}.
FT   STRAND       41     51       {ECO:0000244|PDB:2DKO}.
FT   HELIX        57     59       {ECO:0000244|PDB:2DKO}.
FT   HELIX        67     80       {ECO:0000244|PDB:2DKO}.
FT   STRAND       84     90       {ECO:0000244|PDB:2DKO}.
FT   HELIX        93    105       {ECO:0000244|PDB:2DKO}.
FT   HELIX       108    110       {ECO:0000244|PDB:1I3O}.
FT   STRAND      111    120       {ECO:0000244|PDB:2DKO}.
FT   STRAND      126    129       {ECO:0000244|PDB:2DKO}.
FT   STRAND      132    135       {ECO:0000244|PDB:2DKO}.
FT   HELIX       136    141       {ECO:0000244|PDB:2DKO}.
FT   TURN        145    147       {ECO:0000244|PDB:2DKO}.
FT   HELIX       149    151       {ECO:0000244|PDB:2DKO}.
FT   STRAND      156    162       {ECO:0000244|PDB:2DKO}.
FT   STRAND      165    167       {ECO:0000244|PDB:2DKO}.
FT   STRAND      178    181       {ECO:0000244|PDB:2DKO}.
FT   TURN        183    185       {ECO:0000244|PDB:1NMS}.
FT   TURN        189    192       {ECO:0000244|PDB:2DKO}.
FT   STRAND      193    199       {ECO:0000244|PDB:2DKO}.
FT   STRAND      206    208       {ECO:0000244|PDB:2DKO}.
FT   TURN        209    211       {ECO:0000244|PDB:2DKO}.
FT   HELIX       214    226       {ECO:0000244|PDB:2DKO}.
FT   TURN        227    229       {ECO:0000244|PDB:2DKO}.
FT   HELIX       232    246       {ECO:0000244|PDB:2DKO}.
FT   HELIX       254    256       {ECO:0000244|PDB:2DKO}.
FT   STRAND      264    267       {ECO:0000244|PDB:2DKO}.
FT   STRAND      270    272       {ECO:0000244|PDB:2DKO}.
SQ   SEQUENCE   277 AA;  31608 MW;  2F35CD3BCF7FF64A CRC64;
     MENTENSVDS KSIKNLEPKI IHGSESMDSG ISLDNSYKMD YPEMGLCIII NNKNFHKSTG
     MTSRSGTDVD AANLRETFRN LKYEVRNKND LTREEIVELM RDVSKEDHSK RSSFVCVLLS
     HGEEGIIFGT NGPVDLKKIT NFFRGDRCRS LTGKPKLFII QACRGTELDC GIETDSGVDD
     DMACHKIPVE ADFLYAYSTA PGYYSWRNSK DGSWFIQSLC AMLKQYADKL EFMHILTRVN
     RKVATEFESF SFDATFHAKK QIPCIVSMLT KELYFYH
//
ID   F8VVS7_HUMAN            Unreviewed;       421 AA.
AC   F8VVS7;
DT   21-SEP-2011, integrated into UniProtKB/TrEMBL.
DT   21-SEP-2011, sequence version 1.
DT   16-JAN-2019, entry version 74.
DE   SubName: Full=Caspase-9 {ECO:0000313|Ensembl:ENSP00000449584};
GN   Name=CASP9 {ECO:0000313|Ensembl:ENSP00000449584};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000449584, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000449584, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S., Hart E., Haugen E., Heath P.D., Holmes S.,
RA   Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J.,
RA   James R., Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K.,
RA   Kibukawa M., Kimberley A.M., King A., Knights A.J., Lad H., Laird G.,
RA   Lawlor S., Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J.,
RA   Lush M.J., Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L.,
RA   Matthews N.S., McLaren S., Milne S., Mistry S., Moore M.J.,
RA   Nickerson T., O'Dell C.N., Oliver K., Palmeiri A., Palmer S.A.,
RA   Parker A., Patel D., Pearce A.V., Peck A.I., Pelan S., Phelps K.,
RA   Phillimore B.J., Plumb R., Rajan J., Raymond C., Rouse G.,
RA   Saenphimmachak C., Sehra H.K., Sheridan E., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M., Steward C., Subramanian S., Sycamore N.,
RA   Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M., White S.,
RA   Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H., Wilming L.,
RA   Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E., Durbin R.,
RA   Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G., Ross M.T.,
RA   Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R., Banerjee R.,
RA   Bryant S.P., Burford D.C., Burrill W.D., Clegg S.M., Dhami P.,
RA   Dovey O., Faulkner L.M., Gribble S.M., Langford C.F., Pandian R.D.,
RA   Porter K.M., Prigmore E.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [2] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [3] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:ra3-RA3(2010).
RN   [4] {ECO:0000313|Ensembl:ENSP00000449584}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
RN   [5] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- SIMILARITY: Belongs to the peptidase C14A family.
CC       {ECO:0000256|RuleBase:RU003971, ECO:0000256|SAAS:SAAS01080359}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AL512883; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; XP_011540575.1; XM_011542273.2.
DR   UniGene; Hs.329502; -.
DR   ProteinModelPortal; F8VVS7; -.
DR   EPD; F8VVS7; -.
DR   MaxQB; F8VVS7; -.
DR   PeptideAtlas; F8VVS7; -.
DR   PRIDE; F8VVS7; -.
DR   Ensembl; ENST00000546424; ENSP00000449584; ENSG00000132906.
DR   GeneID; 842; -.
DR   UCSC; uc001awm.3; human.
DR   CTD; 842; -.
DR   EuPathDB; HostDB:ENSG00000132906.17; -.
DR   HGNC; HGNC:1511; CASP9.
DR   OpenTargets; ENSG00000132906; -.
DR   eggNOG; KOG3573; Eukaryota.
DR   eggNOG; ENOG410ZQIE; LUCA.
DR   GeneTree; ENSGT00940000159698; -.
DR   OrthoDB; 1092723at2759; -.
DR   GenomeRNAi; 842; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000132906; Expressed in 232 organ(s), highest expression level in adrenal tissue.
DR   ExpressionAtlas; F8VVS7; baseline and differential.
DR   GO; GO:0004197; F:cysteine-type endopeptidase activity; IEA:InterPro.
DR   GO; GO:0006915; P:apoptotic process; IEA:InterPro.
DR   GO; GO:0042981; P:regulation of apoptotic process; IEA:InterPro.
DR   CDD; cd00032; CASc; 1.
DR   InterPro; IPR001315; CARD.
DR   InterPro; IPR033171; Caspase-9.
DR   InterPro; IPR029030; Caspase-like_dom_sf.
DR   InterPro; IPR033139; Caspase_cys_AS.
DR   InterPro; IPR016129; Caspase_his_AS.
DR   InterPro; IPR011029; DEATH-like_dom_sf.
DR   InterPro; IPR002398; Pept_C14.
DR   InterPro; IPR002138; Pept_C14_p10.
DR   InterPro; IPR001309; Pept_C14_p20.
DR   InterPro; IPR015917; Pept_C14A.
DR   PANTHER; PTHR10454; PTHR10454; 2.
DR   PANTHER; PTHR10454:SF157; PTHR10454:SF157; 2.
DR   Pfam; PF00619; CARD; 1.
DR   PRINTS; PR00376; IL1BCENZYME.
DR   SMART; SM00114; CARD; 1.
DR   SMART; SM00115; CASc; 1.
DR   SUPFAM; SSF47986; SSF47986; 1.
DR   SUPFAM; SSF52129; SSF52129; 1.
DR   PROSITE; PS50209; CARD; 1.
DR   PROSITE; PS01122; CASPASE_CYS; 1.
DR   PROSITE; PS01121; CASPASE_HIS; 1.
DR   PROSITE; PS50207; CASPASE_P10; 1.
DR   PROSITE; PS50208; CASPASE_P20; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Hydrolase {ECO:0000256|SAAS:SAAS00710708};
KW   Protease {ECO:0000256|SAAS:SAAS00710708};
KW   Proteomics identification {ECO:0000213|EPD:F8VVS7,
KW   ECO:0000213|MaxQB:F8VVS7, ECO:0000213|PeptideAtlas:F8VVS7};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Thiol protease {ECO:0000256|SAAS:SAAS00710708}.
FT   DOMAIN        1     92       CARD. {ECO:0000259|PROSITE:PS50209}.
FT   DOMAIN      159    291       CASPASE_P20.
FT                                {ECO:0000259|PROSITE:PS50208}.
FT   DOMAIN      331    397       CASPASE_P10.
FT                                {ECO:0000259|PROSITE:PS50207}.
SQ   SEQUENCE   421 AA;  46453 MW;  6B5EC6A06494125F CRC64;
     MDEADRRLLR RCRLRLVEEL QVDQLWDALL SRELFRPHMI EDIQRAGSGS RRDQARQLII
     DLETRGSQAL PLFISCLEDT GQDMLASFLR TNRQAAKLSK PTLENLTPVV LRPEIRKPEV
     LRPETPRPVD IGSGGFGDVG ALESLRGNAD LAYILSMEPC GHCLIINNVN FCRESGLRTR
     TGSNIDCEKL RRRFSSLHFM VEVKGDLTAK KMVLALLELA QQDHGALDCC VVVILSHGCQ
     ASHLQFPGAV YGTDGCPVSV EKIVNIFNGT SCPSLGGKPK LFFIQACGGE QKDHGFEVAS
     TSPEDESPGS NPEPDATPFQ EGLRTFDQLD AISSLPTPSD IFVSYSTFPG FVSWRDPKSG
     SWYVETLDDI FEQWAHSEDL QSLLLRVSAA FLCKGEGRLL RGSVSSWGWG FGVSRAGPNQ
     G
//
ID   CASP9_HUMAN             Reviewed;         416 AA.
AC   P55211; B4E1A3; O95348; Q53Y70; Q5JRU9; Q5UGI1; Q92852; Q9BQ62;
AC   Q9UEQ3; Q9UIJ8;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   22-FEB-2003, sequence version 3.
DT   13-FEB-2019, entry version 212.
DE   RecName: Full=Caspase-9;
DE            Short=CASP-9;
DE            EC=3.4.22.62 {ECO:0000269|PubMed:23516580};
DE   AltName: Full=Apoptotic protease Mch-6;
DE   AltName: Full=Apoptotic protease-activating factor 3;
DE            Short=APAF-3;
DE   AltName: Full=ICE-like apoptotic protease 6;
DE            Short=ICE-LAP6;
DE   Contains:
DE     RecName: Full=Caspase-9 subunit p35;
DE   Contains:
DE     RecName: Full=Caspase-9 subunit p10;
DE   Flags: Precursor;
GN   Name=CASP9; Synonyms=MCH6;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS VAL-28 AND
RP   ARG-221.
RX   PubMed=8663294; DOI=10.1074/jbc.271.28.16720;
RA   Duan H., Orth K., Chinnaiyan A.M., Poirier G.G., Froelich C.J.,
RA   He W.-W., Dixit V.M.;
RT   "ICE-LAP6, a novel member of the ICE/Ced-3 gene family, is activated
RT   by the cytotoxic T cell protease granzyme B.";
RL   J. Biol. Chem. 271:16720-16724(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND PROTEOLYTIC PROCESSING.
RC   TISSUE=T-cell;
RX   PubMed=8900201; DOI=10.1074/jbc.271.43.27099;
RA   Srinivasula S.M., Fernandes-Alnemri T., Zangrilli J., Robertson N.,
RA   Armstrong R.C., Wang L., Trapani J.A., Tomaselli K.J., Litwack G.,
RA   Alnemri E.S.;
RT   "The Ced-3/interleukin 1beta converting enzyme-like homolog Mch6 and
RT   the lamin-cleaving enzyme Mch2alpha are substrates for the apoptotic
RT   mediator CPP32.";
RL   J. Biol. Chem. 271:27099-27106(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10384055; DOI=10.1007/s003359901086;
RA   Hadano S., Nasir J., Nichol K., Rasper D.M., Vaillancourt J.P.,
RA   Sherer S.W., Beatty B.G., Ikeda J.E., Nicholson D.W., Hayden M.R.;
RT   "Genomic organization of the human caspase-9 gene on chromosome
RT   1p36.1-p36.3.";
RL   Mamm. Genome 10:757-760(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=10070954;
RA   Srinivasula S.M., Ahmad M., Guo Y., Zhan Y., Lazebnik Y.,
RA   Fernandes-Alnemri T., Alnemri E.S.;
RT   "Identification of an endogenous dominant-negative short isoform of
RT   caspase-9 that can regulate apoptosis.";
RL   Cancer Res. 59:999-1002(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Stomach cancer;
RA   Izawa M., Mori T., Ito H., Sairenji T.;
RT   "Molecular cloning and sequencing of a cDNA predicting an alternative
RT   form of pro-caspase-9 from human gastric cancer cell lines.";
RL   Submitted (JUN-1998) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RA   Miho Y., Momoi T., Fujita E.;
RT   "A novel splicing product of human caspase-9 lacking protease
RT   activity.";
RL   Submitted (DEC-1998) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND VARIANT VAL-28.
RX   PubMed=9890966; DOI=10.1074/jbc.274.4.2072;
RA   Seol D.W., Billiar T.R.;
RT   "A caspase-9 variant missing the catalytic site is an endogenous
RT   inhibitor of apoptosis.";
RL   J. Biol. Chem. 274:2072-2076(1999).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), AND VARIANT VAL-28.
RX   PubMed=16780893; DOI=10.1016/j.lfs.2006.04.026;
RA   Wang P., Shi T., Ma D.;
RT   "Cloning of a novel human caspase-9 splice variant containing only the
RT   CARD domain.";
RL   Life Sci. 79:934-940(2006).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS VAL-28; LEU-99;
RP   ILE-102; VAL-106; ASP-114; HIS-173 AND ARG-221.
RG   NIEHS SNPs program;
RL   Submitted (JAN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Kidney;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [14]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Eye, and Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [15]
RP   PHOSPHORYLATION AT THR-125.
RX   PubMed=12792650; DOI=10.1038/ncb1005;
RA   Allan L.A., Morrice N., Brady S., Magee G., Pathak S., Clarke P.R.;
RT   "Inhibition of caspase-9 through phosphorylation at Thr 125 by ERK
RT   MAPK.";
RL   Nat. Cell Biol. 5:647-654(2003).
RN   [16]
RP   INTERACTION WITH BIRC6/BRUCE.
RX   PubMed=15200957; DOI=10.1016/j.molcel.2004.05.018;
RA   Bartke T., Pohl C., Pyrowolakis G., Jentsch S.;
RT   "Dual role of BRUCE as an antiapoptotic IAP and a chimeric E2/E3
RT   ubiquitin ligase.";
RL   Mol. Cell 14:801-811(2004).
RN   [17]
RP   FUNCTION IN APOPTOSIS, INTERACTION WITH ABL1, PROTEOLYTIC PROCESSING,
RP   PHOSPHORYLATION AT TYR-153 BY ABL1, AND MUTAGENESIS OF TYR-153.
RX   PubMed=15657060; DOI=10.1074/jbc.M413787200;
RA   Raina D., Pandey P., Ahmad R., Bharti A., Ren J., Kharbanda S.,
RA   Weichselbaum R., Kufe D.;
RT   "c-Abl tyrosine kinase regulates caspase-9 autocleavage in the
RT   apoptotic response to DNA damage.";
RL   J. Biol. Chem. 280:11147-11151(2005).
RN   [18]
RP   INTERACTION WITH HAX1, TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=16857965; DOI=10.1161/01.RES.0000237387.05259.a5;
RA   Han Y., Chen Y.S., Liu Z., Bodyak N., Rigor D., Bisping E., Pu W.T.,
RA   Kang P.M.;
RT   "Overexpression of HAX-1 protects cardiac myocytes from apoptosis
RT   through caspase-9 inhibition.";
RL   Circ. Res. 99:415-423(2006).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-125; SER-302 AND
RP   SER-307, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [20]
RP   INTERACTION WITH EFHD2.
RX   PubMed=19118655; DOI=10.1016/j.jprot.2008.11.016;
RA   Checinska A., Giaccone G., Rodriguez J.A., Kruyt F.A.E., Jimenez C.R.;
RT   "Comparative proteomics analysis of caspase-9-protein complexes in
RT   untreated and cytochrome c/dATP stimulated lysates of NSCLC cells.";
RL   J. Proteomics 72:575-585(2009).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-307, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-310, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [23]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 140-416, AND SUBUNIT.
RX   PubMed=11734640; DOI=10.1073/pnas.231465798;
RA   Renatus M., Stennicke H.R., Scott F.L., Liddington R.C.,
RA   Salvesen G.S.;
RT   "Dimer formation drives the activation of the cell death protease
RT   caspase 9.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:14250-14255(2001).
RN   [24]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 140-416 IN COMPLEX WITH
RP   BIRC4/XIAP.
RX   PubMed=12620238; DOI=10.1016/S1097-2765(03)00054-6;
RA   Shiozaki E.N., Chai J., Rigotti D.J., Riedl S.J., Li P.,
RA   Srinivasula S.M., Alnemri E.S., Fairman R., Shi Y.;
RT   "Mechanism of XIAP-mediated inhibition of caspase-9.";
RL   Mol. Cell 11:519-527(2003).
RN   [25]
RP   X-RAY CRYSTALLOGRAPHY (3.49 ANGSTROMS) OF 140-416 IN COMPLEX WITH
RP   E.COLI NLEF, INTERACTION WITH E.COLI NLEF, SUBUNIT, CATALYTIC
RP   ACTIVITY, FUNCTION, AND ACTIVITY REGULATION.
RX   PubMed=23516580; DOI=10.1371/journal.pone.0058937;
RA   Blasche S., Mortl M., Steuber H., Siszler G., Nisa S., Schwarz F.,
RA   Lavrik I., Gronewold T.M., Maskos K., Donnenberg M.S., Ullmann D.,
RA   Uetz P., Kogl M.;
RT   "The E. coli effector protein NleF is a caspase inhibitor.";
RL   PLoS ONE 8:E58937-E58937(2013).
CC   -!- FUNCTION: Involved in the activation cascade of caspases
CC       responsible for apoptosis execution. Binding of caspase-9 to Apaf-
CC       1 leads to activation of the protease which then cleaves and
CC       activates caspase-3. Promotes DNA damage-induced apoptosis in a
CC       ABL1/c-Abl-dependent manner. Proteolytically cleaves poly(ADP-
CC       ribose) polymerase (PARP).
CC   -!- FUNCTION: Isoform 2 lacks activity is an dominant-negative
CC       inhibitor of caspase-9.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Strict requirement for an Asp residue at position P1 and
CC         with a marked preference for His at position P2. It has a
CC         preferred cleavage sequence of Leu-Gly-His-Asp-|-Xaa.;
CC         EC=3.4.22.62; Evidence={ECO:0000269|PubMed:23516580};
CC   -!- ACTIVITY REGULATION: Inhibited by the effector protein NleF that
CC       is produced by pathogenic E.coli; this inhibits apoptosis.
CC       {ECO:0000269|PubMed:23516580}.
CC   -!- SUBUNIT: Heterotetramer that consists of two anti-parallel
CC       arranged heterodimers, each one formed by a 35 kDa (p35) and a 10
CC       kDa (p10) subunit. Caspase-9 and APAF1 bind to each other via
CC       their respective NH2-terminal CED-3 homologous domains in the
CC       presence of cytochrome C and ATP. Interacts (inactive form) with
CC       EFHD2. Interacts with HAX1. Interacts with BIRC2/c-IAP1,
CC       XIAP/BIRC4, BIRC5/survivin, BIRC6/bruce and BIRC7/livin. Interacts
CC       with ABL1 (via SH3 domain); the interaction is direct and
CC       increases in the response of cells to genotoxic stress and ABL1/c-
CC       Abl activation. Interacts with NleF from pathogenic E.coli.
CC       {ECO:0000269|PubMed:11734640, ECO:0000269|PubMed:12620238,
CC       ECO:0000269|PubMed:15200957, ECO:0000269|PubMed:15657060,
CC       ECO:0000269|PubMed:16857965, ECO:0000269|PubMed:19118655,
CC       ECO:0000269|PubMed:23516580}.
CC   -!- INTERACTION:
CC       O14727:APAF1; NbExp=22; IntAct=EBI-516799, EBI-446492;
CC       Q13490:BIRC2; NbExp=9; IntAct=EBI-516799, EBI-514538;
CC       Q13489:BIRC3; NbExp=2; IntAct=EBI-516799, EBI-517709;
CC       O15392:BIRC5; NbExp=2; IntAct=EBI-516799, EBI-518823;
CC       Q96CA5:BIRC7; NbExp=10; IntAct=EBI-516799, EBI-517623;
CC       Q6PIA0:BIRC8; NbExp=3; IntAct=EBI-516799, EBI-2129837;
CC       P42574:CASP3; NbExp=2; IntAct=EBI-516799, EBI-524064;
CC       P43146:DCC; NbExp=2; IntAct=EBI-516799, EBI-1222919;
CC       Q13418:ILK; NbExp=2; IntAct=EBI-516799, EBI-747644;
CC       P98170:XIAP; NbExp=17; IntAct=EBI-516799, EBI-517127;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=9L, Alpha;
CC         IsoId=P55211-1; Sequence=Displayed;
CC       Name=2; Synonyms=9S, Beta;
CC         IsoId=P55211-2; Sequence=VSP_000818;
CC       Name=3; Synonyms=Gamma;
CC         IsoId=P55211-3; Sequence=VSP_043910, VSP_043911;
CC         Note=May function as an endogenous apoptotic inhibitor, inhibits
CC         the BAX-mediated cleavage of procaspase-3.;
CC       Name=4;
CC         IsoId=P55211-4; Sequence=VSP_044256;
CC   -!- TISSUE SPECIFICITY: Ubiquitous, with highest expression in the
CC       heart, moderate expression in liver, skeletal muscle, and
CC       pancreas. Low levels in all other tissues. Within the heart,
CC       specifically expressed in myocytes. {ECO:0000269|PubMed:16857965}.
CC   -!- DEVELOPMENTAL STAGE: Expressed at low levels in fetal heart, at
CC       moderate levels in neonate heart, and at high levels in adult
CC       heart. {ECO:0000269|PubMed:16857965}.
CC   -!- PTM: Cleavages at Asp-315 by granzyme B and at Asp-330 by caspase-
CC       3 generate the two active subunits. Caspase-8 and -10 can also be
CC       involved in these processing events.
CC   -!- PTM: Phosphorylated at Thr-125 by MAPK1/ERK2. Phosphorylation at
CC       Thr-125 is sufficient to block caspase-9 processing and subsequent
CC       caspase-3 activation. Phosphorylation on Tyr-153 by ABL1/c-Abl;
CC       occurs in the response of cells to DNA damage.
CC       {ECO:0000269|PubMed:12792650, ECO:0000269|PubMed:15657060}.
CC   -!- SIMILARITY: Belongs to the peptidase C14A family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/CASP9ID423ch1p36.html";
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/casp9/";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Caspase-9 entry;
CC       URL="https://en.wikipedia.org/wiki/Caspase-9";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; U56390; AAC50640.1; -; mRNA.
DR   EMBL; U60521; AAC50776.1; -; mRNA.
DR   EMBL; AB019205; BAA82697.1; -; Genomic_DNA.
DR   EMBL; AF093130; AAD12248.1; -; mRNA.
DR   EMBL; AB015653; BAA78780.1; -; mRNA.
DR   EMBL; AB020979; BAA87905.1; -; mRNA.
DR   EMBL; AF110376; AAD13615.1; -; mRNA.
DR   EMBL; AY732490; AAV33129.1; -; mRNA.
DR   EMBL; AY214168; AAO21133.1; -; Genomic_DNA.
DR   EMBL; BT006911; AAP35557.1; -; mRNA.
DR   EMBL; AK303743; BAG64715.1; -; mRNA.
DR   EMBL; AL512883; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471167; EAW51730.1; -; Genomic_DNA.
DR   EMBL; CH471167; EAW51731.1; -; Genomic_DNA.
DR   EMBL; BC002452; AAH02452.1; -; mRNA.
DR   EMBL; BC006463; AAH06463.1; -; mRNA.
DR   CCDS; CCDS158.1; -. [P55211-1]
DR   CCDS; CCDS159.2; -. [P55211-4]
DR   CCDS; CCDS59995.1; -. [P55211-2]
DR   PIR; G02635; G02635.
DR   RefSeq; NP_001220.2; NM_001229.4. [P55211-1]
DR   RefSeq; NP_001264983.1; NM_001278054.1. [P55211-2]
DR   RefSeq; NP_127463.2; NM_032996.3. [P55211-4]
DR   RefSeq; XP_005246071.1; XM_005246014.2. [P55211-4]
DR   UniGene; Hs.329502; -.
DR   PDB; 1JXQ; X-ray; 2.80 A; A/B/C/D=140-416.
DR   PDB; 1NW9; X-ray; 2.40 A; B=140-416.
DR   PDB; 2AR9; X-ray; 2.80 A; A/B/C/D=139-416.
DR   PDB; 3D9T; X-ray; 1.50 A; C/D=316-321.
DR   PDB; 3V3K; X-ray; 3.49 A; A/C/E/G/I/K/M/O=141-416.
DR   PDB; 3YGS; X-ray; 2.50 A; P=1-95.
DR   PDB; 4RHW; X-ray; 2.10 A; E/F=1-100.
DR   PDB; 5JUY; EM; 4.10 A; O/P/Q/R=1-95.
DR   PDB; 5WVC; X-ray; 2.99 A; B/D/F=1-128.
DR   PDB; 5WVE; EM; 4.40 A; S/T/U/V/Y=1-100.
DR   PDBsum; 1JXQ; -.
DR   PDBsum; 1NW9; -.
DR   PDBsum; 2AR9; -.
DR   PDBsum; 3D9T; -.
DR   PDBsum; 3V3K; -.
DR   PDBsum; 3YGS; -.
DR   PDBsum; 4RHW; -.
DR   PDBsum; 5JUY; -.
DR   PDBsum; 5WVC; -.
DR   PDBsum; 5WVE; -.
DR   ProteinModelPortal; P55211; -.
DR   SMR; P55211; -.
DR   BioGrid; 107292; 37.
DR   ComplexPortal; CPX-3762; Apoptosome.
DR   ComplexPortal; CPX-991; Caspase-9 complex.
DR   CORUM; P55211; -.
DR   DIP; DIP-27625N; -.
DR   ELM; P55211; -.
DR   IntAct; P55211; 18.
DR   MINT; P55211; -.
DR   STRING; 9606.ENSP00000330237; -.
DR   BindingDB; P55211; -.
DR   ChEMBL; CHEMBL2273; -.
DR   GuidetoPHARMACOLOGY; 1625; -.
DR   MEROPS; C14.010; -.
DR   iPTMnet; P55211; -.
DR   PhosphoSitePlus; P55211; -.
DR   BioMuta; CASP9; -.
DR   DMDM; 28558771; -.
DR   EPD; P55211; -.
DR   jPOST; P55211; -.
DR   MaxQB; P55211; -.
DR   PaxDb; P55211; -.
DR   PeptideAtlas; P55211; -.
DR   PRIDE; P55211; -.
DR   ProteomicsDB; 56814; -.
DR   ProteomicsDB; 56815; -. [P55211-2]
DR   ProteomicsDB; 56816; -. [P55211-3]
DR   DNASU; 842; -.
DR   Ensembl; ENST00000333868; ENSP00000330237; ENSG00000132906. [P55211-1]
DR   Ensembl; ENST00000348549; ENSP00000255256; ENSG00000132906. [P55211-2]
DR   Ensembl; ENST00000375890; ENSP00000365051; ENSG00000132906. [P55211-4]
DR   GeneID; 842; -.
DR   KEGG; hsa:842; -.
DR   UCSC; uc001awn.5; human. [P55211-1]
DR   CTD; 842; -.
DR   DisGeNET; 842; -.
DR   EuPathDB; HostDB:ENSG00000132906.17; -.
DR   GeneCards; CASP9; -.
DR   HGNC; HGNC:1511; CASP9.
DR   HPA; CAB004348; -.
DR   HPA; HPA001473; -.
DR   HPA; HPA046488; -.
DR   MIM; 602234; gene.
DR   neXtProt; NX_P55211; -.
DR   OpenTargets; ENSG00000132906; -.
DR   PharmGKB; PA26094; -.
DR   eggNOG; KOG3573; Eukaryota.
DR   eggNOG; ENOG410ZQIE; LUCA.
DR   GeneTree; ENSGT00940000159698; -.
DR   HOVERGEN; HBG059022; -.
DR   InParanoid; P55211; -.
DR   KO; K04399; -.
DR   OrthoDB; 1092723at2759; -.
DR   PhylomeDB; P55211; -.
DR   TreeFam; TF102023; -.
DR   BRENDA; 3.4.22.62; 2681.
DR   Reactome; R-HSA-111458; Formation of apoptosome.
DR   Reactome; R-HSA-111459; Activation of caspases through apoptosome-mediated cleavage.
DR   Reactome; R-HSA-111463; SMAC (DIABLO) binds to IAPs.
DR   Reactome; R-HSA-111464; SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes.
DR   Reactome; R-HSA-168638; NOD1/2 Signaling Pathway.
DR   Reactome; R-HSA-198323; AKT phosphorylates targets in the cytosol.
DR   Reactome; R-HSA-418889; Caspase activation via Dependence Receptors in the absence of ligand.
DR   Reactome; R-HSA-5674400; Constitutive Signaling by AKT1 E17K in Cancer.
DR   Reactome; R-HSA-9627069; Regulation of the apoptosome activity.
DR   SABIO-RK; P55211; -.
DR   SIGNOR; P55211; -.
DR   EvolutionaryTrace; P55211; -.
DR   GeneWiki; Caspase-9; -.
DR   GenomeRNAi; 842; -.
DR   PMAP-CutDB; P55211; -.
DR   PRO; PR:P55211; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000132906; Expressed in 232 organ(s), highest expression level in adrenal tissue.
DR   ExpressionAtlas; P55211; baseline and differential.
DR   Genevisible; P55211; HS.
DR   GO; GO:0043293; C:apoptosome; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IEA:Ensembl.
DR   GO; GO:0032991; C:protein-containing complex; IDA:UniProtKB.
DR   GO; GO:0004197; F:cysteine-type endopeptidase activity; IDA:UniProtKB.
DR   GO; GO:0097153; F:cysteine-type endopeptidase activity involved in apoptotic process; IBA:GO_Central.
DR   GO; GO:0097199; F:cysteine-type endopeptidase activity involved in apoptotic signaling pathway; IMP:UniProtKB.
DR   GO; GO:0008047; F:enzyme activator activity; TAS:ProtInc.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0008233; F:peptidase activity; IDA:BHF-UCL.
DR   GO; GO:0019901; F:protein kinase binding; IDA:UniProtKB.
DR   GO; GO:0017124; F:SH3 domain binding; IDA:UniProtKB.
DR   GO; GO:0008635; P:activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c; TAS:ProtInc.
DR   GO; GO:0007568; P:aging; IEA:Ensembl.
DR   GO; GO:0006915; P:apoptotic process; IMP:UniProtKB.
DR   GO; GO:0071549; P:cellular response to dexamethasone stimulus; IEA:Ensembl.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB.
DR   GO; GO:0034644; P:cellular response to UV; IDA:UniProtKB.
DR   GO; GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; TAS:Reactome.
DR   GO; GO:0034349; P:glial cell apoptotic process; IEA:Ensembl.
DR   GO; GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; IMP:UniProtKB.
DR   GO; GO:0001822; P:kidney development; IEA:Ensembl.
DR   GO; GO:0071887; P:leukocyte apoptotic process; IEA:Ensembl.
DR   GO; GO:0030220; P:platelet formation; TAS:UniProtKB.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IMP:UniProtKB.
DR   GO; GO:0043525; P:positive regulation of neuron apoptotic process; IEA:Ensembl.
DR   GO; GO:2001020; P:regulation of response to DNA damage stimulus; IMP:UniProtKB.
DR   GO; GO:0046677; P:response to antibiotic; IEA:Ensembl.
DR   GO; GO:0032025; P:response to cobalt ion; IEA:Ensembl.
DR   GO; GO:0032355; P:response to estradiol; IEA:Ensembl.
DR   GO; GO:0002931; P:response to ischemia; IEA:Ensembl.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl.
DR   GO; GO:0042770; P:signal transduction in response to DNA damage; IDA:UniProtKB.
DR   CDD; cd00032; CASc; 1.
DR   InterPro; IPR001315; CARD.
DR   InterPro; IPR033171; Caspase-9.
DR   InterPro; IPR029030; Caspase-like_dom_sf.
DR   InterPro; IPR033139; Caspase_cys_AS.
DR   InterPro; IPR016129; Caspase_his_AS.
DR   InterPro; IPR011029; DEATH-like_dom_sf.
DR   InterPro; IPR002398; Pept_C14.
DR   InterPro; IPR002138; Pept_C14_p10.
DR   InterPro; IPR001309; Pept_C14_p20.
DR   InterPro; IPR015917; Pept_C14A.
DR   PANTHER; PTHR10454; PTHR10454; 2.
DR   PANTHER; PTHR10454:SF157; PTHR10454:SF157; 2.
DR   Pfam; PF00619; CARD; 1.
DR   PRINTS; PR00376; IL1BCENZYME.
DR   SMART; SM00114; CARD; 1.
DR   SMART; SM00115; CASc; 1.
DR   SUPFAM; SSF47986; SSF47986; 1.
DR   SUPFAM; SSF52129; SSF52129; 1.
DR   PROSITE; PS50209; CARD; 1.
DR   PROSITE; PS01122; CASPASE_CYS; 1.
DR   PROSITE; PS01121; CASPASE_HIS; 1.
DR   PROSITE; PS50207; CASPASE_P10; 1.
DR   PROSITE; PS50208; CASPASE_P20; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Apoptosis; Complete proteome;
KW   Hydrolase; Phosphoprotein; Polymorphism; Protease; Reference proteome;
KW   Thiol protease; Zymogen.
FT   PROPEP        1      ?       {ECO:0000255}.
FT                                /FTId=PRO_0000004640.
FT   CHAIN         ?    315       Caspase-9 subunit p35.
FT                                /FTId=PRO_0000004641.
FT   PROPEP      316    330
FT                                /FTId=PRO_0000004642.
FT   CHAIN       331    416       Caspase-9 subunit p10.
FT                                /FTId=PRO_0000004643.
FT   DOMAIN        1     92       CARD. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00046}.
FT   ACT_SITE    237    237       {ECO:0000250}.
FT   ACT_SITE    287    287       {ECO:0000250}.
FT   MOD_RES     125    125       Phosphothreonine; by MAPK1.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000269|PubMed:12792650}.
FT   MOD_RES     153    153       Phosphotyrosine; by ABL1.
FT                                {ECO:0000269|PubMed:15657060}.
FT   MOD_RES     302    302       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     307    307       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES     310    310       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1     83       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_044256.
FT   VAR_SEQ     140    289       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:10070954,
FT                                ECO:0000303|PubMed:9890966,
FT                                ECO:0000303|Ref.5, ECO:0000303|Ref.6}.
FT                                /FTId=VSP_000818.
FT   VAR_SEQ     152    154       AYI -> TVL (in isoform 3).
FT                                {ECO:0000303|PubMed:16780893}.
FT                                /FTId=VSP_043910.
FT   VAR_SEQ     155    416       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:16780893}.
FT                                /FTId=VSP_043911.
FT   VARIANT      28     28       A -> V (in dbSNP:rs1052571).
FT                                {ECO:0000269|PubMed:16780893,
FT                                ECO:0000269|PubMed:8663294,
FT                                ECO:0000269|PubMed:9890966,
FT                                ECO:0000269|Ref.9}.
FT                                /FTId=VAR_015415.
FT   VARIANT      99     99       S -> L (in dbSNP:rs4646008).
FT                                {ECO:0000269|Ref.9}.
FT                                /FTId=VAR_015416.
FT   VARIANT     102    102       T -> I (in dbSNP:rs2308941).
FT                                {ECO:0000269|Ref.9}.
FT                                /FTId=VAR_015417.
FT   VARIANT     106    106       L -> V (in dbSNP:rs2308938).
FT                                {ECO:0000269|Ref.9}.
FT                                /FTId=VAR_015418.
FT   VARIANT     114    114       E -> D (in dbSNP:rs2020897).
FT                                {ECO:0000269|Ref.9}.
FT                                /FTId=VAR_015419.
FT   VARIANT     136    136       F -> L (in dbSNP:rs1132312).
FT                                /FTId=VAR_059198.
FT   VARIANT     173    173       R -> H (in dbSNP:rs2308950).
FT                                {ECO:0000269|Ref.9}.
FT                                /FTId=VAR_015420.
FT   VARIANT     176    176       G -> R (in dbSNP:rs2308949).
FT                                /FTId=VAR_016131.
FT   VARIANT     185    185       I -> M (in dbSNP:rs9282624).
FT                                /FTId=VAR_022053.
FT   VARIANT     192    192       R -> C (in dbSNP:rs2308939).
FT                                /FTId=VAR_016132.
FT   VARIANT     221    221       Q -> R (in dbSNP:rs1052576).
FT                                {ECO:0000269|PubMed:8663294,
FT                                ECO:0000269|Ref.9}.
FT                                /FTId=VAR_015421.
FT   MUTAGEN     153    153       Y->F: Inhibits tyrosine phosphorylation.
FT                                Reduces caspase-9 subunit p35 formation
FT                                in response to genotoxic stress.
FT                                Attenuates ABL1/c-Abl-mediated caspase-3
FT                                activation, DNA fragmentation and UV
FT                                irradiation-induced apoptosis.
FT                                {ECO:0000269|PubMed:15657060}.
FT   CONFLICT     32     32       R -> S (in Ref. 2; AAC50776, 3; BAA82697
FT                                and 6; BAA87905). {ECO:0000305}.
FT   CONFLICT     96     96       A -> G (in Ref. 1; AAC50640).
FT                                {ECO:0000305}.
FT   CONFLICT    197    197       L -> P (in Ref. 2; AAC50776 and 3;
FT                                BAA82697). {ECO:0000305}.
FT   HELIX         3     11       {ECO:0000244|PDB:4RHW}.
FT   HELIX        13     19       {ECO:0000244|PDB:4RHW}.
FT   TURN         23     25       {ECO:0000244|PDB:4RHW}.
FT   HELIX        26     31       {ECO:0000244|PDB:4RHW}.
FT   HELIX        37     44       {ECO:0000244|PDB:4RHW}.
FT   HELIX        51     62       {ECO:0000244|PDB:4RHW}.
FT   HELIX        69     79       {ECO:0000244|PDB:4RHW}.
FT   HELIX        83     93       {ECO:0000244|PDB:4RHW}.
FT   HELIX       143    147       {ECO:0000244|PDB:1NW9}.
FT   TURN        149    151       {ECO:0000244|PDB:1NW9}.
FT   STRAND      157    159       {ECO:0000244|PDB:1JXQ}.
FT   STRAND      161    167       {ECO:0000244|PDB:1NW9}.
FT   HELIX       173    175       {ECO:0000244|PDB:1NW9}.
FT   HELIX       183    196       {ECO:0000244|PDB:1NW9}.
FT   STRAND      199    206       {ECO:0000244|PDB:1NW9}.
FT   HELIX       209    221       {ECO:0000244|PDB:1NW9}.
FT   HELIX       224    226       {ECO:0000244|PDB:2AR9}.
FT   STRAND      228    239       {ECO:0000244|PDB:1NW9}.
FT   STRAND      244    246       {ECO:0000244|PDB:1NW9}.
FT   STRAND      249    251       {ECO:0000244|PDB:1NW9}.
FT   STRAND      257    259       {ECO:0000244|PDB:1NW9}.
FT   HELIX       260    265       {ECO:0000244|PDB:1NW9}.
FT   TURN        269    271       {ECO:0000244|PDB:1NW9}.
FT   HELIX       273    275       {ECO:0000244|PDB:1NW9}.
FT   STRAND      280    287       {ECO:0000244|PDB:1NW9}.
FT   STRAND      317    319       {ECO:0000244|PDB:3D9T}.
FT   STRAND      340    346       {ECO:0000244|PDB:1NW9}.
FT   STRAND      351    353       {ECO:0000244|PDB:1NW9}.
FT   STRAND      354    356       {ECO:0000244|PDB:3V3K}.
FT   TURN        357    359       {ECO:0000244|PDB:1JXQ}.
FT   HELIX       362    374       {ECO:0000244|PDB:1NW9}.
FT   TURN        375    377       {ECO:0000244|PDB:1NW9}.
FT   HELIX       380    392       {ECO:0000244|PDB:1NW9}.
FT   STRAND      395    398       {ECO:0000244|PDB:1JXQ}.
FT   STRAND      402    406       {ECO:0000244|PDB:1JXQ}.
FT   STRAND      408    410       {ECO:0000244|PDB:1NW9}.
SQ   SEQUENCE   416 AA;  46281 MW;  78E0180DF2A3BDD2 CRC64;
     MDEADRRLLR RCRLRLVEEL QVDQLWDALL SRELFRPHMI EDIQRAGSGS RRDQARQLII
     DLETRGSQAL PLFISCLEDT GQDMLASFLR TNRQAAKLSK PTLENLTPVV LRPEIRKPEV
     LRPETPRPVD IGSGGFGDVG ALESLRGNAD LAYILSMEPC GHCLIINNVN FCRESGLRTR
     TGSNIDCEKL RRRFSSLHFM VEVKGDLTAK KMVLALLELA QQDHGALDCC VVVILSHGCQ
     ASHLQFPGAV YGTDGCPVSV EKIVNIFNGT SCPSLGGKPK LFFIQACGGE QKDHGFEVAS
     TSPEDESPGS NPEPDATPFQ EGLRTFDQLD AISSLPTPSD IFVSYSTFPG FVSWRDPKSG
     SWYVETLDDI FEQWAHSEDL QSLLLRVANA VSVKGIYKQM PGCFNFLRKK LFFKTS
//
ID   E5RFK5_HUMAN            Unreviewed;       282 AA.
AC   E5RFK5;
DT   08-FEB-2011, integrated into UniProtKB/TrEMBL.
DT   08-FEB-2011, sequence version 1.
DT   16-JAN-2019, entry version 74.
DE   SubName: Full=Cyclin-C {ECO:0000313|Ensembl:ENSP00000430381};
GN   Name=CCNC {ECO:0000313|Ensembl:ENSP00000430381};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000430381, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000430381, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [2] {ECO:0000213|PubMed:19369195}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [3] {ECO:0000313|Ensembl:ENSP00000430381}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
RN   [4] {ECO:0000313|Ensembl:ENSP00000430294}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (FEB-2012) to UniProtKB.
CC   -!- SIMILARITY: Belongs to the cyclin family.
CC       {ECO:0000256|RuleBase:RU000383}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AL137784; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; XP_006715657.1; XM_006715594.1.
DR   UniGene; Hs.430646; -.
DR   UniGene; Hs.633351; -.
DR   IntAct; E5RFK5; 1.
DR   EPD; E5RFK5; -.
DR   jPOST; E5RFK5; -.
DR   MaxQB; E5RFK5; -.
DR   PRIDE; E5RFK5; -.
DR   Ensembl; ENST00000518714; ENSP00000430294; ENSG00000112237.
DR   Ensembl; ENST00000520371; ENSP00000430381; ENSG00000112237.
DR   GeneID; 892; -.
DR   UCSC; uc063qfz.1; human.
DR   CTD; 892; -.
DR   EuPathDB; HostDB:ENSG00000112237.12; -.
DR   HGNC; HGNC:1581; CCNC.
DR   OpenTargets; ENSG00000112237; -.
DR   eggNOG; KOG0794; Eukaryota.
DR   eggNOG; COG5333; LUCA.
DR   GeneTree; ENSGT00940000155625; -.
DR   OrthoDB; 1079428at2759; -.
DR   ChiTaRS; CCNC; human.
DR   GenomeRNAi; 892; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000112237; Expressed in 236 organ(s), highest expression level in nasal cavity mucosa.
DR   ExpressionAtlas; E5RFK5; baseline and differential.
DR   GO; GO:0016592; C:mediator complex; IEA:InterPro.
DR   GO; GO:0016538; F:cyclin-dependent protein serine/threonine kinase regulator activity; IEA:InterPro.
DR   CDD; cd00043; CYCLIN; 2.
DR   InterPro; IPR013763; Cyclin-like.
DR   InterPro; IPR036915; Cyclin-like_sf.
DR   InterPro; IPR031658; Cyclin_C_2.
DR   InterPro; IPR006671; Cyclin_N.
DR   InterPro; IPR028367; CyclinC/Ssn8.
DR   PANTHER; PTHR10026:SF7; PTHR10026:SF7; 1.
DR   Pfam; PF16899; Cyclin_C_2; 1.
DR   Pfam; PF00134; Cyclin_N; 1.
DR   SMART; SM00385; CYCLIN; 2.
DR   SUPFAM; SSF47954; SSF47954; 2.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Cyclin {ECO:0000256|RuleBase:RU000383};
KW   Proteomics identification {ECO:0000213|EPD:E5RFK5,
KW   ECO:0000213|MaxQB:E5RFK5, ECO:0000213|PeptideAtlas:E5RFK5};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN       46    144       CYCLIN. {ECO:0000259|SMART:SM00385}.
FT   DOMAIN      161    236       CYCLIN. {ECO:0000259|SMART:SM00385}.
SQ   SEQUENCE   282 AA;  33140 MW;  77380A1C0D421B80 CRC64;
     MAGNFWQSSH YLQWILDKQD LLKERQKDLK FLSEEEYWKL QIFFTNVIQA LGEHLKLRQQ
     VIATATVYFK RFYARYSLKS IDPVLMAPTC VFLASKVEEF GVVSNTRLIA AATSVLKTRF
     SYAFPKEFPY RMNHILECEF YLLELMDCCL IVYHPYRPLL QYVQDMGQED MLLPLAWRIV
     NDTYRTDLCL LYPPFMIALA CLHVACVVQQ KDARQWFAEL SVDMEKILEI IRVILKLYEQ
     WKNFDERKEM ATILSKMPKP KPPPNRNSLS DSPLVAGPEA AR
//
ID   CCNC_HUMAN              Reviewed;         283 AA.
AC   P24863; B4DPZ1; Q9H543;
DT   01-MAR-1992, integrated into UniProtKB/Swiss-Prot.
DT   15-JAN-2008, sequence version 2.
DT   13-FEB-2019, entry version 188.
DE   RecName: Full=Cyclin-C;
DE   AltName: Full=SRB11 homolog;
DE            Short=hSRB11;
GN   Name=CCNC;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=1833066; DOI=10.1016/0092-8674(91)90042-W;
RA   Lew D.J., Dulic V., Reed S.I.;
RT   "Isolation of three novel human cyclins by rescue of G1 cyclin (Cln)
RT   function in yeast.";
RL   Cell 66:1197-1206(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8833152; DOI=10.1006/geno.1996.0112;
RA   Li H., Lahti J.M., Valentine M., Saito M., Reed S.I., Look A.T.,
RA   Kidd V.J.;
RT   "Molecular cloning and chromosomal localization of the human cyclin C
RT   (CCNC) and cyclin E (CCNE) genes: deletion of the CCNC gene in human
RT   tumors.";
RL   Genomics 32:253-259(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [5]
RP   FUNCTION.
RX   PubMed=8700522;
RA   Rickert P., Seghezzi W., Shanahan F., Cho H., Lees E.;
RT   "Cyclin C/CDK8 is a novel CTD kinase associated with RNA polymerase
RT   II.";
RL   Oncogene 12:2631-2640(1996).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND IDENTIFICATION IN A FORM OF
RP   THE MEDIATOR COMPLEX.
RX   PubMed=9734358; DOI=10.1016/S1097-2765(00)80131-8;
RA   Sun X., Zhang Y., Cho H., Rickert P., Lees E., Lane W.S., Reinberg D.;
RT   "NAT, a human complex containing Srb polypeptides that functions as a
RT   negative regulator of activated transcription.";
RL   Mol. Cell 2:213-222(1998).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND IDENTIFICATION IN THE SMCC
RP   COMPLEX.
RX   PubMed=10024883; DOI=10.1016/S1097-2765(00)80178-1;
RA   Gu W., Malik S., Ito M., Yuan C.-X., Fondell J.D., Zhang X.,
RA   Martinez E., Qin J., Roeder R.G.;
RT   "A novel human SRB/MED-containing cofactor complex, SMCC, involved in
RT   transcription regulation.";
RL   Mol. Cell 3:97-108(1999).
RN   [8]
RP   ERRATUM.
RA   Gu W., Malik S., Ito M., Yuan C.-X., Fondell J.D., Zhang X.,
RA   Martinez E., Qin J., Roeder R.G.;
RL   Mol. Cell 3:541-541(1999).
RN   [9]
RP   INTERACTION WITH MED6.
RX   PubMed=10993082; DOI=10.1038/35024111;
RA   Akoulitchev S., Chuikov S., Reinberg D.;
RT   "TFIIH is negatively regulated by cdk8-containing mediator
RT   complexes.";
RL   Nature 407:102-106(2000).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND IDENTIFICATION IN THE
RP   MEDIATOR COMPLEX.
RX   PubMed=15175163; DOI=10.1016/j.molcel.2004.05.006;
RA   Sato S., Tomomori-Sato C., Parmely T.J., Florens L., Zybailov B.,
RA   Swanson S.K., Banks C.A.S., Jin J., Cai Y., Washburn M.P.,
RA   Conaway J.W., Conaway R.C.;
RT   "A set of consensus mammalian mediator subunits identified by
RT   multidimensional protein identification technology.";
RL   Mol. Cell 14:685-691(2004).
RN   [11]
RP   FUNCTION, AND INTERACTION WITH MED1 AND MED10.
RX   PubMed=16595664; DOI=10.1074/jbc.M601983200;
RA   Baek H.J., Kang Y.K., Roeder R.G.;
RT   "Human Mediator enhances basal transcription by facilitating
RT   recruitment of transcription factor IIB during preinitiation complex
RT   assembly.";
RL   J. Biol. Chem. 281:15172-15181(2006).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-275, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) IN COMPLEX WITH CDK8 AND
RP   INHIBITOR.
RX   PubMed=21806996; DOI=10.1016/j.jmb.2011.07.020;
RA   Schneider E.V., Bottcher J., Blaesse M., Neumann L., Huber R.,
RA   Maskos K.;
RT   "The structure of CDK8/CycC implicates specificity in the CDK/cyclin
RT   family and reveals interaction with a deep pocket binder.";
RL   J. Mol. Biol. 412:251-266(2011).
CC   -!- FUNCTION: Component of the Mediator complex, a coactivator
CC       involved in regulated gene transcription of nearly all RNA
CC       polymerase II-dependent genes. Mediator functions as a bridge to
CC       convey information from gene-specific regulatory proteins to the
CC       basal RNA polymerase II transcription machinery. Mediator is
CC       recruited to promoters by direct interactions with regulatory
CC       proteins and serves as a scaffold for the assembly of a functional
CC       preinitiation complex with RNA polymerase II and the general
CC       transcription factors. Binds to and activates cyclin-dependent
CC       kinase CDK8 that phosphorylates the CTD (C-terminal domain) of the
CC       large subunit of RNA polymerase II (RNAp II), which may inhibit
CC       the formation of a transcription initiation complex.
CC       {ECO:0000269|PubMed:16595664, ECO:0000269|PubMed:8700522}.
CC   -!- SUBUNIT: Component of the Mediator complex, which is composed of
CC       MED1, MED4, MED6, MED7, MED8, MED9, MED10, MED11, MED12, MED13,
CC       MED13L, MED14, MED15, MED16, MED17, MED18, MED19, MED20, MED21,
CC       MED22, MED23, MED24, MED25, MED26, MED27, MED29, MED30, MED31,
CC       CCNC, CDK8 and CDC2L6/CDK11. The MED12, MED13, CCNC and CDK8
CC       subunits form a distinct module termed the CDK8 module. Mediator
CC       containing the CDK8 module is less active than Mediator lacking
CC       this module in supporting transcriptional activation. Individual
CC       preparations of the Mediator complex lacking one or more distinct
CC       subunits have been variously termed ARC, CRSP, DRIP, PC2, SMCC and
CC       TRAP. The cylin/CDK pair formed by CCNC/CDK8 also associates with
CC       the large subunit of RNA polymerase II.
CC       {ECO:0000269|PubMed:10024883, ECO:0000269|PubMed:15175163,
CC       ECO:0000269|PubMed:21806996, ECO:0000269|PubMed:9734358}.
CC   -!- INTERACTION:
CC       Q00526:CDK3; NbExp=6; IntAct=EBI-395261, EBI-1245761;
CC       Q00535:CDK5; NbExp=2; IntAct=EBI-395261, EBI-1041567;
CC       P49336:CDK8; NbExp=36; IntAct=EBI-395261, EBI-394377;
CC       O43186:CRX; NbExp=3; IntAct=EBI-395261, EBI-748171;
CC       Q8WWB3:DYDC1; NbExp=3; IntAct=EBI-395261, EBI-740680;
CC       O15409:FOXP2; NbExp=3; IntAct=EBI-395261, EBI-983612;
CC       Q49A26:GLYR1; NbExp=3; IntAct=EBI-395261, EBI-2804292;
CC       Q08379:GOLGA2; NbExp=3; IntAct=EBI-395261, EBI-618309;
CC       A1A4E9:KRT13; NbExp=3; IntAct=EBI-395261, EBI-10171552;
CC       P19012:KRT15; NbExp=3; IntAct=EBI-395261, EBI-739566;
CC       Q15323:KRT31; NbExp=5; IntAct=EBI-395261, EBI-948001;
CC       Q9BRK4:LZTS2; NbExp=3; IntAct=EBI-395261, EBI-741037;
CC       Q9NS73-5:MBIP; NbExp=3; IntAct=EBI-395261, EBI-10182361;
CC       P50222:MEOX2; NbExp=3; IntAct=EBI-395261, EBI-748397;
CC       O14880:MGST3; NbExp=3; IntAct=EBI-395261, EBI-724754;
CC       I6L9F6:NEFL; NbExp=3; IntAct=EBI-395261, EBI-10178578;
CC       Q9HAN9:NMNAT1; NbExp=3; IntAct=EBI-395261, EBI-3917542;
CC       Q96AQ6:PBXIP1; NbExp=3; IntAct=EBI-395261, EBI-740845;
CC       Q96PV4:PNMA5; NbExp=3; IntAct=EBI-395261, EBI-10171633;
CC       Q9UHX1:PUF60; NbExp=3; IntAct=EBI-395261, EBI-1053259;
CC       P06400:RB1; NbExp=4; IntAct=EBI-395261, EBI-491274;
CC       O75528:TADA3; NbExp=3; IntAct=EBI-395261, EBI-473249;
CC       Q9HCM9:TRIM39; NbExp=3; IntAct=EBI-395261, EBI-739510;
CC       P17022:ZNF18; NbExp=4; IntAct=EBI-395261, EBI-8648067;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P24863-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P24863-2; Sequence=VSP_043075;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Highest levels in pancreas. High levels in
CC       heart, liver, skeletal muscle and kidney. Low levels in brain.
CC   -!- SIMILARITY: Belongs to the cyclin family. Cyclin C subfamily.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC50825.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; M74091; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; U40739; AAC50825.1; ALT_INIT; Genomic_DNA.
DR   EMBL; U40728; AAC50825.1; JOINED; Genomic_DNA.
DR   EMBL; U40729; AAC50825.1; JOINED; Genomic_DNA.
DR   EMBL; U40730; AAC50825.1; JOINED; Genomic_DNA.
DR   EMBL; U40731; AAC50825.1; JOINED; Genomic_DNA.
DR   EMBL; U40732; AAC50825.1; JOINED; Genomic_DNA.
DR   EMBL; U40733; AAC50825.1; JOINED; Genomic_DNA.
DR   EMBL; U40734; AAC50825.1; JOINED; Genomic_DNA.
DR   EMBL; U40735; AAC50825.1; JOINED; Genomic_DNA.
DR   EMBL; U40736; AAC50825.1; JOINED; Genomic_DNA.
DR   EMBL; U40737; AAC50825.1; JOINED; Genomic_DNA.
DR   EMBL; U40738; AAC50825.1; JOINED; Genomic_DNA.
DR   EMBL; AK298558; BAG60753.1; -; mRNA.
DR   EMBL; AL137784; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS34502.1; -. [P24863-1]
DR   CCDS; CCDS47461.1; -. [P24863-2]
DR   PIR; A40268; A40268.
DR   RefSeq; NP_001013417.1; NM_001013399.1. [P24863-2]
DR   RefSeq; NP_005181.2; NM_005190.3. [P24863-1]
DR   UniGene; Hs.430646; -.
DR   UniGene; Hs.633351; -.
DR   PDB; 3RGF; X-ray; 2.20 A; B=1-283.
DR   PDB; 4CRL; X-ray; 2.40 A; B=1-283.
DR   PDB; 4F6S; X-ray; 2.60 A; B=1-283.
DR   PDB; 4F6U; X-ray; 2.10 A; B=1-283.
DR   PDB; 4F6W; X-ray; 2.39 A; B=1-283.
DR   PDB; 4F70; X-ray; 3.00 A; B=1-283.
DR   PDB; 4F7J; X-ray; 2.60 A; B=1-283.
DR   PDB; 4F7L; X-ray; 2.90 A; B=1-283.
DR   PDB; 4F7N; X-ray; 2.65 A; B=1-283.
DR   PDB; 4F7S; X-ray; 2.20 A; B=1-283.
DR   PDB; 4G6L; X-ray; 2.70 A; B=1-283.
DR   PDB; 5BNJ; X-ray; 2.64 A; B=1-283.
DR   PDB; 5CEI; X-ray; 2.24 A; B=1-283.
DR   PDB; 5FGK; X-ray; 2.36 A; B=1-264.
DR   PDB; 5HBE; X-ray; 2.38 A; B=1-264.
DR   PDB; 5HBH; X-ray; 2.50 A; B=1-264.
DR   PDB; 5HBJ; X-ray; 3.00 A; B=1-264.
DR   PDB; 5HNB; X-ray; 2.35 A; B=1-264.
DR   PDB; 5HVY; X-ray; 2.39 A; B=1-283.
DR   PDB; 5I5Z; X-ray; 2.60 A; B=1-264.
DR   PDB; 5ICP; X-ray; 2.18 A; B=1-264.
DR   PDB; 5IDN; X-ray; 2.26 A; B=1-264.
DR   PDB; 5IDP; X-ray; 2.65 A; B=1-264.
DR   PDB; 5XQX; X-ray; 2.30 A; B=2-264.
DR   PDB; 5XS2; X-ray; 2.04 A; B=2-264.
DR   PDBsum; 3RGF; -.
DR   PDBsum; 4CRL; -.
DR   PDBsum; 4F6S; -.
DR   PDBsum; 4F6U; -.
DR   PDBsum; 4F6W; -.
DR   PDBsum; 4F70; -.
DR   PDBsum; 4F7J; -.
DR   PDBsum; 4F7L; -.
DR   PDBsum; 4F7N; -.
DR   PDBsum; 4F7S; -.
DR   PDBsum; 4G6L; -.
DR   PDBsum; 5BNJ; -.
DR   PDBsum; 5CEI; -.
DR   PDBsum; 5FGK; -.
DR   PDBsum; 5HBE; -.
DR   PDBsum; 5HBH; -.
DR   PDBsum; 5HBJ; -.
DR   PDBsum; 5HNB; -.
DR   PDBsum; 5HVY; -.
DR   PDBsum; 5I5Z; -.
DR   PDBsum; 5ICP; -.
DR   PDBsum; 5IDN; -.
DR   PDBsum; 5IDP; -.
DR   PDBsum; 5XQX; -.
DR   PDBsum; 5XS2; -.
DR   ProteinModelPortal; P24863; -.
DR   SMR; P24863; -.
DR   BioGrid; 107333; 74.
DR   ComplexPortal; CPX-1969; Cyclin C-CDK8 complex.
DR   ComplexPortal; CPX-3232; CKM complex variant 1.
DR   ComplexPortal; CPX-3263; CKM complex variant 2.
DR   ComplexPortal; CPX-330; Cyclin C-CDK3 complex.
DR   CORUM; P24863; -.
DR   DIP; DIP-32920N; -.
DR   IntAct; P24863; 102.
DR   MINT; P24863; -.
DR   STRING; 9606.ENSP00000428982; -.
DR   BindingDB; P24863; -.
DR   ChEMBL; CHEMBL3883323; -.
DR   iPTMnet; P24863; -.
DR   PhosphoSitePlus; P24863; -.
DR   BioMuta; CCNC; -.
DR   DMDM; 166214910; -.
DR   EPD; P24863; -.
DR   jPOST; P24863; -.
DR   PaxDb; P24863; -.
DR   PeptideAtlas; P24863; -.
DR   PRIDE; P24863; -.
DR   ProteomicsDB; 54234; -.
DR   ProteomicsDB; 54235; -. [P24863-2]
DR   DNASU; 892; -.
DR   Ensembl; ENST00000520429; ENSP00000428982; ENSG00000112237. [P24863-1]
DR   Ensembl; ENST00000523799; ENSP00000430014; ENSG00000112237. [P24863-2]
DR   Ensembl; ENST00000523985; ENSP00000430119; ENSG00000112237. [P24863-2]
DR   GeneID; 892; -.
DR   KEGG; hsa:892; -.
DR   UCSC; uc003pqd.4; human. [P24863-1]
DR   CTD; 892; -.
DR   DisGeNET; 892; -.
DR   EuPathDB; HostDB:ENSG00000112237.12; -.
DR   GeneCards; CCNC; -.
DR   HGNC; HGNC:1581; CCNC.
DR   HPA; CAB010499; -.
DR   HPA; HPA069322; -.
DR   MIM; 123838; gene.
DR   neXtProt; NX_P24863; -.
DR   OpenTargets; ENSG00000112237; -.
DR   PharmGKB; PA26149; -.
DR   eggNOG; KOG0794; Eukaryota.
DR   eggNOG; COG5333; LUCA.
DR   GeneTree; ENSGT00940000155625; -.
DR   HOGENOM; HOG000008007; -.
DR   HOVERGEN; HBG050836; -.
DR   InParanoid; P24863; -.
DR   KO; K15161; -.
DR   OMA; SSHHQQW; -.
DR   OrthoDB; 1506373at2759; -.
DR   PhylomeDB; P24863; -.
DR   Reactome; R-HSA-1989781; PPARA activates gene expression.
DR   Reactome; R-HSA-2122947; NOTCH1 Intracellular Domain Regulates Transcription.
DR   Reactome; R-HSA-212436; Generic Transcription Pathway.
DR   Reactome; R-HSA-2173796; SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription.
DR   Reactome; R-HSA-2644606; Constitutive Signaling by NOTCH1 PEST Domain Mutants.
DR   Reactome; R-HSA-2894862; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants.
DR   Reactome; R-HSA-381340; Transcriptional regulation of white adipocyte differentiation.
DR   SignaLink; P24863; -.
DR   SIGNOR; P24863; -.
DR   ChiTaRS; CCNC; human.
DR   GeneWiki; CCNC_(gene); -.
DR   GenomeRNAi; 892; -.
DR   PRO; PR:P24863; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000112237; Expressed in 236 organ(s), highest expression level in nasal cavity mucosa.
DR   ExpressionAtlas; P24863; baseline and differential.
DR   Genevisible; P24863; HS.
DR   GO; GO:0016592; C:mediator complex; IBA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0016538; F:cyclin-dependent protein serine/threonine kinase regulator activity; IBA:GO_Central.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; TAS:Reactome.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome.
DR   CDD; cd00043; CYCLIN; 2.
DR   InterPro; IPR013763; Cyclin-like.
DR   InterPro; IPR036915; Cyclin-like_sf.
DR   InterPro; IPR031658; Cyclin_C_2.
DR   InterPro; IPR006671; Cyclin_N.
DR   InterPro; IPR028367; CyclinC/Ssn8.
DR   PANTHER; PTHR10026:SF7; PTHR10026:SF7; 1.
DR   Pfam; PF16899; Cyclin_C_2; 1.
DR   Pfam; PF00134; Cyclin_N; 1.
DR   SMART; SM00385; CYCLIN; 2.
DR   SUPFAM; SSF47954; SSF47954; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; Alternative splicing; Complete proteome;
KW   Cyclin; Nucleus; Phosphoprotein; Reference proteome; Repressor;
KW   Transcription; Transcription regulation.
FT   CHAIN         1    283       Cyclin-C.
FT                                /FTId=PRO_0000080420.
FT   DOMAIN       46    144       Cyclin N-terminal.
FT   MOD_RES     275    275       Phosphoserine.
FT                                {ECO:0000244|PubMed:17525332}.
FT   VAR_SEQ       1     85       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_043075.
FT   TURN          1      3       {ECO:0000244|PDB:4F6U}.
FT   HELIX         5      7       {ECO:0000244|PDB:5XS2}.
FT   HELIX         9     13       {ECO:0000244|PDB:5XS2}.
FT   HELIX        18     25       {ECO:0000244|PDB:5XS2}.
FT   TURN         26     31       {ECO:0000244|PDB:5XS2}.
FT   HELIX        34     54       {ECO:0000244|PDB:5XS2}.
FT   HELIX        59     75       {ECO:0000244|PDB:5XS2}.
FT   TURN         78     80       {ECO:0000244|PDB:5XS2}.
FT   HELIX        83     97       {ECO:0000244|PDB:5XS2}.
FT   STRAND       98    100       {ECO:0000244|PDB:5HBE}.
FT   HELIX       105    119       {ECO:0000244|PDB:5XS2}.
FT   TURN        121    123       {ECO:0000244|PDB:5XS2}.
FT   HELIX       132    145       {ECO:0000244|PDB:5XS2}.
FT   TURN        146    148       {ECO:0000244|PDB:5XS2}.
FT   HELIX       156    166       {ECO:0000244|PDB:5XS2}.
FT   HELIX       169    183       {ECO:0000244|PDB:5XS2}.
FT   TURN        184    187       {ECO:0000244|PDB:4F7S}.
FT   HELIX       188    191       {ECO:0000244|PDB:5XS2}.
FT   HELIX       194    208       {ECO:0000244|PDB:5XS2}.
FT   HELIX       214    218       {ECO:0000244|PDB:5XS2}.
FT   HELIX       224    243       {ECO:0000244|PDB:5XS2}.
FT   HELIX       246    256       {ECO:0000244|PDB:5XS2}.
SQ   SEQUENCE   283 AA;  33243 MW;  CF8AC5E94E621F4C CRC64;
     MAGNFWQSSH YLQWILDKQD LLKERQKDLK FLSEEEYWKL QIFFTNVIQA LGEHLKLRQQ
     VIATATVYFK RFYARYSLKS IDPVLMAPTC VFLASKVEEF GVVSNTRLIA AATSVLKTRF
     SYAFPKEFPY RMNHILECEF YLLELMDCCL IVYHPYRPLL QYVQDMGQED MLLPLAWRIV
     NDTYRTDLCL LYPPFMIALA CLHVACVVQQ KDARQWFAEL SVDMEKILEI IRVILKLYEQ
     WKNFDERKEM ATILSKMPKP KPPPNSEGEQ GPNGSQNSSY SQS
//
ID   Q7Z4L3_HUMAN            Unreviewed;       283 AA.
AC   Q7Z4L3;
DT   01-OCT-2003, integrated into UniProtKB/TrEMBL.
DT   01-OCT-2003, sequence version 1.
DT   13-FEB-2019, entry version 151.
DE   SubName: Full=Cyclin C {ECO:0000313|EMBL:AAH56153.1};
DE   SubName: Full=Cyclin C, isoform CRA_a {ECO:0000313|EMBL:EAW48465.1};
GN   Name=CCNC {ECO:0000313|EMBL:AAH56153.1};
GN   ORFNames=hCG_1757197 {ECO:0000313|EMBL:EAW48465.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH56153.1};
RN   [1] {ECO:0000313|EMBL:EAW48465.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:BAD00144.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Ouchida M., Ohata N., Shimizu K.;
RT   "Expression of the CCNC gene in human tumor cells.";
RL   Submitted (OCT-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:AAH56153.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon {ECO:0000313|EMBL:AAH41123.1},
RC   Muscle {ECO:0000313|EMBL:AAH10135.1}, and
RC   Skin {ECO:0000313|EMBL:AAH56153.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M.,
RA   Peck A.M., Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S.,
RA   Feolo M., Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F.,
RA   Schaefer C.F., Buetow K., Bonner T.I., Haussler D., Kent J.,
RA   Kiekhaus M., Furey T., Brent M., Prange C., Schreiber K., Shapiro N.,
RA   Bhat N.K., Hopkins R.F., Hsie F., Driscoll T., Soares M.B.,
RA   Casavant T.L., Scheetz T.E., Brown-stein M.J., Usdin T.B.,
RA   Toshiyuki S., Carninci P., Piao Y., Dudekula D.B., Ko M.S.,
RA   Kawakami K., Suzuki Y., Sugano S., Gruber C.E., Smith M.R.,
RA   Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y., Wei C.L.,
RA   Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W., Fuh E.,
RA   Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D.,
RA   Granite S.J., Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G.,
RA   Blakesly R.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J.,
RA   Schmutz J., Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L.,
RA   Krzywinski M.I., Liao N., Morin R., Morrin R., Palmquist D.,
RA   Petrescu A.S., Skalska U., Smailus D.E., Stott J.M., Schnerch A.,
RA   Schein J.E., Jones S.J., Holt R.A., Baross A., Marra M.A., Clifton S.,
RA   Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4] {ECO:0000313|EMBL:EAW48465.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the cyclin family.
CC       {ECO:0000256|RuleBase:RU000383}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; BC010135; AAH10135.1; -; mRNA.
DR   EMBL; BC041123; AAH41123.1; -; mRNA.
DR   EMBL; BC056153; AAH56153.1; -; mRNA.
DR   EMBL; AB125137; BAD00144.1; -; mRNA.
DR   EMBL; CH471051; EAW48465.1; -; Genomic_DNA.
DR   EMBL; CH471051; EAW48466.1; -; Genomic_DNA.
DR   RefSeq; NP_001013417.1; NM_001013399.1.
DR   RefSeq; NP_005181.2; NM_005190.3.
DR   UniGene; Hs.430646; -.
DR   UniGene; Hs.633351; -.
DR   DNASU; 892; -.
DR   GeneID; 892; -.
DR   KEGG; hsa:892; -.
DR   UCSC; uc003pqe.4; human.
DR   CTD; 892; -.
DR   EuPathDB; HostDB:ENSG00000112237.12; -.
DR   PharmGKB; PA26149; -.
DR   eggNOG; KOG0794; Eukaryota.
DR   eggNOG; COG5333; LUCA.
DR   HOVERGEN; HBG050836; -.
DR   KO; K15161; -.
DR   OMA; SSHHQQW; -.
DR   OrthoDB; 1079428at2759; -.
DR   ChiTaRS; CCNC; human.
DR   GenomeRNAi; 892; -.
DR   Bgee; ENSG00000112237; Expressed in 236 organ(s), highest expression level in nasal cavity mucosa.
DR   GO; GO:0016592; C:mediator complex; IEA:Ensembl.
DR   GO; GO:0016538; F:cyclin-dependent protein serine/threonine kinase regulator activity; IEA:InterPro.
DR   CDD; cd00043; CYCLIN; 2.
DR   InterPro; IPR013763; Cyclin-like.
DR   InterPro; IPR036915; Cyclin-like_sf.
DR   InterPro; IPR031658; Cyclin_C_2.
DR   InterPro; IPR006671; Cyclin_N.
DR   InterPro; IPR028367; CyclinC/Ssn8.
DR   PANTHER; PTHR10026:SF7; PTHR10026:SF7; 1.
DR   Pfam; PF16899; Cyclin_C_2; 1.
DR   Pfam; PF00134; Cyclin_N; 1.
DR   SMART; SM00385; CYCLIN; 2.
DR   SUPFAM; SSF47954; SSF47954; 2.
PE   2: Evidence at transcript level;
KW   Cyclin {ECO:0000256|RuleBase:RU000383}.
FT   DOMAIN       46    144       CYCLIN. {ECO:0000259|SMART:SM00385}.
FT   DOMAIN      161    236       CYCLIN. {ECO:0000259|SMART:SM00385}.
SQ   SEQUENCE   283 AA;  33243 MW;  CF8AC5E94E621F4C CRC64;
     MAGNFWQSSH YLQWILDKQD LLKERQKDLK FLSEEEYWKL QIFFTNVIQA LGEHLKLRQQ
     VIATATVYFK RFYARYSLKS IDPVLMAPTC VFLASKVEEF GVVSNTRLIA AATSVLKTRF
     SYAFPKEFPY RMNHILECEF YLLELMDCCL IVYHPYRPLL QYVQDMGQED MLLPLAWRIV
     NDTYRTDLCL LYPPFMIALA CLHVACVVQQ KDARQWFAEL SVDMEKILEI IRVILKLYEQ
     WKNFDERKEM ATILSKMPKP KPPPNSEGEQ GPNGSQNSSY SQS
//
ID   CAD10_HUMAN             Reviewed;         788 AA.
AC   Q9Y6N8; Q9ULB3;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 2.
DT   13-FEB-2019, entry version 155.
DE   RecName: Full=Cadherin-10;
DE   AltName: Full=T2-cadherin;
DE   Flags: Precursor;
GN   Name=CDH10;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RX   PubMed=10386616; DOI=10.1016/S0014-5793(99)00672-9;
RA   Kools P., Vanhalst K., van den Eynde E., van Roy F.;
RT   "The human cadherin-10 gene: complete coding sequence, predominant
RT   expression in the brain, and mapping on chromosome 5p13-14.";
RL   FEBS Lett. 452:328-334(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=10861224; DOI=10.1042/0264-6021:3490159;
RA   Shimoyama Y., Tsujimoto G., Kitajima M., Natori M.;
RT   "Identification of three human type-II classic cadherins and frequent
RT   heterophilic interactions between different subclasses of type-II
RT   classic cadherins.";
RL   Biochem. J. 349:159-167(2000).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-784, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-784, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [5]
RP   VARIANT [LARGE SCALE ANALYSIS] LEU-371.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Cadherins are calcium-dependent cell adhesion proteins.
CC       They preferentially interact with themselves in a homophilic
CC       manner in connecting cells; cadherins may thus contribute to the
CC       sorting of heterogeneous cell types.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Single-pass
CC       type I membrane protein {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in brain. Also found
CC       in adult and fetal kidney. Very low levels detected in prostate
CC       and fetal lung. {ECO:0000269|PubMed:10386616}.
CC   -!- DOMAIN: Three calcium ions are usually bound at the interface of
CC       each cadherin domain and rigidify the connections, imparting a
CC       strong curvature to the full-length ectodomain. {ECO:0000250}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AF039747; AAD44017.1; -; mRNA.
DR   EMBL; AB035303; BAA87417.1; -; mRNA.
DR   CCDS; CCDS3892.1; -.
DR   RefSeq; NP_006718.2; NM_006727.4.
DR   RefSeq; XP_011512225.1; XM_011513923.2.
DR   UniGene; Hs.92489; -.
DR   ProteinModelPortal; Q9Y6N8; -.
DR   SMR; Q9Y6N8; -.
DR   BioGrid; 107443; 6.
DR   IntAct; Q9Y6N8; 4.
DR   STRING; 9606.ENSP00000264463; -.
DR   iPTMnet; Q9Y6N8; -.
DR   PhosphoSitePlus; Q9Y6N8; -.
DR   BioMuta; CDH10; -.
DR   DMDM; 116241276; -.
DR   PaxDb; Q9Y6N8; -.
DR   PeptideAtlas; Q9Y6N8; -.
DR   PRIDE; Q9Y6N8; -.
DR   ProteomicsDB; 86749; -.
DR   DNASU; 1008; -.
DR   Ensembl; ENST00000264463; ENSP00000264463; ENSG00000040731.
DR   GeneID; 1008; -.
DR   KEGG; hsa:1008; -.
DR   CTD; 1008; -.
DR   DisGeNET; 1008; -.
DR   EuPathDB; HostDB:ENSG00000040731.10; -.
DR   GeneCards; CDH10; -.
DR   HGNC; HGNC:1749; CDH10.
DR   HPA; HPA010651; -.
DR   MIM; 604555; gene.
DR   neXtProt; NX_Q9Y6N8; -.
DR   OpenTargets; ENSG00000040731; -.
DR   PharmGKB; PA26283; -.
DR   eggNOG; KOG3594; Eukaryota.
DR   eggNOG; ENOG410XQHI; LUCA.
DR   GeneTree; ENSGT00940000154187; -.
DR   HOGENOM; HOG000231252; -.
DR   HOVERGEN; HBG005217; -.
DR   InParanoid; Q9Y6N8; -.
DR   KO; K06802; -.
DR   OMA; LWVCLPH; -.
DR   OrthoDB; 201053at2759; -.
DR   PhylomeDB; Q9Y6N8; -.
DR   TreeFam; TF329887; -.
DR   Reactome; R-HSA-418990; Adherens junctions interactions.
DR   ChiTaRS; CDH10; human.
DR   GeneWiki; CDH10; -.
DR   GenomeRNAi; 1008; -.
DR   PRO; PR:Q9Y6N8; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000040731; Expressed in 119 organ(s), highest expression level in middle temporal gyrus.
DR   ExpressionAtlas; Q9Y6N8; baseline and differential.
DR   Genevisible; Q9Y6N8; HS.
DR   GO; GO:0016342; C:catenin complex; IBA:GO_Central.
DR   GO; GO:0009986; C:cell surface; IBA:GO_Central.
DR   GO; GO:0005913; C:cell-cell adherens junction; IBA:GO_Central.
DR   GO; GO:0098982; C:GABA-ergic synapse; IEA:Ensembl.
DR   GO; GO:0098978; C:glutamatergic synapse; IEA:Ensembl.
DR   GO; GO:0099060; C:integral component of postsynaptic specialization membrane; IEA:Ensembl.
DR   GO; GO:0099059; C:integral component of presynaptic active zone membrane; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0045296; F:cadherin binding; IBA:GO_Central.
DR   GO; GO:0005509; F:calcium ion binding; IBA:GO_Central.
DR   GO; GO:0008092; F:cytoskeletal protein binding; IBA:GO_Central.
DR   GO; GO:0042803; F:protein homodimerization activity; IBA:GO_Central.
DR   GO; GO:0034332; P:adherens junction organization; IBA:GO_Central.
DR   GO; GO:0016339; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; IBA:GO_Central.
DR   GO; GO:0000902; P:cell morphogenesis; IBA:GO_Central.
DR   GO; GO:0098609; P:cell-cell adhesion; IBA:GO_Central.
DR   GO; GO:0044331; P:cell-cell adhesion mediated by cadherin; IBA:GO_Central.
DR   GO; GO:0007043; P:cell-cell junction assembly; IBA:GO_Central.
DR   GO; GO:0007156; P:homophilic cell adhesion via plasma membrane adhesion molecules; IBA:GO_Central.
DR   Gene3D; 4.10.900.10; -; 1.
DR   InterPro; IPR039808; Cadherin.
DR   InterPro; IPR002126; Cadherin-like_dom.
DR   InterPro; IPR015919; Cadherin-like_sf.
DR   InterPro; IPR020894; Cadherin_CS.
DR   InterPro; IPR000233; Cadherin_cytoplasmic-dom.
DR   InterPro; IPR027397; Catenin_binding_dom_sf.
DR   PANTHER; PTHR24027; PTHR24027; 1.
DR   Pfam; PF00028; Cadherin; 5.
DR   Pfam; PF01049; Cadherin_C; 1.
DR   PRINTS; PR00205; CADHERIN.
DR   SMART; SM00112; CA; 5.
DR   SUPFAM; SSF49313; SSF49313; 5.
DR   PROSITE; PS00232; CADHERIN_1; 3.
DR   PROSITE; PS50268; CADHERIN_2; 5.
PE   1: Evidence at protein level;
KW   Calcium; Cell adhesion; Cell membrane;
KW   Cleavage on pair of basic residues; Complete proteome; Glycoprotein;
KW   Membrane; Metal-binding; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repeat; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     22       {ECO:0000255}.
FT   PROPEP       23     54       {ECO:0000255}.
FT                                /FTId=PRO_0000003781.
FT   CHAIN        55    788       Cadherin-10.
FT                                /FTId=PRO_0000003782.
FT   TOPO_DOM     55    613       Extracellular. {ECO:0000255}.
FT   TRANSMEM    614    634       Helical. {ECO:0000255}.
FT   TOPO_DOM    635    788       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       55    160       Cadherin 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN      161    269       Cadherin 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN      270    384       Cadherin 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN      385    487       Cadherin 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN      488    606       Cadherin 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   MOD_RES     784    784       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES     788    788       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P97326}.
FT   CARBOHYD    256    256       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    438    438       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    456    456       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    534    534       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT     371    371       V -> L (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036102.
FT   VARIANT     413    413       S -> F (in dbSNP:rs1395027).
FT                                /FTId=VAR_028751.
FT   CONFLICT     34     34       Q -> R (in Ref. 1; AAD44017).
FT                                {ECO:0000305}.
FT   CONFLICT    482    482       V -> A (in Ref. 1; AAD44017).
FT                                {ECO:0000305}.
SQ   SEQUENCE   788 AA;  88451 MW;  E92908F9C19270B2 CRC64;
     MTIHQFLLLF LFWVCLPHFC SPEIMFRRTP VPQQRILSSR VPRSDGKILH RQKRGWMWNQ
     FFLLEEYTGS DYQYVGKLHS DQDKGDGSLK YILSGDGAGT LFIIDEKTGD IHATRRIDRE
     EKAFYTLRAQ AINRRTLRPV EPESEFVIKI HDINDNEPTF PEEIYTASVP EMSVVGTSVV
     QVTATDADDP SYGNSARVIY SILQGQPYFS VEPETGIIRT ALPNMNRENR EQYQVVIQAK
     DMGGQMGGLS GTTTVNITLT DVNDNPPRFP QNTIHLRVLE SSPVGTAIGS VKATDADTGK
     NAEVEYRIID GDGTDMFDIV TEKDTQEGII TVKKPLDYES RRLYTLKVEA ENTHVDPRFY
     YLGPFKDTTI VKISIEDVDE PPVFSRSSYL FEVHEDIEVG TIIGTVMARD PDSISSPIRF
     SLDRHTDLDR IFNIHSGNGS LYTSKPLDRE LSQWHNLTVI AAEINNPKET TRVAVFVRIL
     DVNDNAPQFA VFYDTFVCEN ARPGQLIQTI SAVDKDDPLG GQKFFFSLAA VNPNFTVQDN
     EDNTARILTR KNGFNRHEIS TYLLPVVISD NDYPIQSSTG TLTIRVCACD SQGNMQSCSA
     EALLLPAGLS TGALIAILLC IIILLVIVVL FAALKRQRKK EPLILSKEDI RDNIVSYNDE
     GGGEEDTQAF DIGTLRNPAA IEEKKLRRDI IPETLFIPRR TPTAPDNTDV RDFINERLKE
     HDLDPTAPPY DSLATYAYEG NDSIAESLSS LESGTTEGDQ NYDYLREWGP RFNKLAEMYG
     GGESDKDS
//
ID   X5D8X5_HUMAN            Unreviewed;       788 AA.
AC   X5D8X5;
DT   11-JUN-2014, integrated into UniProtKB/TrEMBL.
DT   11-JUN-2014, sequence version 1.
DT   16-JAN-2019, entry version 44.
DE   SubName: Full=Cadherin 10 type 2 isoform A {ECO:0000313|EMBL:AHW56448.1};
DE   SubName: Full=Cadherin 10, type 2 (T2-cadherin) {ECO:0000313|EMBL:EAX10742.1};
DE   Flags: Fragment;
GN   Name=CDH10 {ECO:0000313|EMBL:AHW56448.1};
GN   ORFNames=hCG_36812 {ECO:0000313|EMBL:EAX10742.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AHW56448.1};
RN   [1] {ECO:0000313|EMBL:EAX10742.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAX10742.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:AHW56448.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Fetal whole brain {ECO:0000313|EMBL:AHW56448.1};
RX   PubMed=24722188;
RA   Corominas R., Yang X., Lin G.N., Kang S., Shen Y., Ghamsari L.,
RA   Broly M., Rodriguez M., Tam S., Wanamaker S.A., Fan C., Yi S.,
RA   Tasan M., Lemmens I., Kuang X., Zhao N., Malhotra D., Michaelson J.J.,
RA   Vacic V., Calderwood M.A., Roth F.P., Tavernier J., Horvath S.,
RA   Salehi-Ashtiani K., Korkin D., Sebat J., Hill D.E., Hao T., Vidal M.,
RA   Iakoucheva L.M.;
RT   "Protein interaction network of alternatively spliced isoforms from
RT   brain links genetic risk factors for autism.";
RL   Nat. Commun. 5:3650-3650(2014).
CC   -!- FUNCTION: Cadherins are calcium-dependent cell adhesion proteins.
CC       {ECO:0000256|RuleBase:RU004357}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane
CC       {ECO:0000256|RuleBase:RU003318}; Single-pass type I membrane
CC       protein {ECO:0000256|RuleBase:RU003318}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; KJ534808; AHW56448.1; -; mRNA.
DR   EMBL; CH471118; EAX10742.1; -; Genomic_DNA.
DR   RefSeq; NP_006718.2; NM_006727.4.
DR   RefSeq; XP_011512225.1; XM_011513923.2.
DR   UniGene; Hs.92489; -.
DR   SMR; X5D8X5; -.
DR   MaxQB; X5D8X5; -.
DR   GeneID; 1008; -.
DR   KEGG; hsa:1008; -.
DR   UCSC; uc003jgr.3; human.
DR   CTD; 1008; -.
DR   EuPathDB; HostDB:ENSG00000040731.10; -.
DR   eggNOG; KOG3594; Eukaryota.
DR   eggNOG; ENOG410XQHI; LUCA.
DR   KO; K06802; -.
DR   OMA; LWVCLPH; -.
DR   OrthoDB; 201053at2759; -.
DR   ChiTaRS; CDH10; human.
DR   GenomeRNAi; 1008; -.
DR   Bgee; ENSG00000040731; Expressed in 119 organ(s), highest expression level in middle temporal gyrus.
DR   ExpressionAtlas; X5D8X5; baseline and differential.
DR   GO; GO:0098982; C:GABA-ergic synapse; IEA:Ensembl.
DR   GO; GO:0098978; C:glutamatergic synapse; IEA:Ensembl.
DR   GO; GO:0099060; C:integral component of postsynaptic specialization membrane; IEA:Ensembl.
DR   GO; GO:0099059; C:integral component of presynaptic active zone membrane; IEA:Ensembl.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0007156; P:homophilic cell adhesion via plasma membrane adhesion molecules; IEA:InterPro.
DR   Gene3D; 4.10.900.10; -; 1.
DR   InterPro; IPR039808; Cadherin.
DR   InterPro; IPR002126; Cadherin-like_dom.
DR   InterPro; IPR015919; Cadherin-like_sf.
DR   InterPro; IPR020894; Cadherin_CS.
DR   InterPro; IPR000233; Cadherin_cytoplasmic-dom.
DR   InterPro; IPR027397; Catenin_binding_dom_sf.
DR   PANTHER; PTHR24027; PTHR24027; 1.
DR   Pfam; PF00028; Cadherin; 5.
DR   Pfam; PF01049; Cadherin_C; 1.
DR   PRINTS; PR00205; CADHERIN.
DR   SMART; SM00112; CA; 5.
DR   SUPFAM; SSF49313; SSF49313; 5.
DR   PROSITE; PS00232; CADHERIN_1; 2.
PE   2: Evidence at transcript level;
KW   Calcium {ECO:0000256|RuleBase:RU003318,
KW   ECO:0000256|SAAS:SAAS00020193};
KW   Cell adhesion {ECO:0000256|RuleBase:RU003318,
KW   ECO:0000256|SAAS:SAAS01075623};
KW   Cell membrane {ECO:0000256|SAAS:SAAS01075618};
KW   Membrane {ECO:0000256|SAAS:SAAS00662277,
KW   ECO:0000256|SAAS:SAAS01075618, ECO:0000256|SAM:Phobius};
KW   Metal-binding {ECO:0000256|SAAS:SAAS01075609};
KW   Repeat {ECO:0000256|SAAS:SAAS00020163};
KW   Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAAS:SAAS00662277,
KW   ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAAS:SAAS00662277,
KW   ECO:0000256|SAM:Phobius}.
FT   SIGNAL        1     22       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        23    788       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5011954870.
FT   TRANSMEM    603    634       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN       77    158       CA. {ECO:0000259|SMART:SM00112}.
FT   DOMAIN      182    267       CA. {ECO:0000259|SMART:SM00112}.
FT   DOMAIN      291    383       CA. {ECO:0000259|SMART:SM00112}.
FT   DOMAIN      406    487       CA. {ECO:0000259|SMART:SM00112}.
FT   DOMAIN      510    594       CA. {ECO:0000259|SMART:SM00112}.
FT   NON_TER     788    788       {ECO:0000313|EMBL:AHW56448.1}.
SQ   SEQUENCE   788 AA;  88451 MW;  E92908F9C19270B2 CRC64;
     MTIHQFLLLF LFWVCLPHFC SPEIMFRRTP VPQQRILSSR VPRSDGKILH RQKRGWMWNQ
     FFLLEEYTGS DYQYVGKLHS DQDKGDGSLK YILSGDGAGT LFIIDEKTGD IHATRRIDRE
     EKAFYTLRAQ AINRRTLRPV EPESEFVIKI HDINDNEPTF PEEIYTASVP EMSVVGTSVV
     QVTATDADDP SYGNSARVIY SILQGQPYFS VEPETGIIRT ALPNMNRENR EQYQVVIQAK
     DMGGQMGGLS GTTTVNITLT DVNDNPPRFP QNTIHLRVLE SSPVGTAIGS VKATDADTGK
     NAEVEYRIID GDGTDMFDIV TEKDTQEGII TVKKPLDYES RRLYTLKVEA ENTHVDPRFY
     YLGPFKDTTI VKISIEDVDE PPVFSRSSYL FEVHEDIEVG TIIGTVMARD PDSISSPIRF
     SLDRHTDLDR IFNIHSGNGS LYTSKPLDRE LSQWHNLTVI AAEINNPKET TRVAVFVRIL
     DVNDNAPQFA VFYDTFVCEN ARPGQLIQTI SAVDKDDPLG GQKFFFSLAA VNPNFTVQDN
     EDNTARILTR KNGFNRHEIS TYLLPVVISD NDYPIQSSTG TLTIRVCACD SQGNMQSCSA
     EALLLPAGLS TGALIAILLC IIILLVIVVL FAALKRQRKK EPLILSKEDI RDNIVSYNDE
     GGGEEDTQAF DIGTLRNPAA IEEKKLRRDI IPETLFIPRR TPTAPDNTDV RDFINERLKE
     HDLDPTAPPY DSLATYAYEG NDSIAESLSS LESGTTEGDQ NYDYLREWGP RFNKLAEMYG
     GGESDKDS
//
ID   X5DNG6_HUMAN            Unreviewed;       786 AA.
AC   X5DNG6;
DT   11-JUN-2014, integrated into UniProtKB/TrEMBL.
DT   11-JUN-2014, sequence version 1.
DT   16-JAN-2019, entry version 33.
DE   SubName: Full=Cadherin 10 type 2 isoform B {ECO:0000313|EMBL:AHW56446.1};
DE   Flags: Fragment;
GN   Name=CDH10 {ECO:0000313|EMBL:AHW56446.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AHW56446.1};
RN   [1] {ECO:0000313|EMBL:AHW56446.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Fetal whole brain {ECO:0000313|EMBL:AHW56446.1};
RX   PubMed=24722188;
RA   Corominas R., Yang X., Lin G.N., Kang S., Shen Y., Ghamsari L.,
RA   Broly M., Rodriguez M., Tam S., Wanamaker S.A., Fan C., Yi S.,
RA   Tasan M., Lemmens I., Kuang X., Zhao N., Malhotra D., Michaelson J.J.,
RA   Vacic V., Calderwood M.A., Roth F.P., Tavernier J., Horvath S.,
RA   Salehi-Ashtiani K., Korkin D., Sebat J., Hill D.E., Hao T., Vidal M.,
RA   Iakoucheva L.M.;
RT   "Protein interaction network of alternatively spliced isoforms from
RT   brain links genetic risk factors for autism.";
RL   Nat. Commun. 5:3650-3650(2014).
CC   -!- FUNCTION: Cadherins are calcium-dependent cell adhesion proteins.
CC       {ECO:0000256|RuleBase:RU004357}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane
CC       {ECO:0000256|RuleBase:RU003318}; Single-pass type I membrane
CC       protein {ECO:0000256|RuleBase:RU003318}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; KJ534806; AHW56446.1; -; mRNA.
DR   RefSeq; NP_001304153.1; NM_001317224.1.
DR   RefSeq; XP_016864404.1; XM_017008915.1.
DR   UniGene; Hs.92489; -.
DR   ProteinModelPortal; X5DNG6; -.
DR   GeneID; 1008; -.
DR   CTD; 1008; -.
DR   eggNOG; KOG3594; Eukaryota.
DR   eggNOG; ENOG410XQHI; LUCA.
DR   OrthoDB; 201053at2759; -.
DR   ChiTaRS; CDH10; human.
DR   GenomeRNAi; 1008; -.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0007156; P:homophilic cell adhesion via plasma membrane adhesion molecules; IEA:InterPro.
DR   Gene3D; 4.10.900.10; -; 1.
DR   InterPro; IPR039808; Cadherin.
DR   InterPro; IPR002126; Cadherin-like_dom.
DR   InterPro; IPR015919; Cadherin-like_sf.
DR   InterPro; IPR020894; Cadherin_CS.
DR   InterPro; IPR000233; Cadherin_cytoplasmic-dom.
DR   InterPro; IPR027397; Catenin_binding_dom_sf.
DR   PANTHER; PTHR24027; PTHR24027; 1.
DR   Pfam; PF00028; Cadherin; 5.
DR   Pfam; PF01049; Cadherin_C; 1.
DR   PRINTS; PR00205; CADHERIN.
DR   SMART; SM00112; CA; 5.
DR   SUPFAM; SSF49313; SSF49313; 5.
DR   PROSITE; PS00232; CADHERIN_1; 2.
PE   2: Evidence at transcript level;
KW   Calcium {ECO:0000256|RuleBase:RU003318,
KW   ECO:0000256|SAAS:SAAS00020193};
KW   Cell adhesion {ECO:0000256|RuleBase:RU003318,
KW   ECO:0000256|SAAS:SAAS01075623};
KW   Cell membrane {ECO:0000256|SAAS:SAAS01075618};
KW   Membrane {ECO:0000256|SAAS:SAAS00662277,
KW   ECO:0000256|SAAS:SAAS01075618, ECO:0000256|SAM:Phobius};
KW   Metal-binding {ECO:0000256|SAAS:SAAS01075609};
KW   Repeat {ECO:0000256|SAAS:SAAS00020163};
KW   Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAAS:SAAS00662277,
KW   ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAAS:SAAS00662277,
KW   ECO:0000256|SAM:Phobius}.
FT   SIGNAL        1     22       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        23    786       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5004954902.
FT   TRANSMEM    603    632       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN       77    158       CA. {ECO:0000259|SMART:SM00112}.
FT   DOMAIN      182    267       CA. {ECO:0000259|SMART:SM00112}.
FT   DOMAIN      291    383       CA. {ECO:0000259|SMART:SM00112}.
FT   DOMAIN      406    487       CA. {ECO:0000259|SMART:SM00112}.
FT   DOMAIN      510    594       CA. {ECO:0000259|SMART:SM00112}.
FT   NON_TER     786    786       {ECO:0000313|EMBL:AHW56446.1}.
SQ   SEQUENCE   786 AA;  88239 MW;  3BE3B1BD6B060377 CRC64;
     MTIHQFLLLF LFWVCLPHFC SPEIMFRRTP VPQQRILSSR VPRSDGKILH RQKRGWMWNQ
     FFLLEEYTGS DYQYVGKLHS DQDKGDGSLK YILSGDGAGT LFIIDEKTGD IHATRRIDRE
     EKAFYTLRAQ AINRRTLRPV EPESEFVIKI HDINDNEPTF PEEIYTASVP EMSVVGTSVV
     QVTATDADDP SYGNSARVIY SILQGQPYFS VEPETGIIRT ALPNMNRENR EQYQVVIQAK
     DMGGQMGGLS GTTTVNITLT DVNDNPPRFP QNTIHLRVLE SSPVGTAIGS VKATDADTGK
     NAEVEYRIID GDGTDMFDIV TEKDTQEGII TVKKPLDYES RRLYTLKVEA ENTHVDPRFY
     YLGPFKDTTI VKISIEDVDE PPVFSRSSYL FEVHEDIEVG TIIGTVMARD PDSISSPIRF
     SLDRHTDLDR IFNIHSGNGS LYTSKPLDRE LSQWHNLTVI AAEINNPKET TRVAVFVRIL
     DVNDNAPQFA VFYDTFVCEN ARPGQLIQTI SAVDKDDPLG GQKFFFSLAA VNPNFTVQDN
     EDNTARILTR KNGFNRHEIS TYLLPVVISD NDYPIQSSTG TLTIRVCACD SQGNMQSCSA
     EALLLPAGLS TGALIAILLC IIILLVVLFA ALKRQRKKEP LILSKEDIRD NIVSYNDEGG
     GEEDTQAFDI GTLRNPAAIE EKKLRRDIIP ETLFIPRRTP TAPDNTDVRD FINERLKEHD
     LDPTAPPYDS LATYAYEGND SIAESLSSLE SGTTEGDQNY DYLREWGPRF NKLAEMYGGG
     ESDKDS
//
ID   CHD2_HUMAN              Reviewed;        1828 AA.
AC   O14647; C6G482; Q96IP5;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   12-DEC-2006, sequence version 2.
DT   13-FEB-2019, entry version 172.
DE   RecName: Full=Chromodomain-helicase-DNA-binding protein 2;
DE            Short=CHD-2;
DE            EC=3.6.4.12;
DE   AltName: Full=ATP-dependent helicase CHD2;
GN   Name=CHD2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=9326634; DOI=10.1073/pnas.94.21.11472;
RA   Woodage T., Basrai M.A., Baxevanis A.D., Hieter P., Collins F.S.;
RT   "Characterization of the CHD family of proteins.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:11472-11477(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (DEC-2008) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R.,
RA   Fahey J., Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G.,
RA   Johnson E., Jones C., Kamat A., Kaur A., Locke D.P., Madan A.,
RA   Munson G., Jaffe D.B., Lui A., Macdonald P., Mauceli E., Naylor J.W.,
RA   Nesbitt R., Nicol R., O'Leary S.B., Ratcliffe A., Rounsley S., She X.,
RA   Sneddon K.M.B., Stewart S., Sougnez C., Stone S.M., Topham K.,
RA   Vincent D., Wang S., Zimmer A.R., Birren B.W., Hood L., Lander E.S.,
RA   Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human
RT   chromosome 15.";
RL   Nature 440:671-675(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1635-1828 (ISOFORM 1).
RC   TISSUE=T-cell;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-240 AND SER-242, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-207 AND SER-208, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-207; SER-208; THR-240
RP   AND SER-242, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1365; SER-1386 AND
RP   SER-1807, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-207; SER-208; SER-1085
RP   AND SER-1087, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [14]
RP   VARIANTS EEOC 121-ARG--THR-1828 DEL; ARG-548 AND PRO-823.
RX   PubMed=23708187; DOI=10.1038/ng.2646;
RA   Carvill G.L., Heavin S.B., Yendle S.C., McMahon J.M., O'Roak B.J.,
RA   Cook J., Khan A., Dorschner M.O., Weaver M., Calvert S., Malone S.,
RA   Wallace G., Stanley T., Bye A.M., Bleasel A., Howell K.B., Kivity S.,
RA   Mackay M.T., Rodriguez-Casero V., Webster R., Korczyn A., Afawi Z.,
RA   Zelnick N., Lerman-Sagie T., Lev D., Moeller R.S., Gill D.,
RA   Andrade D.M., Freeman J.L., Sadleir L.G., Shendure J., Berkovic S.F.,
RA   Scheffer I.E., Mefford H.C.;
RT   "Targeted resequencing in epileptic encephalopathies identifies de
RT   novo mutations in CHD2 and SYNGAP1.";
RL   Nat. Genet. 45:825-830(2013).
RN   [15]
RP   VARIANT EEOC 112-SER--THR-1828 DEL.
RX   PubMed=25356899; DOI=10.1371/journal.pgen.1004772;
RA   Hamdan F.F., Srour M., Capo-Chichi J.M., Daoud H., Nassif C.,
RA   Patry L., Massicotte C., Ambalavanan A., Spiegelman D., Diallo O.,
RA   Henrion E., Dionne-Laporte A., Fougerat A., Pshezhetsky A.V.,
RA   Venkateswaran S., Rouleau G.A., Michaud J.L.;
RT   "De novo mutations in moderate or severe intellectual disability.";
RL   PLoS Genet. 10:E1004772-E1004772(2014).
CC   -!- FUNCTION: DNA-binding helicase that specifically binds to the
CC       promoter of target genes, leading to chromatin remodeling,
CC       possibly by promoting deposition of histone H3.3. Involved in
CC       myogenesis via interaction with MYOD1: binds to myogenic gene
CC       regulatory sequences and mediates incorporation of histone H3.3
CC       prior to the onset of myogenic gene expression, promoting their
CC       expression (By similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O = ADP + H(+) + phosphate; Xref=Rhea:RHEA:13065,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:456216; EC=3.6.4.12;
CC   -!- SUBUNIT: Interacts with MYOD1. Interacts with histone H3.3 (By
CC       similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q8N7W2-2:BEND7; NbExp=3; IntAct=EBI-1210503, EBI-10181188;
CC       Q9UJV3-2:MID2; NbExp=3; IntAct=EBI-1210503, EBI-10172526;
CC       Q969V4:TEKT1; NbExp=3; IntAct=EBI-1210503, EBI-10180409;
CC       Q9NVV9:THAP1; NbExp=3; IntAct=EBI-1210503, EBI-741515;
CC       Q8WV44:TRIM41; NbExp=4; IntAct=EBI-1210503, EBI-725997;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Note=Binds to
CC       myogenic gene promoters. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=O14647-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O14647-2; Sequence=VSP_021918, VSP_021919;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=O14647-3; Sequence=VSP_042791;
CC   -!- DISEASE: Epileptic encephalopathy, childhood-onset (EEOC)
CC       [MIM:615369]: A severe form of epilepsy characterized by onset of
CC       multiple seizure types in the first few years of life and
CC       associated with poor prognosis. Affected individuals have
CC       cognitive regression and intellectual disability.
CC       {ECO:0000269|PubMed:23708187, ECO:0000269|PubMed:25356899}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the SNF2/RAD54 helicase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AF006514; AAB87382.1; -; mRNA.
DR   EMBL; BT007050; AAP35699.1; -; mRNA.
DR   EMBL; FJ515838; ACS13730.1; -; Genomic_DNA.
DR   EMBL; AC013394; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471101; EAX02160.1; -; Genomic_DNA.
DR   EMBL; BC007347; AAH07347.1; -; mRNA.
DR   EMBL; CR978407; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS10374.2; -. [O14647-1]
DR   CCDS; CCDS45356.1; -. [O14647-3]
DR   RefSeq; NP_001036037.1; NM_001042572.2. [O14647-3]
DR   RefSeq; NP_001262.3; NM_001271.3. [O14647-1]
DR   UniGene; Hs.220864; -.
DR   ProteinModelPortal; O14647; -.
DR   SMR; O14647; -.
DR   BioGrid; 107531; 17.
DR   IntAct; O14647; 18.
DR   MINT; O14647; -.
DR   STRING; 9606.ENSP00000377747; -.
DR   iPTMnet; O14647; -.
DR   PhosphoSitePlus; O14647; -.
DR   SwissPalm; O14647; -.
DR   BioMuta; CHD2; -.
DR   EPD; O14647; -.
DR   jPOST; O14647; -.
DR   MaxQB; O14647; -.
DR   PaxDb; O14647; -.
DR   PeptideAtlas; O14647; -.
DR   PRIDE; O14647; -.
DR   ProteomicsDB; 48144; -.
DR   ProteomicsDB; 48145; -. [O14647-2]
DR   ProteomicsDB; 48146; -. [O14647-3]
DR   DNASU; 1106; -.
DR   Ensembl; ENST00000394196; ENSP00000377747; ENSG00000173575. [O14647-1]
DR   Ensembl; ENST00000420239; ENSP00000406581; ENSG00000173575. [O14647-3]
DR   Ensembl; ENST00000626874; ENSP00000486629; ENSG00000173575. [O14647-2]
DR   GeneID; 1106; -.
DR   KEGG; hsa:1106; -.
DR   UCSC; uc002bsn.4; human. [O14647-1]
DR   CTD; 1106; -.
DR   DisGeNET; 1106; -.
DR   EuPathDB; HostDB:ENSG00000173575.18; -.
DR   GeneCards; CHD2; -.
DR   GeneReviews; CHD2; -.
DR   HGNC; HGNC:1917; CHD2.
DR   HPA; HPA060744; -.
DR   HPA; HPA060960; -.
DR   MalaCards; CHD2; -.
DR   MIM; 602119; gene.
DR   MIM; 615369; phenotype.
DR   neXtProt; NX_O14647; -.
DR   OpenTargets; ENSG00000173575; -.
DR   Orphanet; 2382; Lennox-Gastaut syndrome.
DR   Orphanet; 1942; Myoclonic-astastic epilepsy.
DR   PharmGKB; PA26453; -.
DR   eggNOG; KOG0383; Eukaryota.
DR   eggNOG; COG0553; LUCA.
DR   GeneTree; ENSGT00940000155888; -.
DR   HOGENOM; HOG000207917; -.
DR   HOVERGEN; HBG057476; -.
DR   InParanoid; O14647; -.
DR   KO; K20091; -.
DR   OMA; WQRDRKF; -.
DR   OrthoDB; 1094764at2759; -.
DR   PhylomeDB; O14647; -.
DR   TreeFam; TF313461; -.
DR   ChiTaRS; CHD2; human.
DR   GeneWiki; CHD2; -.
DR   GenomeRNAi; 1106; -.
DR   PRO; PR:O14647; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000173575; Expressed in 205 organ(s), highest expression level in corpus callosum.
DR   ExpressionAtlas; O14647; baseline and differential.
DR   Genevisible; O14647; HS.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004003; F:ATP-dependent DNA helicase activity; TAS:ProtInc.
DR   GO; GO:0003677; F:DNA binding; TAS:ProtInc.
DR   GO; GO:0042393; F:histone binding; ISS:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0000978; F:RNA polymerase II proximal promoter sequence-specific DNA binding; ISS:UniProtKB.
DR   GO; GO:0006325; P:chromatin organization; IEA:UniProtKB-KW.
DR   GO; GO:0007517; P:muscle organ development; ISS:UniProtKB.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; TAS:ProtInc.
DR   CDD; cd00024; CHROMO; 2.
DR   CDD; cd00079; HELICc; 1.
DR   Gene3D; 3.40.50.10810; -; 1.
DR   InterPro; IPR016197; Chromo-like_dom_sf.
DR   InterPro; IPR000953; Chromo/chromo_shadow_dom.
DR   InterPro; IPR023780; Chromo_domain.
DR   InterPro; IPR023779; Chromodomain_CS.
DR   InterPro; IPR025260; DUF4208.
DR   InterPro; IPR014001; Helicase_ATP-bd.
DR   InterPro; IPR001650; Helicase_C.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR038718; SNF2-like_sf.
DR   InterPro; IPR000330; SNF2_N.
DR   Pfam; PF00385; Chromo; 2.
DR   Pfam; PF13907; DUF4208; 1.
DR   Pfam; PF00271; Helicase_C; 1.
DR   Pfam; PF00176; SNF2_N; 1.
DR   SMART; SM00298; CHROMO; 2.
DR   SMART; SM00487; DEXDc; 1.
DR   SMART; SM01176; DUF4208; 1.
DR   SMART; SM00490; HELICc; 1.
DR   SUPFAM; SSF52540; SSF52540; 2.
DR   SUPFAM; SSF54160; SSF54160; 2.
DR   PROSITE; PS00598; CHROMO_1; 2.
DR   PROSITE; PS50013; CHROMO_2; 2.
DR   PROSITE; PS51192; HELICASE_ATP_BIND_1; 1.
DR   PROSITE; PS51194; HELICASE_CTER; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Chromatin regulator;
KW   Complete proteome; Disease mutation; DNA-binding; Epilepsy; Helicase;
KW   Hydrolase; Myogenesis; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome; Repeat; Transcription;
KW   Transcription regulation.
FT   CHAIN         1   1828       Chromodomain-helicase-DNA-binding protein
FT                                2.
FT                                /FTId=PRO_0000080226.
FT   DOMAIN      261    353       Chromo 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00053}.
FT   DOMAIN      378    456       Chromo 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00053}.
FT   DOMAIN      496    666       Helicase ATP-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00541}.
FT   DOMAIN      795    946       Helicase C-terminal.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00542}.
FT   NP_BIND     509    516       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00541}.
FT   MOTIF       617    620       DEAH box.
FT   COMPBIAS     13     74       Ser-rich.
FT   COMPBIAS    121    139       Ser-rich.
FT   COMPBIAS    966   1066       Glu-rich.
FT   MOD_RES     207    207       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     208    208       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     240    240       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES     242    242       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES    1085   1085       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES    1087   1087       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES    1365   1365       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1386   1386       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1807   1807       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ     502   1828       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.2}.
FT                                /FTId=VSP_042791.
FT   VAR_SEQ    1719   1739       HHHDSKRRRSDEFRPQNYHQQ -> YAKGCETPGANLCQEL
FT                                FLGRK (in isoform 2).
FT                                {ECO:0000303|PubMed:9326634}.
FT                                /FTId=VSP_021918.
FT   VAR_SEQ    1740   1828       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:9326634}.
FT                                /FTId=VSP_021919.
FT   VARIANT     112   1828       Missing (in EEOC).
FT                                {ECO:0000269|PubMed:25356899}.
FT                                /FTId=VAR_078614.
FT   VARIANT     121   1828       Missing (in EEOC).
FT                                {ECO:0000269|PubMed:23708187}.
FT                                /FTId=VAR_078615.
FT   VARIANT     548    548       W -> R (in EEOC; dbSNP:rs864309537).
FT                                {ECO:0000269|PubMed:23708187}.
FT                                /FTId=VAR_070209.
FT   VARIANT     823    823       L -> P (in EEOC; dbSNP:rs864309540).
FT                                {ECO:0000269|PubMed:23708187}.
FT                                /FTId=VAR_070210.
FT   VARIANT    1574   1574       G -> A (in dbSNP:rs56227200).
FT                                /FTId=VAR_061099.
FT   CONFLICT   1156   1156       I -> L (in Ref. 1; AAB87382).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1828 AA;  211344 MW;  13139D6059210F00 CRC64;
     MMRNKDKSQE EDSSLHSNAS SHSASEEASG SDSGSQSESE QGSDPGSGHG SESNSSSESS
     ESQSESESES AGSKSQPVLP EAKEKPASKK ERIADVKKMW EEYPDVYGVR RSNRSRQEPS
     RFNIKEEASS GSESGSPKRR GQRQLKKQEK WKQEPSEDEQ EQGTSAESEP EQKKVKARRP
     VPRRTVPKPR VKKQPKTQRG KRKKQDSSDE DDDDDEAPKR QTRRRAAKNV SYKEDDDFET
     DSDDLIEMTG EGVDEQQDNS ETIEKVLDSR LGKKGATGAS TTVYAIEANG DPSGDFDTEK
     DEGEIQYLIK WKGWSYIHST WESEESLQQQ KVKGLKKLEN FKKKEDEIKQ WLGKVSPEDV
     EYFNCQQELA SELNKQYQIV ERVIAVKTSK STLGQTDFPA HSRKPAPSNE PEYLCKWMGL
     PYSECSWEDE ALIGKKFQNC IDSFHSRNNS KTIPTRECKA LKQRPRFVAL KKQPAYLGGE
     NLELRDYQLE GLNWLAHSWC KNNSVILADE MGLGKTIQTI SFLSYLFHQH QLYGPFLIVV
     PLSTLTSWQR EFEIWAPEIN VVVYIGDLMS RNTIREYEWI HSQTKRLKFN ALITTYEILL
     KDKTVLGSIN WAFLGVDEAH RLKNDDSLLY KTLIDFKSNH RLLITGTPLQ NSLKELWSLL
     HFIMPEKFEF WEDFEEDHGK GRENGYQSLH KVLEPFLLRR VKKDVEKSLP AKVEQILRVE
     MSALQKQYYK WILTRNYKAL AKGTRGSTSG FLNIVMELKK CCNHCYLIKP PEENERENGQ
     EILLSLIRSS GKLILLDKLL TRLRERGNRV LIFSQMVRML DILAEYLTIK HYPFQRLDGS
     IKGEIRKQAL DHFNADGSED FCFLLSTRAG GLGINLASAD TVVIFDSDWN PQNDLQAQAR
     AHRIGQKKQV NIYRLVTKGT VEEEIIERAK KKMVLDHLVI QRMDTTGRTI LENNSGRSNS
     NPFNKEELTA ILKFGAEDLF KELEGEESEP QEMDIDEILR LAETRENEVS TSATDELLSQ
     FKVANFATME DEEELEERPH KDWDEIIPEE QRKKVEEEER QKELEEIYML PRIRSSTKKA
     QTNDSDSDTE SKRQAQRSSA SESETEDSDD DKKPKRRGRP RSVRKDLVEG FTDAEIRRFI
     KAYKKFGLPL ERLECIARDA ELVDKSVADL KRLGELIHNS CVSAMQEYEE QLKENASEGK
     GPGKRRGPTI KISGVQVNVK SIIQHEEEFE MLHKSIPVDP EEKKKYCLTC RVKAAHFDVE
     WGVEDDSRLL LGIYEHGYGN WELIKTDPEL KLTDKILPVE TDKKPQGKQL QTRADYLLKL
     LRKGLEKKGA VTGGEEAKLK KRKPRVKKEN KVPRLKEEHG IELSSPRHSD NPSEEGEVKD
     DGLEKSPMKK KQKKKENKEN KEKQMSSRKD KEGDKERKKS KDKKEKPKSG DAKSSSKSKR
     SQGPVHITAG SEPVPIGEDE DDDLDQETFS ICKERMRPVK KALKQLDKPD KGLNVQEQLE
     HTRNCLLKIG DRIAECLKAY SDQEHIKLWR RNLWIFVSKF TEFDARKLHK LYKMAHKKRS
     QEEEEQKKKD DVTGGKKPFR PEASGSSRDS LISQSHTSHN LHPQKPHLPA SHGPQMHGHP
     RDNYNHPNKR HFSNADRGDW QRERKFNYGG GNNNPPWGSD RHHQYEQHWY KDHHYGDRRH
     MDAHRSGSYR PNNMSRKRPY DQYSSDRDHR GHRDYYDRHH HDSKRRRSDE FRPQNYHQQD
     FRRMSDHRPA MGYHGQGPSD HYRSFHTDKL GEYKQPLPPL HPAVSDPRSP PSQKSPHDSK
     SPLDHRSPLE RSLEQKNNPD YNWNVRKT
//
ID   A0A090N7T7_HUMAN        Unreviewed;      1331 AA.
AC   A0A090N7T7;
DT   26-NOV-2014, integrated into UniProtKB/TrEMBL.
DT   26-NOV-2014, sequence version 1.
DT   13-FEB-2019, entry version 47.
DE   SubName: Full=Contactin associated protein-like 2 {ECO:0000313|EMBL:EAL24417.1};
DE   SubName: Full=Contactin associated protein-like 2, isoform CRA_b {ECO:0000313|EMBL:EAW80083.1};
GN   Name=CNTNAP2 {ECO:0000313|EMBL:EAL24417.1};
GN   ORFNames=hCG_15499 {ECO:0000313|EMBL:EAW80083.1},
GN   tcag7.496 {ECO:0000313|EMBL:EAL24417.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAL24417.1};
RN   [1] {ECO:0000313|EMBL:EAW80083.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAL24417.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D., Zhang Q., Gu Z., Lu F.,
RA   Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
RA   Rahman N., Friedman J.M., Heng H.H., Pelicci P.G., Lo-Coco F.,
RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
RA   Bruns G.A., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
RA   Kim H.G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
RA   Winsor E.J., Grzeschik K.H., Teebi A., Minassian B.A., Kere J.,
RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Dohner H., Dohner K.,
RA   Rommens J.M., Vincent J.B., Venter J.C., Li P.W., Mural R.J.,
RA   Adams M.D., Tsui L.C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [3] {ECO:0000313|EMBL:EAL24417.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Nusskern D., Zhang Q., Gu Z., Lu F.,
RA   Zeesman S., Teshima I., Chitayat D., Shuman C., Weksberg R.,
RA   Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J., Rahman N.,
RA   Friedman J.M., Heng H.H.Q., Pelicci P., Lococo F., Belloni E.,
RA   Shaffer L.G., Morton C.C., Pober B., Gusella J., Bruns G., Korf B.R.,
RA   Quade B.J., Ligon A.H., Ferguson H., Higgins A.W., Leach N.T.,
RA   Herrick S.R., Lemyre E., Farra C.G., Kim H.-G., Summers A.M.,
RA   Gripp K.W., Roberts W., Szatmari P., Winsor E.J.T., Grzeschik K.-H.,
RA   Teebi A., Minassian B.A., Kere J., Armengol L., Pujana M.Angel.,
RA   Estivill X., Wilson M.D., Koop B.F., Tosi S., Moore G.E.,
RA   Boright A.P., Zlotorynski E., Kerem B., Kroisel P.M., Petek E.,
RA   Oscier D.G., Mould S.J., Doehner H., Doehner K., Rommens J.M.,
RA   Vincent J.B., Venter J.C., Li P.W., Mural R.J., Adams M.D.,
RA   Tsui L.-C.;
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:EAW80083.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation
CC       of feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00122}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AACC02000041; EAL24417.1; -; Genomic_DNA.
DR   EMBL; CH471146; EAW80083.1; -; Genomic_DNA.
DR   RefSeq; NP_054860.1; NM_014141.5.
DR   UniGene; Hs.655684; -.
DR   GeneID; 26047; -.
DR   KEGG; hsa:26047; -.
DR   CTD; 26047; -.
DR   EuPathDB; HostDB:ENSG00000174469.17; -.
DR   eggNOG; KOG3516; Eukaryota.
DR   eggNOG; ENOG410XPHG; LUCA.
DR   KO; K07380; -.
DR   OMA; GGRCKQT; -.
DR   OrthoDB; 338397at2759; -.
DR   ChiTaRS; CNTNAP2; human.
DR   GenomeRNAi; 26047; -.
DR   Bgee; ENSG00000174469; Expressed in 163 organ(s), highest expression level in forebrain.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0071205; P:protein localization to juxtaparanode region of axon; IEA:InterPro.
DR   CDD; cd00057; FA58C; 1.
DR   Gene3D; 2.60.120.260; -; 1.
DR   InterPro; IPR029831; Caspr2.
DR   InterPro; IPR013320; ConA-like_dom_sf.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR000421; FA58C.
DR   InterPro; IPR036056; Fibrinogen-like_C.
DR   InterPro; IPR002181; Fibrinogen_a/b/g_C_dom.
DR   InterPro; IPR008979; Galactose-bd-like_sf.
DR   InterPro; IPR001791; Laminin_G.
DR   InterPro; IPR003585; Neurexin-like.
DR   PANTHER; PTHR43925:SF3; PTHR43925:SF3; 1.
DR   Pfam; PF00754; F5_F8_type_C; 1.
DR   Pfam; PF02210; Laminin_G_2; 4.
DR   SMART; SM00294; 4.1m; 1.
DR   SMART; SM00181; EGF; 2.
DR   SMART; SM00231; FA58C; 1.
DR   SMART; SM00282; LamG; 4.
DR   SUPFAM; SSF49785; SSF49785; 1.
DR   SUPFAM; SSF49899; SSF49899; 4.
DR   SUPFAM; SSF56496; SSF56496; 1.
DR   PROSITE; PS50026; EGF_3; 2.
DR   PROSITE; PS01285; FA58C_1; 1.
DR   PROSITE; PS01286; FA58C_2; 1.
DR   PROSITE; PS50022; FA58C_3; 1.
DR   PROSITE; PS51406; FIBRINOGEN_C_2; 1.
DR   PROSITE; PS50025; LAM_G_DOMAIN; 4.
PE   4: Predicted;
KW   Disulfide bond {ECO:0000256|PROSITE-ProRule:PRU00122,
KW   ECO:0000256|SAAS:SAAS00814887};
KW   EGF-like domain {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   Membrane {ECO:0000256|SAAS:SAAS00094946, ECO:0000256|SAM:Phobius};
KW   Repeat {ECO:0000256|SAAS:SAAS00966518};
KW   Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAAS:SAAS00094946,
KW   ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAAS:SAAS00094946,
KW   ECO:0000256|SAM:Phobius}.
FT   SIGNAL        1     23       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        24   1331       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5014219317.
FT   TRANSMEM   1262   1283       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN       35    181       F5/8 type C.
FT                                {ECO:0000259|PROSITE:PS50022}.
FT   DOMAIN      187    368       LAM_G_DOMAIN.
FT                                {ECO:0000259|PROSITE:PS50025}.
FT   DOMAIN      373    552       LAM_G_DOMAIN.
FT                                {ECO:0000259|PROSITE:PS50025}.
FT   DOMAIN      554    591       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   DOMAIN      590    642       Fibrinogen C-terminal.
FT                                {ECO:0000259|PROSITE:PS51406}.
FT   DOMAIN      799    963       LAM_G_DOMAIN.
FT                                {ECO:0000259|PROSITE:PS50025}.
FT   DOMAIN      964   1002       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   DOMAIN     1023   1214       LAM_G_DOMAIN.
FT                                {ECO:0000259|PROSITE:PS50025}.
FT   DISULFID    936    963       {ECO:0000256|PROSITE-ProRule:PRU00122}.
SQ   SEQUENCE   1331 AA;  148167 MW;  CFB2CB55BEFB99C2 CRC64;
     MQAAPRAGCG AALLLWIVSS CLCRAWTAPS TSQKCDEPLV SGLPHVAFSS SSSISGSYSP
     GYAKINKRGG AGGWSPSDSD HYQWLQVDFG NRKQISAIAT QGRYSSSDWV TQYRMLYSDT
     GRNWKPYHQD GNIWAFPGNI NSDGVVRHEL QHPIIARYVR IVPLDWNGEG RIGLRIEVYG
     CSYWADVINF DGHVVLPYRF RNKKMKTLKD VIALNFKTSE SEGVILHGEG QQGDYITLEL
     KKAKLVLSLN LGSNQLGPIY GHTSVMTGSL LDDHHWHSVV IERQGRSINL TLDRSMQHFR
     TNGEFDYLDL DYEITFGGIP FSGKPSSSSR KNFKGCMESI NYNGVNITDL ARRKKLEPSN
     VGNLSFSCVE PYTVPVFFNA TSYLEVPGRL NQDLFSVSFQ FRTWNPNGLL VFSHFADNLG
     NVEIDLTESK VGVHINITQT KMSQIDISSG SGLNDGQWHE VRFLAKENFA ILTIDGDEAS
     AVRTNSPLQV KTGEKYFFGG FLNQMNNSSH SVLQPSFQGC MQLIQVDDQL VNLYEVAQRK
     PGSFANVSID MCAIIDRCVP NHCEHGGKCS QTWDSFKCTC DETGYSGATC HNSIYEPSCE
     AYKHLGQTSN YYWIDPDGSG PLGPLKVYCN MTEDKVWTIV SHDLQMQTPV VGYNPEKYSV
     TQLVYSASMD QISAITDSAE YCEQYVSYFC KMSRLLNTPD GSPYTWWVGK ANEKHYYWGG
     SGPGIQKCAC GIERNCTDPK YYCNCDADYK QWRKDAGFLS YKDHLPVSQV VVGDTDRQGS
     EAKLSVGPLR CQGDRNYWNA ASFPNPSSYL HFSTFQGETS ADISFYFKTL TPWGVFLENM
     GKEDFIKLEL KSATEVSFSF DVGNGPVEIV VRSPTPLNDD QWHRVTAERN VKQASLQVDR
     LPQQIRKAPT EGHTRLELYS QLFVGGAGGQ QGFLGCIRSL RMNGVTLDLE ERAKVTSGFI
     SGCSGHCTSY GTNCENGGKC LERYHGYSCD CSNTAYDGTF CNKDVGAFFE EGMWLRYNFQ
     APATNARDSS SRVDNAPDQQ NSHPDLAQEE IRFSFSTTKA PCILLYISSF TTDFLAVLVK
     PTGSLQIRYN LGGTREPYNI DVDHRNMANG QPHSVNITRH EKTIFLKLDH YPSVSYHLPS
     SSDTLFNSPK SLFLGKVIET GKIDQEIHKY NTPGFTGCLS RVQFNQIAPL KAALRQTNAS
     AHVHIQGELV ESNCGASPLT LSPMSSATDP WHLDHLDSAS ADFPYNPGQG QAIRNGVNRN
     SAIIGGVIAV VIFTILCTLV FLIRYMFRHK GTYHTNEAKG AESAESADAA IMNNDPNFTE
     TIDESKKEWL I
//
ID   B2RCH4_HUMAN            Unreviewed;      1331 AA.
AC   B2RCH4;
DT   01-JUL-2008, integrated into UniProtKB/TrEMBL.
DT   01-JUL-2008, sequence version 1.
DT   16-JAN-2019, entry version 90.
DE   SubName: Full=cDNA, FLJ96073, highly similar to Homo sapiens contactin associated protein-like 2 (CNTNAP2), mRNA {ECO:0000313|EMBL:BAG37571.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG37571.1};
RN   [1] {ECO:0000313|EMBL:BAG37571.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Hippocampus {ECO:0000313|EMBL:BAG37571.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Kaida T., Tsuchiya K., Iida Y.,
RA   Takayama Y., Murakawa K., Kanehori K., Andoh T., Kagawa N., Sato R.,
RA   Kawamura Y., Tanaka S., Kisu Y., Sugano S., Goshima N., Nomura N.,
RA   Isogai T.;
RT   "NEDO functional analysis of protein and research application
RT   project.";
RL   Submitted (JAN-2008) to the EMBL/GenBank/DDBJ databases.
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation
CC       of feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00122}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AK315113; BAG37571.1; -; mRNA.
DR   RefSeq; NP_054860.1; NM_014141.5.
DR   UniGene; Hs.655684; -.
DR   ProteinModelPortal; B2RCH4; -.
DR   PRIDE; B2RCH4; -.
DR   GeneID; 26047; -.
DR   KEGG; hsa:26047; -.
DR   CTD; 26047; -.
DR   PharmGKB; PA26692; -.
DR   eggNOG; KOG3516; Eukaryota.
DR   eggNOG; ENOG410XPHG; LUCA.
DR   HOVERGEN; HBG057718; -.
DR   KO; K07380; -.
DR   OrthoDB; 338397at2759; -.
DR   GenomeRNAi; 26047; -.
DR   Genevisible; B2RCH4; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0071205; P:protein localization to juxtaparanode region of axon; IEA:InterPro.
DR   CDD; cd00057; FA58C; 1.
DR   Gene3D; 2.60.120.260; -; 1.
DR   InterPro; IPR029831; Caspr2.
DR   InterPro; IPR013320; ConA-like_dom_sf.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR000421; FA58C.
DR   InterPro; IPR036056; Fibrinogen-like_C.
DR   InterPro; IPR002181; Fibrinogen_a/b/g_C_dom.
DR   InterPro; IPR008979; Galactose-bd-like_sf.
DR   InterPro; IPR001791; Laminin_G.
DR   InterPro; IPR003585; Neurexin-like.
DR   PANTHER; PTHR43925:SF3; PTHR43925:SF3; 1.
DR   Pfam; PF00754; F5_F8_type_C; 1.
DR   Pfam; PF02210; Laminin_G_2; 4.
DR   SMART; SM00294; 4.1m; 1.
DR   SMART; SM00181; EGF; 2.
DR   SMART; SM00231; FA58C; 1.
DR   SMART; SM00282; LamG; 4.
DR   SUPFAM; SSF49785; SSF49785; 1.
DR   SUPFAM; SSF49899; SSF49899; 4.
DR   SUPFAM; SSF56496; SSF56496; 1.
DR   PROSITE; PS50026; EGF_3; 2.
DR   PROSITE; PS01285; FA58C_1; 1.
DR   PROSITE; PS01286; FA58C_2; 1.
DR   PROSITE; PS50022; FA58C_3; 1.
DR   PROSITE; PS51406; FIBRINOGEN_C_2; 1.
DR   PROSITE; PS50025; LAM_G_DOMAIN; 4.
PE   2: Evidence at transcript level;
KW   Disulfide bond {ECO:0000256|PROSITE-ProRule:PRU00122,
KW   ECO:0000256|SAAS:SAAS00814887};
KW   EGF-like domain {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   Membrane {ECO:0000256|SAAS:SAAS00094946, ECO:0000256|SAM:Phobius};
KW   Repeat {ECO:0000256|SAAS:SAAS00966518};
KW   Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAAS:SAAS00094946,
KW   ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAAS:SAAS00094946,
KW   ECO:0000256|SAM:Phobius}.
FT   SIGNAL        1     23       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        24   1331       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5002779571.
FT   TRANSMEM   1262   1283       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN       35    181       F5/8 type C.
FT                                {ECO:0000259|PROSITE:PS50022}.
FT   DOMAIN      187    368       LAM_G_DOMAIN.
FT                                {ECO:0000259|PROSITE:PS50025}.
FT   DOMAIN      373    552       LAM_G_DOMAIN.
FT                                {ECO:0000259|PROSITE:PS50025}.
FT   DOMAIN      554    591       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   DOMAIN      590    642       Fibrinogen C-terminal.
FT                                {ECO:0000259|PROSITE:PS51406}.
FT   DOMAIN      799    963       LAM_G_DOMAIN.
FT                                {ECO:0000259|PROSITE:PS50025}.
FT   DOMAIN      964   1002       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   DOMAIN     1023   1214       LAM_G_DOMAIN.
FT                                {ECO:0000259|PROSITE:PS50025}.
FT   DISULFID    936    963       {ECO:0000256|PROSITE-ProRule:PRU00122}.
SQ   SEQUENCE   1331 AA;  148133 MW;  59962C173F56F35B CRC64;
     MQAAPRAGCG AALLLWIVSS CLCRAWTAPS TSQKCDEPLV SGLPHVAFSS SSSISGSYSP
     GYAKINKRGG AGGWSPSDSD HYQWLQVDFG NRKQISAIAT QGRYSSSDWV TQYRMLYSDT
     GRNWKPYHQD GNIWAFPGNI NSDGVVRHEL QHPIIARYVR IVPLDWNGEG RIGLRIEVYG
     CSYWADVINF DGHVVLPYRF RNKKMKTLKD VIALNFKTSE SEGVILHGEG QQGDYITLEL
     KKAKLVLSLN LGSNQLGPIY GHTSVMTGSL LDDHHWHSVV IERQGRSINL TLDRSMQHFR
     TNGEFDYLDL DYEITFGGIP FSGKPSSSSR KNFKGCMESI NYNGVNITDL ARRKKLEPSN
     VGNLSFSCVE PYTVPVFFNA TSYLEVPGRL NQDLFSVSFQ FRTWNPNGLL VFSHFADNLG
     NVEIDLTESK VGVHINITQT KMSQIDISSG SGLNDGQWHE VRFLAKENFA ILTIDGDEAS
     AVRTNSPLQV KTGEKYLFGG FLNQMNNSSH SVLQPSFQGC MQLIQVDDQL VNLYEVAQRK
     PGSFANVSID MCAIIDRCVP NHCEHGGKCS QTWDSFKCTC DETGYSGATC HNSIYEPSCE
     AYKHLGQTSN YYWIDPDGSG PLGPLKVYCN MTEDKVWTIV SHDLQMQTPV VGYNPEKYSV
     TQLVYSASMD QISAITDSAE YCEQYVSYFC KMSRLLNTPD GSPYTWWVGK ANEKHYYWGG
     SGPGIQKCAC GIERNCTDPK YYCNCDADYK QWRKDAGFLS YKDHLPVSQV VVGDTDRQGS
     EAKLSVGPLR CQGDRNYWNA ASFPNPSSYL HFSTFQGETS ADISFYFKTL TPWGVFLENM
     GKEDFIKLEL KSATEVSFSF DVGNGPVEIV VRSPTPLNDD QWHRVTAERN VKQASLQVDR
     LPQQIRKAPT EGHTRLELYS QLFVGGAGGQ QGFLGCIRSL RMNGVTLDLE ERAKVTSGFI
     SGCSGHCTSY GTNCENGGKC LERYHGYSCD CSNTAYDGTF CNKDVGAFFE EGMWLRYNFQ
     APATNARDSS SRVDNAPDQQ NSHPDLAQEE IRFSFSTTKA PCILLYISSF TTDFLAVLVK
     PTGSLQIRYN LGGTREPYNI DVDHRNMANG QPHSVNITRH EKTIFLKLDH YPSVSYHLPS
     SSDTLFNSPK SLFLGKVIET GKIDQEIHKY NTPGFTGCLS RVQFNQIAPL KAALRQTNAS
     AHVHIQGELV ESNCGASPLT LSPMSSATDP WHLDHLDSAS ADFPYNPGQG QAIRNGVNRN
     SAIIGGVIAV VIFTILCTLV FLIRYMFRHK GTYHTNEAKG AESAESADAA IMNNDPNFTE
     TIDESKKEWL I
//
ID   CNTP2_HUMAN             Reviewed;        1331 AA.
AC   Q9UHC6; D3DWG2; Q14DG2; Q52LV1; Q5H9Q7; Q9UQ12;
DT   05-DEC-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   13-FEB-2019, entry version 186.
DE   RecName: Full=Contactin-associated protein-like 2;
DE   AltName: Full=Cell recognition molecule Caspr2;
DE   Flags: Precursor;
GN   Name=CNTNAP2; Synonyms=CASPR2 {ECO:0000303|PubMed:10624965}, KIAA0868;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INTERACTION WITH KCNA2, AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=10624965; DOI=10.1016/S0896-6273(00)81049-1;
RA   Poliak S., Gollan L., Martinez R., Custer A., Einheber S.,
RA   Salzer J.L., Trimmer J.S., Shrager P., Peles E.;
RT   "Caspr2, a new member of the neurexin superfamily, is localized at the
RT   juxtaparanodes of myelinated axons and associates with K+ channels.";
RL   Neuron 24:1037-1047(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=11352571; DOI=10.1006/geno.2001.6517;
RA   Nakabayashi K., Scherer S.W.;
RT   "The human contactin-associated protein-like 2 gene (CNTNAP2) spans
RT   over 2 Mb of DNA at chromosome 7q35.";
RL   Genomics 73:108-112(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=10048485; DOI=10.1093/dnares/5.6.355;
RA   Nagase T., Ishikawa K., Suyama M., Kikuno R., Hirosawa M.,
RA   Miyajima N., Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XII.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 5:355-364(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Retina;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   INVOLVEMENT IN PTHSL1.
RX   PubMed=16571880; DOI=10.1056/NEJMoa052773;
RA   Strauss K.A., Puffenberger E.G., Huentelman M.J., Gottlieb S.,
RA   Dobrin S.E., Parod J.M., Stephan D.A., Morton D.H.;
RT   "Recessive symptomatic focal epilepsy and mutant contactin-associated
RT   protein-like 2.";
RL   N. Engl. J. Med. 354:1370-1377(2006).
RN   [8]
RP   INVOLVEMENT IN PTHSL1.
RX   PubMed=19896112; DOI=10.1016/j.ajhg.2009.10.004;
RA   Zweier C., de Jong E.K., Zweier M., Orrico A., Ousager L.B.,
RA   Collins A.L., Bijlsma E.K., Oortveld M.A., Ekici A.B., Reis A.,
RA   Schenck A., Rauch A.;
RT   "CNTNAP2 and NRXN1 are mutated in autosomal-recessive Pitt-Hopkins-
RT   like mental retardation and determine the level of a common synaptic
RT   protein in Drosophila.";
RL   Am. J. Hum. Genet. 85:655-666(2009).
RN   [9]
RP   INVOLVEMENT IN AUTS15, VARIANTS GLN-114; MET-218; MET-226; CYS-283;
RP   ASN-382; SER-407; ASP-418; LYS-680; GLN-699; CYS-716; SER-731;
RP   ASP-779; THR-869; HIS-906; ASN-1038; ALA-1102; GLY-1114; HIS-1119;
RP   HIS-1129; THR-1227; THR-1253 AND ILE-1278, AND CHROMOSOMAL
RP   REARRANGEMENT.
RX   PubMed=18179895; DOI=10.1016/j.ajhg.2007.09.017;
RA   Bakkaloglu B., O'Roak B.J., Louvi A., Gupta A.R., Abelson J.F.,
RA   Morgan T.M., Chawarska K., Klin A., Ercan-Sencicek A.G.,
RA   Stillman A.A., Tanriover G., Abrahams B.S., Duvall J.A., Robbins E.M.,
RA   Geschwind D.H., Biederer T., Gunel M., Lifton R.P., State M.W.;
RT   "Molecular cytogenetic analysis and resequencing of contactin
RT   associated protein-like 2 in autism spectrum disorders.";
RL   Am. J. Hum. Genet. 82:165-173(2008).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
CC   -!- FUNCTION: Required, with CNTNAP1, for radial and longitudinal
CC       organization of myelinated axons. Plays a role in the formation of
CC       functional distinct domains critical for saltatory conduction of
CC       nerve impulses in myelinated nerve fibers. Demarcates the
CC       juxtaparanodal region of the axo-glial junction.
CC       {ECO:0000250|UniProtKB:Q9CPW0}.
CC   -!- SUBUNIT: Interacts (via C-terminus) with KCNA2.
CC       {ECO:0000269|PubMed:10624965}.
CC   -!- INTERACTION:
CC       P27824:CANX; NbExp=2; IntAct=EBI-16594440, EBI-355947;
CC       Q12860:CNTN1; NbExp=5; IntAct=EBI-310892, EBI-5564336;
CC       P50222:MEOX2; NbExp=3; IntAct=EBI-310892, EBI-748397;
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250|UniProtKB:Q9CPW0};
CC       Single-pass type I membrane protein {ECO:0000305}. Cell
CC       projection, axon {ECO:0000250|UniProtKB:Q9CPW0}. Cell junction,
CC       paranodal septate junction {ECO:0000250|UniProtKB:Q9CPW0}.
CC       Note=Expressed in the juxtaparadonal region.
CC       {ECO:0000250|UniProtKB:Q9CPW0}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9UHC6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UHC6-2; Sequence=VSP_014976;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in nervous system.
CC       {ECO:0000269|PubMed:10624965}.
CC   -!- DISEASE: Autism 15 (AUTS15) [MIM:612100]: A complex
CC       multifactorial, pervasive developmental disorder characterized by
CC       impairments in reciprocal social interaction and communication,
CC       restricted and stereotyped patterns of interests and activities,
CC       and the presence of developmental abnormalities by 3 years of age.
CC       Most individuals with autism also manifest moderate mental
CC       retardation. {ECO:0000269|PubMed:18179895}. Note=Disease
CC       susceptibility is associated with variations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Note=A chromosomal aberration involving CNTNAP2 is found
CC       in a patient with autism spectrum disorder. Paracentric inversion
CC       46,XY,inv(7)(q11.22;q35). The inversion breakpoints disrupt the
CC       genes AUTS2 and CNTNAP2.
CC   -!- DISEASE: Pitt-Hopkins-like syndrome 1 (PTHSL1) [MIM:610042]: A
CC       syndrome characterized by severe mental retardation and variable
CC       additional symptoms, such as impaired speech development,
CC       seizures, autistic behavior, breathing anomalies and a broad
CC       mouth, resembling Pitt-Hopkins syndrome. In contrast to patients
CC       with Pitt-Hopkins syndrome, PTHSL1 patients present with normal or
CC       only mildly to moderately delayed motor milestones.
CC       {ECO:0000269|PubMed:16571880, ECO:0000269|PubMed:19896112}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the neurexin family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA74891.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AF193613; AAF25199.1; -; mRNA.
DR   EMBL; AF319045; AAK34932.1; -; mRNA.
DR   EMBL; AF318292; AAK49902.1; -; Genomic_DNA.
DR   EMBL; AF318298; AAK49903.1; -; Genomic_DNA.
DR   EMBL; AB020675; BAA74891.1; ALT_INIT; mRNA.
DR   EMBL; CR933671; CAI45967.1; -; mRNA.
DR   EMBL; CH471146; EAW80084.1; -; Genomic_DNA.
DR   EMBL; BC093780; AAH93780.1; -; mRNA.
DR   EMBL; BC113373; AAI13374.1; -; mRNA.
DR   CCDS; CCDS5889.1; -. [Q9UHC6-1]
DR   RefSeq; NP_054860.1; NM_014141.5. [Q9UHC6-1]
DR   UniGene; Hs.655684; -.
DR   PDB; 5Y4M; X-ray; 1.31 A; A=35-181.
DR   PDBsum; 5Y4M; -.
DR   ProteinModelPortal; Q9UHC6; -.
DR   SMR; Q9UHC6; -.
DR   BioGrid; 117510; 8.
DR   IntAct; Q9UHC6; 12.
DR   MINT; Q9UHC6; -.
DR   STRING; 9606.ENSP00000354778; -.
DR   iPTMnet; Q9UHC6; -.
DR   PhosphoSitePlus; Q9UHC6; -.
DR   SwissPalm; Q9UHC6; -.
DR   BioMuta; CNTNAP2; -.
DR   DMDM; 17433089; -.
DR   EPD; Q9UHC6; -.
DR   jPOST; Q9UHC6; -.
DR   PaxDb; Q9UHC6; -.
DR   PeptideAtlas; Q9UHC6; -.
DR   PRIDE; Q9UHC6; -.
DR   ProteomicsDB; 84311; -.
DR   ProteomicsDB; 84312; -. [Q9UHC6-2]
DR   Ensembl; ENST00000361727; ENSP00000354778; ENSG00000174469. [Q9UHC6-1]
DR   Ensembl; ENST00000463592; ENSP00000486292; ENSG00000174469. [Q9UHC6-2]
DR   Ensembl; ENST00000613345; ENSP00000481057; ENSG00000278728. [Q9UHC6-2]
DR   Ensembl; ENST00000649351; ENSP00000496805; ENSG00000174469. [Q9UHC6-1]
DR   GeneID; 26047; -.
DR   KEGG; hsa:26047; -.
DR   UCSC; uc003weu.3; human. [Q9UHC6-1]
DR   CTD; 26047; -.
DR   DisGeNET; 26047; -.
DR   EuPathDB; HostDB:ENSG00000174469.17; -.
DR   GeneCards; CNTNAP2; -.
DR   HGNC; HGNC:13830; CNTNAP2.
DR   HPA; HPA002739; -.
DR   MalaCards; CNTNAP2; -.
DR   MIM; 604569; gene.
DR   MIM; 610042; phenotype.
DR   MIM; 612100; phenotype.
DR   neXtProt; NX_Q9UHC6; -.
DR   OpenTargets; ENSG00000174469; -.
DR   Orphanet; 163681; Cortical dysplasia-focal epilepsy syndrome.
DR   Orphanet; 106; NON RARE IN EUROPE: Autism.
DR   Orphanet; 221150; Pitt-Hopkins-like syndrome.
DR   PharmGKB; PA26692; -.
DR   eggNOG; KOG3516; Eukaryota.
DR   eggNOG; ENOG410XPHG; LUCA.
DR   GeneTree; ENSGT00940000154516; -.
DR   HOGENOM; HOG000230964; -.
DR   HOVERGEN; HBG057718; -.
DR   InParanoid; Q9UHC6; -.
DR   KO; K07380; -.
DR   OMA; GGRCKQT; -.
DR   OrthoDB; 338397at2759; -.
DR   PhylomeDB; Q9UHC6; -.
DR   TreeFam; TF321823; -.
DR   SIGNOR; Q9UHC6; -.
DR   ChiTaRS; CNTNAP2; human.
DR   GeneWiki; CNTNAP2; -.
DR   GenomeRNAi; 26047; -.
DR   PRO; PR:Q9UHC6; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000174469; Expressed in 163 organ(s), highest expression level in forebrain.
DR   ExpressionAtlas; Q9UHC6; baseline and differential.
DR   Genevisible; Q9UHC6; HS.
DR   GO; GO:0030673; C:axolemma; IDA:BHF-UCL.
DR   GO; GO:0030424; C:axon; NAS:BHF-UCL.
DR   GO; GO:0009986; C:cell surface; IDA:BHF-UCL.
DR   GO; GO:0030425; C:dendrite; NAS:BHF-UCL.
DR   GO; GO:0005769; C:early endosome; IDA:BHF-UCL.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:BHF-UCL.
DR   GO; GO:0016021; C:integral component of membrane; NAS:UniProtKB.
DR   GO; GO:0044224; C:juxtaparanode region of axon; ISS:BHF-UCL.
DR   GO; GO:0016020; C:membrane; IDA:BHF-UCL.
DR   GO; GO:0043025; C:neuronal cell body; NAS:BHF-UCL.
DR   GO; GO:0033010; C:paranodal junction; IEA:UniProtKB-SubCell.
DR   GO; GO:0043204; C:perikaryon; NAS:BHF-UCL.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IDA:BHF-UCL.
DR   GO; GO:0019899; F:enzyme binding; IPI:BHF-UCL.
DR   GO; GO:0030534; P:adult behavior; IMP:BHF-UCL.
DR   GO; GO:0007420; P:brain development; TAS:BHF-UCL.
DR   GO; GO:0007155; P:cell adhesion; IEA:UniProtKB-KW.
DR   GO; GO:0021987; P:cerebral cortex development; IEP:BHF-UCL.
DR   GO; GO:0045163; P:clustering of voltage-gated potassium channels; ISS:BHF-UCL.
DR   GO; GO:0007612; P:learning; IMP:BHF-UCL.
DR   GO; GO:0021761; P:limbic system development; IEP:BHF-UCL.
DR   GO; GO:0031175; P:neuron projection development; ISS:BHF-UCL.
DR   GO; GO:0048812; P:neuron projection morphogenesis; ISS:UniProtKB.
DR   GO; GO:0008038; P:neuron recognition; NAS:UniProtKB.
DR   GO; GO:0071205; P:protein localization to juxtaparanode region of axon; ISS:BHF-UCL.
DR   GO; GO:0035176; P:social behavior; IMP:BHF-UCL.
DR   GO; GO:0021756; P:striatum development; IEP:BHF-UCL.
DR   GO; GO:0071109; P:superior temporal gyrus development; IEP:BHF-UCL.
DR   GO; GO:0021794; P:thalamus development; IEP:BHF-UCL.
DR   GO; GO:0019226; P:transmission of nerve impulse; NAS:UniProtKB.
DR   GO; GO:0042297; P:vocal learning; IMP:BHF-UCL.
DR   GO; GO:0071625; P:vocalization behavior; IMP:BHF-UCL.
DR   CDD; cd00057; FA58C; 1.
DR   Gene3D; 2.60.120.260; -; 1.
DR   InterPro; IPR029831; Caspr2.
DR   InterPro; IPR013320; ConA-like_dom_sf.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR000421; FA58C.
DR   InterPro; IPR036056; Fibrinogen-like_C.
DR   InterPro; IPR002181; Fibrinogen_a/b/g_C_dom.
DR   InterPro; IPR008979; Galactose-bd-like_sf.
DR   InterPro; IPR001791; Laminin_G.
DR   InterPro; IPR003585; Neurexin-like.
DR   PANTHER; PTHR43925:SF3; PTHR43925:SF3; 1.
DR   Pfam; PF00754; F5_F8_type_C; 1.
DR   Pfam; PF02210; Laminin_G_2; 4.
DR   SMART; SM00294; 4.1m; 1.
DR   SMART; SM00181; EGF; 2.
DR   SMART; SM00231; FA58C; 1.
DR   SMART; SM00282; LamG; 4.
DR   SUPFAM; SSF49785; SSF49785; 1.
DR   SUPFAM; SSF49899; SSF49899; 4.
DR   SUPFAM; SSF56496; SSF56496; 1.
DR   PROSITE; PS50026; EGF_3; 2.
DR   PROSITE; PS01285; FA58C_1; 1.
DR   PROSITE; PS01286; FA58C_2; 1.
DR   PROSITE; PS50022; FA58C_3; 1.
DR   PROSITE; PS51406; FIBRINOGEN_C_2; 1.
DR   PROSITE; PS50025; LAM_G_DOMAIN; 4.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Autism; Autism spectrum disorder;
KW   Cell adhesion; Cell junction; Cell projection;
KW   Chromosomal rearrangement; Complete proteome; Disulfide bond;
KW   EGF-like domain; Epilepsy; Glycoprotein; Membrane; Mental retardation;
KW   Phosphoprotein; Polymorphism; Reference proteome; Repeat; Signal;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL        1     27       {ECO:0000255}.
FT   CHAIN        28   1331       Contactin-associated protein-like 2.
FT                                /FTId=PRO_0000019506.
FT   TOPO_DOM     28   1262       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1263   1283       Helical. {ECO:0000255}.
FT   TOPO_DOM   1284   1331       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       35    181       F5/8 type C. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00081}.
FT   DOMAIN      216    368       Laminin G-like 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00122}.
FT   DOMAIN      401    552       Laminin G-like 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00122}.
FT   DOMAIN      554    591       EGF-like 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      592    798       Fibrinogen C-terminal.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00739}.
FT   DOMAIN      799    963       Laminin G-like 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00122}.
FT   DOMAIN      963   1002       EGF-like 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN     1055   1214       Laminin G-like 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00122}.
FT   MOD_RES    1303   1303       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9CPW0}.
FT   MOD_RES    1306   1306       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9CPW0}.
FT   CARBOHYD    289    289       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    346    346       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    363    363       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    379    379       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    436    436       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    506    506       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    507    507       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    546    546       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    630    630       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    735    735       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1116   1116       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1198   1198       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     35    181       {ECO:0000250}.
FT   DISULFID    336    368       {ECO:0000250}.
FT   DISULFID    520    552       {ECO:0000250}.
FT   DISULFID    558    569       {ECO:0000250}.
FT   DISULFID    563    578       {ECO:0000250}.
FT   DISULFID    580    590       {ECO:0000250}.
FT   DISULFID    936    963       {ECO:0000250}.
FT   DISULFID    967    980       {ECO:0000250}.
FT   DISULFID    974    989       {ECO:0000250}.
FT   DISULFID    991   1001       {ECO:0000250}.
FT   DISULFID   1178   1214       {ECO:0000250}.
FT   VAR_SEQ       1   1223       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_014976.
FT   VARIANT     114    114       R -> Q (in dbSNP:rs189731792).
FT                                {ECO:0000269|PubMed:18179895}.
FT                                /FTId=VAR_046227.
FT   VARIANT     218    218       T -> M (in dbSNP:rs771028883).
FT                                {ECO:0000269|PubMed:18179895}.
FT                                /FTId=VAR_046228.
FT   VARIANT     226    226       L -> M (in dbSNP:rs372345438).
FT                                {ECO:0000269|PubMed:18179895}.
FT                                /FTId=VAR_046229.
FT   VARIANT     283    283       R -> C (in dbSNP:rs794727802).
FT                                {ECO:0000269|PubMed:18179895}.
FT                                /FTId=VAR_046230.
FT   VARIANT     382    382       S -> N (in dbSNP:rs371839994).
FT                                {ECO:0000269|PubMed:18179895}.
FT                                /FTId=VAR_046231.
FT   VARIANT     407    407       N -> S (in dbSNP:rs143877693).
FT                                {ECO:0000269|PubMed:18179895}.
FT                                /FTId=VAR_046232.
FT   VARIANT     418    418       N -> D (in dbSNP:rs772179690).
FT                                {ECO:0000269|PubMed:18179895}.
FT                                /FTId=VAR_046233.
FT   VARIANT     680    680       E -> K (in dbSNP:rs368905425).
FT                                {ECO:0000269|PubMed:18179895}.
FT                                /FTId=VAR_046234.
FT   VARIANT     699    699       P -> Q (in dbSNP:rs764412489).
FT                                {ECO:0000269|PubMed:18179895}.
FT                                /FTId=VAR_046235.
FT   VARIANT     716    716       Y -> C (in dbSNP:rs760930032).
FT                                {ECO:0000269|PubMed:18179895}.
FT                                /FTId=VAR_046236.
FT   VARIANT     731    731       G -> S (in dbSNP:rs369867547).
FT                                {ECO:0000269|PubMed:18179895}.
FT                                /FTId=VAR_046237.
FT   VARIANT     779    779       G -> D (in dbSNP:rs200413148).
FT                                {ECO:0000269|PubMed:18179895}.
FT                                /FTId=VAR_046238.
FT   VARIANT     869    869       I -> T (rare polymorphism; may be a risk
FT                                factor for autism; dbSNP:rs121908445).
FT                                {ECO:0000269|PubMed:18179895}.
FT                                /FTId=VAR_046239.
FT   VARIANT     906    906       R -> H (in dbSNP:rs759801195).
FT                                {ECO:0000269|PubMed:18179895}.
FT                                /FTId=VAR_046240.
FT   VARIANT    1038   1038       D -> N (in dbSNP:rs144003410).
FT                                {ECO:0000269|PubMed:18179895}.
FT                                /FTId=VAR_046241.
FT   VARIANT    1102   1102       V -> A (in dbSNP:rs111599875).
FT                                {ECO:0000269|PubMed:18179895}.
FT                                /FTId=VAR_046242.
FT   VARIANT    1114   1114       S -> G (in dbSNP:rs983036503).
FT                                {ECO:0000269|PubMed:18179895}.
FT                                /FTId=VAR_046243.
FT   VARIANT    1119   1119       R -> H (in dbSNP:rs774709566).
FT                                {ECO:0000269|PubMed:18179895}.
FT                                /FTId=VAR_046244.
FT   VARIANT    1129   1129       D -> H (in dbSNP:rs781236853).
FT                                {ECO:0000269|PubMed:18179895}.
FT                                /FTId=VAR_046245.
FT   VARIANT    1227   1227       A -> T (in dbSNP:rs761684414).
FT                                {ECO:0000269|PubMed:18179895}.
FT                                /FTId=VAR_046246.
FT   VARIANT    1253   1253       I -> T (in dbSNP:rs767821521).
FT                                {ECO:0000269|PubMed:18179895}.
FT                                /FTId=VAR_046247.
FT   VARIANT    1278   1278       T -> I (in dbSNP:rs760047247).
FT                                {ECO:0000269|PubMed:18179895}.
FT                                /FTId=VAR_046248.
FT   STRAND       37     40       {ECO:0000244|PDB:5Y4M}.
FT   HELIX        45     47       {ECO:0000244|PDB:5Y4M}.
FT   STRAND       48     51       {ECO:0000244|PDB:5Y4M}.
FT   HELIX        56     58       {ECO:0000244|PDB:5Y4M}.
FT   HELIX        60     62       {ECO:0000244|PDB:5Y4M}.
FT   STRAND       72     74       {ECO:0000244|PDB:5Y4M}.
FT   STRAND       85    101       {ECO:0000244|PDB:5Y4M}.
FT   STRAND      110    123       {ECO:0000244|PDB:5Y4M}.
FT   STRAND      140    143       {ECO:0000244|PDB:5Y4M}.
FT   STRAND      146    166       {ECO:0000244|PDB:5Y4M}.
FT   STRAND      174    181       {ECO:0000244|PDB:5Y4M}.
SQ   SEQUENCE   1331 AA;  148167 MW;  CFB2CB55BEFB99C2 CRC64;
     MQAAPRAGCG AALLLWIVSS CLCRAWTAPS TSQKCDEPLV SGLPHVAFSS SSSISGSYSP
     GYAKINKRGG AGGWSPSDSD HYQWLQVDFG NRKQISAIAT QGRYSSSDWV TQYRMLYSDT
     GRNWKPYHQD GNIWAFPGNI NSDGVVRHEL QHPIIARYVR IVPLDWNGEG RIGLRIEVYG
     CSYWADVINF DGHVVLPYRF RNKKMKTLKD VIALNFKTSE SEGVILHGEG QQGDYITLEL
     KKAKLVLSLN LGSNQLGPIY GHTSVMTGSL LDDHHWHSVV IERQGRSINL TLDRSMQHFR
     TNGEFDYLDL DYEITFGGIP FSGKPSSSSR KNFKGCMESI NYNGVNITDL ARRKKLEPSN
     VGNLSFSCVE PYTVPVFFNA TSYLEVPGRL NQDLFSVSFQ FRTWNPNGLL VFSHFADNLG
     NVEIDLTESK VGVHINITQT KMSQIDISSG SGLNDGQWHE VRFLAKENFA ILTIDGDEAS
     AVRTNSPLQV KTGEKYFFGG FLNQMNNSSH SVLQPSFQGC MQLIQVDDQL VNLYEVAQRK
     PGSFANVSID MCAIIDRCVP NHCEHGGKCS QTWDSFKCTC DETGYSGATC HNSIYEPSCE
     AYKHLGQTSN YYWIDPDGSG PLGPLKVYCN MTEDKVWTIV SHDLQMQTPV VGYNPEKYSV
     TQLVYSASMD QISAITDSAE YCEQYVSYFC KMSRLLNTPD GSPYTWWVGK ANEKHYYWGG
     SGPGIQKCAC GIERNCTDPK YYCNCDADYK QWRKDAGFLS YKDHLPVSQV VVGDTDRQGS
     EAKLSVGPLR CQGDRNYWNA ASFPNPSSYL HFSTFQGETS ADISFYFKTL TPWGVFLENM
     GKEDFIKLEL KSATEVSFSF DVGNGPVEIV VRSPTPLNDD QWHRVTAERN VKQASLQVDR
     LPQQIRKAPT EGHTRLELYS QLFVGGAGGQ QGFLGCIRSL RMNGVTLDLE ERAKVTSGFI
     SGCSGHCTSY GTNCENGGKC LERYHGYSCD CSNTAYDGTF CNKDVGAFFE EGMWLRYNFQ
     APATNARDSS SRVDNAPDQQ NSHPDLAQEE IRFSFSTTKA PCILLYISSF TTDFLAVLVK
     PTGSLQIRYN LGGTREPYNI DVDHRNMANG QPHSVNITRH EKTIFLKLDH YPSVSYHLPS
     SSDTLFNSPK SLFLGKVIET GKIDQEIHKY NTPGFTGCLS RVQFNQIAPL KAALRQTNAS
     AHVHIQGELV ESNCGASPLT LSPMSSATDP WHLDHLDSAS ADFPYNPGQG QAIRNGVNRN
     SAIIGGVIAV VIFTILCTLV FLIRYMFRHK GTYHTNEAKG AESAESADAA IMNNDPNFTE
     TIDESKKEWL I
//
ID   B3KXC1_HUMAN            Unreviewed;       390 AA.
AC   B3KXC1;
DT   02-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   02-SEP-2008, sequence version 1.
DT   16-JAN-2019, entry version 58.
DE   SubName: Full=Cytoplasmic polyadenylation element binding protein 3, isoform CRA_b {ECO:0000313|EMBL:EAW50098.1};
DE   SubName: Full=cDNA FLJ45117 fis, clone BRAWH3035403, highly similar to Mus musculus cytoplasmic polyadenylation element binding protein 3 (Cpeb3), mRNA {ECO:0000313|EMBL:BAG54433.1};
GN   Name=CPEB3 {ECO:0000313|EMBL:EAW50098.1};
GN   ORFNames=hCG_20317 {ECO:0000313|EMBL:EAW50098.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG54433.1};
RN   [1] {ECO:0000313|EMBL:EAW50098.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:BAG54433.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:BAG54433.1};
RA   Ota T., Nakagawa S., Senoh A., Mizuguchi H., Inagaki H., Sugiyama T.,
RA   Irie R., Otsuki T., Sato H., Wakamatsu A., Ishii S., Yamamoto J.,
RA   Isono Y., Kawai-Hio Y., Saito K., Nishikawa T., Kimura K.,
RA   Yamashita H., Matsuo K., Nakamura Y., Sekine M., Kikuchi H., Kanda K.,
RA   Wagatsuma M., Murakawa K., Kanehori K., Takahashi-Fujii A., Oshima A.,
RA   Sugiyama A., Kawakami B., Suzuki Y., Sugano S., Nagahari K.,
RA   Masuho Y., Nagai K., Isogai T.;
RT   "NEDO human cDNA sequencing project.";
RL   Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:EAW50098.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AK127060; BAG54433.1; -; mRNA.
DR   EMBL; CH471066; EAW50098.1; -; Genomic_DNA.
DR   RefSeq; NP_055727.3; NM_014912.4.
DR   UniGene; Hs.131683; -.
DR   UniGene; Hs.701732; -.
DR   PeptideAtlas; B3KXC1; -.
DR   PRIDE; B3KXC1; -.
DR   DNASU; 22849; -.
DR   GeneID; 22849; -.
DR   KEGG; hsa:22849; -.
DR   CTD; 22849; -.
DR   eggNOG; KOG0129; Eukaryota.
DR   eggNOG; ENOG410Y1XZ; LUCA.
DR   HOVERGEN; HBG058010; -.
DR   KO; K02602; -.
DR   OrthoDB; 1075356at2759; -.
DR   ChiTaRS; CPEB3; human.
DR   GenomeRNAi; 22849; -.
DR   GO; GO:0003730; F:mRNA 3'-UTR binding; IEA:InterPro.
DR   GO; GO:0045182; F:translation regulator activity; IEA:InterPro.
DR   Gene3D; 3.30.40.130; -; 1.
DR   Gene3D; 3.30.70.330; -; 2.
DR   InterPro; IPR032296; CEBP_ZZ.
DR   InterPro; IPR038446; CEBP_ZZ_sf.
DR   InterPro; IPR034819; CPEB.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   PANTHER; PTHR12566; PTHR12566; 1.
DR   Pfam; PF16366; CEBP_ZZ; 1.
DR   Pfam; PF16367; RRM_7; 1.
DR   SMART; SM00360; RRM; 2.
DR   SUPFAM; SSF54928; SSF54928; 1.
DR   PROSITE; PS50102; RRM; 2.
PE   2: Evidence at transcript level;
KW   RNA-binding {ECO:0000256|PROSITE-ProRule:PRU00176}.
FT   DOMAIN      133    220       RRM. {ECO:0000259|PROSITE:PS50102}.
FT   DOMAIN      241    319       RRM. {ECO:0000259|PROSITE:PS50102}.
SQ   SEQUENCE   390 AA;  44200 MW;  BD86765B618E5F22 CRC64;
     MEDNAFRTDN GNNLLPFQDR SRPYDTFNLH SLENSLMDMI RTDHEPLKGK HYPPSGPPMS
     FADIMWRNHF AGRMGINFHH PGTDNIMALN SRSSLFPFED AFLDDSHGDQ ALSSGLSSPT
     RCQNGERVER YSRKVFVGGL PPDIDEDEIT ASFRRFGPLV VDWPHKAESK SYFPPKGYAF
     LLFQEESSVQ ALIDACLEED GKLYLCVSSP TIKDKPVQIR PWNLSDSDFV MDGSQPLDPR
     KTIFVGGVPR PLRAVELAMI MDRLYGGVCY AGIDTDPELK YPKGAGRVAF SNQQSYIAAI
     SARFVQLQHN DIDKRVEVKP YVLDDQMCDE CQGTRCGGKF APFFCANVTC LQYYCEYCWA
     SIHSRAGREF HKPLVKEGGD RPRHVPFRWS
//
ID   Q5QP71_HUMAN            Unreviewed;       684 AA.
AC   Q5QP71;
DT   05-FEB-2008, integrated into UniProtKB/TrEMBL.
DT   05-FEB-2008, sequence version 1.
DT   13-FEB-2019, entry version 82.
DE   SubName: Full=Cytoplasmic polyadenylation element binding protein 3, isoform CRA_a {ECO:0000313|EMBL:EAW50097.1};
DE   SubName: Full=cDNA FLJ61637, highly similar to Homo sapiens cytoplasmic polyadenylation element binding protein 3 (CPEB3), mRNA {ECO:0000313|EMBL:BAH13751.1};
GN   Name=CPEB3 {ECO:0000313|EMBL:EAW50097.1};
GN   ORFNames=hCG_20317 {ECO:0000313|EMBL:EAW50097.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAH13751.1};
RN   [1] {ECO:0000313|EMBL:EAW50097.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW50097.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:BAH13751.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Testis {ECO:0000313|EMBL:BAH13751.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AK302576; BAH13751.1; -; mRNA.
DR   EMBL; CH471066; EAW50097.1; -; Genomic_DNA.
DR   RefSeq; NP_001171608.1; NM_001178137.1.
DR   RefSeq; XP_005269687.1; XM_005269630.4.
DR   UniGene; Hs.131683; -.
DR   UniGene; Hs.701732; -.
DR   DNASU; 22849; -.
DR   GeneID; 22849; -.
DR   CTD; 22849; -.
DR   EuPathDB; HostDB:ENSG00000107864.14; -.
DR   PharmGKB; PA134903478; -.
DR   eggNOG; KOG0129; Eukaryota.
DR   eggNOG; ENOG410Y1XZ; LUCA.
DR   HOGENOM; HOG000290660; -.
DR   HOVERGEN; HBG058010; -.
DR   OrthoDB; 1075356at2759; -.
DR   ChiTaRS; CPEB3; human.
DR   GenomeRNAi; 22849; -.
DR   Bgee; ENSG00000107864; Expressed in 206 organ(s), highest expression level in buccal mucosa cell.
DR   GO; GO:0003730; F:mRNA 3'-UTR binding; IEA:InterPro.
DR   GO; GO:0045182; F:translation regulator activity; IEA:InterPro.
DR   Gene3D; 3.30.40.130; -; 1.
DR   Gene3D; 3.30.70.330; -; 2.
DR   InterPro; IPR032296; CEBP_ZZ.
DR   InterPro; IPR038446; CEBP_ZZ_sf.
DR   InterPro; IPR034819; CPEB.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   PANTHER; PTHR12566; PTHR12566; 1.
DR   Pfam; PF16366; CEBP_ZZ; 1.
DR   Pfam; PF16367; RRM_7; 1.
DR   SMART; SM00360; RRM; 2.
DR   SUPFAM; SSF54928; SSF54928; 1.
DR   PROSITE; PS50102; RRM; 2.
PE   2: Evidence at transcript level;
KW   RNA-binding {ECO:0000256|PROSITE-ProRule:PRU00176}.
FT   DOMAIN      427    514       RRM. {ECO:0000259|PROSITE:PS50102}.
FT   DOMAIN      535    613       RRM. {ECO:0000259|PROSITE:PS50102}.
SQ   SEQUENCE   684 AA;  74440 MW;  7CD47A66E821AE71 CRC64;
     MQDDLLMDKS KTQPQPQQQQ RQQQQPQPES SVSEAPSTPL SSETPKPEEN SAVPALSPAA
     APPAPNGPDK MQMESPLLPG LSFHQPPQQP PPPQEPAAPG ASLSPSFGST WSTGTTNAVE
     DSFFQGITPV NGTMLFQNFP HHVNPVFGGT FSPQIGLAQT QHHQQPPPPA PAPQPAQPAQ
     PPQAQPPQQR RSPASPSQAP YAQRSAAAAY GHQPIMTSKP SSSSAVAAAA AAAAASSASS
     SWNTHQSVNA AWSAPSNPWG GLQAGRDPRR AVGVGVGVGV GVPSPLNPIS PLKKPFSSNV
     IAPPKFPRAA PLTSKSWMED NAFRTDNGNN LLPFQDRSRP YDTFNLHSLE NSLMDMIRTD
     HEPLKGRMGI NFHHPGTDNI MALNSRSSLF PFEDAFLDDS HGDQALSSGL SSPTRCQNGE
     RVERYSRKVF VGGLPPDIDE DEITASFRRF GPLVVDWPHK AESKSYFPPK GYAFLLFQEE
     SSVQALIDAC LEEDGKLYLC VSSPTIKDKP VQIRPWNLSD SDFVMDGSQP LDPRKTIFVG
     GVPRPLRAVE LAMIMDRLYG GVCYAGIDTD PELKYPKGAG RVAFSNQQSY IAAISARFVQ
     LQHNDIDKRV EVKPYVLDDQ MCDECQGTRC GGKFAPFFCA NVTCLQYYCE YCWASIHSRA
     GREFHKPLVK EGGDRPRHVP FRWS
//
ID   CPEB3_HUMAN             Reviewed;         698 AA.
AC   Q8NE35; Q5T389; Q9NQJ7; Q9Y2E9;
DT   12-DEC-2006, integrated into UniProtKB/Swiss-Prot.
DT   12-DEC-2006, sequence version 2.
DT   13-FEB-2019, entry version 137.
DE   RecName: Full=Cytoplasmic polyadenylation element-binding protein 3;
DE            Short=CPE-BP3;
DE            Short=CPE-binding protein 3;
DE            Short=hCPEB-3;
GN   Name=CPEB3; Synonyms=KIAA0940;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=10231032; DOI=10.1093/dnares/6.1.63;
RA   Nagase T., Ishikawa K., Suyama M., Kikuno R., Hirosawa M.,
RA   Miyajima N., Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XIII.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 6:63-70(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   TRP-324.
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   RIBOZYME-ENCODING INTRON.
RX   PubMed=16990549; DOI=10.1126/science.1129308;
RA   Salehi-Ashtiani K., Luptak A., Litovchick A., Szostak J.W.;
RT   "A genomewide search for ribozymes reveals an HDV-like sequence in the
RT   human CPEB3 gene.";
RL   Science 313:1788-1792(2006).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-192, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [6]
RP   ROLE OF RIBOZYME POLYMORPHISM IN MEMORY.
RX   PubMed=19503753; DOI=10.3389/neuro.08.004.2009;
RA   Vogler C., Spalek K., Aerni A., Demougin P., Mueller A., Huynh K.D.,
RA   Papassotiropoulos A., de Quervain D.J.;
RT   "CPEB3 is associated with human episodic memory.";
RL   Front. Behav. Neurosci. 3:4-4(2009).
RN   [7]
RP   FUNCTION, INTERACTION WITH STAT5B, AND SUBCELLULAR LOCATION.
RX   PubMed=20639532; DOI=10.1093/nar/gkq634;
RA   Peng S.C., Lai Y.T., Huang H.Y., Huang H.D., Huang Y.S.;
RT   "A novel role of CPEB3 in regulating EGFR gene transcription via
RT   association with Stat5b in neurons.";
RL   Nucleic Acids Res. 38:7446-7457(2010).
RN   [8]
RP   FUNCTION, AND INTERACTION WITH TOB1.
RX   PubMed=21336257; DOI=10.1038/emboj.2011.37;
RA   Hosoda N., Funakoshi Y., Hirasawa M., Yamagishi R., Asano Y.,
RA   Miyagawa R., Ogami K., Tsujimoto M., Hoshino S.;
RT   "Anti-proliferative protein Tob negatively regulates CPEB3 target by
RT   recruiting Caf1 deadenylase.";
RL   EMBO J. 30:1311-1323(2011).
RN   [9]
RP   INTERACTION WITH IPO5 AND XPO1, SUBCELLULAR LOCATION, AND MUTAGENESIS
RP   OF LEU-349 AND LEU-353.
RX   PubMed=22730302; DOI=10.1093/nar/gks598;
RA   Chao H.W., Lai Y.T., Lu Y.L., Lin C.L., Mai W., Huang Y.S.;
RT   "NMDAR signaling facilitates the IPO5-mediated nuclear import of
RT   CPEB3.";
RL   Nucleic Acids Res. 40:8484-8498(2012).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12]
RP   SITES IMPORTANT FOR BINDING RNA, AND MUTAGENESIS OF ARG-441; PHE-444;
RP   GLY-446; ARG-463; ASP-470; LYS-474; SER-479; PHE-488 AND ARG-528.
RX   PubMed=24343026; DOI=10.1093/nar/gkt1299;
RA   Chen Y.C., Sargsyan K., Wright J.D., Huang Y.S., Lim C.;
RT   "Identifying RNA-binding residues based on evolutionary conserved
RT   structural and energetic features.";
RL   Nucleic Acids Res. 42:E15-E15(2014).
RN   [13]
RP   FUNCTION.
RX   PubMed=26398195; DOI=10.1371/journal.pone.0138794;
RA   Giangarra V., Igea A., Castellazzi C.L., Bava F.A., Mendez R.;
RT   "Global analysis of CPEBs reveals sequential and non-redundant
RT   functions in mitotic cell cycle.";
RL   PLoS ONE 10:E0138794-E0138794(2015).
RN   [14]
RP   STRUCTURE BY NMR OF 440-540.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of RNA binding domain in cytoplasmic
RT   polyadenylation element binding protein 3.";
RL   Submitted (OCT-2006) to the PDB data bank.
RN   [15]
RP   STRUCTURE BY NMR OF 440-540.
RX   PubMed=25066254; DOI=10.1002/prot.24651;
RA   Tsuda K., Kuwasako K., Nagata T., Takahashi M., Kigawa T.,
RA   Kobayashi N., Guentert P., Shirouzu M., Yokoyama S., Muto Y.;
RT   "Novel RNA recognition motif domain in the cytoplasmic polyadenylation
RT   element binding protein 3.";
RL   Proteins 82:2879-2886(2014).
CC   -!- FUNCTION: Sequence-specific RNA-binding protein which acts as a
CC       translational repressor in the basal unstimulated state but,
CC       following neuronal stimulation, acts as a translational activator
CC       (By similarity). In contrast to CPEB1, does not bind to the
CC       cytoplasmic polyadenylation element (CPE), a uridine-rich sequence
CC       element within the mRNA 3'-UTR, but binds to a U-rich loop within
CC       a stem-loop structure (By similarity). Required for the
CC       consolidation and maintenance of hippocampal-based long term
CC       memory (By similarity). In the basal state, binds to the mRNA 3'-
CC       UTR of the glutamate receptors GRIA2/GLUR2 mRNA and negatively
CC       regulates their translation (By similarity). Also represses the
CC       translation of DLG4, GRIN1, GRIN2A and GRIN2B (By similarity).
CC       When activated, acts as a translational activator of GRIA1 and
CC       GRIA2 (By similarity). In the basal state, suppresses SUMO2
CC       translation but activates it following neuronal stimulation (By
CC       similarity). Binds to the 3'-UTR of TRPV1 mRNA and represses TRPV1
CC       translation which is required to maintain normal thermoception (By
CC       similarity). Binds actin mRNA, leading to actin translational
CC       repression in the basal state and to translational activation
CC       following neuronal stimulation (By similarity). Negatively
CC       regulates target mRNA levels by binding to TOB1 which recruits
CC       CNOT7/CAF1 to a ternary complex and this leads to target mRNA
CC       deadenylation and decay (PubMed:21336257). In addition to its role
CC       in translation, binds to and inhibits the transcriptional
CC       activation activity of STAT5B without affecting its dimerization
CC       or DNA-binding activity. This, in turn, represses transcription of
CC       the STAT5B target gene EGFR which has been shown to play a role in
CC       enhancing learning and memory performance (PubMed:20639532). In
CC       contrast to CPEB1, CPEB2 and CPEB4, not required for cell cycle
CC       progression (PubMed:26398195). {ECO:0000250|UniProtKB:Q7TN99,
CC       ECO:0000269|PubMed:20639532, ECO:0000269|PubMed:21336257,
CC       ECO:0000269|PubMed:26398195}.
CC   -!- SUBUNIT: Following synaptic activity, forms amyloid-like oligomers
CC       (By similarity). Aggregation requires an intact actin cytoskeleton
CC       (By similarity). Interacts with STAT5B; this inhibits STAT5B-
CC       mediated transcriptional activation (PubMed:20639532). Interacts
CC       with E3 ubiquitin-protein ligase NEURL1; this leads to
CC       monoubiquitination and activation of CPEB3 (By similarity).
CC       Interacts with CAPN2; this leads to cleavage of CPEB3 (By
CC       similarity). Interacts (via C-terminal RNA-binding region) with
CC       TOB1; TOB1 also binds CNOT7/CAF1 and recruits it to CPEB3 to form
CC       a ternary complex (PubMed:21336257). Interacts with SUMO-
CC       conjugating enzyme UBC9 (By similarity). Interacts with IPO5; the
CC       interaction is enhanced in a RAN-regulated manner following
CC       neuronal stimulation and mediates CPEB3 nuclear import
CC       (PubMed:22730302). Interacts with exportin XPO1/CRM1
CC       (PubMed:22730302). {ECO:0000250|UniProtKB:Q7TN99,
CC       ECO:0000269|PubMed:20639532, ECO:0000269|PubMed:21336257,
CC       ECO:0000269|PubMed:22730302}.
CC   -!- INTERACTION:
CC       P50616:TOB1; NbExp=7; IntAct=EBI-8596191, EBI-723281;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:20639532,
CC       ECO:0000269|PubMed:22730302}. Nucleus
CC       {ECO:0000269|PubMed:20639532, ECO:0000269|PubMed:22730302}. Cell
CC       junction, synapse {ECO:0000250|UniProtKB:Q7TN99}. Cell projection,
CC       dendrite {ECO:0000250|UniProtKB:Q7TN99}. Cell junction, synapse,
CC       postsynaptic cell membrane, postsynaptic density
CC       {ECO:0000250|UniProtKB:Q7TN99}. Note=Predominantly cytoplasmic in
CC       unstimulated neurons but translocates to the nucleus following
CC       neuronal stimulation (PubMed:20639532, PubMed:22730302). Nuclear
CC       import is mediated by importin IPO5 (By similarity).
CC       {ECO:0000250|UniProtKB:Q7TN99, ECO:0000269|PubMed:20639532,
CC       ECO:0000269|PubMed:22730302}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8NE35-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8NE35-2; Sequence=VSP_022034, VSP_022035;
CC   -!- DOMAIN: The N-terminal Gln-rich region is required for the
CC       formation of amyloid-like oligomers and for the stability of long-
CC       term potentiation and spatial memory.
CC       {ECO:0000250|UniProtKB:Q7TN99}.
CC   -!- PTM: Activated by NEURL1-mediated monoubiquitination, resulting in
CC       the growth of new dendritic spines and increased levels of GRIA1
CC       and GRIA2. NEURL1-mediated monoubiquitination facilitates synaptic
CC       plasticity and hippocampal-dependent memory storage.
CC       {ECO:0000250|UniProtKB:Q7TN99}.
CC   -!- PTM: Under basal unstimulated conditions when CPEB3 is mainly
CC       unaggregated, sumoylated and acts as a translational repressor.
CC       Following neuronal stimulation, becomes desumoylated and
CC       aggregated which is required for the translation of mRNA targets
CC       and for dendritic filopodia formation.
CC       {ECO:0000250|UniProtKB:Q7TN99}.
CC   -!- PTM: Following neuronal stimulation, cleaved by CAPN2 which
CC       abolishes its translational repressor activity, leading to
CC       translation of CPEB3 target mRNAs. {ECO:0000250|UniProtKB:Q7TN99}.
CC   -!- PTM: Phosphorylation is enhanced by neuronal stimulation.
CC       {ECO:0000250|UniProtKB:Q7TN99}.
CC   -!- MISCELLANEOUS: The CPEB3 gene contains an intron-encoded self-
CC       cleaving ribozyme which is structurally and biochemically related
CC       to human hepatitis delta virus ribozymes and which may play a role
CC       in the regulation of CPEB3 translation (PubMed:16990549). A
CC       polymorphism in the ribozyme sequence which influences cleavage
CC       activity of the ribozyme may play a role in episodic memory with
CC       carriers of a rare C allele-containing ribozyme showing
CC       significantly poorer memory recall performance than T allele
CC       carriers (PubMed:19503753). {ECO:0000269|PubMed:16990549,
CC       ECO:0000269|PubMed:19503753}.
CC   -!- SIMILARITY: Belongs to the RRM CPEB family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA76784.2; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Protein Spotlight; Note=Tenacious memory
CC       - Issue 185 of November 2016;
CC       URL="https://web.expasy.org/spotlight/back_issues/185/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AB023157; BAA76784.2; ALT_INIT; mRNA.
DR   EMBL; AL158040; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL365398; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC036444; AAH36444.1; -; mRNA.
DR   CCDS; CCDS31246.1; -. [Q8NE35-1]
DR   CCDS; CCDS53553.1; -. [Q8NE35-2]
DR   RefSeq; NP_001171608.1; NM_001178137.1. [Q8NE35-2]
DR   RefSeq; NP_055727.3; NM_014912.4. [Q8NE35-1]
DR   RefSeq; XP_005269687.1; XM_005269630.4. [Q8NE35-2]
DR   UniGene; Hs.131683; -.
DR   UniGene; Hs.701732; -.
DR   PDB; 2DNL; NMR; -; A=440-540.
DR   PDB; 2RUG; NMR; -; A=440-540.
DR   PDBsum; 2DNL; -.
DR   PDBsum; 2RUG; -.
DR   ProteinModelPortal; Q8NE35; -.
DR   SMR; Q8NE35; -.
DR   BioGrid; 116521; 4.
DR   IntAct; Q8NE35; 7.
DR   MINT; Q8NE35; -.
DR   STRING; 9606.ENSP00000265997; -.
DR   iPTMnet; Q8NE35; -.
DR   PhosphoSitePlus; Q8NE35; -.
DR   BioMuta; CPEB3; -.
DR   DMDM; 119368633; -.
DR   EPD; Q8NE35; -.
DR   jPOST; Q8NE35; -.
DR   MaxQB; Q8NE35; -.
DR   PaxDb; Q8NE35; -.
DR   PeptideAtlas; Q8NE35; -.
DR   PRIDE; Q8NE35; -.
DR   ProteomicsDB; 73124; -.
DR   ProteomicsDB; 73125; -. [Q8NE35-2]
DR   DNASU; 22849; -.
DR   Ensembl; ENST00000265997; ENSP00000265997; ENSG00000107864. [Q8NE35-1]
DR   Ensembl; ENST00000412050; ENSP00000398310; ENSG00000107864. [Q8NE35-2]
DR   Ensembl; ENST00000614585; ENSP00000482128; ENSG00000107864. [Q8NE35-1]
DR   GeneID; 22849; -.
DR   KEGG; hsa:22849; -.
DR   UCSC; uc001khv.3; human. [Q8NE35-1]
DR   CTD; 22849; -.
DR   DisGeNET; 22849; -.
DR   EuPathDB; HostDB:ENSG00000107864.14; -.
DR   GeneCards; CPEB3; -.
DR   HGNC; HGNC:21746; CPEB3.
DR   MIM; 610606; gene.
DR   neXtProt; NX_Q8NE35; -.
DR   OpenTargets; ENSG00000107864; -.
DR   PharmGKB; PA134903478; -.
DR   eggNOG; KOG0129; Eukaryota.
DR   eggNOG; ENOG410Y1XZ; LUCA.
DR   GeneTree; ENSGT00940000158949; -.
DR   HOGENOM; HOG000290660; -.
DR   HOVERGEN; HBG058010; -.
DR   InParanoid; Q8NE35; -.
DR   KO; K02602; -.
DR   OMA; QMESPIL; -.
DR   OrthoDB; 1075356at2759; -.
DR   PhylomeDB; Q8NE35; -.
DR   TreeFam; TF317658; -.
DR   ChiTaRS; CPEB3; human.
DR   EvolutionaryTrace; Q8NE35; -.
DR   GenomeRNAi; 22849; -.
DR   PRO; PR:Q8NE35; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000107864; Expressed in 206 organ(s), highest expression level in buccal mucosa cell.
DR   Genevisible; Q8NE35; HS.
DR   GO; GO:0097440; C:apical dendrite; ISS:UniProtKB.
DR   GO; GO:0030014; C:CCR4-NOT complex; IDA:UniProtKB.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0030425; C:dendrite; ISS:UniProtKB.
DR   GO; GO:1990124; C:messenger ribonucleoprotein complex; IBA:GO_Central.
DR   GO; GO:0043005; C:neuron projection; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0014069; C:postsynaptic density; IEA:UniProtKB-SubCell.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-KW.
DR   GO; GO:0045202; C:synapse; ISS:UniProtKB.
DR   GO; GO:0035925; F:mRNA 3'-UTR AU-rich region binding; ISS:UniProtKB.
DR   GO; GO:0003730; F:mRNA 3'-UTR binding; IDA:UniProtKB.
DR   GO; GO:0043022; F:ribosome binding; IBA:GO_Central.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0035613; F:RNA stem-loop binding; ISS:UniProtKB.
DR   GO; GO:0008135; F:translation factor activity, RNA binding; IDA:UniProtKB.
DR   GO; GO:0000900; F:translation repressor activity, mRNA regulatory element binding; ISS:UniProtKB.
DR   GO; GO:0061158; P:3'-UTR-mediated mRNA destabilization; IDA:UniProtKB.
DR   GO; GO:0071230; P:cellular response to amino acid stimulus; IDA:UniProtKB.
DR   GO; GO:0007616; P:long-term memory; ISS:UniProtKB.
DR   GO; GO:2000766; P:negative regulation of cytoplasmic translation; IBA:GO_Central.
DR   GO; GO:1900248; P:negative regulation of cytoplasmic translational elongation; ISS:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IDA:UniProtKB.
DR   GO; GO:0017148; P:negative regulation of translation; IDA:UniProtKB.
DR   GO; GO:0060999; P:positive regulation of dendritic spine development; ISS:UniProtKB.
DR   GO; GO:1900365; P:positive regulation of mRNA polyadenylation; ISS:UniProtKB.
DR   GO; GO:1900153; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; IDA:UniProtKB.
DR   GO; GO:0060213; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; IDA:UniProtKB.
DR   GO; GO:0045727; P:positive regulation of translation; ISS:UniProtKB.
DR   GO; GO:0060998; P:regulation of dendritic spine development; ISS:UniProtKB.
DR   GO; GO:0048167; P:regulation of synaptic plasticity; ISS:UniProtKB.
DR   Gene3D; 3.30.40.130; -; 1.
DR   Gene3D; 3.30.70.330; -; 2.
DR   InterPro; IPR032296; CEBP_ZZ.
DR   InterPro; IPR038446; CEBP_ZZ_sf.
DR   InterPro; IPR034819; CPEB.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   PANTHER; PTHR12566; PTHR12566; 1.
DR   Pfam; PF16366; CEBP_ZZ; 1.
DR   Pfam; PF16367; RRM_7; 1.
DR   SMART; SM00360; RRM; 2.
DR   SUPFAM; SSF54928; SSF54928; 1.
DR   PROSITE; PS50102; RRM; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; Alternative splicing; Amyloid; Cell junction;
KW   Cell membrane; Cell projection; Complete proteome; Cytoplasm;
KW   Membrane; Methylation; Nucleus; Phosphoprotein; Polymorphism;
KW   Postsynaptic cell membrane; Reference proteome; Repeat; Repressor;
KW   RNA-binding; Synapse; Translation regulation; Ubl conjugation.
FT   CHAIN         1    698       Cytoplasmic polyadenylation element-
FT                                binding protein 3.
FT                                /FTId=PRO_0000269261.
FT   DOMAIN      441    532       RRM 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00176}.
FT   DOMAIN      549    631       RRM 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00176}.
FT   COMPBIAS     13     27       Gln-rich.
FT   COMPBIAS     26    200       Pro-rich.
FT   COMPBIAS    170    238       Ala-rich.
FT   SITE        441    442       Cleavage; by CAPN2.
FT                                {ECO:0000250|UniProtKB:Q7TN99}.
FT   SITE        444    444       Required for RNA-binding activity.
FT                                {ECO:0000269|PubMed:24343026}.
FT   SITE        488    488       Required for RNA-binding activity.
FT                                {ECO:0000269|PubMed:24343026}.
FT   MOD_RES     192    192       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     195    195       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q7TN99}.
FT   MOD_RES     290    290       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q7TN99}.
FT   MOD_RES     308    308       Asymmetric dimethylarginine.
FT                                {ECO:0000250|UniProtKB:Q7TN99}.
FT   VAR_SEQ     366    388       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:10231032}.
FT                                /FTId=VSP_022034.
FT   VAR_SEQ     408    408       N -> SRSSLFPFED (in isoform 2).
FT                                {ECO:0000303|PubMed:10231032}.
FT                                /FTId=VSP_022035.
FT   VARIANT     324    324       R -> W (in dbSNP:rs17853616).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_029776.
FT   MUTAGEN     349    349       L->A: Abolishes nuclear export; when
FT                                associated with A-353.
FT                                {ECO:0000269|PubMed:22730302}.
FT   MUTAGEN     353    353       L->A: Abolishes nuclear export; when
FT                                associated with A-349.
FT                                {ECO:0000269|PubMed:22730302}.
FT   MUTAGEN     441    441       R->A: Does not impair RNA binding.
FT                                {ECO:0000269|PubMed:24343026}.
FT   MUTAGEN     444    444       F->A,N: Abolishes RNA binding.
FT                                {ECO:0000269|PubMed:24343026}.
FT   MUTAGEN     444    444       F->Y: Does not impair RNA binding.
FT                                {ECO:0000269|PubMed:24343026}.
FT   MUTAGEN     446    446       G->A: Does not impair RNA binding.
FT                                {ECO:0000269|PubMed:24343026}.
FT   MUTAGEN     463    463       R->A: Does not impair RNA binding.
FT                                {ECO:0000269|PubMed:24343026}.
FT   MUTAGEN     470    470       D->A: Does not impair RNA binding.
FT                                {ECO:0000269|PubMed:24343026}.
FT   MUTAGEN     474    474       K->A: Does not impair RNA binding.
FT                                {ECO:0000269|PubMed:24343026}.
FT   MUTAGEN     479    479       S->A: Does not impair RNA binding.
FT                                {ECO:0000269|PubMed:24343026}.
FT   MUTAGEN     488    488       F->A: Reduced RNA binding.
FT                                {ECO:0000269|PubMed:24343026}.
FT   MUTAGEN     488    488       F->Y: Does not impair RNA binding.
FT                                {ECO:0000269|PubMed:24343026}.
FT   MUTAGEN     528    528       R->A: Does not impair RNA binding.
FT                                {ECO:0000269|PubMed:24343026}.
FT   CONFLICT    519    519       Missing (in Ref. 3; AAH36444).
FT                                {ECO:0000305}.
FT   STRAND      443    446       {ECO:0000244|PDB:2DNL}.
FT   HELIX       454    460       {ECO:0000244|PDB:2DNL}.
FT   TURN        461    464       {ECO:0000244|PDB:2DNL}.
FT   STRAND      467    470       {ECO:0000244|PDB:2RUG}.
FT   STRAND      474    477       {ECO:0000244|PDB:2DNL}.
FT   STRAND      478    481       {ECO:0000244|PDB:2RUG}.
FT   STRAND      485    489       {ECO:0000244|PDB:2DNL}.
FT   HELIX       494    503       {ECO:0000244|PDB:2DNL}.
FT   STRAND      504    507       {ECO:0000244|PDB:2DNL}.
FT   STRAND      510    515       {ECO:0000244|PDB:2DNL}.
FT   STRAND      518    520       {ECO:0000244|PDB:2DNL}.
FT   STRAND      522    528       {ECO:0000244|PDB:2DNL}.
SQ   SEQUENCE   698 AA;  76014 MW;  0E67DCB7F8A40C96 CRC64;
     MQDDLLMDKS KTQPQPQQQQ RQQQQPQPES SVSEAPSTPL SSETPKPEEN SAVPALSPAA
     APPAPNGPDK MQMESPLLPG LSFHQPPQQP PPPQEPAAPG ASLSPSFGST WSTGTTNAVE
     DSFFQGITPV NGTMLFQNFP HHVNPVFGGT FSPQIGLAQT QHHQQPPPPA PAPQPAQPAQ
     PPQAQPPQQR RSPASPSQAP YAQRSAAAAY GHQPIMTSKP SSSSAVAAAA AAAAASSASS
     SWNTHQSVNA AWSAPSNPWG GLQAGRDPRR AVGVGVGVGV GVPSPLNPIS PLKKPFSSNV
     IAPPKFPRAA PLTSKSWMED NAFRTDNGNN LLPFQDRSRP YDTFNLHSLE NSLMDMIRTD
     HEPLKGKHYP PSGPPMSFAD IMWRNHFAGR MGINFHHPGT DNIMALNNAF LDDSHGDQAL
     SSGLSSPTRC QNGERVERYS RKVFVGGLPP DIDEDEITAS FRRFGPLVVD WPHKAESKSY
     FPPKGYAFLL FQEESSVQAL IDACLEEDGK LYLCVSSPTI KDKPVQIRPW NLSDSDFVMD
     GSQPLDPRKT IFVGGVPRPL RAVELAMIMD RLYGGVCYAG IDTDPELKYP KGAGRVAFSN
     QQSYIAAISA RFVQLQHNDI DKRVEVKPYV LDDQMCDECQ GTRCGGKFAP FFCANVTCLQ
     YYCEYCWASI HSRAGREFHK PLVKEGGDRP RHVPFRWS
//
ID   CSMD3_HUMAN             Reviewed;        3707 AA.
AC   Q7Z407; Q96PZ3;
DT   28-NOV-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-SEP-2009, sequence version 3.
DT   13-FEB-2019, entry version 132.
DE   RecName: Full=CUB and sushi domain-containing protein 3;
DE   AltName: Full=CUB and sushi multiple domains protein 3;
GN   Name=CSMD3; Synonyms=KIAA1894;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RX   PubMed=12906867; DOI=10.1016/S0888-7543(03)00149-6;
RA   Lau W.L., Scholnick S.B.;
RT   "Identification of two new members of the CSMD gene family.";
RL   Genomics 82:412-415(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), TISSUE SPECIFICITY, AND
RP   VARIANTS MET-219 AND HIS-3621.
RC   TISSUE=Brain, and Testis;
RX   PubMed=12943675; DOI=10.1016/S0006-291X(03)01555-9;
RA   Shimizu A., Asakawa S., Shimizu N.;
RT   "A novel giant gene CSMD3 encoding a protein with CUB and sushi
RT   multiple domains: a candidate gene for benign adult familial myoclonic
RT   epilepsy on human chromosome 8q23.3-q24.1.";
RL   Biochem. Biophys. Res. Commun. 309:143-154(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 661-3707 (ISOFORM 4), AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=11572484; DOI=10.1093/dnares/8.4.179;
RA   Nagase T., Kikuno R., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XXI.
RT   The complete sequences of 60 new cDNA clones from brain which code for
RT   large proteins.";
RL   DNA Res. 8:179-187(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 2271-3707 (ISOFORM 5).
RC   TISSUE=Liver;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   VARIANTS [LARGE SCALE ANALYSIS] GLY-322; HIS-3079 AND GLN-3359.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [6]
RP   VARIANT CYS-2020.
RX   PubMed=21248752; DOI=10.1038/nature09639;
RA   Varela I., Tarpey P., Raine K., Huang D., Ong C.K., Stephens P.,
RA   Davies H., Jones D., Lin M.L., Teague J., Bignell G., Butler A.,
RA   Cho J., Dalgliesh G.L., Galappaththige D., Greenman C., Hardy C.,
RA   Jia M., Latimer C., Lau K.W., Marshall J., McLaren S., Menzies A.,
RA   Mudie L., Stebbings L., Largaespada D.A., Wessels L.F.A., Richard S.,
RA   Kahnoski R.J., Anema J., Tuveson D.A., Perez-Mancera P.A.,
RA   Mustonen V., Fischer A., Adams D.J., Rust A., Chan-On W., Subimerb C.,
RA   Dykema K., Furge K., Campbell P.J., Teh B.T., Stratton M.R.,
RA   Futreal P.A.;
RT   "Exome sequencing identifies frequent mutation of the SWI/SNF complex
RT   gene PBRM1 in renal carcinoma.";
RL   Nature 469:539-542(2011).
CC   -!- FUNCTION: Involved in dendrite development.
CC       {ECO:0000250|UniProtKB:Q80T79}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane
CC       {ECO:0000250|UniProtKB:Q80T79}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q80T79}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=Q7Z407-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q7Z407-2; Sequence=VSP_009047;
CC       Name=3;
CC         IsoId=Q7Z407-3; Sequence=VSP_009048, VSP_009049;
CC       Name=4;
CC         IsoId=Q7Z407-4; Sequence=VSP_009050;
CC         Note=No experimental confirmation available.;
CC       Name=5;
CC         IsoId=Q7Z407-5; Sequence=VSP_009051, VSP_009052;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Weakly expressed in most tissues, except in
CC       brain. Expressed at intermediate level in brain, including
CC       cerebellum, substantia nigra, thalamus, spinal cord, hippocampus
CC       and fetal brain. Also expressed in testis.
CC       {ECO:0000269|PubMed:11572484, ECO:0000269|PubMed:12943675}.
CC   -!- DOMAIN: The intracellular region is dispensable for its function.
CC       {ECO:0000250|UniProtKB:Q80T79}.
CC   -!- SIMILARITY: Belongs to the CSMD family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAO34702.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AY210419; AAO34702.1; ALT_INIT; mRNA.
DR   EMBL; AB114604; BAC82443.1; -; mRNA.
DR   EMBL; AB114605; BAC82444.1; -; mRNA.
DR   EMBL; AB067481; BAB67787.2; -; mRNA.
DR   EMBL; AK126252; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS6315.1; -. [Q7Z407-1]
DR   CCDS; CCDS6316.2; -. [Q7Z407-3]
DR   CCDS; CCDS6317.1; -. [Q7Z407-2]
DR   RefSeq; NP_443132.3; NM_052900.2. [Q7Z407-3]
DR   RefSeq; NP_937756.1; NM_198123.1. [Q7Z407-1]
DR   RefSeq; NP_937757.1; NM_198124.1. [Q7Z407-2]
DR   RefSeq; XP_016868498.1; XM_017013009.1. [Q7Z407-4]
DR   UniGene; Hs.91381; -.
DR   ProteinModelPortal; Q7Z407; -.
DR   SMR; Q7Z407; -.
DR   BioGrid; 125350; 1.
DR   IntAct; Q7Z407; 1.
DR   MINT; Q7Z407; -.
DR   STRING; 9606.ENSP00000297405; -.
DR   iPTMnet; Q7Z407; -.
DR   PhosphoSitePlus; Q7Z407; -.
DR   BioMuta; CSMD3; -.
DR   DMDM; 257051058; -.
DR   jPOST; Q7Z407; -.
DR   MaxQB; Q7Z407; -.
DR   PaxDb; Q7Z407; -.
DR   PeptideAtlas; Q7Z407; -.
DR   PRIDE; Q7Z407; -.
DR   ProteomicsDB; 69118; -.
DR   ProteomicsDB; 69119; -. [Q7Z407-2]
DR   ProteomicsDB; 69120; -. [Q7Z407-3]
DR   ProteomicsDB; 69121; -. [Q7Z407-4]
DR   ProteomicsDB; 69122; -. [Q7Z407-5]
DR   Ensembl; ENST00000297405; ENSP00000297405; ENSG00000164796. [Q7Z407-1]
DR   Ensembl; ENST00000343508; ENSP00000345799; ENSG00000164796. [Q7Z407-2]
DR   Ensembl; ENST00000455883; ENSP00000412263; ENSG00000164796. [Q7Z407-3]
DR   GeneID; 114788; -.
DR   KEGG; hsa:114788; -.
DR   UCSC; uc003ynt.4; human. [Q7Z407-1]
DR   CTD; 114788; -.
DR   DisGeNET; 114788; -.
DR   EuPathDB; HostDB:ENSG00000164796.17; -.
DR   GeneCards; CSMD3; -.
DR   HGNC; HGNC:19291; CSMD3.
DR   HPA; HPA029007; -.
DR   MIM; 608399; gene.
DR   neXtProt; NX_Q7Z407; -.
DR   OpenTargets; ENSG00000164796; -.
DR   PharmGKB; PA134926063; -.
DR   eggNOG; KOG4297; Eukaryota.
DR   eggNOG; ENOG410XPJ1; LUCA.
DR   GeneTree; ENSGT00940000155549; -.
DR   HOGENOM; HOG000112015; -.
DR   HOVERGEN; HBG051134; -.
DR   InParanoid; Q7Z407; -.
DR   KO; K17495; -.
DR   OMA; SADHGTN; -.
DR   OrthoDB; 2377at2759; -.
DR   PhylomeDB; Q7Z407; -.
DR   TreeFam; TF316872; -.
DR   ChiTaRS; CSMD3; human.
DR   GenomeRNAi; 114788; -.
DR   PRO; PR:Q7Z407; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000164796; Expressed in 83 organ(s), highest expression level in middle temporal gyrus.
DR   ExpressionAtlas; Q7Z407; baseline and differential.
DR   Genevisible; Q7Z407; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0050773; P:regulation of dendrite development; ISS:UniProtKB.
DR   CDD; cd00033; CCP; 28.
DR   CDD; cd00041; CUB; 14.
DR   Gene3D; 2.60.120.290; -; 14.
DR   InterPro; IPR000859; CUB_dom.
DR   InterPro; IPR035914; Sperma_CUB_dom_sf.
DR   InterPro; IPR035976; Sushi/SCR/CCP_sf.
DR   InterPro; IPR000436; Sushi_SCR_CCP_dom.
DR   Pfam; PF00431; CUB; 14.
DR   Pfam; PF00084; Sushi; 28.
DR   SMART; SM00032; CCP; 28.
DR   SMART; SM00042; CUB; 14.
DR   SUPFAM; SSF49854; SSF49854; 14.
DR   SUPFAM; SSF57535; SSF57535; 28.
DR   PROSITE; PS01180; CUB; 14.
DR   PROSITE; PS50923; SUSHI; 28.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Cell membrane; Complete proteome;
KW   Disulfide bond; Glycoprotein; Membrane; Polymorphism;
KW   Reference proteome; Repeat; Sushi; Transmembrane; Transmembrane helix.
FT   CHAIN         1   3707       CUB and sushi domain-containing protein
FT                                3.
FT                                /FTId=PRO_0000021027.
FT   TOPO_DOM      1     42       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     43     63       Helical. {ECO:0000255}.
FT   TOPO_DOM     64   3630       Extracellular. {ECO:0000255}.
FT   TRANSMEM   3631   3651       Helical. {ECO:0000255}.
FT   TOPO_DOM   3652   3707       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       65    173       CUB 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00059}.
FT   DOMAIN      176    237       Sushi 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00302}.
FT   DOMAIN      241    345       CUB 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00059}.
FT   DOMAIN      484    545       Sushi 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00302}.
FT   DOMAIN      548    659       CUB 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00059}.
FT   DOMAIN      662    719       Sushi 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00302}.
FT   DOMAIN      721    829       CUB 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00059}.
FT   DOMAIN      832    893       Sushi 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00302}.
FT   DOMAIN      895   1003       CUB 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00059}.
FT   DOMAIN     1008   1065       Sushi 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00302}.
FT   DOMAIN     1067   1177       CUB 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00059}.
FT   DOMAIN     1180   1239       Sushi 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00302}.
FT   DOMAIN     1241   1349       CUB 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00059}.
FT   DOMAIN     1352   1412       Sushi 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00302}.
FT   DOMAIN     1414   1523       CUB 8. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00059}.
FT   DOMAIN     1526   1586       Sushi 8. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00302}.
FT   DOMAIN     1588   1696       CUB 9. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00059}.
FT   DOMAIN     1699   1760       Sushi 9. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00302}.
FT   DOMAIN     1762   1870       CUB 10. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00059}.
FT   DOMAIN     1876   1937       Sushi 10. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00302}.
FT   DOMAIN     1939   2047       CUB 11. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00059}.
FT   DOMAIN     2050   2109       Sushi 11. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00302}.
FT   DOMAIN     2111   2219       CUB 12. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00059}.
FT   DOMAIN     2222   2281       Sushi 12. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00302}.
FT   DOMAIN     2283   2394       CUB 13. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00059}.
FT   DOMAIN     2393   2454       Sushi 13. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00302}.
FT   DOMAIN     2456   2567       CUB 14. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00059}.
FT   DOMAIN     2567   2629       Sushi 14. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00302}.
FT   DOMAIN     2630   2691       Sushi 15. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00302}.
FT   DOMAIN     2692   2756       Sushi 16. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00302}.
FT   DOMAIN     2757   2814       Sushi 17. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00302}.
FT   DOMAIN     2815   2872       Sushi 18. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00302}.
FT   DOMAIN     2873   2930       Sushi 19. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00302}.
FT   DOMAIN     2931   2992       Sushi 20. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00302}.
FT   DOMAIN     2993   3050       Sushi 21. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00302}.
FT   DOMAIN     3054   3111       Sushi 22. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00302}.
FT   DOMAIN     3112   3170       Sushi 23. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00302}.
FT   DOMAIN     3171   3230       Sushi 24. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00302}.
FT   DOMAIN     3231   3288       Sushi 25. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00302}.
FT   DOMAIN     3289   3346       Sushi 26. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00302}.
FT   DOMAIN     3350   3408       Sushi 27. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00302}.
FT   DOMAIN     3409   3468       Sushi 28. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00302}.
FT   CARBOHYD     73     73       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     90     90       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    361    361       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    409    409       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    724    724       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    823    823       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    966    966       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1092   1092       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1126   1126       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1171   1171       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1280   1280       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1536   1536       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1591   1591       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1709   1709       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1781   1781       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1929   1929       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   2019   2019       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   2155   2155       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   2286   2286       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   2291   2291       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   2324   2324       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   2495   2495       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   2537   2537       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   2711   2711       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   2742   2742       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   2862   2862       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   2932   2932       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   2952   2952       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   3099   3099       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   3158   3158       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   3167   3167       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   3194   3194       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   3208   3208       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   3218   3218       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   3276   3276       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   3364   3364       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   3522   3522       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   3529   3529       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   3612   3612       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   3618   3618       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   3627   3627       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     65     91       {ECO:0000250}.
FT   DISULFID    178    218       {ECO:0000250}.
FT   DISULFID    204    235       {ECO:0000250}.
FT   DISULFID    241    267       {ECO:0000250}.
FT   DISULFID    486    526       {ECO:0000250}.
FT   DISULFID    512    543       {ECO:0000250}.
FT   DISULFID    548    574       {ECO:0000250}.
FT   DISULFID    664    704       {ECO:0000250}.
FT   DISULFID    690    717       {ECO:0000250}.
FT   DISULFID    721    747       {ECO:0000250}.
FT   DISULFID    834    875       {ECO:0000250}.
FT   DISULFID    860    891       {ECO:0000250}.
FT   DISULFID    895    921       {ECO:0000250}.
FT   DISULFID   1010   1050       {ECO:0000250}.
FT   DISULFID   1036   1063       {ECO:0000250}.
FT   DISULFID   1067   1093       {ECO:0000250}.
FT   DISULFID   1182   1222       {ECO:0000250}.
FT   DISULFID   1208   1237       {ECO:0000250}.
FT   DISULFID   1241   1267       {ECO:0000250}.
FT   DISULFID   1354   1395       {ECO:0000250}.
FT   DISULFID   1381   1410       {ECO:0000250}.
FT   DISULFID   1414   1441       {ECO:0000250}.
FT   DISULFID   1528   1568       {ECO:0000250}.
FT   DISULFID   1554   1584       {ECO:0000250}.
FT   DISULFID   1588   1614       {ECO:0000250}.
FT   DISULFID   1701   1741       {ECO:0000250}.
FT   DISULFID   1727   1758       {ECO:0000250}.
FT   DISULFID   1762   1788       {ECO:0000250}.
FT   DISULFID   1878   1918       {ECO:0000250}.
FT   DISULFID   1904   1935       {ECO:0000250}.
FT   DISULFID   1939   1965       {ECO:0000250}.
FT   DISULFID   2052   2092       {ECO:0000250}.
FT   DISULFID   2078   2107       {ECO:0000250}.
FT   DISULFID   2111   2137       {ECO:0000250}.
FT   DISULFID   2224   2264       {ECO:0000250}.
FT   DISULFID   2250   2279       {ECO:0000250}.
FT   DISULFID   2283   2309       {ECO:0000250}.
FT   DISULFID   2395   2437       {ECO:0000250}.
FT   DISULFID   2423   2452       {ECO:0000250}.
FT   DISULFID   2456   2484       {ECO:0000250}.
FT   DISULFID   2569   2610       {ECO:0000250}.
FT   DISULFID   2596   2627       {ECO:0000250}.
FT   DISULFID   2632   2674       {ECO:0000250}.
FT   DISULFID   2658   2689       {ECO:0000250}.
FT   DISULFID   2694   2739       {ECO:0000250}.
FT   DISULFID   2725   2754       {ECO:0000250}.
FT   DISULFID   2759   2799       {ECO:0000250}.
FT   DISULFID   2785   2812       {ECO:0000250}.
FT   DISULFID   2817   2857       {ECO:0000250}.
FT   DISULFID   2843   2870       {ECO:0000250}.
FT   DISULFID   2875   2915       {ECO:0000250}.
FT   DISULFID   2901   2928       {ECO:0000250}.
FT   DISULFID   2933   2977       {ECO:0000250}.
FT   DISULFID   2963   2990       {ECO:0000250}.
FT   DISULFID   2995   3035       {ECO:0000250}.
FT   DISULFID   3021   3048       {ECO:0000250}.
FT   DISULFID   3056   3096       {ECO:0000250}.
FT   DISULFID   3082   3109       {ECO:0000250}.
FT   DISULFID   3114   3155       {ECO:0000250}.
FT   DISULFID   3141   3168       {ECO:0000250}.
FT   DISULFID   3173   3215       {ECO:0000250}.
FT   DISULFID   3199   3228       {ECO:0000250}.
FT   DISULFID   3233   3273       {ECO:0000250}.
FT   DISULFID   3259   3286       {ECO:0000250}.
FT   DISULFID   3291   3331       {ECO:0000250}.
FT   DISULFID   3317   3344       {ECO:0000250}.
FT   DISULFID   3352   3393       {ECO:0000250}.
FT   DISULFID   3379   3406       {ECO:0000250}.
FT   DISULFID   3411   3453       {ECO:0000250}.
FT   DISULFID   3438   3466       {ECO:0000250}.
FT   VAR_SEQ       1     59       MKGIRKGESRAKESKPWEPGKRRCAKCGRLDFILMKKMGIK
FT                                SGFTFWNLVFLLTVSCVK -> MWSWFLCWKPVQLDRQTAS
FT                                (in isoform 2).
FT                                {ECO:0000303|PubMed:12943675}.
FT                                /FTId=VSP_009047.
FT   VAR_SEQ     344    447       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:12906867}.
FT                                /FTId=VSP_009048.
FT   VAR_SEQ    1799   1868       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:11572484}.
FT                                /FTId=VSP_009050.
FT   VAR_SEQ    2629   2675       AISCGIPKAPTNGGILTTDYLVGTRVTYFCNDGYRLSSKEL
FT                                TTAVCQ -> GEVYYAKMNKNMNVRLAPFNVFIWITHFSEN
FT                                GNIRKHIVNSFHKNKA (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_009051.
FT   VAR_SEQ    2676   3707       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_009052.
FT   VAR_SEQ    2692   2756       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:12906867}.
FT                                /FTId=VSP_009049.
FT   VARIANT     219    219       I -> M (in dbSNP:rs2219898).
FT                                {ECO:0000269|PubMed:12943675}.
FT                                /FTId=VAR_017404.
FT   VARIANT     322    322       W -> G (in a colorectal cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035688.
FT   VARIANT    2020   2020       S -> C (found in a renal cell carcinoma
FT                                case; somatic mutation).
FT                                {ECO:0000269|PubMed:21248752}.
FT                                /FTId=VAR_064703.
FT   VARIANT    3000   3000       V -> L (in dbSNP:rs2193430).
FT                                /FTId=VAR_017405.
FT   VARIANT    3079   3079       R -> H (in a colorectal cancer sample;
FT                                somatic mutation; dbSNP:rs780986269).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035689.
FT   VARIANT    3359   3359       R -> Q (in a colorectal cancer sample;
FT                                somatic mutation; dbSNP:rs139968762).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035690.
FT   VARIANT    3621   3621       N -> H (in dbSNP:rs1592624).
FT                                {ECO:0000269|PubMed:12943675}.
FT                                /FTId=VAR_017406.
FT   CONFLICT    510    510       F -> L (in Ref. 1; AAO34702).
FT                                {ECO:0000305}.
FT   CONFLICT    726    726       T -> A (in Ref. 1; AAO34702).
FT                                {ECO:0000305}.
FT   CONFLICT    977    977       S -> I (in Ref. 3; BAB67787).
FT                                {ECO:0000305}.
FT   CONFLICT   2104   2104       I -> T (in Ref. 1; AAO34702).
FT                                {ECO:0000305}.
SQ   SEQUENCE   3707 AA;  406000 MW;  3194CBF8FE56ED76 CRC64;
     MKGIRKGESR AKESKPWEPG KRRCAKCGRL DFILMKKMGI KSGFTFWNLV FLLTVSCVKG
     FIYTCGGTLK GLNGTIESPG FPYGYPNGAN CTWVIIAEER NRIQIVFQSF ALEEEYDYLS
     LYDGHPHPTN FRTRLTGFHL PPPVTSTKSV FSLRLTSDFA VSAHGFKVYY EELQSSSCGN
     PGVPPKGVLY GTRFDVGDKI RYSCVTGYIL DGHPQLTCIA NSVNTASWDF PVPICRAEDA
     CGGTMRGSSG IISSPSFPNE YHNNADCTWT IVAEPGDTIS LIFTDFQMEE KYDYLEIEGS
     EPPTIWLSGM NIPPPIISNK NWLRLHFVTD SNHRYRGFSA PYQGSSTLTH TTSTGELEEH
     NRTTTGAIAV ASTPADVTVS SVTAVTIHRL SEEQRVQVTS LRNSGLDPNT SKDGLSPHPA
     DTQSTRRRPR HAEQIERTKE LAVVTHRVKK AIDFKSRGFK LFPGKDNSNK FSILNEGGIK
     TASNLCPDPG EPENGKRIGS DFSLGSTVQF SCDEDYVLQG AKSITCQRIA EVFAAWSDHR
     PVCKVKTCGS NLQGPSGTFT SPNFPFQYDS NAQCVWVITA VNTNKVIQIN FEEFDLEIGY
     DTLTIGDGGE VGDPRTVLQV LTGSFVPDLI VSMSSQMWLH LQTDESVGSV GFKVNYKEIE
     KESCGDPGTP LYGIREGDGF SNRDVLRFEC QFGFELIGEK SIVCQENNQW SANIPICIFP
     CLSNFTAPMG TVLSPDYPEG YGNNLNCIWT IISDPGSRIH LSFNDFDLES QFDFLAVKDG
     DSPESPILGT FTGAEVPSHL TSNSHILRLE FQADHSMSGR GFNITYNTFG HNECPDPGIP
     INARRFGDNF QLGSSISVIC EEGFIKTQGT ETITCILMDG KVMWSGLIPK CGAPCGGHFS
     APSGVILSPG WPGYYKDSLN CEWVIEAEPG HSIKITFERF QTELNYDVLE VHDGPNLLSP
     LLGSYNGTQV PQFLFSSSNF IYLLFTTDNS RSNNGFKIHY ESVTVNTYSC LDPGIPVHGR
     RYGHDFSIGS TVSFSCDSGY RLSHEEPLLC EKNHWWSHPL PTCDALCGGD VRGPSGTILS
     PGYPEFYPNS LNCTWTVDVT HGKGVQFNFH TFHLEDHHDY LLITENGSFT QPLARLTGSD
     LPPTINAGLY GNFRAQLRFI SDFSISYEGF NITFSEYNLE PCEDPGIPQY GSRIGFNFGI
     GDTLTFSCSS GYRLEGTSEI ICLGGGRRVW SAPLPRCVAE CGASATNNEG ILLSPNYPLN
     YENNHECIYS IQVQAGKGIN ISARTFHLAQ GDVLKIYDGK DKTTHLLGAF TGASMRGLTL
     SSTSNQLWLE FNSDTEGTDE GFQLVYTSFE LSHCEDPGIP QFGYKISDQG HFAGSTIIYG
     CNPGYTLHGS SLLKCMTGER RAWDYPLPSC IAECGGRFKG ESSGRILSPG YPFPYDNNLR
     CMWMIEVDPG NIVSLQFLAF DTEASHDILR VWDGPPENDM LLKEISGSLI PEGIHSTLNI
     VTIQFDTDFY ISKSGFAIQF SSSVATACRD PGVPMNGTRN GDGREPGDTV VFQCDPGYEL
     QGEERITCIQ VENRYFWQPS PPVCIAPCGG NLTGSSGFIL SPNFPHPYPH SRDCDWTITV
     NADYVISLAF ISFSIEPNYD FLYIYDGPDS NSPLIGSFQD SKLPERIESS SNTMHLAFRS
     DGSVSYTGFH LEYKAKLRES CFDPGNIMNG TRLGMDYKLG STVTYYCDAG YVLQGYSTLT
     CIMGDDGRPG WNRALPSCHA PCGSRSTGSE GTVLSPNYPK NYSVGHNCVY SIAVPKEFVV
     FGQFVFFQTS LHDVVEVYDG PTQQSSLLSS LSGSHSGESL PLSSGNQITI RFTSVGPITA
     KGFHFVYQAV PRTSSTQCSS VPEPRFGRRI GNEFAVGSSV LFDCNPGYIL HGSIAIRCET
     VPNSLAQWND SLPTCIVPCG GILTKRKGTI LSPGYPEPYD NNLNCVWKIT VPEGAGIQVQ
     VVSFATEHNW DSLDFYDGGD NNAPRLGSYS GTTIPHLLNS TSNNLYLNFQ SDISVSAAGF
     HLEYTAIGLD SCPEPQTPSS GIKIGDRYMV GDVVSFQCDQ GYSLQGHSHI TCMPGPVRRW
     NYPIPICLAQ CGGAMSDFSG VILSPGFPGN YPSSLDCTWT INLPIGFGVH LQFVNFSTET
     IHDYLEVRSG SSETSTVIGR LSGPQIPSSL FSTTHETSLY FHSDYSQNKQ GFHIVYQAYQ
     LQSCPDPRPF RNGFVIGNDF TVGQTISFEC FPGYTLIGNS ALTCLHGVSR NWNHPLPRCE
     ALCGGNITAM NGTIYSPGYP DEYPNFQDCF WLVRVPPGNG IYINFTVLQT EPIYDFITVW
     DGPDQNSPQI GQFSGNTALE SVYSTSNQIL IKFHSDFTTS GFFVLSYHAY QLRVCQPPPP
     VPNAEILTED DEFEIGDIIR YQCLPGFTLV GNAILTCRLG ERLQMDGAPP VCQVLCPANE
     LRLDSTGVIL SPGYPDSYPN LQMCAWSISV EKGYNITMFV EFFQTEKEFD VLQVYDGPNI
     QSPVLISLSG DYSSAFNITS NGHEVFLQWS ADHGNNKKGF RIRYIAFYCS TPESPPHGYI
     ISQTGGQLNS VVRWACDRGF RLVGKSSAVC RKSSYGYHAW DAPVPACQAI SCGIPKAPTN
     GGILTTDYLV GTRVTYFCND GYRLSSKELT TAVCQSDGTW SNHNKTPRCV VVTCPSINSF
     ILEHGRWRIV NGSHYEYKTK VVFSCDPGYH GLGPASIECL PNGTWSWRNE RPYCQIISCG
     ELPTPPNGNK IGTQTSYGST AIFTCDLGFM LVGSAVRECL SSGLWSESET RCLAGHCGIP
     ELIVNGQVIG ENYGYRDTVV YQCNPGFRLI GSSVRICQQD HNWSGQLPSC VPVSCGHPGS
     PIYGRTSGNG FNFNDVVTFS CNIGYLMQGP TKAQCQANRQ WSHPPPMCKV VNCSDPGIPA
     NSKRESKIEH GNFTYGTVVF YDCNPGYFLF GSSVLICQPN GQWDKPLPEC IMIDCGHPGV
     PPNAVLSGEK YTFGSTVHYS CTGKRSLLGQ SSRTCQLNGH WSGSQPHCSG DATGTCGDPG
     TPGHGSRQES NFRTKSTVRY ACDTGYILHG SEERTCLANG SWTGRQPECK AVQCGNPGTT
     ANGKVFRIDG TTFSSSVIYS CMEGYILSGP SVRQCTANGT WSGTLPNCTI ISCGDPGIPA
     NGLRYGDDYV VGQNVSYMCQ PGYTMELNGS RIRTCTINGT WSGVMPTCRA VTCPTPPQIS
     NGRLEGTNFD WGFSISYICS PGYELSFPAV LTCVGNGTWS GEVPQCLPKF CGDPGIPAQG
     KREGKSFIYQ SEVSFSCNFP FILVGSSTRI CQADGTWSGS SPHCIEPTQT SCENPGVPRH
     GSQNNTFGFQ VGSVVQFHCK KGHLLQGSTT RTCLPDLTWS GIQPECIPHS CKQPETPAHA
     NVVGMDLPSH GYTLIYTCQP GFFLAGGTEH RVCRSDNTWT GKVPICEAGS KILVKDPRPA
     LGTPSPKLSV PDDVFAQNYI WKGSYNFKGR KQPMTLTVTS FNASTGRVNA TLSNSNMELL
     LSGVYKSQEA RLMLRIYLIK VPAHASVKKM KEENWAMDGF VSAEPDGATY VFQGFIQGKD
     YGQFGLQRLG LNMSEGSNSS NQPHGTNSSS VAIAILVPFF ALIFAGFGFY LYKQRTAPKT
     QYTGCSVHEN NNGQAAFENP MYDTNAKSVE GKAVRFDPNL NTVCTMV
//
ID   A0A024R475_HUMAN        Unreviewed;       768 AA.
AC   A0A024R475;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   16-JAN-2019, entry version 30.
DE   SubName: Full=Cullin 3, isoform CRA_a {ECO:0000313|EMBL:EAW70830.1};
GN   Name=CUL3 {ECO:0000313|EMBL:EAW70830.1};
GN   ORFNames=hCG_21435 {ECO:0000313|EMBL:EAW70830.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW70830.1};
RN   [1] {ECO:0000313|EMBL:EAW70830.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW70830.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the cullin family. {ECO:0000256|PROSITE-
CC       ProRule:PRU00330, ECO:0000256|RuleBase:RU003829,
CC       ECO:0000256|SAAS:SAAS00585788}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471063; EAW70830.1; -; Genomic_DNA.
DR   RefSeq; NP_003581.1; NM_003590.4.
DR   UniGene; Hs.372286; -.
DR   ProteinModelPortal; A0A024R475; -.
DR   SMR; A0A024R475; -.
DR   PRIDE; A0A024R475; -.
DR   GeneID; 8452; -.
DR   KEGG; hsa:8452; -.
DR   CTD; 8452; -.
DR   EuPathDB; HostDB:ENSG00000036257.12; -.
DR   eggNOG; KOG2167; Eukaryota.
DR   eggNOG; COG5647; LUCA.
DR   KO; K03869; -.
DR   OMA; TSTFWPM; -.
DR   OrthoDB; 1040292at2759; -.
DR   PhylomeDB; A0A024R475; -.
DR   ChiTaRS; CUL3; human.
DR   GenomeRNAi; 8452; -.
DR   Bgee; ENSG00000036257; Expressed in 230 organ(s), highest expression level in sperm.
DR   ExpressionAtlas; A0A024R475; baseline and differential.
DR   GO; GO:0031461; C:cullin-RING ubiquitin ligase complex; IEA:InterPro.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IEA:Ensembl.
DR   GO; GO:0030332; F:cyclin binding; IEA:Ensembl.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:Ensembl.
DR   GO; GO:0042803; F:protein homodimerization activity; IEA:Ensembl.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IEA:InterPro.
DR   GO; GO:0040016; P:embryonic cleavage; IEA:Ensembl.
DR   GO; GO:0044346; P:fibroblast apoptotic process; IEA:Ensembl.
DR   GO; GO:0007369; P:gastrulation; IEA:Ensembl.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IEA:Ensembl.
DR   GO; GO:0072576; P:liver morphogenesis; IEA:Ensembl.
DR   GO; GO:0000278; P:mitotic cell cycle; IEA:Ensembl.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IEA:Ensembl.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IEA:Ensembl.
DR   GO; GO:0017145; P:stem cell division; IEA:Ensembl.
DR   GO; GO:0001831; P:trophectodermal cellular morphogenesis; IEA:Ensembl.
DR   GO; GO:0016055; P:Wnt signaling pathway; IEA:Ensembl.
DR   Gene3D; 1.10.10.10; -; 1.
DR   InterPro; IPR016157; Cullin_CS.
DR   InterPro; IPR016158; Cullin_homology.
DR   InterPro; IPR036317; Cullin_homology_sf.
DR   InterPro; IPR001373; Cullin_N.
DR   InterPro; IPR019559; Cullin_neddylation_domain.
DR   InterPro; IPR016159; Cullin_repeat-like_dom_sf.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   Pfam; PF00888; Cullin; 1.
DR   Pfam; PF10557; Cullin_Nedd8; 1.
DR   SMART; SM00182; CULLIN; 1.
DR   SMART; SM00884; Cullin_Nedd8; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
DR   SUPFAM; SSF74788; SSF74788; 1.
DR   SUPFAM; SSF75632; SSF75632; 1.
DR   PROSITE; PS01256; CULLIN_1; 1.
DR   PROSITE; PS50069; CULLIN_2; 1.
PE   3: Inferred from homology;
FT   DOMAIN      383    635       CULLIN_2. {ECO:0000259|PROSITE:PS50069}.
SQ   SEQUENCE   768 AA;  88930 MW;  A1A02022480BF099 CRC64;
     MSNLSKGTGS RKDTKMRIRA FPMTMDEKYV NSIWDLLKNA IQEIQRKNNS GLSFEELYRN
     AYTMVLHKHG EKLYTGLREV VTEHLINKVR EDVLNSLNNN FLQTLNQAWN DHQTAMVMIR
     DILMYMDRVY VQQNNVENVY NLGLIIFRDQ VVRYGCIRDH LRQTLLDMIA RERKGEVVDR
     GAIRNACQML MILGLEGRSV YEEDFEAPFL EMSAEFFQME SQKFLAENSA SVYIKKVEAR
     INEEIERVMH CLDKSTEEPI VKVVERELIS KHMKTIVEME NSGLVHMLKN GKTEDLGCMY
     KLFSRVPNGL KTMCECMSSY LREQGKALVS EEGEGKNPVD YIQGLLDLKS RFDRFLLESF
     NNDRLFKQTI AGDFEYFLNL NSRSPEYLSL FIDDKLKKGV KGLTEQEVET ILDKAMVLFR
     FMQEKDVFER YYKQHLARRL LTNKSVSDDS EKNMISKLKT ECGCQFTSKL EGMFRDMSIS
     NTTMDEFRQH LQATGVSLGG VDLTVRVLTT GYWPTQSATP KCNIPPAPRH AFEIFRRFYL
     AKHSGRQLTL QHHMGSADLN ATFYGPVKKE DGSEVGVGGA QVTGSNTRKH ILQVSTFQMT
     ILMLFNNREK YTFEEIQQET DIPERELVRA LQSLACGKPT QRVLTKEPKS KEIENGHIFT
     VNDQFTSKLH RVKIQTVAAK QGESDPERKE TRQKVDDDRK HEIEAAIVRI MKSRKKMQHN
     VLVAEVTQQL KARFLPSPVV IKKRIEGLIE REYLARTPED RKVYTYVA
//
ID   B7Z600_HUMAN            Unreviewed;       550 AA.
AC   B7Z600;
DT   03-MAR-2009, integrated into UniProtKB/TrEMBL.
DT   03-MAR-2009, sequence version 1.
DT   16-JAN-2019, entry version 48.
DE   SubName: Full=cDNA FLJ53180, highly similar to Cullin-3 {ECO:0000313|EMBL:BAH13086.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAH13086.1};
RN   [1] {ECO:0000313|EMBL:BAH13086.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:BAH13086.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the cullin family. {ECO:0000256|PROSITE-
CC       ProRule:PRU00330, ECO:0000256|RuleBase:RU003829,
CC       ECO:0000256|SAAS:SAAS00585788}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AK299644; BAH13086.1; -; mRNA.
DR   RefSeq; NP_001244126.1; NM_001257197.1.
DR   UniGene; Hs.372286; -.
DR   PeptideAtlas; B7Z600; -.
DR   PRIDE; B7Z600; -.
DR   GeneID; 8452; -.
DR   CTD; 8452; -.
DR   eggNOG; KOG2167; Eukaryota.
DR   eggNOG; COG5647; LUCA.
DR   HOGENOM; HOG000176712; -.
DR   HOVERGEN; HBG003619; -.
DR   OrthoDB; 1040292at2759; -.
DR   GenomeRNAi; 8452; -.
DR   GO; GO:0031461; C:cullin-RING ubiquitin ligase complex; IEA:InterPro.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IEA:InterPro.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro.
DR   Gene3D; 1.10.10.10; -; 1.
DR   InterPro; IPR016157; Cullin_CS.
DR   InterPro; IPR016158; Cullin_homology.
DR   InterPro; IPR036317; Cullin_homology_sf.
DR   InterPro; IPR001373; Cullin_N.
DR   InterPro; IPR019559; Cullin_neddylation_domain.
DR   InterPro; IPR016159; Cullin_repeat-like_dom_sf.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   Pfam; PF00888; Cullin; 1.
DR   Pfam; PF10557; Cullin_Nedd8; 1.
DR   SMART; SM00182; CULLIN; 1.
DR   SMART; SM00884; Cullin_Nedd8; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
DR   SUPFAM; SSF74788; SSF74788; 1.
DR   SUPFAM; SSF75632; SSF75632; 1.
DR   PROSITE; PS01256; CULLIN_1; 1.
DR   PROSITE; PS50069; CULLIN_2; 1.
PE   2: Evidence at transcript level;
FT   DOMAIN      165    417       CULLIN_2. {ECO:0000259|PROSITE:PS50069}.
SQ   SEQUENCE   550 AA;  63310 MW;  511659C88F9360D0 CRC64;
     MESQKFLAEN SASVYIKKVE ARINEEIERV MHCLDKSTEE PIVKVVEREL ISKHMKTIVE
     MENSGLVHML KNGKTEDLGC MYKLFSRVPN GLKTMCECMS SYLREQGKAL VSEEGEGKNP
     VDYIQGLLDL KSRFDRFLLE SFNNDRLFKQ TIAGDFEYFL NLNSRSPEYL SLFIDDKLKK
     GVKGLTEQEV ETILDKAMVL FRFMQEKDVF ERYYKQHLAR RLLTNKSVSD DSEKNMISKL
     KTECGCQFTS KLEGMFRDMS ISNTTMDEFR QHLQATGVSL GGVDLTVRVL TTGYWPTQSA
     TPKCNIPPAP RHAFEIFRRF YLAKHSGRQL TLQHHMGSAD LNATFYGPIK KEDGSEVGVG
     GAQVTGSNTR KHILQVSTFQ MTILMLFNNR EKYTFEEIQQ ETDIPERELV RALQSLACGK
     PTQRVLTKEP KSKEIENGHI FTVNDQFTSK LHRVKIQTVA AKQGESDPER KETRQKVDDD
     RKHEIEAAIV RIMKSRKKMQ HNVLVAEVTQ QLKARFLPSP VVIKKRIEGL IEREYLARTP
     EDRKVYTYVA
//
ID   CUL3_HUMAN              Reviewed;         768 AA.
AC   Q13618; A8K536; B8ZZC3; O75415; Q569L3; Q9UBI8; Q9UET7;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   24-JAN-2001, sequence version 2.
DT   13-FEB-2019, entry version 194.
DE   RecName: Full=Cullin-3;
DE            Short=CUL-3;
GN   Name=CUL3; Synonyms=KIAA0617;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=9733711; DOI=10.1074/jbc.273.38.24289;
RA   Du M., Sansores-Garcia L., Zu Z., Wu K.K.;
RT   "Cloning and expression analysis of a novel salicylate suppressible
RT   gene, Hs-CUL-3, a member of cullin/Cdc53 family.";
RL   J. Biol. Chem. 273:24289-24292(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=9734811; DOI=10.1093/dnares/5.3.169;
RA   Ishikawa K., Nagase T., Suyama M., Miyajima N., Tanaka A., Kotani H.,
RA   Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. X.
RT   The complete sequences of 100 new cDNA clones from brain which can
RT   code for large proteins in vitro.";
RL   DNA Res. 5:169-176(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Colon carcinoma;
RX   PubMed=9663463;
RA   Michel J.J., Xiong Y.;
RT   "Human CUL-1, but not other cullin family members, selectively
RT   interacts with SKP1 to form a complex with SKP2 and cyclin A.";
RL   Cell Growth Differ. 9:435-449(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RA   Xu M., Huang X.Y., Yin L.L., Xu Z.Y., Lu L., Zhou Z.M., Sha J.H.;
RT   "Cloning and characterization of a new isoform of CUL3 gene in
RT   testis.";
RL   Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Ovary, Skin, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 192-768.
RX   PubMed=8681378; DOI=10.1016/S0092-8674(00)81267-2;
RA   Kipreos E.T., Lander L.E., Wing J.P., He W.W., Hedgecock E.M.;
RT   "cul-1 is required for cell cycle exit in C. elegans and identifies a
RT   novel gene family.";
RL   Cell 85:829-839(1996).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 398-768.
RC   TISSUE=Brain;
RA   Yu W., Sarginson J., Gibbs R.A.;
RL   Submitted (MAR-1998) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   ALTERNATIVE SPLICING (ISOFORMS 1 AND 3), FUNCTION, SUBCELLULAR
RP   LOCATION, INTERACTION WITH CYCE, AND NEDDYLATION.
RX   PubMed=10500095; DOI=10.1101/gad.13.18.2375;
RA   Singer J.D., Gurian-West M., Clurman B., Roberts J.M.;
RT   "Cullin-3 targets cyclin E for ubiquitination and controls S phase in
RT   mammalian cells.";
RL   Genes Dev. 13:2375-2387(1999).
RN   [12]
RP   FUNCTION.
RX   PubMed=11311237; DOI=10.1016/S0014-5793(01)02343-2;
RA   Maeda I., Ohta T., Koizumi H., Fukuda M.;
RT   "In vitro ubiquitination of cyclin D1 by ROC1-CUL1 and ROC1-CUL3.";
RL   FEBS Lett. 494:181-185(2001).
RN   [13]
RP   NEDDYLATION.
RX   PubMed=10597293; DOI=10.1038/sj.onc.1203093;
RA   Hori T., Osaka F., Chiba T., Miyamoto C., Okabayashi K., Shimbara N.,
RA   Kato S., Tanaka K.;
RT   "Covalent modification of all members of human cullin family proteins
RT   by NEDD8.";
RL   Oncogene 18:6829-6834(1999).
RN   [14]
RP   INTERACTION WITH RBX1 AND RNF7.
RX   PubMed=10230407; DOI=10.1016/S1097-2765(00)80482-7;
RA   Ohta T., Michel J.J., Schottelius A.J., Xiong Y.;
RT   "ROC1, a homolog of APC11, represents a family of cullin partners with
RT   an associated ubiquitin ligase activity.";
RL   Mol. Cell 3:535-541(1999).
RN   [15]
RP   INTERACTION WITH TIP120A.
RX   PubMed=12609982; DOI=10.1074/jbc.M213070200;
RA   Min K.-W., Hwang J.-W., Lee J.-S., Park Y., Tamura T.-A., Yoon J.-B.;
RT   "TIP120A associates with cullins and modulates ubiquitin ligase
RT   activity.";
RL   J. Biol. Chem. 278:15905-15910(2003).
RN   [16]
RP   INTERACTION WITH GAN; ZBTB16; KLHL9; KLHL13; KLHL21; KLHL3; KLHL15;
RP   KLHL20; KLHL36; GMCL2; BTBD1 AND SPOP.
RX   PubMed=14528312; DOI=10.1038/ncb1056;
RA   Furukawa M., He Y.J., Borchers C., Xiong Y.;
RT   "Targeting of protein ubiquitination by BTB-Cullin 3-Roc1 ubiquitin
RT   ligases.";
RL   Nat. Cell Biol. 5:1001-1007(2003).
RN   [17]
RP   FUNCTION, IDENTIFICATION IN THE BCR(KLHL41) COMPLEX, IDENTIFICATION IN
RP   THE BCR(ENC1) COMPLEX, IDENTIFICATION IN THE BCR(KEAP1) COMPLEX, AND
RP   IDENTIFICATION IN THE BCR(GAN) COMPLEX.
RX   PubMed=15983046; DOI=10.1074/jbc.M501279200;
RA   Zhang D.D., Lo S.C., Sun Z., Habib G.M., Lieberman M.W., Hannink M.;
RT   "Ubiquitination of Keap1, a BTB-Kelch substrate adaptor protein for
RT   Cul3, targets Keap1 for degradation by a proteasome-independent
RT   pathway.";
RL   J. Biol. Chem. 280:30091-30099(2005).
RN   [18]
RP   IDENTIFICATION IN A COMPLEX WITH SPOP AND BMI1, IDENTIFICATION IN A
RP   COMPLEX WITH SPOP AND H2AFY, AND FUNCTION.
RX   PubMed=15897469; DOI=10.1073/pnas.0408918102;
RA   Hernandez-Munoz I., Lund A.H., van der Stoop P., Boutsma E.,
RA   Muijrers I., Verhoeven E., Nusinow D.A., Panning B., Marahrens Y.,
RA   van Lohuizen M.;
RT   "Stable X chromosome inactivation involves the PRC1 Polycomb complex
RT   and requires histone MACROH2A1 and the CULLIN3/SPOP ubiquitin E3
RT   ligase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:7635-7640(2005).
RN   [19]
RP   IDENTIFICATION IN THE BCR(SPOP) COMPLEX, INTERACTION WITH SPOP, AND
RP   FUNCTION IN UBIQUITINATION OF DAXX.
RX   PubMed=16524876; DOI=10.1074/jbc.M600204200;
RA   Kwon J.E., La M., Oh K.H., Oh Y.M., Kim G.R., Seol J.H., Baek S.H.,
RA   Chiba T., Tanaka K., Bang O.S., Joe C.O., Chung C.H.;
RT   "BTB domain-containing speckle-type POZ protein (SPOP) serves as an
RT   adaptor of Daxx for ubiquitination by Cul3-based ubiquitin ligase.";
RL   J. Biol. Chem. 281:12664-12672(2006).
RN   [20]
RP   FUNCTION, AND INTERACTION WITH KLHL9 AND KLHL13.
RX   PubMed=17543862; DOI=10.1016/j.devcel.2007.03.019;
RA   Sumara I., Quadroni M., Frei C., Olma M.H., Sumara G., Ricci R.,
RA   Peter M.;
RT   "A Cul3-based E3 ligase removes Aurora B from mitotic chromosomes,
RT   regulating mitotic progression and completion of cytokinesis in human
RT   cells.";
RL   Dev. Cell 12:887-900(2007).
RN   [21]
RP   SELF-ASSOCIATION.
RX   PubMed=17254749; DOI=10.1016/j.cellsig.2006.12.002;
RA   Chew E.H., Poobalasingam T., Hawkey C.J., Hagen T.;
RT   "Characterization of cullin-based E3 ubiquitin ligases in intact
RT   mammalian cells -- evidence for cullin dimerization.";
RL   Cell. Signal. 19:1071-1080(2007).
RN   [22]
RP   BCR COMPLEX HOMODIMERIZATION.
RX   PubMed=17192413; DOI=10.1091/mbc.E06-06-0542;
RA   Wimuttisuk W., Singer J.D.;
RT   "The Cullin3 ubiquitin ligase functions as a Nedd8-bound
RT   heterodimer.";
RL   Mol. Biol. Cell 18:899-909(2007).
RN   [23]
RP   INTERACTION WITH KCTD5.
RX   PubMed=18573101; DOI=10.1111/j.1742-4658.2008.06537.x;
RA   Bayon Y., Trinidad A.G., de la Puerta M.L., Del Carmen Rodriguez M.,
RA   Bogetz J., Rojas A., De Pereda J.M., Rahmouni S., Williams S.,
RA   Matsuzawa S., Reed J.C., Crespo M.S., Mustelin T., Alonso A.;
RT   "KCTD5, a putative substrate adaptor for cullin3 ubiquitin ligases.";
RL   FEBS J. 275:3900-3910(2008).
RN   [24]
RP   FUNCTION, AND INTERACTION WITH ATF2 AND KAT5.
RX   PubMed=18397884; DOI=10.1074/jbc.M802030200;
RA   Bhoumik A., Singha N., O'Connell M.J., Ronai Z.A.;
RT   "Regulation of TIP60 by ATF2 modulates ATM activation.";
RL   J. Biol. Chem. 283:17605-17614(2008).
RN   [25]
RP   IDENTIFICATION IN THE BCR(KLHL42) COMPLEX, FUNCTION IN UBIQUITINATION
RP   OF KATNA1, AND INTERACTION WITH KATNA1 AND KLHL42.
RX   PubMed=19261606; DOI=10.1074/jbc.M809374200;
RA   Cummings C.M., Bentley C.A., Perdue S.A., Baas P.W., Singer J.D.;
RT   "The Cul3/Klhdc5 E3 ligase regulates p60/katanin and is required for
RT   normal mitosis in mammalian cells.";
RL   J. Biol. Chem. 284:11663-11675(2009).
RN   [26]
RP   IDENTIFICATION IN THE BCR(KLHL21) COMPLEX, AND FUNCTION.
RX   PubMed=19995937; DOI=10.1083/jcb.200906117;
RA   Maerki S., Olma M.H., Staubli T., Steigemann P., Gerlich D.W.,
RA   Quadroni M., Sumara I., Peter M.;
RT   "The Cul3-KLHL21 E3 ubiquitin ligase targets aurora B to midzone
RT   microtubules in anaphase and is required for cytokinesis.";
RL   J. Cell Biol. 187:791-800(2009).
RN   [27]
RP   FUNCTION, AND IDENTIFICATION IN A BCR (BTB-CUL3-RBX1) E3 UBIQUITIN
RP   LIGASE COMPLEX.
RX   PubMed=20389280; DOI=10.1038/emboj.2010.62;
RA   Lee Y.R., Yuan W.C., Ho H.C., Chen C.H., Shih H.M., Chen R.H.;
RT   "The Cullin 3 substrate adaptor KLHL20 mediates DAPK ubiquitination to
RT   control interferon responses.";
RL   EMBO J. 29:1748-1761(2010).
RN   [28]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [29]
RP   FUNCTION, SUBCELLULAR LOCATION, AND IDENTIFICATION IN A COMPLEX WITH
RP   SPOP AND BRMS1.
RX   PubMed=22085717; DOI=10.1016/j.bbrc.2011.10.154;
RA   Kim B., Nam H.J., Pyo K.E., Jang M.J., Kim I.S., Kim D., Boo K.,
RA   Lee S.H., Yoon J.B., Baek S.H., Kim J.H.;
RT   "Breast cancer metastasis suppressor 1 (BRMS1) is destabilized by the
RT   Cul3-SPOP E3 ubiquitin ligase complex.";
RL   Biochem. Biophys. Res. Commun. 415:720-726(2011).
RN   [30]
RP   FUNCTION, AND IDENTIFICATION IN A BCR (BTB-CUL3-RBX1) E3 UBIQUITIN
RP   LIGASE COMPLEX.
RX   PubMed=21840486; DOI=10.1016/j.ccr.2011.07.008;
RA   Yuan W.C., Lee Y.R., Huang S.F., Lin Y.M., Chen T.Y., Chung H.C.,
RA   Tsai C.H., Chen H.Y., Chiang C.T., Lai C.K., Lu L.T., Chen C.H.,
RA   Gu D.L., Pu Y.S., Jou Y.S., Lu K.P., Hsiao P.W., Shih H.M., Chen R.H.;
RT   "A Cullin3-KLHL20 Ubiquitin ligase-dependent pathway targets PML to
RT   potentiate HIF-1 signaling and prostate cancer progression.";
RL   Cancer Cell 20:214-228(2011).
RN   [31]
RP   FUNCTION, AND IDENTIFICATION IN A BCR (BTB-CUL3-RBX1) E3 UBIQUITIN
RP   LIGASE COMPLEX.
RX   PubMed=21670212; DOI=10.1083/jcb.201103015;
RA   Lin M.Y., Lin Y.M., Kao T.C., Chuang H.H., Chen R.H.;
RT   "PDZ-RhoGEF ubiquitination by Cullin3-KLHL20 controls neurotrophin-
RT   induced neurite outgrowth.";
RL   J. Cell Biol. 193:985-994(2011).
RN   [32]
RP   INTERACTION WITH KCTD7.
RX   PubMed=22748208; DOI=10.1016/j.ajhg.2012.05.023;
RA   Staropoli J.F., Karaa A., Lim E.T., Kirby A., Elbalalesy N.,
RA   Romansky S.G., Leydiker K.B., Coppel S.H., Barone R., Xin W.,
RA   MacDonald M.E., Abdenur J.E., Daly M.J., Sims K.B., Cotman S.L.;
RT   "A homozygous mutation in KCTD7 links neuronal ceroid lipofuscinosis
RT   to the ubiquitin-proteasome system.";
RL   Am. J. Hum. Genet. 91:202-208(2012).
RN   [33]
RP   INTERACTION WITH PPP2R5B.
RX   PubMed=23135275; DOI=10.1074/jbc.M112.420281;
RA   Oberg E.A., Nifoussi S.K., Gingras A.C., Strack S.;
RT   "Selective proteasomal degradation of the B'beta subunit of protein
RT   phosphatase 2A by the E3 ubiquitin ligase adaptor Kelch-like 15.";
RL   J. Biol. Chem. 287:43378-43389(2012).
RN   [34]
RP   IDENTIFICATION IN THE BCR(KLHL25) COMPLEX, AND FUNCTION.
RX   PubMed=22578813; DOI=10.1016/j.molcel.2012.04.004;
RA   Yanagiya A., Suyama E., Adachi H., Svitkin Y.V., Aza-Blanc P.,
RA   Imataka H., Mikami S., Martineau Y., Ronai Z.A., Sonenberg N.;
RT   "Translational homeostasis via the mRNA cap-binding protein, eIF4E.";
RL   Mol. Cell 46:847-858(2012).
RN   [35]
RP   IDENTIFICATION IN THE BCR(KLHL12) COMPLEX, AND FUNCTION.
RX   PubMed=22358839; DOI=10.1038/nature10822;
RA   Jin L., Pahuja K.B., Wickliffe K.E., Gorur A., Baumgartel C.,
RA   Schekman R., Rape M.;
RT   "Ubiquitin-dependent regulation of COPII coat size and function.";
RL   Nature 482:495-500(2012).
RN   [36]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [37]
RP   FUNCTION, AND INTERACTION WITH KLHL3.
RX   PubMed=23387299; DOI=10.1042/BJ20121903;
RA   Ohta A., Schumacher F.R., Mehellou Y., Johnson C., Knebel A.,
RA   Macartney T.J., Wood N.T., Alessi D.R., Kurz T.;
RT   "The CUL3-KLHL3 E3 ligase complex mutated in Gordon's hypertension
RT   syndrome interacts with and ubiquitylates WNK isoforms: disease-
RT   causing mutations in KLHL3 and WNK4 disrupt interaction.";
RL   Biochem. J. 451:111-122(2013).
RN   [38]
RP   FUNCTION, AND IDENTIFICATION IN THE BCR(KLHL3) COMPLEX.
RX   PubMed=23453970; DOI=10.1016/j.celrep.2013.02.024;
RA   Wakabayashi M., Mori T., Isobe K., Sohara E., Susa K., Araki Y.,
RA   Chiga M., Kikuchi E., Nomura N., Mori Y., Matsuo H., Murata T.,
RA   Nomura S., Asano T., Kawaguchi H., Nonoyama S., Rai T., Sasaki S.,
RA   Uchida S.;
RT   "Impaired KLHL3-mediated ubiquitination of WNK4 causes human
RT   hypertension.";
RL   Cell Rep. 3:858-868(2013).
RN   [39]
RP   INTERACTION WITH ARIH1, AND NEDDYLATION.
RX   PubMed=24076655; DOI=10.1038/emboj.2013.209;
RA   Kelsall I.R., Duda D.M., Olszewski J.L., Hofmann K., Knebel A.,
RA   Langevin F., Wood N., Wightman M., Schulman B.A., Alpi A.F.;
RT   "TRIAD1 and HHARI bind to and are activated by distinct neddylated
RT   Cullin-RING ligase complexes.";
RL   EMBO J. 32:2848-2860(2013).
RN   [40]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-585, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [41]
RP   IDENTIFICATION IN THE BCR(KLHL22) COMPLEX, AND FUNCTION.
RX   PubMed=23455478; DOI=10.1038/ncb2695;
RA   Beck J., Maerki S., Posch M., Metzger T., Persaud A., Scheel H.,
RA   Hofmann K., Rotin D., Pedrioli P., Swedlow J.R., Peter M., Sumara I.;
RT   "Ubiquitylation-dependent localization of PLK1 in mitosis.";
RL   Nat. Cell Biol. 15:430-439(2013).
RN   [42]
RP   INTERACTION WITH COPS9.
RX   PubMed=23776465; DOI=10.1371/journal.pone.0065285;
RA   Ebina M., Tsuruta F., Katoh M.C., Kigoshi Y., Someya A., Chiba T.;
RT   "Myeloma overexpressed 2 (Myeov2) regulates L11 subnuclear
RT   localization through Nedd8 modification.";
RL   PLoS ONE 8:E65285-E65285(2013).
RN   [43]
RP   FUNCTION, AND IDENTIFICATION IN THE BCR(KLHL3) COMPLEX.
RX   PubMed=23576762; DOI=10.1073/pnas.1304592110;
RA   Shibata S., Zhang J., Puthumana J., Stone K.L., Lifton R.P.;
RT   "Kelch-like 3 and Cullin 3 regulate electrolyte homeostasis via
RT   ubiquitination and degradation of WNK4.";
RL   Proc. Natl. Acad. Sci. U.S.A. 110:7838-7843(2013).
RN   [44]
RP   INTERACTION WITH DCUN1D3.
RX   PubMed=25349211; DOI=10.1074/jbc.M114.585505;
RA   Huang G., Stock C., Bommelje C.C., Weeda V.B., Shah K., Bains S.,
RA   Buss E., Shaha M., Rechler W., Ramanathan S.Y., Singh B.;
RT   "SCCRO3 (DCUN1D3) antagonizes the neddylation and oncogenic activity
RT   of SCCRO (DCUN1D1).";
RL   J. Biol. Chem. 289:34728-34742(2014).
RN   [45]
RP   FUNCTION, AND IDENTIFICATION IN A BCR (BTB-CUL3-RBX1) E3 UBIQUITIN
RP   LIGASE COMPLEX.
RX   PubMed=24768539; DOI=10.1016/j.molcel.2014.03.035;
RA   Yuan W.C., Lee Y.R., Lin S.Y., Chang L.Y., Tan Y.P., Hung C.C.,
RA   Kuo J.C., Liu C.H., Lin M.Y., Xu M., Chen Z.J., Chen R.H.;
RT   "K33-linked polyubiquitination of coronin 7 by Cul3-KLHL20 ubiquitin
RT   E3 ligase regulates protein trafficking.";
RL   Mol. Cell 54:586-600(2014).
RN   [46]
RP   INTERACTION WITH KCTD17, IDENTIFICATION IN THE BCR(KCTD17) E3
RP   UBIQUITIN LIGASE COMPLEX, AND FUNCTION.
RX   PubMed=25270598; DOI=10.1038/ncomms6081;
RA   Kasahara K., Kawakami Y., Kiyono T., Yonemura S., Kawamura Y., Era S.,
RA   Matsuzaki F., Goshima N., Inagaki M.;
RT   "Ubiquitin-proteasome system controls ciliogenesis at the initial step
RT   of axoneme extension.";
RL   Nat. Commun. 5:5081-5081(2014).
RN   [47]
RP   FUNCTION, AND INTERACTION WITH KBTBD8.
RX   PubMed=26399832; DOI=10.1038/nature14978;
RA   Werner A., Iwasaki S., McGourty C.A., Medina-Ruiz S., Teerikorpi N.,
RA   Fedrigo I., Ingolia N.T., Rape M.;
RT   "Cell-fate determination by ubiquitin-dependent regulation of
RT   translation.";
RL   Nature 525:523-527(2015).
RN   [48]
RP   FUNCTION.
RX   PubMed=27716508; DOI=10.1016/j.cell.2016.09.026;
RA   McGourty C.A., Akopian D., Walsh C., Gorur A., Werner A., Schekman R.,
RA   Bautista D., Rape M.;
RT   "Regulation of the CUL3 ubiquitin ligase by a calcium-dependent co-
RT   adaptor.";
RL   Cell 167:525-538(2016).
RN   [49]
RP   FUNCTION, INTERACTION WITH ARIH1, AND NEDDYLATION.
RX   PubMed=27565346; DOI=10.1016/j.cell.2016.07.027;
RA   Scott D.C., Rhee D.Y., Duda D.M., Kelsall I.R., Olszewski J.L.,
RA   Paulo J.A., de Jong A., Ovaa H., Alpi A.F., Harper J.W.,
RA   Schulman B.A.;
RT   "Two distinct types of E3 ligases work in unison to regulate substrate
RT   ubiquitylation.";
RL   Cell 166:1198-1214(2016).
RN   [50]
RP   INTERACTION WITH KLHL15 AND RBBP8, AND NEDDYLATION.
RX   PubMed=27561354; DOI=10.1038/ncomms12628;
RA   Ferretti L.P., Himmels S.F., Trenner A., Walker C., von Aesch C.,
RA   Eggenschwiler A., Murina O., Enchev R.I., Peter M., Freire R.,
RA   Porro A., Sartori A.A.;
RT   "Cullin3-KLHL15 ubiquitin ligase mediates CtIP protein turnover to
RT   fine-tune DNA-end resection.";
RL   Nat. Commun. 7:12628-12628(2016).
RN   [51]
RP   FUNCTION, IDENTIFICATION IN THE BCR(KLHL24) COMPLEX, AND INTERACTION
RP   WITH KLHL24.
RX   PubMed=27798626; DOI=10.1038/ng.3701;
RA   Lin Z., Li S., Feng C., Yang S., Wang H., Ma D., Zhang J., Gou M.,
RA   Bu D., Zhang T., Kong X., Wang X., Sarig O., Ren Y., Dai L., Liu H.,
RA   Zhang J., Li F., Hu Y., Padalon-Brauch G., Vodo D., Zhou F., Chen T.,
RA   Deng H., Sprecher E., Yang Y., Tan X.;
RT   "Stabilizing mutations of KLHL24 ubiquitin ligase cause loss of
RT   keratin 14 and human skin fragility.";
RL   Nat. Genet. 48:1508-1516(2016).
RN   [52]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=28395323; DOI=10.1095/biolreprod.116.143479;
RA   Jumeau F., Chalmel F., Fernandez-Gomez F.J., Carpentier C., Obriot H.,
RA   Tardivel M., Caillet-Boudin M.L., Rigot J.M., Rives N., Buee L.,
RA   Sergeant N., Mitchell V.;
RT   "Defining the human sperm microtubulome: an integrated genomics
RT   approach.";
RL   Biol. Reprod. 96:93-106(2017).
RN   [53]
RP   INTERACTION WITH RHOBTB2.
RX   PubMed=29276004; DOI=10.1016/j.ajhg.2017.11.008;
RG   Deciphering Developmental Disorders Study;
RA   Straub J., Konrad E.D.H., Gruener J., Toutain A., Bok L.A., Cho M.T.,
RA   Crawford H.P., Dubbs H., Douglas G., Jobling R., Johnson D., Krock B.,
RA   Mikati M.A., Nesbitt A., Nicolai J., Phillips M., Poduri A.,
RA   Ortiz-Gonzalez X.R., Powis Z., Santani A., Smith L., Stegmann A.P.A.,
RA   Stumpel C., Vreeburg M., Fliedner A., Gregor A., Sticht H., Zweier C.;
RT   "Missense variants in RHOBTB2 cause a developmental and epileptic
RT   encephalopathy in humans, and altered levels cause neurological
RT   defects in Drosophila.";
RL   Am. J. Hum. Genet. 102:44-57(2018).
RN   [54]
RP   FUNCTION.
RX   PubMed=29769719; DOI=10.1038/s41586-018-0128-9;
RA   Chen J., Ou Y., Yang Y., Li W., Xu Y., Xie Y., Liu Y.;
RT   "KLHL22 activates amino-acid-dependent mTORC1 signalling to promote
RT   tumorigenesis and ageing.";
RL   Nature 557:585-589(2018).
RN   [55]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 20-381 IN COMPLEX WITH SPOP,
RP   FUNCTION, IDENTIFICATION IN UBIQUITIN LIGASE COMPLEXES WITH SPOP AND
RP   SPOPL, AND SUBUNIT.
RX   PubMed=22632832; DOI=10.1016/j.str.2012.04.009;
RA   Errington W.J., Khan M.Q., Bueler S.A., Rubinstein J.L.,
RA   Chakrabartty A., Prive G.G.;
RT   "Adaptor protein self-assembly drives the control of a cullin-RING
RT   ubiquitin ligase.";
RL   Structure 20:1141-1153(2012).
RN   [56]
RP   X-RAY CRYSTALLOGRAPHY (3.51 ANGSTROMS) OF 20-381 IN COMPLEX WITH
RP   KLHL3.
RX   PubMed=23573258; DOI=10.1371/journal.pone.0060445;
RA   Ji A.X., Prive G.G.;
RT   "Crystal structure of KLHL3 in complex with Cullin3.";
RL   PLoS ONE 8:E60445-E60445(2013).
RN   [57]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 1-388 IN COMPLEX WITH KLHL11,
RP   AND INTERACTION WITH KLHL11.
RX   PubMed=23349464; DOI=10.1074/jbc.M112.437996;
RA   Canning P., Cooper C.D., Krojer T., Murray J.W., Pike A.C.,
RA   Chaikuad A., Keates T., Thangaratnarajah C., Hojzan V., Marsden B.D.,
RA   Gileadi O., Knapp S., von Delft F., Bullock A.N.;
RT   "Structural basis for Cul3 assembly with the BTB-Kelch family of E3
RT   ubiquitin ligases.";
RL   J. Biol. Chem. 288:7803-7814(2013).
RN   [58]
RP   VARIANTS PHA2E GLY-413 AND ARG-459.
RX   PubMed=22266938; DOI=10.1038/nature10814;
RA   Boyden L.M., Choi M., Choate K.A., Nelson-Williams C.J., Farhi A.,
RA   Toka H.R., Tikhonova I.R., Bjornson R., Mane S.M., Colussi G.,
RA   Lebel M., Gordon R.D., Semmekrot B.A., Poujol A., Valimaki M.J.,
RA   De Ferrari M.E., Sanjad S.A., Gutkin M., Karet F.E., Tucci J.R.,
RA   Stockigt J.R., Keppler-Noreuil K.M., Porter C.C., Anand S.K.,
RA   Whiteford M.L., Davis I.D., Dewar S.B., Bettinelli A., Fadrowski J.J.,
RA   Belsha C.W., Hunley T.E., Nelson R.D., Trachtman H., Cole T.R.,
RA   Pinsk M., Bockenhauer D., Shenoy M., Vaidyanathan P., Foreman J.W.,
RA   Rasoulpour M., Thameem F., Al-Shahrouri H.Z., Radhakrishnan J.,
RA   Gharavi A.G., Goilav B., Lifton R.P.;
RT   "Mutations in kelch-like 3 and cullin 3 cause hypertension and
RT   electrolyte abnormalities.";
RL   Nature 482:98-102(2012).
RN   [59]
RP   VARIANT ARG-719.
RX   PubMed=25969726; DOI=10.1186/s13229-015-0017-0;
RA   Codina-Sola M., Rodriguez-Santiago B., Homs A., Santoyo J., Rigau M.,
RA   Aznar-Lain G., Del Campo M., Gener B., Gabau E., Botella M.P.,
RA   Gutierrez-Arumi A., Antinolo G., Perez-Jurado L.A., Cusco I.;
RT   "Integrated analysis of whole-exome sequencing and transcriptome
RT   profiling in males with autism spectrum disorders.";
RL   Mol. Autism 6:21-21(2015).
CC   -!- FUNCTION: Core component of multiple cullin-RING-based BCR (BTB-
CC       CUL3-RBX1) E3 ubiquitin-protein ligase complexes which mediate the
CC       ubiquitination and subsequent proteasomal degradation of target
CC       proteins. BCR complexes and ARIH1 collaborate in tandem to mediate
CC       ubiquitination of target proteins (PubMed:27565346). As a scaffold
CC       protein may contribute to catalysis through positioning of the
CC       substrate and the ubiquitin-conjugating enzyme. The E3 ubiquitin-
CC       protein ligase activity of the complex is dependent on the
CC       neddylation of the cullin subunit and is inhibited by the
CC       association of the deneddylated cullin subunit with TIP120A/CAND1.
CC       The functional specificity of the BCR complex depends on the BTB
CC       domain-containing protein as the substrate recognition component.
CC       BCR(KLHL42) is involved in ubiquitination of KATNA1. BCR(SPOP) is
CC       involved in ubiquitination of BMI1/PCGF4, BRMS1, H2AFY and DAXX,
CC       GLI2 and GLI3. Can also form a cullin-RING-based BCR (BTB-CUL3-
CC       RBX1) E3 ubiquitin-protein ligase complex containing homodimeric
CC       SPOPL or the heterodimer formed by SPOP and SPOPL; these complexes
CC       have lower ubiquitin ligase activity. BCR(KLHL9-KLHL13) controls
CC       the dynamic behavior of AURKB on mitotic chromosomes and thereby
CC       coordinates faithful mitotic progression and completion of
CC       cytokinesis. BCR(KLHL12) is involved in ER-Golgi transport by
CC       regulating the size of COPII coats, thereby playing a key role in
CC       collagen export, which is required for embryonic stem (ES) cells
CC       division: BCR(KLHL12) acts by mediating monoubiquitination of
CC       SEC31 (SEC31A or SEC31B) (PubMed:22358839, PubMed:27716508).
CC       BCR(KLHL3) acts as a regulator of ion transport in the distal
CC       nephron; by mediating ubiquitination of WNK4 (PubMed:23387299,
CC       PubMed:23453970, PubMed:23576762). The BCR(KLHL20) E3 ubiquitin
CC       ligase complex is involved in interferon response and anterograde
CC       Golgi to endosome transport: it mediates both ubiquitination
CC       leading to degradation and 'Lys-33'-linked ubiquitination
CC       (PubMed:20389280, PubMed:21840486, PubMed:21670212,
CC       PubMed:24768539). The BCR(KLHL21) E3 ubiquitin ligase complex
CC       regulates localization of the chromosomal passenger complex (CPC)
CC       from chromosomes to the spindle midzone in anaphase and mediates
CC       the ubiquitination of AURKB (PubMed:19995937). The BCR(KLHL22)
CC       ubiquitin ligase complex mediates monoubiquitination of PLK1,
CC       leading to PLK1 dissociation from phosphoreceptor proteins and
CC       subsequent removal from kinetochores, allowing silencing of the
CC       spindle assembly checkpoint (SAC) and chromosome segregation
CC       (PubMed:23455478). The BCR(KLHL22) ubiquitin ligase complex is
CC       also responsible for the amino acid-stimulated 'Lys-48'
CC       polyubiquitination and proteasomal degradation of DEPDC5. Through
CC       the degradation of DEPDC5, releases the GATOR1 complex-mediated
CC       inhibition of the TORC1 pathway (PubMed:29769719). The BCR(KLHL25)
CC       ubiquitin ligase complex is involved in translational homeostasis
CC       by mediating ubiquitination and subsequent degradation of
CC       hypophosphorylated EIF4EBP1 (4E-BP1) (PubMed:22578813). The
CC       BCR(KBTBD8) complex acts by mediating monoubiquitination of NOLC1
CC       and TCOF1, leading to remodel the translational program of
CC       differentiating cells in favor of neural crest specification
CC       (PubMed:26399832). Involved in ubiquitination of cyclin E and of
CC       cyclin D1 (in vitro) thus involved in regulation of G1/S
CC       transition. Involved in the ubiquitination of KEAP1, ENC1 and
CC       KLHL41. In concert with ATF2 and RBX1, promotes degradation of
CC       KAT5 thereby attenuating its ability to acetylate and activate
CC       ATM. The BCR(KCTD17) E3 ubiquitin ligase complex mediates
CC       ubiquitination and degradation of TCHP, a down-regulator of cilium
CC       assembly, thereby inducing ciliogenesis (PubMed:25270598). The
CC       BCR(KLHL24) E3 ubiquitin ligase complex mediates ubiquitination of
CC       KRT14, controls KRT14 levels during keratinocytes differentiation,
CC       and is essential for skin integrity (PubMed:27798626).
CC       {ECO:0000269|PubMed:10500095, ECO:0000269|PubMed:11311237,
CC       ECO:0000269|PubMed:15897469, ECO:0000269|PubMed:15983046,
CC       ECO:0000269|PubMed:16524876, ECO:0000269|PubMed:17543862,
CC       ECO:0000269|PubMed:18397884, ECO:0000269|PubMed:19261606,
CC       ECO:0000269|PubMed:19995937, ECO:0000269|PubMed:20389280,
CC       ECO:0000269|PubMed:21670212, ECO:0000269|PubMed:21840486,
CC       ECO:0000269|PubMed:22085717, ECO:0000269|PubMed:22358839,
CC       ECO:0000269|PubMed:22578813, ECO:0000269|PubMed:22632832,
CC       ECO:0000269|PubMed:23387299, ECO:0000269|PubMed:23453970,
CC       ECO:0000269|PubMed:23455478, ECO:0000269|PubMed:23576762,
CC       ECO:0000269|PubMed:24768539, ECO:0000269|PubMed:25270598,
CC       ECO:0000269|PubMed:26399832, ECO:0000269|PubMed:27565346,
CC       ECO:0000269|PubMed:27716508, ECO:0000269|PubMed:27798626,
CC       ECO:0000269|PubMed:29769719}.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Forms neddylation-dependent homodimers. Component of
CC       multiple BCR (BTB-CUL3-RBX1) E3 ubiquitin-protein ligase complexes
CC       formed of CUL3, RBX1 and a variable BTB domain-containing protein
CC       acting as both, adapter to cullin and substrate recognition
CC       subunit. The BCR complex may be active as a heterodimeric complex,
CC       in which NEDD8, covalently attached to one CUL3 molecule, binds to
CC       the C-terminus of a second CUL3 molecule. Interacts with RBX1,
CC       RNF7, CYCE and TIP120A/CAND1 (PubMed:10500095, PubMed:10230407,
CC       PubMed:12609982). Part of the BCR(SPOP) containing SPOP, and of
CC       BCR containing homodimeric SPOPL or the heterodimer formed by SPOP
CC       and SPOPL. Part of the probable BCR(KLHL9-KLHL13) complex with BTB
CC       domain proteins KLHL9 and KLHL13. Part of the BCR(KLHL41) complex
CC       containing KLHL41. Component of the BCR(KLHL12) E3 ubiquitin
CC       ligase complex, at least composed of CUL3 and KLHL12 and RBX1.
CC       Component of the BCR(KLHL3) E3 ubiquitin ligase complex, at least
CC       composed of CUL3 and KLHL3 and RBX1 (Probable). Part of the
CC       BCR(ENC1) complex containing ENC1. Part of a complex consisting of
CC       BMI1/PCGF4, CUL3 and SPOP. Part of a complex consisting of BRMS1,
CC       CUL3 and SPOP. Component of the BCR(KLHL21) E3 ubiquitin ligase
CC       complex, at least composed of CUL3, KLHL21 and RBX1. Component of
CC       the BCR(KLHL22) E3 ubiquitin ligase complex, at least composed of
CC       CUL3, KLHL22 and RBX1. Component of the BCR(KLHL25) E3 ubiquitin
CC       ligase complex, at least composed of CUL3, KLHL25 and RBX1. Part
CC       of a complex consisting of H2AFY, CUL3 and SPOP. Component of the
CC       BCR(KLHL42) E3 ubiquitin ligase complex, at least composed of CUL3
CC       and KLHL42. Interacts with KLHL42 (via the BTB domain). Interacts
CC       with KATNA1; the interaction is enhanced by KLHL42. Component of
CC       the BCR(KBTBD8) E3 ubiquitin ligase complex, at least composed of
CC       CUL3, KBTBD8 and RBX1 (PubMed:26399832). Interacts with KCTD5,
CC       KLHL9, KLHL11, KLHL13, GAN, ZBTB16, KLHL3, KLHL15, KLHL20, KLHL36,
CC       GMCL2, BTBD1. Part of a complex that contains CUL3, RBX1 and GAN.
CC       Interacts (via BTB domain) with KLHL17; the interaction regulates
CC       surface GRIK2 expression. Interacts with KCTD7. Part of the
CC       BCR(GAN) complex containing GAN. Part of the BCR(KEAP1) complex
CC       containing KEAP1. Interacts with KLHL10 (By similarity). Interacts
CC       with KAT5 and ATF2. Interacts with DCUN1D3. Interacts with KCTD17
CC       in the BCR(KCTD17) E3 ubiquitin ligase complex, at least composed
CC       of CUL3, KCTD17 and RBX1 (PubMed:25270598). Interacts (when
CC       neddylated) with ARIH1; leading to activate the E3 ligase activity
CC       of ARIH1 (PubMed:24076655, PubMed:27565346). Interacts with COPS9
CC       isoform 2 (PubMed:23776465). Interacts with PPP2R5B; this
CC       interaction is indirect and mediated through KLHL15-binding and
CC       leads to PPP2R5B proteasomal degradation (PubMed:23135275).
CC       Interacts with RBBP8/CtIP; this interaction is indirect and
CC       mediated through KLHL15-binding and leads to RBBP8 proteasomal
CC       degradation (PubMed:27561354). Interacts with KLHL24 in the
CC       BCR(KLHL24) E3 ubiquitin ligase complex, composed of CUL3, RBX1
CC       and KLHL24 (PubMed:27798626). Interacts with RHOBTB2
CC       (PubMed:29276004). {ECO:0000250, ECO:0000269|PubMed:10230407,
CC       ECO:0000269|PubMed:10500095, ECO:0000269|PubMed:12609982,
CC       ECO:0000269|PubMed:14528312, ECO:0000269|PubMed:15897469,
CC       ECO:0000269|PubMed:15983046, ECO:0000269|PubMed:16524876,
CC       ECO:0000269|PubMed:17543862, ECO:0000269|PubMed:18397884,
CC       ECO:0000269|PubMed:18573101, ECO:0000269|PubMed:19261606,
CC       ECO:0000269|PubMed:19995937, ECO:0000269|PubMed:20389280,
CC       ECO:0000269|PubMed:21670212, ECO:0000269|PubMed:21840486,
CC       ECO:0000269|PubMed:22085717, ECO:0000269|PubMed:22358839,
CC       ECO:0000269|PubMed:22578813, ECO:0000269|PubMed:22632832,
CC       ECO:0000269|PubMed:22748208, ECO:0000269|PubMed:23135275,
CC       ECO:0000269|PubMed:23349464, ECO:0000269|PubMed:23387299,
CC       ECO:0000269|PubMed:23453970, ECO:0000269|PubMed:23455478,
CC       ECO:0000269|PubMed:23573258, ECO:0000269|PubMed:23576762,
CC       ECO:0000269|PubMed:23776465, ECO:0000269|PubMed:24076655,
CC       ECO:0000269|PubMed:24768539, ECO:0000269|PubMed:25270598,
CC       ECO:0000269|PubMed:25349211, ECO:0000269|PubMed:26399832,
CC       ECO:0000269|PubMed:27561354, ECO:0000269|PubMed:27565346,
CC       ECO:0000269|PubMed:27798626, ECO:0000269|PubMed:29276004,
CC       ECO:0000305}.
CC   -!- INTERACTION:
CC       Q969K4:ABTB1; NbExp=3; IntAct=EBI-456129, EBI-7223971;
CC       Q86VP6:CAND1; NbExp=2; IntAct=EBI-456129, EBI-456077;
CC       Q14790:CASP8; NbExp=6; IntAct=EBI-456129, EBI-78060;
CC       O60826:CCDC22; NbExp=2; IntAct=EBI-456129, EBI-3943153;
CC       Q8IWE4:DCUN1D3; NbExp=3; IntAct=EBI-15794202, EBI-15794102;
CC       Q53SE7:FLJ13057; NbExp=3; IntAct=EBI-456129, EBI-10172181;
CC       P08238:HSP90AB1; NbExp=2; IntAct=EBI-456129, EBI-352572;
CC       Q8WZ19:KCTD13; NbExp=5; IntAct=EBI-456129, EBI-742916;
CC       Q8NC69:KCTD6; NbExp=6; IntAct=EBI-456129, EBI-2511344;
CC       Q7L273:KCTD9; NbExp=5; IntAct=EBI-456129, EBI-4397613;
CC       Q53G59:KLHL12; NbExp=5; IntAct=EBI-456129, EBI-740929;
CC       O95198:KLHL2; NbExp=3; IntAct=EBI-456129, EBI-746999;
CC       Q9Y2M5:KLHL20; NbExp=2; IntAct=EBI-456129, EBI-714379;
CC       Q8N4I8:KLHL3; NbExp=3; IntAct=EBI-456129, EBI-10230467;
CC       Q9UH77:KLHL3; NbExp=3; IntAct=EBI-456129, EBI-8524663;
CC       Q8IXQ5:KLHL7; NbExp=7; IntAct=EBI-456129, EBI-6153160;
CC       Q8TBC3:SHKBP1; NbExp=3; IntAct=EBI-456129, EBI-724292;
CC       O43791:SPOP; NbExp=2; IntAct=EBI-456129, EBI-743549;
CC       Q13829:TNFAIP1; NbExp=3; IntAct=EBI-456129, EBI-2505861;
CC       P50591:TNFSF10; NbExp=2; IntAct=EBI-456129, EBI-495373;
CC       O94888:UBXN7; NbExp=6; IntAct=EBI-456129, EBI-1993627;
CC       Q9H898:ZMAT4; NbExp=3; IntAct=EBI-456129, EBI-2548542;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10500095,
CC       ECO:0000269|PubMed:22085717}. Golgi apparatus
CC       {ECO:0000269|PubMed:10500095}. Cell projection, cilium, flagellum
CC       {ECO:0000269|PubMed:28395323}. Cytoplasm. Note=Detected along the
CC       length of the sperm flagellum and in the cytoplasm of the germ
CC       cells. {ECO:0000269|PubMed:28395323}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=Cul-3 Long;
CC         IsoId=Q13618-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q13618-2; Sequence=VSP_008824;
CC       Name=3; Synonyms=Cul-3 Short;
CC         IsoId=Q13618-3; Sequence=VSP_008825;
CC   -!- TISSUE SPECIFICITY: Brain, spermatozoa, and testis (at protein
CC       level). Widely expressed. {ECO:0000269|PubMed:28395323}.
CC   -!- PTM: Neddylated. Attachment of NEDD8 is required for the E3
CC       ubiquitin-protein ligase activity of the BCR complex. Deneddylated
CC       via its interaction with the COP9 signalosome (CSN) complex.
CC       {ECO:0000269|PubMed:10500095, ECO:0000269|PubMed:10597293,
CC       ECO:0000269|PubMed:24076655, ECO:0000269|PubMed:27565346}.
CC   -!- DISEASE: Pseudohypoaldosteronism 2E (PHA2E) [MIM:614496]: An
CC       autosomal dominant disorder characterized by severe hypertension,
CC       hyperkalemia, hyperchloremia, hyperchloremic metabolic acidosis,
CC       and correction of physiologic abnormalities by thiazide diuretics.
CC       {ECO:0000269|PubMed:22266938}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the cullin family. {ECO:0000255|PROSITE-
CC       ProRule:PRU00330}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC28621.1; Type=Frameshift; Positions=452; Evidence={ECO:0000305};
CC       Sequence=AAC36682.1; Type=Frameshift; Positions=159, 179; Evidence={ECO:0000305};
CC       Sequence=BAA31592.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AF064087; AAC36304.1; -; mRNA.
DR   EMBL; AB014517; BAA31592.2; ALT_INIT; mRNA.
DR   EMBL; AF062537; AAC36682.1; ALT_FRAME; mRNA.
DR   EMBL; AY337761; AAQ01660.1; -; mRNA.
DR   EMBL; AK291151; BAF83840.1; -; mRNA.
DR   EMBL; AC073052; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC092679; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471063; EAW70828.1; -; Genomic_DNA.
DR   EMBL; BC031844; AAH31844.1; -; mRNA.
DR   EMBL; BC039598; AAH39598.1; -; mRNA.
DR   EMBL; BC092409; AAH92409.1; -; mRNA.
DR   EMBL; U58089; AAC50546.1; -; mRNA.
DR   EMBL; AF052147; AAC28621.1; ALT_FRAME; mRNA.
DR   CCDS; CCDS2462.1; -. [Q13618-1]
DR   CCDS; CCDS58751.1; -. [Q13618-3]
DR   RefSeq; NP_001244126.1; NM_001257197.1. [Q13618-3]
DR   RefSeq; NP_001244127.1; NM_001257198.1.
DR   RefSeq; NP_003581.1; NM_003590.4. [Q13618-1]
DR   UniGene; Hs.372286; -.
DR   PDB; 2MYL; NMR; -; A=49-68.
DR   PDB; 2MYM; NMR; -; A=49-68.
DR   PDB; 4AP2; X-ray; 2.80 A; B=1-388.
DR   PDB; 4APF; X-ray; 3.10 A; B=23-388.
DR   PDB; 4EOZ; X-ray; 2.40 A; B/D=20-381.
DR   PDB; 4HXI; X-ray; 3.51 A; B=20-381.
DR   PDB; 5NLB; X-ray; 3.45 A; B=26-381.
DR   PDBsum; 2MYL; -.
DR   PDBsum; 2MYM; -.
DR   PDBsum; 4AP2; -.
DR   PDBsum; 4APF; -.
DR   PDBsum; 4EOZ; -.
DR   PDBsum; 4HXI; -.
DR   PDBsum; 5NLB; -.
DR   ProteinModelPortal; Q13618; -.
DR   SMR; Q13618; -.
DR   BioGrid; 114030; 1233.
DR   CORUM; Q13618; -.
DR   DIP; DIP-31611N; -.
DR   IntAct; Q13618; 71.
DR   MINT; Q13618; -.
DR   STRING; 9606.ENSP00000264414; -.
DR   iPTMnet; Q13618; -.
DR   PhosphoSitePlus; Q13618; -.
DR   BioMuta; CUL3; -.
DR   DMDM; 12643396; -.
DR   EPD; Q13618; -.
DR   jPOST; Q13618; -.
DR   MaxQB; Q13618; -.
DR   PaxDb; Q13618; -.
DR   PeptideAtlas; Q13618; -.
DR   PRIDE; Q13618; -.
DR   ProteomicsDB; 59606; -.
DR   ProteomicsDB; 59607; -. [Q13618-2]
DR   ProteomicsDB; 59608; -. [Q13618-3]
DR   Ensembl; ENST00000264414; ENSP00000264414; ENSG00000036257. [Q13618-1]
DR   Ensembl; ENST00000344951; ENSP00000343601; ENSG00000036257. [Q13618-3]
DR   Ensembl; ENST00000409096; ENSP00000387200; ENSG00000036257. [Q13618-2]
DR   Ensembl; ENST00000409777; ENSP00000386525; ENSG00000036257. [Q13618-2]
DR   GeneID; 8452; -.
DR   KEGG; hsa:8452; -.
DR   UCSC; uc002vny.4; human. [Q13618-1]
DR   CTD; 8452; -.
DR   DisGeNET; 8452; -.
DR   EuPathDB; HostDB:ENSG00000036257.12; -.
DR   GeneCards; CUL3; -.
DR   GeneReviews; CUL3; -.
DR   HGNC; HGNC:2553; CUL3.
DR   HPA; CAB002678; -.
DR   MalaCards; CUL3; -.
DR   MIM; 603136; gene.
DR   MIM; 614496; phenotype.
DR   neXtProt; NX_Q13618; -.
DR   OpenTargets; ENSG00000036257; -.
DR   Orphanet; 300530; Pseudohypoaldosteronism type 2E.
DR   PharmGKB; PA27049; -.
DR   eggNOG; KOG2167; Eukaryota.
DR   eggNOG; COG5647; LUCA.
DR   GeneTree; ENSGT00940000155066; -.
DR   HOVERGEN; HBG003619; -.
DR   InParanoid; Q13618; -.
DR   KO; K03869; -.
DR   OMA; TSTFWPM; -.
DR   OrthoDB; 1040292at2759; -.
DR   PhylomeDB; Q13618; -.
DR   TreeFam; TF105858; -.
DR   BRENDA; 6.3.2.19; 2681.
DR   Reactome; R-HSA-4641258; Degradation of DVL.
DR   Reactome; R-HSA-5632684; Hedgehog 'on' state.
DR   Reactome; R-HSA-5658442; Regulation of RAS by GAPs.
DR   Reactome; R-HSA-8951664; Neddylation.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   SignaLink; Q13618; -.
DR   SIGNOR; Q13618; -.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; CUL3; human.
DR   GeneWiki; CUL3; -.
DR   GenomeRNAi; 8452; -.
DR   PRO; PR:Q13618; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000036257; Expressed in 230 organ(s), highest expression level in sperm.
DR   ExpressionAtlas; Q13618; baseline and differential.
DR   Genevisible; Q13618; HS.
DR   GO; GO:0031463; C:Cul3-RING ubiquitin ligase complex; IDA:UniProtKB.
DR   GO; GO:0031461; C:cullin-RING ubiquitin ligase complex; IBA:GO_Central.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; IEA:GOC.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005827; C:polar microtubule; IDA:UniProtKB.
DR   GO; GO:0019005; C:SCF ubiquitin ligase complex; IBA:GO_Central.
DR   GO; GO:0036126; C:sperm flagellum; IDA:UniProtKB.
DR   GO; GO:0030332; F:cyclin binding; IEA:Ensembl.
DR   GO; GO:0005112; F:Notch binding; IPI:MGI.
DR   GO; GO:0031208; F:POZ domain binding; IDA:UniProtKB.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:Ensembl.
DR   GO; GO:0042803; F:protein homodimerization activity; IEA:Ensembl.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IBA:GO_Central.
DR   GO; GO:0031145; P:anaphase-promoting complex-dependent catabolic process; IDA:MGI.
DR   GO; GO:0007050; P:cell cycle arrest; TAS:ProtInc.
DR   GO; GO:0016477; P:cell migration; IMP:UniProtKB.
DR   GO; GO:0030030; P:cell projection organization; IEA:UniProtKB-KW.
DR   GO; GO:0048208; P:COPII vesicle coating; IMP:UniProtKB.
DR   GO; GO:0040016; P:embryonic cleavage; ISS:UniProtKB.
DR   GO; GO:0006888; P:endoplasmic reticulum to Golgi vesicle-mediated transport; IDA:UniProtKB.
DR   GO; GO:0044346; P:fibroblast apoptotic process; IEA:Ensembl.
DR   GO; GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:ProtInc.
DR   GO; GO:0007369; P:gastrulation; IEA:Ensembl.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; ISS:UniProtKB.
DR   GO; GO:0097193; P:intrinsic apoptotic signaling pathway; TAS:ProtInc.
DR   GO; GO:0072576; P:liver morphogenesis; IEA:Ensembl.
DR   GO; GO:0000165; P:MAPK cascade; TAS:Reactome.
DR   GO; GO:0007080; P:mitotic metaphase plate congression; IMP:UniProtKB.
DR   GO; GO:0090090; P:negative regulation of canonical Wnt signaling pathway; TAS:Reactome.
DR   GO; GO:0035024; P:negative regulation of Rho protein signal transduction; IMP:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IEA:Ensembl.
DR   GO; GO:0071630; P:nuclear protein quality control by the ubiquitin-proteasome system; IDA:UniProtKB.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; TAS:ProtInc.
DR   GO; GO:0032467; P:positive regulation of cytokinesis; IMP:UniProtKB.
DR   GO; GO:0045842; P:positive regulation of mitotic metaphase/anaphase transition; IMP:UniProtKB.
DR   GO; GO:0031398; P:positive regulation of protein ubiquitination; IGI:BHF-UCL.
DR   GO; GO:0043687; P:post-translational protein modification; TAS:Reactome.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IDA:UniProtKB.
DR   GO; GO:0031648; P:protein destabilization; IGI:BHF-UCL.
DR   GO; GO:0006513; P:protein monoubiquitination; IDA:UniProtKB.
DR   GO; GO:0000209; P:protein polyubiquitination; IDA:UniProtKB.
DR   GO; GO:0016567; P:protein ubiquitination; IDA:UniProtKB.
DR   GO; GO:0031146; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; IBA:GO_Central.
DR   GO; GO:0017145; P:stem cell division; ISS:UniProtKB.
DR   GO; GO:0043149; P:stress fiber assembly; IMP:UniProtKB.
DR   GO; GO:0001831; P:trophectodermal cellular morphogenesis; IEA:Ensembl.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IDA:UniProtKB.
DR   GO; GO:0016055; P:Wnt signaling pathway; IEA:Ensembl.
DR   Gene3D; 1.10.10.10; -; 1.
DR   InterPro; IPR016157; Cullin_CS.
DR   InterPro; IPR016158; Cullin_homology.
DR   InterPro; IPR036317; Cullin_homology_sf.
DR   InterPro; IPR001373; Cullin_N.
DR   InterPro; IPR019559; Cullin_neddylation_domain.
DR   InterPro; IPR016159; Cullin_repeat-like_dom_sf.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   Pfam; PF00888; Cullin; 1.
DR   Pfam; PF10557; Cullin_Nedd8; 1.
DR   SMART; SM00182; CULLIN; 1.
DR   SMART; SM00884; Cullin_Nedd8; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
DR   SUPFAM; SSF74788; SSF74788; 1.
DR   SUPFAM; SSF75632; SSF75632; 1.
DR   PROSITE; PS01256; CULLIN_1; 1.
DR   PROSITE; PS50069; CULLIN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Cell projection;
KW   Cilium; Cilium biogenesis/degradation; Complete proteome; Cytoplasm;
KW   Disease mutation; ER-Golgi transport; Flagellum; Golgi apparatus;
KW   Isopeptide bond; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Transport; Ubl conjugation;
KW   Ubl conjugation pathway.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:22814378}.
FT   CHAIN         2    768       Cullin-3.
FT                                /FTId=PRO_0000119793.
FT   MOD_RES       2      2       N-acetylserine.
FT                                {ECO:0000244|PubMed:22814378}.
FT   MOD_RES     585    585       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   CROSSLNK    712    712       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in NEDD8).
FT                                {ECO:0000250|UniProtKB:Q13616}.
FT   VAR_SEQ       1     24       Missing (in isoform 2).
FT                                {ECO:0000303|Ref.4}.
FT                                /FTId=VSP_008824.
FT   VAR_SEQ      23     88       Missing (in isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_008825.
FT   VARIANT      13     13       D -> H (in dbSNP:rs2969802).
FT                                /FTId=VAR_017194.
FT   VARIANT     184    184       R -> S (in dbSNP:rs17480168).
FT                                /FTId=VAR_048839.
FT   VARIANT     413    413       D -> G (in PHA2E; dbSNP:rs199469656).
FT                                {ECO:0000269|PubMed:22266938}.
FT                                /FTId=VAR_067532.
FT   VARIANT     459    459       K -> R (in PHA2E; dbSNP:rs199469658).
FT                                {ECO:0000269|PubMed:22266938}.
FT                                /FTId=VAR_067533.
FT   VARIANT     567    567       V -> I (in dbSNP:rs3738952).
FT                                /FTId=VAR_017195.
FT   VARIANT     719    719       H -> R (found in a patient with autism
FT                                spectrum disorder; unknown pathological
FT                                significance; dbSNP:rs763087632).
FT                                {ECO:0000269|PubMed:25969726}.
FT                                /FTId=VAR_078688.
FT   CONFLICT     13     13       D -> G (in Ref. 3; AAC36682).
FT                                {ECO:0000305}.
FT   CONFLICT    397    397       K -> T (in Ref. 4; AAQ01660).
FT                                {ECO:0000305}.
FT   CONFLICT    481    481       N -> T (in Ref. 4; AAQ01660).
FT                                {ECO:0000305}.
FT   CONFLICT    609    609       E -> G (in Ref. 8; AAH31844).
FT                                {ECO:0000305}.
FT   CONFLICT    666    666       T -> I (in Ref. 4; AAQ01660).
FT                                {ECO:0000305}.
FT   HELIX        26     45       {ECO:0000244|PDB:4EOZ}.
FT   HELIX        49     51       {ECO:0000244|PDB:4EOZ}.
FT   HELIX        54     66       {ECO:0000244|PDB:4EOZ}.
FT   HELIX        70     87       {ECO:0000244|PDB:4EOZ}.
FT   HELIX        89     94       {ECO:0000244|PDB:4EOZ}.
FT   TURN         95     98       {ECO:0000244|PDB:4EOZ}.
FT   HELIX       101    122       {ECO:0000244|PDB:4EOZ}.
FT   HELIX       124    129       {ECO:0000244|PDB:4EOZ}.
FT   HELIX       132    134       {ECO:0000244|PDB:4EOZ}.
FT   HELIX       139    150       {ECO:0000244|PDB:4EOZ}.
FT   TURN        151    153       {ECO:0000244|PDB:4EOZ}.
FT   HELIX       155    173       {ECO:0000244|PDB:4EOZ}.
FT   HELIX       180    192       {ECO:0000244|PDB:4EOZ}.
FT   STRAND      195    198       {ECO:0000244|PDB:4EOZ}.
FT   HELIX       199    204       {ECO:0000244|PDB:4EOZ}.
FT   HELIX       206    227       {ECO:0000244|PDB:4EOZ}.
FT   HELIX       230    251       {ECO:0000244|PDB:4EOZ}.
FT   HELIX       254    256       {ECO:0000244|PDB:4EOZ}.
FT   HELIX       257    268       {ECO:0000244|PDB:4EOZ}.
FT   TURN        269    272       {ECO:0000244|PDB:4EOZ}.
FT   HELIX       273    277       {ECO:0000244|PDB:4EOZ}.
FT   TURN        280    282       {ECO:0000244|PDB:4EOZ}.
FT   HELIX       284    287       {ECO:0000244|PDB:4EOZ}.
FT   TURN        288    291       {ECO:0000244|PDB:4EOZ}.
FT   HELIX       293    303       {ECO:0000244|PDB:4EOZ}.
FT   HELIX       309    323       {ECO:0000244|PDB:4EOZ}.
FT   HELIX       339    358       {ECO:0000244|PDB:4AP2}.
FT   HELIX       364    380       {ECO:0000244|PDB:4AP2}.
SQ   SEQUENCE   768 AA;  88930 MW;  A1A02022480BF099 CRC64;
     MSNLSKGTGS RKDTKMRIRA FPMTMDEKYV NSIWDLLKNA IQEIQRKNNS GLSFEELYRN
     AYTMVLHKHG EKLYTGLREV VTEHLINKVR EDVLNSLNNN FLQTLNQAWN DHQTAMVMIR
     DILMYMDRVY VQQNNVENVY NLGLIIFRDQ VVRYGCIRDH LRQTLLDMIA RERKGEVVDR
     GAIRNACQML MILGLEGRSV YEEDFEAPFL EMSAEFFQME SQKFLAENSA SVYIKKVEAR
     INEEIERVMH CLDKSTEEPI VKVVERELIS KHMKTIVEME NSGLVHMLKN GKTEDLGCMY
     KLFSRVPNGL KTMCECMSSY LREQGKALVS EEGEGKNPVD YIQGLLDLKS RFDRFLLESF
     NNDRLFKQTI AGDFEYFLNL NSRSPEYLSL FIDDKLKKGV KGLTEQEVET ILDKAMVLFR
     FMQEKDVFER YYKQHLARRL LTNKSVSDDS EKNMISKLKT ECGCQFTSKL EGMFRDMSIS
     NTTMDEFRQH LQATGVSLGG VDLTVRVLTT GYWPTQSATP KCNIPPAPRH AFEIFRRFYL
     AKHSGRQLTL QHHMGSADLN ATFYGPVKKE DGSEVGVGGA QVTGSNTRKH ILQVSTFQMT
     ILMLFNNREK YTFEEIQQET DIPERELVRA LQSLACGKPT QRVLTKEPKS KEIENGHIFT
     VNDQFTSKLH RVKIQTVAAK QGESDPERKE TRQKVDDDRK HEIEAAIVRI MKSRKKMQHN
     VLVAEVTQQL KARFLPSPVV IKKRIEGLIE REYLARTPED RKVYTYVA
//
ID   E9PJK2_HUMAN            Unreviewed;       361 AA.
AC   E9PJK2;
DT   05-APR-2011, integrated into UniProtKB/TrEMBL.
DT   05-APR-2011, sequence version 1.
DT   16-JAN-2019, entry version 59.
DE   SubName: Full=Polycomb protein EED {ECO:0000313|Ensembl:ENSP00000431778};
GN   Name=EED {ECO:0000313|Ensembl:ENSP00000431778};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000431778, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000431778, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [2] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [3] {ECO:0000213|PubMed:19413330}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [4] {ECO:0000213|PubMed:21406692}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:rs3-RS3(2011).
RN   [5] {ECO:0000313|Ensembl:ENSP00000431778}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
RN   [6] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [7] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AP003084; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001317263.1; NM_001330334.1.
DR   UniGene; Hs.503510; -.
DR   UniGene; Hs.528103; -.
DR   ProteinModelPortal; E9PJK2; -.
DR   EPD; E9PJK2; -.
DR   jPOST; E9PJK2; -.
DR   MaxQB; E9PJK2; -.
DR   PeptideAtlas; E9PJK2; -.
DR   PRIDE; E9PJK2; -.
DR   Ensembl; ENST00000528180; ENSP00000431778; ENSG00000074266.
DR   GeneID; 8726; -.
DR   UCSC; uc058gfr.1; human.
DR   CTD; 8726; -.
DR   EuPathDB; HostDB:ENSG00000074266.17; -.
DR   HGNC; HGNC:3188; EED.
DR   OpenTargets; ENSG00000074266; -.
DR   GeneTree; ENSGT00510000047334; -.
DR   OrthoDB; 1191277at2759; -.
DR   SignaLink; E9PJK2; -.
DR   ChiTaRS; EED; human.
DR   GenomeRNAi; 8726; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000074266; Expressed in 107 organ(s), highest expression level in endocervix.
DR   ExpressionAtlas; E9PJK2; baseline and differential.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0035098; C:ESC/E(Z) complex; IEA:InterPro.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0016571; P:histone methylation; IEA:InterPro.
DR   Gene3D; 2.130.10.10; -; 2.
DR   InterPro; IPR037352; Polycomb_EED.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom_sf.
DR   InterPro; IPR001680; WD40_repeat.
DR   InterPro; IPR019775; WD40_repeat_CS.
DR   InterPro; IPR017986; WD40_repeat_dom.
DR   InterPro; IPR036322; WD40_repeat_dom_sf.
DR   PANTHER; PTHR10253; PTHR10253; 2.
DR   Pfam; PF00400; WD40; 1.
DR   SMART; SM00320; WD40; 4.
DR   SUPFAM; SSF50978; SSF50978; 1.
DR   PROSITE; PS00678; WD_REPEATS_1; 1.
DR   PROSITE; PS50082; WD_REPEATS_2; 1.
DR   PROSITE; PS50294; WD_REPEATS_REGION; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:E9PJK2,
KW   ECO:0000213|MaxQB:E9PJK2, ECO:0000213|PeptideAtlas:E9PJK2};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   WD repeat {ECO:0000256|PROSITE-ProRule:PRU00221}.
FT   REPEAT      186    228       WD. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00221}.
FT   DOMAIN      186    228       WD_REPEATS_REGION.
FT                                {ECO:0000259|PROSITE:PS50294}.
SQ   SEQUENCE   361 AA;  40635 MW;  B8E21C011F16AA49 CRC64;
     MSEREVSTAP AGTDMPAAKK QKLSSDENSN PDLSGDENDD AVSIESGTNT ERPDTPTNTP
     NAPGRKSWGK GKWKSKKCKY SFKCVNSLKE DHNQPLFGVQ FNWHSKEGDP LVFATVGSNR
     VTLYECHSQG EIRLLQSYVD ADADENFYTC AWTYDSNTSH PLLAVAGSRG IIRIINPITM
     QCIKHYVGHG NAINELKFHP RDPNLLLSVS KDHALRLWNI QTDTLVAIFG GVEGHRDEVL
     SASCENAIVC WKPGKMEDDI DKIKPSESNV TILGRFDYSQ CDIWYMRFSM DFWQKMLALG
     NQVGKLYVWD LEVEDPHKAK CTTLTHHKCG AAIRQTSFSR DSSILIAVCD DASIWRWDRL
     R
//
ID   EED_HUMAN               Reviewed;         441 AA.
AC   O75530; A8K7V5; O00149; Q6NTH2; Q7LDA5; Q7LDG8; Q86VV2; Q9UNY7;
DT   22-JUL-2008, integrated into UniProtKB/Swiss-Prot.
DT   22-JUL-2008, sequence version 2.
DT   13-FEB-2019, entry version 165.
DE   RecName: Full=Polycomb protein EED {ECO:0000305};
DE            Short=hEED;
DE   AltName: Full=Embryonic ectoderm development protein {ECO:0000303|PubMed:28229514};
DE   AltName: Full=WD protein associating with integrin cytoplasmic tails 1;
DE            Short=WAIT-1;
GN   Name=EED {ECO:0000312|HGNC:HGNC:3188};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=9806832; DOI=10.1006/geno.1998.5509;
RA   Schumacher A., Lichtarge O., Schwartz S., Magnuson T.;
RT   "The murine Polycomb-group gene eed and its human orthologue:
RT   functional implications of evolutionary conservation.";
RL   Genomics 54:79-88(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, INTERACTION WITH
RP   EZH2, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, MUTAGENESIS OF ILE-193
RP   AND LEU-196, AND PUTATIVE ALTERNATIVE INITIATION.
RX   PubMed=9584199; DOI=10.1128/MCB.18.6.3586;
RA   Sewalt R.G.A.B., van der Vlag J., Gunster M.J., Hamer K.M.,
RA   den Blaauwen J.L., Satijn D.P.E., Hendrix T., van Driel R., Otte A.P.;
RT   "Characterization of interactions between the mammalian polycomb-group
RT   proteins Enx1/EZH2 and EED suggests the existence of different
RT   mammalian polycomb-group protein complexes.";
RL   Mol. Cell. Biol. 18:3586-3595(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 3), INTERACTION WITH THE
RP   HIV-1 MA PROTEIN, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND
RP   MUTAGENESIS OF 300-SER-THR-301 AND 305-HIS-TYR-308.
RC   TISSUE=Spleen;
RX   PubMed=9880543; DOI=10.1074/jbc.274.3.1635;
RA   Peytavi R., Hong S.S., Gay B., d'Angeac A.D., Selig L., Benichou S.,
RA   Benarous R., Boulanger P.;
RT   "HEED, the product of the human homolog of the murine eed gene, binds
RT   to the matrix protein of HIV-1.";
RL   J. Biol. Chem. 274:1635-1645(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Synovium;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 15-441 (ISOFORM 1).
RC   TISSUE=Eye, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 4-441 (ISOFORM 1), INTERACTION WITH
RP   ITGA4; ITGAE AND ITGB7, AND TISSUE SPECIFICITY.
RX   PubMed=9765275; DOI=10.1074/jbc.273.42.27459;
RA   Rietzler M., Bittner M., Kolanus W., Schuster A., Holzmann B.;
RT   "The human WD repeat protein WAIT-1 specifically interacts with the
RT   cytoplasmic tails of beta7-integrins.";
RL   J. Biol. Chem. 273:27459-27466(1998).
RN   [9]
RP   FUNCTION, AND INTERACTION WITH EZH2; HDAC1 AND HDAC2.
RX   PubMed=10581039; DOI=10.1038/70602;
RA   van der Vlag J., Otte A.P.;
RT   "Transcriptional repression mediated by the human polycomb-group
RT   protein EED involves histone deacetylation.";
RL   Nat. Genet. 23:474-478(1999).
RN   [10]
RP   INTERACTION WITH EZH2 AND YY1.
RX   PubMed=11158321; DOI=10.1128/MCB.21.4.1360-1369.2001;
RA   Satijn D.P.E., Hamer K.M., den Blaauwen J., Otte A.P.;
RT   "The polycomb group protein EED interacts with YY1, and both proteins
RT   induce neural tissue in Xenopus embryos.";
RL   Mol. Cell. Biol. 21:1360-1369(2001).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY, IDENTIFICATION IN THE PRC2
RP   COMPLEX WITH EZH2; RBBP4; RBBP7 AND SUZ12, AND METHYLTRANSFERASE
RP   ACTIVITY OF THE PRC2 COMPLEX.
RX   PubMed=12435631; DOI=10.1101/gad.1035902;
RA   Kuzmichev A., Nishioka K., Erdjument-Bromage H., Tempst P.,
RA   Reinberg D.;
RT   "Histone methyltransferase activity associated with a human
RT   multiprotein complex containing the Enhancer of Zeste protein.";
RL   Genes Dev. 16:2893-2905(2002).
RN   [12]
RP   SUBCELLULAR LOCATION.
RX   PubMed=12101246; DOI=10.1128/MCB.22.15.5539-5553.2002;
RA   Sewalt R.G.A.B., Lachner M., Vargas M., Hamer K.M., den Blaauwen J.L.,
RA   Hendrix T., Melcher M., Schweizer D., Jenuwein T., Otte A.P.;
RT   "Selective interactions between vertebrate polycomb homologs and the
RT   SUV39H1 histone lysine methyltransferase suggest that histone H3-K9
RT   methylation contributes to chromosomal targeting of Polycomb group
RT   proteins.";
RL   Mol. Cell. Biol. 22:5539-5553(2002).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY, IDENTIFICATION IN THE PRC2
RP   COMPLEX WITH EZH2; RBBP4; RBBP7 AND SUZ12, AND METHYLTRANSFERASE
RP   ACTIVITY OF THE PRC2 COMPLEX.
RX   PubMed=12351676; DOI=10.1126/science.1076997;
RA   Cao R., Wang L., Wang H., Xia L., Erdjument-Bromage H., Tempst P.,
RA   Jones R.S., Zhang Y.;
RT   "Role of histone H3 lysine 27 methylation in Polycomb-group
RT   silencing.";
RL   Science 298:1039-1043(2002).
RN   [14]
RP   FUNCTION, DEVELOPMENTAL STAGE, AND INDUCTION.
RX   PubMed=14532106; DOI=10.1093/emboj/cdg542;
RA   Bracken A.P., Pasini D., Capra M., Prosperini E., Colli E., Helin K.;
RT   "EZH2 is downstream of the pRB-E2F pathway, essential for
RT   proliferation and amplified in cancer.";
RL   EMBO J. 22:5323-5335(2003).
RN   [15]
RP   SUBCELLULAR LOCATION.
RX   PubMed=12649488; DOI=10.1126/science.1084274;
RA   Plath K., Fang J., Mlynarczyk-Evans S.K., Cao R., Worringer K.A.,
RA   Wang H., de la Cruz C.C., Otte A.P., Panning B., Zhang Y.;
RT   "Role of histone H3 lysine 27 methylation in X inactivation.";
RL   Science 300:131-135(2003).
RN   [16]
RP   FUNCTION, INTERACTION WITH EZH2, AND METHYLTRANSFERASE ACTIVITY OF THE
RP   PRC2 COMPLEX.
RX   PubMed=15385962; DOI=10.1038/sj.emboj.7600402;
RA   Pasini D., Bracken A.P., Jensen M.R., Lazzerini Denchi E., Helin K.;
RT   "Suz12 is essential for mouse development and for EZH2 histone
RT   methyltransferase activity.";
RL   EMBO J. 23:4061-4071(2004).
RN   [17]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=15231737; DOI=10.1101/gad.1200204;
RA   Kirmizis A., Bartley S.M., Kuzmichev A., Margueron R., Reinberg D.,
RA   Green R., Farnham P.J.;
RT   "Silencing of human polycomb target genes is associated with
RT   methylation of histone H3 Lys 27.";
RL   Genes Dev. 18:1592-1605(2004).
RN   [18]
RP   CHARACTERIZATION OF THE PRC2 AND PRC3 COMPLEXES INCLUDING EED; EZH2;
RP   RBBP4; RBBP7 AND SUZ12, METHYLTRANSFERASE ACTIVITY OF THE PRC2 AND
RP   PRC3 COMPLEXES, AND PUTATIVE ALTERNATIVE INITIATION.
RX   PubMed=15099518; DOI=10.1016/S1097-2765(04)00185-6;
RA   Kuzmichev A., Jenuwein T., Tempst P., Reinberg D.;
RT   "Different EZH2-containing complexes target methylation of histone H1
RT   or nucleosomal histone H3.";
RL   Mol. Cell 14:183-193(2004).
RN   [19]
RP   FUNCTION, CHARACTERIZATION OF THE PRC2 COMPLEX INCLUDING AEBP2; EED;
RP   EZH2; RBBP4 AND SUZ12, AND METHYLTRANSFERASE ACTIVITY OF THE PRC2
RP   COMPLEX.
RX   PubMed=15225548; DOI=10.1016/j.molcel.2004.06.020;
RA   Cao R., Zhang Y.;
RT   "SUZ12 is required for both the histone methyltransferase activity and
RT   the silencing function of the EED-EZH2 complex.";
RL   Mol. Cell 15:57-67(2004).
RN   [20]
RP   CHARACTERIZATION OF THE PRC4 COMPLEX INCLUDING EED; EZH2; RBBP4;
RP   RBBP7; SUZ12 AND SIRT1, METHYLTRANSFERASE ACTIVITY OF THE PRC4
RP   COMPLEX, AND TISSUE SPECIFICITY.
RX   PubMed=15684044; DOI=10.1073/pnas.0409875102;
RA   Kuzmichev A., Margueron R., Vaquero A., Preissner T.S., Scher M.,
RA   Kirmizis A., Ouyang X., Brockdorff N., Abate-Shen C., Farnham P.J.,
RA   Reinberg D.;
RT   "Composition and histone substrates of polycomb repressive group
RT   complexes change during cellular differentiation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:1859-1864(2005).
RN   [21]
RP   METHYLTRANSFERASE ACTIVITY OF THE PRC2 COMPLEX, AND INTERACTION WITH
RP   HISTONE H1.
RX   PubMed=16431907; DOI=10.1074/jbc.M513425200;
RA   Martin C., Cao R., Zhang Y.;
RT   "Substrate preferences of the EZH2 histone methyltransferase
RT   complex.";
RL   J. Biol. Chem. 281:8365-8370(2006).
RN   [22]
RP   FUNCTION, AND INTERACTION OF THE PRC2 COMPLEX WITH DNMT1; DNMT3A AND
RP   DNMT3B.
RX   PubMed=16357870; DOI=10.1038/nature04431;
RA   Vire E., Brenner C., Deplus R., Blanchon L., Fraga M., Didelot C.,
RA   Morey L., Van Eynde A., Bernard D., Vanderwinden J.-M., Bollen M.,
RA   Esteller M., Di Croce L., de Launoit Y., Fuks F.;
RT   "The Polycomb group protein EZH2 directly controls DNA methylation.";
RL   Nature 439:871-874(2006).
RN   [23]
RP   ERRATUM.
RA   Vire E., Brenner C., Deplus R., Blanchon L., Fraga M., Didelot C.,
RA   Morey L., Van Eynde A., Bernard D., Vanderwinden J.-M., Bollen M.,
RA   Esteller M., Di Croce L., de Launoit Y., Fuks F.;
RL   Nature 446:824-824(2007).
RN   [24]
RP   DE NOVO DNA METHYLATION OF PRC2 TARGET GENES.
RX   PubMed=17200670; DOI=10.1038/ng1950;
RA   Schlesinger Y., Straussman R., Keshet I., Farkash S., Hecht M.,
RA   Zimmerman J., Eden E., Yakhini Z., Ben-Shushan E., Reubinoff B.E.,
RA   Bergman Y., Simon I., Cedar H.;
RT   "Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes
RT   for de novo methylation in cancer.";
RL   Nat. Genet. 39:232-236(2007).
RN   [25]
RP   IDENTIFICATION IN THE PRC2/EED-EZH1 COMPLEX.
RX   PubMed=19026781; DOI=10.1016/j.molcel.2008.11.004;
RA   Margueron R., Li G., Sarma K., Blais A., Zavadil J., Woodcock C.L.,
RA   Dynlacht B.D., Reinberg D.;
RT   "Ezh1 and Ezh2 maintain repressive chromatin through different
RT   mechanisms.";
RL   Mol. Cell 32:503-518(2008).
RN   [26]
RP   IDENTIFICATION BY MASS SPECTROMETRY, INTERACTION OF THE PRC2 COMPLEX
RP   WITH PHF1, AND METHYLTRANSFERASE ACTIVITY OF THE PRC2 COMPLEX.
RX   PubMed=18086877; DOI=10.1128/MCB.01589-07;
RA   Cao R., Wang H., He J., Erdjument-Bromage H., Tempst P., Zhang Y.;
RT   "Role of hPHF1 in H3K27 methylation and Hox gene silencing.";
RL   Mol. Cell. Biol. 28:1862-1872(2008).
RN   [27]
RP   FUNCTION, INTERACTION WITH EZH2 AND SUZ12, INTERACTION OF THE PRC2
RP   COMPLEX WITH PHF1, AND METHYLTRANSFERASE ACTIVITY OF THE PRC2 COMPLEX.
RX   PubMed=18285464; DOI=10.1128/MCB.02017-07;
RA   Sarma K., Margueron R., Ivanov A., Pirrotta V., Reinberg D.;
RT   "Ezh2 requires PHF1 to efficiently catalyze H3 lysine 27
RT   trimethylation in vivo.";
RL   Mol. Cell. Biol. 28:2718-2731(2008).
RN   [28]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-55, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [29]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [30]
RP   INTERACTION WITH CDYL.
RX   PubMed=22009739; DOI=10.1074/jbc.M111.271064;
RA   Zhang Y., Yang X., Gui B., Xie G., Zhang D., Shang Y., Liang J.;
RT   "Corepressor protein CDYL functions as a molecular bridge between
RT   polycomb repressor complex 2 and repressive chromatin mark
RT   trimethylated histone lysine 27.";
RL   J. Biol. Chem. 286:42414-42425(2011).
RN   [31]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [32]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [33]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [34]
RP   X-RAY CRYSTALLOGRAPHY (2.05 ANGSTROMS) OF 40-441 ALONE AND IN COMPLEX
RP   WITH METHYLATED HISTONE PEPTIDES, FUNCTION, DOMAIN WD REPEATS,
RP   METHYLATION AT LYS-66; LYS-197; LYS-268 AND LYS-284, AND MUTAGENESIS
RP   OF PHE-97; TYR-148; TRP-364 AND TYR-365.
RX   PubMed=20974918; DOI=10.1073/pnas.1008937107;
RA   Xu C., Bian C., Yang W., Galka M., Ouyang H., Chen C., Qiu W., Liu H.,
RA   Jones A.E., MacKenzie F., Pan P., Li S.S., Wang H., Min J.;
RT   "Binding of different histone marks differentially regulates the
RT   activity and specificity of polycomb repressive complex 2 (PRC2).";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:19266-19271(2010).
RN   [35]
RP   INVOLVEMENT IN COGIS, AND VARIANT COGIS SER-302.
RX   PubMed=25787343; DOI=10.1038/jhg.2015.26;
RA   Cohen A.S., Tuysuz B., Shen Y., Bhalla S.K., Jones S.J., Gibson W.T.;
RT   "A novel mutation in EED associated with overgrowth.";
RL   J. Hum. Genet. 60:339-342(2015).
RN   [36]
RP   VARIANT COGIS TYR-258.
RX   PubMed=27193220; DOI=10.1038/jhg.2016.51;
RA   Cohen A.S., Gibson W.T.;
RT   "EED-associated overgrowth in a second male patient.";
RL   J. Hum. Genet. 61:831-834(2016).
RN   [37]
RP   VARIANTS COGIS SER-194 AND GLY-236.
RX   PubMed=28475857; DOI=10.1016/j.ajhg.2017.03.010;
RG   Childhood Overgrowth Collaboration;
RA   Tatton-Brown K., Loveday C., Yost S., Clarke M., Ramsay E.,
RA   Zachariou A., Elliott A., Wylie H., Ardissone A., Rittinger O.,
RA   Stewart F., Temple I.K., Cole T., Mahamdallie S., Seal S., Ruark E.,
RA   Rahman N.;
RT   "Mutations in epigenetic regulation genes are a major cause of
RT   overgrowth with intellectual disability.";
RL   Am. J. Hum. Genet. 100:725-736(2017).
RN   [38]
RP   VARIANT COGIS GLY-302.
RX   PubMed=27868325; DOI=10.1002/ajmg.a.38055;
RA   Cooney E., Bi W., Schlesinger A.E., Vinson S., Potocki L.;
RT   "Novel EED mutation in patient with Weaver syndrome.";
RL   Am. J. Med. Genet. A 173:541-545(2017).
RN   [39]
RP   VARIANT COGIS THR-236, CHARACTERIZATION OF VARIANTS COGIS THR-236 AND
RP   SER-302, AND FUNCTION.
RX   PubMed=28229514; DOI=10.1002/humu.23200;
RA   Imagawa E., Higashimoto K., Sakai Y., Numakura C., Okamoto N.,
RA   Matsunaga S., Ryo A., Sato Y., Sanefuji M., Ihara K., Takada Y.,
RA   Nishimura G., Saitsu H., Mizuguchi T., Miyatake S., Nakashima M.,
RA   Miyake N., Soejima H., Matsumoto N.;
RT   "Mutations in genes encoding polycomb repressive complex 2 subunits
RT   cause Weaver syndrome.";
RL   Hum. Mutat. 38:637-648(2017).
CC   -!- FUNCTION: Polycomb group (PcG) protein. Component of the PRC2/EED-
CC       EZH2 complex, which methylates 'Lys-9' and 'Lys-27' of histone H3,
CC       leading to transcriptional repression of the affected target gene.
CC       Also recognizes 'Lys-26' trimethylated histone H1 with the effect
CC       of inhibiting PRC2 complex methyltransferase activity on
CC       nucleosomal histone H3 'Lys-27', whereas H3 'Lys-27' recognition
CC       has the opposite effect, enabling the propagation of this
CC       repressive mark. The PRC2/EED-EZH2 complex may also serve as a
CC       recruiting platform for DNA methyltransferases, thereby linking
CC       two epigenetic repression systems. Genes repressed by the
CC       PRC2/EED-EZH2 complex include HOXC8, HOXA9, MYT1 and CDKN2A.
CC       {ECO:0000269|PubMed:10581039, ECO:0000269|PubMed:14532106,
CC       ECO:0000269|PubMed:15225548, ECO:0000269|PubMed:15231737,
CC       ECO:0000269|PubMed:15385962, ECO:0000269|PubMed:16357870,
CC       ECO:0000269|PubMed:18285464, ECO:0000269|PubMed:20974918,
CC       ECO:0000269|PubMed:28229514, ECO:0000269|PubMed:9584199}.
CC   -!- SUBUNIT: Component of the PRC2/EED-EZH2 complex, which includes
CC       EED, EZH2, SUZ12, RBBP4 and RBBP7 and possibly AEBP2. The minimum
CC       components required for methyltransferase activity of the
CC       PRC2/EED-EZH2 complex are EED, EZH2 and SUZ12. Component of the
CC       PRC2/EED-EZH1 complex, which includes EED, EZH1, SUZ12, RBBP4 and
CC       AEBP2. The PRC2 complex may also interact with DNMT1, DNMT3A,
CC       DNMT3B and PHF1 via the EZH2 subunit and with SIRT1 via the SUZ12
CC       subunit. Interacts with HDAC, HDAC2, histone H1 and YY1. May
CC       interact with ITGA4, ITGAE and ITGB7. Interacts with CDYL.
CC       Interacts with ARNTL/BMAL1. Interacts with KMT2A/MLL1 (By
CC       similarity). {ECO:0000250|UniProtKB:Q921E6,
CC       ECO:0000269|PubMed:10581039, ECO:0000269|PubMed:11158321,
CC       ECO:0000269|PubMed:12351676, ECO:0000269|PubMed:12435631,
CC       ECO:0000269|PubMed:15385962, ECO:0000269|PubMed:16357870,
CC       ECO:0000269|PubMed:16431907, ECO:0000269|PubMed:18086877,
CC       ECO:0000269|PubMed:18285464, ECO:0000269|PubMed:19026781,
CC       ECO:0000269|PubMed:20974918, ECO:0000269|PubMed:22009739,
CC       ECO:0000269|PubMed:9584199, ECO:0000269|PubMed:9765275}.
CC   -!- SUBUNIT: (Microbial infection) May interact with the MA protein of
CC       HIV-1. {ECO:0000269|PubMed:9880543}.
CC   -!- INTERACTION:
CC       Self; NbExp=2; IntAct=EBI-923794, EBI-923794;
CC       Q8IXJ9:ASXL1; NbExp=5; IntAct=EBI-923794, EBI-1646500;
CC       P49368:CCT3; NbExp=2; IntAct=EBI-923794, EBI-356673;
CC       Q16531:DDB1; NbExp=4; IntAct=EBI-923794, EBI-350322;
CC       P26358:DNMT1; NbExp=3; IntAct=EBI-923794, EBI-719459;
CC       Q9Y6K1:DNMT3A; NbExp=2; IntAct=EBI-923794, EBI-923653;
CC       Q9UBC3:DNMT3B; NbExp=4; IntAct=EBI-923794, EBI-80125;
CC       Q15910:EZH2; NbExp=11; IntAct=EBI-923794, EBI-530054;
CC       Q92833-1:JARID2; NbExp=4; IntAct=EBI-923794, EBI-15825247;
CC       Q15156:PML-RAR; NbExp=2; IntAct=EBI-923794, EBI-867256;
CC       P63244:RACK1; NbExp=3; IntAct=EBI-923794, EBI-296739;
CC       Q9NY59:SMPD3; NbExp=2; IntAct=EBI-923794, EBI-715400;
CC       Q9JJY3:Smpd3 (xeno); NbExp=5; IntAct=EBI-923794, EBI-9817007;
CC       Q15022:SUZ12; NbExp=8; IntAct=EBI-923794, EBI-1264675;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Chromosome. Note=Transiently
CC       colocalizes with XIST at inactive X chromosomes.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing, Alternative initiation; Named isoforms=3;
CC         Comment=Additional isoforms may be produced by alternative
CC         initiation, both from non-canonical start codons upstream of the
CC         initiator methionine displayed and from other canonical start
CC         codons downstream of that displayed (PubMed:15099518 and
CC         PubMed:15684044). The precise sites of translation initiation
CC         have not been unambiguously identified.;
CC       Name=1;
CC         IsoId=O75530-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O75530-2; Sequence=VSP_034691;
CC       Name=3;
CC         IsoId=O75530-3; Sequence=VSP_034692;
CC   -!- TISSUE SPECIFICITY: Expressed in brain, colon, heart, kidney,
CC       liver, lung, muscle, ovary, peripheral blood leukocytes, pancreas,
CC       placenta, prostate, spleen, small intestine, testis, thymus and
CC       uterus. Appears to be overexpressed in breast and colon cancer.
CC       {ECO:0000269|PubMed:15684044, ECO:0000269|PubMed:9584199,
CC       ECO:0000269|PubMed:9765275, ECO:0000269|PubMed:9806832,
CC       ECO:0000269|PubMed:9880543}.
CC   -!- DEVELOPMENTAL STAGE: Expression peaks at the G1/S phase boundary.
CC       {ECO:0000269|PubMed:14532106}.
CC   -!- INDUCTION: Expression is induced by E2F1, E2F2 and E2F3.
CC       {ECO:0000269|PubMed:14532106}.
CC   -!- DOMAIN: The WD repeat domain mediates recognition of trimethylated
CC       histone peptides at the consensus sequence Ala-Arg-Lys-Ser. This
CC       is achieved through an aromatic cage encircling the methyllysine,
CC       and involving Phe-97, Tyr-148 and Tyr-365.
CC       {ECO:0000269|PubMed:20974918}.
CC   -!- PTM: Methylated. Binding to histone H1 'Lys-26' promotes mono-,
CC       di-, and trimethylation of internal lysines.
CC       {ECO:0000269|PubMed:20974918}.
CC   -!- DISEASE: Cohen-Gibson syndrome (COGIS) [MIM:617561]: An autosomal
CC       dominant overgrowth disorder characterized by accelerated osseous
CC       maturation, advanced bone age, skeletal abnormalities including
CC       flaring of the metaphyses of the long bones, large hands with long
CC       fingers and camptodactyly, scoliosis, cervical spine anomalies,
CC       dysmorphic facial features, and variable intellectual disability.
CC       {ECO:0000269|PubMed:25787343, ECO:0000269|PubMed:27193220,
CC       ECO:0000269|PubMed:27868325, ECO:0000269|PubMed:28229514,
CC       ECO:0000269|PubMed:28475857}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the WD repeat ESC family. {ECO:0000305}.
CC   -!- CAUTION: Two variants of the PRC2 complex have been described,
CC       termed PRC3 and PRC4. Each of the three complexes may include a
CC       different complement of EED isoforms, although the precise
CC       sequences of the isoforms in each complex have not been
CC       determined. The PRC2 and PRC4 complexes may also methylate 'Lys-
CC       26' of histone H1 in addition to 'Lys-27' of histone H3
CC       (PubMed:15099518 and PubMed:15684044), although other studies have
CC       demonstrated no methylation of 'Lys-26' of histone H1 by PRC2
CC       (PubMed:16431907). {ECO:0000305|PubMed:16431907}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC23685.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=AAC68675.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AF080227; AAC95144.1; -; mRNA.
DR   EMBL; AF070418; AAC23685.1; ALT_INIT; mRNA.
DR   EMBL; U90651; AAD08714.1; -; mRNA.
DR   EMBL; AF099032; AAD08815.1; -; mRNA.
DR   EMBL; AK292120; BAF84809.1; -; mRNA.
DR   EMBL; AP003084; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471076; EAW75129.1; -; Genomic_DNA.
DR   EMBL; CH471076; EAW75130.1; -; Genomic_DNA.
DR   EMBL; BC047672; AAH47672.1; -; mRNA.
DR   EMBL; BC068995; AAH68995.1; -; mRNA.
DR   EMBL; AF078933; AAC68675.1; ALT_INIT; mRNA.
DR   CCDS; CCDS76463.1; -. [O75530-2]
DR   CCDS; CCDS8273.1; -. [O75530-1]
DR   RefSeq; NP_001294936.1; NM_001308007.1. [O75530-2]
DR   RefSeq; NP_003788.2; NM_003797.4. [O75530-1]
DR   UniGene; Hs.503510; -.
DR   UniGene; Hs.528103; -.
DR   PDB; 3IIW; X-ray; 1.80 A; A=77-441.
DR   PDB; 3IIY; X-ray; 2.65 A; A=77-441.
DR   PDB; 3IJ0; X-ray; 2.45 A; A=77-441.
DR   PDB; 3IJ1; X-ray; 2.10 A; A=77-441.
DR   PDB; 3IJC; X-ray; 1.95 A; A=77-441.
DR   PDB; 3JPX; X-ray; 2.05 A; A=40-441.
DR   PDB; 3JZG; X-ray; 2.10 A; A=40-441.
DR   PDB; 3JZH; X-ray; 2.05 A; A=40-441.
DR   PDB; 3JZN; X-ray; 2.60 A; A=76-441.
DR   PDB; 3K26; X-ray; 1.58 A; A=76-441.
DR   PDB; 3K27; X-ray; 1.76 A; A=76-441.
DR   PDB; 4W2R; X-ray; 2.81 A; E/F=81-441.
DR   PDB; 4X3E; X-ray; 2.30 A; A=77-441.
DR   PDB; 5GSA; X-ray; 2.49 A; A/B=76-441.
DR   PDB; 5H13; X-ray; 1.90 A; A=76-441.
DR   PDB; 5H14; X-ray; 1.90 A; A/B=76-441.
DR   PDB; 5H15; X-ray; 2.27 A; A/B=76-441.
DR   PDB; 5H17; X-ray; 2.30 A; A=76-441.
DR   PDB; 5H19; X-ray; 1.90 A; A=76-441.
DR   PDB; 5H24; X-ray; 2.50 A; A/B=76-441.
DR   PDB; 5H25; X-ray; 2.88 A; A/B=76-441.
DR   PDB; 5HYN; X-ray; 2.95 A; B/G/L/R=77-441.
DR   PDB; 5IJ7; X-ray; 2.62 A; E/F=81-441.
DR   PDB; 5IJ8; X-ray; 2.99 A; E/F=81-441.
DR   PDB; 5K0M; X-ray; 1.83 A; A=77-441.
DR   PDB; 5LS6; X-ray; 3.47 A; B/E/H/K=77-441.
DR   PDB; 5TTW; X-ray; 1.74 A; A/C=76-441.
DR   PDB; 5U5H; X-ray; 1.80 A; A=76-441.
DR   PDB; 5U5K; X-ray; 2.33 A; A=76-441.
DR   PDB; 5U5T; X-ray; 1.60 A; A/B=76-441.
DR   PDB; 5U62; X-ray; 1.90 A; A/B=76-441.
DR   PDB; 5U69; X-ray; 1.28 A; A=77-441.
DR   PDB; 5U6D; X-ray; 1.64 A; A=77-441.
DR   PDB; 5U8A; X-ray; 1.45 A; A=77-441.
DR   PDB; 5U8F; X-ray; 1.34 A; A=77-441.
DR   PDB; 5WG6; X-ray; 3.90 A; B/D=2-441.
DR   PDB; 5WP3; X-ray; 2.55 A; A=75-441.
DR   PDB; 5WUK; X-ray; 2.03 A; A=76-441.
DR   PDB; 6B3W; X-ray; 3.05 A; E/F=81-441.
DR   PDB; 6C23; EM; 3.90 A; L=1-441.
DR   PDB; 6C24; EM; 3.50 A; L=1-441.
DR   PDBsum; 3IIW; -.
DR   PDBsum; 3IIY; -.
DR   PDBsum; 3IJ0; -.
DR   PDBsum; 3IJ1; -.
DR   PDBsum; 3IJC; -.
DR   PDBsum; 3JPX; -.
DR   PDBsum; 3JZG; -.
DR   PDBsum; 3JZH; -.
DR   PDBsum; 3JZN; -.
DR   PDBsum; 3K26; -.
DR   PDBsum; 3K27; -.
DR   PDBsum; 4W2R; -.
DR   PDBsum; 4X3E; -.
DR   PDBsum; 5GSA; -.
DR   PDBsum; 5H13; -.
DR   PDBsum; 5H14; -.
DR   PDBsum; 5H15; -.
DR   PDBsum; 5H17; -.
DR   PDBsum; 5H19; -.
DR   PDBsum; 5H24; -.
DR   PDBsum; 5H25; -.
DR   PDBsum; 5HYN; -.
DR   PDBsum; 5IJ7; -.
DR   PDBsum; 5IJ8; -.
DR   PDBsum; 5K0M; -.
DR   PDBsum; 5LS6; -.
DR   PDBsum; 5TTW; -.
DR   PDBsum; 5U5H; -.
DR   PDBsum; 5U5K; -.
DR   PDBsum; 5U5T; -.
DR   PDBsum; 5U62; -.
DR   PDBsum; 5U69; -.
DR   PDBsum; 5U6D; -.
DR   PDBsum; 5U8A; -.
DR   PDBsum; 5U8F; -.
DR   PDBsum; 5WG6; -.
DR   PDBsum; 5WP3; -.
DR   PDBsum; 5WUK; -.
DR   PDBsum; 6B3W; -.
DR   PDBsum; 6C23; -.
DR   PDBsum; 6C24; -.
DR   ProteinModelPortal; O75530; -.
DR   SMR; O75530; -.
DR   BioGrid; 114265; 492.
DR   CORUM; O75530; -.
DR   DIP; DIP-36673N; -.
DR   IntAct; O75530; 71.
DR   MINT; O75530; -.
DR   STRING; 9606.ENSP00000263360; -.
DR   BindingDB; O75530; -.
DR   ChEMBL; CHEMBL2189117; -.
DR   GuidetoPHARMACOLOGY; 2487; -.
DR   iPTMnet; O75530; -.
DR   PhosphoSitePlus; O75530; -.
DR   BioMuta; EED; -.
DR   EPD; O75530; -.
DR   jPOST; O75530; -.
DR   MaxQB; O75530; -.
DR   PaxDb; O75530; -.
DR   PeptideAtlas; O75530; -.
DR   PRIDE; O75530; -.
DR   ProteomicsDB; 50068; -.
DR   ProteomicsDB; 50069; -. [O75530-2]
DR   ProteomicsDB; 50070; -. [O75530-3]
DR   DNASU; 8726; -.
DR   Ensembl; ENST00000263360; ENSP00000263360; ENSG00000074266. [O75530-1]
DR   Ensembl; ENST00000327320; ENSP00000315587; ENSG00000074266. [O75530-3]
DR   Ensembl; ENST00000351625; ENSP00000338186; ENSG00000074266. [O75530-2]
DR   GeneID; 8726; -.
DR   KEGG; hsa:8726; -.
DR   UCSC; uc001pbp.4; human. [O75530-1]
DR   CTD; 8726; -.
DR   DisGeNET; 8726; -.
DR   EuPathDB; HostDB:ENSG00000074266.17; -.
DR   GeneCards; EED; -.
DR   HGNC; HGNC:3188; EED.
DR   HPA; CAB012211; -.
DR   HPA; HPA060089; -.
DR   HPA; HPA061140; -.
DR   MalaCards; EED; -.
DR   MIM; 605984; gene.
DR   MIM; 617561; phenotype.
DR   neXtProt; NX_O75530; -.
DR   OpenTargets; ENSG00000074266; -.
DR   Orphanet; 3447; Weaver syndrome.
DR   PharmGKB; PA27624; -.
DR   eggNOG; KOG1034; Eukaryota.
DR   eggNOG; ENOG410XRQI; LUCA.
DR   GeneTree; ENSGT00510000047334; -.
DR   HOVERGEN; HBG052708; -.
DR   InParanoid; O75530; -.
DR   KO; K11462; -.
DR   OMA; CTTLTHP; -.
DR   OrthoDB; 1339129at2759; -.
DR   PhylomeDB; O75530; -.
DR   TreeFam; TF314451; -.
DR   Reactome; R-HSA-212300; PRC2 methylates histones and DNA.
DR   Reactome; R-HSA-2559580; Oxidative Stress Induced Senescence.
DR   Reactome; R-HSA-3214841; PKMTs methylate histone lysines.
DR   Reactome; R-HSA-5617472; Activation of anterior HOX genes in hindbrain development during early embryogenesis.
DR   Reactome; R-HSA-8943724; Regulation of PTEN gene transcription.
DR   Reactome; R-HSA-8953750; Transcriptional Regulation by E2F6.
DR   SignaLink; O75530; -.
DR   SIGNOR; O75530; -.
DR   ChiTaRS; EED; human.
DR   EvolutionaryTrace; O75530; -.
DR   GeneWiki; EED; -.
DR   GenomeRNAi; 8726; -.
DR   PRO; PR:O75530; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000074266; Expressed in 107 organ(s), highest expression level in endocervix.
DR   ExpressionAtlas; O75530; baseline and differential.
DR   Genevisible; O75530; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0035098; C:ESC/E(Z) complex; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; NAS:UniProtKB.
DR   GO; GO:0045120; C:pronucleus; IEA:Ensembl.
DR   GO; GO:0001739; C:sex chromatin; IEA:Ensembl.
DR   GO; GO:0003682; F:chromatin binding; IEA:Ensembl.
DR   GO; GO:0042054; F:histone methyltransferase activity; IDA:MGI.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0000978; F:RNA polymerase II proximal promoter sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:1990830; P:cellular response to leukemia inhibitory factor; IEA:Ensembl.
DR   GO; GO:0006342; P:chromatin silencing; IBA:GO_Central.
DR   GO; GO:0070734; P:histone H3-K27 methylation; IEA:GOC.
DR   GO; GO:0070317; P:negative regulation of G0 to G1 transition; TAS:Reactome.
DR   GO; GO:0045814; P:negative regulation of gene expression, epigenetic; TAS:Reactome.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; NAS:UniProtKB.
DR   GO; GO:0061087; P:positive regulation of histone H3-K27 methylation; IEA:Ensembl.
DR   GO; GO:2000011; P:regulation of adaxial/abaxial pattern formation; IEA:Ensembl.
DR   GO; GO:0006349; P:regulation of gene expression by genetic imprinting; IEA:Ensembl.
DR   GO; GO:0021510; P:spinal cord development; IEA:Ensembl.
DR   Gene3D; 2.130.10.10; -; 1.
DR   InterPro; IPR037352; Polycomb_EED.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom_sf.
DR   InterPro; IPR001680; WD40_repeat.
DR   InterPro; IPR019775; WD40_repeat_CS.
DR   InterPro; IPR017986; WD40_repeat_dom.
DR   InterPro; IPR036322; WD40_repeat_dom_sf.
DR   PANTHER; PTHR10253; PTHR10253; 1.
DR   Pfam; PF00400; WD40; 2.
DR   SMART; SM00320; WD40; 6.
DR   SUPFAM; SSF50978; SSF50978; 1.
DR   PROSITE; PS00678; WD_REPEATS_1; 1.
DR   PROSITE; PS50082; WD_REPEATS_2; 2.
DR   PROSITE; PS50294; WD_REPEATS_REGION; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative initiation;
KW   Alternative splicing; Chromatin regulator; Chromosome;
KW   Complete proteome; Disease mutation; Methylation; Nucleus;
KW   Phosphoprotein; Reference proteome; Repeat; Repressor; Transcription;
KW   Transcription regulation; WD repeat.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330}.
FT   CHAIN         2    441       Polycomb protein EED.
FT                                /FTId=PRO_0000343725.
FT   REPEAT       91    134       WD 1.
FT   REPEAT      142    185       WD 2.
FT   REPEAT      188    228       WD 3.
FT   REPEAT      234    275       WD 4.
FT   REPEAT      304    341       WD 5.
FT   REPEAT      359    399       WD 6.
FT   REPEAT      408    441       WD 7.
FT   REGION       81    441       Interaction with EZH2. {ECO:0000250}.
FT   REGION      149    303       Required for interaction with the matrix
FT                                protein MA of HIV-1.
FT   REGION      301    441       Required for interaction with the matrix
FT                                protein MA of HIV-1.
FT   MOD_RES       2      2       N-acetylserine.
FT                                {ECO:0000244|PubMed:19413330}.
FT   MOD_RES       2      2       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      34     34       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q921E6}.
FT   MOD_RES      55     55       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES      66     66       N6,N6,N6-trimethyllysine; alternate.
FT                                {ECO:0000269|PubMed:20974918}.
FT   MOD_RES      66     66       N6,N6-dimethyllysine; alternate.
FT                                {ECO:0000269|PubMed:20974918}.
FT   MOD_RES      66     66       N6-methyllysine; alternate.
FT                                {ECO:0000269|PubMed:20974918}.
FT   MOD_RES     197    197       N6,N6,N6-trimethyllysine; alternate.
FT                                {ECO:0000269|PubMed:20974918}.
FT   MOD_RES     197    197       N6,N6-dimethyllysine; alternate.
FT                                {ECO:0000269|PubMed:20974918}.
FT   MOD_RES     197    197       N6-methyllysine; alternate.
FT                                {ECO:0000269|PubMed:20974918}.
FT   MOD_RES     268    268       N6,N6,N6-trimethyllysine; alternate.
FT                                {ECO:0000269|PubMed:20974918}.
FT   MOD_RES     268    268       N6,N6-dimethyllysine; alternate.
FT                                {ECO:0000269|PubMed:20974918}.
FT   MOD_RES     268    268       N6-methyllysine; alternate.
FT                                {ECO:0000269|PubMed:20974918}.
FT   MOD_RES     284    284       N6,N6,N6-trimethyllysine; alternate.
FT                                {ECO:0000269|PubMed:20974918}.
FT   MOD_RES     284    284       N6,N6-dimethyllysine; alternate.
FT                                {ECO:0000269|PubMed:20974918}.
FT   MOD_RES     284    284       N6-methyllysine; alternate.
FT                                {ECO:0000269|PubMed:20974918}.
FT   VAR_SEQ     322    322       K -> KSGRAILHSHQQCMRDPVSPNLRQHL (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_034691.
FT   VAR_SEQ     401    441       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:9880543}.
FT                                /FTId=VSP_034692.
FT   VARIANT     194    194       N -> S (in COGIS).
FT                                {ECO:0000269|PubMed:28475857}.
FT                                /FTId=VAR_079255.
FT   VARIANT     236    236       R -> G (in COGIS).
FT                                {ECO:0000269|PubMed:28475857}.
FT                                /FTId=VAR_079256.
FT   VARIANT     236    236       R -> T (in COGIS; decreased
FT                                trimethylation of 'Lys-27' of histone H3;
FT                                no effect on interaction with EZH2;
FT                                dbSNP:rs1131692176).
FT                                {ECO:0000269|PubMed:28229514}.
FT                                /FTId=VAR_078316.
FT   VARIANT     258    258       H -> Y (in COGIS; dbSNP:rs1131692174).
FT                                {ECO:0000269|PubMed:27193220}.
FT                                /FTId=VAR_079257.
FT   VARIANT     302    302       R -> G (in COGIS; dbSNP:rs1131692175).
FT                                {ECO:0000269|PubMed:27868325}.
FT                                /FTId=VAR_079258.
FT   VARIANT     302    302       R -> S (in COGIS; decreased
FT                                trimethylation of 'Lys-27' of histone H3;
FT                                dbSNP:rs1131692173).
FT                                {ECO:0000269|PubMed:25787343,
FT                                ECO:0000269|PubMed:28229514}.
FT                                /FTId=VAR_078317.
FT   MUTAGEN      97     97       F->A: Abolishes binding to H3K27me3.
FT                                {ECO:0000269|PubMed:20974918}.
FT   MUTAGEN     148    148       Y->A: Abolishes binding to H3K27me3.
FT                                {ECO:0000269|PubMed:20974918}.
FT   MUTAGEN     193    193       I->N: Impairs interaction with EZH2.
FT                                {ECO:0000269|PubMed:9584199}.
FT   MUTAGEN     196    196       L->P: Impairs interaction with EZH2.
FT                                {ECO:0000269|PubMed:9584199}.
FT   MUTAGEN     300    301       ST->AA: Impairs interaction with the
FT                                matrix protein MA of HIV-1.
FT                                {ECO:0000269|PubMed:9880543}.
FT   MUTAGEN     305    308       HRNY->AAAA: Impairs interaction with the
FT                                matrix protein MA of HIV-1.
FT                                {ECO:0000269|PubMed:9880543}.
FT   MUTAGEN     364    364       W->A: Abolishes binding to H3K27me3.
FT                                {ECO:0000269|PubMed:20974918}.
FT   MUTAGEN     364    364       W->L: Abolishes binding to H3K27me3.
FT                                {ECO:0000269|PubMed:20974918}.
FT   MUTAGEN     365    365       Y->A: Abolishes binding to H3K27me3.
FT                                {ECO:0000269|PubMed:20974918}.
FT   CONFLICT     32     32       D -> E (in Ref. 8; AAC68675).
FT                                {ECO:0000305}.
FT   CONFLICT     74     74       K -> S (in Ref. 3; AAD08714/AAD08815).
FT                                {ECO:0000305}.
FT   CONFLICT    337    337       E -> K (in Ref. 3; AAD08714/AAD08815).
FT                                {ECO:0000305}.
FT   CONFLICT    417    417       S -> G (in Ref. 4; BAF84809).
FT                                {ECO:0000305}.
FT   STRAND       83     89       {ECO:0000244|PDB:5U69}.
FT   STRAND       96    101       {ECO:0000244|PDB:5U69}.
FT   STRAND      103    105       {ECO:0000244|PDB:5H17}.
FT   STRAND      107    109       {ECO:0000244|PDB:5U5K}.
FT   STRAND      111    117       {ECO:0000244|PDB:5U69}.
FT   STRAND      120    126       {ECO:0000244|PDB:5U69}.
FT   HELIX       128    130       {ECO:0000244|PDB:3K26}.
FT   STRAND      132    139       {ECO:0000244|PDB:5U69}.
FT   STRAND      147    154       {ECO:0000244|PDB:5U69}.
FT   TURN        156    158       {ECO:0000244|PDB:5U69}.
FT   STRAND      161    167       {ECO:0000244|PDB:5U69}.
FT   TURN        168    170       {ECO:0000244|PDB:6C24}.
FT   STRAND      171    175       {ECO:0000244|PDB:5U69}.
FT   TURN        177    179       {ECO:0000244|PDB:5U69}.
FT   STRAND      182    190       {ECO:0000244|PDB:5U69}.
FT   STRAND      193    198       {ECO:0000244|PDB:5U69}.
FT   STRAND      200    202       {ECO:0000244|PDB:6C24}.
FT   STRAND      205    210       {ECO:0000244|PDB:5U69}.
FT   STRAND      211    213       {ECO:0000244|PDB:6C24}.
FT   STRAND      215    219       {ECO:0000244|PDB:5U69}.
FT   TURN        220    223       {ECO:0000244|PDB:5U69}.
FT   STRAND      224    229       {ECO:0000244|PDB:5U69}.
FT   STRAND      231    234       {ECO:0000244|PDB:3JZN}.
FT   STRAND      239    244       {ECO:0000244|PDB:5U69}.
FT   STRAND      248    255       {ECO:0000244|PDB:5U69}.
FT   STRAND      260    265       {ECO:0000244|PDB:5U69}.
FT   HELIX       268    279       {ECO:0000244|PDB:5U69}.
FT   HELIX       282    284       {ECO:0000244|PDB:5U69}.
FT   STRAND      292    294       {ECO:0000244|PDB:5U69}.
FT   STRAND      298    301       {ECO:0000244|PDB:5U69}.
FT   STRAND      311    315       {ECO:0000244|PDB:5U69}.
FT   STRAND      318    322       {ECO:0000244|PDB:5U69}.
FT   STRAND      324    335       {ECO:0000244|PDB:5U69}.
FT   HELIX       340    342       {ECO:0000244|PDB:5U69}.
FT   STRAND      350    357       {ECO:0000244|PDB:5U69}.
FT   STRAND      363    365       {ECO:0000244|PDB:5GSA}.
FT   STRAND      368    370       {ECO:0000244|PDB:5U69}.
FT   STRAND      372    374       {ECO:0000244|PDB:4W2R}.
FT   STRAND      376    380       {ECO:0000244|PDB:5U69}.
FT   STRAND      382    384       {ECO:0000244|PDB:4W2R}.
FT   STRAND      386    390       {ECO:0000244|PDB:5U69}.
FT   STRAND      393    395       {ECO:0000244|PDB:5U69}.
FT   HELIX       396    398       {ECO:0000244|PDB:5U69}.
FT   STRAND      400    404       {ECO:0000244|PDB:5U69}.
FT   STRAND      413    418       {ECO:0000244|PDB:5U69}.
FT   STRAND      422    429       {ECO:0000244|PDB:5U69}.
FT   STRAND      432    438       {ECO:0000244|PDB:5U69}.
SQ   SEQUENCE   441 AA;  50198 MW;  D2E0A5BA27C0499A CRC64;
     MSEREVSTAP AGTDMPAAKK QKLSSDENSN PDLSGDENDD AVSIESGTNT ERPDTPTNTP
     NAPGRKSWGK GKWKSKKCKY SFKCVNSLKE DHNQPLFGVQ FNWHSKEGDP LVFATVGSNR
     VTLYECHSQG EIRLLQSYVD ADADENFYTC AWTYDSNTSH PLLAVAGSRG IIRIINPITM
     QCIKHYVGHG NAINELKFHP RDPNLLLSVS KDHALRLWNI QTDTLVAIFG GVEGHRDEVL
     SADYDLLGEK IMSCGMDHSL KLWRINSKRM MNAIKESYDY NPNKTNRPFI SQKIHFPDFS
     TRDIHRNYVD CVRWLGDLIL SKSCENAIVC WKPGKMEDDI DKIKPSESNV TILGRFDYSQ
     CDIWYMRFSM DFWQKMLALG NQVGKLYVWD LEVEDPHKAK CTTLTHHKCG AAIRQTSFSR
     DSSILIAVCD DASIWRWDRL R
//
ID   A0A024R974_HUMAN        Unreviewed;       371 AA.
AC   A0A024R974;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   16-JAN-2019, entry version 40.
DE   SubName: Full=E74-like factor 3 (Ets domain transcription factor, epithelial-specific ), isoform CRA_b {ECO:0000313|EMBL:EAW91391.1};
GN   Name=ELF3 {ECO:0000313|EMBL:EAW91391.1};
GN   ORFNames=hCG_96709 {ECO:0000313|EMBL:EAW91391.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW91391.1};
RN   [1] {ECO:0000313|EMBL:EAW91391.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW91391.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000256|RuleBase:RU004019,
CC       ECO:0000256|SAAS:SAAS00594387}.
CC   -!- SIMILARITY: Belongs to the ETS family.
CC       {ECO:0000256|RuleBase:RU004019, ECO:0000256|SAAS:SAAS00594391}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471067; EAW91390.1; -; Genomic_DNA.
DR   EMBL; CH471067; EAW91391.1; -; Genomic_DNA.
DR   RefSeq; NP_001107781.1; NM_001114309.1.
DR   RefSeq; NP_004424.3; NM_004433.4.
DR   UniGene; Hs.603657; -.
DR   GeneID; 1999; -.
DR   KEGG; hsa:1999; -.
DR   CTD; 1999; -.
DR   EuPathDB; HostDB:ENSG00000163435.15; -.
DR   eggNOG; KOG3804; Eukaryota.
DR   eggNOG; ENOG4111K4J; LUCA.
DR   KO; K09429; -.
DR   OMA; NCAPEEL; -.
DR   OrthoDB; 837296at2759; -.
DR   ChiTaRS; ELF3; human.
DR   GenomeRNAi; 1999; -.
DR   Bgee; ENSG00000163435; Expressed in 133 organ(s), highest expression level in ectocervix.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; IEA:Ensembl.
DR   GO; GO:0000978; F:RNA polymerase II proximal promoter sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0001824; P:blastocyst development; IEA:Ensembl.
DR   GO; GO:0030855; P:epithelial cell differentiation; IEA:InterPro.
DR   GO; GO:0030198; P:extracellular matrix organization; IEA:Ensembl.
DR   GO; GO:0006954; P:inflammatory response; IEA:InterPro.
DR   GO; GO:0060056; P:mammary gland involution; IEA:Ensembl.
DR   GO; GO:0006366; P:transcription by RNA polymerase II; IEA:InterPro.
DR   Gene3D; 1.10.10.10; -; 1.
DR   InterPro; IPR033074; Elf3.
DR   InterPro; IPR000418; Ets_dom.
DR   InterPro; IPR003118; Pointed_dom.
DR   InterPro; IPR013761; SAM/pointed_sf.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   PANTHER; PTHR11849:SF13; PTHR11849:SF13; 1.
DR   Pfam; PF00178; Ets; 1.
DR   Pfam; PF02198; SAM_PNT; 1.
DR   PRINTS; PR00454; ETSDOMAIN.
DR   SMART; SM00413; ETS; 1.
DR   SMART; SM00251; SAM_PNT; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
DR   SUPFAM; SSF47769; SSF47769; 1.
DR   PROSITE; PS50061; ETS_DOMAIN_3; 1.
DR   PROSITE; PS51433; PNT; 1.
PE   3: Inferred from homology;
KW   DNA-binding {ECO:0000256|RuleBase:RU004019,
KW   ECO:0000256|SAAS:SAAS00594397};
KW   Nucleus {ECO:0000256|RuleBase:RU004019,
KW   ECO:0000256|SAAS:SAAS00594400}.
FT   DOMAIN       46    132       PNT. {ECO:0000259|PROSITE:PS51433}.
FT   DOMAIN      273    355       ETS. {ECO:0000259|PROSITE:PS50061}.
SQ   SEQUENCE   371 AA;  41454 MW;  81A23A7DECBE2EF9 CRC64;
     MAATCEISNI FSNYFSAMYS SEDSTLASVP PAATFGADDL VLTLSNPQMS LEGTEKASWL
     GEQPQFWSKT QVLDWISYQV EKNKYDASAI DFSRCDMDGA TLCNCALEEL RLVFGPLGDQ
     LHAQLRDLTS SSSDELSWII ELLEKDGMAF QEALDPGPFD QGSPFAQELL DDGQQASPYH
     PGSCGAGAPS PGSSDVSTAG TGASRSSHSS DSGGSDVDLD PTDGKLFPSD GFRDCKKGDP
     KHGKRKRGRP RKLSKEYWDC LEGKKSKHAP RGTHLWEFIR DILIHPELNE GLMKWENRHE
     GVFKFLRSEA VAQLWGQKKK NSNMTYEKLS RAMRYYYKRE ILERVDGRRL VYKFGKNSSG
     WKEEEVLQSR N
//
ID   ELF3_HUMAN              Reviewed;         371 AA.
AC   P78545; B2R5Q6; Q6IAP8; Q7RU03; Q7Z3X2; Q8NFG2; Q99718;
DT   15-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1997, sequence version 1.
DT   13-FEB-2019, entry version 175.
DE   RecName: Full=ETS-related transcription factor Elf-3;
DE   AltName: Full=E74-like factor 3;
DE   AltName: Full=Epithelial-restricted with serine box;
DE   AltName: Full=Epithelium-restricted Ets protein ESX;
DE   AltName: Full=Epithelium-specific Ets transcription factor 1;
DE            Short=ESE-1;
GN   Name=ELF3 {ECO:0000312|HGNC:HGNC:3318};
GN   Synonyms=ERT {ECO:0000312|EMBL:AAB67238.1},
GN   ESX {ECO:0000312|EMBL:AAB58075.1}, JEN;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:AAB65823.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), FUNCTION, ALTERNATIVE
RP   SPLICING, AND TISSUE SPECIFICITY.
RX   PubMed=9234700; DOI=10.1128/MCB.17.8.4419;
RA   Oettgen P., Alani R.M., Barcinski M.A., Brown L., Akbarali Y.,
RA   Boltax J., Kunsch C., Munger K., Libermann T.A.;
RT   "Isolation and characterization of a novel epithelium-specific
RT   transcription factor, ESE-1, a member of the ets family.";
RL   Mol. Cell. Biol. 17:4419-4433(1997).
RN   [2] {ECO:0000305, ECO:0000312|EMBL:AAC51884.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=9336459; DOI=10.1093/nar/25.21.4287;
RA   Andreoli J.M., Jang S.-I., Chung E., Coticchia C.M., Steinert P.M.,
RA   Markova N.G.;
RT   "The expression of a novel, epithelium-specific ets transcription
RT   factor is restricted to the most differentiated layers in the
RT   epidermis.";
RL   Nucleic Acids Res. 25:4287-4295(1997).
RN   [3] {ECO:0000305, ECO:0000312|EMBL:AAB58075.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Placenta {ECO:0000312|EMBL:AAB58075.1};
RX   PubMed=9129154; DOI=10.1038/sj.onc.1200978;
RA   Chang C.-H., Scott G.K., Kuo W.-L., Xiong X., Suzdaltseva Y.,
RA   Park J.W., Sayre P., Erny K., Collins C., Gray J.W., Benz C.C.;
RT   "ESX: a structurally unique Ets overexpressed early during human
RT   breast tumorigenesis.";
RL   Oncogene 14:1617-1622(1997).
RN   [4] {ECO:0000305, ECO:0000312|EMBL:AAB96586.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Fetal lung {ECO:0000312|EMBL:AAB96586.1};
RX   PubMed=9395241; DOI=10.1038/sj.onc.1201427;
RA   Tymms M.J., Ng A.Y.N., Thomas R.S., Schutte B.C., Zhou J., Eyre H.J.,
RA   Sutherland G.R., Seth A., Rosenberg M., Papas T., Debouck C., Kola I.;
RT   "A novel epithelial-expressed ETS gene, ELF3: human and murine cDNA
RT   sequences, murine genomic organization, human mapping to 1q32.2 and
RT   expression in tissues and cancer.";
RL   Oncogene 15:2449-2462(1997).
RN   [5] {ECO:0000305, ECO:0000312|EMBL:AAB67238.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND FUNCTION.
RC   TISSUE=Placenta {ECO:0000312|EMBL:AAB67238.1};
RX   PubMed=9417054; DOI=10.1074/jbc.273.1.110;
RA   Choi S.-G., Yi Y., Kim Y.-S., Kato M., Chang J., Chung H.-W.,
RA   Hahm K.-B., Yang H.-K., Rhee H.H., Bang Y.-J., Kim S.-J.;
RT   "A novel ets-related transcription factor, ERT/ESX/ESE-1, regulates
RT   expression of the transforming growth factor-beta type II receptor.";
RL   J. Biol. Chem. 273:110-117(1998).
RN   [6] {ECO:0000305, ECO:0000312|EMBL:AAD45237.1}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1), FUNCTION, INTERACTION
RP   WITH TBP, AND SUBCELLULAR LOCATION.
RX   PubMed=10391676; DOI=10.1038/sj.onc.1202674;
RA   Chang C.-H., Scott G.K., Baldwin M.A., Benz C.C.;
RT   "Exon 4-encoded acidic domain in the epithelium-restricted Ets factor,
RT   ESX, confers potent transactivating capacity and binds to TATA-binding
RT   protein (TBP).";
RL   Oncogene 18:3682-3695(1999).
RN   [7] {ECO:0000305, ECO:0000312|EMBL:CAD29859.1}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RX   PubMed=12119107; DOI=10.1016/S0378-1119(02)00650-9;
RA   Piesse C., Tymms M., Garrafa E., Gouzy C., Lacasa M., Cadel S.,
RA   Cohen P., Foulon T.;
RT   "Human aminopeptidase B (rnpep) on chromosome 1q32.2: complementary
RT   DNA, genomic structure and expression.";
RL   Gene 292:129-140(2002).
RN   [8] {ECO:0000305, ECO:0000312|EMBL:AAM70481.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND ALTERNATIVE SPLICING.
RC   TISSUE=Mammary cancer {ECO:0000269|PubMed:14997048};
RX   PubMed=14997048; DOI=10.1023/B:BREA.0000010710.51614.2d;
RA   Kaplan M.H., Wang X.P., Xu H.P., Dosik M.H.;
RT   "Partially unspliced and fully spliced ELF3 mRNA, including a new Alu
RT   element in human breast cancer.";
RL   Breast Cancer Res. Treat. 83:171-187(2004).
RN   [9] {ECO:0000305, ECO:0000312|EMBL:CAD97611.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Urinary bladder;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Retina;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [12] {ECO:0000312|EMBL:AL691482}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [13] {ECO:0000305, ECO:0000312|EMBL:CAD97611.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [14] {ECO:0000305, ECO:0000312|EMBL:AAH03569.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung {ECO:0000312|EMBL:AAH03569.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [15] {ECO:0000305}
RP   FUNCTION.
RX   PubMed=10644990; DOI=10.1038/sj.onc.1203252;
RA   Chang J., Lee C., Hahm K.-B., Yi Y., Choi S.-G., Kim S.-J.;
RT   "Over-expression of ERT(ESX/ESE-1/ELF3), an ets-related transcription
RT   factor, induces endogenous TGF-beta type II receptor expression and
RT   restores the TGF-beta signaling pathway in Hs578t human breast cancer
RT   cells.";
RL   Oncogene 19:151-154(2000).
RN   [16] {ECO:0000305}
RP   FUNCTION, AND MUTAGENESIS OF 247-ARG--PRO-250; TRP-315; LYS-319 AND
RP   334-ARG--TYR-337.
RX   PubMed=10773884; DOI=10.1038/sj.onc.1203441;
RA   Brembeck F.H., Opitz O.G., Libermann T.A., Rustgi A.K.;
RT   "Dual function of the epithelial specific ets transcription factor,
RT   ELF3, in modulating differentiation.";
RL   Oncogene 19:1941-1949(2000).
RN   [17] {ECO:0000305}
RP   FUNCTION.
RX   PubMed=11036073; DOI=10.1074/jbc.M006507200;
RA   Rudders S., Gaspar J., Madore R., Voland C., Grall F., Patel A.,
RA   Pellacani A., Perrella M.A., Libermann T.A., Oettgen P.;
RT   "ESE-1 is a novel transcriptional mediator of inflammation that
RT   interacts with NF-kappa B to regulate the inducible nitric-oxide
RT   synthase gene.";
RL   J. Biol. Chem. 276:3302-3309(2001).
RN   [18] {ECO:0000305}
RP   FUNCTION.
RX   PubMed=11313868; DOI=10.1038/sj.onc.1204227;
RA   Park S.H., Kim Y.S., Park B.-K., Hougaard S., Kim S.-J.;
RT   "Sequence-specific enhancer binding protein is responsible for the
RT   differential expression of ERT/ESX/ELF-3/ESE-1/jen gene in human
RT   gastric cancer cell lines: implication for the loss of TGF-beta type
RT   II receptor expression.";
RL   Oncogene 20:1235-1245(2001).
RN   [19] {ECO:0000305}
RP   INDUCTION.
RX   PubMed=12032832; DOI=10.1038/sj.onc.1205503;
RA   Neve R.M., Ylstra B., Chang C.-H., Albertson D.G., Benz C.C.;
RT   "ErbB2 activation of ESX gene expression.";
RL   Oncogene 21:3934-3938(2002).
RN   [20] {ECO:0000305}
RP   FUNCTION.
RX   PubMed=12713734; DOI=10.1089/104454903321515896;
RA   Eckel K.L., Tentler J.J., Cappetta G.J., Diamond S.E.,
RA   Gutierrez-Hartmann A.;
RT   "The epithelial-specific ETS transcription factor ESX/ESE-1/Elf-3
RT   modulates breast cancer-associated gene expression.";
RL   DNA Cell Biol. 22:79-94(2003).
RN   [21] {ECO:0000305}
RP   FUNCTION.
RX   PubMed=12414801; DOI=10.1074/jbc.M208241200;
RA   Kwon J.H., Keates S., Simeonidis S., Grall F., Libermann T.A.,
RA   Keates A.C.;
RT   "ESE-1, an enterocyte-specific Ets transcription factor, regulates
RT   MIP-3alpha gene expression in Caco-2 human colonic epithelial cells.";
RL   J. Biol. Chem. 278:875-884(2003).
RN   [22] {ECO:0000305}
RP   FUNCTION, AND SUBUNIT.
RX   PubMed=12624109; DOI=10.1074/jbc.M300508200;
RA   Cabral A., Fischer D.F., Vermeij W.P., Backendorf C.;
RT   "Distinct functional interactions of human Skn-1 isoforms with Ese-1
RT   during keratinocyte terminal differentiation.";
RL   J. Biol. Chem. 278:17792-17799(2003).
RN   [23] {ECO:0000305}
RP   FUNCTION, AND INDUCTION.
RX   PubMed=12682075; DOI=10.1074/jbc.M212258200;
RA   Reddy S.P.M., Vuong H., Adiseshaiah P.;
RT   "Interplay between proximal and distal promoter elements is required
RT   for squamous differentiation marker induction in the bronchial
RT   epithelium: role for ESE-1, Sp1, and AP-1 proteins.";
RL   J. Biol. Chem. 278:21378-21387(2003).
RN   [24] {ECO:0000305}
RP   FUNCTION.
RX   PubMed=14715662; DOI=10.1074/jbc.M308593200;
RA   Brown C., Gaspar J., Pettit A., Lee R., Gu X., Wang H., Manning C.,
RA   Voland C., Goldring S.R., Goldring M.B., Libermann T.A.,
RA   Gravallese E.M., Oettgen P.;
RT   "ESE-1 is a novel transcriptional mediator of angiopoietin-1
RT   expression in the setting of inflammation.";
RL   J. Biol. Chem. 279:12794-12803(2004).
RN   [25] {ECO:0000305}
RP   FUNCTION, AND INTERACTION WITH CREBBP; EP300; XRCC5 AND XRCC6.
RX   PubMed=15075319; DOI=10.1074/jbc.M401356200;
RA   Wang H., Fang R., Cho J.-Y., Libermann T.A., Oettgen P.;
RT   "Positive and negative modulation of the transcriptional activity of
RT   the ETS factor ESE-1 through interaction with p300, CREB-binding
RT   protein, and Ku 70/86.";
RL   J. Biol. Chem. 279:25241-25250(2004).
RN   [26] {ECO:0000305}
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=15169914; DOI=10.1128/MCB.24.12.5548-5564.2004;
RA   Prescott J.D., Koto K.S.N., Singh M., Gutierrez-Hartmann A.;
RT   "The ETS transcription factor ESE-1 transforms MCF-12A human mammary
RT   epithelial cells via a novel cytoplasmic mechanism.";
RL   Mol. Cell. Biol. 24:5548-5564(2004).
RN   [27] {ECO:0000305}
RP   FUNCTION.
RX   PubMed=14767472; DOI=10.1038/sj.onc.1207391;
RA   Schedin P.J., Eckel-Mahan K.L., McDaniel S.M., Prescott J.D.,
RA   Brodsky K.S., Tentler J.J., Gutierrez-Hartmann A.;
RT   "ESX induces transformation and functional epithelial to mesenchymal
RT   transition in MCF-12A mammary epithelial cells.";
RL   Oncogene 23:1766-1779(2004).
RN   [28] {ECO:0000305}
RP   FUNCTION.
RX   PubMed=15794755; DOI=10.1111/j.1742-4658.2005.04592.x;
RA   Grall F.T., Prall W.C., Wei W., Gu X., Cho J.-Y., Choy B.K.,
RA   Zerbini L.F., Inan M.S., Goldring S.R., Gravallese E.M.,
RA   Goldring M.B., Oettgen P., Libermann T.A.;
RT   "The Ets transcription factor ESE-1 mediates induction of the COX-2
RT   gene by LPS in monocytes.";
RL   FEBS J. 272:1676-1687(2005).
RN   [29] {ECO:0000305}
RP   FUNCTION, AND INDUCTION.
RX   PubMed=16307850; DOI=10.1016/j.gene.2005.10.001;
RA   Neve R.M., Parmar H., Amend C., Chen C., Rizzino A., Benz C.C.;
RT   "Identification of an epithelial-specific enhancer regulating ESX
RT   expression.";
RL   Gene 367:118-125(2006).
RN   [30] {ECO:0000305}
RP   FUNCTION, SUBUNIT, AND SUBCELLULAR LOCATION.
RX   PubMed=17060315; DOI=10.1074/jbc.M608389200;
RA   Kohno Y., Okamoto T., Ishibe T., Nagayama S., Shima Y., Nishijo K.,
RA   Shibata K.R., Fukiage K., Otsuka S., Uejima D., Araki N., Naka N.,
RA   Nakashima Y., Aoyama T., Nakayama T., Nakamura T., Toguchida J.;
RT   "Expression of claudin7 is tightly associated with epithelial
RT   structures in synovial sarcomas and regulated by an Ets family
RT   transcription factor, ELF3.";
RL   J. Biol. Chem. 281:38941-38950(2006).
RN   [31]
RP   DOMAIN.
RX   PubMed=17467953; DOI=10.1016/j.ygeno.2007.02.003;
RA   Piskacek S., Gregor M., Nemethova M., Grabner M., Kovarik P.,
RA   Piskacek M.;
RT   "Nine-amino-acid transactivation domain: establishment and prediction
RT   utilities.";
RL   Genomics 89:756-768(2007).
RN   [32]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [33] {ECO:0000305, ECO:0000312|EMBL:CAD97611.1}
RP   STRUCTURE BY NMR OF 45-132.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the N-terminal SAM-domain of E74-like factor
RT   3.";
RL   Submitted (JUL-2007) to the PDB data bank.
CC   -!- FUNCTION: Transcriptional activator that binds and transactivates
CC       ETS sequences containing the consensus nucleotide core sequence
CC       GGA[AT]. Acts synergistically with POU2F3 to transactivate the
CC       SPRR2A promoter and with RUNX1 to transactivate the ANGPT1
CC       promoter. Also transactivates collagenase, CCL20, CLND7, FLG,
CC       KRT8, NOS2, PTGS2, SPRR2B, TGFBR2 and TGM3 promoters. Represses
CC       KRT4 promoter activity. Involved in mediating vascular
CC       inflammation. May play an important role in epithelial cell
CC       differentiation and tumorigenesis. May be a critical downstream
CC       effector of the ERBB2 signaling pathway. May be associated with
CC       mammary gland development and involution. Plays an important role
CC       in the regulation of transcription with TATA-less promoters in
CC       preimplantation embryos, which is essential in preimplantation
CC       development (By similarity). {ECO:0000250,
CC       ECO:0000269|PubMed:10391676, ECO:0000269|PubMed:10644990,
CC       ECO:0000269|PubMed:10773884, ECO:0000269|PubMed:11036073,
CC       ECO:0000269|PubMed:11313868, ECO:0000269|PubMed:12414801,
CC       ECO:0000269|PubMed:12624109, ECO:0000269|PubMed:12682075,
CC       ECO:0000269|PubMed:12713734, ECO:0000269|PubMed:14715662,
CC       ECO:0000269|PubMed:14767472, ECO:0000269|PubMed:15075319,
CC       ECO:0000269|PubMed:15169914, ECO:0000269|PubMed:15794755,
CC       ECO:0000269|PubMed:16307850, ECO:0000269|PubMed:17060315,
CC       ECO:0000269|PubMed:9129154, ECO:0000269|PubMed:9234700,
CC       ECO:0000269|PubMed:9336459, ECO:0000269|PubMed:9395241,
CC       ECO:0000269|PubMed:9417054}.
CC   -!- SUBUNIT: Interacts with TBP. Interacts with CREBBP and EP300;
CC       these act as transcriptional coactivators of ELF3 and positively
CC       modulate its function. Interacts with XRCC5/KU86 and XRCC6/KU70;
CC       these inhibit the ability of ELF3 to bind DNA and negatively
CC       modulate its transcriptional activity. Associated with CLND7 and
CC       POU2F3. {ECO:0000269|PubMed:10391676, ECO:0000269|PubMed:12624109,
CC       ECO:0000269|PubMed:15075319, ECO:0000269|PubMed:17060315}.
CC   -!- INTERACTION:
CC       P41743:PRKCI; NbExp=2; IntAct=EBI-1057285, EBI-286199;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10391676,
CC       ECO:0000269|PubMed:15169914, ECO:0000269|PubMed:17060315}. Nucleus
CC       {ECO:0000255|PROSITE-ProRule:PRU00237,
CC       ECO:0000269|PubMed:10391676, ECO:0000269|PubMed:15169914,
CC       ECO:0000269|PubMed:17060315}. Note=Localizes to the cytoplasm
CC       where it has been shown to transform MCF-12A mammary epithelial
CC       cells via a novel cytoplasmic mechanism. Also transiently
CC       expressed and localized to the nucleus where it induces apoptosis
CC       in non-transformed breast epithelial cells MCF-10A and MCF-12A via
CC       a transcription-dependent mechanism. {ECO:0000269|PubMed:10391676,
CC       ECO:0000269|PubMed:15169914, ECO:0000269|PubMed:17060315}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC         Comment=Additional isoforms may exist.
CC         {ECO:0000269|PubMed:9234700};
CC       Name=1 {ECO:0000269|PubMed:9234700}; Synonyms=ESE-1b
CC       {ECO:0000269|PubMed:9234700};
CC         IsoId=P78545-1; Sequence=Displayed;
CC       Name=2 {ECO:0000269|PubMed:9234700}; Synonyms=ESE-1a
CC       {ECO:0000269|PubMed:9234700};
CC         IsoId=P78545-2; Sequence=VSP_052433;
CC   -!- TISSUE SPECIFICITY: Expressed exclusively in tissues containing a
CC       high content of terminally differentiated epithelial cells
CC       including mammary gland, colon, trachea, kidney, prostate, uterus,
CC       stomach and skin. {ECO:0000269|PubMed:9129154,
CC       ECO:0000269|PubMed:9234700, ECO:0000269|PubMed:9336459,
CC       ECO:0000269|PubMed:9395241}.
CC   -!- INDUCTION: Transcriptionally regulated by ERBB2 receptor signaling
CC       in breast cancer epithelial cells. Up-regulated by phorbol 12-
CC       myristate 13-acetate (PMA) in bronchial epithelial cells. By
CC       retinoic acid in MCF-7 mammary epithelial cells (at protein
CC       level). {ECO:0000269|PubMed:12032832, ECO:0000269|PubMed:12682075,
CC       ECO:0000269|PubMed:16307850}.
CC   -!- DOMAIN: the 9aaTAD motif is a transactivation domain present in a
CC       large number of yeast and animal transcription factors.
CC       {ECO:0000269|PubMed:17467953}.
CC   -!- SIMILARITY: Belongs to the ETS family. {ECO:0000255}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; U73843; AAB65823.1; -; mRNA.
DR   EMBL; U73844; AAB65824.1; -; mRNA.
DR   EMBL; U97156; AAC51884.1; -; mRNA.
DR   EMBL; U66894; AAB58075.1; -; mRNA.
DR   EMBL; AF016295; AAB96586.1; -; mRNA.
DR   EMBL; AF017307; AAB67238.1; -; mRNA.
DR   EMBL; AF110184; AAD45237.1; -; Genomic_DNA.
DR   EMBL; BN000001; CAD29859.1; -; Genomic_DNA.
DR   EMBL; AF517841; AAM70481.1; -; mRNA.
DR   EMBL; CR457106; CAG33387.1; -; mRNA.
DR   EMBL; AK312273; BAG35203.1; -; mRNA.
DR   EMBL; BX537368; CAD97611.1; -; mRNA.
DR   EMBL; AL691482; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471067; EAW91389.1; -; Genomic_DNA.
DR   EMBL; BC003569; AAH03569.1; -; mRNA.
DR   CCDS; CCDS1419.1; -. [P78545-1]
DR   RefSeq; NP_001107781.1; NM_001114309.1. [P78545-1]
DR   RefSeq; NP_004424.3; NM_004433.4. [P78545-1]
DR   UniGene; Hs.603657; -.
DR   PDB; 2E8P; NMR; -; A=48-132.
DR   PDBsum; 2E8P; -.
DR   ProteinModelPortal; P78545; -.
DR   SMR; P78545; -.
DR   BioGrid; 108314; 31.
DR   IntAct; P78545; 5.
DR   STRING; 9606.ENSP00000352673; -.
DR   iPTMnet; P78545; -.
DR   PhosphoSitePlus; P78545; -.
DR   BioMuta; ELF3; -.
DR   DMDM; 74739735; -.
DR   EPD; P78545; -.
DR   jPOST; P78545; -.
DR   MaxQB; P78545; -.
DR   PaxDb; P78545; -.
DR   PeptideAtlas; P78545; -.
DR   PRIDE; P78545; -.
DR   ProteomicsDB; 57646; -.
DR   ProteomicsDB; 57647; -. [P78545-2]
DR   DNASU; 1999; -.
DR   Ensembl; ENST00000359651; ENSP00000352673; ENSG00000163435. [P78545-1]
DR   Ensembl; ENST00000367283; ENSP00000356252; ENSG00000163435. [P78545-1]
DR   Ensembl; ENST00000367284; ENSP00000356253; ENSG00000163435. [P78545-1]
DR   GeneID; 1999; -.
DR   KEGG; hsa:1999; -.
DR   UCSC; uc001gxg.5; human. [P78545-1]
DR   CTD; 1999; -.
DR   DisGeNET; 1999; -.
DR   EuPathDB; HostDB:ENSG00000163435.15; -.
DR   GeneCards; ELF3; -.
DR   HGNC; HGNC:3318; ELF3.
DR   HPA; HPA003316; -.
DR   HPA; HPA003479; -.
DR   MIM; 602191; gene.
DR   neXtProt; NX_P78545; -.
DR   OpenTargets; ENSG00000163435; -.
DR   PharmGKB; PA27746; -.
DR   eggNOG; KOG3804; Eukaryota.
DR   eggNOG; ENOG4111K4J; LUCA.
DR   GeneTree; ENSGT00940000158955; -.
DR   HOVERGEN; HBG074143; -.
DR   InParanoid; P78545; -.
DR   KO; K09429; -.
DR   OMA; NCAPEEL; -.
DR   OrthoDB; 837296at2759; -.
DR   PhylomeDB; P78545; -.
DR   TreeFam; TF318679; -.
DR   Reactome; R-HSA-1912408; Pre-NOTCH Transcription and Translation.
DR   SIGNOR; P78545; -.
DR   ChiTaRS; ELF3; human.
DR   EvolutionaryTrace; P78545; -.
DR   GenomeRNAi; 1999; -.
DR   PRO; PR:P78545; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000163435; Expressed in 133 organ(s), highest expression level in ectocervix.
DR   ExpressionAtlas; P78545; baseline and differential.
DR   Genevisible; P78545; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; IEA:Ensembl.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; TAS:ProtInc.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISA:NTNU_SB.
DR   GO; GO:0000978; F:RNA polymerase II proximal promoter sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0003713; F:transcription coactivator activity; IDA:UniProtKB.
DR   GO; GO:0001824; P:blastocyst development; IEA:Ensembl.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0008544; P:epidermis development; NAS:UniProtKB.
DR   GO; GO:0030855; P:epithelial cell differentiation; IEP:UniProtKB.
DR   GO; GO:0030198; P:extracellular matrix organization; IEA:Ensembl.
DR   GO; GO:0006954; P:inflammatory response; IEP:UniProtKB.
DR   GO; GO:0060056; P:mammary gland involution; ISS:UniProtKB.
DR   GO; GO:0007275; P:multicellular organism development; TAS:ProtInc.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0045747; P:positive regulation of Notch signaling pathway; TAS:Reactome.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0006366; P:transcription by RNA polymerase II; TAS:ProtInc.
DR   Gene3D; 1.10.10.10; -; 1.
DR   InterPro; IPR033074; Elf3.
DR   InterPro; IPR000418; Ets_dom.
DR   InterPro; IPR003118; Pointed_dom.
DR   InterPro; IPR013761; SAM/pointed_sf.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   PANTHER; PTHR11849:SF13; PTHR11849:SF13; 1.
DR   Pfam; PF00178; Ets; 1.
DR   Pfam; PF02198; SAM_PNT; 1.
DR   PRINTS; PR00454; ETSDOMAIN.
DR   SMART; SM00413; ETS; 1.
DR   SMART; SM00251; SAM_PNT; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
DR   SUPFAM; SSF47769; SSF47769; 1.
DR   PROSITE; PS50061; ETS_DOMAIN_3; 1.
DR   PROSITE; PS51433; PNT; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; Alternative splicing; Complete proteome;
KW   Cytoplasm; Developmental protein; Differentiation; DNA-binding;
KW   Inflammatory response; Nucleus; Polymorphism; Reference proteome;
KW   Repressor; Transcription; Transcription regulation.
FT   CHAIN         1    371       ETS-related transcription factor Elf-3.
FT                                /FTId=PRO_0000287681.
FT   DOMAIN       46    132       PNT. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00762}.
FT   DNA_BIND    273    355       ETS. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00237}.
FT   MOTIF       137    145       9aaTAD.
FT   VAR_SEQ     173    195       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:9234700}.
FT                                /FTId=VSP_052433.
FT   VARIANT     317    317       Q -> K (in dbSNP:rs1135542).
FT                                /FTId=VAR_048945.
FT   MUTAGEN     247    250       RGRP->AAAA: No effect on transcriptional
FT                                repression on KRT4 promoter.
FT                                {ECO:0000269|PubMed:10773884}.
FT   MUTAGEN     315    315       W->A: Partially abrogates repressive
FT                                effect on the KRT4 promoter; when
FT                                associated with A-319.
FT                                {ECO:0000269|PubMed:10773884}.
FT   MUTAGEN     319    319       K->A: Partially abrogates repressive
FT                                effect on the KRT4 promoter; when
FT                                associated with A-315.
FT                                {ECO:0000269|PubMed:10773884}.
FT   MUTAGEN     334    337       RYYY->AAAA: Partially abrogates
FT                                repressive effect on the KRT4 promoter.
FT                                {ECO:0000269|PubMed:10773884}.
FT   CONFLICT      3      3       A -> T (in Ref. 8; AAM70481).
FT                                {ECO:0000305}.
FT   CONFLICT     55     56       EK -> GE (in Ref. 7; CAD29859).
FT                                {ECO:0000305}.
FT   CONFLICT     68     68       S -> L (in Ref. 8; AAM70481).
FT                                {ECO:0000305}.
FT   CONFLICT    129    130       TS -> SA (in Ref. 7; CAD29859).
FT                                {ECO:0000305}.
FT   CONFLICT    134    134       D -> Y (in Ref. 8; AAM70481).
FT                                {ECO:0000305}.
FT   CONFLICT    160    161       DQ -> GE (in Ref. 7; CAD29859).
FT                                {ECO:0000305}.
FT   CONFLICT    201    201       T -> A (in Ref. 7; CAD29859).
FT                                {ECO:0000305}.
FT   CONFLICT    242    242       H -> L (in Ref. 9; CAG33387).
FT                                {ECO:0000305}.
FT   CONFLICT    244    244       K -> E (in Ref. 11; CAD97611).
FT                                {ECO:0000305}.
FT   CONFLICT    257    257       Y -> C (in Ref. 8; AAM70481).
FT                                {ECO:0000305}.
FT   CONFLICT    269    269       A -> G (in Ref. 7; CAD29859).
FT                                {ECO:0000305}.
FT   STRAND       60     62       {ECO:0000244|PDB:2E8P}.
FT   HELIX        64     66       {ECO:0000244|PDB:2E8P}.
FT   HELIX        69     82       {ECO:0000244|PDB:2E8P}.
FT   TURN         92     94       {ECO:0000244|PDB:2E8P}.
FT   HELIX       100    104       {ECO:0000244|PDB:2E8P}.
FT   HELIX       107    113       {ECO:0000244|PDB:2E8P}.
FT   HELIX       115    117       {ECO:0000244|PDB:2E8P}.
FT   HELIX       118    130       {ECO:0000244|PDB:2E8P}.
SQ   SEQUENCE   371 AA;  41454 MW;  81A23A7DECBE2EF9 CRC64;
     MAATCEISNI FSNYFSAMYS SEDSTLASVP PAATFGADDL VLTLSNPQMS LEGTEKASWL
     GEQPQFWSKT QVLDWISYQV EKNKYDASAI DFSRCDMDGA TLCNCALEEL RLVFGPLGDQ
     LHAQLRDLTS SSSDELSWII ELLEKDGMAF QEALDPGPFD QGSPFAQELL DDGQQASPYH
     PGSCGAGAPS PGSSDVSTAG TGASRSSHSS DSGGSDVDLD PTDGKLFPSD GFRDCKKGDP
     KHGKRKRGRP RKLSKEYWDC LEGKKSKHAP RGTHLWEFIR DILIHPELNE GLMKWENRHE
     GVFKFLRSEA VAQLWGQKKK NSNMTYEKLS RAMRYYYKRE ILERVDGRRL VYKFGKNSSG
     WKEEEVLQSR N
//
ID   FBLN2_HUMAN             Reviewed;        1184 AA.
AC   P98095; B7Z9C5; Q8IUI0; Q8IUI1;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   03-MAR-2009, sequence version 2.
DT   13-FEB-2019, entry version 177.
DE   RecName: Full=Fibulin-2;
DE            Short=FIBL-2;
DE   Flags: Precursor;
GN   Name=FBLN2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT ALA-854.
RC   TISSUE=Fibroblast;
RX   PubMed=7806230; DOI=10.1006/geno.1994.1404;
RA   Zhang R.-Z., Pan T.-C., Zhang Z.-Y., Mattei M.-G., Timpl R.,
RA   Chu M.-L.;
RT   "Fibulin-2 (FBLN2): human cDNA sequence, mRNA expression, and mapping
RT   of the gene on human and mouse chromosomes.";
RL   Genomics 22:425-430(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 2), AND ALTERNATIVE
RP   SPLICING.
RA   Li D., Marian A.J., Roberts R.;
RT   "Identification of a novel alternatively spliced isoform of human
RT   fibulin-2 gene abundantly expressed in heart and genetic evaluation in
RT   patients with ARVD.";
RL   Submitted (JUL-2002) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Uterus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [5]
RP   DEVELOPMENTAL STAGE.
RX   PubMed=8737292; DOI=10.1007/BF02331415;
RA   Miosge N., Gotz W., Sasaki T., Chu M.-L., Timpl R., Herken R.;
RT   "The extracellular matrix proteins fibulin-1 and fibulin-2 in the
RT   early human embryo.";
RL   Histochem. J. 28:109-116(1996).
RN   [6]
RP   FUNCTION, AND INTERACTION WITH FBN1 AND ELN.
RX   PubMed=17255108; DOI=10.1074/jbc.M608204200;
RA   El-Hallous E., Sasaki T., Hubmacher D., Getie M., Tiedemann K.,
RA   Brinckmann J., Baetge B., Davis E.C., Reinhardt D.P.;
RT   "Fibrillin-1 interactions with fibulins depend on the first hybrid
RT   domain and provide an adaptor function to tropoelastin.";
RL   J. Biol. Chem. 282:8935-8946(2007).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-277, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by
RT   enrichment and fractionation of phosphopeptides with strong anion
RT   exchange chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [8]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-1035.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [9]
RP   GLYCOSYLATION, STRUCTURE OF CARBOHYDRATES, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=22171320; DOI=10.1074/mcp.M111.013649;
RA   Halim A., Nilsson J., Ruetschi U., Hesse C., Larson G.;
RT   "Human urinary glycoproteomics; attachment site specific analysis of
RT   N-and O-linked glycosylations by CID and ECD.";
RL   Mol. Cell. Proteomics 11:1-17(2012).
CC   -!- FUNCTION: Its binding to fibronectin and some other ligands is
CC       calcium dependent. May act as an adapter that mediates the
CC       interaction between FBN1 and ELN (PubMed:17255108).
CC       {ECO:0000269|PubMed:17255108}.
CC   -!- SUBUNIT: Homotrimer; disulfide-linked. Interacts with LAMA2 (By
CC       similarity). Interacts with FBN1 (via N-terminal domain). Forms a
CC       ternary complex with ELN and FBN1 (PubMed:17255108).
CC       {ECO:0000250|UniProtKB:P37889, ECO:0000269|PubMed:17255108}.
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
CC       matrix.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P98095-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P98095-2; Sequence=VSP_041404;
CC   -!- TISSUE SPECIFICITY: Component of both basement membranes and other
CC       connective tissues. Expressed in heart, placenta and ovary.
CC   -!- DEVELOPMENTAL STAGE: Widely expressed during embryonic
CC       development. Primarily detected within the neuropithelium, spinal
CC       ganglia and peripheral nerves. {ECO:0000269|PubMed:8737292}.
CC   -!- PTM: O-glycosylated with core 1 or possibly core 8 glycans. It is
CC       unsure if the O-glycosylation is on Thr-347 or Ser-348.
CC       {ECO:0000269|PubMed:19159218, ECO:0000269|PubMed:22171320}.
CC   -!- SIMILARITY: Belongs to the fibulin family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; X82494; CAA57876.1; -; mRNA.
DR   EMBL; AY130458; AAN05435.1; -; Genomic_DNA.
DR   EMBL; AY130456; AAN05435.1; JOINED; Genomic_DNA.
DR   EMBL; AY130457; AAN05435.1; JOINED; Genomic_DNA.
DR   EMBL; AY130459; AAN05436.1; -; mRNA.
DR   EMBL; AK304827; BAH14261.1; -; mRNA.
DR   EMBL; AC090509; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS46761.1; -. [P98095-2]
DR   CCDS; CCDS46762.1; -. [P98095-1]
DR   PIR; A55184; A55184.
DR   RefSeq; NP_001004019.1; NM_001004019.1. [P98095-2]
DR   RefSeq; NP_001158507.1; NM_001165035.1. [P98095-2]
DR   RefSeq; NP_001989.2; NM_001998.2. [P98095-1]
DR   UniGene; Hs.198862; -.
DR   ProteinModelPortal; P98095; -.
DR   SMR; P98095; -.
DR   BioGrid; 108493; 37.
DR   CORUM; P98095; -.
DR   IntAct; P98095; 13.
DR   STRING; 9606.ENSP00000384169; -.
DR   GlyConnect; 751; -.
DR   iPTMnet; P98095; -.
DR   PhosphoSitePlus; P98095; -.
DR   UniCarbKB; P98095; -.
DR   BioMuta; FBLN2; -.
DR   DMDM; 224471827; -.
DR   jPOST; P98095; -.
DR   MaxQB; P98095; -.
DR   PaxDb; P98095; -.
DR   PeptideAtlas; P98095; -.
DR   PRIDE; P98095; -.
DR   ProteomicsDB; 57790; -.
DR   ProteomicsDB; 57791; -. [P98095-2]
DR   Ensembl; ENST00000295760; ENSP00000295760; ENSG00000163520. [P98095-1]
DR   Ensembl; ENST00000404922; ENSP00000384169; ENSG00000163520. [P98095-2]
DR   Ensembl; ENST00000492059; ENSP00000420042; ENSG00000163520. [P98095-2]
DR   GeneID; 2199; -.
DR   KEGG; hsa:2199; -.
DR   UCSC; uc011ava.3; human. [P98095-1]
DR   CTD; 2199; -.
DR   DisGeNET; 2199; -.
DR   EuPathDB; HostDB:ENSG00000163520.13; -.
DR   GeneCards; FBLN2; -.
DR   H-InvDB; HIX0003076; -.
DR   HGNC; HGNC:3601; FBLN2.
DR   HPA; CAB018622; -.
DR   HPA; HPA001934; -.
DR   MIM; 135821; gene.
DR   neXtProt; NX_P98095; -.
DR   OpenTargets; ENSG00000163520; -.
DR   PharmGKB; PA28014; -.
DR   eggNOG; ENOG410IR7F; Eukaryota.
DR   eggNOG; ENOG410Y194; LUCA.
DR   GeneTree; ENSGT00940000156047; -.
DR   HOGENOM; HOG000007079; -.
DR   HOVERGEN; HBG051559; -.
DR   InParanoid; P98095; -.
DR   KO; K17307; -.
DR   OMA; CKVCHCP; -.
DR   OrthoDB; 1174178at2759; -.
DR   PhylomeDB; P98095; -.
DR   TreeFam; TF317514; -.
DR   Reactome; R-HSA-2129379; Molecules associated with elastic fibres.
DR   ChiTaRS; FBLN2; human.
DR   GeneWiki; FBLN2; -.
DR   GenomeRNAi; 2199; -.
DR   PRO; PR:P98095; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000163520; Expressed in 190 organ(s), highest expression level in right atrium auricular region.
DR   ExpressionAtlas; P98095; baseline and differential.
DR   Genevisible; P98095; HS.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; HDA:UniProtKB.
DR   GO; GO:0031012; C:extracellular matrix; TAS:ProtInc.
DR   GO; GO:0005576; C:extracellular region; HDA:BHF-UCL.
DR   GO; GO:1903561; C:extracellular vesicle; HDA:UniProtKB.
DR   GO; GO:0005509; F:calcium ion binding; TAS:ProtInc.
DR   GO; GO:0050840; F:extracellular matrix binding; IBA:GO_Central.
DR   GO; GO:0030023; F:extracellular matrix constituent conferring elasticity; HDA:BHF-UCL.
DR   GO; GO:0005201; F:extracellular matrix structural constituent; HDA:BHF-UCL.
DR   GO; GO:0030198; P:extracellular matrix organization; IEA:InterPro.
DR   GO; GO:0010811; P:positive regulation of cell-substrate adhesion; IBA:GO_Central.
DR   CDD; cd00017; ANATO; 2.
DR   InterPro; IPR000020; Anaphylatoxin/fibulin.
DR   InterPro; IPR026823; cEGF.
DR   InterPro; IPR001881; EGF-like_Ca-bd_dom.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR000152; EGF-type_Asp/Asn_hydroxyl_site.
DR   InterPro; IPR018097; EGF_Ca-bd_CS.
DR   InterPro; IPR037286; Fibulin-2.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   PANTHER; PTHR44887; PTHR44887; 2.
DR   Pfam; PF01821; ANATO; 1.
DR   Pfam; PF12662; cEGF; 2.
DR   Pfam; PF07645; EGF_CA; 5.
DR   SMART; SM00104; ANATO; 3.
DR   SMART; SM00181; EGF; 11.
DR   SMART; SM00179; EGF_CA; 9.
DR   SUPFAM; SSF57184; SSF57184; 4.
DR   PROSITE; PS01177; ANAPHYLATOXIN_1; 3.
DR   PROSITE; PS01178; ANAPHYLATOXIN_2; 3.
DR   PROSITE; PS00010; ASX_HYDROXYL; 5.
DR   PROSITE; PS01186; EGF_2; 5.
DR   PROSITE; PS50026; EGF_3; 4.
DR   PROSITE; PS01187; EGF_CA; 9.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Complete proteome; Disulfide bond;
KW   EGF-like domain; Extracellular matrix; Glycoprotein; Phosphoprotein;
KW   Polymorphism; Reference proteome; Repeat; Secreted; Signal.
FT   SIGNAL        1     27       {ECO:0000255}.
FT   CHAIN        28   1184       Fibulin-2.
FT                                /FTId=PRO_0000007568.
FT   DOMAIN      445    480       Anaphylatoxin-like 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00022}.
FT   DOMAIN      488    519       Anaphylatoxin-like 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00022}.
FT   DOMAIN      521    553       Anaphylatoxin-like 3.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00022}.
FT   DOMAIN      604    645       EGF-like 1; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      679    718       EGF-like 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      719    763       EGF-like 3; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      764    809       EGF-like 4; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      810    857       EGF-like 5; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      858    900       EGF-like 6; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      901    942       EGF-like 7; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      943    981       EGF-like 8; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      982   1024       EGF-like 9; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN     1025   1069       EGF-like 10; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   REGION       28    444       N.
FT   REGION       28    177       Subdomain NA (Cys-rich).
FT   REGION      178    444       Subdomain NB (Cys-free).
FT   REGION     1070   1184       Domain III.
FT   MOD_RES     277    277       Phosphoserine.
FT                                {ECO:0000244|PubMed:18318008}.
FT   CARBOHYD    180    180       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    507    507       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1035   1035       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   DISULFID    445    472       {ECO:0000250}.
FT   DISULFID    446    479       {ECO:0000250}.
FT   DISULFID    459    480       {ECO:0000250}.
FT   DISULFID    489    518       {ECO:0000250}.
FT   DISULFID    502    519       {ECO:0000250}.
FT   DISULFID    521    545       {ECO:0000250}.
FT   DISULFID    522    552       {ECO:0000250}.
FT   DISULFID    535    553       {ECO:0000250}.
FT   DISULFID    608    620       {ECO:0000250}.
FT   DISULFID    616    629       {ECO:0000250}.
FT   DISULFID    631    644       {ECO:0000250}.
FT   DISULFID    683    693       {ECO:0000250}.
FT   DISULFID    689    702       {ECO:0000250}.
FT   DISULFID    704    717       {ECO:0000250}.
FT   DISULFID    723    736       {ECO:0000250}.
FT   DISULFID    730    745       {ECO:0000250}.
FT   DISULFID    751    762       {ECO:0000250}.
FT   DISULFID    768    781       {ECO:0000250}.
FT   DISULFID    775    790       {ECO:0000250}.
FT   DISULFID    796    808       {ECO:0000250}.
FT   DISULFID    814    827       {ECO:0000250}.
FT   DISULFID    821    836       {ECO:0000250}.
FT   DISULFID    843    856       {ECO:0000250}.
FT   DISULFID    862    875       {ECO:0000250}.
FT   DISULFID    869    884       {ECO:0000250}.
FT   DISULFID    886    899       {ECO:0000250}.
FT   DISULFID    905    917       {ECO:0000250}.
FT   DISULFID    913    926       {ECO:0000250}.
FT   DISULFID    928    941       {ECO:0000250}.
FT   DISULFID    947    956       {ECO:0000250}.
FT   DISULFID    952    965       {ECO:0000250}.
FT   DISULFID    967    980       {ECO:0000250}.
FT   DISULFID    986    998       {ECO:0000250}.
FT   DISULFID    994   1007       {ECO:0000250}.
FT   DISULFID   1009   1023       {ECO:0000250}.
FT   DISULFID   1029   1042       {ECO:0000250}.
FT   DISULFID   1036   1051       {ECO:0000250}.
FT   DISULFID   1056   1068       {ECO:0000250}.
FT   VAR_SEQ     718    718       E -> EDQDECLMGAHDCSRRQFCVNTLGSFYCVNHTVLCA
FT                                DGYILNAHRKCV (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|Ref.2}.
FT                                /FTId=VSP_041404.
FT   VARIANT      45     45       I -> V (in dbSNP:rs60850813).
FT                                /FTId=VAR_061159.
FT   VARIANT     144    144       H -> R (in dbSNP:rs28587534).
FT                                /FTId=VAR_061160.
FT   VARIANT     361    361       S -> G (in dbSNP:rs3732666).
FT                                /FTId=VAR_059266.
FT   VARIANT     387    387       N -> T (in dbSNP:rs3796318).
FT                                /FTId=VAR_059267.
FT   VARIANT     854    854       T -> A (in dbSNP:rs9843344).
FT                                {ECO:0000269|PubMed:7806230}.
FT                                /FTId=VAR_059268.
FT   VARIANT    1114   1114       G -> R (in dbSNP:rs1061375).
FT                                /FTId=VAR_055722.
FT   CONFLICT    145    145       K -> E (in Ref. 1; CAA57876 and 2;
FT                                AAN05436). {ECO:0000305}.
FT   CONFLICT    664    664       E -> G (in Ref. 3; BAH14261).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1184 AA;  126573 MW;  D46890D93518B343 CRC64;
     MVLLWEPAGA WLALGLALAL GPSVAAAAPR QDCTGVECPP LENCIEEALE PGACCATCVQ
     QGCACEGYQY YDCLQGGFVR GRVPAGQSYF VDFGSTECSC PPGGGKISCQ FMLCPELPPN
     CIEAVVVADS CPQCGQVGCV HAGHKYAAGH TVHLPPCRAC HCPDAGGELI CYQLPGCHGN
     FSDAEEGDPE RHYEDPYSYD QEVAEVEAAT ALGGEVQAGA VQAGAGGPPA ALGGGSQPLS
     TIQAPPWPAV LPRPTAAAAL GPPAPVQAKA RRVTEDSEEE EEEEEEREEM AVTEQLAAGG
     HRGLDGLPTT APAGPSLPIQ EERAEAGARA EAGARPEENL ILDAQATSRS TGPEGVTHAP
     SLGKAALVPT QAVPGSPRDP VKPSPHNILS TSLPDAAWIP PTREVPRKPQ VLPHSHVEED
     TDPNSVHSIP RSSPEGSTKD LIETCCAAGQ QWAIDNDECL EIPESGTEDN VCRTAQRHCC
     VSYLQEKSCM AGVLGAKEGE TCGAEDNDSC GISLYKQCCD CCGLGLRVRA EGQSCESNPN
     LGYPCNHVML SCCEGEEPLI VPEVRRPPEP AAAPRRVSEA EMAGREALSL GTEAELPNSL
     PGDDQDECLL LPGELCQHLC INTVGSYHCA CFPGFSLQDD GRTCRPEGHP PQPEAPQEPA
     LKSEFSQVAS NTIPLPLPQP NTCKDNGPCK QVCSTVGGSA ICSCFPGYAI MADGVSCEDI
     NECVTDLHTC SRGEHCVNTL GSFHCYKALT CEPGYALKDG ECEDVDECAM GTHTCQPGFL
     CQNTKGSFYC QARQRCMDGF LQDPEGNCVD INECTSLSEP CRPGFSCINT VGSYTCQRNP
     LICARGYHAS DDGTKCVDVN ECETGVHRCG EGQVCHNLPG SYRCDCKAGF QRDAFGRGCI
     DVNECWASPG RLCQHTCENT LGSYRCSCAS GFLLAADGKR CEDVNECEAQ RCSQECANIY
     GSYQCYCRQG YQLAEDGHTC TDIDECAQGA GILCTFRCLN VPGSYQCACP EQGYTMTANG
     RSCKDVDECA LGTHNCSEAE TCHNIQGSFR CLRFECPPNY VQVSKTKCER TTCHDFLECQ
     NSPARITHYQ LNFQTGLLVP AHIFRIGPAP AFTGDTIALN IIKGNEEGYF GTRRLNAYTG
     VVYLQRAVLE PRDFALDVEM KLWRQGSVTT FLAKMHIFFT TFAL
//
ID   Q86V58_HUMAN            Unreviewed;      1184 AA.
AC   Q86V58;
DT   01-JUN-2003, integrated into UniProtKB/TrEMBL.
DT   01-JUN-2003, sequence version 1.
DT   16-JAN-2019, entry version 132.
DE   SubName: Full=Fibulin 2 {ECO:0000313|EMBL:AAH51690.1};
GN   Name=FBLN2 {ECO:0000313|EMBL:AAH51690.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH51690.1};
RN   [1] {ECO:0000313|EMBL:AAH51690.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis {ECO:0000313|EMBL:AAH51690.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M.,
RA   Peck A.M., Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S.,
RA   Feolo M., Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F.,
RA   Schaefer C.F., Buetow K., Bonner T.I., Haussler D., Kent J.,
RA   Kiekhaus M., Furey T., Brent M., Prange C., Schreiber K., Shapiro N.,
RA   Bhat N.K., Hopkins R.F., Hsie F., Driscoll T., Soares M.B.,
RA   Casavant T.L., Scheetz T.E., Brown-stein M.J., Usdin T.B.,
RA   Toshiyuki S., Carninci P., Piao Y., Dudekula D.B., Ko M.S.,
RA   Kawakami K., Suzuki Y., Sugano S., Gruber C.E., Smith M.R.,
RA   Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y., Wei C.L.,
RA   Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W., Fuh E.,
RA   Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D.,
RA   Granite S.J., Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G.,
RA   Blakesly R.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J.,
RA   Schmutz J., Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L.,
RA   Krzywinski M.I., Liao N., Morin R., Morrin R., Palmquist D.,
RA   Petrescu A.S., Skalska U., Smailus D.E., Stott J.M., Schnerch A.,
RA   Schein J.E., Jones S.J., Holt R.A., Baross A., Marra M.A., Clifton S.,
RA   Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation
CC       of feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00076}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; BC051690; AAH51690.1; -; mRNA.
DR   RefSeq; NP_001004019.1; NM_001004019.1.
DR   RefSeq; NP_001158507.1; NM_001165035.1.
DR   RefSeq; NP_001989.2; NM_001998.2.
DR   UniGene; Hs.198862; -.
DR   ProteinModelPortal; Q86V58; -.
DR   IntAct; Q86V58; 1.
DR   PeptideAtlas; Q86V58; -.
DR   PRIDE; Q86V58; -.
DR   GeneID; 2199; -.
DR   KEGG; hsa:2199; -.
DR   CTD; 2199; -.
DR   PharmGKB; PA28014; -.
DR   eggNOG; ENOG410IR7F; Eukaryota.
DR   eggNOG; ENOG410Y194; LUCA.
DR   HOVERGEN; HBG051559; -.
DR   KO; K17307; -.
DR   OrthoDB; 1174178at2759; -.
DR   ChiTaRS; FBLN2; human.
DR   GenomeRNAi; 2199; -.
DR   Genevisible; Q86V58; HS.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; IEA:InterPro.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0030198; P:extracellular matrix organization; IEA:InterPro.
DR   CDD; cd00017; ANATO; 2.
DR   InterPro; IPR000020; Anaphylatoxin/fibulin.
DR   InterPro; IPR026823; cEGF.
DR   InterPro; IPR001881; EGF-like_Ca-bd_dom.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR000152; EGF-type_Asp/Asn_hydroxyl_site.
DR   InterPro; IPR018097; EGF_Ca-bd_CS.
DR   InterPro; IPR037286; Fibulin-2.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   PANTHER; PTHR44887; PTHR44887; 2.
DR   Pfam; PF01821; ANATO; 1.
DR   Pfam; PF12662; cEGF; 2.
DR   Pfam; PF07645; EGF_CA; 5.
DR   SMART; SM00104; ANATO; 3.
DR   SMART; SM00181; EGF; 11.
DR   SMART; SM00179; EGF_CA; 9.
DR   SUPFAM; SSF57184; SSF57184; 4.
DR   PROSITE; PS01177; ANAPHYLATOXIN_1; 1.
DR   PROSITE; PS01178; ANAPHYLATOXIN_2; 3.
DR   PROSITE; PS00010; ASX_HYDROXYL; 4.
DR   PROSITE; PS01186; EGF_2; 3.
DR   PROSITE; PS50026; EGF_3; 4.
DR   PROSITE; PS01187; EGF_CA; 3.
PE   2: Evidence at transcript level;
KW   Calcium {ECO:0000256|SAAS:SAAS00909960};
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Disulfide bond {ECO:0000256|SAAS:SAAS00601599};
KW   EGF-like domain {ECO:0000256|PROSITE-ProRule:PRU00076,
KW   ECO:0000256|SAAS:SAAS00032677};
KW   Repeat {ECO:0000256|SAAS:SAAS00594563};
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     27       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        28   1184       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5004300515.
FT   DOMAIN      445    480       Anaphylatoxin-like.
FT                                {ECO:0000259|PROSITE:PS01178}.
FT   DOMAIN      488    519       Anaphylatoxin-like.
FT                                {ECO:0000259|PROSITE:PS01178}.
FT   DOMAIN      521    553       Anaphylatoxin-like.
FT                                {ECO:0000259|PROSITE:PS01178}.
FT   DOMAIN      604    645       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   DOMAIN      858    896       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   DOMAIN      901    942       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   DOMAIN      943    981       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   COILED      270    290       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   1184 AA;  126509 MW;  4240CD6ADBB9EC5D CRC64;
     MVLLWEPAGA WLALGLALAL GPSVAAAAPR QDCTGVECPP LENCIEEALE PGACCATCVQ
     QGCACEGYQY YDCLQGGFVR GRVPAGQSYF VDFGSTECSC PPGGGKISCQ FMLCPELPPN
     CIEAVVVADS CPQCGQVGCV HAGHKYAAGH TVHLPPCRAC HCPDAGGELI CYQLPGCHGN
     FSDAEEGDPE RHYEDPYSYD QEVAEVEAAT ALGGEVQAGA VQAGAGGPPA ALGGGSQPLS
     TIQAPPWPAV LPRPTAAAAL GPPAPVQAKA RRVTEDSEEE EEEEEEREEM AVTEQLAAGG
     HRGLDGLPTT APAGPSLPIQ EERAEAGARA EAGARPEENL ILDAQATSRS TGPEGVTHAP
     SLGKAALVPT QAVPGSPRDP VKPSPHNILS TSLPDAAWIP PTREVPRKPQ VLPHSHVEED
     TDPNSVHSIP RSSPEGSTKD LIETCCAAGQ QWAIDNDECL EIPESGTEDN VCRTAQRHCC
     VSYLQEKSCM AGVLGAKEGE TCGAEDNDSC GISLYKQCCD CCGLGLRVRA EGQSCESNPN
     LGYPCNHVML SCCEGEEPLI VPEVRRPPEP AAAPRRVSEA EMAGREALSL GTEAELPNSL
     PGDDQDECLL LPGELCQHLC INTVGSYHCA CFPGFSLQDD GRTCRPEGHP PQPEAPQEPA
     LKSEFSQVAS NTIPLPLPQP NTCKDNGPCK QVCSTVGGSA ICSCFPGYAI MADGVSCEDI
     NECVTDLHTC SRGEHCVNTL GSFHCYKALT CEPGYALKDG ECEDVDECAM GTHTCQPGFL
     CQNTKGSFYC QARQRCMDGF LQDPEGNCVD INECTSLSEP CRPGFSCINT VGSYTCQRNP
     LICARGYHAS DDGAKCVDVN ECETGVHRCG EGQVCHNLPG SYRCDCKAGF QRDAFGRGCI
     DVNECWASPG RLCQHTCENT LGSYRCSCAS GFLLAADGKR CEDVNECEAQ RCSQECANIY
     GSYQCYCRQG YQLAEDGHTC TDIDECAQGA GILCTFRCLN VPGSYQCACP EQGYTMTANG
     RSCKDVDECA LGTHNCSEAE TCHNIQGSFR CLRLECPPNY VQVSKTKCER TTCHDFLECQ
     NSPARITHYQ LNFQTGLLVP AHIFRIGPAP AFTGDTIALN IIKGNEEGYF GTRRLNAYTG
     VVYLQRAVLE PRDFALDVEM KLWRQGSVTT FLAKMHIFFT TFAL
//
ID   Q9Y3V7_HUMAN            Unreviewed;       576 AA.
AC   Q9Y3V7;
DT   01-NOV-1999, integrated into UniProtKB/TrEMBL.
DT   01-NOV-1999, sequence version 1.
DT   16-JAN-2019, entry version 110.
DE   SubName: Full=Uncharacterized protein DKFZp586A1519 {ECO:0000313|EMBL:CAB43267.1};
DE   Flags: Fragment;
GN   Name=DKFZp586A1519 {ECO:0000313|EMBL:CAB43267.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:CAB43267.1};
RN   [1] {ECO:0000313|EMBL:CAB43267.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Uterus {ECO:0000313|EMBL:CAB43267.1};
RG   The German cDNA Consortium;
RA   Wambutt R., Heubner D., Mewes H.W., Weil B., Amid C., Osanger A.,
RA   Fobo G., Han M., Wiemann S.;
RL   Submitted (SEP-2004) to the EMBL/GenBank/DDBJ databases.
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation
CC       of feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00076}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AL050095; CAB43267.1; -; mRNA.
DR   RefSeq; NP_001004019.1; NM_001004019.1.
DR   RefSeq; NP_001158507.1; NM_001165035.1.
DR   RefSeq; NP_001989.2; NM_001998.2.
DR   UniGene; Hs.198862; -.
DR   ProteinModelPortal; Q9Y3V7; -.
DR   PeptideAtlas; Q9Y3V7; -.
DR   GeneID; 2199; -.
DR   KEGG; hsa:2199; -.
DR   CTD; 2199; -.
DR   PharmGKB; PA28014; -.
DR   eggNOG; ENOG410IR7F; Eukaryota.
DR   eggNOG; ENOG410Y194; LUCA.
DR   HOVERGEN; HBG051559; -.
DR   KO; K17307; -.
DR   OrthoDB; 1174178at2759; -.
DR   GenomeRNAi; 2199; -.
DR   Genevisible; Q9Y3V7; HS.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; IEA:InterPro.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0016504; F:peptidase activator activity; IEA:InterPro.
DR   GO; GO:0030198; P:extracellular matrix organization; IEA:InterPro.
DR   InterPro; IPR026823; cEGF.
DR   InterPro; IPR001881; EGF-like_Ca-bd_dom.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR000152; EGF-type_Asp/Asn_hydroxyl_site.
DR   InterPro; IPR018097; EGF_Ca-bd_CS.
DR   InterPro; IPR017048; Fibulin-1.
DR   InterPro; IPR037286; Fibulin-2.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   PANTHER; PTHR44887; PTHR44887; 1.
DR   Pfam; PF12662; cEGF; 2.
DR   Pfam; PF07645; EGF_CA; 6.
DR   PIRSF; PIRSF036313; Fibulin-1; 2.
DR   SMART; SM00181; EGF; 10.
DR   SMART; SM00179; EGF_CA; 9.
DR   SUPFAM; SSF57184; SSF57184; 3.
DR   PROSITE; PS00010; ASX_HYDROXYL; 3.
DR   PROSITE; PS01186; EGF_2; 2.
DR   PROSITE; PS50026; EGF_3; 3.
DR   PROSITE; PS01187; EGF_CA; 3.
PE   2: Evidence at transcript level;
KW   Disulfide bond {ECO:0000256|SAAS:SAAS00601599};
KW   EGF-like domain {ECO:0000256|PROSITE-ProRule:PRU00076,
KW   ECO:0000256|SAAS:SAAS00602928};
KW   Repeat {ECO:0000256|SAAS:SAAS00594563}.
FT   DOMAIN      250    288       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   DOMAIN      293    334       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   DOMAIN      335    373       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   NON_TER       1      1       {ECO:0000313|EMBL:CAB43267.1}.
SQ   SEQUENCE   576 AA;  63274 MW;  FF2F0E9B185D8AC3 CRC64;
     PQEPALKSEF SQVASNTIPL PLPQPNTCKD NGPCKQVCST VGGSAICSCF PGYAIMADGV
     SCEDQDECLM GAHDCSRRQF CVNTLGSFYC VNHTVLCADG YILNAHRKCV DINECVTDLH
     TCSRGEHCVN TLGSFHCYKA LTCEPGYALK DGECEDVDEC AMGTHTCQPG FLCQNTKGSF
     YCQARQRCMD GFLQDPEGNC VDINECTSLS EPCRPGFSCI NTVGSYTCQR NPLICARGYH
     ASDDGTKCVD VNECETGVHR CGEGQVCHNL PGSYRCDCKA GFQRDAFGRG CIDVNECWAS
     PGRLCQHTCE NTLGSYRCSC ASGFLLAADG KRCEDVNECE AQRCSQECAN IYGSYQCYCR
     QGYQLAEDGH TCTDIDECAQ GAGILCTFRC LNVPGSYQCA CPEQGYTMTA NGRSCKDVDE
     CALGTHNCSE AETCHNIQGS FRCLRFECPP NYVQVSKTKC ERTTCHDFLE CQNSPARITH
     YQLNFQTGLL VPAHIFRIGP APAFTGDTIA LNIIKGNEEG YFGTRRLNAY TGVVYLQRAV
     LEPRDFALDV EMKLWRQGSV TTFLAKMHIF FTTFAL
//
ID   FEN1_HUMAN              Reviewed;         380 AA.
AC   P39748;
DT   01-FEB-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1995, sequence version 1.
DT   13-FEB-2019, entry version 191.
DE   RecName: Full=Flap endonuclease 1 {ECO:0000255|HAMAP-Rule:MF_03140};
DE            Short=FEN-1 {ECO:0000255|HAMAP-Rule:MF_03140};
DE            EC=3.1.-.- {ECO:0000255|HAMAP-Rule:MF_03140};
DE   AltName: Full=DNase IV;
DE   AltName: Full=Flap structure-specific endonuclease 1 {ECO:0000255|HAMAP-Rule:MF_03140};
DE   AltName: Full=Maturation factor 1;
DE            Short=MF1;
DE            Short=hFEN-1;
GN   Name=FEN1 {ECO:0000255|HAMAP-Rule:MF_03140}; Synonyms=RAD2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8007985; DOI=10.1128/MCB.14.7.4878;
RA   Murray J.M., Tavassoli M., Al-Harithy R., Sheldrick K.S.,
RA   Lehmann A.R., Carr A.M., Watts F.Z.;
RT   "Structural and functional conservation of the human homolog of the
RT   Schizosaccharomyces pombe rad2 gene, which is required for chromosome
RT   segregation and recovery from DNA damage.";
RL   Mol. Cell. Biol. 14:4878-4888(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=7774922; DOI=10.1016/0888-7543(95)80129-A;
RA   Hiraoka L.R., Harrington J.J., Gerhard D.S., Lieber M.R., Hsieh C.-L.;
RT   "Sequence of human FEN-1, a structure-specific endonuclease, and
RT   chromosomal localization of the gene (FEN1) in mouse and human.";
RL   Genomics 25:220-225(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NIEHS SNPs program;
RL   Submitted (JUN-2002) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PARTIAL PROTEIN SEQUENCE, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=7961795;
RA   Robins P., Pappin D.J.C., Wood R.D., Lindahl T.;
RT   "Structural and functional homology between mammalian DNase IV and the
RT   5'-nuclease domain of Escherichia coli DNA polymerase I.";
RL   J. Biol. Chem. 269:28535-28538(1994).
RN   [7]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBSTRATE-BINDING SITES, AND MUTAGENESIS
RP   OF ASP-34; ASP-86; ARG-103; GLU-158; ASP-179; ASP-181; GLY-231 AND
RP   ASP-233.
RX   PubMed=8621570; DOI=10.1074/jbc.271.16.9173;
RA   Shen B., Nolan J.P., Sklar L.A., Park M.S.;
RT   "Essential amino acids for substrate binding and catalysis of human
RT   flap endonuclease 1.";
RL   J. Biol. Chem. 271:9173-9176(1996).
RN   [8]
RP   INTERACTION WITH PCNA.
RX   PubMed=9305916; DOI=10.1074/jbc.272.39.24522;
RA   Gary R., Ludwig D.L., Cornelius H.L., MacInnes M.A., Park M.S.;
RT   "The DNA repair endonuclease XPG binds to proliferating cell nuclear
RT   antigen (PCNA) and shares sequence elements with the PCNA-binding
RT   regions of FEN-1 and cyclin-dependent kinase inhibitor p21.";
RL   J. Biol. Chem. 272:24522-24529(1997).
RN   [9]
RP   FUNCTION.
RX   PubMed=10744741; DOI=10.1074/jbc.275.14.10498;
RA   Tom S., Henricksen L.A., Bambara R.A.;
RT   "Mechanism whereby proliferating cell nuclear antigen stimulates flap
RT   endonuclease 1.";
RL   J. Biol. Chem. 275:10498-10505(2000).
RN   [10]
RP   INTERACTION WITH PCNA AND P300, AND ACETYLATION AT LYS-354; LYS-375;
RP   LYS-377 AND LYS-380.
RX   PubMed=11430825; DOI=10.1016/S1097-2765(01)00272-6;
RA   Hasan S., Stucki M., Hassa P.O., Imhof R., Gehrig P., Hunziker P.,
RA   Hubscher U., Hottiger M.O.;
RT   "Regulation of human flap endonuclease-1 activity by acetylation
RT   through the transcriptional coactivator p300.";
RL   Mol. Cell 7:1221-1231(2001).
RN   [11]
RP   FUNCTION, SUBSTRATE-BINDING SITES ARG-47 AND ARG-70, AND MUTAGENESIS
RP   OF ARG-29; ARG-47; ARG-70; ARG-73 AND LYS-80.
RX   PubMed=11986308; DOI=10.1074/jbc.M111941200;
RA   Qiu J., Bimston D.N., Partikian A., Shen B.;
RT   "Arginine residues 47 and 70 of human flap endonuclease-1 are involved
RT   in DNA substrate interactions and cleavage site determination.";
RL   J. Biol. Chem. 277:24659-24666(2002).
RN   [12]
RP   INTERACTION WITH DDX11.
RX   PubMed=18499658; DOI=10.1074/jbc.M802696200;
RA   Farina A., Shin J.H., Kim D.H., Bermudez V.P., Kelman Z., Seo Y.S.,
RA   Hurwitz J.;
RT   "Studies with the human cohesin establishment factor, ChlR1.
RT   Association of ChlR1 with Ctf18-RFC and Fen1.";
RL   J. Biol. Chem. 283:20925-20936(2008).
RN   [13]
RP   FUNCTION, SUBCELLULAR LOCATION, PHOSPHORYLATION, AND MUTAGENESIS OF
RP   SER-187.
RX   PubMed=18443037; DOI=10.1128/MCB.00200-08;
RA   Guo Z., Qian L., Liu R., Dai H., Zhou M., Zheng L., Shen B.;
RT   "Nucleolar localization and dynamic roles of flap endonuclease 1 in
RT   ribosomal DNA replication and damage repair.";
RL   Mol. Cell. Biol. 28:4310-4319(2008).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-80 AND LYS-375, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [15]
RP   FUNCTION, MUTAGENESIS OF ARG-192, METHYLATION AT ARG-19; ARG-100;
RP   ARG-104 AND ARG-192, AND PHOSPHORYLATION AT SER-187.
RX   PubMed=20729856; DOI=10.1038/nchembio.422;
RA   Guo Z., Zheng L., Xu H., Dai H., Zhou M., Pascua M.R., Chen Q.M.,
RA   Shen B.;
RT   "Methylation of FEN1 suppresses nearby phosphorylation and facilitates
RT   PCNA binding.";
RL   Nat. Chem. Biol. 6:766-773(2010).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-197 AND THR-364, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-255; SER-293; SER-335
RP   AND THR-336, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [20]
RP   ALTERNATIVE INITIATION (ISOFORM FENMIT), AND SUBCELLULAR LOCATION
RP   (ISOFORM FENMIT).
RX   PubMed=23675412; DOI=10.1371/journal.pone.0062340;
RA   Kazak L., Reyes A., He J., Wood S.R., Brea-Calvo G., Holen T.T.,
RA   Holt I.J.;
RT   "A cryptic targeting signal creates a mitochondrial FEN1 isoform with
RT   tailed R-loop binding properties.";
RL   PLoS ONE 8:E62340-E62340(2013).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [22]
RP   X-RAY CRYSTALLOGRAPHY (1.88 ANGSTROMS) OF 331-350.
RX   PubMed=15576034; DOI=10.1016/j.str.2004.09.018;
RA   Bruning J.B., Shamoo Y.;
RT   "Structural and thermodynamic analysis of human PCNA with peptides
RT   derived from DNA polymerase-delta p66 subunit and flap endonuclease-
RT   1.";
RL   Structure 12:2209-2219(2004).
RN   [23]
RP   X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 2-380 IN COMPLEX WITH PCNA.
RX   PubMed=15616578; DOI=10.1038/sj.emboj.7600519;
RA   Sakurai S., Kitano K., Yamaguchi H., Hamada K., Okada K., Fukuda K.,
RA   Uchida M., Ohtsuka E., Morioka H., Hakoshima T.;
RT   "Structural basis for recruitment of human flap endonuclease 1 to
RT   PCNA.";
RL   EMBO J. 24:683-693(2005).
CC   -!- FUNCTION: Structure-specific nuclease with 5'-flap endonuclease
CC       and 5'-3' exonuclease activities involved in DNA replication and
CC       repair. During DNA replication, cleaves the 5'-overhanging flap
CC       structure that is generated by displacement synthesis when DNA
CC       polymerase encounters the 5'-end of a downstream Okazaki fragment.
CC       It enters the flap from the 5'-end and then tracks to cleave the
CC       flap base, leaving a nick for ligation. Also involved in the long
CC       patch base excision repair (LP-BER) pathway, by cleaving within
CC       the apurinic/apyrimidinic (AP) site-terminated flap. Acts as a
CC       genome stabilization factor that prevents flaps from equilibrating
CC       into structurs that lead to duplications and deletions. Also
CC       possesses 5'-3' exonuclease activity on nicked or gapped double-
CC       stranded DNA, and exhibits RNase H activity. Also involved in
CC       replication and repair of rDNA and in repairing mitochondrial DNA.
CC       {ECO:0000255|HAMAP-Rule:MF_03140, ECO:0000269|PubMed:10744741,
CC       ECO:0000269|PubMed:11986308, ECO:0000269|PubMed:18443037,
CC       ECO:0000269|PubMed:20729856, ECO:0000269|PubMed:7961795,
CC       ECO:0000269|PubMed:8621570}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC       Note=Binds 2 magnesium ions per subunit. They probably participate
CC       in the reaction catalyzed by the enzyme. May bind an additional
CC       third magnesium ion after substrate binding.;
CC   -!- SUBUNIT: Three molecules of FEN1 bind to one PCNA trimer with each
CC       molecule binding to one PCNA monomer (PubMed:15616578). PCNA
CC       stimulates the nuclease activity without altering cleavage
CC       specificity (PubMed:15616578). The C-terminal domain binds EP300;
CC       can bind simultaneously to both PCNA and EP300 (PubMed:11430825).
CC       Interacts with PCNA; can bind simultaneously to both PCNA and
CC       EP300 (PubMed:9305916, PubMed:11430825). Interacts with DDX11;
CC       this interaction is direct and increases flap endonuclease
CC       activity of FEN1 (PubMed:18499658). {ECO:0000255|HAMAP-
CC       Rule:MF_03140, ECO:0000269|PubMed:11430825,
CC       ECO:0000269|PubMed:15616578, ECO:0000269|PubMed:18499658,
CC       ECO:0000269|PubMed:9305916}.
CC   -!- INTERACTION:
CC       P54132:BLM; NbExp=4; IntAct=EBI-707816, EBI-621372;
CC       Q96NY9:MUS81; NbExp=5; IntAct=EBI-707816, EBI-2370806;
CC       P12004:PCNA; NbExp=10; IntAct=EBI-707816, EBI-358311;
CC       P57081:WDR4; NbExp=8; IntAct=EBI-707816, EBI-750427;
CC       Q14191:WRN; NbExp=9; IntAct=EBI-707816, EBI-368417;
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Nucleus, nucleolus. Nucleus,
CC       nucleoplasm. Note=Resides mostly in the nucleoli and relocalizes
CC       to the nucleoplasm upon DNA damage.
CC   -!- SUBCELLULAR LOCATION: Isoform FENMIT: Mitochondrion
CC       {ECO:0000255|HAMAP-Rule:MF_03140, ECO:0000269|PubMed:23675412}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative initiation; Named isoforms=2;
CC       Name=1;
CC         IsoId=P39748-1; Sequence=Displayed;
CC       Name=FENMIT;
CC         IsoId=P39748-2; Sequence=VSP_047520;
CC         Note=No nuclease activity. Binds preferentially to RNA flap
CC         structures and R-loops.;
CC   -!- PTM: Acetylated by EP300. Acetylation inhibits both endonuclease
CC       and exonuclease activity. Acetylation also reduces DNA-binding
CC       activity but does not affect interaction with PCNA or EP300.
CC       {ECO:0000255|HAMAP-Rule:MF_03140, ECO:0000269|PubMed:11430825}.
CC   -!- PTM: Phosphorylation upon DNA damage induces relocalization to the
CC       nuclear plasma. Phosphorylation at Ser-187 by CDK2 occurs during
CC       late S-phase and results in dissociation from PCNA.
CC       {ECO:0000255|HAMAP-Rule:MF_03140, ECO:0000269|PubMed:20729856}.
CC   -!- PTM: Methylation at Arg-192 by PRMT5 impedes Ser-187
CC       phosphorylation and increases interaction with PCNA.
CC       {ECO:0000255|HAMAP-Rule:MF_03140, ECO:0000269|PubMed:20729856}.
CC   -!- SIMILARITY: Belongs to the XPG/RAD2 endonuclease family. FEN1
CC       subfamily. {ECO:0000255|HAMAP-Rule:MF_03140}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/fen1/";
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/FEN1ID40543ch11q12.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; X76771; CAA54166.1; -; mRNA.
DR   EMBL; L37374; AAA91331.1; -; mRNA.
DR   EMBL; AF523117; AAM74238.1; -; Genomic_DNA.
DR   EMBL; AC004770; AAC23394.1; -; Genomic_DNA.
DR   EMBL; BC000323; AAH00323.1; -; mRNA.
DR   CCDS; CCDS8010.1; -. [P39748-1]
DR   PIR; A56531; A56531.
DR   RefSeq; NP_004102.1; NM_004111.5. [P39748-1]
DR   UniGene; Hs.409065; -.
DR   PDB; 1U7B; X-ray; 1.88 A; B=331-350.
DR   PDB; 1UL1; X-ray; 2.90 A; X/Y/Z=2-380.
DR   PDB; 3Q8K; X-ray; 2.20 A; A=2-336.
DR   PDB; 3Q8L; X-ray; 2.32 A; A=2-336.
DR   PDB; 3Q8M; X-ray; 2.60 A; A/B=2-336.
DR   PDB; 3UVU; X-ray; 2.38 A; B=352-370.
DR   PDB; 5E0V; X-ray; 2.07 A; C/D=335-350.
DR   PDB; 5FV7; X-ray; 2.84 A; A/B=1-336.
DR   PDB; 5K97; X-ray; 2.10 A; A=2-336.
DR   PDB; 5KSE; X-ray; 2.10 A; A=2-336.
DR   PDB; 5UM9; X-ray; 2.81 A; A=2-336.
DR   PDBsum; 1U7B; -.
DR   PDBsum; 1UL1; -.
DR   PDBsum; 3Q8K; -.
DR   PDBsum; 3Q8L; -.
DR   PDBsum; 3Q8M; -.
DR   PDBsum; 3UVU; -.
DR   PDBsum; 5E0V; -.
DR   PDBsum; 5FV7; -.
DR   PDBsum; 5K97; -.
DR   PDBsum; 5KSE; -.
DR   PDBsum; 5UM9; -.
DR   ProteinModelPortal; P39748; -.
DR   SMR; P39748; -.
DR   BioGrid; 108528; 82.
DR   CORUM; P39748; -.
DR   DIP; DIP-24216N; -.
DR   ELM; P39748; -.
DR   IntAct; P39748; 38.
DR   MINT; P39748; -.
DR   STRING; 9606.ENSP00000305480; -.
DR   BindingDB; P39748; -.
DR   ChEMBL; CHEMBL5027; -.
DR   iPTMnet; P39748; -.
DR   PhosphoSitePlus; P39748; -.
DR   SwissPalm; P39748; -.
DR   BioMuta; FEN1; -.
DR   DMDM; 729475; -.
DR   EPD; P39748; -.
DR   jPOST; P39748; -.
DR   PaxDb; P39748; -.
DR   PeptideAtlas; P39748; -.
DR   PRIDE; P39748; -.
DR   ProteomicsDB; 55319; -.
DR   TopDownProteomics; P39748-1; -. [P39748-1]
DR   DNASU; 2237; -.
DR   Ensembl; ENST00000305885; ENSP00000305480; ENSG00000168496. [P39748-1]
DR   GeneID; 2237; -.
DR   KEGG; hsa:2237; -.
DR   CTD; 2237; -.
DR   DisGeNET; 2237; -.
DR   EuPathDB; HostDB:ENSG00000168496.3; -.
DR   GeneCards; FEN1; -.
DR   HGNC; HGNC:3650; FEN1.
DR   HPA; CAB002262; -.
DR   HPA; HPA006748; -.
DR   MIM; 600393; gene.
DR   neXtProt; NX_P39748; -.
DR   OpenTargets; ENSG00000168496; -.
DR   PharmGKB; PA28090; -.
DR   eggNOG; KOG2519; Eukaryota.
DR   eggNOG; COG0258; LUCA.
DR   GeneTree; ENSGT00940000155807; -.
DR   HOGENOM; HOG000193853; -.
DR   HOVERGEN; HBG000844; -.
DR   InParanoid; P39748; -.
DR   KO; K04799; -.
DR   OMA; GSQDYDS; -.
DR   OrthoDB; 1094524at2759; -.
DR   PhylomeDB; P39748; -.
DR   TreeFam; TF105701; -.
DR   Reactome; R-HSA-110362; POLB-Dependent Long Patch Base Excision Repair.
DR   Reactome; R-HSA-162594; Early Phase of HIV Life Cycle.
DR   Reactome; R-HSA-174437; Removal of the Flap Intermediate from the C-strand.
DR   Reactome; R-HSA-5651801; PCNA-Dependent Long Patch Base Excision Repair.
DR   Reactome; R-HSA-5685939; HDR through MMEJ (alt-NHEJ).
DR   Reactome; R-HSA-69166; Removal of the Flap Intermediate.
DR   SignaLink; P39748; -.
DR   SIGNOR; P39748; -.
DR   ChiTaRS; FEN1; human.
DR   EvolutionaryTrace; P39748; -.
DR   GeneWiki; Flap_structure-specific_endonuclease_1; -.
DR   GenomeRNAi; 2237; -.
DR   PRO; PR:P39748; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000168496; Expressed in 219 organ(s), highest expression level in amniotic fluid.
DR   ExpressionAtlas; P39748; baseline and differential.
DR   Genevisible; P39748; HS.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0000784; C:nuclear chromosome, telomeric region; HDA:BHF-UCL.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0032991; C:protein-containing complex; IDA:MGI.
DR   GO; GO:0008409; F:5'-3' exonuclease activity; IDA:UniProtKB.
DR   GO; GO:0017108; F:5'-flap endonuclease activity; IDA:UniProtKB.
DR   GO; GO:0003684; F:damaged DNA binding; TAS:ProtInc.
DR   GO; GO:0003677; F:DNA binding; IMP:UniProtKB.
DR   GO; GO:0003690; F:double-stranded DNA binding; TAS:ProtInc.
DR   GO; GO:0008309; F:double-stranded DNA exodeoxyribonuclease activity; TAS:ProtInc.
DR   GO; GO:0004519; F:endonuclease activity; TAS:ProtInc.
DR   GO; GO:0004527; F:exonuclease activity; TAS:ProtInc.
DR   GO; GO:0048256; F:flap endonuclease activity; IDA:UniProtKB.
DR   GO; GO:0000287; F:magnesium ion binding; IBA:GO_Central.
DR   GO; GO:0030145; F:manganese ion binding; IBA:GO_Central.
DR   GO; GO:0004523; F:RNA-DNA hybrid ribonuclease activity; IDA:UniProtKB.
DR   GO; GO:0006284; P:base-excision repair; IEA:UniProtKB-UniRule.
DR   GO; GO:0006281; P:DNA repair; TAS:ProtInc.
DR   GO; GO:0006260; P:DNA replication; TAS:ProtInc.
DR   GO; GO:0043137; P:DNA replication, removal of RNA primer; IDA:UniProtKB.
DR   GO; GO:0006302; P:double-strand break repair; TAS:ProtInc.
DR   GO; GO:0000724; P:double-strand break repair via homologous recombination; TAS:Reactome.
DR   GO; GO:0007613; P:memory; IEA:Ensembl.
DR   GO; GO:0090305; P:nucleic acid phosphodiester bond hydrolysis; IDA:UniProtKB.
DR   GO; GO:0045876; P:positive regulation of sister chromatid cohesion; IMP:UniProtKB.
DR   GO; GO:0032201; P:telomere maintenance via semi-conservative replication; TAS:Reactome.
DR   GO; GO:0009650; P:UV protection; TAS:ProtInc.
DR   CDD; cd09867; PIN_FEN1; 1.
DR   HAMAP; MF_00614; Fen; 1.
DR   InterPro; IPR036279; 5-3_exonuclease_C_sf.
DR   InterPro; IPR023426; Flap_endonuc.
DR   InterPro; IPR008918; HhH2.
DR   InterPro; IPR029060; PIN-like_dom_sf.
DR   InterPro; IPR006086; XPG-I_dom.
DR   InterPro; IPR006084; XPG/Rad2.
DR   InterPro; IPR019974; XPG_CS.
DR   InterPro; IPR006085; XPG_DNA_repair_N.
DR   PANTHER; PTHR11081; PTHR11081; 1.
DR   Pfam; PF00867; XPG_I; 1.
DR   Pfam; PF00752; XPG_N; 1.
DR   PRINTS; PR00853; XPGRADSUPER.
DR   SMART; SM00279; HhH2; 1.
DR   SMART; SM00484; XPGI; 1.
DR   SMART; SM00485; XPGN; 1.
DR   SUPFAM; SSF47807; SSF47807; 1.
DR   SUPFAM; SSF88723; SSF88723; 1.
DR   PROSITE; PS00841; XPG_1; 1.
DR   PROSITE; PS00842; XPG_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative initiation; Complete proteome;
KW   Direct protein sequencing; DNA damage; DNA repair; DNA replication;
KW   Endonuclease; Exonuclease; Hydrolase; Magnesium; Metal-binding;
KW   Methylation; Mitochondrion; Nuclease; Nucleus; Phosphoprotein;
KW   Reference proteome.
FT   CHAIN         1    380       Flap endonuclease 1.
FT                                /FTId=PRO_0000154069.
FT   REGION        1    104       N-domain.
FT   REGION      122    253       I-domain.
FT   REGION      336    344       Interaction with PCNA.
FT                                {ECO:0000269|PubMed:9305916}.
FT   METAL        34     34       Magnesium 1.
FT   METAL        86     86       Magnesium 1.
FT   METAL       158    158       Magnesium 1.
FT   METAL       160    160       Magnesium 1.
FT   METAL       179    179       Magnesium 2.
FT   METAL       181    181       Magnesium 2.
FT   METAL       233    233       Magnesium 2.
FT   BINDING      47     47       DNA substrate.
FT   BINDING      70     70       DNA substrate.
FT   BINDING     158    158       DNA substrate.
FT   BINDING     231    231       DNA substrate.
FT   BINDING     233    233       DNA substrate.
FT   MOD_RES      19     19       Symmetric dimethylarginine; by PRMT5.
FT                                {ECO:0000255|HAMAP-Rule:MF_03140,
FT                                ECO:0000269|PubMed:20729856}.
FT   MOD_RES      80     80       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     100    100       Symmetric dimethylarginine; by PRMT5.
FT                                {ECO:0000255|HAMAP-Rule:MF_03140,
FT                                ECO:0000269|PubMed:20729856}.
FT   MOD_RES     104    104       Symmetric dimethylarginine; by PRMT5.
FT                                {ECO:0000255|HAMAP-Rule:MF_03140,
FT                                ECO:0000269|PubMed:20729856}.
FT   MOD_RES     187    187       Phosphoserine; by CDK2.
FT                                {ECO:0000255|HAMAP-Rule:MF_03140,
FT                                ECO:0000269|PubMed:20729856}.
FT   MOD_RES     192    192       Symmetric dimethylarginine; by PRMT5.
FT                                {ECO:0000255|HAMAP-Rule:MF_03140,
FT                                ECO:0000269|PubMed:20729856}.
FT   MOD_RES     197    197       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     255    255       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     293    293       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     335    335       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     336    336       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     354    354       N6-acetyllysine. {ECO:0000255|HAMAP-
FT                                Rule:MF_03140,
FT                                ECO:0000269|PubMed:11430825}.
FT   MOD_RES     364    364       Phosphothreonine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     375    375       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861,
FT                                ECO:0000255|HAMAP-Rule:MF_03140,
FT                                ECO:0000269|PubMed:11430825}.
FT   MOD_RES     377    377       N6-acetyllysine. {ECO:0000255|HAMAP-
FT                                Rule:MF_03140,
FT                                ECO:0000269|PubMed:11430825}.
FT   MOD_RES     380    380       N6-acetyllysine. {ECO:0000255|HAMAP-
FT                                Rule:MF_03140,
FT                                ECO:0000269|PubMed:11430825}.
FT   VAR_SEQ       1     64       Missing (in isoform FENMIT).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_047520.
FT   MUTAGEN      29     29       R->A: No significant effect on
FT                                exonuclease activity or flap endonuclease
FT                                activity. {ECO:0000269|PubMed:11986308}.
FT   MUTAGEN      34     34       D->A: Loss of flap endonuclease activity
FT                                but substrate binding activity is
FT                                retained. {ECO:0000269|PubMed:8621570}.
FT   MUTAGEN      47     47       R->A: Significantly reduced exonuclease
FT                                activity and reduced substrate binding.
FT                                The positions of the cleavage sites are
FT                                also shifted.
FT                                {ECO:0000269|PubMed:11986308}.
FT   MUTAGEN      70     70       R->A: Loss of exonuclease activity and
FT                                reduced endonuclease activity. Reduced
FT                                substrate binding.
FT                                {ECO:0000269|PubMed:11986308}.
FT   MUTAGEN      73     73       R->A: No significant effect on
FT                                exonuclease activity or flap endonuclease
FT                                activity. {ECO:0000269|PubMed:11986308}.
FT   MUTAGEN      80     80       K->A: No significant effect on
FT                                exonuclease activity or flap endonuclease
FT                                activity. {ECO:0000269|PubMed:11986308}.
FT   MUTAGEN      86     86       D->A: Loss of flap endonuclease activity
FT                                but substrate binding activity is
FT                                retained. {ECO:0000269|PubMed:8621570}.
FT   MUTAGEN     103    103       R->A: No effect on flap endonuclease
FT                                activity or substrate binding.
FT                                {ECO:0000269|PubMed:8621570}.
FT   MUTAGEN     158    158       E->A: Loss of flap endonuclease activity
FT                                and substrate binding.
FT                                {ECO:0000269|PubMed:8621570}.
FT   MUTAGEN     179    179       D->A: No effect on flap endonuclease
FT                                activity or substrate binding.
FT                                {ECO:0000269|PubMed:8621570}.
FT   MUTAGEN     181    181       D->A: Loss of flap endonuclease activity
FT                                but substrate binding activity is
FT                                retained. {ECO:0000269|PubMed:8621570}.
FT   MUTAGEN     187    187       S->A: Fails to translocate from nucleoli
FT                                to the nuclear plasma.
FT                                {ECO:0000269|PubMed:18443037}.
FT   MUTAGEN     187    187       S->D: Diminishes nucleolar localization.
FT                                {ECO:0000269|PubMed:18443037}.
FT   MUTAGEN     192    192       R->K: Impairs ability to localize to
FT                                sites of DNA replication or repair.
FT                                {ECO:0000269|PubMed:20729856}.
FT   MUTAGEN     231    231       G->A: Loss of flap endonuclease activity
FT                                and substrate binding.
FT                                {ECO:0000269|PubMed:8621570}.
FT   MUTAGEN     233    233       D->A: Loss of flap endonuclease activity
FT                                and substrate binding.
FT                                {ECO:0000269|PubMed:8621570}.
FT   HELIX         6     13       {ECO:0000244|PDB:5K97}.
FT   HELIX        15     17       {ECO:0000244|PDB:5K97}.
FT   STRAND       18     20       {ECO:0000244|PDB:5K97}.
FT   HELIX        23     26       {ECO:0000244|PDB:5K97}.
FT   STRAND       30     34       {ECO:0000244|PDB:5K97}.
FT   HELIX        35     45       {ECO:0000244|PDB:5K97}.
FT   STRAND       46     48       {ECO:0000244|PDB:5K97}.
FT   HELIX        62     76       {ECO:0000244|PDB:5K97}.
FT   STRAND       80     85       {ECO:0000244|PDB:5K97}.
FT   HELIX        91     93       {ECO:0000244|PDB:5K97}.
FT   HELIX        94    116       {ECO:0000244|PDB:5K97}.
FT   STRAND      120    122       {ECO:0000244|PDB:5K97}.
FT   HELIX       123    129       {ECO:0000244|PDB:5K97}.
FT   HELIX       135    148       {ECO:0000244|PDB:5K97}.
FT   STRAND      152    154       {ECO:0000244|PDB:5K97}.
FT   HELIX       159    168       {ECO:0000244|PDB:5K97}.
FT   STRAND      171    176       {ECO:0000244|PDB:5K97}.
FT   HELIX       181    184       {ECO:0000244|PDB:5K97}.
FT   STRAND      188    193       {ECO:0000244|PDB:5K97}.
FT   STRAND      205    208       {ECO:0000244|PDB:5K97}.
FT   HELIX       209    216       {ECO:0000244|PDB:5K97}.
FT   HELIX       220    230       {ECO:0000244|PDB:5K97}.
FT   STRAND      233    235       {ECO:0000244|PDB:5K97}.
FT   HELIX       243    253       {ECO:0000244|PDB:5K97}.
FT   HELIX       256    262       {ECO:0000244|PDB:5K97}.
FT   TURN        265    267       {ECO:0000244|PDB:5K97}.
FT   HELIX       276    284       {ECO:0000244|PDB:5K97}.
FT   TURN        291    293       {ECO:0000244|PDB:5K97}.
FT   HELIX       303    310       {ECO:0000244|PDB:5K97}.
FT   TURN        311    314       {ECO:0000244|PDB:5K97}.
FT   HELIX       318    335       {ECO:0000244|PDB:5K97}.
FT   HELIX       340    342       {ECO:0000244|PDB:1U7B}.
FT   STRAND      344    351       {ECO:0000244|PDB:1UL1}.
SQ   SEQUENCE   380 AA;  42593 MW;  5154F2F6E57592C5 CRC64;
     MGIQGLAKLI ADVAPSAIRE NDIKSYFGRK VAIDASMSIY QFLIAVRQGG DVLQNEEGET
     TSHLMGMFYR TIRMMENGIK PVYVFDGKPP QLKSGELAKR SERRAEAEKQ LQQAQAAGAE
     QEVEKFTKRL VKVTKQHNDE CKHLLSLMGI PYLDAPSEAE ASCAALVKAG KVYAAATEDM
     DCLTFGSPVL MRHLTASEAK KLPIQEFHLS RILQELGLNQ EQFVDLCILL GSDYCESIRG
     IGPKRAVDLI QKHKSIEEIV RRLDPNKYPV PENWLHKEAH QLFLEPEVLD PESVELKWSE
     PNEEELIKFM CGEKQFSEER IRSGVKRLSK SRQGSTQGRL DDFFKVTGSL SSAKRKEPEP
     KGSTKKKAKT GAAGKFKRGK
//
ID   Q6FHX6_HUMAN            Unreviewed;       380 AA.
AC   Q6FHX6;
DT   10-MAY-2005, integrated into UniProtKB/TrEMBL.
DT   10-MAY-2005, sequence version 1.
DT   13-FEB-2019, entry version 129.
DE   RecName: Full=Flap endonuclease 1 {ECO:0000256|HAMAP-Rule:MF_03140};
DE            Short=FEN-1 {ECO:0000256|HAMAP-Rule:MF_03140};
DE            EC=3.1.-.- {ECO:0000256|HAMAP-Rule:MF_03140};
DE   AltName: Full=Flap structure-specific endonuclease 1 {ECO:0000256|HAMAP-Rule:MF_03140};
GN   Name=FEN1 {ECO:0000256|HAMAP-Rule:MF_03140,
GN   ECO:0000313|EMBL:CAG38799.1};
GN   ORFNames=hCG_40848 {ECO:0000313|EMBL:EAW73972.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:CAG38799.1};
RN   [1] {ECO:0000313|EMBL:EAW73972.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:CAG38799.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S.,
RA   Neubert P., Kstrang K., Schatten R., Shen B., Henze S., Mar W.,
RA   Korn B., Zuo D., Hu Y., LaBaer J.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:AAV38331.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) System Donor
RT   vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:EAW73972.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5] {ECO:0000313|EMBL:BAG35627.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Breast {ECO:0000313|EMBL:BAG35627.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Kaida T., Tsuchiya K., Iida Y.,
RA   Takayama Y., Murakawa K., Kanehori K., Andoh T., Kagawa N., Sato R.,
RA   Kawamura Y., Tanaka S., Kisu Y., Sugano S., Goshima N., Nomura N.,
RA   Isogai T.;
RT   "NEDO functional analysis of protein and research application
RT   project.";
RL   Submitted (JAN-2008) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Structure-specific nuclease with 5'-flap endonuclease
CC       and 5'-3' exonuclease activities involved in DNA replication and
CC       repair. During DNA replication, cleaves the 5'-overhanging flap
CC       structure that is generated by displacement synthesis when DNA
CC       polymerase encounters the 5'-end of a downstream Okazaki fragment.
CC       It enters the flap from the 5'-end and then tracks to cleave the
CC       flap base, leaving a nick for ligation. Also involved in the long
CC       patch base excision repair (LP-BER) pathway, by cleaving within
CC       the apurinic/apyrimidinic (AP) site-terminated flap. Acts as a
CC       genome stabilization factor that prevents flaps from equilibrating
CC       into structurs that lead to duplications and deletions. Also
CC       possesses 5'-3' exonuclease activity on nicked or gapped double-
CC       stranded DNA, and exhibits RNase H activity. Also involved in
CC       replication and repair of rDNA and in repairing mitochondrial DNA.
CC       {ECO:0000256|HAMAP-Rule:MF_03140, ECO:0000256|SAAS:SAAS00882638}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000256|HAMAP-Rule:MF_03140};
CC       Note=Binds 2 magnesium ions per subunit. They probably participate
CC       in the reaction catalyzed by the enzyme. May bind an additional
CC       third magnesium ion after substrate binding. {ECO:0000256|HAMAP-
CC       Rule:MF_03140};
CC   -!- SUBUNIT: Interacts with PCNA. Three molecules of FEN1 bind to one
CC       PCNA trimer with each molecule binding to one PCNA monomer. PCNA
CC       stimulates the nuclease activity without altering cleavage
CC       specificity. The C-terminal domain binds EP300. Can bind
CC       simultaneously to both PCNA and EP300. Interacts with DDX11.
CC       {ECO:0000256|HAMAP-Rule:MF_03140}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000256|HAMAP-
CC       Rule:MF_03140, ECO:0000256|SAAS:SAAS00882753}. Nucleus, nucleolus
CC       {ECO:0000256|HAMAP-Rule:MF_03140}. Nucleus, nucleoplasm
CC       {ECO:0000256|HAMAP-Rule:MF_03140}. Note=Resides mostly in the
CC       nucleoli and relocalizes to the nucleoplasm upon DNA damage.
CC       {ECO:0000256|HAMAP-Rule:MF_03140}.
CC   -!- PTM: Acetylated by EP300. Acetylation inhibits both endonuclease
CC       and exonuclease activity. Acetylation also reduces DNA-binding
CC       activity but does not affect interaction with PCNA or EP300.
CC       {ECO:0000256|HAMAP-Rule:MF_03140}.
CC   -!- PTM: Methylation at Arg-192 by PRMT5 impedes Ser-187
CC       phosphorylation and increases interaction with PCNA.
CC       {ECO:0000256|HAMAP-Rule:MF_03140}.
CC   -!- PTM: Phosphorylation upon DNA damage induces relocalization to the
CC       nuclear plasma. Phosphorylation at Ser-187 by CDK2 occurs during
CC       late S-phase and results in dissociation from PCNA.
CC       {ECO:0000256|HAMAP-Rule:MF_03140}.
CC   -!- SIMILARITY: Belongs to the XPG/RAD2 endonuclease family. FEN1
CC       subfamily. {ECO:0000256|HAMAP-Rule:MF_03140}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; BT019524; AAV38331.1; -; mRNA.
DR   EMBL; AK312761; BAG35627.1; -; mRNA.
DR   EMBL; CR536562; CAG38799.1; -; mRNA.
DR   EMBL; CH471076; EAW73972.1; -; Genomic_DNA.
DR   RefSeq; NP_004102.1; NM_004111.5.
DR   UniGene; Hs.409065; -.
DR   DNASU; 2237; -.
DR   GeneID; 2237; -.
DR   KEGG; hsa:2237; -.
DR   UCSC; uc001nsg.4; human.
DR   CTD; 2237; -.
DR   EuPathDB; HostDB:ENSG00000168496.3; -.
DR   PharmGKB; PA28090; -.
DR   eggNOG; KOG2519; Eukaryota.
DR   eggNOG; COG0258; LUCA.
DR   HOVERGEN; HBG000844; -.
DR   KO; K04799; -.
DR   OMA; GSQDYDS; -.
DR   OrthoDB; 1094524at2759; -.
DR   ChiTaRS; FEN1; human.
DR   GenomeRNAi; 2237; -.
DR   Bgee; ENSG00000168496; Expressed in 219 organ(s), highest expression level in amniotic fluid.
DR   GO; GO:0005739; C:mitochondrion; IEA:UniProtKB-SubCell.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0008409; F:5'-3' exonuclease activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0017108; F:5'-flap endonuclease activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0006284; P:base-excision repair; IEA:UniProtKB-UniRule.
DR   GO; GO:0006260; P:DNA replication; IEA:UniProtKB-KW.
DR   GO; GO:0043137; P:DNA replication, removal of RNA primer; IEA:UniProtKB-UniRule.
DR   GO; GO:0007613; P:memory; IEA:Ensembl.
DR   CDD; cd09867; PIN_FEN1; 1.
DR   HAMAP; MF_00614; Fen; 1.
DR   InterPro; IPR036279; 5-3_exonuclease_C_sf.
DR   InterPro; IPR023426; Flap_endonuc.
DR   InterPro; IPR008918; HhH2.
DR   InterPro; IPR029060; PIN-like_dom_sf.
DR   InterPro; IPR006086; XPG-I_dom.
DR   InterPro; IPR006084; XPG/Rad2.
DR   InterPro; IPR019974; XPG_CS.
DR   InterPro; IPR006085; XPG_DNA_repair_N.
DR   PANTHER; PTHR11081; PTHR11081; 1.
DR   Pfam; PF00867; XPG_I; 1.
DR   Pfam; PF00752; XPG_N; 1.
DR   PRINTS; PR00853; XPGRADSUPER.
DR   SMART; SM00279; HhH2; 1.
DR   SMART; SM00484; XPGI; 1.
DR   SMART; SM00485; XPGN; 1.
DR   SUPFAM; SSF47807; SSF47807; 1.
DR   SUPFAM; SSF88723; SSF88723; 1.
DR   PROSITE; PS00841; XPG_1; 1.
DR   PROSITE; PS00842; XPG_2; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   DNA damage {ECO:0000256|HAMAP-Rule:MF_03140};
KW   DNA repair {ECO:0000256|HAMAP-Rule:MF_03140};
KW   DNA replication {ECO:0000256|HAMAP-Rule:MF_03140};
KW   Endonuclease {ECO:0000256|HAMAP-Rule:MF_03140,
KW   ECO:0000313|EMBL:AAV38331.1};
KW   Exonuclease {ECO:0000256|HAMAP-Rule:MF_03140};
KW   Hydrolase {ECO:0000256|HAMAP-Rule:MF_03140,
KW   ECO:0000313|EMBL:AAV38331.1};
KW   Magnesium {ECO:0000256|HAMAP-Rule:MF_03140};
KW   Metal-binding {ECO:0000256|HAMAP-Rule:MF_03140};
KW   Methylation {ECO:0000256|HAMAP-Rule:MF_03140};
KW   Mitochondrion {ECO:0000256|HAMAP-Rule:MF_03140,
KW   ECO:0000256|SAAS:SAAS00882738};
KW   Nuclease {ECO:0000256|HAMAP-Rule:MF_03140,
KW   ECO:0000313|EMBL:AAV38331.1};
KW   Nucleus {ECO:0000256|HAMAP-Rule:MF_03140,
KW   ECO:0000256|SAAS:SAAS00022948};
KW   Phosphoprotein {ECO:0000256|HAMAP-Rule:MF_03140}.
FT   DOMAIN        1    107       XPGN. {ECO:0000259|SMART:SM00485}.
FT   DOMAIN      146    218       XPGI. {ECO:0000259|SMART:SM00484}.
FT   REGION        1    104       N-domain. {ECO:0000256|HAMAP-
FT                                Rule:MF_03140}.
FT   REGION      122    253       I-domain. {ECO:0000256|HAMAP-
FT                                Rule:MF_03140}.
FT   REGION      336    344       Interaction with PCNA.
FT                                {ECO:0000256|HAMAP-Rule:MF_03140}.
FT   COILED       97    136       {ECO:0000256|SAM:Coils}.
FT   METAL        34     34       Magnesium 1. {ECO:0000256|HAMAP-
FT                                Rule:MF_03140}.
FT   METAL        86     86       Magnesium 1. {ECO:0000256|HAMAP-
FT                                Rule:MF_03140}.
FT   METAL       158    158       Magnesium 1. {ECO:0000256|HAMAP-
FT                                Rule:MF_03140}.
FT   METAL       160    160       Magnesium 1. {ECO:0000256|HAMAP-
FT                                Rule:MF_03140}.
FT   METAL       179    179       Magnesium 2. {ECO:0000256|HAMAP-
FT                                Rule:MF_03140}.
FT   METAL       181    181       Magnesium 2. {ECO:0000256|HAMAP-
FT                                Rule:MF_03140}.
FT   METAL       233    233       Magnesium 2. {ECO:0000256|HAMAP-
FT                                Rule:MF_03140}.
FT   BINDING      47     47       DNA substrate. {ECO:0000256|HAMAP-
FT                                Rule:MF_03140}.
FT   BINDING      70     70       DNA substrate. {ECO:0000256|HAMAP-
FT                                Rule:MF_03140}.
FT   BINDING     158    158       DNA substrate. {ECO:0000256|HAMAP-
FT                                Rule:MF_03140}.
FT   BINDING     231    231       DNA substrate. {ECO:0000256|HAMAP-
FT                                Rule:MF_03140}.
FT   BINDING     233    233       DNA substrate. {ECO:0000256|HAMAP-
FT                                Rule:MF_03140}.
FT   MOD_RES      19     19       Symmetric dimethylarginine; by PRMT5.
FT                                {ECO:0000256|HAMAP-Rule:MF_03140}.
FT   MOD_RES     100    100       Symmetric dimethylarginine; by PRMT5.
FT                                {ECO:0000256|HAMAP-Rule:MF_03140}.
FT   MOD_RES     104    104       Symmetric dimethylarginine; by PRMT5.
FT                                {ECO:0000256|HAMAP-Rule:MF_03140}.
FT   MOD_RES     187    187       Phosphoserine; by CDK2.
FT                                {ECO:0000256|HAMAP-Rule:MF_03140}.
FT   MOD_RES     192    192       Symmetric dimethylarginine; by PRMT5.
FT                                {ECO:0000256|HAMAP-Rule:MF_03140}.
SQ   SEQUENCE   380 AA;  42593 MW;  5154F2F6E57592C5 CRC64;
     MGIQGLAKLI ADVAPSAIRE NDIKSYFGRK VAIDASMSIY QFLIAVRQGG DVLQNEEGET
     TSHLMGMFYR TIRMMENGIK PVYVFDGKPP QLKSGELAKR SERRAEAEKQ LQQAQAAGAE
     QEVEKFTKRL VKVTKQHNDE CKHLLSLMGI PYLDAPSEAE ASCAALVKAG KVYAAATEDM
     DCLTFGSPVL MRHLTASEAK KLPIQEFHLS RILQELGLNQ EQFVDLCILL GSDYCESIRG
     IGPKRAVDLI QKHKSIEEIV RRLDPNKYPV PENWLHKEAH QLFLEPEVLD PESVELKWSE
     PNEEELIKFM CGEKQFSEER IRSGVKRLSK SRQGSTQGRL DDFFKVTGSL SSAKRKEPEP
     KGSTKKKAKT GAAGKFKRGK
//
ID   GPC5_HUMAN              Reviewed;         572 AA.
AC   P78333; B2R726; O60436; Q9BX27;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1997, sequence version 1.
DT   13-FEB-2019, entry version 155.
DE   RecName: Full=Glypican-5;
DE   Contains:
DE     RecName: Full=Secreted glypican-5;
DE   Flags: Precursor;
GN   Name=GPC5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=9070915; DOI=10.1006/geno.1996.4518;
RA   Veugelers M., Vermeesch J., Reekmans G., Steinfeld R., Marynen P.,
RA   David G.;
RT   "Characterization of glypican-5 and chromosomal localization of human
RT   GPC5, a new member of the glypican gene family.";
RL   Genomics 40:24-30(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=9331333; DOI=10.1006/dbio.1997.8690;
RA   Saunders S., Paine-Saunders S., Lander A.D.;
RT   "Expression of the cell surface proteoglycan glypican-5 is
RT   developmentally regulated in kidney, limb, and brain.";
RL   Dev. Biol. 190:78-93(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E.,
RA   Griffiths-Jones S., Jones M.C., Keenan S.J., Oliver K., Scott C.E.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Andrews D.T.,
RA   Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J., Bannerjee R.,
RA   Barlow K.F., Bates K., Beasley H., Bird C.P., Bray-Allen S.,
RA   Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M.,
RA   Clegg S.C., Cobley V., Collins J.E., Corby N., Coville G.J.,
RA   Deloukas P., Dhami P., Dunham I., Dunn M., Earthrowl M.E.,
RA   Ellington A.G., Faulkner L., Frankish A.G., Frankland J., French L.,
RA   Garner P., Garnett J., Gilbert J.G.R., Gilson C.J., Ghori J.,
RA   Grafham D.V., Gribble S.M., Griffiths C., Hall R.E., Hammond S.,
RA   Harley J.L., Hart E.A., Heath P.D., Howden P.J., Huckle E.J.,
RA   Hunt P.J., Hunt A.R., Johnson C., Johnson D., Kay M., Kimberley A.M.,
RA   King A., Laird G.K., Langford C.J., Lawlor S., Leongamornlert D.A.,
RA   Lloyd D.M., Lloyd C., Loveland J.E., Lovell J., Martin S.,
RA   Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K.M., Rice C.M., Searle S.,
RA   Sehra H.K., Shownkeen R., Skuce C.D., Smith M., Steward C.A.,
RA   Sycamore N., Tester J., Thomas D.W., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., Whitehead S.L., Willey D.L.,
RA   Wilming L., Wray P.W., Wright M.W., Young L., Coulson A., Durbin R.M.,
RA   Hubbard T., Sulston J.E., Beck S., Bentley D.R., Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Cell surface proteoglycan that bears heparan sulfate.
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Lipid-anchor,
CC       GPI-anchor {ECO:0000250}; Extracellular side {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Secreted glypican-5: Secreted, extracellular
CC       space {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: In adult, primarily expressed in the brain.
CC       Also detected in fetal brain, lung and liver.
CC       {ECO:0000269|PubMed:9070915, ECO:0000269|PubMed:9331333}.
CC   -!- SIMILARITY: Belongs to the glypican family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/GPC5ID45705ch13q31.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; U66033; AAC51118.1; -; mRNA.
DR   EMBL; AF001462; AAC12261.1; -; mRNA.
DR   EMBL; AK312815; BAG35673.1; -; mRNA.
DR   EMBL; AL157363; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL138714; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL157821; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL163537; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL162456; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC039730; AAH39730.1; -; mRNA.
DR   CCDS; CCDS9468.1; -.
DR   RefSeq; NP_004457.1; NM_004466.5.
DR   UniGene; Hs.655675; -.
DR   ProteinModelPortal; P78333; -.
DR   SMR; P78333; -.
DR   BioGrid; 108553; 6.
DR   IntAct; P78333; 3.
DR   STRING; 9606.ENSP00000366267; -.
DR   iPTMnet; P78333; -.
DR   PhosphoSitePlus; P78333; -.
DR   BioMuta; GPC5; -.
DR   DMDM; 2829667; -.
DR   jPOST; P78333; -.
DR   MaxQB; P78333; -.
DR   PaxDb; P78333; -.
DR   PeptideAtlas; P78333; -.
DR   PRIDE; P78333; -.
DR   ProteomicsDB; 57571; -.
DR   DNASU; 2262; -.
DR   Ensembl; ENST00000377067; ENSP00000366267; ENSG00000179399.
DR   GeneID; 2262; -.
DR   KEGG; hsa:2262; -.
DR   UCSC; uc010tif.3; human.
DR   CTD; 2262; -.
DR   DisGeNET; 2262; -.
DR   EuPathDB; HostDB:ENSG00000179399.14; -.
DR   GeneCards; GPC5; -.
DR   HGNC; HGNC:4453; GPC5.
DR   HPA; HPA040152; -.
DR   HPA; HPA044081; -.
DR   MIM; 602446; gene.
DR   neXtProt; NX_P78333; -.
DR   OpenTargets; ENSG00000179399; -.
DR   PharmGKB; PA28834; -.
DR   eggNOG; KOG3821; Eukaryota.
DR   eggNOG; ENOG410XST2; LUCA.
DR   GeneTree; ENSGT00940000153447; -.
DR   HOGENOM; HOG000049177; -.
DR   HOVERGEN; HBG005896; -.
DR   InParanoid; P78333; -.
DR   KO; K08111; -.
DR   OMA; FPVAYHQ; -.
DR   OrthoDB; 1097767at2759; -.
DR   PhylomeDB; P78333; -.
DR   TreeFam; TF105317; -.
DR   Reactome; R-HSA-1971475; A tetrasaccharide linker sequence is required for GAG synthesis.
DR   Reactome; R-HSA-2022928; HS-GAG biosynthesis.
DR   Reactome; R-HSA-2024096; HS-GAG degradation.
DR   Reactome; R-HSA-3560783; Defective B4GALT7 causes EDS, progeroid type.
DR   Reactome; R-HSA-3560801; Defective B3GAT3 causes JDSSDHD.
DR   Reactome; R-HSA-3656237; Defective EXT2 causes exostoses 2.
DR   Reactome; R-HSA-3656253; Defective EXT1 causes exostoses 1, TRPS2 and CHDS.
DR   Reactome; R-HSA-4420332; Defective B3GALT6 causes EDSP2 and SEMDJL1.
DR   Reactome; R-HSA-5362798; Release of Hh-Np from the secreting cell.
DR   Reactome; R-HSA-975634; Retinoid metabolism and transport.
DR   ChiTaRS; GPC5; human.
DR   GeneWiki; Glypican_5; -.
DR   GenomeRNAi; 2262; -.
DR   PRO; PR:P78333; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   Bgee; ENSG00000179399; Expressed in 121 organ(s), highest expression level in amygdala.
DR   ExpressionAtlas; P78333; baseline and differential.
DR   Genevisible; P78333; HS.
DR   GO; GO:0046658; C:anchored component of plasma membrane; IEA:InterPro.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; IEA:InterPro.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IEA:UniProtKB-SubCell.
DR   GO; GO:0005796; C:Golgi lumen; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; TAS:UniProtKB.
DR   GO; GO:0043202; C:lysosomal lumen; TAS:Reactome.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0006024; P:glycosaminoglycan biosynthetic process; TAS:Reactome.
DR   GO; GO:0006027; P:glycosaminoglycan catabolic process; TAS:Reactome.
DR   GO; GO:0009966; P:regulation of signal transduction; IEA:InterPro.
DR   GO; GO:0001523; P:retinoid metabolic process; TAS:Reactome.
DR   InterPro; IPR001863; Glypican.
DR   InterPro; IPR031188; Glypican-5.
DR   InterPro; IPR019803; Glypican_CS.
DR   PANTHER; PTHR10822; PTHR10822; 1.
DR   PANTHER; PTHR10822:SF12; PTHR10822:SF12; 1.
DR   Pfam; PF01153; Glypican; 1.
DR   PROSITE; PS01207; GLYPICAN; 1.
PE   2: Evidence at transcript level;
KW   Cell membrane; Complete proteome; Glycoprotein; GPI-anchor;
KW   Heparan sulfate; Lipoprotein; Membrane; Polymorphism; Proteoglycan;
KW   Reference proteome; Secreted; Signal.
FT   SIGNAL        1     24       {ECO:0000255}.
FT   CHAIN        25      ?       Glypican-5.
FT                                /FTId=PRO_0000012319.
FT   CHAIN        25      ?       Secreted glypican-5.
FT                                /FTId=PRO_0000333849.
FT   PROPEP        ?    572       Removed in mature form. {ECO:0000255}.
FT                                /FTId=PRO_0000012320.
FT   CARBOHYD    120    120       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    237    237       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    441    441       O-linked (Xyl...) (glycosaminoglycan)
FT                                serine. {ECO:0000255}.
FT   CARBOHYD    486    486       O-linked (Xyl...) (glycosaminoglycan)
FT                                serine. {ECO:0000255}.
FT   CARBOHYD    495    495       O-linked (Xyl...) (glycosaminoglycan)
FT                                serine. {ECO:0000255}.
FT   CARBOHYD    507    507       O-linked (Xyl...) (glycosaminoglycan)
FT                                serine. {ECO:0000255}.
FT   CARBOHYD    509    509       O-linked (Xyl...) (glycosaminoglycan)
FT                                serine. {ECO:0000255}.
FT   CARBOHYD    527    527       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT     155    155       A -> V (in dbSNP:rs553717).
FT                                /FTId=VAR_024228.
FT   CONFLICT    205    205       G -> C (in Ref. 2; AAC12261).
FT                                {ECO:0000305}.
FT   CONFLICT    245    245       S -> F (in Ref. 2; AAC12261).
FT                                {ECO:0000305}.
SQ   SEQUENCE   572 AA;  63707 MW;  A17969FE0DD0D308 CRC64;
     MDAQTWPVGF RCLLLLALVG SARSEGVQTC EEVRKLFQWR LLGAVRGLPD SPRAGPDLQV
     CISKKPTCCT RKMEERYQIA ARQDMQQFLQ TSSSTLKFLI SRNAAAFQET LETLIKQAEN
     YTSILFCSTY RNMALEAAAS VQEFFTDVGL YLFGADVNPE EFVNRFFDSL FPLVYNHLIN
     PGVTDSSLEY SECIRMARRD VSPFGNIPQR VMGQMGRSLL PSRTFLQALN LGIEVINTTD
     YLHFSKECSR ALLKMQYCPH CQGLALTKPC MGYCLNVMRG CLAHMAELNP HWHAYIRSLE
     ELSDAMHGTY DIGHVLLNFH LLVNDAVLQA HLNGQKLLEQ VNRICGRPVR TPTQSPRCSF
     DQSKEKHGMK TTTRNSEETL ANRRKEFINS LRLYRSFYGG LADQLCANEL AAADGLPCWN
     GEDIVKSYTQ RVVGNGIKAQ SGNPEVKVKG IDPVINQIID KLKHVVQLLQ GRSPKPDKWE
     LLQLGSGGGM VEQVSGDCDD EDGCGGSGSG EVKRTLKITD WMPDDMNFSD VKQIHQTDTG
     STLDTTGAGC AVATESMTFT LISVVMLLPG IW
//
ID   ID3_HUMAN               Reviewed;         119 AA.
AC   Q02535; A8K1T8; O75641;
DT   01-FEB-1995, integrated into UniProtKB/Swiss-Prot.
DT   08-FEB-2011, sequence version 2.
DT   13-FEB-2019, entry version 181.
DE   RecName: Full=DNA-binding protein inhibitor ID-3;
DE   AltName: Full=Class B basic helix-loop-helix protein 25;
DE            Short=bHLHb25;
DE   AltName: Full=Helix-loop-helix protein HEIR-1;
DE   AltName: Full=ID-like protein inhibitor HLH 1R21;
DE   AltName: Full=Inhibitor of DNA binding 3;
DE   AltName: Full=Inhibitor of differentiation 3;
GN   Name=ID3; Synonyms=1R21, BHLHB25, HEIR1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT ALA-105.
RX   PubMed=1628620;
RA   Ellmeier W., Aguzzi A., Kleiner E., Kurzbauer R., Weith A.;
RT   "Mutually exclusive expression of a helix-loop-helix gene and N-myc in
RT   human neuroblastomas and in normal development.";
RL   EMBO J. 11:2563-2571(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND VARIANT ALA-105.
RX   PubMed=8437843;
RA   Deed R.W., Bianchi S.M., Atherton G.T., Johnston D.,
RA   Santibanez-Koref M., Murphy J.J., Norton J.D.;
RT   "An immediate early human gene encodes an Id-like helix-loop-helix
RT   protein and is regulated by protein kinase C activation in diverse
RT   cell types.";
RL   Oncogene 8:599-607(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT ALA-105.
RC   TISSUE=Blood;
RX   PubMed=7828896; DOI=10.1016/0378-1119(94)90676-9;
RA   Deed R.W., Hirose T., Mitchell E.L.D., Santibanez-Koref M.F.,
RA   Norton J.D.;
RT   "Structural organisation and chromosomal mapping of the human Id-3
RT   gene.";
RL   Gene 151:309-314(1994).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ALA-105.
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ALA-105.
RC   TISSUE=Hippocampus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT ALA-105.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ALA-105.
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   INTERACTION WITH CLOCK AND ARNTL.
RX   PubMed=20861012; DOI=10.1074/jbc.M110.175182;
RA   Ward S.M., Fernando S.J., Hou T.Y., Duffield G.E.;
RT   "The transcriptional repressor ID2 can interact with the canonical
RT   clock components CLOCK and BMAL1 and mediate inhibitory effects on
RT   mPer1 expression.";
RL   J. Biol. Chem. 285:38987-39000(2010).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
CC   -!- FUNCTION: Transcriptional regulator (lacking a basic DNA binding
CC       domain) which negatively regulates the basic helix-loop-helix
CC       (bHLH) transcription factors by forming heterodimers and
CC       inhibiting their DNA binding and transcriptional activity.
CC       Implicated in regulating a variety of cellular processes,
CC       including cellular growth, senescence, differentiation, apoptosis,
CC       angiogenesis, and neoplastic transformation. Involved in
CC       myogenesis by inhibiting skeletal muscle and cardiac myocyte
CC       differentiation and promoting muscle precursor cells
CC       proliferation. Inhibits the binding of E2A-containing protein
CC       complexes to muscle creatine kinase E-box enhancer. Regulates the
CC       circadian clock by repressing the transcriptional activator
CC       activity of the CLOCK-ARNTL/BMAL1 heterodimer.
CC       {ECO:0000269|PubMed:8437843}.
CC   -!- SUBUNIT: Homodimer, and heterodimer with other HLH proteins.
CC       Interacts with COPS5 and COPS7A. Interacts with IFI204. Interacts
CC       with GATA4 and NKX2-5. Interacts with ANKRD2; both proteins
CC       cooperate in myoblast differentiation (By similarity). Interacts
CC       with CLOCK and ARNTL/BMAL1. {ECO:0000250,
CC       ECO:0000269|PubMed:20861012}.
CC   -!- INTERACTION:
CC       Q5RGS3:FAM74A1; NbExp=3; IntAct=EBI-1387094, EBI-10244822;
CC       Q99081:TCF12; NbExp=3; IntAct=EBI-1387094, EBI-722877;
CC       P15923:TCF3; NbExp=3; IntAct=EBI-1387094, EBI-769630;
CC       P15884:TCF4; NbExp=4; IntAct=EBI-1387094, EBI-533224;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- TISSUE SPECIFICITY: Expressed abundantly in lung, kidney and
CC       adrenal gland, but not in adult brain.
CC   -!- INDUCTION: By phorbol 12-myristate 13-acetate (PMA).
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA47360.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; X66924; CAA47360.1; ALT_INIT; mRNA.
DR   EMBL; X69111; CAA48862.1; -; mRNA.
DR   EMBL; X73428; CAA51827.1; -; Genomic_DNA.
DR   EMBL; BT006791; AAP35437.1; -; mRNA.
DR   EMBL; AK290003; BAF82692.1; -; mRNA.
DR   EMBL; AL021154; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471134; EAW95060.1; -; Genomic_DNA.
DR   EMBL; BC003107; AAH03107.1; -; mRNA.
DR   CCDS; CCDS237.1; -.
DR   PIR; I37092; S28529.
DR   RefSeq; NP_002158.3; NM_002167.4.
DR   UniGene; Hs.76884; -.
DR   PDB; 2LFH; NMR; -; A/B=29-83.
DR   PDBsum; 2LFH; -.
DR   ProteinModelPortal; Q02535; -.
DR   SMR; Q02535; -.
DR   BioGrid; 109625; 32.
DR   DIP; DIP-713N; -.
DR   IntAct; Q02535; 30.
DR   MINT; Q02535; -.
DR   STRING; 9606.ENSP00000363689; -.
DR   iPTMnet; Q02535; -.
DR   PhosphoSitePlus; Q02535; -.
DR   BioMuta; ID3; -.
DR   DMDM; 322510035; -.
DR   EPD; Q02535; -.
DR   jPOST; Q02535; -.
DR   MaxQB; Q02535; -.
DR   PaxDb; Q02535; -.
DR   PeptideAtlas; Q02535; -.
DR   PRIDE; Q02535; -.
DR   ProteomicsDB; 58106; -.
DR   DNASU; 3399; -.
DR   Ensembl; ENST00000374561; ENSP00000363689; ENSG00000117318.
DR   Ensembl; ENST00000634790; ENSP00000489102; ENSG00000283060.
DR   GeneID; 3399; -.
DR   KEGG; hsa:3399; -.
DR   UCSC; uc001bhh.5; human.
DR   CTD; 3399; -.
DR   DisGeNET; 3399; -.
DR   EuPathDB; HostDB:ENSG00000117318.8; -.
DR   GeneCards; ID3; -.
DR   HGNC; HGNC:5362; ID3.
DR   HPA; CAB021353; -.
DR   HPA; HPA024677; -.
DR   MIM; 600277; gene.
DR   neXtProt; NX_Q02535; -.
DR   OpenTargets; ENSG00000117318; -.
DR   PharmGKB; PA29610; -.
DR   eggNOG; ENOG410IYKY; Eukaryota.
DR   eggNOG; ENOG4112051; LUCA.
DR   GeneTree; ENSGT00940000160504; -.
DR   HOGENOM; HOG000234788; -.
DR   HOVERGEN; HBG009009; -.
DR   InParanoid; Q02535; -.
DR   KO; K17694; -.
DR   OMA; LYDMNDC; -.
DR   OrthoDB; 1624054at2759; -.
DR   PhylomeDB; Q02535; -.
DR   TreeFam; TF326217; -.
DR   SIGNOR; Q02535; -.
DR   ChiTaRS; ID3; human.
DR   GeneWiki; ID3_(gene); -.
DR   GenomeRNAi; 3399; -.
DR   PRO; PR:Q02535; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000117318; Expressed in 214 organ(s), highest expression level in right lobe of thyroid gland.
DR   Genevisible; Q02535; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IBA:GO_Central.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISM:NTNU_SB.
DR   GO; GO:1901707; F:leptomycin B binding; IEA:Ensembl.
DR   GO; GO:0046983; F:protein dimerization activity; IEA:InterPro.
DR   GO; GO:0019904; F:protein domain specific binding; IEA:Ensembl.
DR   GO; GO:0001085; F:RNA polymerase II transcription factor binding; IBA:GO_Central.
DR   GO; GO:0003714; F:transcription corepressor activity; TAS:ProtInc.
DR   GO; GO:0008134; F:transcription factor binding; IBA:GO_Central.
DR   GO; GO:0072750; P:cellular response to leptomycin B; IEA:Ensembl.
DR   GO; GO:0007417; P:central nervous system development; IEA:Ensembl.
DR   GO; GO:0007623; P:circadian rhythm; IBA:GO_Central.
DR   GO; GO:0030855; P:epithelial cell differentiation; IEA:Ensembl.
DR   GO; GO:0007507; P:heart development; IEA:Ensembl.
DR   GO; GO:0001656; P:metanephros development; IEA:Ensembl.
DR   GO; GO:0007275; P:multicellular organism development; TAS:ProtInc.
DR   GO; GO:0007517; P:muscle organ development; IEA:UniProtKB-KW.
DR   GO; GO:0043392; P:negative regulation of DNA binding; IBA:GO_Central.
DR   GO; GO:0043433; P:negative regulation of DNA-binding transcription factor activity; IDA:GDB.
DR   GO; GO:0045662; P:negative regulation of myoblast differentiation; IEA:Ensembl.
DR   GO; GO:0045665; P:negative regulation of neuron differentiation; IBA:GO_Central.
DR   GO; GO:0045668; P:negative regulation of osteoblast differentiation; IEA:Ensembl.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IEA:Ensembl.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:GDB.
DR   GO; GO:0030182; P:neuron differentiation; IBA:GO_Central.
DR   GO; GO:0030903; P:notochord development; IEA:Ensembl.
DR   GO; GO:0042476; P:odontogenesis; IEA:Ensembl.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl.
DR   GO; GO:0051726; P:regulation of cell cycle; IBA:GO_Central.
DR   GO; GO:0006275; P:regulation of DNA replication; IEA:Ensembl.
DR   GO; GO:0009611; P:response to wounding; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:Ensembl.
DR   CDD; cd00083; HLH; 1.
DR   Gene3D; 4.10.280.10; -; 1.
DR   InterPro; IPR011598; bHLH_dom.
DR   InterPro; IPR026052; DNA-bd_prot-inh.
DR   InterPro; IPR036638; HLH_DNA-bd_sf.
DR   PANTHER; PTHR11723; PTHR11723; 1.
DR   Pfam; PF00010; HLH; 1.
DR   SMART; SM00353; HLH; 1.
DR   SUPFAM; SSF47459; SSF47459; 1.
DR   PROSITE; PS50888; BHLH; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Biological rhythms; Complete proteome; Myogenesis;
KW   Nucleus; Polymorphism; Reference proteome; Repressor; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    119       DNA-binding protein inhibitor ID-3.
FT                                /FTId=PRO_0000127247.
FT   DOMAIN       28     80       bHLH. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00981}.
FT   VARIANT     105    105       T -> A (in dbSNP:rs11574).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:1628620,
FT                                ECO:0000269|PubMed:7828896,
FT                                ECO:0000269|PubMed:8437843,
FT                                ECO:0000269|Ref.4, ECO:0000269|Ref.7}.
FT                                /FTId=VAR_016122.
FT   VARIANT     111    111       S -> A (in dbSNP:rs11542317).
FT                                /FTId=VAR_030739.
FT   STRAND       40     42       {ECO:0000244|PDB:2LFH}.
FT   HELIX        43     54       {ECO:0000244|PDB:2LFH}.
FT   HELIX        66     81       {ECO:0000244|PDB:2LFH}.
SQ   SEQUENCE   119 AA;  12999 MW;  7FC38B56B4DCEFBC CRC64;
     MKALSPVRGC YEAVCCLSER SLAIARGRGK GPAAEEPLSL LDDMNHCYSR LRELVPGVPR
     GTQLSQVEIL QRVIDYILDL QVVLAEPAPG PPDGPHLPIQ TAELTPELVI SNDKRSFCH
//
ID   B3FTN5_HUMAN            Unreviewed;        55 AA.
AC   B3FTN5;
DT   22-JUL-2008, integrated into UniProtKB/TrEMBL.
DT   22-JUL-2008, sequence version 1.
DT   16-JAN-2019, entry version 42.
DE   SubName: Full=Truncated insulin-like 2 growth factor 2-binding protein 2 {ECO:0000313|EMBL:ACB86628.1};
GN   Name=IGF2BP2 {ECO:0000313|EMBL:ACB86628.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ACB86628.1};
RN   [1] {ECO:0000313|EMBL:ACB86628.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Prokunina-Olsson L., Hanisch J.J., Jackson A., Chines P.S.,
RA   Erdos M.R., Bonnycastle L.L., Swift A., Narisu N., Scott L.J.,
RA   Morken M., Mohlke K., Bergman R., Tuomilehto J., Boehnke M.,
RA   Rotimi C.N., Watanabe R.N., Collins F.S.;
RT   "A novel type 2 diabetes-associated variant of IGF2BP2 gene affects
RT   expression of a functional alternative splicing form.";
RL   Submitted (JAN-2008) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; EU408704; ACB86628.1; -; mRNA.
DR   RefSeq; NP_001278804.1; NM_001291875.2.
DR   UniGene; Hs.293396; -.
DR   UniGene; Hs.35354; -.
DR   PRIDE; B3FTN5; -.
DR   GeneID; 10644; -.
DR   CTD; 10644; -.
DR   eggNOG; KOG2193; Eukaryota.
DR   eggNOG; ENOG410ZKB4; LUCA.
DR   OrthoDB; 286875at2759; -.
DR   ChiTaRS; IGF2BP2; human.
DR   GenomeRNAi; 10644; -.
DR   GO; GO:0003729; F:mRNA binding; IEA:InterPro.
DR   InterPro; IPR028743; IGF2BP2.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   PANTHER; PTHR10288:SF93; PTHR10288:SF93; 1.
DR   SUPFAM; SSF54928; SSF54928; 1.
PE   2: Evidence at transcript level;
SQ   SEQUENCE   55 AA;  6361 MW;  04DBD5934A111D4B CRC64;
     MFSCPGHYHV DGFLNPGSRK IQIRNIPPHL QWEVLDGLLA QYGTVENVEQ EPWRS
//
ID   B4DKT5_HUMAN            Unreviewed;       300 AA.
AC   B4DKT5;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   16-JAN-2019, entry version 47.
DE   SubName: Full=cDNA FLJ53054, highly similar to Insulin-like growth factor 2 mRNA-binding protein 2 {ECO:0000313|EMBL:BAG59297.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG59297.1};
RN   [1] {ECO:0000313|EMBL:BAG59297.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Tongue {ECO:0000313|EMBL:BAG59297.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AK296703; BAG59297.1; -; mRNA.
DR   RefSeq; NP_001278803.1; NM_001291874.2.
DR   UniGene; Hs.293396; -.
DR   UniGene; Hs.35354; -.
DR   PeptideAtlas; B4DKT5; -.
DR   PRIDE; B4DKT5; -.
DR   GeneID; 10644; -.
DR   CTD; 10644; -.
DR   HOGENOM; HOG000000675; -.
DR   HOVERGEN; HBG052725; -.
DR   OrthoDB; 286875at2759; -.
DR   GenomeRNAi; 10644; -.
DR   GO; GO:0003729; F:mRNA binding; IEA:InterPro.
DR   Gene3D; 3.30.1370.10; -; 1.
DR   InterPro; IPR028743; IGF2BP2.
DR   InterPro; IPR004087; KH_dom.
DR   InterPro; IPR004088; KH_dom_type_1.
DR   InterPro; IPR036612; KH_dom_type_1_sf.
DR   PANTHER; PTHR10288:SF93; PTHR10288:SF93; 2.
DR   Pfam; PF00013; KH_1; 3.
DR   SMART; SM00322; KH; 3.
DR   SUPFAM; SSF54791; SSF54791; 3.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   DOMAIN       17     90       KH. {ECO:0000259|SMART:SM00322}.
FT   DOMAIN      127    198       KH. {ECO:0000259|SMART:SM00322}.
FT   DOMAIN      209    281       KH. {ECO:0000259|SMART:SM00322}.
FT   COILED      269    289       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   300 AA;  33323 MW;  955E57C0D69902D0 CRC64;
     MILEIMQKEA DETKLAEEIP LKILAHNGLV GRLIGKEGRN LKKIEHETGT KITISSLQDL
     SIYNPERTIT VKGTVEACAS AEIEIMKKLR EAFENDMLAV NTHSGYFSSL YPHHQFGPFP
     HHHSYPEQEI VNLFIPTQAV GAIIGKKGAH IKQLARFAGA SIKIAPAEGP DVSERMVIIT
     GPPEAQFKAQ GRIFGKLKEE NFFNPKEEVK LEAHIRVPSS TAGRVIGKGG KTVNELQNLT
     SAEVIVPRGQ TPDENEEVIV RIIGHFFASQ TAQRKIREIV QQVKQQEQKY PQGVASQRSK
//
ID   F8W930_HUMAN            Unreviewed;       605 AA.
AC   F8W930;
DT   21-SEP-2011, integrated into UniProtKB/TrEMBL.
DT   21-SEP-2011, sequence version 1.
DT   16-JAN-2019, entry version 67.
DE   SubName: Full=Insulin-like growth factor 2 mRNA-binding protein 2 {ECO:0000313|Ensembl:ENSP00000410242};
GN   Name=IGF2BP2 {ECO:0000313|Ensembl:ENSP00000410242};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000410242, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000410242, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [2] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [3] {ECO:0000213|PubMed:19413330}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [4] {ECO:0000213|PubMed:19690332}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:ra46-RA46(2009).
RN   [5] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [6] {ECO:0000213|PubMed:21406692}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:rs3-RS3(2011).
RN   [7] {ECO:0000313|Ensembl:ENSP00000410242}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
RN   [8] {ECO:0000213|PubMed:22223895}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large scale characterization of plant versus mammal
RT   proteins reveals similar and idiosyncratic N-alpha-acetylation
RT   features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [9] {ECO:0000213|PubMed:22814378}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [10] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AC016961; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC108670; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001278798.1; NM_001291869.2.
DR   UniGene; Hs.293396; -.
DR   UniGene; Hs.35354; -.
DR   ProteinModelPortal; F8W930; -.
DR   EPD; F8W930; -.
DR   jPOST; F8W930; -.
DR   MaxQB; F8W930; -.
DR   PRIDE; F8W930; -.
DR   Ensembl; ENST00000457616; ENSP00000410242; ENSG00000073792.
DR   GeneID; 10644; -.
DR   UCSC; uc062qzi.1; human.
DR   CTD; 10644; -.
DR   EuPathDB; HostDB:ENSG00000073792.15; -.
DR   HGNC; HGNC:28867; IGF2BP2.
DR   OpenTargets; ENSG00000073792; -.
DR   eggNOG; KOG2193; Eukaryota.
DR   eggNOG; ENOG410ZKB4; LUCA.
DR   GeneTree; ENSGT00940000154913; -.
DR   OMA; TERMVII; -.
DR   OrthoDB; 286875at2759; -.
DR   PhylomeDB; F8W930; -.
DR   ChiTaRS; IGF2BP2; human.
DR   GenomeRNAi; 10644; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000073792; Expressed in 204 organ(s), highest expression level in kidney.
DR   ExpressionAtlas; F8W930; baseline and differential.
DR   GO; GO:0003729; F:mRNA binding; IEA:InterPro.
DR   CDD; cd12626; RRM1_IGF2BP2; 1.
DR   Gene3D; 3.30.1370.10; -; 2.
DR   Gene3D; 3.30.70.330; -; 2.
DR   InterPro; IPR028743; IGF2BP2.
DR   InterPro; IPR034843; IGF2BP2_RRM1.
DR   InterPro; IPR004087; KH_dom.
DR   InterPro; IPR004088; KH_dom_type_1.
DR   InterPro; IPR036612; KH_dom_type_1_sf.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   PANTHER; PTHR10288:SF93; PTHR10288:SF93; 1.
DR   Pfam; PF00013; KH_1; 4.
DR   Pfam; PF00076; RRM_1; 2.
DR   SMART; SM00322; KH; 4.
DR   SMART; SM00360; RRM; 2.
DR   SUPFAM; SSF54791; SSF54791; 4.
DR   SUPFAM; SSF54928; SSF54928; 1.
DR   PROSITE; PS50102; RRM; 2.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:F8W930,
KW   ECO:0000213|MaxQB:F8W930, ECO:0000213|PeptideAtlas:F8W930};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   RNA-binding {ECO:0000256|PROSITE-ProRule:PRU00176}.
FT   DOMAIN        3     76       RRM. {ECO:0000259|PROSITE:PS50102}.
FT   DOMAIN       82    163       RRM. {ECO:0000259|PROSITE:PS50102}.
FT   COILED      574    594       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   605 AA;  66786 MW;  8A8554375CE9ED0D CRC64;
     MMNKLYIGNL SPAVTADDLR QLFGDRKLPL AGQVLLKSGY AFVDYPDQNW AIRAIETLSG
     KVELHGKIME VDYSVSKKLR SRKIQIRNIP PHLQWEVLDG LLAQYGTVEN VEQVFAFSLV
     NTDTETAVVN VTYATREEAK IAMEKLSGHQ FENYSFKISY IPDEEVSSPS PPQRAQRGDH
     SSREQGHAPG GTSQARQIDF PLRILVPTQF VGAIIGKEGL TIKNITKQTQ SRVDIHRKEN
     SGAAEKPVTI HATPEGTSEA CRMILEIMQK EADETKLAEE IPLKILAHNG LVGRLIGKEG
     RNLKKIEHET GTKITISSLQ DLSIYNPERT ITVKGTVEAC ASAEIEIMKK LREAFENDML
     AVNQQANLIP GLNLSALGIF STGLSVLSPP AGPRGAPPAA PYHPFTTHSG YFSSLYPHHQ
     FGPFPHHHSY PEQEIVNLFI PTQAVGAIIG KKGAHIKQLA RFAGASIKIA PAEGPDVSER
     MVIITGPPEA QFKAQGRIFG KLKEENFFNP KEEVKLEAHI RVPSSTAGRV IGKGGKTVNE
     LQNLTSAEVI VPRDQTPDEN EEVIVRIIGH FFASQTAQRK IREIVQQVKQ QEQKYPQGVA
     SQRSK
//
ID   IF2B2_HUMAN             Reviewed;         599 AA.
AC   Q9Y6M1; A0A4Z0; B3FTN2; B3FTN3; B3FTN4;
DT   27-JUN-2006, integrated into UniProtKB/Swiss-Prot.
DT   03-MAR-2009, sequence version 2.
DT   13-FEB-2019, entry version 165.
DE   RecName: Full=Insulin-like growth factor 2 mRNA-binding protein 2;
DE            Short=IGF2 mRNA-binding protein 2;
DE            Short=IMP-2;
DE   AltName: Full=Hepatocellular carcinoma autoantigen p62;
DE   AltName: Full=IGF-II mRNA-binding protein 2;
DE   AltName: Full=VICKZ family member 2;
GN   Name=IGF2BP2; Synonyms=IMP2, VICKZ2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), IDENTIFICATION AS A
RP   HEPATOCELLULAR CARCINOMA ANTIGEN, TISSUE SPECIFICITY, AND SUBCELLULAR
RP   LOCATION.
RC   TISSUE=Colon adenocarcinoma;
RX   PubMed=10190901; DOI=10.1084/jem.189.7.1101;
RA   Zhang J.-Y., Chan E.K.L., Peng X.-X., Tan E.M.;
RT   "A novel cytoplasmic protein with RNA-binding motifs is an autoantigen
RT   in human hepatocellular carcinoma.";
RL   J. Exp. Med. 189:1101-1110(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 3; 4 AND 5).
RC   TISSUE=Pancreatic islet;
RA   Prokunina-Olsson L., Hanisch J.J., Jackson A., Chines P.S.,
RA   Erdos M.R., Bonnycastle L.L., Swift A., Narisu N., Scott L.J.,
RA   Morken M., Mohlke K., Bergman R., Tuomilehto J., Boehnke M.,
RA   Rotimi C.N., Watanabe R.N., Collins F.S.;
RT   "A novel type 2 diabetes-associated variant of IGF2BP2 gene affects
RT   expression of a functional alternative splicing form.";
RL   Submitted (JAN-2008) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=9891060; DOI=10.1128/MCB.19.2.1262;
RA   Nielsen J., Christiansen J., Lykke-Andersen J., Johnsen A.H.,
RA   Wewer U.M., Nielsen F.C.;
RT   "A family of insulin-like growth factor II mRNA-binding proteins
RT   represses translation in late development.";
RL   Mol. Cell. Biol. 19:1262-1270(1999).
RN   [6]
RP   INTERACTION WITH HNRPD.
RX   PubMed=12674497; DOI=10.1515/BC.2003.004;
RA   Moraes K.C., Quaresma A.J., Maehnss K., Kobarg J.;
RT   "Identification and characterization of proteins that selectively
RT   interact with isoforms of the mRNA binding protein AUF1 (hnRNP D).";
RL   Biol. Chem. 384:25-37(2003).
RN   [7]
RP   REVIEW.
RX   PubMed=15601260; DOI=10.1042/BC20040151;
RA   Yisraeli J.K.;
RT   "VICKZ proteins: a multi-talented family of regulatory RNA-binding
RT   proteins.";
RL   Biol. Cell 97:87-96(2005).
RN   [8]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=16049158; DOI=10.1530/rep.1.00664;
RA   Hammer N.A., Hansen T.O., Byskov A.G., Rajpert-De Meyts E.,
RA   Groendahl M.L., Bredkjaer H.E., Wewer U.M., Christiansen J.,
RA   Nielsen F.C.;
RT   "Expression of IGF-II mRNA-binding proteins (IMPs) in gonads and
RT   testicular cancer.";
RL   Reproduction 130:203-212(2005).
RN   [9]
RP   INTERACTION WITH IGF2BP1, AND SUBCELLULAR LOCATION.
RX   PubMed=17289661; DOI=10.1074/mcp.M600346-MCP200;
RA   Joeson L., Vikesaa J., Krogh A., Nielsen L.K., Hansen T., Borup R.,
RA   Johnsen A.H., Christiansen J., Nielsen F.C.;
RT   "Molecular composition of IMP1 ribonucleoprotein granules.";
RL   Mol. Cell. Proteomics 6:798-811(2007).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-162 AND SER-164, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-164, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [13]
RP   RNA-BINDING, AND DOMAIN.
RX   PubMed=20080952; DOI=10.1101/gad.1862910;
RA   Chao J.A., Patskovsky Y., Patel V., Levy M., Almo S.C., Singer R.H.;
RT   "ZBP1 recognition of beta-actin zipcode induces RNA looping.";
RL   Genes Dev. 24:148-158(2010).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-162 AND SER-164, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1 (ISOFORM 6), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [17]
RP   ALTERNATIVE INITIATION (ISOFORM 6).
RX   PubMed=22427968; DOI=10.1371/journal.pone.0033140;
RA   Le H.T., Sorrell A.M., Siddle K.;
RT   "Two isoforms of the mRNA binding protein IGF2BP2 are generated by
RT   alternative translational initiation.";
RL   PLoS ONE 7:E33140-E33140(2012).
RN   [18]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1 (ISOFORM 6), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [19]
RP   FUNCTION, RNA-BINDING, OLIGOMERIZATION, INTERACTION WITH ELAVL1; DHX9
RP   AND HNRNPU, SUBCELLULAR LOCATION, DOMAIN, AND MUTAGENESIS OF LYS-211;
RP   LYS-292; 445-LYS-LYS-446 AND 527-LYS-GLY-528.
RX   PubMed=23640942; DOI=10.1515/hsz-2013-0111;
RA   Wachter K., Kohn M., Stohr N., Huttelmaier S.;
RT   "Subcellular localization and RNP formation of IGF2BPs (IGF2 mRNA-
RT   binding proteins) is modulated by distinct RNA-binding domains.";
RL   Biol. Chem. 394:1077-1090(2013).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-11 AND SER-164, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [21]
RP   STRUCTURE BY NMR OF 2-81.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the RNA binding domain of IGF-II mRNA-binding
RT   protein 2.";
RL   Submitted (NOV-2005) to the PDB data bank.
CC   -!- FUNCTION: RNA-binding factor that recruits target transcripts to
CC       cytoplasmic protein-RNA complexes (mRNPs). This transcript
CC       'caging' into mRNPs allows mRNA transport and transient storage.
CC       It also modulates the rate and location at which target
CC       transcripts encounter the translational apparatus and shields them
CC       from endonuclease attacks or microRNA-mediated degradation (By
CC       similarity). Binds to the 5'-UTR of the insulin-like growth factor
CC       2 (IGF2) mRNAs. Binding is isoform-specific. Binds to beta-
CC       actin/ACTB and MYC transcripts. {ECO:0000250,
CC       ECO:0000269|PubMed:23640942, ECO:0000269|PubMed:9891060}.
CC   -!- SUBUNIT: Can form homooligomers and heterooligomers with IGF2BP1
CC       and IGF2BP3 in an RNA-dependent manner. Interacts with HNRPD and
CC       IGF2BP1. Interacts with ELAVL1, DHX9 and HNRNPU.
CC       {ECO:0000269|PubMed:12674497, ECO:0000269|PubMed:17289661,
CC       ECO:0000269|PubMed:23640942}.
CC   -!- INTERACTION:
CC       Q14103-4:HNRNPD; NbExp=4; IntAct=EBI-1024419, EBI-432545;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Note=Localized in
CC       cytoplasmic mRNP granules containing untranslated mRNAs. Localizes
CC       at the connecting piece and the tail of the spermatozoa. In
CC       response to cellular stress, such as oxidative stress, recruited
CC       to stress granules.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing, Alternative initiation; Named isoforms=6;
CC       Name=1;
CC         IsoId=Q9Y6M1-2; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9Y6M1-1; Sequence=VSP_036553;
CC       Name=3;
CC         IsoId=Q9Y6M1-3; Sequence=VSP_036550;
CC       Name=4;
CC         IsoId=Q9Y6M1-4; Sequence=VSP_036550, VSP_036552;
CC       Name=5;
CC         IsoId=Q9Y6M1-5; Sequence=VSP_036550, VSP_036553;
CC       Name=6;
CC         IsoId=Q9Y6M1-6; Sequence=VSP_043699;
CC         Note=Generated by alternative initiation at Met-69. Contains a
CC         N-acetylmethionine at position 1. {ECO:0000244|PubMed:22223895,
CC         ECO:0000244|PubMed:22814378};
CC   -!- TISSUE SPECIFICITY: Expressed in oocytes, granulosa cells of small
CC       and growing follicles, Leydig cells, spermatogonia and semen (at
CC       protein level). Expressed in testicular cancer (at protein level).
CC       Expressed weakly in heart, placenta, skeletal muscle, bone marrow,
CC       colon, kidney, salivary glands, testis and pancreas. Detected in
CC       fetal liver, fetal ovary, gonocytes and interstitial cells of the
CC       testis. {ECO:0000269|PubMed:10190901,
CC       ECO:0000269|PubMed:16049158}.
CC   -!- DOMAIN: Domain KH3 and KH4 are the major RNA-binding modules,
CC       although KH1 and KH2 may also contribute. The contribution to RNA-
CC       binding of individual KH domains may be target-specific. KH1 and
CC       KH2, and possibly KH3 and KH4, promote the formation of higher
CC       ordered protein-RNA complexes, which may be essential for IGF2BP1
CC       cytoplasmic retention. KH domains are required for RNA-dependent
CC       homo- and heterooligomerization and for localization to stress
CC       granules. {ECO:0000269|PubMed:20080952,
CC       ECO:0000269|PubMed:23640942}.
CC   -!- MISCELLANEOUS: Autoantibodies against IGF2BP2 are detected in sera
CC       from some patients with hepatocellular carcinoma.
CC   -!- SIMILARITY: Belongs to the RRM IMP/VICKZ family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH21290.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AF057352; AAD31596.1; -; mRNA.
DR   EMBL; EU408701; ACB86625.1; -; mRNA.
DR   EMBL; EU408702; ACB86626.1; -; mRNA.
DR   EMBL; EU408703; ACB86627.1; -; mRNA.
DR   EMBL; AC016961; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC108670; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC021290; AAH21290.1; ALT_INIT; mRNA.
DR   CCDS; CCDS3273.2; -. [Q9Y6M1-2]
DR   CCDS; CCDS33903.1; -. [Q9Y6M1-1]
DR   CCDS; CCDS77869.1; -. [Q9Y6M1-3]
DR   RefSeq; NP_001007226.1; NM_001007225.2. [Q9Y6M1-1]
DR   RefSeq; NP_001278801.1; NM_001291872.2. [Q9Y6M1-4]
DR   RefSeq; NP_001278802.1; NM_001291873.2. [Q9Y6M1-3]
DR   RefSeq; NP_001278803.1; NM_001291874.2. [Q9Y6M1-5]
DR   RefSeq; NP_001278804.1; NM_001291875.2.
DR   RefSeq; NP_006539.3; NM_006548.5. [Q9Y6M1-2]
DR   UniGene; Hs.293396; -.
DR   UniGene; Hs.35354; -.
DR   PDB; 2CQH; NMR; -; A=2-81.
DR   PDBsum; 2CQH; -.
DR   ProteinModelPortal; Q9Y6M1; -.
DR   SMR; Q9Y6M1; -.
DR   BioGrid; 115888; 128.
DR   DIP; DIP-35539N; -.
DR   IntAct; Q9Y6M1; 38.
DR   MINT; Q9Y6M1; -.
DR   STRING; 9606.ENSP00000371634; -.
DR   iPTMnet; Q9Y6M1; -.
DR   PhosphoSitePlus; Q9Y6M1; -.
DR   SwissPalm; Q9Y6M1; -.
DR   BioMuta; IGF2BP2; -.
DR   DMDM; 224471831; -.
DR   EPD; Q9Y6M1; -.
DR   jPOST; Q9Y6M1; -.
DR   MaxQB; Q9Y6M1; -.
DR   PaxDb; Q9Y6M1; -.
DR   PeptideAtlas; Q9Y6M1; -.
DR   PRIDE; Q9Y6M1; -.
DR   ProteomicsDB; 86724; -.
DR   ProteomicsDB; 86725; -. [Q9Y6M1-1]
DR   ProteomicsDB; 86726; -. [Q9Y6M1-3]
DR   ProteomicsDB; 86727; -. [Q9Y6M1-4]
DR   ProteomicsDB; 86728; -. [Q9Y6M1-5]
DR   ProteomicsDB; 86729; -. [Q9Y6M1-6]
DR   DNASU; 10644; -.
DR   Ensembl; ENST00000346192; ENSP00000320204; ENSG00000073792. [Q9Y6M1-1]
DR   Ensembl; ENST00000382199; ENSP00000371634; ENSG00000073792. [Q9Y6M1-2]
DR   Ensembl; ENST00000421047; ENSP00000413787; ENSG00000073792. [Q9Y6M1-3]
DR   GeneID; 10644; -.
DR   KEGG; hsa:10644; -.
DR   UCSC; uc003fpo.4; human. [Q9Y6M1-2]
DR   CTD; 10644; -.
DR   DisGeNET; 10644; -.
DR   EuPathDB; HostDB:ENSG00000073792.15; -.
DR   GeneCards; IGF2BP2; -.
DR   HGNC; HGNC:28867; IGF2BP2.
DR   HPA; CAB017126; -.
DR   HPA; HPA035145; -.
DR   MalaCards; IGF2BP2; -.
DR   MIM; 608289; gene.
DR   neXtProt; NX_Q9Y6M1; -.
DR   OpenTargets; ENSG00000073792; -.
DR   PharmGKB; PA128394577; -.
DR   eggNOG; KOG2193; Eukaryota.
DR   eggNOG; ENOG410ZKB4; LUCA.
DR   GeneTree; ENSGT00940000154913; -.
DR   HOGENOM; HOG000000675; -.
DR   HOVERGEN; HBG052725; -.
DR   InParanoid; Q9Y6M1; -.
DR   KO; K17392; -.
DR   OrthoDB; 286875at2759; -.
DR   PhylomeDB; Q9Y6M1; -.
DR   TreeFam; TF320229; -.
DR   Reactome; R-HSA-428359; Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA.
DR   ChiTaRS; IGF2BP2; human.
DR   EvolutionaryTrace; Q9Y6M1; -.
DR   GeneWiki; IGF2BP2; -.
DR   GenomeRNAi; 10644; -.
DR   PRO; PR:Q9Y6M1; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000073792; Expressed in 204 organ(s), highest expression level in kidney.
DR   ExpressionAtlas; Q9Y6M1; baseline and differential.
DR   Genevisible; Q9Y6M1; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0005856; C:cytoskeleton; IDA:BHF-UCL.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:BHF-UCL.
DR   GO; GO:0003730; F:mRNA 3'-UTR binding; IDA:UniProtKB.
DR   GO; GO:0048027; F:mRNA 5'-UTR binding; IDA:BHF-UCL.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0045182; F:translation regulator activity; ISS:BHF-UCL.
DR   GO; GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc.
DR   GO; GO:0051028; P:mRNA transport; IEA:UniProtKB-KW.
DR   GO; GO:0017148; P:negative regulation of translation; ISS:BHF-UCL.
DR   GO; GO:0042035; P:regulation of cytokine biosynthetic process; IC:BHF-UCL.
DR   GO; GO:0043488; P:regulation of mRNA stability; TAS:Reactome.
DR   CDD; cd12626; RRM1_IGF2BP2; 1.
DR   Gene3D; 3.30.1370.10; -; 2.
DR   Gene3D; 3.30.70.330; -; 2.
DR   InterPro; IPR028743; IGF2BP2.
DR   InterPro; IPR034843; IGF2BP2_RRM1.
DR   InterPro; IPR004087; KH_dom.
DR   InterPro; IPR004088; KH_dom_type_1.
DR   InterPro; IPR036612; KH_dom_type_1_sf.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   PANTHER; PTHR10288:SF93; PTHR10288:SF93; 1.
DR   Pfam; PF00013; KH_1; 4.
DR   Pfam; PF00076; RRM_1; 2.
DR   SMART; SM00322; KH; 4.
DR   SMART; SM00360; RRM; 2.
DR   SUPFAM; SSF54791; SSF54791; 4.
DR   SUPFAM; SSF54928; SSF54928; 1.
DR   PROSITE; PS50084; KH_TYPE_1; 4.
DR   PROSITE; PS50102; RRM; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative initiation;
KW   Alternative splicing; Complete proteome; Cytoplasm; mRNA transport;
KW   Nucleus; Phosphoprotein; Reference proteome; Repeat; RNA-binding;
KW   Translation regulation; Transport.
FT   CHAIN         1    599       Insulin-like growth factor 2 mRNA-binding
FT                                protein 2.
FT                                /FTId=PRO_0000244496.
FT   DOMAIN        3     76       RRM 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00176}.
FT   DOMAIN       82    157       RRM 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00176}.
FT   DOMAIN      193    258       KH 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00117}.
FT   DOMAIN      274    341       KH 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00117}.
FT   DOMAIN      427    492       KH 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00117}.
FT   DOMAIN      509    575       KH 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00117}.
FT   MOD_RES      11     11       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     162    162       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES     164    164       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     550    550       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q5SF07}.
FT   VAR_SEQ       1     80       MMNKLYIGNLSPAVTADDLRQLFGDRKLPLAGQVLLKSGYA
FT                                FVDYPDQNWAIRAIETLSGKVELHGKIMEVDYSVSKKLR
FT                                -> MFSCPGHYHVDGFLNPG (in isoform 3,
FT                                isoform 4 and isoform 5).
FT                                {ECO:0000303|Ref.2}.
FT                                /FTId=VSP_036550.
FT   VAR_SEQ       1     68       Missing (in isoform 6). {ECO:0000305}.
FT                                /FTId=VSP_043699.
FT   VAR_SEQ     113    113       Q -> QVFAFSL (in isoform 4).
FT                                {ECO:0000303|Ref.2}.
FT                                /FTId=VSP_036552.
FT   VAR_SEQ     358    400       Missing (in isoform 2 and isoform 5).
FT                                {ECO:0000303|PubMed:10190901,
FT                                ECO:0000303|Ref.2}.
FT                                /FTId=VSP_036553.
FT   MUTAGEN     211    211       K->E: Significantly impaired binding to
FT                                ACTB transcript, but little effect on MYC
FT                                transcript binding, accumulation in the
FT                                nucleus; when associated with E-292. Loss
FT                                of homo- and heterooligomerization with
FT                                IGF2BP1 and IGF2BP2, almost complete loss
FT                                of ACTB and MYC transcript binding,
FT                                almost complete loss of ELAVL1-,
FT                                DHX9- and HNRNPU-binding and perturbed
FT                                subcellular location, including
FT                                accumulation in the nucleus and loss of
FT                                localization to stress granules; when
FT                                associated with E-292; 445-E-E-446 and
FT                                526-E-E-527.
FT                                {ECO:0000269|PubMed:23640942}.
FT   MUTAGEN     292    292       K->E: Significantly impaired binding to
FT                                ACTB transcript, but little effect on MYC
FT                                transcript binding, accumulation in the
FT                                nucleus; when associated with E-211. Loss
FT                                of homo- and heterooligomerization with
FT                                IGF2BP1 and IGF2BP2, almost complete loss
FT                                of ACTB and MYC transcript binding,
FT                                almost complete loss of ELAVL1-,
FT                                DHX9- and HNRNPU-binding and perturbed
FT                                subcellular location, including
FT                                accumulation in the nucleus and loss of
FT                                localization to stress granules; when
FT                                associated with E-211; 445-E-E-445 and
FT                                526-E-E-527.
FT                                {ECO:0000269|PubMed:23640942}.
FT   MUTAGEN     445    446       KK->EE: Significantly impaired binding to
FT                                ACTB and MYC transcripts; when associated
FT                                with 527-E-E-528. Loss of homo- and
FT                                heterooligomerization with IGF2BP1 and
FT                                IGF2BP2, almost complete loss of ACTB and
FT                                MYC transcript binding, almost complete
FT                                loss of ELAVL1-, DHX9- and HNRNPU-binding
FT                                and perturbed subcellular location,
FT                                including accumulation in the nucleus and
FT                                loss of localization to stress granules;
FT                                when associated with E-211; E-292 and
FT                                527-E-E-528.
FT                                {ECO:0000269|PubMed:23640942}.
FT   MUTAGEN     527    528       KG->EE: Significantly impaired binding to
FT                                ACTB and MYC transcripts; when associated
FT                                with 445-E-E-446. Loss of homo- and
FT                                heterooligomerization with IGF2BP1 and
FT                                IGF2BP2, almost complete loss of ACTB and
FT                                MYC transcript binding, almost complete
FT                                loss of ELAVL1-, DHX9- and HNRNPU-binding
FT                                and perturbed subcellular location,
FT                                including accumulation in the nucleus and
FT                                loss of localization to stress granules;
FT                                when associated with E-211; E-292 and
FT                                445-E-E-446.
FT                                {ECO:0000269|PubMed:23640942}.
FT   STRAND        5      8       {ECO:0000244|PDB:2CQH}.
FT   HELIX        16     25       {ECO:0000244|PDB:2CQH}.
FT   STRAND       34     37       {ECO:0000244|PDB:2CQH}.
FT   STRAND       40     43       {ECO:0000244|PDB:2CQH}.
FT   HELIX        48     58       {ECO:0000244|PDB:2CQH}.
FT   TURN         59     61       {ECO:0000244|PDB:2CQH}.
FT   STRAND       70     73       {ECO:0000244|PDB:2CQH}.
SQ   SEQUENCE   599 AA;  66121 MW;  EA656F8733BBB39A CRC64;
     MMNKLYIGNL SPAVTADDLR QLFGDRKLPL AGQVLLKSGY AFVDYPDQNW AIRAIETLSG
     KVELHGKIME VDYSVSKKLR SRKIQIRNIP PHLQWEVLDG LLAQYGTVEN VEQVNTDTET
     AVVNVTYATR EEAKIAMEKL SGHQFENYSF KISYIPDEEV SSPSPPQRAQ RGDHSSREQG
     HAPGGTSQAR QIDFPLRILV PTQFVGAIIG KEGLTIKNIT KQTQSRVDIH RKENSGAAEK
     PVTIHATPEG TSEACRMILE IMQKEADETK LAEEIPLKIL AHNGLVGRLI GKEGRNLKKI
     EHETGTKITI SSLQDLSIYN PERTITVKGT VEACASAEIE IMKKLREAFE NDMLAVNQQA
     NLIPGLNLSA LGIFSTGLSV LSPPAGPRGA PPAAPYHPFT THSGYFSSLY PHHQFGPFPH
     HHSYPEQEIV NLFIPTQAVG AIIGKKGAHI KQLARFAGAS IKIAPAEGPD VSERMVIITG
     PPEAQFKAQG RIFGKLKEEN FFNPKEEVKL EAHIRVPSST AGRVIGKGGK TVNELQNLTS
     AEVIVPRDQT PDENEEVIVR IIGHFFASQT AQRKIREIVQ QVKQQEQKYP QGVASQRSK
//
ID   LAR4B_HUMAN             Reviewed;         738 AA.
AC   Q92615; A7MD20; Q5T3R3; Q5T3R4; Q5T3R5; Q68CY4;
DT   20-MAR-2007, integrated into UniProtKB/Swiss-Prot.
DT   20-MAR-2007, sequence version 3.
DT   13-FEB-2019, entry version 162.
DE   RecName: Full=La-related protein 4B;
DE   AltName: Full=La ribonucleoprotein domain family member 4B;
DE   AltName: Full=La ribonucleoprotein domain family member 5;
DE   AltName: Full=La-related protein 5;
GN   Name=LARP4B; Synonyms=KIAA0217, LARP5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=9039502; DOI=10.1093/dnares/3.5.321;
RA   Nagase T., Seki N., Ishikawa K., Ohira M., Kawarabayasi Y., Ohara O.,
RA   Tanaka A., Kotani H., Miyajima N., Nomura N.;
RT   "Prediction of the coding sequences of unidentified human genes. VI.
RT   The coding sequences of 80 new genes (KIAA0201-KIAA0280) deduced by
RT   analysis of cDNA clones from cell line KG-1 and brain.";
RL   DNA Res. 3:321-329(1996).
RN   [2]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 495-738.
RC   TISSUE=Fetal kidney;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-434 AND THR-566, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17924679; DOI=10.1021/pr070152u;
RA   Yu L.R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
RT   "Improved titanium dioxide enrichment of phosphopeptides from HeLa
RT   cells and high confident phosphopeptide identification by cross-
RT   validation of MS/MS and MS/MS/MS spectra.";
RL   J. Proteome Res. 6:4150-4162(2007).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=T-cell;
RX   PubMed=19367720; DOI=10.1021/pr800500r;
RA   Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.;
RT   "Phosphorylation analysis of primary human T lymphocytes using
RT   sequential IMAC and titanium oxide enrichment.";
RL   J. Proteome Res. 7:5167-5176(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-424; SER-434; SER-451;
RP   SER-524; SER-727 AND SER-736, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-424; THR-518 AND
RP   SER-524, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-724, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [16]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH PABPC1 AND RACK1.
RX   PubMed=20573744; DOI=10.1261/rna.2146910;
RA   Schaffler K., Schulz K., Hirmer A., Wiesner J., Grimm M., Sickmann A.,
RA   Fischer U.;
RT   "A stimulatory role for the La-related protein 4B in translation.";
RL   RNA 16:1488-1499(2010).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [19]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-451; SER-488; SER-524;
RP   SER-556; SER-568; SER-601; SER-664 AND SER-718, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-601, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [22]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-404 AND ARG-419, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.O113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V.,
RA   Aguiar M., Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C.,
RA   Vemulapalli V., Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [23] {ECO:0000244|PDB:3PTH}
RP   X-RAY CRYSTALLOGRAPHY (1.70 ANGSTROMS) OF 55-69 IN COMPLEX WITH
RP   PABPC1.
RA   Grimm C., Pelz J.P.;
RT   "LARP4B binds to the PABC1 MLLE domain via a variant PAM2 motif.";
RL   Submitted (DEC-2010) to the PDB data bank.
CC   -!- FUNCTION: Stimulates mRNA translation.
CC       {ECO:0000269|PubMed:20573744}.
CC   -!- SUBUNIT: Interacts with PABPC1 (PubMed:20573744, Ref.23).
CC       Interacts with RACK1 (PubMed:20573744). Associates with polysomes
CC       via the 40S ribosomal subunit (PubMed:20573744).
CC       {ECO:0000269|PubMed:20573744, ECO:0000269|Ref.23}.
CC   -!- INTERACTION:
CC       E9KL35:-; NbExp=3; IntAct=EBI-1052558, EBI-8456500;
CC       P63244:RACK1; NbExp=3; IntAct=EBI-1052558, EBI-296739;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol
CC       {ECO:0000269|PubMed:20573744}. Note=Localized in cytoplasmic mRNP
CC       granules containing untranslated mRNAs in response to arsenite
CC       treatment. {ECO:0000269|PubMed:20573744}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA13207.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; D86971; BAA13207.2; ALT_INIT; mRNA.
DR   EMBL; AK292946; BAF85635.1; -; mRNA.
DR   EMBL; AL359878; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL157709; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471072; EAW86530.1; -; Genomic_DNA.
DR   EMBL; BC131630; AAI31631.1; -; mRNA.
DR   EMBL; BC152443; AAI52444.1; -; mRNA.
DR   EMBL; CR749653; CAH18446.1; -; mRNA.
DR   CCDS; CCDS31131.1; -.
DR   RefSeq; NP_055970.1; NM_015155.2.
DR   UniGene; Hs.159069; -.
DR   UniGene; Hs.215766; -.
DR   PDB; 3PTH; X-ray; 1.70 A; B=55-69.
DR   PDBsum; 3PTH; -.
DR   ProteinModelPortal; Q92615; -.
DR   SMR; Q92615; -.
DR   BioGrid; 116795; 100.
DR   ELM; Q92615; -.
DR   IntAct; Q92615; 27.
DR   MINT; Q92615; -.
DR   STRING; 9606.ENSP00000326128; -.
DR   iPTMnet; Q92615; -.
DR   PhosphoSitePlus; Q92615; -.
DR   BioMuta; LARP4B; -.
DR   DMDM; 134034150; -.
DR   EPD; Q92615; -.
DR   jPOST; Q92615; -.
DR   MaxQB; Q92615; -.
DR   PaxDb; Q92615; -.
DR   PeptideAtlas; Q92615; -.
DR   PRIDE; Q92615; -.
DR   ProteomicsDB; 75363; -.
DR   Ensembl; ENST00000316157; ENSP00000326128; ENSG00000107929.
DR   Ensembl; ENST00000612396; ENSP00000482767; ENSG00000107929.
DR   GeneID; 23185; -.
DR   KEGG; hsa:23185; -.
DR   UCSC; uc031ptb.1; human.
DR   CTD; 23185; -.
DR   DisGeNET; 23185; -.
DR   EuPathDB; HostDB:ENSG00000107929.14; -.
DR   GeneCards; LARP4B; -.
DR   HGNC; HGNC:28987; LARP4B.
DR   HPA; HPA036566; -.
DR   HPA; HPA042738; -.
DR   MIM; 616513; gene.
DR   neXtProt; NX_Q92615; -.
DR   OpenTargets; ENSG00000107929; -.
DR   PharmGKB; PA165548762; -.
DR   eggNOG; ENOG410IN3Y; Eukaryota.
DR   eggNOG; ENOG4111REM; LUCA.
DR   GeneTree; ENSGT00940000157755; -.
DR   HOGENOM; HOG000004803; -.
DR   HOVERGEN; HBG055137; -.
DR   InParanoid; Q92615; -.
DR   KO; K18763; -.
DR   OMA; FRPLDMS; -.
DR   OrthoDB; 263288at2759; -.
DR   PhylomeDB; Q92615; -.
DR   TreeFam; TF321960; -.
DR   ChiTaRS; LARP4B; human.
DR   GenomeRNAi; 23185; -.
DR   PRO; PR:Q92615; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000107929; Expressed in 226 organ(s), highest expression level in adrenal tissue.
DR   ExpressionAtlas; Q92615; baseline and differential.
DR   Genevisible; Q92615; HS.
DR   GO; GO:0010494; C:cytoplasmic stress granule; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0042788; C:polysomal ribosome; IDA:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0045727; P:positive regulation of translation; IMP:UniProtKB.
DR   CDD; cd12706; RRM_LARP5; 1.
DR   Gene3D; 1.10.10.10; -; 1.
DR   InterPro; IPR006630; La_HTH.
DR   InterPro; IPR034900; LARP5_RRM.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   Pfam; PF05383; La; 1.
DR   SMART; SM00715; LA; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
DR   SUPFAM; SSF54928; SSF54928; 1.
DR   PROSITE; PS50961; HTH_LA; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome; Cytoplasm; Methylation;
KW   Phosphoprotein; Reference proteome; RNA-binding;
KW   Translation regulation.
FT   CHAIN         1    738       La-related protein 4B.
FT                                /FTId=PRO_0000281139.
FT   DOMAIN      150    239       HTH La-type RNA-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00332}.
FT   DOMAIN      240    307       RRM.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:22814378}.
FT   MOD_RES     244    244       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q6A0A2}.
FT   MOD_RES     404    404       Omega-N-methylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     419    419       Omega-N-methylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     424    424       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332}.
FT   MOD_RES     434    434       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18669648}.
FT   MOD_RES     451    451       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     488    488       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     493    493       Omega-N-methylarginine.
FT                                {ECO:0000250|UniProtKB:Q6A0A2}.
FT   MOD_RES     498    498       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q6A0A2}.
FT   MOD_RES     518    518       Phosphothreonine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     524    524       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     556    556       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     566    566       Phosphothreonine.
FT                                {ECO:0000244|PubMed:16964243}.
FT   MOD_RES     568    568       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     601    601       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     664    664       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     718    718       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     724    724       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     727    727       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     732    732       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q6A0A2}.
FT   MOD_RES     736    736       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
SQ   SEQUENCE   738 AA;  80552 MW;  A0E5D44ECA58265D CRC64;
     MTSDQDAKVV AEPQTQRVQE GKDSAHLMNG PISQTTSQTS SIPPLSQVPA TKVSELNPNA
     EVWGAPVLHL EASSAADGVS AAWEEVAGHH ADRGPQGSDA NGDGDQGHEN AALPDPQESD
     PADMNALALG PSEYDSLPEN SETGGNESQP DSQEDPREVL KKTLEFCLSR ENLASDMYLI
     SQMDSDQYVP ITTVANLDHI KKLSTDVDLI VEVLRSLPLV QVDEKGEKVR PNQNRCIVIL
     REISESTPVE EVEALFKGDN LPKFINCEFA YNDNWFITFE TEADAQQAYK YLREEVKTFQ
     GKPIKARIKA KAIAINTFLP KNGFRPLDVS LYAQQRYATS FYFPPMYSPQ QQFPLYSLIT
     PQTWSATHSY LDPPLVTPFP NTGFINGFTS PAFKPAASPL TSLRQYPPRS RNPSKSHLRH
     AIPSAERGPG LLESPSIFNF TADRLINGVR SPQTRQAGQT RTRIQNPSAY AKREAGPGRV
     EPGSLESSPG LGRGRKNSFG YRKKREEKFT SSQTQSPTPP KPPSPSFELG LSSFPPLPGA
     AGNLKTEDLF ENRLSSLIIG PSKERTLSAD ASVNTLPVVV SREPSVPASC AVSATYERSP
     SPAHLPDDPK VAEKQRETHS VDRLPSALTA TACKSVQVNG AATELRKPSY AEICQRTSKE
     PPSSPLQPQK EQKPNTVGCG KEEKKLAEPA ERYREPPALK STPGAPRDQR RPAGGRPSPS
     AMGKRLSREQ STPPKSPQ
//
ID   LERL1_HUMAN             Reviewed;         131 AA.
AC   O95214; E9PHP8; Q9BW48;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   13-APR-2004, sequence version 2.
DT   13-FEB-2019, entry version 136.
DE   RecName: Full=Leptin receptor overlapping transcript-like 1;
DE   AltName: Full=Endospanin-2;
GN   Name=LEPROTL1; ORFNames=My047, UNQ577/PRO1139;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Fetal brain;
RX   PubMed=11342119; DOI=10.1016/S0167-4781(00)00266-9;
RA   Huang Y., Ying K., Xie Y., Zhou Z., Wang W., Tang R., Zhao W.,
RA   Zhao S., Wu H., Gu S., Mao Y.M.;
RT   "Cloning and characterization of a novel human leptin receptor
RT   overlapping transcript-like 1 gene (LEPROTL1).";
RL   Biochim. Biophys. Acta 1517:327-331(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Placenta;
RA   Li W.B., Gruber C., Jessee J., Polayes D.;
RT   "Full-length cDNA libraries and normalization.";
RL   Submitted (APR-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S.,
RA   Garber M., Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A.,
RA   Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X.,
RA   Allen N.R., Anderson S., Asakawa T., Blechschmidt K., Bloom T.,
RA   Borowsky M.L., Butler J., Cook A., Corum B., DeArellano K.,
RA   DeCaprio D., Dooley K.T., Dorris L. III, Engels R., Gloeckner G.,
RA   Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K., Jaffe D.B.,
RA   Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C.,
RA   O'Leary S.B., O'Neill K., Parker S.C.J., Polley A., Raymond C.K.,
RA   Reichwald K., Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R.,
RA   Smith C.L., Sneddon T.P., Talamas J.A., Tenzin P., Topham K.,
RA   Venkataraman V., Wen G., Yamazaki S., Young S.K., Zeng Q.,
RA   Zimmer A.R., Rosenthal A., Birren B.W., Platzer M., Shimizu N.,
RA   Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION.
RX   PubMed=19907080; DOI=10.1172/JCI34997;
RA   Touvier T., Conte-Auriol F., Briand O., Cudejko C., Paumelle R.,
RA   Caron S., Bauge E., Rouille Y., Salles J.P., Staels B., Bailleul B.;
RT   "LEPROT and LEPROTL1 cooperatively decrease hepatic growth hormone
RT   action in mice.";
RL   J. Clin. Invest. 119:3830-3838(2009).
CC   -!- FUNCTION: Negatively regulates growth hormone (GH) receptor cell
CC       surface expression in liver. May play a role in liver resistance
CC       to GH during periods of reduced nutrient availability.
CC       {ECO:0000269|PubMed:19907080}.
CC   -!- SUBUNIT: Interacts with RAB13. {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q96E93:KLRG1; NbExp=3; IntAct=EBI-750776, EBI-750770;
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O95214-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O95214-2; Sequence=VSP_046307;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Widely expressed, with highest expression in
CC       heart, testis, adrenal gland, thymus, and spleen, and lowest
CC       expression in lung and skeletal muscle.
CC   -!- SIMILARITY: Belongs to the OB-RGRP/VPS55 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AF063605; AAC98697.1; -; mRNA.
DR   EMBL; AY358674; AAQ89037.1; -; mRNA.
DR   EMBL; AC026979; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC044849; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL546441; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; BC000642; AAH00642.1; -; mRNA.
DR   CCDS; CCDS47834.1; -. [O95214-2]
DR   CCDS; CCDS6075.1; -. [O95214-1]
DR   RefSeq; NP_001121680.1; NM_001128208.1. [O95214-2]
DR   RefSeq; NP_056159.2; NM_015344.2. [O95214-1]
DR   UniGene; Hs.146585; -.
DR   ProteinModelPortal; O95214; -.
DR   BioGrid; 117042; 6.
DR   IntAct; O95214; 59.
DR   STRING; 9606.ENSP00000428281; -.
DR   SwissPalm; O95214; -.
DR   BioMuta; LEPROTL1; -.
DR   EPD; O95214; -.
DR   jPOST; O95214; -.
DR   PaxDb; O95214; -.
DR   PeptideAtlas; O95214; -.
DR   PRIDE; O95214; -.
DR   ProteomicsDB; 50721; -.
DR   DNASU; 23484; -.
DR   Ensembl; ENST00000321250; ENSP00000314625; ENSG00000104660. [O95214-1]
DR   Ensembl; ENST00000523116; ENSP00000428281; ENSG00000104660. [O95214-2]
DR   GeneID; 23484; -.
DR   KEGG; hsa:23484; -.
DR   UCSC; uc003xhx.3; human. [O95214-1]
DR   CTD; 23484; -.
DR   DisGeNET; 23484; -.
DR   EuPathDB; HostDB:ENSG00000104660.17; -.
DR   GeneCards; LEPROTL1; -.
DR   HGNC; HGNC:6555; LEPROTL1.
DR   HPA; HPA047911; -.
DR   MIM; 607338; gene.
DR   neXtProt; NX_O95214; -.
DR   OpenTargets; ENSG00000104660; -.
DR   PharmGKB; PA30334; -.
DR   eggNOG; KOG2174; Eukaryota.
DR   eggNOG; ENOG4111UCZ; LUCA.
DR   GeneTree; ENSGT00390000006503; -.
DR   HOGENOM; HOG000038515; -.
DR   HOVERGEN; HBG001034; -.
DR   InParanoid; O95214; -.
DR   OrthoDB; 1642378at2759; -.
DR   PhylomeDB; O95214; -.
DR   TreeFam; TF313689; -.
DR   ChiTaRS; LEPROTL1; human.
DR   GenomeRNAi; 23484; -.
DR   PRO; PR:O95214; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000104660; Expressed in 227 organ(s), highest expression level in forebrain.
DR   ExpressionAtlas; O95214; baseline and differential.
DR   Genevisible; O95214; HS.
DR   GO; GO:0005768; C:endosome; IBA:GO_Central.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0032511; P:late endosome to vacuole transport via multivesicular body sorting pathway; IBA:GO_Central.
DR   GO; GO:2000009; P:negative regulation of protein localization to cell surface; IBA:GO_Central.
DR   InterPro; IPR007262; VPS55.
DR   PANTHER; PTHR12050; PTHR12050; 1.
DR   Pfam; PF04133; Vps55; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Membrane; Reference proteome;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN         1    131       Leptin receptor overlapping transcript-
FT                                like 1.
FT                                /FTId=PRO_0000215197.
FT   TRANSMEM      7     27       Helical. {ECO:0000255}.
FT   TRANSMEM     32     52       Helical. {ECO:0000255}.
FT   TRANSMEM     69     89       Helical. {ECO:0000255}.
FT   TRANSMEM    100    120       Helical. {ECO:0000255}.
FT   VAR_SEQ      94    131       IEWGACALVLTGNTVIFATILGFFLVFGSNDDFSWQQW ->
FT                                MGRLPFFSKMGTAESEGRETLTQQLPLPAAAMRRLLPASRV
FT                                STQPVLRLADSAESLLGRPALWALGFLLCPPSQAQ (in
FT                                isoform 2). {ECO:0000303|Ref.3}.
FT                                /FTId=VSP_046307.
FT   CONFLICT    123    123       N -> K (in Ref. 1; AAC98697).
FT                                {ECO:0000305}.
SQ   SEQUENCE   131 AA;  14428 MW;  E5E75B7C77A99DD7 CRC64;
     MAGIKALISL SFGGAIGLMF LMLGCALPIY NKYWPLFVLF FYILSPIPYC IARRLVDDTD
     AMSNACKELA IFLTTGIVVS AFGLPIVFAR AHLIEWGACA LVLTGNTVIF ATILGFFLVF
     GSNDDFSWQQ W
//
ID   Q6FHL7_HUMAN            Unreviewed;       131 AA.
AC   Q6FHL7;
DT   10-MAY-2005, integrated into UniProtKB/TrEMBL.
DT   10-MAY-2005, sequence version 1.
DT   13-FEB-2019, entry version 110.
DE   SubName: Full=LEPROTL1 protein {ECO:0000313|EMBL:CAG46535.1};
DE   SubName: Full=Leptin receptor overlapping transcript-like 1, isoform CRA_b {ECO:0000313|EMBL:EAW63469.1};
DE   SubName: Full=Transformation-related protein 12 {ECO:0000313|EMBL:AAQ18034.1};
DE   SubName: Full=cDNA PSEC0049 fis, clone NT2RP2000116, highly similar to Leptin receptor overlapping transcript-like 1 {ECO:0000313|EMBL:BAG52122.1};
GN   Name=LEPROTL1 {ECO:0000313|EMBL:CAG46535.1};
GN   Synonyms=TRG12 {ECO:0000313|EMBL:AAQ18034.1};
GN   ORFNames=hCG_15463 {ECO:0000313|EMBL:EAW63469.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:CAG46535.1};
RN   [1] {ECO:0000313|EMBL:EAW63469.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:AAQ18034.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Kim J.W.;
RT   "Identification of a human transforming gene.";
RL   Submitted (APR-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:CAG46535.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S.,
RA   Neubert P., Kstrang K., Schatten R., Shen B., Henze S., Mar W.,
RA   Korn B., Zuo D., Hu Y., LaBaer J.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:BAG52122.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=16303743; DOI=10.1093/dnares/12.2.117;
RA   Otsuki T., Ota T., Nishikawa T., Hayashi K., Suzuki Y., Yamamoto J.,
RA   Wakamatsu A., Kimura K., Sakamoto K., Hatano N., Kawai Y., Ishii S.,
RA   Saito K., Kojima S., Sugiyama T., Ono T., Okano K., Yoshikawa Y.,
RA   Aotsuka S., Sasaki N., Hattori A., Okumura K., Nagai K., Sugano S.,
RA   Isogai T.;
RT   "Signal sequence and keyword trap in silico for selection of full-
RT   length human cDNAs encoding secretion or membrane proteins from oligo-
RT   capped cDNA libraries.";
RL   DNA Res. 12:117-126(2005).
RN   [5] {ECO:0000313|EMBL:EAW63469.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- INTERACTION:
CC       Q92838:EDA; NbExp=3; IntAct=EBI-10249700, EBI-529425;
CC       P21757:MSR1; NbExp=3; IntAct=EBI-10249700, EBI-1776976;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AY277595; AAQ18034.1; -; mRNA.
DR   EMBL; AK075363; BAG52122.1; -; mRNA.
DR   EMBL; CR541735; CAG46535.1; -; mRNA.
DR   EMBL; CR541760; CAG46560.1; -; mRNA.
DR   EMBL; CH471080; EAW63469.1; -; Genomic_DNA.
DR   EMBL; CH471080; EAW63470.1; -; Genomic_DNA.
DR   RefSeq; NP_056159.2; NM_015344.2.
DR   UniGene; Hs.146585; -.
DR   IntAct; Q6FHL7; 2.
DR   DNASU; 23484; -.
DR   GeneID; 23484; -.
DR   KEGG; hsa:23484; -.
DR   UCSC; uc003xhw.5; human.
DR   CTD; 23484; -.
DR   EuPathDB; HostDB:ENSG00000104660.17; -.
DR   PharmGKB; PA30334; -.
DR   eggNOG; KOG2174; Eukaryota.
DR   eggNOG; ENOG4111UCZ; LUCA.
DR   HOVERGEN; HBG001034; -.
DR   OrthoDB; 1642378at2759; -.
DR   ChiTaRS; LEPROTL1; human.
DR   GenomeRNAi; 23484; -.
DR   Bgee; ENSG00000104660; Expressed in 227 organ(s), highest expression level in forebrain.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   InterPro; IPR007262; VPS55.
DR   PANTHER; PTHR12050; PTHR12050; 1.
DR   Pfam; PF04133; Vps55; 1.
PE   1: Evidence at protein level;
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Receptor {ECO:0000313|EMBL:BAG52122.1};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM      7     30       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM     36     56       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM     68     88       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM     94    120       Helical. {ECO:0000256|SAM:Phobius}.
FT   NON_TER     131    131       {ECO:0000313|EMBL:CAG46560.1}.
SQ   SEQUENCE   131 AA;  14428 MW;  E5E75B7C77A99DD7 CRC64;
     MAGIKALISL SFGGAIGLMF LMLGCALPIY NKYWPLFVLF FYILSPIPYC IARRLVDDTD
     AMSNACKELA IFLTTGIVVS AFGLPIVFAR AHLIEWGACA LVLTGNTVIF ATILGFFLVF
     GSNDDFSWQQ W
//
ID   B4DEE8_HUMAN            Unreviewed;       238 AA.
AC   B4DEE8;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   16-JAN-2019, entry version 72.
DE   SubName: Full=cDNA FLJ56323, highly similar to Methylated-DNA--protein-cysteinemethyltransferase {ECO:0000313|EMBL:BAG57059.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG57059.1};
RN   [1] {ECO:0000313|EMBL:BAG57059.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Cerebellum {ECO:0000313|EMBL:BAG57059.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AK293593; BAG57059.1; -; mRNA.
DR   RefSeq; NP_002403.2; NM_002412.4.
DR   UniGene; Hs.501522; -.
DR   ProteinModelPortal; B4DEE8; -.
DR   SMR; B4DEE8; -.
DR   iPTMnet; B4DEE8; -.
DR   MaxQB; B4DEE8; -.
DR   PeptideAtlas; B4DEE8; -.
DR   PRIDE; B4DEE8; -.
DR   DNASU; 4255; -.
DR   GeneID; 4255; -.
DR   KEGG; hsa:4255; -.
DR   CTD; 4255; -.
DR   EuPathDB; HostDB:ENSG00000170430.9; -.
DR   PharmGKB; PA239; -.
DR   eggNOG; KOG4062; Eukaryota.
DR   eggNOG; COG0350; LUCA.
DR   HOGENOM; HOG000244137; -.
DR   HOVERGEN; HBG001146; -.
DR   KO; K00567; -.
DR   OMA; MDKACEM; -.
DR   OrthoDB; 1573162at2759; -.
DR   PhylomeDB; B4DEE8; -.
DR   GenomeRNAi; 4255; -.
DR   Bgee; ENSG00000170430; Expressed in 207 organ(s), highest expression level in liver.
DR   ExpressionAtlas; B4DEE8; baseline and differential.
DR   Genevisible; B4DEE8; HS.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005509; F:calcium ion binding; IEA:Ensembl.
DR   GO; GO:0003908; F:methylated-DNA-[protein]-cysteine S-methyltransferase activity; IEA:Ensembl.
DR   GO; GO:0071479; P:cellular response to ionizing radiation; IEA:Ensembl.
DR   GO; GO:0071407; P:cellular response to organic cyclic compound; IEA:Ensembl.
DR   GO; GO:0034599; P:cellular response to oxidative stress; IEA:Ensembl.
DR   GO; GO:0006307; P:DNA dealkylation involved in DNA repair; IEA:Ensembl.
DR   GO; GO:0060644; P:mammary gland epithelial cell differentiation; IEA:Ensembl.
DR   GO; GO:0060548; P:negative regulation of cell death; IEA:Ensembl.
DR   GO; GO:0045739; P:positive regulation of DNA repair; IEA:Ensembl.
DR   GO; GO:0043281; P:regulation of cysteine-type endopeptidase activity involved in apoptotic process; IEA:Ensembl.
DR   GO; GO:0045471; P:response to ethanol; IEA:Ensembl.
DR   GO; GO:0051593; P:response to folic acid; IEA:Ensembl.
DR   CDD; cd06445; ATase; 1.
DR   Gene3D; 1.10.10.10; -; 1.
DR   InterPro; IPR001497; MethylDNA_cys_MeTrfase_AS.
DR   InterPro; IPR014048; MethylDNA_cys_MeTrfase_DNA-bd.
DR   InterPro; IPR036217; MethylDNA_cys_MeTrfase_DNAb.
DR   InterPro; IPR008332; MethylG_MeTrfase_N.
DR   InterPro; IPR036631; MGMT_N_sf.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   Pfam; PF01035; DNA_binding_1; 1.
DR   Pfam; PF02870; Methyltransf_1N; 1.
DR   SUPFAM; SSF46767; SSF46767; 1.
DR   SUPFAM; SSF53155; SSF53155; 1.
DR   TIGRFAMs; TIGR00589; ogt; 1.
DR   PROSITE; PS00374; MGMT; 1.
PE   2: Evidence at transcript level;
KW   Methyltransferase {ECO:0000313|EMBL:BAG57059.1};
KW   Transferase {ECO:0000313|EMBL:BAG57059.1}.
FT   DOMAIN       37    121       Methyltransf_1N.
FT                                {ECO:0000259|Pfam:PF02870}.
FT   DOMAIN      126    204       DNA_binding_1.
FT                                {ECO:0000259|Pfam:PF01035}.
SQ   SEQUENCE   238 AA;  25050 MW;  9A1774B6637A0788 CRC64;
     MLGQPAPLER FASRRPQVLA VRTVCDLVLG KMDKDCEMKR TTLDSPLGKL ELSGCEQGLH
     EIKLLGKGTS AADAVEVPAP AAVLGGPEPL MQCTAWLNAY FHQPEAIEEF PVPALHHPVF
     QQESFTRQVL WKLLKVVKFG EVISYQQLAA LAGNPKAARA VGGAMRGNPV PILIPCHRVV
     CSSGAVGNYS GGLAVKEWLL AHEGHRLGKP GLGGSSGLAG AWLKGAGATS GSPPAGRN
//
ID   MGMT_HUMAN              Reviewed;         207 AA.
AC   P16455; Q5VY78;
DT   01-AUG-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1990, sequence version 1.
DT   13-FEB-2019, entry version 190.
DE   RecName: Full=Methylated-DNA--protein-cysteine methyltransferase;
DE            EC=2.1.1.63;
DE   AltName: Full=6-O-methylguanine-DNA methyltransferase;
DE            Short=MGMT;
DE   AltName: Full=O-6-methylguanine-DNA-alkyltransferase;
GN   Name=MGMT;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PROTEIN SEQUENCE OF 1-8.
RX   PubMed=2405387; DOI=10.1073/pnas.87.2.686;
RA   Tano K., Shiota S., Collier J., Foote R.S., Mitra S.;
RT   "Isolation and structural characterization of a cDNA clone encoding
RT   the human DNA repair protein for O6-alkylguanine.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:686-690(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2188979;
RA   Rydberg B., Spurr N., Karran P.;
RT   "cDNA cloning and chromosomal assignment of the human O6-
RT   methylguanine-DNA methyltransferase. cDNA expression in Escherichia
RT   coli and gene expression in human cells.";
RL   J. Biol. Chem. 265:9563-9569(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2394694;
RA   Koike G., Maki H., Takeya H., Hayakawa H., Sekiguchi M.;
RT   "Purification, structure, and biochemical properties of human O6-
RT   methylguanine-DNA methyltransferase.";
RL   J. Biol. Chem. 265:14754-14762(1990).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2359121; DOI=10.1016/S0022-2836(05)80260-8;
RA   Hayakawa H., Koike G., Sekiguchi M.;
RT   "Expression and cloning of complementary DNA for a human enzyme that
RT   repairs O6-methylguanine in DNA.";
RL   J. Mol. Biol. 213:739-747(1990).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   PARTIAL PROTEIN SEQUENCE, AND ALKYL GROUP ACCEPTOR.
RX   PubMed=1985934;
RA   von Wronski M.A., Shiota S., Tano K., Mitra S., Bigner D.D.,
RA   Brent T.P.;
RT   "Structural and immunological comparison of indigenous human O6-
RT   methylguanine-DNA methyltransferase with that encoded by a cloned
RT   cDNA.";
RL   J. Biol. Chem. 266:1064-1070(1991).
RN   [10]
RP   CHARACTERIZATION.
RX   PubMed=8202360; DOI=10.1093/nar/22.9.1613;
RA   Liem L.-K., Lim A., Li B.F.L.;
RT   "Specificities of human, rat and E. coli O6-methylguanine-DNA
RT   methyltransferases towards the repair of O6-methyl and O6-ethylguanine
RT   in DNA.";
RL   Nucleic Acids Res. 22:1613-1619(1994).
RN   [11]
RP   MUTAGENESIS OF PRO-138; PRO-140 AND GLY-156.
RX   PubMed=7954470;
RA   Crone T.M., Goodtzova K., Edara S., Pegg A.E.;
RT   "Mutations in human O6-alkylguanine-DNA alkyltransferase imparting
RT   resistance to O6-benzylguanine.";
RL   Cancer Res. 54:6221-6227(1994).
RN   [12]
RP   MUTAGENESIS OF TYR-114; ARG-128 AND CYS-145.
RX   PubMed=7766621; DOI=10.1021/bi00021a024;
RA   Kanugula S., Goodtzova K., Edara S., Pegg A.E.;
RT   "Alteration of arginine-128 to alanine abolishes the ability of human
RT   O6-alkylguanine-DNA alkyltransferase to repair methylated DNA but has
RT   no effect on its reaction with O6-benzylguanine.";
RL   Biochemistry 34:7113-7119(1995).
RN   [13]
RP   MUTAGENESIS OF TYR-158.
RX   PubMed=7614699; DOI=10.1093/carcin/16.7.1637;
RA   Edara S., Goodtzova K., Pegg A.E.;
RT   "The role of tyrosine-158 in O6-alkylguanine-DNA alkyltransferase
RT   activity.";
RL   Carcinogenesis 16:1637-1642(1995).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-14 AND SER-201, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-201, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) IN COMPLEX WITH DNA AND ZINC
RP   IONS, AND MUTAGENESIS OF ARG-128 AND CYS-145.
RX   PubMed=10747039; DOI=10.1093/emboj/19.7.1719;
RA   Daniels D.S., Mol C.D., Arvai A.S., Kanugula S., Pegg A.E.,
RA   Tainer J.A.;
RT   "Active and alkylated human AGT structures: a novel zinc site,
RT   inhibitor and extrahelical base binding.";
RL   EMBO J. 19:1719-1730(2000).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 1-176.
RX   PubMed=10606635; DOI=10.1093/nar/28.2.393;
RA   Wibley J.E., Pegg A.E., Moody P.C.;
RT   "Crystal structure of the human O(6)-alkylguanine-DNA
RT   alkyltransferase.";
RL   Nucleic Acids Res. 28:393-401(2000).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) OF 1-179 IN COMPLEX WITH DNA AND
RP   ZINC IONS.
RX   PubMed=15964013; DOI=10.1016/j.jmb.2005.05.028;
RA   Duguid E.M., Rice P.A., He C.;
RT   "The structure of the human AGT protein bound to DNA and its
RT   implications for damage detection.";
RL   J. Mol. Biol. 350:657-666(2005).
CC   -!- FUNCTION: Involved in the cellular defense against the biological
CC       effects of O6-methylguanine (O6-MeG) and O4-methylthymine (O4-MeT)
CC       in DNA. Repairs the methylated nucleobase in DNA by
CC       stoichiometrically transferring the methyl group to a cysteine
CC       residue in the enzyme. This is a suicide reaction: the enzyme is
CC       irreversibly inactivated.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 6-O-methyl-2'-deoxyguanosine in DNA + L-cysteinyl-
CC         [protein] = a 2'-deoxyguanosine in DNA + S-methyl-L-cysteinyl-
CC         [protein]; Xref=Rhea:RHEA:24000, Rhea:RHEA-COMP:10131,
CC         Rhea:RHEA-COMP:10132, Rhea:RHEA-COMP:11367, Rhea:RHEA-
CC         COMP:11368, ChEBI:CHEBI:29950, ChEBI:CHEBI:82612,
CC         ChEBI:CHEBI:85445, ChEBI:CHEBI:85448; EC=2.1.1.63;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU10017};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 4-O-methyl-thymidine in DNA + L-cysteinyl-[protein] = a
CC         thymidine in DNA + S-methyl-L-cysteinyl-[protein];
CC         Xref=Rhea:RHEA:53428, Rhea:RHEA-COMP:10131, Rhea:RHEA-
CC         COMP:10132, Rhea:RHEA-COMP:13555, Rhea:RHEA-COMP:13556,
CC         ChEBI:CHEBI:29950, ChEBI:CHEBI:82612, ChEBI:CHEBI:137386,
CC         ChEBI:CHEBI:137387; EC=2.1.1.63; Evidence={ECO:0000255|PROSITE-
CC         ProRule:PRU10017};
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC       Note=Binds 1 zinc ion.;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- MISCELLANEOUS: This enzyme catalyzes only one turnover and
CC       therefore is not strictly catalytic. According to one definition,
CC       an enzyme is a biocatalyst that acts repeatedly and over many
CC       reaction cycles.
CC   -!- SIMILARITY: Belongs to the MGMT family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; X54228; CAA38137.1; -; mRNA.
DR   EMBL; M29971; AAA59596.1; -; mRNA.
DR   EMBL; M31767; AAA52317.1; -; mRNA.
DR   EMBL; M60761; AAA59594.1; -; mRNA.
DR   EMBL; BT006714; AAP35360.1; -; mRNA.
DR   EMBL; AL157832; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL355531; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471066; EAW49166.1; -; Genomic_DNA.
DR   EMBL; BC000824; AAH00824.1; -; mRNA.
DR   CCDS; CCDS7660.2; -.
DR   PIR; A34889; XUHUMC.
DR   RefSeq; NP_002403.2; NM_002412.4.
DR   RefSeq; XP_005252739.1; XM_005252682.2.
DR   UniGene; Hs.501522; -.
DR   PDB; 1EH6; X-ray; 2.00 A; A=1-207.
DR   PDB; 1EH7; X-ray; 2.00 A; A=1-207.
DR   PDB; 1EH8; X-ray; 2.50 A; A=1-207.
DR   PDB; 1QNT; X-ray; 1.90 A; A=1-176.
DR   PDB; 1T38; X-ray; 3.20 A; A=1-176.
DR   PDB; 1T39; X-ray; 3.30 A; A/B=1-176.
DR   PDB; 1YFH; X-ray; 3.01 A; A/B/C=1-179.
DR   PDBsum; 1EH6; -.
DR   PDBsum; 1EH7; -.
DR   PDBsum; 1EH8; -.
DR   PDBsum; 1QNT; -.
DR   PDBsum; 1T38; -.
DR   PDBsum; 1T39; -.
DR   PDBsum; 1YFH; -.
DR   ProteinModelPortal; P16455; -.
DR   SMR; P16455; -.
DR   BioGrid; 110411; 75.
DR   IntAct; P16455; 1.
DR   STRING; 9606.ENSP00000302111; -.
DR   BindingDB; P16455; -.
DR   ChEMBL; CHEMBL2864; -.
DR   DrugBank; DB04531; Benzylcysteine.
DR   DrugBank; DB00151; L-Cysteine.
DR   DrugBank; DB02216; S-Methylcysteine.
DR   GlyConnect; 1505; -.
DR   iPTMnet; P16455; -.
DR   PhosphoSitePlus; P16455; -.
DR   BioMuta; MGMT; -.
DR   DMDM; 127069; -.
DR   EPD; P16455; -.
DR   jPOST; P16455; -.
DR   MaxQB; P16455; -.
DR   PaxDb; P16455; -.
DR   PeptideAtlas; P16455; -.
DR   PRIDE; P16455; -.
DR   ProteomicsDB; 53365; -.
DR   Ensembl; ENST00000306010; ENSP00000302111; ENSG00000170430.
DR   GeneID; 4255; -.
DR   KEGG; hsa:4255; -.
DR   UCSC; uc001lkh.3; human.
DR   CTD; 4255; -.
DR   DisGeNET; 4255; -.
DR   EuPathDB; HostDB:ENSG00000170430.9; -.
DR   GeneCards; MGMT; -.
DR   H-InvDB; HIX0009309; -.
DR   HGNC; HGNC:7059; MGMT.
DR   HPA; CAB002786; -.
DR   HPA; CAB069881; -.
DR   HPA; HPA032135; -.
DR   HPA; HPA032136; -.
DR   HPA; HPA069497; -.
DR   MalaCards; MGMT; -.
DR   MIM; 156569; gene.
DR   neXtProt; NX_P16455; -.
DR   Orphanet; 618; Familial melanoma.
DR   Orphanet; 251579; Giant cell glioblastoma.
DR   Orphanet; 251576; Gliosarcoma.
DR   eggNOG; KOG4062; Eukaryota.
DR   eggNOG; COG0350; LUCA.
DR   HOGENOM; HOG000244137; -.
DR   HOVERGEN; HBG001146; -.
DR   InParanoid; P16455; -.
DR   KO; K00567; -.
DR   OrthoDB; 1039038at2759; -.
DR   PhylomeDB; P16455; -.
DR   TreeFam; TF314064; -.
DR   BRENDA; 2.1.1.63; 2681.
DR   Reactome; R-HSA-5657655; MGMT-mediated DNA damage reversal.
DR   SIGNOR; P16455; -.
DR   ChiTaRS; MGMT; human.
DR   EvolutionaryTrace; P16455; -.
DR   GeneWiki; O-6-methylguanine-DNA_methyltransferase; -.
DR   GenomeRNAi; 4255; -.
DR   PRO; PR:P16455; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000170430; Expressed in 207 organ(s), highest expression level in liver.
DR   ExpressionAtlas; P16455; baseline and differential.
DR   Genevisible; P16455; HS.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005509; F:calcium ion binding; IEA:Ensembl.
DR   GO; GO:0003677; F:DNA binding; TAS:ProtInc.
DR   GO; GO:0009008; F:DNA-methyltransferase activity; TAS:ProtInc.
DR   GO; GO:0003908; F:methylated-DNA-[protein]-cysteine S-methyltransferase activity; IBA:GO_Central.
DR   GO; GO:0008168; F:methyltransferase activity; TAS:ProtInc.
DR   GO; GO:0071479; P:cellular response to ionizing radiation; IEA:Ensembl.
DR   GO; GO:0071407; P:cellular response to organic cyclic compound; IEA:Ensembl.
DR   GO; GO:0034599; P:cellular response to oxidative stress; IEA:Ensembl.
DR   GO; GO:0006307; P:DNA dealkylation involved in DNA repair; TAS:Reactome.
DR   GO; GO:0006266; P:DNA ligation; TAS:ProtInc.
DR   GO; GO:0006281; P:DNA repair; IBA:GO_Central.
DR   GO; GO:0060644; P:mammary gland epithelial cell differentiation; IEA:Ensembl.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IDA:BHF-UCL.
DR   GO; GO:2000781; P:positive regulation of double-strand break repair; IDA:BHF-UCL.
DR   GO; GO:0043281; P:regulation of cysteine-type endopeptidase activity involved in apoptotic process; IEA:Ensembl.
DR   GO; GO:0045471; P:response to ethanol; IEA:Ensembl.
DR   GO; GO:0051593; P:response to folic acid; IEA:Ensembl.
DR   CDD; cd06445; ATase; 1.
DR   Gene3D; 1.10.10.10; -; 1.
DR   InterPro; IPR001497; MethylDNA_cys_MeTrfase_AS.
DR   InterPro; IPR014048; MethylDNA_cys_MeTrfase_DNA-bd.
DR   InterPro; IPR036217; MethylDNA_cys_MeTrfase_DNAb.
DR   InterPro; IPR008332; MethylG_MeTrfase_N.
DR   InterPro; IPR036631; MGMT_N_sf.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   Pfam; PF01035; DNA_binding_1; 1.
DR   Pfam; PF02870; Methyltransf_1N; 1.
DR   SUPFAM; SSF46767; SSF46767; 1.
DR   SUPFAM; SSF53155; SSF53155; 1.
DR   TIGRFAMs; TIGR00589; ogt; 1.
DR   PROSITE; PS00374; MGMT; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Direct protein sequencing;
KW   DNA damage; DNA repair; DNA-binding; Metal-binding; Methyltransferase;
KW   Nucleus; Phosphoprotein; Polymorphism; Reference proteome;
KW   Transferase; Zinc.
FT   CHAIN         1    207       Methylated-DNA--protein-cysteine
FT                                methyltransferase.
FT                                /FTId=PRO_0000139359.
FT   ACT_SITE    145    145       Nucleophile; methyl group acceptor.
FT   METAL         5      5       Zinc.
FT   METAL        24     24       Zinc.
FT   METAL        29     29       Zinc.
FT   METAL        85     85       Zinc.
FT   BINDING      95     95       DNA; via amide nitrogen.
FT                                {ECO:0000269|PubMed:10747039,
FT                                ECO:0000269|PubMed:15964013}.
FT   BINDING     114    114       DNA. {ECO:0000269|PubMed:10747039,
FT                                ECO:0000269|PubMed:15964013}.
FT   BINDING     115    115       DNA; via amide nitrogen.
FT                                {ECO:0000269|PubMed:10747039,
FT                                ECO:0000269|PubMed:15964013}.
FT   BINDING     123    123       DNA. {ECO:0000269|PubMed:10747039,
FT                                ECO:0000269|PubMed:15964013}.
FT   BINDING     128    128       DNA. {ECO:0000269|PubMed:10747039,
FT                                ECO:0000269|PubMed:15964013}.
FT   BINDING     151    151       DNA; via amide nitrogen.
FT                                {ECO:0000269|PubMed:10747039,
FT                                ECO:0000269|PubMed:15964013}.
FT   MOD_RES      14     14       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     201    201       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   VARIANT      30     30       E -> K (in dbSNP:rs2020893).
FT                                /FTId=VAR_014750.
FT   VARIANT      53     53       L -> F (in dbSNP:rs12917).
FT                                /FTId=VAR_056129.
FT   VARIANT      58     58       P -> S (in dbSNP:rs2308322).
FT                                /FTId=VAR_029112.
FT   VARIANT      65     65       W -> C (in dbSNP:rs2282164).
FT                                /FTId=VAR_020354.
FT   VARIANT      84     84       L -> F (in dbSNP:rs12917).
FT                                /FTId=VAR_014751.
FT   VARIANT     112    112       I -> V (in dbSNP:rs2308321).
FT                                /FTId=VAR_056130.
FT   VARIANT     143    143       I -> V (in dbSNP:rs2308321).
FT                                /FTId=VAR_014752.
FT   VARIANT     160    160       G -> R (in dbSNP:rs2308318).
FT                                /FTId=VAR_014753.
FT   VARIANT     166    166       E -> D (in dbSNP:rs2308320).
FT                                /FTId=VAR_014754.
FT   VARIANT     178    178       K -> R (in dbSNP:rs2308327).
FT                                /FTId=VAR_014755.
FT   MUTAGEN     114    114       Y->A: Decreases activity towards
FT                                methylated DNA over 1000-fold. Slightly
FT                                reduced reactivity with O6-benzylguanine.
FT                                {ECO:0000269|PubMed:7766621}.
FT   MUTAGEN     114    114       Y->E: Loss of DNA repair activity.
FT                                Slightly reduced reactivity with O6-
FT                                benzylguanine.
FT                                {ECO:0000269|PubMed:7766621}.
FT   MUTAGEN     128    128       R->A,D: Decreases activity towards
FT                                methylated DNA over 1000-fold. No effect
FT                                on reactivity with O6-benzylguanine.
FT                                {ECO:0000269|PubMed:10747039,
FT                                ECO:0000269|PubMed:7766621}.
FT   MUTAGEN     128    128       R->G: Loss of DNA repair activity.
FT                                {ECO:0000269|PubMed:10747039,
FT                                ECO:0000269|PubMed:7766621}.
FT   MUTAGEN     128    128       R->K,L: Slightly reduced DNA repair
FT                                activity. {ECO:0000269|PubMed:10747039,
FT                                ECO:0000269|PubMed:7766621}.
FT   MUTAGEN     138    138       P->K: Decreased reactivity with O6-
FT                                benzylguanine.
FT                                {ECO:0000269|PubMed:7954470}.
FT   MUTAGEN     140    140       P->A: Decreased reactivity with O6-
FT                                benzylguanine.
FT                                {ECO:0000269|PubMed:7954470}.
FT   MUTAGEN     145    145       C->A: Loss of DNA repair activity.
FT                                {ECO:0000269|PubMed:10747039,
FT                                ECO:0000269|PubMed:7766621}.
FT   MUTAGEN     156    156       G->A: Decreased reactivity with O6-
FT                                benzylguanine.
FT                                {ECO:0000269|PubMed:7954470}.
FT   MUTAGEN     158    158       Y->A: Reduced DNA repair activity.
FT                                Decreased reactivity with O6-
FT                                benzylguanine.
FT                                {ECO:0000269|PubMed:7614699}.
FT   MUTAGEN     158    158       Y->F: Slightly reduced DNA repair
FT                                activity. {ECO:0000269|PubMed:7614699}.
FT   CONFLICT    127    127       A -> T (in Ref. 2; AAA52317).
FT                                {ECO:0000305}.
FT   STRAND        8     12       {ECO:0000244|PDB:1QNT}.
FT   STRAND       19     24       {ECO:0000244|PDB:1QNT}.
FT   STRAND       27     33       {ECO:0000244|PDB:1QNT}.
FT   STRAND       50     52       {ECO:0000244|PDB:1EH6}.
FT   HELIX        57     71       {ECO:0000244|PDB:1QNT}.
FT   HELIX        73     78       {ECO:0000244|PDB:1QNT}.
FT   HELIX        87     90       {ECO:0000244|PDB:1QNT}.
FT   HELIX        94    105       {ECO:0000244|PDB:1QNT}.
FT   HELIX       114    120       {ECO:0000244|PDB:1QNT}.
FT   TURN        124    126       {ECO:0000244|PDB:1T38}.
FT   HELIX       127    134       {ECO:0000244|PDB:1QNT}.
FT   STRAND      138    140       {ECO:0000244|PDB:1QNT}.
FT   HELIX       145    147       {ECO:0000244|PDB:1QNT}.
FT   HELIX       162    171       {ECO:0000244|PDB:1QNT}.
SQ   SEQUENCE   207 AA;  21646 MW;  76BBF19DFC4512D6 CRC64;
     MDKDCEMKRT TLDSPLGKLE LSGCEQGLHE IKLLGKGTSA ADAVEVPAPA AVLGGPEPLM
     QCTAWLNAYF HQPEAIEEFP VPALHHPVFQ QESFTRQVLW KLLKVVKFGE VISYQQLAAL
     AGNPKAARAV GGAMRGNPVP ILIPCHRVVC SSGAVGNYSG GLAVKEWLLA HEGHRLGKPG
     LGGSSGLAGA WLKGAGATSG SPPAGRN
//
ID   B2ZZ87_HUMAN            Unreviewed;      1690 AA.
AC   B2ZZ87;
DT   22-JUL-2008, integrated into UniProtKB/TrEMBL.
DT   22-JUL-2008, sequence version 1.
DT   16-JAN-2019, entry version 44.
DE   SubName: Full=Nedd4 binding protein 2 {ECO:0000313|EMBL:BAG48313.1};
GN   Name=N4BP2 {ECO:0000313|EMBL:BAG48313.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG48313.1};
RN   [1] {ECO:0000313|EMBL:BAG48313.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=18487259; DOI=10.1093/dnares/dsn010;
RA   Oshikawa M., Sugai Y., Usami R., Ohtoko K., Toyama S., Kato S.;
RT   "Fine expression profiling of full-length transcripts using a size-
RT   unbiased cDNA library prepared with the vector-capping method.";
RL   DNA Res. 15:123-136(2008).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AB371584; BAG48313.1; -; mRNA.
DR   RefSeq; NP_001305288.1; NM_001318359.1.
DR   RefSeq; NP_060647.2; NM_018177.5.
DR   UniGene; Hs.391463; -.
DR   UniGene; Hs.736026; -.
DR   ProteinModelPortal; B2ZZ87; -.
DR   PeptideAtlas; B2ZZ87; -.
DR   PRIDE; B2ZZ87; -.
DR   GeneID; 55728; -.
DR   KEGG; hsa:55728; -.
DR   CTD; 55728; -.
DR   eggNOG; KOG2401; Eukaryota.
DR   eggNOG; ENOG41101K4; LUCA.
DR   HOVERGEN; HBG101251; -.
DR   KO; K15720; -.
DR   OrthoDB; 76267at2759; -.
DR   ChiTaRS; N4BP2; human.
DR   GenomeRNAi; 55728; -.
DR   InterPro; IPR013899; DUF1771.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR002625; Smr_dom.
DR   InterPro; IPR036063; Smr_dom_sf.
DR   Pfam; PF08590; DUF1771; 1.
DR   Pfam; PF01713; Smr; 1.
DR   SMART; SM01162; DUF1771; 1.
DR   SMART; SM00463; SMR; 1.
DR   SUPFAM; SSF160443; SSF160443; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS50828; SMR; 1.
PE   2: Evidence at transcript level;
FT   DOMAIN     1611   1690       Smr. {ECO:0000259|PROSITE:PS50828}.
SQ   SEQUENCE   1690 AA;  189839 MW;  A896B367A0E10CCC CRC64;
     MDCLLELSAT DTKIEESSSQ SFVASENQVG AAESKIMEKR PEEESEDSKM DSFLDMQLTE
     DLDSLIQNAF EKLNSSPDDQ VYSFLPSQDV NSFNDSSEFI NPDSSNMTPI FSTQNMNLNG
     ENLENSGSTL SLNPLPSHSV LNESKCFIKD NTLALESNYP EDSLLSSSLN VASDSIAGCS
     SLNQKQKELL ESECVEAQFS EAPVDLDASE PQACLNLPGL DLPGTGGDQK STRVSDVFLP
     SEGFNFKPHK HPELPTKGKD VSYCPVLAPL PLLLPPPPPP PMWNPMIPAF DLFQGNHGFV
     APVVTTAAHW RSVNYTFPPS VISHTSPTKV WRNKDGTSAY QVQETPVSQV VRKKTSYVGL
     VLVLLRGLPG SGKSFLARTL QEDNPSGVIL STDDYFYING QYQFDVKYLG EAHEWNQNRA
     KEAFEKKISP IIIDNTNLQA WEMKPYVALS QKHKYKVLFR EPDTWWKFKP KELARRNIHG
     VSKEKITRML EHYQRFVSVP IIMSSSVPEK IERIELCAYS CEDRSTSPRD NEDIISEKEE
     NILSLSLKHL EFTEEKNLDV TKETMLPENV AYLSNADLNK RRKEISDMNP SIQSALILET
     PHMYFSDSES KLQATDKSEN EQIEMVAVKG YSKTDTDSSM ERVSPSTCCS ENNQEDCDLA
     NSGPLQNEKS SPGEIVEERA TVTKKAFGKQ KSKSTLEKFP RHELSNFVGD WPVDKTIGQR
     TKRNRKTEKT SSVQSDKKYN YPQSHKLVNS VSVNTDCVQQ RGSPHESVED GRKSQCDDAS
     EPLNSYKYDA YKNIDKNSFN IMGDWPSSDS LAQREHRSRM PKTGLSEPNL EIGTNDKMNE
     ISLSTAHEAC WGTSSQKLKT LGSSNLGSSE MLLSEMTCES QTCLSKKSHG QHTSLPLTFT
     NSAPTVSGVV EPQTLAECQE QMPKRDPGKE VGMCTQTEPQ DFALLWKIEK NKISISDSIK
     VLTGRLDGFK PKVFNINTKS DVQEAIPYRV MYDKSTFVEE SELTSADESE NLNILCKLFG
     SFSLEALKDL YERCNKDIIW ATSLLLDSET KLCEDTEFEN FQKSCDGSQI GPFSLGLNLK
     EIISQRGTLE NSNSPVPEFS HGIGISNADS QSTCDAERGN SEQAEMRAVT PENHESMTSI
     FPSAAVGLKN NNDILPNSQE ELLYSSKQSF PGILKATTPK DMSETEKNLV VTETGDNIHS
     PSHFSDIFNF VSSTSNLELN EEIYFTDSLE IKRNENFPKD YVKFSDEEEF MNEDEKEMKE
     ILMAGSSLSA GVSGEDKTEI LNPTPAMAKS LTIDCLELAL PPELAFQLNE LFGPVGIDSG
     SLTVEDCVVH IDLNLAKVIH EKWKESVMER QRQEEVSCGK FMQDPSLVGH TGLDNPEQKS
     SQRTGKKLLK TLTASEMLPL LDHWNTQTKK VSLREIMSEE IALQEKHNLK RETLMFEKDC
     ATKLKEKQLF KIFPAINQNF LVDIFKDHNY SLEHTVQFLN CVLEGDPVKT VVAQEFVHQN
     ENVTSHTGQK SKEKKPKKLK ETEETPSELS FQDFEYPDYD DYRAEAFLHQ QKRMECYSKA
     KEAYRIGKKN VATFYAQQGT LHEQKMKEAN HLAAIEIFEK VNASLLPQNV LDLHGLHVDE
     ALEHLMRVLE KKTEEFKQNG GKPYLSVITG RGNHSQGGVA RIKPAVIKYL ISHSFRFSEI
     KPGCLKVMLK
//
ID   N4BP2_HUMAN             Reviewed;        1770 AA.
AC   Q86UW6; A0AVR3; Q9NVK2; Q9P2D4;
DT   15-MAR-2004, integrated into UniProtKB/Swiss-Prot.
DT   17-APR-2007, sequence version 2.
DT   13-FEB-2019, entry version 151.
DE   RecName: Full=NEDD4-binding protein 2;
DE            Short=N4BP2;
DE            EC=3.-.-.-;
DE   AltName: Full=BCL-3-binding protein;
GN   Name=N4BP2; Synonyms=B3BP, KIAA1413;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, INTERACTION WITH
RP   BCL3 AND CREBBP, AND VARIANT ASN-611.
RC   TISSUE=T-cell;
RX   PubMed=12730195; DOI=10.1074/jbc.M303518200;
RA   Watanabe N., Wachi S., Fujita T.;
RT   "Identification and characterization of BCL-3-binding protein:
RT   implications for transcription and DNA repair or recombination.";
RL   J. Biol. Chem. 278:26102-26110(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   ASN-611.
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-659.
RC   TISSUE=Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 355-1770 (ISOFORM 2), AND
RP   VARIANT ASN-611.
RC   TISSUE=Brain;
RX   PubMed=10718198; DOI=10.1093/dnares/7.1.65;
RA   Nagase T., Kikuno R., Ishikawa K., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XVI.
RT   The complete sequences of 150 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 7:65-73(2000).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-906 AND THR-1210, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [7]
RP   STRUCTURE BY NMR OF 1688-1770.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the SMR domain of NEDD4-binding protein 2.";
RL   Submitted (JUN-2006) to the PDB data bank.
RN   [8]
RP   VARIANT [LARGE SCALE ANALYSIS] ALA-283.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Has 5'-polynucleotide kinase and nicking endonuclease
CC       activity. May play a role in DNA repair or recombination.
CC       {ECO:0000269|PubMed:12730195}.
CC   -!- SUBUNIT: Binds NEDD4 (By similarity). Binds BCL3 and CREBBP.
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q86UW6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q86UW6-2; Sequence=VSP_009721;
CC         Note=No experimental confirmation available.;
CC   -!- DOMAIN: The Smr domain has nicking endonuclease activity, but no
CC       significant double strand cleavage or exonuclease activity.
CC   -!- PTM: Ubiquitinated; this targets the protein for degradation by
CC       the proteasome. {ECO:0000250}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AY267013; AAP22172.1; -; mRNA.
DR   EMBL; BC126466; AAI26467.1; -; mRNA.
DR   EMBL; AK001542; BAA91748.1; -; mRNA.
DR   EMBL; AB037834; BAA92651.1; -; mRNA.
DR   CCDS; CCDS3457.1; -. [Q86UW6-1]
DR   RefSeq; NP_001305288.1; NM_001318359.1.
DR   RefSeq; NP_060647.2; NM_018177.5. [Q86UW6-1]
DR   RefSeq; XP_011512020.1; XM_011513718.2. [Q86UW6-1]
DR   RefSeq; XP_016863887.1; XM_017008398.1. [Q86UW6-1]
DR   UniGene; Hs.391463; -.
DR   UniGene; Hs.736026; -.
DR   PDB; 2D9I; NMR; -; A=1688-1770.
DR   PDB; 2VKC; NMR; -; A=1657-1770.
DR   PDB; 3BHB; X-ray; 2.20 A; C=129-138.
DR   PDB; 3FAU; X-ray; 1.90 A; A/B/C/D=1691-1770.
DR   PDBsum; 2D9I; -.
DR   PDBsum; 2VKC; -.
DR   PDBsum; 3BHB; -.
DR   PDBsum; 3FAU; -.
DR   ProteinModelPortal; Q86UW6; -.
DR   SMR; Q86UW6; -.
DR   BioGrid; 120848; 14.
DR   CORUM; Q86UW6; -.
DR   IntAct; Q86UW6; 8.
DR   STRING; 9606.ENSP00000261435; -.
DR   iPTMnet; Q86UW6; -.
DR   PhosphoSitePlus; Q86UW6; -.
DR   BioMuta; N4BP2; -.
DR   DMDM; 145559498; -.
DR   EPD; Q86UW6; -.
DR   jPOST; Q86UW6; -.
DR   MaxQB; Q86UW6; -.
DR   PaxDb; Q86UW6; -.
DR   PeptideAtlas; Q86UW6; -.
DR   PRIDE; Q86UW6; -.
DR   ProteomicsDB; 69917; -.
DR   ProteomicsDB; 69918; -. [Q86UW6-2]
DR   Ensembl; ENST00000261435; ENSP00000261435; ENSG00000078177. [Q86UW6-1]
DR   GeneID; 55728; -.
DR   KEGG; hsa:55728; -.
DR   UCSC; uc003guy.5; human. [Q86UW6-1]
DR   CTD; 55728; -.
DR   DisGeNET; 55728; -.
DR   EuPathDB; HostDB:ENSG00000078177.13; -.
DR   GeneCards; N4BP2; -.
DR   H-InvDB; HIX0004169; -.
DR   HGNC; HGNC:29851; N4BP2.
DR   HPA; HPA036770; -.
DR   HPA; HPA042607; -.
DR   neXtProt; NX_Q86UW6; -.
DR   OpenTargets; ENSG00000078177; -.
DR   PharmGKB; PA162396580; -.
DR   eggNOG; KOG2401; Eukaryota.
DR   eggNOG; ENOG41101K4; LUCA.
DR   GeneTree; ENSGT00940000160604; -.
DR   HOGENOM; HOG000113717; -.
DR   HOVERGEN; HBG101251; -.
DR   InParanoid; Q86UW6; -.
DR   KO; K15720; -.
DR   OMA; NIVGDWP; -.
DR   OrthoDB; 76267at2759; -.
DR   PhylomeDB; Q86UW6; -.
DR   TreeFam; TF327016; -.
DR   ChiTaRS; N4BP2; human.
DR   EvolutionaryTrace; Q86UW6; -.
DR   GenomeRNAi; 55728; -.
DR   PRO; PR:Q86UW6; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000078177; Expressed in 177 organ(s), highest expression level in tibia.
DR   ExpressionAtlas; Q86UW6; baseline and differential.
DR   Genevisible; Q86UW6; HS.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IDA:MGI.
DR   GO; GO:0046404; F:ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity; IDA:MGI.
DR   GO; GO:0004519; F:endonuclease activity; IDA:MGI.
DR   InterPro; IPR003892; CUE.
DR   InterPro; IPR013899; DUF1771.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR002625; Smr_dom.
DR   InterPro; IPR036063; Smr_dom_sf.
DR   InterPro; IPR009060; UBA-like_sf.
DR   Pfam; PF08590; DUF1771; 1.
DR   Pfam; PF01713; Smr; 1.
DR   SMART; SM01162; DUF1771; 1.
DR   SMART; SM00463; SMR; 1.
DR   SUPFAM; SSF160443; SSF160443; 1.
DR   SUPFAM; SSF46934; SSF46934; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS51140; CUE; 1.
DR   PROSITE; PS50828; SMR; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Coiled coil;
KW   Complete proteome; Cytoplasm; Hydrolase; Nucleotide-binding;
KW   Phosphoprotein; Polymorphism; Reference proteome; Ubl conjugation.
FT   CHAIN         1   1770       NEDD4-binding protein 2.
FT                                /FTId=PRO_0000096681.
FT   DOMAIN       46     89       CUE. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00468}.
FT   DOMAIN     1691   1770       Smr. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00321}.
FT   NP_BIND     447    454       ATP. {ECO:0000255}.
FT   COILED       90    177       {ECO:0000255}.
FT   COILED      218    259       {ECO:0000255}.
FT   COMPBIAS    328    368       Pro-rich.
FT   MOD_RES     906    906       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1210   1210       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ    1596   1612       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:10718198}.
FT                                /FTId=VSP_009721.
FT   VARIANT     101    101       S -> I (in dbSNP:rs17511668).
FT                                /FTId=VAR_051215.
FT   VARIANT     196    196       M -> V (in dbSNP:rs10014170).
FT                                /FTId=VAR_051216.
FT   VARIANT     283    283       P -> A (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035474.
FT   VARIANT     611    611       D -> N (in dbSNP:rs794001).
FT                                {ECO:0000269|PubMed:10718198,
FT                                ECO:0000269|PubMed:12730195,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_051217.
FT   VARIANT    1587   1587       T -> A (in dbSNP:rs2271395).
FT                                /FTId=VAR_051218.
FT   CONFLICT    118    118       E -> K (in Ref. 2; AAI26467).
FT                                {ECO:0000305}.
FT   CONFLICT    428    428       S -> F (in Ref. 3; BAA91748).
FT                                {ECO:0000305}.
FT   CONFLICT    660    660       K -> Q (in Ref. 1; AAP22172).
FT                                {ECO:0000305}.
FT   CONFLICT    778    778       K -> E (in Ref. 4; BAA92651).
FT                                {ECO:0000305}.
FT   CONFLICT   1353   1353       S -> R (in Ref. 2; AAI26467 and 4;
FT                                BAA92651). {ECO:0000305}.
FT   CONFLICT   1524   1524       L -> V (in Ref. 1; AAP22172).
FT                                {ECO:0000305}.
FT   CONFLICT   1591   1591       S -> F (in Ref. 1; AAP22172).
FT                                {ECO:0000305}.
FT   HELIX      1669   1685       {ECO:0000244|PDB:2VKC}.
FT   HELIX      1686   1688       {ECO:0000244|PDB:2VKC}.
FT   STRAND     1690   1692       {ECO:0000244|PDB:2D9I}.
FT   HELIX      1698   1719       {ECO:0000244|PDB:3FAU}.
FT   STRAND     1724   1728       {ECO:0000244|PDB:3FAU}.
FT   STRAND     1734   1736       {ECO:0000244|PDB:3FAU}.
FT   HELIX      1742   1752       {ECO:0000244|PDB:3FAU}.
FT   STRAND     1757   1761       {ECO:0000244|PDB:3FAU}.
FT   STRAND     1764   1768       {ECO:0000244|PDB:3FAU}.
SQ   SEQUENCE   1770 AA;  198801 MW;  9A49FAB19C1BD56D CRC64;
     MPRRRKNLGG NPFRKTANPK EVVVSSVASR EEPTTTLPSM GETKVDQEEL FTSISEIFSD
     LDPDVVYLML SECDFKVENA MDCLLELSAT DTKIEESSSQ SFVASENQVG AAESKIMEKR
     PEEESEDSKM DSFLDMQLTE DLDSLIQNAF EKLNSSPDDQ VYSFLPSQDV NSFNDSSEFI
     NPDSSNMTPI FSTQNMNLNG ENLENSGSTL SLNPLPSHSV LNESKCFIKD NTLALESNYP
     EDSLLSSSLN VASDSIAGCS SLNQKQKELL ESECVEAQFS EAPVDLDASE PQACLNLPGL
     DLPGTGGDQK STRVSDVFLP SEGFNFKPHK HPELPTKGKD VSYCPVLAPL PLLLPPPPPP
     PMWNPMIPAF DLFQGNHGFV APVVTTAAHW RSVNYTFPPS VISHTSPTKV WRNKDGTSAY
     QVQETPVSQV VRKKTSYVGL VLVLLRGLPG SGKSFLARTL QEDNPSGVIL STDDYFYING
     QYQFDVKYLG EAHEWNQNRA KEAFEKKISP IIIDNTNLQA WEMKPYVALS QKHKYKVLFR
     EPDTWWKFKP KELARRNIHG VSKEKITRML EHYQRFVSVP IIMSSSVPEK IERIELCAYS
     CEDRSTSPRD DEDIISEKEE NILSLSLKHL EFTEEKNLDV TKETMLPENV AYLSNADLNK
     RRKEISDMNP SIQSALILET PHMYFSDSES KLQATDKSEN EQIEMVAVKG YSKTDTDSSM
     ERVSPSTCCS ENNQEDCDLA NSGPLQNEKS SPGEIVEERA TVTKKAFGKQ KSKSTLEKFP
     RHELSNFVGD WPVDKTIGQR TKRNRKTEKT SSVQSDKKYN YPQSHKLVNS VSVNTDCVQQ
     RGSPHESVED GRKSQCDDAS EPLNSYKYDA YKNIDKNSFN IMGDWPSSDS LAQREHRSRM
     PKTGLSEPNL EIGTNDKMNE ISLSTAHEAC WGTSSQKLKT LGSSNLGSSE MLLSEMTCES
     QTCLSKKSHG QHTSLPLTFT NSAPTVSGVV EPQTLAECQE QMPKRDPGKE VGMCTQTEPQ
     DFALLWKIEK NKISISDSIK VLTGRLDGFK PKVFNINTKS DVQEAIPYRV MYDKSTFVEE
     SELTSADESE NLNILCKLFG SFSLEALKDL YERCNKDIIW ATSLLLDSET KLCEDTEFEN
     FQKSCDGSQI GPFSLGLNLK EIISQRGTLE NSNSPVPEFS HGIGISNADS QSTCDAERGN
     SEQAEMRAVT PENHESMTSI FPSAAVGLKN NNDILPNSQE ELLYSSKQSF PGILKATTPK
     DMSETEKNLV VTETGDNIHS PSHFSDIFNF VSSTSNLELN EEIYFTDSLE IKRNENFPKD
     YVKFSDEEEF MNEDEKEMKE ILMAGSSLSA GVSGEDKTEI LNPTPAMAKS LTIDCLELAL
     PPELAFQLNE LFGPVGIDSG SLTVEDCVVH IDLNLAKVIH EKWKESVMER QRQEEVSCGK
     FMQDPSLVGH TGLDNPEQKS SQRTGKKLLK TLTASEMLPL LDHWNTQTKK VSLREIMSEE
     IALQEKHNLK RETLMFEKDC ATKLKEKQLF KIFPAINQNF LVDIFKDHNY SLEHTVQFLN
     CVLEGDPVKT VVAQEFVHQN ENVTSHTGQK SKEKKPKKLK ETEETPSELS FQDFEYPDYD
     DYRAEAFLHQ QKRMECYSKA KEAYRIGKKN VATFYAQQGT LHEQKMKEAN HLAAIEIFEK
     VNASLLPQNV LDLHGLHVDE ALEHLMRVLE KKTEEFKQNG GKPYLSVITG RGNHSQGGVA
     RIKPAVIKYL ISHSFRFSEI KPGCLKVMLK
//
ID   E5KTI5_HUMAN            Unreviewed;       312 AA.
AC   E5KTI5;
DT   08-FEB-2011, integrated into UniProtKB/TrEMBL.
DT   08-FEB-2011, sequence version 1.
DT   13-FEB-2019, entry version 71.
DE   RecName: Full=Endonuclease III-like protein 1 {ECO:0000256|HAMAP-Rule:MF_03183};
DE            EC=3.2.2.- {ECO:0000256|HAMAP-Rule:MF_03183};
DE            EC=4.2.99.18 {ECO:0000256|HAMAP-Rule:MF_03183};
DE   AltName: Full=Bifunctional DNA N-glycosylase/DNA-(apurinic or apyrimidinic site) lyase {ECO:0000256|HAMAP-Rule:MF_03183};
DE            Short=DNA glycosylase/AP lyase {ECO:0000256|HAMAP-Rule:MF_03183};
GN   Name=NTHL1 {ECO:0000256|HAMAP-Rule:MF_03183,
GN   ECO:0000313|EMBL:EAW85562.1};
GN   ORFNames=hCG_1989994 {ECO:0000313|EMBL:EAW85562.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ADP92214.1};
RN   [1] {ECO:0000313|EMBL:EAW85562.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW85562.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:ADP92214.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=20843780; DOI=10.1093/nar/gkq750;
RA   Wang W., Shen P., Thiyagarajan S., Lin S., Palm C., Horvath R.,
RA   Klopstock T., Cutler D., Pique L., Schrijver I., Davis R.W.,
RA   Mindrinos M., Speed T.P., Scharfe C.;
RT   "Identification of rare DNA variants in mitochondrial disorders with
RT   improved array-based sequencing.";
RL   Nucleic Acids Res. 39:44-58(2011).
CC   -!- FUNCTION: Bifunctional DNA N-glycosylase with associated
CC       apurinic/apyrimidinic (AP) lyase function that catalyzes the first
CC       step in base excision repair (BER), the primary repair pathway for
CC       the repair of oxidative DNA damage. The DNA N-glycosylase activity
CC       releases the damaged DNA base from DNA by cleaving the N-
CC       glycosidic bond, leaving an AP site. The AP lyase activity cleaves
CC       the phosphodiester bond 3' to the AP site by a beta-elimination.
CC       Primarily recognizes and repairs oxidative base damage of
CC       pyrimidines. {ECO:0000256|HAMAP-Rule:MF_03183}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=The C-O-P bond 3' to the apurinic or apyrimidinic site in
CC         DNA is broken by a beta-elimination reaction, leaving a 3'-
CC         terminal unsaturated sugar and a product with a terminal 5'-
CC         phosphate.; EC=4.2.99.18; Evidence={ECO:0000256|HAMAP-
CC         Rule:MF_03183};
CC   -!- COFACTOR:
CC       Name=[4Fe-4S] cluster; Xref=ChEBI:CHEBI:49883;
CC         Evidence={ECO:0000256|HAMAP-Rule:MF_03183};
CC       Note=Binds 1 [4Fe-4S] cluster. The cluster does not appear to play
CC       a role in catalysis, but is probably involved in the proper
CC       positioning of the enzyme along the DNA strand.
CC       {ECO:0000256|HAMAP-Rule:MF_03183};
CC   -!- SUBUNIT: Interacts with YBX1. {ECO:0000256|HAMAP-Rule:MF_03183}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000256|HAMAP-Rule:MF_03183}.
CC       Mitochondrion {ECO:0000256|HAMAP-Rule:MF_03183}.
CC   -!- SIMILARITY: Belongs to the Nth/MutY family. {ECO:0000256|HAMAP-
CC       Rule:MF_03183}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; HQ206266; ADP92214.1; -; Genomic_DNA.
DR   EMBL; HQ206267; ADP92215.1; -; Genomic_DNA.
DR   EMBL; HQ206268; ADP92216.1; -; Genomic_DNA.
DR   EMBL; HQ206269; ADP92217.1; -; Genomic_DNA.
DR   EMBL; HQ206270; ADP92218.1; -; Genomic_DNA.
DR   EMBL; HQ206271; ADP92219.1; -; Genomic_DNA.
DR   EMBL; HQ206272; ADP92220.1; -; Genomic_DNA.
DR   EMBL; HQ206273; ADP92221.1; -; Genomic_DNA.
DR   EMBL; HQ206274; ADP92222.1; -; Genomic_DNA.
DR   EMBL; HQ206275; ADP92223.1; -; Genomic_DNA.
DR   EMBL; HQ206276; ADP92224.1; -; Genomic_DNA.
DR   EMBL; HQ206277; ADP92225.1; -; Genomic_DNA.
DR   EMBL; HQ206278; ADP92226.1; -; Genomic_DNA.
DR   EMBL; HQ206279; ADP92227.1; -; Genomic_DNA.
DR   EMBL; HQ206280; ADP92228.1; -; Genomic_DNA.
DR   EMBL; HQ206281; ADP92229.1; -; Genomic_DNA.
DR   EMBL; HQ206282; ADP92230.1; -; Genomic_DNA.
DR   EMBL; HQ206283; ADP92231.1; -; Genomic_DNA.
DR   EMBL; HQ206284; ADP92232.1; -; Genomic_DNA.
DR   EMBL; HQ206285; ADP92233.1; -; Genomic_DNA.
DR   EMBL; HQ206286; ADP92234.1; -; Genomic_DNA.
DR   EMBL; HQ206287; ADP92235.1; -; Genomic_DNA.
DR   EMBL; HQ206288; ADP92236.1; -; Genomic_DNA.
DR   EMBL; HQ206289; ADP92237.1; -; Genomic_DNA.
DR   EMBL; HQ206290; ADP92238.1; -; Genomic_DNA.
DR   EMBL; HQ206291; ADP92239.1; -; Genomic_DNA.
DR   EMBL; HQ206292; ADP92240.1; -; Genomic_DNA.
DR   EMBL; HQ206293; ADP92241.1; -; Genomic_DNA.
DR   EMBL; HQ206294; ADP92242.1; -; Genomic_DNA.
DR   EMBL; HQ206295; ADP92243.1; -; Genomic_DNA.
DR   EMBL; HQ206296; ADP92244.1; -; Genomic_DNA.
DR   EMBL; HQ206297; ADP92245.1; -; Genomic_DNA.
DR   EMBL; HQ206298; ADP92246.1; -; Genomic_DNA.
DR   EMBL; HQ206299; ADP92247.1; -; Genomic_DNA.
DR   EMBL; HQ206300; ADP92248.1; -; Genomic_DNA.
DR   EMBL; HQ206301; ADP92249.1; -; Genomic_DNA.
DR   EMBL; HQ206302; ADP92250.1; -; Genomic_DNA.
DR   EMBL; HQ206303; ADP92251.1; -; Genomic_DNA.
DR   EMBL; HQ206304; ADP92252.1; -; Genomic_DNA.
DR   EMBL; HQ206305; ADP92253.1; -; Genomic_DNA.
DR   EMBL; CH471112; EAW85562.1; -; Genomic_DNA.
DR   RefSeq; NP_002519.1; NM_002528.6.
DR   UniGene; Hs.66196; -.
DR   GeneID; 4913; -.
DR   KEGG; hsa:4913; -.
DR   CTD; 4913; -.
DR   EuPathDB; HostDB:ENSG00000065057.7; -.
DR   eggNOG; KOG1921; Eukaryota.
DR   eggNOG; COG0177; LUCA.
DR   KO; K10773; -.
DR   OMA; WQQFTHL; -.
DR   OrthoDB; 1322642at2759; -.
DR   GenomeRNAi; 4913; -.
DR   Bgee; ENSG00000065057; Expressed in 173 organ(s), highest expression level in right lobe of liver.
DR   GO; GO:0005739; C:mitochondrion; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0051539; F:4 iron, 4 sulfur cluster binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0140078; F:class I DNA-(apurinic or apyrimidinic site) endonuclease activity; IEA:UniProtKB-EC.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0004519; F:endonuclease activity; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0000703; F:oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0006285; P:base-excision repair, AP site formation; IEA:UniProtKB-UniRule.
DR   GO; GO:0006296; P:nucleotide-excision repair, DNA incision, 5'-to lesion; IEA:Ensembl.
DR   CDD; cd00056; ENDO3c; 1.
DR   Gene3D; 1.10.1670.10; -; 1.
DR   HAMAP; MF_03183; Endonuclease_III_Nth; 1.
DR   InterPro; IPR011257; DNA_glycosylase.
DR   InterPro; IPR004036; Endonuclease-III-like_CS2.
DR   InterPro; IPR003651; Endonuclease3_FeS-loop_motif.
DR   InterPro; IPR003265; HhH-GPD_domain.
DR   InterPro; IPR000445; HhH_motif.
DR   InterPro; IPR023170; HTH_base_excis_C.
DR   InterPro; IPR030841; NTH1.
DR   Pfam; PF00633; HHH; 1.
DR   Pfam; PF00730; HhH-GPD; 1.
DR   SMART; SM00478; ENDO3c; 1.
DR   SMART; SM00525; FES; 1.
DR   SUPFAM; SSF48150; SSF48150; 1.
DR   PROSITE; PS01155; ENDONUCLEASE_III_2; 1.
PE   3: Inferred from homology;
KW   4Fe-4S {ECO:0000256|HAMAP-Rule:MF_03183};
KW   DNA damage {ECO:0000256|HAMAP-Rule:MF_03183};
KW   DNA repair {ECO:0000256|HAMAP-Rule:MF_03183};
KW   Endonuclease {ECO:0000313|EMBL:ADP92214.1};
KW   Glycosidase {ECO:0000256|HAMAP-Rule:MF_03183};
KW   Hydrolase {ECO:0000256|HAMAP-Rule:MF_03183,
KW   ECO:0000313|EMBL:ADP92214.1}; Iron {ECO:0000256|HAMAP-Rule:MF_03183};
KW   Iron-sulfur {ECO:0000256|HAMAP-Rule:MF_03183};
KW   Lyase {ECO:0000256|HAMAP-Rule:MF_03183};
KW   Metal-binding {ECO:0000256|HAMAP-Rule:MF_03183};
KW   Mitochondrion {ECO:0000256|HAMAP-Rule:MF_03183};
KW   Nuclease {ECO:0000313|EMBL:ADP92214.1};
KW   Nucleus {ECO:0000256|HAMAP-Rule:MF_03183}.
FT   DOMAIN      138    288       ENDO3c. {ECO:0000259|SMART:SM00478}.
FT   ACT_SITE    220    220       Nucleophile; for N-glycosylase activity.
FT                                {ECO:0000256|HAMAP-Rule:MF_03183}.
FT   METAL       290    290       Iron-sulfur (4Fe-4S). {ECO:0000256|HAMAP-
FT                                Rule:MF_03183}.
FT   METAL       297    297       Iron-sulfur (4Fe-4S). {ECO:0000256|HAMAP-
FT                                Rule:MF_03183}.
FT   METAL       300    300       Iron-sulfur (4Fe-4S). {ECO:0000256|HAMAP-
FT                                Rule:MF_03183}.
FT   METAL       306    306       Iron-sulfur (4Fe-4S). {ECO:0000256|HAMAP-
FT                                Rule:MF_03183}.
FT   SITE        239    239       Important for catalytic activity.
FT                                {ECO:0000256|HAMAP-Rule:MF_03183}.
SQ   SEQUENCE   312 AA;  34390 MW;  379816A1E0B45050 CRC64;
     MCSPQESGMT ALSARMLTRS RSLGPGAGPR GCREEPGPLR RREAAAEARK SHSPVKRPRK
     AQRLRVAYEG SDSEKGEGAE PLKVPVWEPQ DWQQQLVNIR AMRNKKDAPV DHLGTEHCYD
     SSAPPKVRRY QVLLSLMLSS QTKDQVTAGA MQRLRARGLT VDSILQTDDA TLGKLIYPVG
     FWRSKVKYIK QTSAILQQHY GGDIPASVAE LVALPGVGPK MAHLAMAVAW GTVSGIAVDT
     HVHRIANRLR WTKKATKSPE ETRAALEEWL PRELWHEING LLVGFGQQTC LPVHPRCHAC
     LNQALCPAAQ GL
//
ID   NTH_HUMAN               Reviewed;         312 AA.
AC   P78549; Q1MVR1; Q99566; Q99794; Q9BPX2;
DT   28-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1999, sequence version 2.
DT   13-FEB-2019, entry version 179.
DE   RecName: Full=Endonuclease III-like protein 1 {ECO:0000255|HAMAP-Rule:MF_03183};
DE            Short=hNTH1;
DE            EC=3.2.2.- {ECO:0000255|HAMAP-Rule:MF_03183};
DE            EC=4.2.99.18 {ECO:0000255|HAMAP-Rule:MF_03183};
DE   AltName: Full=Bifunctional DNA N-glycosylase/DNA-(apurinic or apyrimidinic site) lyase {ECO:0000255|HAMAP-Rule:MF_03183};
DE            Short=DNA glycosylase/AP lyase {ECO:0000255|HAMAP-Rule:MF_03183};
DE   Flags: Precursor;
GN   Name=NTHL1 {ECO:0000255|HAMAP-Rule:MF_03183}; Synonyms=NTH1, OCTS3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000312|EMBL:AAM11786.1};
RN   [1] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=8990169; DOI=10.1073/pnas.94.1.109;
RA   Aspinwall R., Rothwell D.G., Roldan-Arjona T., Anselmino C.,
RA   Ward C.J., Cheadle J.P., Sampson J.R., Lindahl T., Harris P.C.,
RA   Hickson I.D.;
RT   "Cloning and characterization of a functional human homolog of
RT   Escherichia coli endonuclease III.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:109-114(1997).
RN   [2] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 2), AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Placenta;
RX   PubMed=9831664; DOI=10.1016/S0378-1119(98)00485-5;
RA   Imai K., Sarker A.H., Akiyama K., Ikeda S., Yao M., Tsutsui K.,
RA   Shohmori T., Seki S.;
RT   "Genomic structure and sequence of a human homologue (NTHL1/NTH1) of
RT   Escherichia coli endonuclease III with those of the adjacent parts of
RT   TSC2 and SLC9A3R2 genes.";
RL   Gene 222:287-295(1998).
RN   [3] {ECO:0000305, ECO:0000312|EMBL:AAM11786.1}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS TRP-21 AND LEU-234.
RG   NIEHS SNPs program;
RL   Submitted (MAR-2002) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X.,
RA   Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A.,
RA   Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J.,
RA   Buckingham J.M., Callen D.F., Campbell C.S., Campbell M.L.,
RA   Campbell E.W., Caoile C., Challacombe J.F., Chasteen L.A.,
RA   Chertkov O., Chi H.C., Christensen M., Clark L.M., Cohn J.D.,
RA   Denys M., Detter J.C., Dickson M., Dimitrijevic-Bussod M., Escobar J.,
RA   Fawcett J.J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., Grigoriev I.,
RA   Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., Huang W.,
RA   Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., Kobayashi A.,
RA   Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., Lowry S.,
RA   Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L.,
RA   Rash S., Retterer J., Ricke D.O., Robinson D.L., Rodriguez A.,
RA   Salamov A., Saunders E.H., Scott D., Shough T., Stallings R.L.,
RA   Stalvey M., Sutherland R.D., Tapia R., Tesmer J.G., Thayer N.,
RA   Thompson L.S., Tice H., Torney D.C., Tran-Gyamfi M., Tsai M.,
RA   Ulanovsky L.E., Ustaszewska A., Vo N., White P.S., Williams A.L.,
RA   Wills P.L., Wu J.-R., Wu K., Yang J., DeJong P., Bruce D.,
RA   Doggett N.A., Deaven L., Schmutz J., Grimwood J., Richardson P.,
RA   Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., Myers R.M.,
RA   Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [5] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, ACTIVE SITE, AND
RP   MUTAGENESIS OF LYS-220.
RC   TISSUE=Bone marrow;
RX   PubMed=9705289; DOI=10.1074/jbc.273.34.21585;
RA   Ikeda S., Biswas T., Roy R., Izumi T., Boldogh I., Kurosky A.,
RA   Sarker A.H., Seki S., Mitra S.;
RT   "Purification and characterization of human NTH1, a homolog of
RT   Escherichia coli endonuclease III. Direct identification of Lys-212 as
RT   the active nucleophilic residue.";
RL   J. Biol. Chem. 273:21585-21593(1998).
RN   [6] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND FUNCTION.
RC   TISSUE=Spleen;
RX   PubMed=9045706; DOI=10.1074/jbc.272.10.6733;
RA   Hilbert T.P., Chaung W., Boorstein R.J., Cunningham R.P., Teebor G.W.;
RT   "Cloning and expression of the cDNA encoding the human homologue of
RT   the DNA repair enzyme, Escherichia coli endonuclease III.";
RL   J. Biol. Chem. 272:6733-6740(1997).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 8-312 (ISOFORMS 1 AND 2).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 9-312, FUNCTION, SUBCELLULAR LOCATION,
RP   AND DEVELOPMENTAL STAGE.
RX   PubMed=10882850; DOI=10.1016/S0921-8777(00)00015-X;
RA   Luna L., Bjoras M., Hoff E., Rognes T., Seeberg E.;
RT   "Cell-cycle regulation, intracellular sorting and induced
RT   overexpression of the human NTH1 DNA glycosylase involved in removal
RT   of formamidopyrimidine residues from DNA.";
RL   Mutat. Res. 460:95-104(2000).
RN   [9]
RP   PROTEIN SEQUENCE OF 31-37; 48-56; 61-78; 107-113; 120-126 AND 221-227,
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=12144783; DOI=10.1016/S0022-2836(02)00623-X;
RA   Liu X., Roy R.;
RT   "Truncation of amino-terminal tail stimulates activity of human
RT   endonuclease III (hNTH1).";
RL   J. Mol. Biol. 321:265-276(2002).
RN   [10]
RP   SUBCELLULAR LOCATION.
RX   PubMed=9611236; DOI=10.1093/nar/26.12.2917;
RA   Takao M., Aburatani H., Kobayashi K., Yasui A.;
RT   "Mitochondrial targeting of human DNA glycosylases for repair of
RT   oxidative DNA damage.";
RL   Nucleic Acids Res. 26:2917-2922(1998).
RN   [11]
RP   FUNCTION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=9890904; DOI=10.1021/bi9819071;
RA   Dizdaroglu M., Karahalil B., Senturker S., Buckley T.J.,
RA   Roldan-Arjona T.;
RT   "Excision of products of oxidative DNA base damage by human NTH1
RT   protein.";
RL   Biochemistry 38:243-246(1999).
RN   [12]
RP   FUNCTION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=11380260; DOI=10.1021/bi0028901;
RA   Eide L., Luna L., Gustad E.C., Henderson P.T., Essigmann J.M.,
RA   Demple B., Seeberg E.;
RT   "Human endonuclease III acts preferentially on DNA damage opposite
RT   guanine residues in DNA.";
RL   Biochemistry 40:6653-6659(2001).
RN   [13]
RP   FUNCTION, AND MUTAGENESIS OF LYS-220.
RX   PubMed=11695910; DOI=10.1021/bi011053b;
RA   Liu X., Roy R.;
RT   "Mutation at active site lysine 212 to arginine uncouples the
RT   glycosylase activity from the lyase activity of human endonuclease
RT   III.";
RL   Biochemistry 40:13617-13622(2001).
RN   [14]
RP   CATALYTIC ACTIVITY, INTERACTION WITH YBX1, AND ACTIVITY REGULATION.
RX   PubMed=11287425; DOI=10.1074/jbc.M101594200;
RA   Marenstein D.R., Ocampo M.T., Chan M.K., Altamirano A., Basu A.K.,
RA   Boorstein R.J., Cunningham R.P., Teebor G.W.;
RT   "Stimulation of human endonuclease III by Y box-binding protein 1
RT   (DNA-binding protein B). Interaction between a base excision repair
RT   enzyme and a transcription factor.";
RL   J. Biol. Chem. 276:21242-21249(2001).
RN   [15]
RP   FUNCTION.
RX   PubMed=11328882; DOI=10.1093/nar/29.9.1975;
RA   Matsumoto Y., Zhang Q.M., Takao M., Yasui A., Yonei S.;
RT   "Escherichia coli Nth and human hNTH1 DNA glycosylases are involved in
RT   removal of 8-oxoguanine from 8-oxoguanine/guanine mispairs in DNA.";
RL   Nucleic Acids Res. 29:1975-1981(2001).
RN   [16] {ECO:0000305}
RP   SUBCELLULAR LOCATION, ALTERNATIVE INITIATION, AND MUTAGENESIS OF
RP   40-ARG--ARG-42; ARG-42 AND ARG-57.
RX   PubMed=12531031; DOI=10.1016/S1568-7864(02)00145-3;
RA   Ikeda S., Kohmoto T., Tabata R., Seki Y.;
RT   "Differential intracellular localization of the human and mouse
RT   endonuclease III homologs and analysis of the sorting signals.";
RL   DNA Repair 1:847-854(2002).
RN   [17]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=12140329; DOI=10.1093/nar/gkf460;
RA   Miyabe I., Zhang Q.M., Kino K., Sugiyama H., Takao M., Yasui A.,
RA   Yonei S.;
RT   "Identification of 5-formyluracil DNA glycosylase activity of human
RT   hNTH1 protein.";
RL   Nucleic Acids Res. 30:3443-3448(2002).
RN   [18]
RP   FUNCTION, SUBSTRATES, AND ACTIVITY REGULATION.
RX   PubMed=12519758; DOI=10.1074/jbc.M212168200;
RA   Marenstein D.R., Chan M.K., Altamirano A., Basu A.K., Boorstein R.J.,
RA   Cunningham R.P., Teebor G.W.;
RT   "Substrate specificity of human endonuclease III (hNTH1). Effect of
RT   human APE1 on hNTH1 activity.";
RL   J. Biol. Chem. 278:9005-9012(2003).
RN   [19]
RP   FUNCTION, AND SUBSTRATES.
RX   PubMed=14734554; DOI=10.1074/jbc.M400393200;
RA   Katafuchi A., Nakano T., Masaoka A., Terato H., Iwai S., Hanaoka F.,
RA   Ide H.;
RT   "Differential specificity of human and Escherichia coli endonuclease
RT   III and VIII homologues for oxidative base lesions.";
RL   J. Biol. Chem. 279:14464-14471(2004).
RN   [20]
RP   FUNCTION, AND SUBSTRATES.
RX   PubMed=15533839; DOI=10.1016/j.dnarep.2004.08.002;
RA   Zhang Q.M., Yonekura S., Takao M., Yasui A., Sugiyama H., Yonei S.;
RT   "DNA glycosylase activities for thymine residues oxidized in the
RT   methyl group are functions of the hNEIL1 and hNTH1 enzymes in human
RT   cells.";
RL   DNA Repair 4:71-79(2005).
RN   [21]
RP   FUNCTION.
RX   PubMed=17923696; DOI=10.1128/MCB.00791-07;
RA   Prasad A., Wallace S.S., Pederson D.S.;
RT   "Initiation of base excision repair of oxidative lesions in
RT   nucleosomes by the human, bifunctional DNA glycosylase NTH1.";
RL   Mol. Cell. Biol. 27:8442-8453(2007).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [23]
RP   FUNCTION.
RX   PubMed=20005182; DOI=10.1016/j.dnarep.2009.11.005;
RA   Odell I.D., Newick K., Heintz N.H., Wallace S.S., Pederson D.S.;
RT   "Non-specific DNA binding interferes with the efficient excision of
RT   oxidative lesions from chromatin by the human DNA glycosylase,
RT   NEIL1.";
RL   DNA Repair 9:134-143(2010).
RN   [24]
RP   FUNCTION.
RX   PubMed=20110254; DOI=10.1093/nar/gkq022;
RA   Matsumoto N., Toga T., Hayashi R., Sugasawa K., Katayanagi K., Ide H.,
RA   Kuraoka I., Iwai S.;
RT   "Fluorescent probes for the analysis of DNA strand scission in base
RT   excision repair.";
RL   Nucleic Acids Res. 38:E101-E101(2010).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-71, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [26]
RP   FUNCTION.
RX   PubMed=21930793; DOI=10.1128/MCB.05715-11;
RA   Odell I.D., Barbour J.E., Murphy D.L., Della-Maria J.A., Sweasy J.B.,
RA   Tomkinson A.E., Wallace S.S., Pederson D.S.;
RT   "Nucleosome disruption by DNA ligase III-XRCC1 promotes efficient base
RT   excision repair.";
RL   Mol. Cell. Biol. 31:4623-4632(2011).
RN   [27]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-71 AND SER-73, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [28]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-71, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [29]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [30]
RP   INVOLVEMENT IN FAP3.
RX   PubMed=25938944; DOI=10.1038/ng.3287;
RA   Weren R.D., Ligtenberg M.J., Kets C.M., de Voer R.M., Verwiel E.T.,
RA   Spruijt L., van Zelst-Stams W.A., Jongmans M.C., Gilissen C.,
RA   Hehir-Kwa J.Y., Hoischen A., Shendure J., Boyle E.A., Kamping E.J.,
RA   Nagtegaal I.D., Tops B.B., Nagengast F.M., Geurts van Kessel A.,
RA   van Krieken J.H., Kuiper R.P., Hoogerbrugge N.;
RT   "A germline homozygous mutation in the base-excision repair gene NTHL1
RT   causes adenomatous polyposis and colorectal cancer.";
RL   Nat. Genet. 47:668-671(2015).
CC   -!- FUNCTION: Bifunctional DNA N-glycosylase with associated
CC       apurinic/apyrimidinic (AP) lyase function that catalyzes the first
CC       step in base excision repair (BER), the primary repair pathway for
CC       the repair of oxidative DNA damage. The DNA N-glycosylase activity
CC       releases the damaged DNA base from DNA by cleaving the N-
CC       glycosidic bond, leaving an AP site. The AP-lyase activity cleaves
CC       the phosphodiester bond 3' to the AP site by a beta-elimination.
CC       Primarily recognizes and repairs oxidative base damage of
CC       pyrimidines. Has also 8-oxo-7,8-dihydroguanine (8-oxoG) DNA
CC       glycosylase activity. Acts preferentially on DNA damage opposite
CC       guanine residues in DNA. Is able to process lesions in nucleosomes
CC       without requiring or inducing nucleosome disruption.
CC       {ECO:0000255|HAMAP-Rule:MF_03183, ECO:0000269|PubMed:10882850,
CC       ECO:0000269|PubMed:11328882, ECO:0000269|PubMed:11380260,
CC       ECO:0000269|PubMed:11695910, ECO:0000269|PubMed:12140329,
CC       ECO:0000269|PubMed:12144783, ECO:0000269|PubMed:12519758,
CC       ECO:0000269|PubMed:14734554, ECO:0000269|PubMed:15533839,
CC       ECO:0000269|PubMed:17923696, ECO:0000269|PubMed:20005182,
CC       ECO:0000269|PubMed:20110254, ECO:0000269|PubMed:21930793,
CC       ECO:0000269|PubMed:8990169, ECO:0000269|PubMed:9045706,
CC       ECO:0000269|PubMed:9705289, ECO:0000269|PubMed:9890904}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=The C-O-P bond 3' to the apurinic or apyrimidinic site in
CC         DNA is broken by a beta-elimination reaction, leaving a 3'-
CC         terminal unsaturated sugar and a product with a terminal 5'-
CC         phosphate.; EC=4.2.99.18;
CC         Evidence={ECO:0000250|UniProtKB:P20625, ECO:0000255|HAMAP-
CC         Rule:MF_03183, ECO:0000269|PubMed:11287425,
CC         ECO:0000269|PubMed:12140329, ECO:0000269|PubMed:12144783};
CC   -!- COFACTOR:
CC       Name=[4Fe-4S] cluster; Xref=ChEBI:CHEBI:49883;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_03183};
CC       Note=Binds 1 [4Fe-4S] cluster. The cluster does not appear to play
CC       a role in catalysis, but is probably involved in the proper
CC       positioning of the enzyme along the DNA strand.
CC       {ECO:0000255|HAMAP-Rule:MF_03183};
CC   -!- ACTIVITY REGULATION: APE1 displaces NTHL1 from the N-glycosylase-
CC       generated AP site in DNA, thereby increasing the turnover of the
CC       DNA N-glycosylase activity. AP lyase activity is stimulated by
CC       YBX1. {ECO:0000269|PubMed:11287425, ECO:0000269|PubMed:12519758}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=371 nM for 5-hydroxy-6-hydrothymine containing duplex
CC         oligonucleotides (N-glycosylase activity)
CC         {ECO:0000269|PubMed:11380260, ECO:0000269|PubMed:9890904};
CC         KM=1093 nM for 5-hydroxyuracil containing duplex
CC         oligonucleotides (N-glycosylase activity)
CC         {ECO:0000269|PubMed:11380260, ECO:0000269|PubMed:9890904};
CC         KM=548 nM for 5-hydroxycytosine containing duplex
CC         oligonucleotides (N-glycosylase activity)
CC         {ECO:0000269|PubMed:11380260, ECO:0000269|PubMed:9890904};
CC         KM=1101 nM for thymine glycol containing duplex oligonucleotides
CC         (N-glycosylase activity) {ECO:0000269|PubMed:11380260,
CC         ECO:0000269|PubMed:9890904};
CC         KM=718 nM for 5,6-dihydroxycytosine containing duplex
CC         oligonucleotides (N-glycosylase activity)
CC         {ECO:0000269|PubMed:11380260, ECO:0000269|PubMed:9890904};
CC         KM=0.05 nM for 5-hydroxycytosine-G containing duplex
CC         oligonucleotides (N-glycosylase activity)
CC         {ECO:0000269|PubMed:11380260, ECO:0000269|PubMed:9890904};
CC         KM=0.2 nM for 5-hydroxycytosine-A containing duplex
CC         oligonucleotides (N-glycosylase activity)
CC         {ECO:0000269|PubMed:11380260, ECO:0000269|PubMed:9890904};
CC   -!- SUBUNIT: Interacts with YBX1. {ECO:0000255|HAMAP-Rule:MF_03183,
CC       ECO:0000269|PubMed:11287425}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|HAMAP-Rule:MF_03183,
CC       ECO:0000269|PubMed:10882850, ECO:0000269|PubMed:12531031,
CC       ECO:0000269|PubMed:9611236}. Mitochondrion {ECO:0000255|HAMAP-
CC       Rule:MF_03183, ECO:0000269|PubMed:9611236}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative initiation; Named isoforms=3;
CC       Name=1; Synonyms=M-8;
CC         IsoId=P78549-1; Sequence=Displayed;
CC       Name=2; Synonyms=M+1;
CC         IsoId=P78549-2; Sequence=VSP_054293;
CC       Name=3; Synonyms=M+8;
CC         IsoId=P78549-3; Sequence=VSP_054292;
CC   -!- TISSUE SPECIFICITY: Widely expressed with highest levels in heart
CC       and lowest levels in lung and liver. {ECO:0000269|PubMed:8990169,
CC       ECO:0000269|PubMed:9831664}.
CC   -!- DEVELOPMENTAL STAGE: Expression levels are regulated during the
CC       cell cycle with increased levels during early and mid S-phase.
CC       {ECO:0000269|PubMed:10882850}.
CC   -!- DISEASE: Familial adenomatous polyposis 3 (FAP3) [MIM:616415]: A
CC       form of familial adenomatous polyposis, a condition characterized
CC       by the development of multiple colorectal adenomatous polyps,
CC       benign neoplasms derived from glandular epithelium. Some affected
CC       individuals may develop colorectal carcinoma.
CC       {ECO:0000269|PubMed:25938944}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the Nth/MutY family. {ECO:0000255|HAMAP-
CC       Rule:MF_03183}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/nthl1/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; U79718; AAB41534.1; -; mRNA.
DR   EMBL; AB014460; BAA32695.1; -; Genomic_DNA.
DR   EMBL; AF498098; AAM11786.1; -; Genomic_DNA.
DR   EMBL; AC005600; AAC34209.1; -; Genomic_DNA.
DR   EMBL; AB001575; BAA19413.1; -; mRNA.
DR   EMBL; U81285; AAC51136.1; -; mRNA.
DR   EMBL; BC003014; AAH03014.1; -; mRNA.
DR   EMBL; BC000391; AAH00391.2; -; mRNA.
DR   EMBL; Y09687; CAA70865.1; -; mRNA.
DR   CCDS; CCDS10457.1; -. [P78549-2]
DR   RefSeq; NP_001305122.1; NM_001318193.1.
DR   RefSeq; NP_001305123.1; NM_001318194.1.
DR   RefSeq; NP_002519.1; NM_002528.6. [P78549-1]
DR   UniGene; Hs.66196; -.
DR   ProteinModelPortal; P78549; -.
DR   SMR; P78549; -.
DR   BioGrid; 110968; 23.
DR   IntAct; P78549; 4.
DR   STRING; 9606.ENSP00000219066; -.
DR   iPTMnet; P78549; -.
DR   PhosphoSitePlus; P78549; -.
DR   BioMuta; NTHL1; -.
DR   DMDM; 29840795; -.
DR   EPD; P78549; -.
DR   jPOST; P78549; -.
DR   MaxQB; P78549; -.
DR   PaxDb; P78549; -.
DR   PeptideAtlas; P78549; -.
DR   PRIDE; P78549; -.
DR   ProteomicsDB; 57648; -.
DR   Ensembl; ENST00000219066; ENSP00000219066; ENSG00000065057. [P78549-1]
DR   GeneID; 4913; -.
DR   KEGG; hsa:4913; -.
DR   UCSC; uc002col.1; human. [P78549-1]
DR   CTD; 4913; -.
DR   DisGeNET; 4913; -.
DR   EuPathDB; HostDB:ENSG00000065057.7; -.
DR   GeneCards; NTHL1; -.
DR   HGNC; HGNC:8028; NTHL1.
DR   HPA; CAB025152; -.
DR   MalaCards; NTHL1; -.
DR   MIM; 602656; gene.
DR   MIM; 616415; phenotype.
DR   neXtProt; NX_P78549; -.
DR   OpenTargets; ENSG00000065057; -.
DR   Orphanet; 454840; NTHL1-related attenuated familial adenomatous polyposis.
DR   PharmGKB; PA31811; -.
DR   eggNOG; KOG1921; Eukaryota.
DR   eggNOG; COG0177; LUCA.
DR   GeneTree; ENSGT00510000047513; -.
DR   HOGENOM; HOG000252209; -.
DR   HOVERGEN; HBG052675; -.
DR   InParanoid; P78549; -.
DR   KO; K10773; -.
DR   OMA; WQQFTHL; -.
DR   OrthoDB; 1322642at2759; -.
DR   PhylomeDB; P78549; -.
DR   TreeFam; TF314967; -.
DR   BRENDA; 4.2.99.18; 2681.
DR   Reactome; R-HSA-110328; Recognition and association of DNA glycosylase with site containing an affected pyrimidine.
DR   Reactome; R-HSA-110329; Cleavage of the damaged pyrimidine.
DR   Reactome; R-HSA-110357; Displacement of DNA glycosylase by APEX1.
DR   SABIO-RK; P78549; -.
DR   GeneWiki; NTHL1; -.
DR   GenomeRNAi; 4913; -.
DR   PRO; PR:P78549; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000065057; Expressed in 173 organ(s), highest expression level in right lobe of liver.
DR   ExpressionAtlas; P78549; baseline and differential.
DR   Genevisible; P78549; HS.
DR   GO; GO:0005739; C:mitochondrion; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0051539; F:4 iron, 4 sulfur cluster binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0140078; F:class I DNA-(apurinic or apyrimidinic site) endonuclease activity; IDA:FlyBase.
DR   GO; GO:0019104; F:DNA N-glycosylase activity; IDA:UniProtKB.
DR   GO; GO:0003906; F:DNA-(apurinic or apyrimidinic site) endonuclease activity; IDA:UniProtKB.
DR   GO; GO:0003690; F:double-stranded DNA binding; IDA:UniProtKB.
DR   GO; GO:0004519; F:endonuclease activity; TAS:ProtInc.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0008534; F:oxidized purine nucleobase lesion DNA N-glycosylase activity; TAS:Reactome.
DR   GO; GO:0000703; F:oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity; IBA:GO_Central.
DR   GO; GO:0006285; P:base-excision repair, AP site formation; IDA:UniProtKB.
DR   GO; GO:0045008; P:depyrimidination; TAS:Reactome.
DR   GO; GO:0006296; P:nucleotide-excision repair, DNA incision, 5'-to lesion; IDA:UniProtKB.
DR   CDD; cd00056; ENDO3c; 1.
DR   Gene3D; 1.10.1670.10; -; 1.
DR   HAMAP; MF_03183; Endonuclease_III_Nth; 1.
DR   InterPro; IPR011257; DNA_glycosylase.
DR   InterPro; IPR004036; Endonuclease-III-like_CS2.
DR   InterPro; IPR003651; Endonuclease3_FeS-loop_motif.
DR   InterPro; IPR003265; HhH-GPD_domain.
DR   InterPro; IPR000445; HhH_motif.
DR   InterPro; IPR023170; HTH_base_excis_C.
DR   InterPro; IPR030841; NTH1.
DR   Pfam; PF00633; HHH; 1.
DR   Pfam; PF00730; HhH-GPD; 1.
DR   SMART; SM00478; ENDO3c; 1.
DR   SMART; SM00525; FES; 1.
DR   SUPFAM; SSF48150; SSF48150; 1.
DR   PROSITE; PS01155; ENDONUCLEASE_III_2; 1.
PE   1: Evidence at protein level;
KW   4Fe-4S; Alternative initiation; Complete proteome;
KW   Direct protein sequencing; DNA damage; DNA repair; Glycosidase;
KW   Hydrolase; Iron; Iron-sulfur; Lyase; Metal-binding; Mitochondrion;
KW   Nucleus; Phosphoprotein; Polymorphism; Reference proteome;
KW   Transit peptide.
FT   TRANSIT       1     30       Mitochondrion. {ECO:0000255|HAMAP-
FT                                Rule:MF_03183,
FT                                ECO:0000269|PubMed:12144783}.
FT   CHAIN        31    312       Endonuclease III-like protein 1.
FT                                /FTId=PRO_0000102227.
FT   DOMAIN      199    223       HhH. {ECO:0000255|HAMAP-Rule:MF_03183}.
FT   MOTIF        36     60       Bipartite nuclear localization signal.
FT                                {ECO:0000255}.
FT   ACT_SITE    220    220       Nucleophile; for N-glycosylase activity.
FT                                {ECO:0000255|HAMAP-Rule:MF_03183,
FT                                ECO:0000269|PubMed:9705289}.
FT   METAL       290    290       Iron-sulfur (4Fe-4S). {ECO:0000255|HAMAP-
FT                                Rule:MF_03183}.
FT   METAL       297    297       Iron-sulfur (4Fe-4S). {ECO:0000255|HAMAP-
FT                                Rule:MF_03183}.
FT   METAL       300    300       Iron-sulfur (4Fe-4S). {ECO:0000255|HAMAP-
FT                                Rule:MF_03183}.
FT   METAL       306    306       Iron-sulfur (4Fe-4S). {ECO:0000255|HAMAP-
FT                                Rule:MF_03183}.
FT   SITE        239    239       Important for catalytic activity.
FT   MOD_RES      71     71       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES      73     73       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   VAR_SEQ       1     15       Missing (in isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_054292.
FT   VAR_SEQ       1      8       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:9045706,
FT                                ECO:0000303|PubMed:9705289,
FT                                ECO:0000303|PubMed:9831664}.
FT                                /FTId=VSP_054293.
FT   VARIANT      21     21       R -> W (in dbSNP:rs3087469).
FT                                {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_016125.
FT   VARIANT      33     33       R -> K (in dbSNP:rs2302172).
FT                                /FTId=VAR_016126.
FT   VARIANT     176    176       I -> T (in dbSNP:rs1805378).
FT                                /FTId=VAR_016127.
FT   VARIANT     234    234       S -> L (in dbSNP:rs3211977).
FT                                {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_029318.
FT   VARIANT     239    239       D -> Y (in dbSNP:rs3087468).
FT                                /FTId=VAR_016128.
FT   MUTAGEN      40     42       Missing: Sorted to the cytoplasm.
FT                                {ECO:0000269|PubMed:12531031}.
FT   MUTAGEN      42     42       R->A: Sorted to both nuclei and
FT                                mitochondria.
FT                                {ECO:0000269|PubMed:12531031}.
FT   MUTAGEN      42     42       R->D: Sorted to the cytoplasm.
FT                                {ECO:0000269|PubMed:12531031}.
FT   MUTAGEN      57     57       R->A,D: Sorted to both nuclei and
FT                                mitochondria.
FT                                {ECO:0000269|PubMed:12531031}.
FT   MUTAGEN     220    220       K->Q: Inactivates enzyme.
FT                                {ECO:0000269|PubMed:11695910,
FT                                ECO:0000269|PubMed:9705289}.
FT   MUTAGEN     220    220       K->R: 85-fold reduction in activity.
FT                                Uncouples the glycosylase activity from
FT                                the lyase activity. Shows glycosylase
FT                                activity without any detectable AP-lyase
FT                                activity during the first 10 min of the
FT                                reaction. {ECO:0000269|PubMed:11695910,
FT                                ECO:0000269|PubMed:9705289}.
FT   CONFLICT      9     10       MT -> TS (in Ref. 8; CAA70865).
FT                                {ECO:0000305}.
FT   CONFLICT     78     78       Missing (in Ref. 8; CAA70865).
FT                                {ECO:0000305}.
FT   CONFLICT    151    151       M -> I (in Ref. 1; AAB41534).
FT                                {ECO:0000305}.
FT   CONFLICT    160    160       T -> A (in Ref. 1; AAB41534).
FT                                {ECO:0000305}.
SQ   SEQUENCE   312 AA;  34390 MW;  379816A1E0B45050 CRC64;
     MCSPQESGMT ALSARMLTRS RSLGPGAGPR GCREEPGPLR RREAAAEARK SHSPVKRPRK
     AQRLRVAYEG SDSEKGEGAE PLKVPVWEPQ DWQQQLVNIR AMRNKKDAPV DHLGTEHCYD
     SSAPPKVRRY QVLLSLMLSS QTKDQVTAGA MQRLRARGLT VDSILQTDDA TLGKLIYPVG
     FWRSKVKYIK QTSAILQQHY GGDIPASVAE LVALPGVGPK MAHLAMAVAW GTVSGIAVDT
     HVHRIANRLR WTKKATKSPE ETRAALEEWL PRELWHEING LLVGFGQQTC LPVHPRCHAC
     LNQALCPAAQ GL
//
ID   E5KNU5_HUMAN            Unreviewed;      1239 AA.
AC   E5KNU5;
DT   08-FEB-2011, integrated into UniProtKB/TrEMBL.
DT   08-FEB-2011, sequence version 1.
DT   13-FEB-2019, entry version 71.
DE   SubName: Full=DNA polymerase subunit gamma-1 {ECO:0000313|EMBL:ADP90854.1};
DE   SubName: Full=Mitochondrial polymerase gamma catalytic subunit {ECO:0000313|EMBL:AZB52146.1};
DE            EC=2.7.7.7 {ECO:0000313|EMBL:AZB52146.1};
DE   SubName: Full=Polymerase (DNA directed), gamma, isoform CRA_a {ECO:0000313|EMBL:EAX02045.1};
GN   Name=POLG {ECO:0000313|EMBL:AZB52146.1};
GN   ORFNames=hCG_28647 {ECO:0000313|EMBL:EAX02045.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ADP90854.1};
RN   [1] {ECO:0000313|EMBL:EAX02045.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAX02045.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:ADP90854.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=20843780; DOI=10.1093/nar/gkq750;
RA   Wang W., Shen P., Thiyagarajan S., Lin S., Palm C., Horvath R.,
RA   Klopstock T., Cutler D., Pique L., Schrijver I., Davis R.W.,
RA   Mindrinos M., Speed T.P., Scharfe C.;
RT   "Identification of rare DNA variants in mitochondrial disorders with
RT   improved array-based sequencing.";
RL   Nucleic Acids Res. 39:44-58(2011).
RN   [4] {ECO:0000313|EMBL:AZB52146.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=30423451;
RA   Piekutowska-Abramczuk D., Kaliszewska M., Sulek A., Jurkowska N.,
RA   Oltarzewski M., Jablonska E., Trubicka J., Glowacka A., Ciara E.,
RA   Kowalski P., Langiewicz-Wojciechowska K., Tesarova M., Zeman J.,
RA   Kierdaszuk B., Kuczynski D., Chmielewski D., Szymanska E., Bakula A.,
RA   Lusakowska A., Lipowska M., Brodacki B., Pera J., Dorobek M.,
RA   Rydzanicz M., Ploski R., Chrzanowska Krystyna H., Bartnik E.,
RA   Placha G., Kaminska A., Kostera-Pruszczyk A., Krajewska-Walasek M.,
RA   Tonska K., Pronicka E.;
RT   "The frequency of mitochondrial polymerase gamma related disorders in
RT   a large Polish population cohort.";
RL   Mitochondrion 0:0-0(2018).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; HQ205386; ADP90854.1; -; Genomic_DNA.
DR   EMBL; HQ205387; ADP90855.1; -; Genomic_DNA.
DR   EMBL; HQ205388; ADP90856.1; -; Genomic_DNA.
DR   EMBL; HQ205389; ADP90857.1; -; Genomic_DNA.
DR   EMBL; HQ205390; ADP90858.1; -; Genomic_DNA.
DR   EMBL; HQ205391; ADP90859.1; -; Genomic_DNA.
DR   EMBL; HQ205392; ADP90860.1; -; Genomic_DNA.
DR   EMBL; HQ205393; ADP90861.1; -; Genomic_DNA.
DR   EMBL; HQ205394; ADP90862.1; -; Genomic_DNA.
DR   EMBL; HQ205395; ADP90863.1; -; Genomic_DNA.
DR   EMBL; HQ205396; ADP90864.1; -; Genomic_DNA.
DR   EMBL; HQ205397; ADP90865.1; -; Genomic_DNA.
DR   EMBL; HQ205398; ADP90866.1; -; Genomic_DNA.
DR   EMBL; HQ205400; ADP90868.1; -; Genomic_DNA.
DR   EMBL; HQ205401; ADP90869.1; -; Genomic_DNA.
DR   EMBL; HQ205402; ADP90870.1; -; Genomic_DNA.
DR   EMBL; HQ205404; ADP90872.1; -; Genomic_DNA.
DR   EMBL; HQ205405; ADP90873.1; -; Genomic_DNA.
DR   EMBL; HQ205406; ADP90874.1; -; Genomic_DNA.
DR   EMBL; HQ205407; ADP90875.1; -; Genomic_DNA.
DR   EMBL; HQ205408; ADP90876.1; -; Genomic_DNA.
DR   EMBL; HQ205409; ADP90877.1; -; Genomic_DNA.
DR   EMBL; HQ205410; ADP90878.1; -; Genomic_DNA.
DR   EMBL; HQ205411; ADP90879.1; -; Genomic_DNA.
DR   EMBL; HQ205412; ADP90880.1; -; Genomic_DNA.
DR   EMBL; HQ205413; ADP90881.1; -; Genomic_DNA.
DR   EMBL; HQ205414; ADP90882.1; -; Genomic_DNA.
DR   EMBL; HQ205415; ADP90883.1; -; Genomic_DNA.
DR   EMBL; HQ205417; ADP90885.1; -; Genomic_DNA.
DR   EMBL; HQ205418; ADP90886.1; -; Genomic_DNA.
DR   EMBL; HQ205419; ADP90887.1; -; Genomic_DNA.
DR   EMBL; HQ205420; ADP90888.1; -; Genomic_DNA.
DR   EMBL; HQ205421; ADP90889.1; -; Genomic_DNA.
DR   EMBL; HQ205422; ADP90890.1; -; Genomic_DNA.
DR   EMBL; HQ205423; ADP90891.1; -; Genomic_DNA.
DR   EMBL; HQ205424; ADP90892.1; -; Genomic_DNA.
DR   EMBL; HQ205425; ADP90893.1; -; Genomic_DNA.
DR   EMBL; MH973638; AZB52146.1; -; Genomic_DNA.
DR   EMBL; CH471101; EAX02045.1; -; Genomic_DNA.
DR   EMBL; CH471101; EAX02047.1; -; Genomic_DNA.
DR   RefSeq; NP_001119603.1; NM_001126131.1.
DR   RefSeq; NP_002684.1; NM_002693.2.
DR   UniGene; Hs.706868; -.
DR   GeneID; 5428; -.
DR   KEGG; hsa:5428; -.
DR   CTD; 5428; -.
DR   EuPathDB; HostDB:ENSG00000140521.11; -.
DR   eggNOG; KOG3657; Eukaryota.
DR   eggNOG; COG0749; LUCA.
DR   KO; K02332; -.
DR   OMA; PKWYKDL; -.
DR   OrthoDB; 86850at2759; -.
DR   ChiTaRS; POLG; human.
DR   GenomeRNAi; 5428; -.
DR   Bgee; ENSG00000140521; Expressed in 240 organ(s), highest expression level in tendon of biceps brachii.
DR   GO; GO:0005760; C:gamma DNA polymerase complex; IEA:Ensembl.
DR   GO; GO:0043195; C:terminal bouton; IEA:Ensembl.
DR   GO; GO:0003677; F:DNA binding; IEA:InterPro.
DR   GO; GO:0003887; F:DNA-directed DNA polymerase activity; IEA:Ensembl.
DR   GO; GO:0007568; P:aging; IEA:Ensembl.
DR   GO; GO:0071333; P:cellular response to glucose stimulus; IEA:Ensembl.
DR   GO; GO:0006260; P:DNA replication; IEA:InterPro.
DR   GO; GO:0010332; P:response to gamma radiation; IEA:Ensembl.
DR   GO; GO:0055093; P:response to hyperoxia; IEA:Ensembl.
DR   GO; GO:0009416; P:response to light stimulus; IEA:Ensembl.
DR   InterPro; IPR019760; DNA-dir_DNA_pol_A_CS.
DR   InterPro; IPR002297; DNA-dir_DNA_pol_A_mt.
DR   InterPro; IPR001098; DNA-dir_DNA_pol_A_palm_dom.
DR   InterPro; IPR012337; RNaseH-like_sf.
DR   PANTHER; PTHR10267; PTHR10267; 1.
DR   Pfam; PF00476; DNA_pol_A; 1.
DR   PIRSF; PIRSF000797; DNA_pol_mt; 1.
DR   PRINTS; PR00867; DNAPOLG.
DR   SMART; SM00482; POLAc; 1.
DR   SUPFAM; SSF53098; SSF53098; 1.
DR   PROSITE; PS00447; DNA_POLYMERASE_A; 1.
PE   4: Predicted;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Nucleotidyltransferase {ECO:0000313|EMBL:AZB52146.1};
KW   Transferase {ECO:0000313|EMBL:AZB52146.1}.
FT   DOMAIN      871   1145       POLAc. {ECO:0000259|SMART:SM00482}.
FT   COILED      438    465       {ECO:0000256|SAM:Coils}.
FT   COILED      691    711       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   1239 AA;  139562 MW;  2D9ECCD75AD6E01E CRC64;
     MSRLLWRKVA GATVGPGPVP APGRWVSSSV PASDPSDGQR RRQQQQQQQQ QQQQQPQQPQ
     VLSSEGGQLR HNPLDIQMLS RGLHEQIFGQ GGEMPGEAAV RRSVEHLQKH GLWGQPAVPL
     PDVELRLPPL YGDNLDQHFR LLAQKQSLPY LEAANLLLQA QLPPKPPAWA WAEGWTRYGP
     EGEAVPVAIP EERALVFDVE VCLAEGTCPT LAVAISPSAW YSWCSQRLVE ERYSWTSQLS
     PADLIPLEVP TGASSPTQRD WQEQLVVGHN VSFDRAHIRE QYLIQGSRMR FLDTMSMHMA
     ISGLSSFQRS LWIAAKQGKH KVQPPTKQGQ KSQRKARRGP AISSWDWLDI SSVNSLAEVH
     RLYVGGPPLE KEPRELFVKG TMKDIRENFQ DLMQYCAQDV WATHEVFQQQ LPLFLERCPH
     PVTLAGMLEM GVSYLPVNQN WERYLAEAQG TYEELQREMK KSLMDLANDA CQLLSGERYK
     EDPWLWDLEW DLQEFKQKKA KKVKKEPATA SKLPIEGAGA PGDPMDQEDL GPCSEEEEFQ
     QDVMARACLQ KLKGTTELLP KRPQHLPGHP GWYRKLCPRL DDPAWTPGPS LLSLQMRVTP
     KLMALTWDGF PLHYSERHGW GYLVPGRRDN LAKLPTGTTL ESAGVVCPYR AIESLYRKHC
     LEQGKQQLMP QEAGLAEEFL LTDNSAIWQT VEELDYLEVE AEAKMENLRA AVPGQPLALT
     ARGGPKDTQP SYHHGNGPYN DVDIPGCWFF KLPHKDGNSC NVGSPFAKDF LPKMEDGTLQ
     AGPGGASGPR ALEINKMISF WRNAHKRISS QMVVWLPRSA LPRAVIRHPD YDEEGLYGAI
     LPQVVTAGTI TRRAVEPTWL TASNARPDRV GSELKAMVQA PPGYTLVGAD VDSQELWIAA
     VLGDAHFAGM HGCTAFGWMT LQGRKSRGTD LHSKTATTVG ISREHAKIFN YGRIYGAGQP
     FAERLLMQFN HRLTQQEAAE KAQQMYAATK GLRWYRLSDE GEWLVRELNL PVDRTEGGWI
     SLQDLRKVQR ETARKSQWKK WEVVAERAWK GGTESEMFNK LESIATSDIP RTPVLGCCIS
     RALEPSAVQE EFMTSRVNWV VQSSAVDYLH LMLVAMKWLF EEFAIDGRFC ISIHDEVRYL
     VREEDRYRAA LALQITNLLT RCMFAYKLGL NDLPQSVAFF SAVDIDRCLR KEVTMDCKTP
     SNPTGMERRY GIPQGEALDI YQIIELTKGS LEKRSQPGP
//
ID   DPOG1_HUMAN             Reviewed;        1239 AA.
AC   P54098; Q8NFM2; Q92515;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   13-FEB-2019, entry version 202.
DE   RecName: Full=DNA polymerase subunit gamma-1;
DE            EC=2.7.7.7;
DE   AltName: Full=Mitochondrial DNA polymerase catalytic subunit;
DE   AltName: Full=PolG-alpha;
GN   Name=POLG; Synonyms=MDP1, POLG1, POLGA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8884268; DOI=10.1006/geno.1996.0490;
RA   Ropp P.A., Copeland W.C.;
RT   "Cloning and characterization of the human mitochondrial DNA
RT   polymerase, DNA polymerase gamma.";
RL   Genomics 36:449-458(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9034326; DOI=10.1016/S0378-1119(96)00663-4;
RA   Lecrenier N.L., van der Bruggen P., Foury F.;
RT   "Mitochondrial DNA polymerases from yeast to man: a new family of
RT   polymerases.";
RL   Gene 185:147-152(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT GLN-GLN-55 INS.
RC   TISSUE=Brain;
RA   Watanabe T.K., Shimizu F., Nishino N., Fujiwara T., Kanemoto N.,
RA   Suzuki M., Nakamura Y., Hirai Y., Maekawa H., Takahashi E.;
RL   Submitted (MAR-1996) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS GLN-55 INS; GLN-193;
RP   CYS-546; LYS-662; TRP-1142; GLY-1143; CYS-1146 AND HIS-1236.
RG   NIEHS SNPs program;
RL   Submitted (APR-2002) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lymph, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   SUBCELLULAR LOCATION, ASSOCIATION WITH MITOCHONDRIAL DNA, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=18063578; DOI=10.1074/jbc.M708444200;
RA   Bogenhagen D.F., Rousseau D., Burke S.;
RT   "The layered structure of human mitochondrial DNA nucleoids.";
RL   J. Biol. Chem. 283:3665-3675(2008).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [8]
RP   INVOLVEMENT IN SCAE, AND VARIANTS SCAE THR-467; HIS-497 AND SER-748.
RX   PubMed=26942291; DOI=10.1016/j.ajhg.2016.01.009;
RA   Sandford E., Bird T.D., Li J.Z., Burmeister M.;
RT   "PRICKLE2 mutations might not be involved in epilepsy.";
RL   Am. J. Hum. Genet. 98:588-589(2016).
RN   [9]
RP   VARIANTS PEOB1 PRO-3; ARG-304; THR-467 AND CYS-955.
RX   PubMed=11431686; DOI=10.1038/90034;
RA   Van Goethem G., Dermaut B., Loefgren A., Martin J.-J.,
RA   Van Broeckhoven C.;
RT   "Mutation of POLG is associated with progressive external
RT   ophthalmoplegia characterized by mtDNA deletions.";
RL   Nat. Genet. 28:211-212(2001).
RN   [10]
RP   VARIANTS PEOA1 ASP-923; HIS-943; CYS-955; SER-957 AND LEU-1176, AND
RP   VARIANTS PEO ILE-251; LEU-309 AND SER-848.
RX   PubMed=12210792; DOI=10.1002/ana.10278;
RA   Lamantea E., Tiranti V., Bordoni A., Toscano A., Bono F., Servidei S.,
RA   Papadimitriou A., Spelbrink H., Silvestri L., Casari G., Comi G.P.,
RA   Zeviani M.;
RT   "Mutations of mitochondrial DNA polymerase gammaA are a frequent cause
RT   of autosomal dominant or recessive progressive external
RT   ophthalmoplegia.";
RL   Ann. Neurol. 52:211-219(2002).
RN   [11]
RP   CHARACTERIZATION OF VARIANT PEOA1 CYS-955.
RX   PubMed=11897778; DOI=10.1074/jbc.C200100200;
RA   Ponamarev M.V., Longley M.J., Nguyen D., Kunkel T.A., Copeland W.C.;
RT   "Active site mutation in DNA polymerase gamma associated with
RT   progressive external ophthalmoplegia causes error-prone DNA
RT   synthesis.";
RL   J. Biol. Chem. 277:15225-15228(2002).
RN   [12]
RP   VARIANTS PEOB1 TRP-579; LEU-587; THR-889 AND VAL-1076, AND VARIANT
RP   HIS-1236.
RX   PubMed=12975295; DOI=10.1001/archneur.60.9.1279;
RA   Filosto M., Mancuso M., Nishigaki Y., Pancrudo J., Harati Y.,
RA   Gooch C., Mankodi A., Bayne L., Bonilla E., Shanske S., Hirano M.,
RA   DiMauro S.;
RT   "Clinical and genetic heterogeneity in progressive external
RT   ophthalmoplegia due to mutations in polymerase gamma.";
RL   Arch. Neurol. 60:1279-1284(2003).
RN   [13]
RP   VARIANTS MTDPS4B ILE-251; LEU-587 AND SER-864.
RX   PubMed=12825077; DOI=10.1038/sj.ejhg.5201002;
RA   Van Goethem G., Schwartz M., Loefgren A., Dermaut B.,
RA   Van Broeckhoven C., Vissing J.;
RT   "Novel POLG mutations in progressive external ophthalmoplegia
RT   mimicking mitochondrial neurogastrointestinal encephalomyopathy.";
RL   Eur. J. Hum. Genet. 11:547-549(2003).
RN   [14]
RP   VARIANT PEOB1 SER-848.
RX   PubMed=12872260; DOI=10.1002/humu.10246;
RA   Van Goethem G., Loefgren A., Dermaut B., Ceuterick C., Martin J.-J.,
RA   Van Broeckhoven C.;
RT   "Digenic progressive external ophthalmoplegia in a sporadic patient:
RT   recessive mutations in POLG and C10orf2/Twinkle.";
RL   Hum. Mutat. 22:175-176(2003).
RN   [15]
RP   VARIANTS PEOB1 ILE-251; ALA-268; ARG-312; THR-467; GLN-562; LEU-587;
RP   PRO-807 AND TYR-932, AND VARIANTS GLY-1143 AND HIS-1236.
RX   PubMed=14635118; DOI=10.1002/humu.9203;
RA   Di Fonzo A., Bordoni A., Crimi M., Sara G., Del Bo R., Bresolin N.,
RA   Comi G.P.;
RT   "POLG mutations in sporadic mitochondrial disorders with multiple
RT   mtDNA deletions.";
RL   Hum. Mutat. 22:498-499(2003).
RN   [16]
RP   VARIANTS PEOB1 TRP-227; ILE-251; ARG-312; VAL-431; THR-467; GLN-1047;
RP   CYS-1096 AND CYS-1104.
RX   PubMed=12707443; DOI=10.1212/01.WNL.0000056088.09408.3C;
RA   Agostino A., Valletta L., Chinnery P.F., Ferrari G., Carrara F.,
RA   Taylor R.W., Schaefer A.M., Turnbull D.M., Tiranti V., Zeviani M.;
RT   "Mutations of ANT1, Twinkle, and POLG1 in sporadic progressive
RT   external ophthalmoplegia (PEO).";
RL   Neurology 60:1354-1356(2003).
RN   [17]
RP   VARIANT MERRF THR-467.
RX   PubMed=14694057; DOI=10.1212/01.WNL.0000098997.23471.65;
RA   Van Goethem G., Mercelis R., Loefgren A., Seneca S., Ceuterick C.,
RA   Martin J.-J., Van Broeckhoven C.;
RT   "Patient homozygous for a recessive POLG mutation presents with
RT   features of MERRF.";
RL   Neurology 61:1811-1813(2003).
RN   [18]
RP   VARIANTS PEOB1 PRO-3; ARG-304; THR-467 AND CYS-955, AND VARIANT SANDO
RP   TRP-627.
RX   PubMed=12565911; DOI=10.1016/S0960-8966(02)00216-X;
RA   Van Goethem G., Martin J.-J., Dermaut B., Loefgren A., Wibail A.,
RA   Ververken D., Tack P., Dehaene I., Van Zandijcke M., Moonen M.,
RA   Ceuterick C., De Jonghe P., Van Broeckhoven C.;
RT   "Recessive POLG mutations presenting with sensory and ataxic
RT   neuropathy in compound heterozygote patients with progressive external
RT   ophthalmoplegia.";
RL   Neuromuscul. Disord. 13:133-142(2003).
RN   [19]
RP   VARIANT MTDPS4A THR-467.
RX   PubMed=15122711; DOI=10.1002/ana.20079;
RA   Naviaux R.K., Nguyen K.V.;
RT   "POLG mutations associated with Alpers' syndrome and mitochondrial DNA
RT   depletion.";
RL   Ann. Neurol. 55:706-712(2004).
RN   [20]
RP   VARIANTS PEOB1 TRP-227; ILE-251 LEU-309; LEU-587; SER-848 ILE-1106 AND
RP   LEU-1176.
RX   PubMed=15349879; DOI=10.1002/ana.20219;
RA   Lamantea E., Zeviani M.;
RT   "Sequence analysis of familial PEO shows additional mutations
RT   associated with the 752C-->T and 3527C-->T changes in the POLG1
RT   gene.";
RL   Ann. Neurol. 56:454-455(2004).
RN   [21]
RP   VARIANT PEOA1 CYS-831.
RX   PubMed=15534189; DOI=10.1001/archneur.61.11.1777;
RA   Mancuso M., Filosto M., Oh S.J., DiMauro S.;
RT   "A novel polymerase gamma mutation in a family with ophthalmoplegia,
RT   neuropathy, and parkinsonism.";
RL   Arch. Neurol. 61:1777-1779(2004).
RN   [22]
RP   VARIANTS PEOA1 CYS-953 AND CYS-955, AND VARIANTS PEOB1 ASP-468 AND
RP   THR-1105.
RX   PubMed=15351195; DOI=10.1016/S0140-6736(04)16983-3;
RA   Luoma P., Melberg A., Rinne J.O., Kaukonen J.A., Nupponen N.N.,
RA   Chalmers R.M., Oldfors A., Rautakorpi I., Peltonen L., Majamaa K.,
RA   Somer H., Suomalainen A.;
RT   "Parkinsonism, premature menopause, and mitochondrial DNA polymerase
RT   gamma mutations: clinical and molecular genetic study.";
RL   Lancet 364:875-882(2004).
RN   [23]
RP   VARIANTS SANDO TYR-932 AND ARG-1051.
RX   PubMed=14745080; DOI=10.1212/WNL.62.2.316;
RA   Mancuso M., Filosto M., Bellan M., Liguori R., Montagna P.,
RA   Baruzzi A., DiMauro S., Carelli V.;
RT   "POLG mutations causing ophthalmoplegia, sensorimotor polyneuropathy,
RT   ataxia, and deafness.";
RL   Neurology 62:316-318(2004).
RN   [24]
RP   VARIANT PEOB1 THR-467, VARIANT SANDO SER-748, AND VARIANT GLY-1143.
RX   PubMed=15477547; DOI=10.1212/01.WNL.0000140494.58732.83;
RA   Van Goethem G., Luoma P., Rantamaeki M., Al-Memar A., Kaakkola S.,
RA   Hackman P., Krahe R., Loefgren A., Martin J.-J., De Jonghe P.,
RA   Suomalainen A., Udd B., Van Broeckhoven C.;
RT   "POLG mutations in neurodegenerative disorders with ataxia but no
RT   muscle involvement.";
RL   Neurology 63:1251-1257(2004).
RN   [25]
RP   VARIANT SANDO SER-748, AND VARIANT GLY-1143.
RX   PubMed=16080118; DOI=10.1086/444548;
RA   Hakonen A.H., Heiskanen S., Juvonen V., Lappalainen I., Luoma P.T.,
RA   Rantamaeki M., Van Goethem G., Loefgren A., Hackman P., Paetau A.,
RA   Kaakkola S., Majamaa K., Varilo T., Udd B., Kaeaeriaeinen H.,
RA   Bindoff L.A., Suomalainen A.;
RT   "Mitochondrial DNA polymerase W748S mutation: a common cause of
RT   autosomal recessive ataxia with ancient European origin.";
RL   Am. J. Hum. Genet. 77:430-441(2005).
RN   [26]
RP   VARIANTS MTDPS4A SER-748 AND SER-848.
RX   PubMed=15929042; DOI=10.1002/ana.20498;
RA   Davidzon G., Mancuso M., Ferraris S., Quinzii C., Hirano M.,
RA   Peters H.L., Kirby D., Thorburn D.R., DiMauro S.;
RT   "POLG mutations and Alpers syndrome.";
RL   Ann. Neurol. 57:921-923(2005).
RN   [27]
RP   VARIANTS MTDPS4A GLY-232; PRO-244; ILE-251 THR-467; LEU-587; SER-748
RP   SER-848 AND PRO-957, AND VARIANT GLY-1143.
RX   PubMed=15689359; DOI=10.1093/brain/awh410;
RA   Ferrari G., Lamantea E., Donati A., Filosto M., Briem E., Carrara F.,
RA   Parini R., Simonati A., Santer R., Zeviani M.;
RT   "Infantile hepatocerebral syndromes associated with mutations in the
RT   mitochondrial DNA polymerase-gammaA.";
RL   Brain 128:723-731(2005).
RN   [28]
RP   VARIANT PEOB1 THR-467, VARIANT SANDO GLN-627, VARIANT HIS-1236,
RP   CHARACTERIZATION OF VARIANT PEOB1 THR-467, AND CHARACTERIZATION OF
RP   VARIANT SANDO GLN-627.
RX   PubMed=15917273; DOI=10.1093/hmg/ddi196;
RA   Luoma P.T., Luo N., Loescher W.N., Farr C.L., Horvath R.,
RA   Wanschitz J., Kiechl S., Kaguni L.S., Suomalainen A.;
RT   "Functional defects due to spacer-region mutations of human
RT   mitochondrial DNA polymerase in a family with an ataxia-myopathy
RT   syndrome.";
RL   Hum. Mol. Genet. 14:1907-1920(2005).
RN   [29]
RP   VARIANTS SANDO THR-467; HIS-497 AND SER-748.
RX   PubMed=15824347; DOI=10.1212/01.WNL.0000156516.77696.5A;
RA   Winterthun S., Ferrari G., He L., Taylor R.W., Zeviani M.,
RA   Turnbull D.M., Engelsen B.A., Moen G., Bindoff L.A.;
RT   "Autosomal recessive mitochondrial ataxic syndrome due to
RT   mitochondrial polymerase gamma mutations.";
RL   Neurology 64:1204-1208(2005).
RN   [30]
RP   VARIANTS PEOB1 ARG-737 AND TRP-853.
RX   PubMed=16634032; DOI=10.1002/ana.20831;
RA   Davidzon G., Greene P., Mancuso M., Klos K.J., Ahlskog J.E.,
RA   Hirano M., DiMauro S.;
RT   "Early-onset familial parkinsonism due to POLG mutations.";
RL   Ann. Neurol. 59:859-862(2006).
RN   [31]
RP   VARIANTS PEOB1 LEU-603; TRP-853; CYS-1146 AND ASN-1184.
RX   PubMed=16401742; DOI=10.1001/archneur.63.1.107;
RA   Gonzalez-Vioque E., Blazquez A., Fernandez-Moreira D., Bornstein B.,
RA   Bautista J., Arpa J., Navarro C., Campos Y., Fernandez-Moreno M.A.,
RA   Garesse R., Arenas J., Martin M.A.;
RT   "Association of novel POLG mutations and multiple mitochondrial DNA
RT   deletions with variable clinical phenotypes in a Spanish population.";
RL   Arch. Neurol. 63:107-111(2006).
RN   [32]
RP   VARIANTS PEOB1 HIS-308; TRP-574 AND ARG-648, VARIANT SANDO VAL-517,
RP   AND VARIANTS MTDPS4A ASP-767; HIS-879; SER-885; PRO-914; HIS-1096 AND
RP   ASN-1191.
RX   PubMed=16621917; DOI=10.1093/brain/awl088;
RA   Horvath R., Hudson G., Ferrari G., Fuetterer N., Ahola S.,
RA   Lamantea E., Prokisch H., Lochmueller H., McFarland R., Ramesh V.,
RA   Klopstock T., Freisinger P., Salvi F., Mayr J.A., Santer R.,
RA   Tesarova M., Zeman J., Udd B., Taylor R.W., Turnbull D., Hanna M.,
RA   Fialho D., Suomalainen A., Zeviani M., Chinnery P.F.;
RT   "Phenotypic spectrum associated with mutations of the mitochondrial
RT   polymerase gamma gene.";
RL   Brain 129:1674-1684(2006).
RN   [33]
RP   VARIANTS PEOB1 ARG-304; ASP-380 AND THR-467, VARIANT SANDO SER-748,
RP   VARIANT MTDPS4A PRO-914, AND VARIANTS GLY-1143 AND HIS-1236.
RX   PubMed=16639411; DOI=10.1038/sj.ejhg.5201627;
RA   Naiemi M., Bannwarth S., Procaccio V., Pouget J., Desnuelle C.,
RA   Pellissier J.-F., Roetig A., Munnich A., Calvas P., Richelme C.,
RA   Jonveaux P., Castelnovo G., Simon M., Clanet M., Wallace D.,
RA   Paquis-Flucklinger V.;
RT   "Molecular analysis of ANT1, TWINKLE and POLG in patients with
RT   multiple deletions or depletion of mitochondrial DNA by a dHPLC-based
RT   assay.";
RL   Eur. J. Hum. Genet. 14:917-922(2006).
RN   [34]
RP   ERRATUM.
RA   Naiemi M., Bannwarth S., Procaccio V., Pouget J., Desnuelle C.,
RA   Pellissier J.-F., Roetig A., Munnich A., Calvas P., Richelme C.,
RA   Jonveaux P., Castelnovo G., Simon M., Clanet M., Wallace D.,
RA   Paquis-Flucklinger V.;
RL   Eur. J. Hum. Genet. 15:607-607(2006).
RN   [35]
RP   VARIANTS SANDO ARG-648 AND CYS-807.
RX   PubMed=16919951; DOI=10.1016/j.nmd.2006.05.016;
RA   Gago M.F., Rosas M.J., Guimaraes J., Ferreira M., Vilarinho L.,
RA   Castro L., Carpenter S.;
RT   "SANDO: two novel mutations in POLG1 gene.";
RL   Neuromuscul. Disord. 16:507-509(2006).
RN   [36]
RP   VARIANT PEOA1 ASN-511, AND VARIANT PHE-463.
RX   PubMed=17420318; DOI=10.1001/archneur.64.4.553;
RA   Hudson G., Schaefer A.M., Taylor R.W., Tiangyou W., Gibson A.,
RA   Venables G., Griffiths P., Burn D.J., Turnbull D.M., Chinnery P.F.;
RT   "Mutation of the linker region of the polymerase gamma-1 (POLG1) gene
RT   associated with progressive external ophthalmoplegia and
RT   Parkinsonism.";
RL   Arch. Neurol. 64:553-557(2007).
RN   [37]
RP   VARIANT PEOA1 CYS-831.
RX   PubMed=17846414; DOI=10.1212/01.wnl.0000276955.23735.eb;
RA   Luoma P.T., Eerola J., Ahola S., Hakonen A.H., Hellstroem O.,
RA   Kivistoe K.T., Tienari P.J., Suomalainen A.;
RT   "Mitochondrial DNA polymerase gamma variants in idiopathic sporadic
RT   Parkinson disease.";
RL   Neurology 69:1152-1159(2007).
RN   [38]
RP   VARIANT PEOA1 HIS-1186.
RX   PubMed=18575922; DOI=10.1007/s00415-008-0926-3;
RA   Virgilio R., Ronchi D., Hadjigeorgiou G.M., Bordoni A., Saladino F.,
RA   Moggio M., Adobbati L., Kafetsouli D., Tsironi E., Previtali S.,
RA   Papadimitriou A., Bresolin N., Comi G.P.;
RT   "Novel Twinkle (PEO1) gene mutations in Mendelian progressive external
RT   ophthalmoplegia.";
RL   J. Neurol. 255:1384-1391(2008).
RN   [39]
RP   VARIANTS LS HIS-232 AND SER-848, VARIANTS MTDPS4A ILE-251; THR-467;
RP   LEU-587; SER-748; CYS-831; SER-848; PRO-914; TYR-1110; ARG-1134 AND
RP   LYS-1136, AND VARIANTS GLY-1143 AND HIS-1236.
RX   PubMed=18828154; DOI=10.1002/humu.20852;
RA   Taanman J.-W., Rahman S., Pagnamenta A.T., Morris A.A.M.,
RA   Bitner-Glindzicz M., Wolf N.I., Leonard J.V., Clayton P.T.,
RA   Schapira A.H.V.;
RT   "Analysis of mutant DNA polymerase gamma in patients with
RT   mitochondrial DNA depletion.";
RL   Hum. Mutat. 30:248-254(2009).
RN   [40]
RP   VARIANTS MTDPS4B TRP-227 AND SER-848.
RX   PubMed=19307547; DOI=10.1212/01.wnl.0000345002.47396.e1;
RA   Giordano C., Powell H., Leopizzi M., de Curtis M., Travaglini C.,
RA   Sebastiani M., Gallo P., Taylor R.W., d'Amati G.;
RT   "Fatal congenital myopathy and gastrointestinal pseudo-obstruction due
RT   to POLG1 mutations.";
RL   Neurology 72:1103-1105(2009).
CC   -!- FUNCTION: Involved in the replication of mitochondrial DNA.
CC       Associates with mitochondrial DNA.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 2'-deoxyribonucleoside 5'-triphosphate + DNA(n) =
CC         diphosphate + DNA(n+1); Xref=Rhea:RHEA:22508, Rhea:RHEA-
CC         COMP:11130, Rhea:RHEA-COMP:11131, ChEBI:CHEBI:33019,
CC         ChEBI:CHEBI:61560, ChEBI:CHEBI:83828; EC=2.7.7.7;
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC   -!- SUBUNIT: Heterotrimer composed of a catalytic subunit and a
CC       homodimer of accessory subunits.
CC   -!- INTERACTION:
CC       Q9UHN1:POLG2; NbExp=10; IntAct=EBI-852624, EBI-852642;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:18063578}.
CC       Mitochondrion matrix, mitochondrion nucleoid
CC       {ECO:0000269|PubMed:18063578}.
CC   -!- POLYMORPHISM: The poly-Gln region seems to be polymorphic.
CC   -!- DISEASE: Progressive external ophthalmoplegia with mitochondrial
CC       DNA deletions, autosomal dominant, 1 (PEOA1) [MIM:157640]: A
CC       disorder characterized by progressive weakness of ocular muscles
CC       and levator muscle of the upper eyelid. In a minority of cases, it
CC       is associated with skeletal myopathy, which predominantly involves
CC       axial or proximal muscles and which causes abnormal fatigability
CC       and even permanent muscle weakness. Ragged-red fibers and atrophy
CC       are found on muscle biopsy. A large proportion of chronic
CC       ophthalmoplegias are associated with other symptoms, leading to a
CC       multisystemic pattern of this disease. Additional symptoms are
CC       variable, and may include cataracts, hearing loss, sensory axonal
CC       neuropathy, ataxia, depression, hypogonadism, and parkinsonism.
CC       {ECO:0000269|PubMed:11897778, ECO:0000269|PubMed:12210792,
CC       ECO:0000269|PubMed:15351195, ECO:0000269|PubMed:15534189,
CC       ECO:0000269|PubMed:17420318, ECO:0000269|PubMed:17846414,
CC       ECO:0000269|PubMed:18575922}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Progressive external ophthalmoplegia with mitochondrial
CC       DNA deletions, autosomal recessive, 1 (PEOB1) [MIM:258450]: A
CC       severe form of progressive external ophthalmoplegia, a disorder
CC       characterized by progressive weakness of ocular muscles and
CC       levator muscle of the upper eyelid. It is clinically more
CC       heterogeneous than the autosomal dominant forms.
CC       {ECO:0000269|PubMed:11431686, ECO:0000269|PubMed:12565911,
CC       ECO:0000269|PubMed:12707443, ECO:0000269|PubMed:12872260,
CC       ECO:0000269|PubMed:12975295, ECO:0000269|PubMed:14635118,
CC       ECO:0000269|PubMed:15349879, ECO:0000269|PubMed:15351195,
CC       ECO:0000269|PubMed:15477547, ECO:0000269|PubMed:15917273,
CC       ECO:0000269|PubMed:16401742, ECO:0000269|PubMed:16621917,
CC       ECO:0000269|PubMed:16634032, ECO:0000269|PubMed:16639411}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Sensory ataxic neuropathy dysarthria and ophthalmoparesis
CC       (SANDO) [MIM:607459]: A systemic disorder resulting from
CC       mitochondrial dysfunction associated with mitochondrial depletion
CC       in skeletal muscle and peripheral nerve tissue. The clinical triad
CC       of symptoms consists of sensory ataxic neuropathy, dysarthria, and
CC       ophthalmoparesis. However, the phenotype varies widely, even
CC       within the same family, and can also include myopathy, seizures,
CC       and hearing loss. {ECO:0000269|PubMed:12565911,
CC       ECO:0000269|PubMed:14745080, ECO:0000269|PubMed:15477547,
CC       ECO:0000269|PubMed:15824347, ECO:0000269|PubMed:15917273,
CC       ECO:0000269|PubMed:16080118, ECO:0000269|PubMed:16621917,
CC       ECO:0000269|PubMed:16639411, ECO:0000269|PubMed:16919951}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Mitochondrial DNA depletion syndrome 4A (MTDPS4A)
CC       [MIM:203700]: An autosomal recessive hepatocerebral syndrome due
CC       to mitochondrial dysfunction. The typical course of the disease
CC       includes severe developmental delay, intractable seizures, liver
CC       failure, and death in childhood. Refractory seizures, cortical
CC       blindness, progressive liver dysfunction, and acute liver failure
CC       after exposure to valproic acid are considered diagnostic
CC       features. The neuropathological hallmarks are neuronal loss,
CC       spongiform degeneration, and astrocytosis of the visual cortex.
CC       Liver biopsy results show steatosis, often progressing to
CC       cirrhosis. {ECO:0000269|PubMed:15122711,
CC       ECO:0000269|PubMed:15689359, ECO:0000269|PubMed:15929042,
CC       ECO:0000269|PubMed:16621917, ECO:0000269|PubMed:16639411,
CC       ECO:0000269|PubMed:18828154}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Mitochondrial DNA depletion syndrome 4B (MTDPS4B)
CC       [MIM:613662]: An autosomal recessive progressive multisystem
CC       disorder due to mitochondrial dysfunction. It is clinically
CC       characterized by chronic gastrointestinal dysmotility and pseudo-
CC       obstruction, cachexia, progressive external ophthalmoplegia,
CC       axonal sensory ataxic neuropathy, and muscle weakness.
CC       {ECO:0000269|PubMed:12825077, ECO:0000269|PubMed:19307547}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Leigh syndrome (LS) [MIM:256000]: An early-onset
CC       progressive neurodegenerative disorder characterized by the
CC       presence of focal, bilateral lesions in one or more areas of the
CC       central nervous system including the brainstem, thalamus, basal
CC       ganglia, cerebellum and spinal cord. Clinical features depend on
CC       which areas of the central nervous system are involved and include
CC       subacute onset of psychomotor retardation, hypotonia, ataxia,
CC       weakness, vision loss, eye movement abnormalities, seizures, and
CC       dysphagia. {ECO:0000269|PubMed:18828154}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Spinocerebellar ataxia with epilepsy (SCAE) [MIM:607459]:
CC       An autosomal recessive syndrome characterized by headaches and/or
CC       seizures manifesting in childhood or adolescence, cerebellar and
CC       sensory ataxia, dysarthria, and myoclonus manifesting in early
CC       adulthood. Neuropathological findings include spinocerebellar
CC       degeneration associated with cortical neuronal degeneration in
CC       advanced cases. {ECO:0000269|PubMed:26942291}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the DNA polymerase type-A family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/polg/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; U60325; AAC50712.1; -; mRNA.
DR   EMBL; X98093; CAA66719.1; -; mRNA.
DR   EMBL; D84103; BAA12223.1; -; mRNA.
DR   EMBL; AF497906; AAM77583.1; -; Genomic_DNA.
DR   EMBL; BC042571; AAH42571.1; -; mRNA.
DR   EMBL; BC050559; AAH50559.1; -; mRNA.
DR   CCDS; CCDS10350.1; -.
DR   PIR; G02750; G02750.
DR   RefSeq; NP_001119603.1; NM_001126131.1.
DR   RefSeq; NP_002684.1; NM_002693.2.
DR   UniGene; Hs.706868; -.
DR   PDB; 3IKM; X-ray; 3.24 A; A/D=70-1239.
DR   PDB; 4ZTU; X-ray; 3.30 A; A=30-1239.
DR   PDB; 4ZTZ; X-ray; 3.44 A; A=30-1239.
DR   PDB; 5C51; X-ray; 3.43 A; A=25-1239.
DR   PDB; 5C52; X-ray; 3.64 A; A=25-1239.
DR   PDB; 5C53; X-ray; 3.57 A; A=25-1239.
DR   PDBsum; 3IKM; -.
DR   PDBsum; 4ZTU; -.
DR   PDBsum; 4ZTZ; -.
DR   PDBsum; 5C51; -.
DR   PDBsum; 5C52; -.
DR   PDBsum; 5C53; -.
DR   ProteinModelPortal; P54098; -.
DR   SMR; P54098; -.
DR   BioGrid; 111424; 23.
DR   ComplexPortal; CPX-2093; DNA polymerase gamma complex.
DR   IntAct; P54098; 11.
DR   MINT; P54098; -.
DR   STRING; 9606.ENSP00000268124; -.
DR   BindingDB; P54098; -.
DR   ChEMBL; CHEMBL2732; -.
DR   iPTMnet; P54098; -.
DR   PhosphoSitePlus; P54098; -.
DR   BioMuta; POLG; -.
DR   DMDM; 1706507; -.
DR   EPD; P54098; -.
DR   jPOST; P54098; -.
DR   MaxQB; P54098; -.
DR   PaxDb; P54098; -.
DR   PeptideAtlas; P54098; -.
DR   PRIDE; P54098; -.
DR   ProteomicsDB; 56642; -.
DR   Ensembl; ENST00000268124; ENSP00000268124; ENSG00000140521.
DR   Ensembl; ENST00000442287; ENSP00000399851; ENSG00000140521.
DR   GeneID; 5428; -.
DR   KEGG; hsa:5428; -.
DR   UCSC; uc002bnr.5; human.
DR   CTD; 5428; -.
DR   DisGeNET; 5428; -.
DR   EuPathDB; HostDB:ENSG00000140521.11; -.
DR   GeneCards; POLG; -.
DR   GeneReviews; POLG; -.
DR   HGNC; HGNC:9179; POLG.
DR   HPA; HPA056821; -.
DR   MalaCards; POLG; -.
DR   MIM; 157640; phenotype.
DR   MIM; 174763; gene.
DR   MIM; 203700; phenotype.
DR   MIM; 256000; phenotype.
DR   MIM; 258450; phenotype.
DR   MIM; 607459; phenotype.
DR   MIM; 613662; phenotype.
DR   neXtProt; NX_P54098; -.
DR   OpenTargets; ENSG00000140521; -.
DR   Orphanet; 726; Alpers-Huttenlocher syndrome.
DR   Orphanet; 254892; Autosomal dominant progressive external ophthalmoplegia.
DR   Orphanet; 254886; Autosomal recessive progressive external ophthalmoplegia.
DR   Orphanet; 298; Mitochondrial neurogastrointestinal encephalomyopathy.
DR   Orphanet; 402082; Progressive myoclonic epilepsy type 5.
DR   Orphanet; 94125; Recessive mitochondrial ataxia syndrome.
DR   Orphanet; 70595; Sensory ataxic neuropathy-dysarthria-ophthalmoparesis syndrome.
DR   Orphanet; 254881; Spinocerebellar ataxia with epilepsy.
DR   PharmGKB; PA33500; -.
DR   eggNOG; KOG3657; Eukaryota.
DR   eggNOG; COG0749; LUCA.
DR   GeneTree; ENSGT00390000000453; -.
DR   HOGENOM; HOG000176668; -.
DR   HOVERGEN; HBG051400; -.
DR   InParanoid; P54098; -.
DR   KO; K02332; -.
DR   OMA; PKWYKDL; -.
DR   OrthoDB; 86850at2759; -.
DR   PhylomeDB; P54098; -.
DR   ChiTaRS; POLG; human.
DR   GeneWiki; POLG; -.
DR   GenomeRNAi; 5428; -.
DR   PRO; PR:P54098; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000140521; Expressed in 240 organ(s), highest expression level in tendon of biceps brachii.
DR   ExpressionAtlas; P54098; baseline and differential.
DR   Genevisible; P54098; HS.
DR   GO; GO:0005760; C:gamma DNA polymerase complex; IEA:Ensembl.
DR   GO; GO:0042645; C:mitochondrial nucleoid; IDA:BHF-UCL.
DR   GO; GO:0005739; C:mitochondrion; IBA:GO_Central.
DR   GO; GO:0032991; C:protein-containing complex; IDA:MGI.
DR   GO; GO:0043195; C:terminal bouton; IEA:Ensembl.
DR   GO; GO:0008408; F:3'-5' exonuclease activity; IBA:GO_Central.
DR   GO; GO:0003682; F:chromatin binding; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0003887; F:DNA-directed DNA polymerase activity; IDA:MGI.
DR   GO; GO:0002020; F:protease binding; IPI:UniProtKB.
DR   GO; GO:0007568; P:aging; IEA:Ensembl.
DR   GO; GO:0006287; P:base-excision repair, gap-filling; IDA:MGI.
DR   GO; GO:0071333; P:cellular response to glucose stimulus; IEA:Ensembl.
DR   GO; GO:0006259; P:DNA metabolic process; TAS:ProtInc.
DR   GO; GO:0006261; P:DNA-dependent DNA replication; TAS:ProtInc.
DR   GO; GO:0006264; P:mitochondrial DNA replication; IBA:GO_Central.
DR   GO; GO:0010332; P:response to gamma radiation; IEA:Ensembl.
DR   GO; GO:0055093; P:response to hyperoxia; IEA:Ensembl.
DR   GO; GO:0009416; P:response to light stimulus; IEA:Ensembl.
DR   InterPro; IPR019760; DNA-dir_DNA_pol_A_CS.
DR   InterPro; IPR002297; DNA-dir_DNA_pol_A_mt.
DR   InterPro; IPR001098; DNA-dir_DNA_pol_A_palm_dom.
DR   InterPro; IPR012337; RNaseH-like_sf.
DR   PANTHER; PTHR10267; PTHR10267; 1.
DR   Pfam; PF00476; DNA_pol_A; 1.
DR   PIRSF; PIRSF000797; DNA_pol_mt; 1.
DR   PRINTS; PR00867; DNAPOLG.
DR   SMART; SM00482; POLAc; 1.
DR   SUPFAM; SSF53098; SSF53098; 1.
DR   PROSITE; PS00447; DNA_POLYMERASE_A; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Disease mutation; DNA replication;
KW   DNA-binding; DNA-directed DNA polymerase; Epilepsy; Leigh syndrome;
KW   Magnesium; Mitochondrion; Mitochondrion nucleoid; Neurodegeneration;
KW   Neuropathy; Nucleotidyltransferase; Polymorphism;
KW   Primary mitochondrial disease; Progressive external ophthalmoplegia;
KW   Reference proteome; Transferase.
FT   CHAIN         1   1239       DNA polymerase subunit gamma-1.
FT                                /FTId=PRO_0000101270.
FT   COMPBIAS     43     60       Poly-Gln.
FT   COMPBIAS    535    538       Poly-Glu.
FT   VARIANT       3      3       R -> P (in PEOB1; dbSNP:rs121918045).
FT                                {ECO:0000269|PubMed:11431686,
FT                                ECO:0000269|PubMed:12565911}.
FT                                /FTId=VAR_012153.
FT   VARIANT      18     18       P -> S (in dbSNP:rs3087373).
FT                                /FTId=VAR_014904.
FT   VARIANT      55     55       Q -> QQ. {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_019265.
FT   VARIANT      55     55       Q -> QQQ. {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_019266.
FT   VARIANT     193    193       R -> Q (in dbSNP:rs3176162).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_019267.
FT   VARIANT     227    227       R -> W (in PEOB1 and MTDPS4B;
FT                                dbSNP:rs121918056).
FT                                {ECO:0000269|PubMed:12707443,
FT                                ECO:0000269|PubMed:15349879,
FT                                ECO:0000269|PubMed:19307547}.
FT                                /FTId=VAR_023663.
FT   VARIANT     232    232       R -> G (in MTDPS4A).
FT                                {ECO:0000269|PubMed:15689359}.
FT                                /FTId=VAR_058870.
FT   VARIANT     232    232       R -> H (in LS; dbSNP:rs113994093).
FT                                {ECO:0000269|PubMed:18828154}.
FT                                /FTId=VAR_058871.
FT   VARIANT     244    244       L -> P (in MTDPS4A).
FT                                {ECO:0000269|PubMed:15689359}.
FT                                /FTId=VAR_058872.
FT   VARIANT     251    251       T -> I (in PEOB1, MTDPS4A and MTDPS4B;
FT                                dbSNP:rs113994094).
FT                                {ECO:0000269|PubMed:12210792,
FT                                ECO:0000269|PubMed:12707443,
FT                                ECO:0000269|PubMed:12825077,
FT                                ECO:0000269|PubMed:14635118,
FT                                ECO:0000269|PubMed:18828154,
FT                                ECO:0000269|PubMed:26942291}.
FT                                /FTId=VAR_023664.
FT   VARIANT     268    268       G -> A (in PEOB1; sporadic case;
FT                                dbSNP:rs61752784).
FT                                {ECO:0000269|PubMed:14635118}.
FT                                /FTId=VAR_058873.
FT   VARIANT     304    304       L -> R (in PEOB1; also found in SANDO;
FT                                dbSNP:rs121918044).
FT                                {ECO:0000269|PubMed:11431686,
FT                                ECO:0000269|PubMed:12565911,
FT                                ECO:0000269|PubMed:16639411}.
FT                                /FTId=VAR_012154.
FT   VARIANT     304    304       L -> SANDO (in PEOB1).
FT                                /FTId=VAR_058874.
FT   VARIANT     308    308       Q -> H (in PEOB1; sporadic case;
FT                                dbSNP:rs745539599).
FT                                {ECO:0000269|PubMed:16621917}.
FT                                /FTId=VAR_058875.
FT   VARIANT     309    309       R -> L (in PEOB1).
FT                                {ECO:0000269|PubMed:12210792,
FT                                ECO:0000269|PubMed:15349879}.
FT                                /FTId=VAR_023665.
FT   VARIANT     312    312       W -> R (in PEOB1; sporadic case).
FT                                {ECO:0000269|PubMed:12707443,
FT                                ECO:0000269|PubMed:14635118}.
FT                                /FTId=VAR_023666.
FT   VARIANT     324    324       P -> S (in dbSNP:rs2307437).
FT                                /FTId=VAR_014905.
FT   VARIANT     380    380       G -> D (in PEOB1).
FT                                {ECO:0000269|PubMed:16639411}.
FT                                /FTId=VAR_058876.
FT   VARIANT     431    431       G -> V (in PEOB1; sporadic case).
FT                                {ECO:0000269|PubMed:12707443}.
FT                                /FTId=VAR_023667.
FT   VARIANT     463    463       L -> F (in dbSNP:rs150828914).
FT                                {ECO:0000269|PubMed:17420318}.
FT                                /FTId=VAR_058877.
FT   VARIANT     467    467       A -> T (in PEOB1, SANDO, SCAE and
FT                                MTDPS4A; results in clearly decreased
FT                                activity, DNA binding and processivity of
FT                                the polymerase; dbSNP:rs113994095).
FT                                {ECO:0000269|PubMed:11431686,
FT                                ECO:0000269|PubMed:12565911,
FT                                ECO:0000269|PubMed:12707443,
FT                                ECO:0000269|PubMed:14635118,
FT                                ECO:0000269|PubMed:14694057,
FT                                ECO:0000269|PubMed:15122711,
FT                                ECO:0000269|PubMed:15477547,
FT                                ECO:0000269|PubMed:15689359,
FT                                ECO:0000269|PubMed:15824347,
FT                                ECO:0000269|PubMed:15917273,
FT                                ECO:0000269|PubMed:16639411,
FT                                ECO:0000269|PubMed:18828154,
FT                                ECO:0000269|PubMed:26942291}.
FT                                /FTId=VAR_012155.
FT   VARIANT     468    468       N -> D (in PEOB1; dbSNP:rs145843073).
FT                                {ECO:0000269|PubMed:15351195}.
FT                                /FTId=VAR_023668.
FT   VARIANT     497    497       Q -> H (in SANDO and SCAE;
FT                                dbSNP:rs121918052).
FT                                {ECO:0000269|PubMed:15824347,
FT                                ECO:0000269|PubMed:26942291}.
FT                                /FTId=VAR_023669.
FT   VARIANT     511    511       S -> N (in PEOA1; dbSNP:rs121918055).
FT                                {ECO:0000269|PubMed:17420318}.
FT                                /FTId=VAR_058878.
FT   VARIANT     517    517       G -> V (in SANDO; dbSNP:rs61752783).
FT                                {ECO:0000269|PubMed:16621917}.
FT                                /FTId=VAR_058879.
FT   VARIANT     546    546       R -> C (in dbSNP:rs2307447).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_014906.
FT   VARIANT     562    562       R -> Q (in PEOB1; sporadic case;
FT                                dbSNP:rs781168350).
FT                                {ECO:0000269|PubMed:14635118}.
FT                                /FTId=VAR_058880.
FT   VARIANT     574    574       R -> W (in PEOB1; sporadic case;
FT                                dbSNP:rs774474723).
FT                                {ECO:0000269|PubMed:16621917}.
FT                                /FTId=VAR_058881.
FT   VARIANT     579    579       R -> W (in PEOB1; dbSNP:rs556925652).
FT                                {ECO:0000269|PubMed:12975295}.
FT                                /FTId=VAR_023670.
FT   VARIANT     587    587       P -> L (in PEOB1, MTDPS4A and MTDPS4B;
FT                                dbSNP:rs113994096).
FT                                {ECO:0000269|PubMed:12825077,
FT                                ECO:0000269|PubMed:12975295,
FT                                ECO:0000269|PubMed:14635118,
FT                                ECO:0000269|PubMed:15349879,
FT                                ECO:0000269|PubMed:15689359,
FT                                ECO:0000269|PubMed:18828154}.
FT                                /FTId=VAR_023671.
FT   VARIANT     603    603       M -> L (in PEOB1).
FT                                {ECO:0000269|PubMed:16401742}.
FT                                /FTId=VAR_058882.
FT   VARIANT     627    627       R -> Q (in SANDO; shows DNA binding
FT                                affinity and processivities similar to
FT                                the controls; dbSNP:rs375305567).
FT                                {ECO:0000269|PubMed:15917273}.
FT                                /FTId=VAR_058883.
FT   VARIANT     627    627       R -> W (in SANDO; sporadic case;
FT                                dbSNP:rs121918046).
FT                                {ECO:0000269|PubMed:12565911}.
FT                                /FTId=VAR_023672.
FT   VARIANT     648    648       P -> R (in PEOB1; sporadic case; also in
FT                                SANDO; dbSNP:rs796052906).
FT                                {ECO:0000269|PubMed:16621917,
FT                                ECO:0000269|PubMed:16919951}.
FT                                /FTId=VAR_058884.
FT   VARIANT     662    662       E -> K (in dbSNP:rs2307450).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_014907.
FT   VARIANT     737    737       G -> R (in PEOB1; with absence of
FT                                progressive external ophthalmoplegia;
FT                                dbSNP:rs121918054).
FT                                {ECO:0000269|PubMed:16634032}.
FT                                /FTId=VAR_058885.
FT   VARIANT     748    748       W -> S (in SANDO, SCAE and MTDPS4A;
FT                                unknown pathological significance;
FT                                dbSNP:rs113994097).
FT                                {ECO:0000269|PubMed:15477547,
FT                                ECO:0000269|PubMed:15824347,
FT                                ECO:0000269|PubMed:15929042,
FT                                ECO:0000269|PubMed:16080118,
FT                                ECO:0000269|PubMed:16639411,
FT                                ECO:0000269|PubMed:18828154}.
FT                                /FTId=VAR_023673.
FT   VARIANT     767    767       A -> D (in MTDPS4A).
FT                                {ECO:0000269|PubMed:16621917}.
FT                                /FTId=VAR_058886.
FT   VARIANT     807    807       R -> C (in SANDO; dbSNP:rs769827124).
FT                                {ECO:0000269|PubMed:16919951}.
FT                                /FTId=VAR_058887.
FT   VARIANT     807    807       R -> P (in PEOB1; sporadic case).
FT                                {ECO:0000269|PubMed:14635118}.
FT                                /FTId=VAR_058888.
FT   VARIANT     831    831       Y -> C (in PEOA1 and MTDPS4A; unknown
FT                                pathological significance;
FT                                dbSNP:rs41549716).
FT                                {ECO:0000269|PubMed:15534189,
FT                                ECO:0000269|PubMed:17846414,
FT                                ECO:0000269|PubMed:18828154}.
FT                                /FTId=VAR_023674.
FT   VARIANT     848    848       G -> S (in PEOB1, MTDPS4A, MTDPS4B and
FT                                LS; dbSNP:rs113994098).
FT                                {ECO:0000269|PubMed:12210792,
FT                                ECO:0000269|PubMed:12872260,
FT                                ECO:0000269|PubMed:15689359,
FT                                ECO:0000269|PubMed:15929042,
FT                                ECO:0000269|PubMed:18828154,
FT                                ECO:0000269|PubMed:19307547}.
FT                                /FTId=VAR_023675.
FT   VARIANT     853    853       R -> W (in PEOB1; with absence of
FT                                progressive external ophthalmoplegia;
FT                                dbSNP:rs121918053).
FT                                {ECO:0000269|PubMed:16401742,
FT                                ECO:0000269|PubMed:16634032}.
FT                                /FTId=VAR_058889.
FT   VARIANT     864    864       N -> S (in MTDPS4B; dbSNP:rs121918050).
FT                                {ECO:0000269|PubMed:12825077}.
FT                                /FTId=VAR_023676.
FT   VARIANT     879    879       Q -> H (in MTDPS4A).
FT                                {ECO:0000269|PubMed:16621917}.
FT                                /FTId=VAR_058890.
FT   VARIANT     885    885       T -> S (in MTDPS4A).
FT                                {ECO:0000269|PubMed:16621917}.
FT                                /FTId=VAR_058891.
FT   VARIANT     889    889       A -> T (in PEOB1; dbSNP:rs763393580).
FT                                {ECO:0000269|PubMed:12975295}.
FT                                /FTId=VAR_023677.
FT   VARIANT     914    914       T -> P (in MTDPS4A; dbSNP:rs139590686).
FT                                {ECO:0000269|PubMed:16621917,
FT                                ECO:0000269|PubMed:16639411,
FT                                ECO:0000269|PubMed:18828154}.
FT                                /FTId=VAR_058892.
FT   VARIANT     923    923       G -> D (in PEOA1).
FT                                {ECO:0000269|PubMed:12210792}.
FT                                /FTId=VAR_023678.
FT   VARIANT     932    932       H -> Y (in SANDO and PEOB1; sporadic
FT                                case; dbSNP:rs121918048).
FT                                {ECO:0000269|PubMed:14635118,
FT                                ECO:0000269|PubMed:14745080}.
FT                                /FTId=VAR_023679.
FT   VARIANT     943    943       R -> H (in PEOA1).
FT                                {ECO:0000269|PubMed:12210792}.
FT                                /FTId=VAR_023680.
FT   VARIANT     953    953       R -> C (in PEOA1; dbSNP:rs11546842).
FT                                {ECO:0000269|PubMed:15351195}.
FT                                /FTId=VAR_023681.
FT   VARIANT     955    955       Y -> C (in PEOA1; can underlie
FT                                parkinsonism; 45-fold decrease in
FT                                apparent binding affinity for the
FT                                incoming nucleoside triphosphate; 2-fold
FT                                less accurate for basepair substitutions
FT                                than wild-type; dbSNP:rs113994099).
FT                                {ECO:0000269|PubMed:11431686,
FT                                ECO:0000269|PubMed:11897778,
FT                                ECO:0000269|PubMed:12210792,
FT                                ECO:0000269|PubMed:12565911,
FT                                ECO:0000269|PubMed:15351195}.
FT                                /FTId=VAR_012156.
FT   VARIANT     957    957       A -> P (in MTDPS4A).
FT                                {ECO:0000269|PubMed:15689359}.
FT                                /FTId=VAR_058893.
FT   VARIANT     957    957       A -> S (in PEOA1; dbSNP:rs121918051).
FT                                {ECO:0000269|PubMed:12210792}.
FT                                /FTId=VAR_023682.
FT   VARIANT    1047   1047       R -> Q (in PEOB1; sporadic case;
FT                                dbSNP:rs768028281).
FT                                {ECO:0000269|PubMed:12707443}.
FT                                /FTId=VAR_023683.
FT   VARIANT    1051   1051       G -> R (in SANDO; dbSNP:rs121918049).
FT                                {ECO:0000269|PubMed:14745080}.
FT                                /FTId=VAR_023684.
FT   VARIANT    1076   1076       G -> V (in PEOB1).
FT                                {ECO:0000269|PubMed:12975295}.
FT                                /FTId=VAR_023685.
FT   VARIANT    1096   1096       R -> C (in PEOB1; sporadic case;
FT                                dbSNP:rs201732356).
FT                                {ECO:0000269|PubMed:12707443}.
FT                                /FTId=VAR_023686.
FT   VARIANT    1096   1096       R -> H (in MTDPS4A; dbSNP:rs368435864).
FT                                {ECO:0000269|PubMed:16621917}.
FT                                /FTId=VAR_058894.
FT   VARIANT    1104   1104       S -> C (in PEOB1; sporadic case;
FT                                dbSNP:rs1010372555).
FT                                {ECO:0000269|PubMed:12707443}.
FT                                /FTId=VAR_023687.
FT   VARIANT    1105   1105       A -> T (in PEOB1; dbSNP:rs753410045).
FT                                {ECO:0000269|PubMed:15351195}.
FT                                /FTId=VAR_023688.
FT   VARIANT    1106   1106       V -> I (in PEOB1).
FT                                {ECO:0000269|PubMed:15349879}.
FT                                /FTId=VAR_023689.
FT   VARIANT    1110   1110       H -> Y (in MTDPS4A).
FT                                {ECO:0000269|PubMed:18828154}.
FT                                /FTId=VAR_058895.
FT   VARIANT    1134   1134       H -> R (in MTDPS4A).
FT                                {ECO:0000269|PubMed:18828154}.
FT                                /FTId=VAR_058896.
FT   VARIANT    1136   1136       E -> K (in MTDPS4A; dbSNP:rs56047213).
FT                                {ECO:0000269|PubMed:18828154}.
FT                                /FTId=VAR_065092.
FT   VARIANT    1142   1142       R -> W (in dbSNP:rs2307442).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_014908.
FT   VARIANT    1143   1143       E -> G (in dbSNP:rs2307441).
FT                                {ECO:0000269|PubMed:14635118,
FT                                ECO:0000269|PubMed:15477547,
FT                                ECO:0000269|PubMed:15689359,
FT                                ECO:0000269|PubMed:16080118,
FT                                ECO:0000269|PubMed:16639411,
FT                                ECO:0000269|PubMed:18828154,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_014909.
FT   VARIANT    1146   1146       R -> C (in PEOB1; dbSNP:rs2307440).
FT                                {ECO:0000269|PubMed:16401742,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_014910.
FT   VARIANT    1176   1176       S -> L (in PEOA1; dbSNP:rs776031396).
FT                                {ECO:0000269|PubMed:12210792,
FT                                ECO:0000269|PubMed:15349879}.
FT                                /FTId=VAR_023690.
FT   VARIANT    1184   1184       D -> N (in PEOB1; dbSNP:rs1131691575).
FT                                {ECO:0000269|PubMed:16401742}.
FT                                /FTId=VAR_058897.
FT   VARIANT    1186   1186       D -> H (in PEOA1).
FT                                {ECO:0000269|PubMed:18575922}.
FT                                /FTId=VAR_065119.
FT   VARIANT    1191   1191       K -> N (in MTDPS4A; dbSNP:rs1085307741).
FT                                {ECO:0000269|PubMed:16621917}.
FT                                /FTId=VAR_058898.
FT   VARIANT    1236   1236       Q -> H (in dbSNP:rs3087374).
FT                                {ECO:0000269|PubMed:12975295,
FT                                ECO:0000269|PubMed:14635118,
FT                                ECO:0000269|PubMed:15917273,
FT                                ECO:0000269|PubMed:16639411,
FT                                ECO:0000269|PubMed:18828154,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_014911.
FT   STRAND       75     77       {ECO:0000244|PDB:3IKM}.
FT   HELIX        83     86       {ECO:0000244|PDB:3IKM}.
FT   HELIX        97    105       {ECO:0000244|PDB:3IKM}.
FT   TURN        106    111       {ECO:0000244|PDB:3IKM}.
FT   STRAND      114    116       {ECO:0000244|PDB:3IKM}.
FT   STRAND      132    134       {ECO:0000244|PDB:5C51}.
FT   HELIX       135    159       {ECO:0000244|PDB:3IKM}.
FT   STRAND      173    178       {ECO:0000244|PDB:4ZTU}.
FT   STRAND      179    181       {ECO:0000244|PDB:3IKM}.
FT   STRAND      184    189       {ECO:0000244|PDB:4ZTU}.
FT   STRAND      192    195       {ECO:0000244|PDB:3IKM}.
FT   STRAND      198    201       {ECO:0000244|PDB:4ZTU}.
FT   HELIX       203    205       {ECO:0000244|PDB:4ZTU}.
FT   STRAND      207    210       {ECO:0000244|PDB:3IKM}.
FT   HELIX       224    227       {ECO:0000244|PDB:3IKM}.
FT   STRAND      235    237       {ECO:0000244|PDB:3IKM}.
FT   STRAND      240    242       {ECO:0000244|PDB:3IKM}.
FT   TURN        243    247       {ECO:0000244|PDB:3IKM}.
FT   HELIX       248    251       {ECO:0000244|PDB:3IKM}.
FT   STRAND      254    256       {ECO:0000244|PDB:3IKM}.
FT   STRAND      260    262       {ECO:0000244|PDB:3IKM}.
FT   STRAND      265    268       {ECO:0000244|PDB:4ZTU}.
FT   STRAND      271    274       {ECO:0000244|PDB:3IKM}.
FT   HELIX       277    279       {ECO:0000244|PDB:3IKM}.
FT   STRAND      282    285       {ECO:0000244|PDB:4ZTU}.
FT   STRAND      290    293       {ECO:0000244|PDB:4ZTU}.
FT   HELIX       296    301       {ECO:0000244|PDB:3IKM}.
FT   HELIX       306    317       {ECO:0000244|PDB:3IKM}.
FT   HELIX       347    349       {ECO:0000244|PDB:4ZTU}.
FT   HELIX       356    360       {ECO:0000244|PDB:3IKM}.
FT   STRAND      373    376       {ECO:0000244|PDB:3IKM}.
FT   TURN        377    380       {ECO:0000244|PDB:3IKM}.
FT   HELIX       385    415       {ECO:0000244|PDB:3IKM}.
FT   HELIX       422    431       {ECO:0000244|PDB:3IKM}.
FT   STRAND      435    438       {ECO:0000244|PDB:4ZTU}.
FT   HELIX       440    473       {ECO:0000244|PDB:3IKM}.
FT   HELIX       478    480       {ECO:0000244|PDB:4ZTU}.
FT   HELIX       483    490       {ECO:0000244|PDB:3IKM}.
FT   STRAND      503    505       {ECO:0000244|PDB:5C51}.
FT   STRAND      519    521       {ECO:0000244|PDB:3IKM}.
FT   STRAND      537    540       {ECO:0000244|PDB:3IKM}.
FT   HELIX       541    558       {ECO:0000244|PDB:3IKM}.
FT   STRAND      559    561       {ECO:0000244|PDB:3IKM}.
FT   STRAND      563    568       {ECO:0000244|PDB:3IKM}.
FT   HELIX       571    575       {ECO:0000244|PDB:4ZTU}.
FT   STRAND      587    589       {ECO:0000244|PDB:3IKM}.
FT   TURN        592    595       {ECO:0000244|PDB:3IKM}.
FT   TURN        597    604       {ECO:0000244|PDB:3IKM}.
FT   STRAND      607    610       {ECO:0000244|PDB:4ZTU}.
FT   STRAND      616    618       {ECO:0000244|PDB:3IKM}.
FT   STRAND      627    629       {ECO:0000244|PDB:3IKM}.
FT   HELIX       636    644       {ECO:0000244|PDB:3IKM}.
FT   HELIX       647    671       {ECO:0000244|PDB:3IKM}.
FT   HELIX       716    721       {ECO:0000244|PDB:3IKM}.
FT   TURN        738    740       {ECO:0000244|PDB:3IKM}.
FT   STRAND      743    745       {ECO:0000244|PDB:4ZTU}.
FT   TURN        755    757       {ECO:0000244|PDB:3IKM}.
FT   HELIX       770    775       {ECO:0000244|PDB:3IKM}.
FT   STRAND      776    778       {ECO:0000244|PDB:3IKM}.
FT   STRAND      784    786       {ECO:0000244|PDB:3IKM}.
FT   HELIX       787    810       {ECO:0000244|PDB:3IKM}.
FT   STRAND      818    821       {ECO:0000244|PDB:3IKM}.
FT   TURN        822    829       {ECO:0000244|PDB:3IKM}.
FT   STRAND      833    835       {ECO:0000244|PDB:3IKM}.
FT   STRAND      837    840       {ECO:0000244|PDB:4ZTU}.
FT   STRAND      845    848       {ECO:0000244|PDB:4ZTU}.
FT   TURN        849    851       {ECO:0000244|PDB:3IKM}.
FT   STRAND      853    855       {ECO:0000244|PDB:4ZTU}.
FT   HELIX       859    861       {ECO:0000244|PDB:3IKM}.
FT   STRAND      867    869       {ECO:0000244|PDB:4ZTU}.
FT   TURN        870    873       {ECO:0000244|PDB:4ZTU}.
FT   HELIX       875    878       {ECO:0000244|PDB:3IKM}.
FT   STRAND      884    890       {ECO:0000244|PDB:3IKM}.
FT   HELIX       894    906       {ECO:0000244|PDB:3IKM}.
FT   STRAND      907    909       {ECO:0000244|PDB:3IKM}.
FT   TURN        914    919       {ECO:0000244|PDB:3IKM}.
FT   TURN        924    926       {ECO:0000244|PDB:3IKM}.
FT   HELIX       929    937       {ECO:0000244|PDB:3IKM}.
FT   HELIX       944    955       {ECO:0000244|PDB:3IKM}.
FT   HELIX       960    969       {ECO:0000244|PDB:3IKM}.
FT   HELIX       974    990       {ECO:0000244|PDB:3IKM}.
FT   STRAND      992    995       {ECO:0000244|PDB:3IKM}.
FT   STRAND      997    999       {ECO:0000244|PDB:3IKM}.
FT   HELIX      1001   1009       {ECO:0000244|PDB:3IKM}.
FT   STRAND     1010   1013       {ECO:0000244|PDB:3IKM}.
FT   HELIX      1027   1030       {ECO:0000244|PDB:3IKM}.
FT   STRAND     1033   1035       {ECO:0000244|PDB:3IKM}.
FT   HELIX      1037   1040       {ECO:0000244|PDB:3IKM}.
FT   TURN       1041   1046       {ECO:0000244|PDB:3IKM}.
FT   HELIX      1047   1058       {ECO:0000244|PDB:3IKM}.
FT   STRAND     1061   1065       {ECO:0000244|PDB:3IKM}.
FT   STRAND     1068   1070       {ECO:0000244|PDB:3IKM}.
FT   TURN       1073   1075       {ECO:0000244|PDB:5C51}.
FT   TURN       1081   1083       {ECO:0000244|PDB:4ZTU}.
FT   HELIX      1093   1121       {ECO:0000244|PDB:3IKM}.
FT   STRAND     1122   1124       {ECO:0000244|PDB:3IKM}.
FT   STRAND     1130   1133       {ECO:0000244|PDB:4ZTU}.
FT   STRAND     1136   1143       {ECO:0000244|PDB:3IKM}.
FT   HELIX      1146   1168       {ECO:0000244|PDB:3IKM}.
FT   HELIX      1175   1178       {ECO:0000244|PDB:3IKM}.
FT   STRAND     1184   1188       {ECO:0000244|PDB:3IKM}.
FT   HELIX      1193   1195       {ECO:0000244|PDB:3IKM}.
FT   STRAND     1200   1203       {ECO:0000244|PDB:3IKM}.
FT   STRAND     1207   1209       {ECO:0000244|PDB:3IKM}.
FT   HELIX      1220   1227       {ECO:0000244|PDB:3IKM}.
FT   STRAND     1232   1235       {ECO:0000244|PDB:3IKM}.
SQ   SEQUENCE   1239 AA;  139562 MW;  2D9ECCD75AD6E01E CRC64;
     MSRLLWRKVA GATVGPGPVP APGRWVSSSV PASDPSDGQR RRQQQQQQQQ QQQQQPQQPQ
     VLSSEGGQLR HNPLDIQMLS RGLHEQIFGQ GGEMPGEAAV RRSVEHLQKH GLWGQPAVPL
     PDVELRLPPL YGDNLDQHFR LLAQKQSLPY LEAANLLLQA QLPPKPPAWA WAEGWTRYGP
     EGEAVPVAIP EERALVFDVE VCLAEGTCPT LAVAISPSAW YSWCSQRLVE ERYSWTSQLS
     PADLIPLEVP TGASSPTQRD WQEQLVVGHN VSFDRAHIRE QYLIQGSRMR FLDTMSMHMA
     ISGLSSFQRS LWIAAKQGKH KVQPPTKQGQ KSQRKARRGP AISSWDWLDI SSVNSLAEVH
     RLYVGGPPLE KEPRELFVKG TMKDIRENFQ DLMQYCAQDV WATHEVFQQQ LPLFLERCPH
     PVTLAGMLEM GVSYLPVNQN WERYLAEAQG TYEELQREMK KSLMDLANDA CQLLSGERYK
     EDPWLWDLEW DLQEFKQKKA KKVKKEPATA SKLPIEGAGA PGDPMDQEDL GPCSEEEEFQ
     QDVMARACLQ KLKGTTELLP KRPQHLPGHP GWYRKLCPRL DDPAWTPGPS LLSLQMRVTP
     KLMALTWDGF PLHYSERHGW GYLVPGRRDN LAKLPTGTTL ESAGVVCPYR AIESLYRKHC
     LEQGKQQLMP QEAGLAEEFL LTDNSAIWQT VEELDYLEVE AEAKMENLRA AVPGQPLALT
     ARGGPKDTQP SYHHGNGPYN DVDIPGCWFF KLPHKDGNSC NVGSPFAKDF LPKMEDGTLQ
     AGPGGASGPR ALEINKMISF WRNAHKRISS QMVVWLPRSA LPRAVIRHPD YDEEGLYGAI
     LPQVVTAGTI TRRAVEPTWL TASNARPDRV GSELKAMVQA PPGYTLVGAD VDSQELWIAA
     VLGDAHFAGM HGCTAFGWMT LQGRKSRGTD LHSKTATTVG ISREHAKIFN YGRIYGAGQP
     FAERLLMQFN HRLTQQEAAE KAQQMYAATK GLRWYRLSDE GEWLVRELNL PVDRTEGGWI
     SLQDLRKVQR ETARKSQWKK WEVVAERAWK GGTESEMFNK LESIATSDIP RTPVLGCCIS
     RALEPSAVQE EFMTSRVNWV VQSSAVDYLH LMLVAMKWLF EEFAIDGRFC ISIHDEVRYL
     VREEDRYRAA LALQITNLLT RCMFAYKLGL NDLPQSVAFF SAVDIDRCLR KEVTMDCKTP
     SNPTGMERRY GIPQGEALDI YQIIELTKGS LEKRSQPGP
//
ID   PRDM2_HUMAN             Reviewed;        1718 AA.
AC   Q13029; B1AJZ4; B5MC68; Q13149; Q14550; Q5THJ1; Q5VUL9;
DT   08-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   21-DEC-2004, sequence version 3.
DT   13-FEB-2019, entry version 197.
DE   RecName: Full=PR domain zinc finger protein 2;
DE            EC=2.1.1.43;
DE   AltName: Full=GATA-3-binding protein G3B;
DE   AltName: Full=Lysine N-methyltransferase 8;
DE   AltName: Full=MTB-ZF;
DE   AltName: Full=MTE-binding protein;
DE   AltName: Full=PR domain-containing protein 2;
DE   AltName: Full=Retinoblastoma protein-interacting zinc finger protein;
DE   AltName: Full=Zinc finger protein RIZ;
GN   Name=PRDM2; Synonyms=KMT8, RIZ;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND SUBCELLULAR LOCATION.
RC   TISSUE=Fetal brain, and Retinoblastoma;
RX   PubMed=7538672; DOI=10.1073/pnas.92.10.4467;
RA   Buyse I.M., Shao G., Huang S.;
RT   "The retinoblastoma protein binds to RIZ, a zinc-finger protein that
RT   shares an epitope with the adenovirus E1A protein.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:4467-4471(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE (ISOFORMS 1 AND 3), ALTERNATIVE INITIATION, TISSUE
RP   SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=9006946; DOI=10.1074/jbc.272.5.2984;
RA   Liu L., Shao G., Steele-Perkins G., Huang S.;
RT   "The retinoblastoma interacting zinc finger gene RIZ produces a PR
RT   domain-lacking product through an internal promoter.";
RL   J. Biol. Chem. 272:2984-2991(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5).
RC   TISSUE=Retina;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 159-550, AND INTERACTION WITH GATA3.
RX   PubMed=7590293; DOI=10.1016/0378-1119(95)00420-B;
RA   Shapiro V.S., Lee P., Winoto A.;
RT   "Identification and cloning of the G3B cDNA encoding a 3' segment of a
RT   protein binding to GATA-3.";
RL   Gene 163:329-330(1995).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 202-1718 (ISOFORM 2), AND TISSUE
RP   SPECIFICITY.
RX   PubMed=8654390; DOI=10.1111/j.1432-1033.1996.00471.x;
RA   Muraosa Y., Takahashi K., Yoshizawa M., Shibahara S.;
RT   "cDNA cloning of a novel protein containing two zinc-finger domains
RT   that may function as a transcription factor for the human heme-
RT   oxygenase-1 gene.";
RL   Eur. J. Biochem. 235:471-479(1996).
RN   [8]
RP   FUNCTION, MUTAGENESIS OF CYS-106; ALA-159 AND ILE-188, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=14633678;
RA   Kim K.-C., Geng L., Huang S.;
RT   "Inactivation of a histone methyltransferase by mutations in human
RT   cancers.";
RL   Cancer Res. 63:7619-7623(2003).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-421; SER-643; SER-743
RP   AND SER-796, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [13]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-651 AND LYS-774, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.O114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to
RT   replication stress reveals novel small ubiquitin-like modified target
RT   proteins and acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [14]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-347; LYS-651; LYS-690;
RP   LYS-692; LYS-774; LYS-866; LYS-879; LYS-1147; LYS-1151; LYS-1257 AND
RP   LYS-1281, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [15]
RP   STRUCTURE BY NMR OF 1-161, AND INTERACTION WITH HISTONE H3.
RX   PubMed=18082620; DOI=10.1016/j.bbrc.2007.12.034;
RA   Briknarova K., Zhou X., Satterthwait A., Hoyt D.W., Ely K.R.,
RA   Huang S.;
RT   "Structural studies of the SET domain from RIZ1 tumor suppressor.";
RL   Biochem. Biophys. Res. Commun. 366:807-813(2008).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (1.79 ANGSTROMS) OF 2-148.
RX   PubMed=20084102; DOI=10.1371/journal.pone.0008570;
RA   Wu H., Min J., Lunin V.V., Antoshenko T., Dombrovski L., Zeng H.,
RA   Allali-Hassani A., Campagna-Slater V., Vedadi M., Arrowsmith C.H.,
RA   Plotnikov A.N., Schapira M.;
RT   "Structural biology of human H3K9 methyltransferases.";
RL   PLoS ONE 5:E8570-E8570(2010).
CC   -!- FUNCTION: S-adenosyl-L-methionine-dependent histone
CC       methyltransferase that specifically methylates 'Lys-9' of histone
CC       H3. May function as a DNA-binding transcription factor. Binds to
CC       the macrophage-specific TPA-responsive element (MTE) of the HMOX1
CC       (heme oxygenase 1) gene and may act as a transcriptional activator
CC       of this gene. {ECO:0000269|PubMed:14633678}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-lysyl-[histone] + S-adenosyl-L-methionine = H(+) +
CC         N(6)-methyl-L-lysyl-[histone] + S-adenosyl-L-homocysteine;
CC         Xref=Rhea:RHEA:10024, Rhea:RHEA-COMP:9845, Rhea:RHEA-COMP:9846,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:29969, ChEBI:CHEBI:57856,
CC         ChEBI:CHEBI:59789, ChEBI:CHEBI:61929; EC=2.1.1.43;
CC   -!- SUBUNIT: Binds to the retinoblastoma protein (RB). Interacts with
CC       GATA3. {ECO:0000269|PubMed:18082620, ECO:0000269|PubMed:7590293}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:14633678,
CC       ECO:0000269|PubMed:7538672, ECO:0000269|PubMed:9006946}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing, Alternative initiation; Named isoforms=5;
CC       Name=1; Synonyms=RIZ1;
CC         IsoId=Q13029-1; Sequence=Displayed;
CC       Name=2; Synonyms=MTB-Zf;
CC         IsoId=Q13029-2; Sequence=VSP_006927, VSP_006928;
CC         Note=No experimental confirmation available.;
CC       Name=3; Synonyms=RIZ2;
CC         IsoId=Q13029-3; Sequence=VSP_018974;
CC         Note=Produced by alternative initiation at Met-202 of isoform
CC         1.;
CC       Name=4;
CC         IsoId=Q13029-4; Sequence=VSP_046421, VSP_046422;
CC         Note=No experimental confirmation available. Ref.5 (BC014468)
CC         sequence is in conflict in position: 198:Q->R. {ECO:0000305};
CC       Name=5;
CC         IsoId=Q13029-5; Sequence=VSP_018974, VSP_006927, VSP_006928;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Highly expressed in retinoblastoma cell lines
CC       and in brain tumors. Also expressed in a number of other cell
CC       lines and in brain, heart, skeletal muscle, liver and spleen.
CC       Isoform 1 is expressed in testis at much higher level than isoform
CC       3. {ECO:0000269|PubMed:8654390, ECO:0000269|PubMed:9006946}.
CC   -!- SIMILARITY: Belongs to the class V-like SAM-binding
CC       methyltransferase superfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00190}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA08110.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/PRDM2ID41834ch1p36.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; U17838; AAC50820.2; -; mRNA.
DR   EMBL; BX647310; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AL031277; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL583942; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL359771; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC014468; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; U23736; AAA87023.1; -; mRNA.
DR   EMBL; D45132; BAA08110.1; ALT_INIT; mRNA.
DR   CCDS; CCDS150.1; -. [Q13029-1]
DR   CCDS; CCDS151.1; -. [Q13029-2]
DR   CCDS; CCDS30603.1; -. [Q13029-5]
DR   CCDS; CCDS44061.1; -. [Q13029-4]
DR   PIR; I38902; I38902.
DR   RefSeq; NP_001007258.1; NM_001007257.2. [Q13029-5]
DR   RefSeq; NP_001129082.1; NM_001135610.1. [Q13029-4]
DR   RefSeq; NP_036363.2; NM_012231.4. [Q13029-1]
DR   RefSeq; NP_056950.2; NM_015866.4. [Q13029-2]
DR   RefSeq; XP_016857744.1; XM_017002255.1. [Q13029-1]
DR   RefSeq; XP_016857745.1; XM_017002256.1. [Q13029-1]
DR   RefSeq; XP_016857746.1; XM_017002257.1. [Q13029-2]
DR   RefSeq; XP_016857748.1; XM_017002259.1. [Q13029-3]
DR   RefSeq; XP_016857749.1; XM_017002260.1. [Q13029-3]
DR   RefSeq; XP_016857750.1; XM_017002261.1. [Q13029-3]
DR   RefSeq; XP_016857751.1; XM_017002262.1. [Q13029-5]
DR   RefSeq; XP_016857752.1; XM_017002263.1. [Q13029-3]
DR   UniGene; Hs.371823; -.
DR   PDB; 2JV0; NMR; -; A=1-161.
DR   PDB; 2QPW; X-ray; 1.79 A; A=2-148.
DR   PDBsum; 2JV0; -.
DR   PDBsum; 2QPW; -.
DR   ProteinModelPortal; Q13029; -.
DR   SMR; Q13029; -.
DR   BioGrid; 113575; 13.
DR   DIP; DIP-428N; -.
DR   IntAct; Q13029; 4.
DR   STRING; 9606.ENSP00000235372; -.
DR   iPTMnet; Q13029; -.
DR   PhosphoSitePlus; Q13029; -.
DR   BioMuta; PRDM2; -.
DR   DMDM; 56757653; -.
DR   EPD; Q13029; -.
DR   jPOST; Q13029; -.
DR   MaxQB; Q13029; -.
DR   PaxDb; Q13029; -.
DR   PeptideAtlas; Q13029; -.
DR   PRIDE; Q13029; -.
DR   ProteomicsDB; 59110; -.
DR   ProteomicsDB; 59111; -. [Q13029-2]
DR   ProteomicsDB; 59112; -. [Q13029-3]
DR   DNASU; 7799; -.
DR   Ensembl; ENST00000235372; ENSP00000235372; ENSG00000116731. [Q13029-1]
DR   Ensembl; ENST00000311066; ENSP00000312352; ENSG00000116731. [Q13029-2]
DR   Ensembl; ENST00000343137; ENSP00000341621; ENSG00000116731. [Q13029-5]
DR   Ensembl; ENST00000376048; ENSP00000365216; ENSG00000116731. [Q13029-4]
DR   Ensembl; ENST00000413440; ENSP00000411103; ENSG00000116731. [Q13029-5]
DR   GeneID; 7799; -.
DR   KEGG; hsa:7799; -.
DR   UCSC; uc001avg.4; human. [Q13029-1]
DR   CTD; 7799; -.
DR   DisGeNET; 7799; -.
DR   EuPathDB; HostDB:ENSG00000116731.22; -.
DR   GeneCards; PRDM2; -.
DR   HGNC; HGNC:9347; PRDM2.
DR   HPA; HPA005809; -.
DR   MIM; 601196; gene.
DR   neXtProt; NX_Q13029; -.
DR   OpenTargets; ENSG00000116731; -.
DR   PharmGKB; PA33715; -.
DR   eggNOG; KOG2461; Eukaryota.
DR   eggNOG; ENOG410ZFVU; LUCA.
DR   GeneTree; ENSGT00940000159410; -.
DR   HOGENOM; HOG000231078; -.
DR   HOVERGEN; HBG053671; -.
DR   InParanoid; Q13029; -.
DR   KO; K11432; -.
DR   OMA; KPKLESH; -.
DR   OrthoDB; 1318335at2759; -.
DR   PhylomeDB; Q13029; -.
DR   TreeFam; TF332173; -.
DR   SIGNOR; Q13029; -.
DR   ChiTaRS; PRDM2; human.
DR   EvolutionaryTrace; Q13029; -.
DR   GeneWiki; PRDM2; -.
DR   GenomeRNAi; 7799; -.
DR   PRO; PR:Q13029; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000116731; Expressed in 229 organ(s), highest expression level in middle temporal gyrus.
DR   ExpressionAtlas; Q13029; baseline and differential.
DR   Genevisible; Q13029; HS.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0031490; F:chromatin DNA binding; IBA:GO_Central.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; IDA:NTNU_SB.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IBA:GO_Central.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISA:NTNU_SB.
DR   GO; GO:0018024; F:histone-lysine N-methyltransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IMP:NTNU_SB.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0008270; F:zinc ion binding; NAS:UniProtKB.
DR   GO; GO:0008340; P:determination of adult lifespan; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:NTNU_SB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB.
DR   InterPro; IPR009170; RIZ_retinblastoma-bd_prot.
DR   InterPro; IPR001214; SET_dom.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   Pfam; PF00856; SET; 1.
DR   Pfam; PF00096; zf-C2H2; 2.
DR   PIRSF; PIRSF002395; RIZ_SET; 1.
DR   SMART; SM00317; SET; 1.
DR   SMART; SM00355; ZnF_C2H2; 8.
DR   SUPFAM; SSF57667; SSF57667; 2.
DR   PROSITE; PS50280; SET; 1.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 6.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 7.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; Alternative initiation; Alternative splicing;
KW   Complete proteome; DNA-binding; Isopeptide bond; Metal-binding;
KW   Methyltransferase; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repeat; S-adenosyl-L-methionine; Transcription;
KW   Transcription regulation; Transferase; Ubl conjugation; Zinc;
KW   Zinc-finger.
FT   CHAIN         1   1718       PR domain zinc finger protein 2.
FT                                /FTId=PRO_0000041634.
FT   DOMAIN       28    141       SET. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00190}.
FT   ZN_FING     360    382       C2H2-type 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     390    412       C2H2-type 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     483    506       C2H2-type 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING    1134   1156       C2H2-type 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING    1162   1185       C2H2-type 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING    1191   1214       C2H2-type 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING    1333   1355       C2H2-type 7; atypical.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00042}.
FT   ZN_FING    1455   1478       C2H2-type 8; atypical.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00042}.
FT   REGION      294    316       Retinoblastoma protein binding.
FT   MOTIF       970    979       SH3-binding. {ECO:0000255}.
FT   MOTIF       985    998       SH3-binding. {ECO:0000255}.
FT   MOTIF      1028   1052       SH3-binding. {ECO:0000255}.
FT   COMPBIAS    268    296       Asp/Glu-rich (acidic).
FT   COMPBIAS    933   1049       Pro-rich.
FT   COMPBIAS   1052   1074       Poly-Ser.
FT   COMPBIAS   1361   1447       Arg/Lys-rich (basic).
FT   MOD_RES     421    421       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     643    643       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     743    743       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     781    781       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q63755}.
FT   MOD_RES     785    785       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q63755}.
FT   MOD_RES     796    796       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   CROSSLNK    347    347       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    651    651       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    690    690       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    692    692       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    774    774       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    866    866       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    879    879       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK   1147   1147       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK   1151   1151       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK   1257   1257       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK   1281   1281       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   VAR_SEQ       1    201       Missing (in isoform 3 and isoform 5).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_018974.
FT   VAR_SEQ     171    226       GKKKSQENKNKGNKIQDIQLKTSEPDFTSANMRDSAEGPKE
FT                                DEEKPSASALEQPAT -> ATASAWRPDALHQRPRTSPGSI
FT                                GRSKLQLQPSSRDHSSKSRHSGCSLTAPEVTWNQ (in
FT                                isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_046421.
FT   VAR_SEQ     227   1718       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_046422.
FT   VAR_SEQ    1679   1682       SYSL -> RNFL (in isoform 2 and isoform
FT                                5). {ECO:0000303|PubMed:17974005,
FT                                ECO:0000303|PubMed:8654390}.
FT                                /FTId=VSP_006927.
FT   VAR_SEQ    1683   1718       Missing (in isoform 2 and isoform 5).
FT                                {ECO:0000303|PubMed:17974005,
FT                                ECO:0000303|PubMed:8654390}.
FT                                /FTId=VSP_006928.
FT   VARIANT     283    283       D -> E (in dbSNP:rs2076324).
FT                                /FTId=VAR_052929.
FT   VARIANT     450    450       S -> N (in dbSNP:rs17350795).
FT                                /FTId=VAR_052930.
FT   MUTAGEN     106    106       C->Y: Reduced histone methyltransferase
FT                                activity. {ECO:0000269|PubMed:14633678}.
FT   MUTAGEN     159    159       A->V: Reduced histone methyltransferase
FT                                activity. {ECO:0000269|PubMed:14633678}.
FT   MUTAGEN     188    188       I->V: Loss of histone methyltransferase
FT                                activity. {ECO:0000269|PubMed:14633678}.
FT   CONFLICT    164    164       S -> T (in Ref. 6; AAA87023).
FT                                {ECO:0000305}.
FT   CONFLICT    196    196       D -> S (in Ref. 6; AAA87023).
FT                                {ECO:0000305}.
FT   CONFLICT    200    200       A -> G (in Ref. 6; AAA87023).
FT                                {ECO:0000305}.
FT   CONFLICT    276    293       EDEEEEEDDDDDELEDEG -> VGGGGGVVVVVSWKARGE
FT                                (in Ref. 6; AAA87023). {ECO:0000305}.
FT   CONFLICT    307    318       EPEIRCDEKPED -> SQKYGVMRSQKI (in Ref. 6;
FT                                AAA87023). {ECO:0000305}.
FT   CONFLICT    336    337       EV -> DL (in Ref. 6; AAA87023).
FT                                {ECO:0000305}.
FT   CONFLICT    371    371       T -> I (in Ref. 6; AAA87023).
FT                                {ECO:0000305}.
FT   CONFLICT    466    467       DT -> VS (in Ref. 6; AAA87023).
FT                                {ECO:0000305}.
FT   CONFLICT    530    530       Q -> L (in Ref. 3; BX647310).
FT                                {ECO:0000305}.
FT   CONFLICT    534    550       TQNVYVPSTEPEEEGEA -> PRTCMYQAQSRRGRGSR
FT                                (in Ref. 6; AAA87023). {ECO:0000305}.
FT   CONFLICT    703    703       P -> PP (in Ref. 1 and 7). {ECO:0000305}.
FT   CONFLICT    856    856       H -> R (in Ref. 3; BX647310).
FT                                {ECO:0000305}.
FT   CONFLICT   1456   1456       I -> T (in Ref. 3; BX647310).
FT                                {ECO:0000305}.
FT   STRAND        5      7       {ECO:0000244|PDB:2QPW}.
FT   HELIX        15     17       {ECO:0000244|PDB:2QPW}.
FT   HELIX        20     24       {ECO:0000244|PDB:2QPW}.
FT   STRAND       27     29       {ECO:0000244|PDB:2JV0}.
FT   STRAND       30     34       {ECO:0000244|PDB:2QPW}.
FT   TURN         36     39       {ECO:0000244|PDB:2JV0}.
FT   STRAND       41     48       {ECO:0000244|PDB:2QPW}.
FT   STRAND       54     59       {ECO:0000244|PDB:2JV0}.
FT   STRAND       62     64       {ECO:0000244|PDB:2QPW}.
FT   HELIX        66     68       {ECO:0000244|PDB:2QPW}.
FT   STRAND       72     80       {ECO:0000244|PDB:2QPW}.
FT   TURN         81     83       {ECO:0000244|PDB:2QPW}.
FT   STRAND       84     89       {ECO:0000244|PDB:2QPW}.
FT   HELIX        93     95       {ECO:0000244|PDB:2QPW}.
FT   HELIX        98    101       {ECO:0000244|PDB:2QPW}.
FT   STRAND      106    110       {ECO:0000244|PDB:2JV0}.
FT   STRAND      113    118       {ECO:0000244|PDB:2QPW}.
FT   STRAND      121    128       {ECO:0000244|PDB:2QPW}.
FT   HELIX       146    158       {ECO:0000244|PDB:2JV0}.
SQ   SEQUENCE   1718 AA;  188915 MW;  536BD68667AFE433 CRC64;
     MNQNTTEPVA ATETLAEVPE HVLRGLPEEV RLFPSAVDKT RIGVWATKPI LKGKKFGPFV
     GDKKKRSQVK NNVYMWEVYY PNLGWMCIDA TDPEKGNWLR YVNWACSGEE QNLFPLEINR
     AIYYKTLKPI APGEELLVWY NGEDNPEIAA AIEEERASAR SKRSSPKSRK GKKKSQENKN
     KGNKIQDIQL KTSEPDFTSA NMRDSAEGPK EDEEKPSASA LEQPATLQEV ASQEVPPELA
     TPAPAWEPQP EPDERLEAAA CEVNDLGEEE EEEEEEDEEE EEDDDDDELE DEGEEEASMP
     NENSVKEPEI RCDEKPEDLL EEPKTTSEET LEDCSEVTPA MQIPRTKEEA NGDVFETFMF
     PCQHCERKFT TKQGLERHMH IHISTVNHAF KCKYCGKAFG TQINRRRHER RHEAGLKRKP
     SQTLQPSEDL ADGKASGENV ASKDDSSPPS LGPDCLIMNS EKASQDTINS SVVEENGEVK
     ELHPCKYCKK VFGTHTNMRR HQRRVHERHL IPKGVRRKGG LEEPQPPAEQ AQATQNVYVP
     STEPEEEGEA DDVYIMDISS NISENLNYYI DGKIQTNNNT SNCDVIEMES ASADLYGINC
     LLTPVTVEIT QNIKTTQVPV TEDLPKEPLG STNSEAKKRR TASPPALPKI KAETDSDPMV
     PSCSLSLPLS ISTTEAVSFH KEKSVYLSSK LKQLLQTQDK LTPAGISATE IAKLGPVCVS
     APASMLPVTS SRFKRRTSSP PSSPQHSPAL RDFGKPSDGK AAWTDAGLTS KKSKLESHSD
     SPAWSLSGRD ERETVSPPCF DEYKMSKEWT ASSAFSSVCN QQPLDLSSGV KQKAEGTGKT
     PVQWESVLDL SVHKKHCSDS EGKEFKESHS VQPTCSAVKK RKPTTCMLQK VLLNEYNGID
     LPVENPADGT RSPSPCKSLE AQPDPDLGPG SGFPAPTVES TPDVCPSSPA LQTPSLSSGQ
     LPPLLIPTDP SSPPPCPPVL TVATPPPPLL PTVPLPAPSS SASPHPCPSP LSNATAQSPL
     PILSPTVSPS PSPIPPVEPL MSAASPGPPT LSSSSSSSSS SSSFSSSSSS SSPSPPPLSA
     ISSVVSSGDN LEASLPMISF KQEELENEGL KPREEPQSAA EQDVVVQETF NKNFVCNVCE
     SPFLSIKDLT KHLSIHAEEW PFKCEFCVQL FKDKTDLSEH RFLLHGVGNI FVCSVCKKEF
     AFLCNLQQHQ RDLHPDKVCT HHEFESGTLR PQNFTDPSKA HVEHMQSLPE DPLETSKEEE
     ELNDSSEELY TTIKIMASGI KTKDPDVRLG LNQHYPSFKP PPFQYHHRNP MGIGVTATNF
     TTHNIPQTFT TAIRCTKCGK GVDNMPELHK HILACASASD KKRYTPKKNP VPLKQTVQPK
     NGVVVLDNSG KNAFRRMGQP KRLNFSVELS KMSSNKLKLN ALKKKNQLVQ KAILQKNKSA
     KQKADLKNAC ESSSHICPYC NREFTYIGSL NKHAAFSCPK KPLSPPKKKV SHSSKKGGHS
     SPASSDKNSN SNHRRRTADA EIKMQSMQTP LGKTRARSSG PTQVPLPSSS FRSKQNVKFA
     ASVKSKKPSS SSLRNSSPIR MAKITHVEGK KPKAVAKNHS AQLSSKTSRS LHVRVQKSKA
     VLQSKSTLAS KKRTDRFNIK SRERSGGPVT RSLQLAAAAD LSENKREDGS AKQELKDFSY
     SLRLASRCSP PAAPYITRQY RKVKAPAAAQ FQGPFFKE
//
ID   PTN6_HUMAN              Reviewed;         595 AA.
AC   P29350; A8K306; G3V0F8; Q969V8; Q9UK67;
DT   01-DEC-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-1992, sequence version 1.
DT   13-FEB-2019, entry version 221.
DE   RecName: Full=Tyrosine-protein phosphatase non-receptor type 6;
DE            EC=3.1.3.48;
DE   AltName: Full=Hematopoietic cell protein-tyrosine phosphatase;
DE   AltName: Full=Protein-tyrosine phosphatase 1C;
DE            Short=PTP-1C;
DE   AltName: Full=Protein-tyrosine phosphatase SHP-1;
DE   AltName: Full=SH-PTP1;
GN   Name=PTPN6; Synonyms=HCP, PTP1C;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=1732748; DOI=10.1128/MCB.12.2.836;
RA   Yi T., Cleveland J.L., Ihle J.N.;
RT   "Protein tyrosine phosphatase containing SH2 domains:
RT   characterization, preferential expression in hematopoietic cells, and
RT   localization to human chromosome 12p12-p13.";
RL   Mol. Cell. Biol. 12:836-846(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RC   TISSUE=Mammary gland;
RX   PubMed=1652101; DOI=10.1038/352736a0;
RA   Shen S.H., Bastien L., Posner B.I., Chretien P.;
RT   "A protein-tyrosine phosphatase with sequence similarity to the SH2
RT   domain of the protein-tyrosine kinases.";
RL   Nature 352:736-739(1991).
RN   [3]
RP   ERRATUM, AND SEQUENCE REVISION.
RA   Shen S.H., Bastien L., Posner B.I., Chretien P.;
RL   Nature 353:868-868(1991).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=1736296; DOI=10.1073/pnas.89.3.1123;
RA   Plutzky J., Neel B.G., Rosenberg R.D.;
RT   "Isolation of a src homology 2-containing tyrosine phosphatase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:1123-1127(1992).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 1; 2 AND 3).
RX   PubMed=7665165; DOI=10.1006/geno.1995.1020;
RA   Banville D., Stocco R., Shen S.H.;
RT   "Human protein tyrosine phosphatase 1C (PTPN6) gene structure:
RT   alternate promoter usage and exon skipping generate multiple
RT   transcripts.";
RL   Genomics 27:165-173(1995).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9074930; DOI=10.1101/gr.7.3.268;
RA   Ansari-Lari M.A., Shen Y., Muzny D.M., Lee W., Gibbs R.A.;
RT   "Large-scale sequencing in human chromosome 12p13: experimental and
RT   computational gene structure determination.";
RL   Genome Res. 7:268-280(1997).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4).
RX   PubMed=10497187; DOI=10.1074/jbc.274.40.28301;
RA   Jin Y.J., Yu C.L., Burakoff S.J.;
RT   "Human 70-kDa SHP-1L differs from 68-kDa SHP-1 in its C-terminal
RT   structure and catalytic activity.";
RL   J. Biol. Chem. 274:28301-28307(1999).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 1 AND 2).
RA   Oka T., Ouchida M.;
RT   "Gene silencing of SHP-1 gene in leukemias/lymphomas by aberrant
RT   methylation.";
RL   Submitted (FEB-2002) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Umbilical cord blood;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [13]
RP   PHOSPHORYLATION.
RX   PubMed=7781604;
RA   Li R.Y., Gaits F., Ragab A., Ragab-Thomas J.M.F., Chap H.;
RT   "Tyrosine phosphorylation of an SH2-containing protein tyrosine
RT   phosphatase is coupled to platelet thrombin receptor via a pertussis
RT   toxin-sensitive heterotrimeric G-protein.";
RL   EMBO J. 14:2519-2526(1995).
RN   [14]
RP   INTERACTION WITH LILRB1.
RX   PubMed=9285411; DOI=10.1016/S1074-7613(00)80529-4;
RA   Cosman D., Fanger N., Borges L., Kubin M., Chin W., Peterson L.,
RA   Hsu M.-L.;
RT   "A novel immunoglobulin superfamily receptor for cellular and viral
RT   MHC class I molecules.";
RL   Immunity 7:273-282(1997).
RN   [15]
RP   INTERACTION WITH LILRB2.
RX   PubMed=9842885;
RX   DOI=10.1002/(SICI)1521-4141(199811)28:11<3423::AID-IMMU3423>3.0.CO;2-2;
RA   Fanger N.A., Cosman D., Peterson L., Braddy S.C., Maliszewski C.R.,
RA   Borges L.;
RT   "The MHC class I binding proteins LIR-1 and LIR-2 inhibit Fc receptor-
RT   mediated signaling in monocytes.";
RL   Eur. J. Immunol. 28:3423-3434(1998).
RN   [16]
RP   INTERACTION WITH SIRPA.
RX   PubMed=9712903; DOI=10.1074/jbc.273.35.22719;
RA   Veillette A., Thibaudeau E., Latour S.;
RT   "High expression of inhibitory receptor SHPS-1 and its association
RT   with protein tyrosine phosphatase SHP-1 in macrophages.";
RL   J. Biol. Chem. 273:22719-22728(1998).
RN   [17]
RP   INTERACTION WITH LYN, AND PHOSPHORYLATION AT TYR-564.
RX   PubMed=10574931; DOI=10.1074/jbc.274.49.34663;
RA   Yoshida K., Kharbanda S., Kufe D.;
RT   "Functional interaction between SHPTP1 and the Lyn tyrosine kinase in
RT   the apoptotic response to DNA damage.";
RL   J. Biol. Chem. 274:34663-34668(1999).
RN   [18]
RP   INTERACTION WITH FCRL2 AND FCRL3.
RX   PubMed=11162587; DOI=10.1006/bbrc.2000.4213;
RA   Xu M.-J., Zhao R., Zhao Z.J.;
RT   "Molecular cloning and characterization of SPAP1, an inhibitory
RT   receptor.";
RL   Biochem. Biophys. Res. Commun. 280:768-775(2001).
RN   [19]
RP   INTERACTION WITH CD84.
RX   PubMed=11414741; DOI=10.1006/clim.2001.5035;
RA   Lewis J., Eiben L.J., Nelson D.L., Cohen J.I., Nichols K.E.,
RA   Ochs H.D., Notarangelo L.D., Duckett C.S.;
RT   "Distinct interactions of the X-linked lymphoproliferative syndrome
RT   gene product SAP with cytoplasmic domains of members of the CD2
RT   receptor family.";
RL   Clin. Immunol. 100:15-23(2001).
RN   [20]
RP   FUNCTION IN ROS1 DEPHOSPHORYLATION, AND INTERACTION WITH ROS1.
RX   PubMed=11266449; DOI=10.1083/jcb.152.2.325;
RA   Keilhack H., Mueller M., Boehmer S.A., Frank C., Weidner K.M.,
RA   Birchmeier W., Ligensa T., Berndt A., Kosmehl H., Guenther B.,
RA   Mueller T., Birchmeier C., Boehmer F.D.;
RT   "Negative regulation of Ros receptor tyrosine kinase signaling. An
RT   epithelial function of the SH2 domain protein tyrosine phosphatase
RT   SHP-1.";
RL   J. Cell Biol. 152:325-334(2001).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Lymphoblast;
RX   PubMed=14654843; DOI=10.1038/nature02166;
RA   Andersen J.S., Wilkinson C.J., Mayor T., Mortensen P., Nigg E.A.,
RA   Mann M.;
RT   "Proteomic characterization of the human centrosome by protein
RT   correlation profiling.";
RL   Nature 426:570-574(2003).
RN   [22]
RP   INTERACTION WITH FCRL4.
RX   PubMed=14597715; DOI=10.1073/pnas.1935944100;
RA   Ehrhardt G.R.A., Davis R.S., Hsu J.T., Leu C.-M., Ehrhardt A.,
RA   Cooper M.D.;
RT   "The inhibitory potential of Fc receptor homolog 4 on memory B
RT   cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:13489-13494(2003).
RN   [23]
RP   INTERACTION WITH CD300LF.
RX   PubMed=15184070; DOI=10.1016/j.bbrc.2004.05.065;
RA   Sui L., Li N., Liu Q., Zhang W., Wan T., Wang B., Luo K., Sun H.,
RA   Cao X.;
RT   "IgSF13, a novel human inhibitory receptor of the immunoglobulin
RT   superfamily, is preferentially expressed in dendritic cells and
RT   monocytes.";
RL   Biochem. Biophys. Res. Commun. 319:920-928(2004).
RN   [24]
RP   REVIEW ON ROLE IN KIT SIGNALING.
RX   PubMed=15526160; DOI=10.1007/s00018-004-4189-6;
RA   Ronnstrand L.;
RT   "Signal transduction via the stem cell factor receptor/c-Kit.";
RL   Cell. Mol. Life Sci. 61:2535-2548(2004).
RN   [25]
RP   REVIEW ON ROLE IN KIT SIGNALING.
RX   PubMed=16129412; DOI=10.1016/j.bbrc.2005.08.055;
RA   Roskoski R. Jr.;
RT   "Signaling by Kit protein-tyrosine kinase--the stem cell factor
RT   receptor.";
RL   Biochem. Biophys. Res. Commun. 337:1-13(2005).
RN   [26]
RP   INTERACTION WITH KIR2DL1.
RX   PubMed=18604210; DOI=10.1038/ni.1635;
RA   Yu M.-C., Su L.-L., Zou L., Liu Y., Wu N., Kong L., Zhuang Z.-H.,
RA   Sun L., Liu H.P., Hu J.-H., Li D., Strominger J.L., Zang J.-W.,
RA   Pei G., Ge B.-X.;
RT   "An essential function for beta-arrestin 2 in the inhibitory signaling
RT   of natural killer cells.";
RL   Nat. Immunol. 9:898-907(2008).
RN   [27]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH PDPK1.
RX   PubMed=19591923; DOI=10.1016/j.cellsig.2009.06.010;
RA   Sephton C.F., Zhang D., Lehmann T.M., Pennington P.R., Scheid M.P.,
RA   Mousseau D.D.;
RT   "The nuclear localization of 3'-phosphoinositide-dependent kinase-1 is
RT   dependent on its association with the protein tyrosine phosphatase
RT   SHP-1.";
RL   Cell. Signal. 21:1634-1644(2009).
RN   [28]
RP   INTERACTION WITH FCRL3.
RX   PubMed=19843936; DOI=10.4049/jimmunol.0901982;
RA   Kochi Y., Myouzen K., Yamada R., Suzuki A., Kurosaki T., Nakamura Y.,
RA   Yamamoto K.;
RT   "FCRL3, an autoimmune susceptibility gene, has inhibitory potential on
RT   B-cell receptor-mediated signaling.";
RL   J. Immunol. 183:5502-5510(2009).
RN   [29]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-64, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [30]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [31]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH CDK2.
RX   PubMed=21262353; DOI=10.1016/j.cellsig.2011.01.019;
RA   Fiset A., Xu E., Bergeron S., Marette A., Pelletier G.,
RA   Siminovitch K.A., Olivier M., Beauchemin N., Faure R.L.;
RT   "Compartmentalized CDK2 is connected with SHP-1 and beta-catenin and
RT   regulates insulin internalization.";
RL   Cell. Signal. 23:911-919(2011).
RN   [32]
RP   INTERACTION WITH FCRL6.
RX   PubMed=20933011; DOI=10.1016/j.imlet.2010.09.023;
RA   Kulemzin S.V., Zamoshnikova A.Y., Yurchenko M.Y., Vitak N.Y.,
RA   Najakshin A.M., Fayngerts S.A., Chikaev N.A., Reshetnikova E.S.,
RA   Kashirina N.M., Peclo M.M., Rutkevich P.N., Shevelev A.Y.,
RA   Yanushevskaya E.V., Baranov K.O., Mamonkin M., Vlasik T.N.,
RA   Sidorenko S.P., Taranin A.V., Mechetina L.V.;
RT   "FCRL6 receptor: expression and associated proteins.";
RL   Immunol. Lett. 134:174-182(2011).
RN   [33]
RP   INTERACTION WITH EGFR.
RX   PubMed=21258366; DOI=10.1038/ncb2158;
RA   Hsu J.M., Chen C.T., Chou C.K., Kuo H.P., Li L.Y., Lin C.Y., Lee H.J.,
RA   Wang Y.N., Liu M., Liao H.W., Shi B., Lai C.C., Bedford M.T.,
RA   Tsai C.H., Hung M.C.;
RT   "Crosstalk between Arg 1175 methylation and Tyr 1173 phosphorylation
RT   negatively modulates EGFR-mediated ERK activation.";
RL   Nat. Cell Biol. 13:174-181(2011).
RN   [34]
RP   INTERACTION WITH MPIG6B.
RX   PubMed=23112346; DOI=10.1126/scisignal.2002936;
RA   Mazharian A., Wang Y.J., Mori J., Bem D., Finney B., Heising S.,
RA   Gissen P., White J.G., Berndt M.C., Gardiner E.E., Nieswandt B.,
RA   Douglas M.R., Campbell R.D., Watson S.P., Senis Y.A.;
RT   "Mice lacking the ITIM-containing receptor G6b-B exhibit
RT   macrothrombocytopenia and aberrant platelet function.";
RL   Sci. Signal. 5:RA78-RA78(2012).
RN   [35]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [36]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [37]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 248-399.
RX   PubMed=9774441; DOI=10.1074/jbc.273.43.28199;
RA   Yang J., Liang X., Niu T., Meng W., Zhao Z., Zhou G.W.;
RT   "Crystal structure of the catalytic domain of protein-tyrosine
RT   phosphatase SHP-1.";
RL   J. Biol. Chem. 273:28199-28207(1998).
RN   [38]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 1-532, AND DOMAIN SH2.
RX   PubMed=12482860; DOI=10.1074/jbc.M210430200;
RA   Yang J., Liu L., He D., Song X., Liang X., Zhao Z.J., Zhou G.W.;
RT   "Crystal structure of human protein-tyrosine phosphatase SHP-1.";
RL   J. Biol. Chem. 278:6516-6520(2003).
RN   [39]
RP   STRUCTURE BY NMR OF 110-214.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structures of the SH2 domain of human protein-tyrosine
RT   phosphatase SHP-1.";
RL   Submitted (NOV-2005) to the PDB data bank.
RN   [40]
RP   X-RAY CRYSTALLOGRAPHY (3.1 ANGSTROMS), AND DOMAIN SH2.
RX   PubMed=21465528; DOI=10.1002/jcb.23125;
RA   Wang W., Liu L., Song X., Mo Y., Komma C., Bellamy H.D., Zhao Z.J.,
RA   Zhou G.W.;
RT   "Crystal structure of human protein tyrosine phosphatase SHP-1 in the
RT   open conformation.";
RL   J. Cell. Biochem. 112:2062-2071(2011).
CC   -!- FUNCTION: Modulates signaling by tyrosine phosphorylated cell
CC       surface receptors such as KIT and the EGF receptor/EGFR. The SH2
CC       regions may interact with other cellular components to modulate
CC       its own phosphatase activity against interacting substrates.
CC       Together with MTUS1, induces UBE2V2 expression upon angiotensin II
CC       stimulation. Plays a key role in hematopoiesis.
CC       {ECO:0000269|PubMed:11266449}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + O-phospho-L-tyrosyl-[protein] = L-tyrosyl-[protein]
CC         + phosphate; Xref=Rhea:RHEA:10684, Rhea:RHEA-COMP:10136,
CC         Rhea:RHEA-COMP:10137, ChEBI:CHEBI:15377, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:46858, ChEBI:CHEBI:82620; EC=3.1.3.48;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU10044};
CC   -!- SUBUNIT: Monomer. Interacts with MTUS1 (By similarity). Interacts
CC       with MILR1 (tyrosine-phosphorylated) (By similarity). Interacts
CC       with KIT (By similarity). Interacts with SIRPA/PTPNS1
CC       (PubMed:9712903). Interacts with LILRB1 and LILRB2
CC       (PubMed:9285411, PubMed:9842885). Interacts with FCRL2 and FCRL4
CC       (PubMed:11162587, PubMed:14597715). Interacts with FCRL3 and FCRL6
CC       (tyrosine phosphorylated form) (PubMed:20933011, PubMed:11162587,
CC       PubMed:19843936). Interacts with CD84 (PubMed:11414741). Interacts
CC       with CD300LF (PubMed:15184070). Interacts with CDK2
CC       (PubMed:21262353). Interacts with KIR2DL1; the interaction is
CC       enhanced by ARRB2 (PubMed:18604210). Interacts (via SH2 1 domain)
CC       with ROS1; the interaction is direct and promotes ROS1
CC       dephosphorylation (PubMed:11266449). Interacts with EGFR; inhibits
CC       EGFR-dependent activation of MAPK/ERK (PubMed:21258366). Interacts
CC       with LYN (PubMed:10574931). Interacts with the tyrosine
CC       phosphorylated form of PDPK1 (PubMed:19591923). Interacts with
CC       CEACAM1 (via cytoplasmic domain); this interaction depends on the
CC       monomer/dimer equilibrium and is phosphorylation-dependent (By
CC       similarity). Interacts with MPIG6B (via ITIM motif)
CC       (PubMed:23112346). {ECO:0000250|UniProtKB:P29351,
CC       ECO:0000250|UniProtKB:P81718, ECO:0000269|PubMed:10574931,
CC       ECO:0000269|PubMed:11162587, ECO:0000269|PubMed:11266449,
CC       ECO:0000269|PubMed:11414741, ECO:0000269|PubMed:14597715,
CC       ECO:0000269|PubMed:15184070, ECO:0000269|PubMed:18604210,
CC       ECO:0000269|PubMed:19591923, ECO:0000269|PubMed:19843936,
CC       ECO:0000269|PubMed:20933011, ECO:0000269|PubMed:21258366,
CC       ECO:0000269|PubMed:21262353, ECO:0000269|PubMed:23112346,
CC       ECO:0000269|PubMed:9285411, ECO:0000269|PubMed:9712903,
CC       ECO:0000269|PubMed:9842885}.
CC   -!- INTERACTION:
CC       Q14790:CASP8; NbExp=3; IntAct=EBI-78260, EBI-78060;
CC       P20273:CD22; NbExp=4; IntAct=EBI-78260, EBI-78277;
CC       Q9BZW8:CD244; NbExp=2; IntAct=EBI-78260, EBI-1580565;
CC       P20138:CD33; NbExp=8; IntAct=EBI-78260, EBI-3906571;
CC       P11049:CD37; NbExp=4; IntAct=EBI-78260, EBI-6139068;
CC       P19235:EPOR; NbExp=11; IntAct=EBI-78260, EBI-617321;
CC       P31994:FCGR2B; NbExp=3; IntAct=EBI-78260, EBI-724784;
CC       Q13643:FHL3; NbExp=3; IntAct=EBI-78260, EBI-741101;
CC       P62993:GRB2; NbExp=3; IntAct=EBI-78260, EBI-401755;
CC       P43626:KIR2DL1; NbExp=4; IntAct=EBI-78260, EBI-8684277;
CC       P43628:KIR2DL3; NbExp=13; IntAct=EBI-78260, EBI-8632435;
CC       Q6GTX8:LAIR1; NbExp=5; IntAct=EBI-78260, EBI-965864;
CC       P06239:LCK; NbExp=5; IntAct=EBI-78260, EBI-1348;
CC       Q8NHL6:LILRB1; NbExp=4; IntAct=EBI-78260, EBI-2805262;
CC       Q8N423:LILRB2; NbExp=3; IntAct=EBI-78260, EBI-2816428;
CC       O75022:LILRB3; NbExp=4; IntAct=EBI-78260, EBI-2830524;
CC       Q8NHJ6:LILRB4; NbExp=4; IntAct=EBI-78260, EBI-2805248;
CC       O94916-1:NFAT5; NbExp=4; IntAct=EBI-78260, EBI-15828651;
CC       P16284:PECAM1; NbExp=4; IntAct=EBI-78260, EBI-716404;
CC       Q9UKJ1:PILRA; NbExp=5; IntAct=EBI-78260, EBI-965833;
CC       O35274:Ppp1r9b (xeno); NbExp=2; IntAct=EBI-78260, EBI-80022;
CC       Q05397:PTK2; NbExp=3; IntAct=EBI-7399369, EBI-702142;
CC       P08922:ROS1; NbExp=2; IntAct=EBI-78260, EBI-7371065;
CC       Q8N1K5:THEMIS; NbExp=4; IntAct=EBI-78260, EBI-2873538;
CC       B7UM99:tir (xeno); NbExp=4; IntAct=EBI-78260, EBI-2504426;
CC       Q7DB77:tir (xeno); NbExp=2; IntAct=EBI-78260, EBI-6480811;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Note=In neurons,
CC       translocates into the nucleus after treatment with angiotensin II
CC       (By similarity). Shuttles between the cytoplasm and nucleus via
CC       its association with PDPK1. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=Long;
CC         IsoId=P29350-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P29350-3; Sequence=VSP_007775;
CC       Name=3; Synonyms=Short;
CC         IsoId=P29350-2; Sequence=VSP_005129, VSP_005130;
CC       Name=4; Synonyms=70-kDa, SHP-1L;
CC         IsoId=P29350-4; Sequence=VSP_044447;
CC   -!- TISSUE SPECIFICITY: Isoform 1 is expressed in hematopoietic cells.
CC       Isoform 2 is expressed in non-hematopoietic cells.
CC   -!- DOMAIN: The N-terminal SH2 domain functions as an auto-inhibitory
CC       domain, blocking the catalytic domain in the ligand-free close
CC       conformation. {ECO:0000269|PubMed:12482860,
CC       ECO:0000269|PubMed:21465528}.
CC   -!- PTM: Phosphorylated on tyrosine residues. Binding of KITLG/SCF to
CC       KIT increases tyrosine phosphorylation (By similarity).
CC       Phosphorylation at Tyr-564 enhances phosphatase activity.
CC       {ECO:0000250, ECO:0000269|PubMed:10574931,
CC       ECO:0000269|PubMed:7781604}.
CC   -!- SIMILARITY: Belongs to the protein-tyrosine phosphatase family.
CC       Non-receptor class 2 subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/PTPN6ID41920ch12p13.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; M74903; AAA35963.1; -; mRNA.
DR   EMBL; X62055; CAA43982.1; -; mRNA.
DR   EMBL; M77273; AAA36610.1; -; mRNA.
DR   EMBL; U15528; AAA82880.1; -; Genomic_DNA.
DR   EMBL; U15536; AAA82880.1; JOINED; Genomic_DNA.
DR   EMBL; U15535; AAA82880.1; JOINED; Genomic_DNA.
DR   EMBL; U15534; AAA82880.1; JOINED; Genomic_DNA.
DR   EMBL; U15533; AAA82880.1; JOINED; Genomic_DNA.
DR   EMBL; U15532; AAA82880.1; JOINED; Genomic_DNA.
DR   EMBL; U15531; AAA82880.1; JOINED; Genomic_DNA.
DR   EMBL; U15530; AAA82880.1; JOINED; Genomic_DNA.
DR   EMBL; U15529; AAA82880.1; JOINED; Genomic_DNA.
DR   EMBL; U15528; AAA82879.1; -; Genomic_DNA.
DR   EMBL; U15537; AAA82879.1; JOINED; Genomic_DNA.
DR   EMBL; U15535; AAA82879.1; JOINED; Genomic_DNA.
DR   EMBL; U15534; AAA82879.1; JOINED; Genomic_DNA.
DR   EMBL; U15533; AAA82879.1; JOINED; Genomic_DNA.
DR   EMBL; U15532; AAA82879.1; JOINED; Genomic_DNA.
DR   EMBL; U15531; AAA82879.1; JOINED; Genomic_DNA.
DR   EMBL; U15530; AAA82879.1; JOINED; Genomic_DNA.
DR   EMBL; U15529; AAA82879.1; JOINED; Genomic_DNA.
DR   EMBL; U47924; AAB51322.1; -; Genomic_DNA.
DR   EMBL; U47924; AAB51323.1; -; Genomic_DNA.
DR   EMBL; AF178946; AAD53317.1; -; mRNA.
DR   EMBL; AB079851; BAC81774.1; -; Genomic_DNA.
DR   EMBL; AB079851; BAC81775.1; -; Genomic_DNA.
DR   EMBL; AK290421; BAF83110.1; -; mRNA.
DR   EMBL; CH471116; EAW88703.1; -; Genomic_DNA.
DR   EMBL; CH471116; EAW88704.1; -; Genomic_DNA.
DR   EMBL; BC002523; AAH02523.1; -; mRNA.
DR   EMBL; BC007667; AAH07667.1; -; mRNA.
DR   CCDS; CCDS41744.1; -. [P29350-3]
DR   CCDS; CCDS44820.1; -. [P29350-1]
DR   CCDS; CCDS44821.1; -. [P29350-4]
DR   PIR; B42031; S20825.
DR   RefSeq; NP_002822.2; NM_002831.5. [P29350-1]
DR   RefSeq; NP_536858.1; NM_080548.4. [P29350-3]
DR   RefSeq; NP_536859.1; NM_080549.3. [P29350-4]
DR   RefSeq; XP_011519290.1; XM_011520988.1. [P29350-3]
DR   UniGene; Hs.63489; -.
DR   PDB; 1FPR; X-ray; 2.50 A; A=243-526.
DR   PDB; 1GWZ; X-ray; 2.50 A; A=243-541.
DR   PDB; 1X6C; NMR; -; A=110-214.
DR   PDB; 2B3O; X-ray; 2.80 A; A=1-532.
DR   PDB; 2RMX; NMR; -; A=110-214.
DR   PDB; 2YU7; NMR; -; A=110-214.
DR   PDB; 3PS5; X-ray; 3.10 A; A=1-595.
DR   PDB; 4GRY; X-ray; 1.70 A; A=243-528.
DR   PDB; 4GRZ; X-ray; 1.37 A; A=243-528.
DR   PDB; 4GS0; X-ray; 1.80 A; A/B=243-528.
DR   PDB; 4HJP; X-ray; 1.40 A; A=243-528.
DR   PDB; 4HJQ; X-ray; 1.80 A; A/B=243-528.
DR   PDBsum; 1FPR; -.
DR   PDBsum; 1GWZ; -.
DR   PDBsum; 1X6C; -.
DR   PDBsum; 2B3O; -.
DR   PDBsum; 2RMX; -.
DR   PDBsum; 2YU7; -.
DR   PDBsum; 3PS5; -.
DR   PDBsum; 4GRY; -.
DR   PDBsum; 4GRZ; -.
DR   PDBsum; 4GS0; -.
DR   PDBsum; 4HJP; -.
DR   PDBsum; 4HJQ; -.
DR   ProteinModelPortal; P29350; -.
DR   SMR; P29350; -.
DR   BioGrid; 111742; 127.
DR   DIP; DIP-31002N; -.
DR   IntAct; P29350; 68.
DR   MINT; P29350; -.
DR   STRING; 9606.ENSP00000391592; -.
DR   BindingDB; P29350; -.
DR   ChEMBL; CHEMBL3166; -.
DR   MoonDB; P29350; Predicted.
DR   DEPOD; P29350; -.
DR   iPTMnet; P29350; -.
DR   PhosphoSitePlus; P29350; -.
DR   BioMuta; PTPN6; -.
DR   DMDM; 131469; -.
DR   OGP; P29350; -.
DR   EPD; P29350; -.
DR   jPOST; P29350; -.
DR   MaxQB; P29350; -.
DR   PaxDb; P29350; -.
DR   PeptideAtlas; P29350; -.
DR   PRIDE; P29350; -.
DR   ProteomicsDB; 54543; -.
DR   ProteomicsDB; 54544; -. [P29350-2]
DR   ProteomicsDB; 54545; -. [P29350-3]
DR   DNASU; 5777; -.
DR   Ensembl; ENST00000318974; ENSP00000326010; ENSG00000111679. [P29350-1]
DR   Ensembl; ENST00000399448; ENSP00000382376; ENSG00000111679. [P29350-3]
DR   Ensembl; ENST00000456013; ENSP00000391592; ENSG00000111679. [P29350-4]
DR   GeneID; 5777; -.
DR   KEGG; hsa:5777; -.
DR   UCSC; uc001qsb.3; human. [P29350-1]
DR   CTD; 5777; -.
DR   DisGeNET; 5777; -.
DR   EuPathDB; HostDB:ENSG00000111679.16; -.
DR   GeneCards; PTPN6; -.
DR   HGNC; HGNC:9658; PTPN6.
DR   HPA; CAB004572; -.
DR   HPA; CAB072845; -.
DR   HPA; HPA001466; -.
DR   MIM; 176883; gene.
DR   neXtProt; NX_P29350; -.
DR   OpenTargets; ENSG00000111679; -.
DR   PharmGKB; PA34002; -.
DR   eggNOG; KOG0790; Eukaryota.
DR   eggNOG; COG5599; LUCA.
DR   GeneTree; ENSGT00940000159480; -.
DR   HOGENOM; HOG000273907; -.
DR   HOVERGEN; HBG000223; -.
DR   InParanoid; P29350; -.
DR   KO; K05697; -.
DR   OMA; NTKTYIA; -.
DR   OrthoDB; 411281at2759; -.
DR   PhylomeDB; P29350; -.
DR   TreeFam; TF351632; -.
DR   BRENDA; 3.1.3.48; 2681.
DR   Reactome; R-HSA-114604; GPVI-mediated activation cascade.
DR   Reactome; R-HSA-1433559; Regulation of KIT signaling.
DR   Reactome; R-HSA-210990; PECAM1 interactions.
DR   Reactome; R-HSA-388841; Costimulation by the CD28 family.
DR   Reactome; R-HSA-389948; PD-1 signaling.
DR   Reactome; R-HSA-391160; Signal regulatory protein family interactions.
DR   Reactome; R-HSA-432142; Platelet sensitization by LDL.
DR   Reactome; R-HSA-512988; Interleukin-3, Interleukin-5 and GM-CSF signaling.
DR   Reactome; R-HSA-5690714; CD22 mediated BCR regulation.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-877300; Interferon gamma signaling.
DR   Reactome; R-HSA-877312; Regulation of IFNG signaling.
DR   Reactome; R-HSA-9008059; Interleukin-37 signaling.
DR   Reactome; R-HSA-909733; Interferon alpha/beta signaling.
DR   Reactome; R-HSA-912526; Interleukin receptor SHC signaling.
DR   Reactome; R-HSA-912694; Regulation of IFNA signaling.
DR   Reactome; R-HSA-982772; Growth hormone receptor signaling.
DR   Reactome; R-HSA-983695; Antigen activates B Cell Receptor (BCR) leading to generation of second messengers.
DR   SignaLink; P29350; -.
DR   SIGNOR; P29350; -.
DR   ChiTaRS; PTPN6; human.
DR   EvolutionaryTrace; P29350; -.
DR   GeneWiki; PTPN6; -.
DR   GenomeRNAi; 5777; -.
DR   PMAP-CutDB; P29350; -.
DR   PRO; PR:P29350; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000111679; Expressed in 217 organ(s), highest expression level in blood.
DR   ExpressionAtlas; P29350; baseline and differential.
DR   Genevisible; P29350; HS.
DR   GO; GO:0042105; C:alpha-beta T cell receptor complex; IEA:Ensembl.
DR   GO; GO:0005911; C:cell-cell junction; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0016020; C:membrane; TAS:ProtInc.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:BHF-UCL.
DR   GO; GO:0032991; C:protein-containing complex; IMP:UniProtKB.
DR   GO; GO:0035580; C:specific granule lumen; TAS:Reactome.
DR   GO; GO:1904724; C:tertiary granule lumen; TAS:Reactome.
DR   GO; GO:0050839; F:cell adhesion molecule binding; IEA:Ensembl.
DR   GO; GO:0140031; F:phosphorylation-dependent protein binding; IPI:UniProtKB.
DR   GO; GO:0001784; F:phosphotyrosine residue binding; IMP:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; IMP:UniProtKB.
DR   GO; GO:0042169; F:SH2 domain binding; IEA:Ensembl.
DR   GO; GO:0017124; F:SH3 domain binding; IEA:Ensembl.
DR   GO; GO:0005001; F:transmembrane receptor protein tyrosine phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0033277; P:abortive mitotic cell cycle; IEA:Ensembl.
DR   GO; GO:0006915; P:apoptotic process; TAS:ProtInc.
DR   GO; GO:0050853; P:B cell receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0030154; P:cell differentiation; IDA:UniProtKB.
DR   GO; GO:0008283; P:cell population proliferation; IDA:UniProtKB.
DR   GO; GO:0071345; P:cellular response to cytokine stimulus; TAS:Reactome.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; TAS:ProtInc.
DR   GO; GO:0002244; P:hematopoietic progenitor cell differentiation; IEA:Ensembl.
DR   GO; GO:0035556; P:intracellular signal transduction; IEA:Ensembl.
DR   GO; GO:0050900; P:leukocyte migration; TAS:Reactome.
DR   GO; GO:0035855; P:megakaryocyte development; IEA:Ensembl.
DR   GO; GO:0042267; P:natural killer cell mediated cytotoxicity; IEA:Ensembl.
DR   GO; GO:0050859; P:negative regulation of B cell receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; NAS:UniProtKB.
DR   GO; GO:0002924; P:negative regulation of humoral immune response mediated by circulating immunoglobulin; IEA:Ensembl.
DR   GO; GO:0032715; P:negative regulation of interleukin-6 production; ISS:ARUK-UCL.
DR   GO; GO:0043407; P:negative regulation of MAP kinase activity; IEA:Ensembl.
DR   GO; GO:0050732; P:negative regulation of peptidyl-tyrosine phosphorylation; IMP:BHF-UCL.
DR   GO; GO:0042130; P:negative regulation of T cell proliferation; IEA:Ensembl.
DR   GO; GO:0050860; P:negative regulation of T cell receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0032720; P:negative regulation of tumor necrosis factor production; ISS:ARUK-UCL.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0035335; P:peptidyl-tyrosine dephosphorylation; IMP:UniProtKB.
DR   GO; GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:UniProtKB.
DR   GO; GO:0030168; P:platelet activation; TAS:Reactome.
DR   GO; GO:0070527; P:platelet aggregation; IEA:Ensembl.
DR   GO; GO:0030220; P:platelet formation; IEA:Ensembl.
DR   GO; GO:0033630; P:positive regulation of cell adhesion mediated by integrin; IEA:Ensembl.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; IMP:BHF-UCL.
DR   GO; GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; IMP:BHF-UCL.
DR   GO; GO:0006470; P:protein dephosphorylation; IDA:UniProtKB.
DR   GO; GO:0045577; P:regulation of B cell differentiation; IEA:Ensembl.
DR   GO; GO:0070372; P:regulation of ERK1 and ERK2 cascade; IDA:UniProtKB.
DR   GO; GO:2000045; P:regulation of G1/S transition of mitotic cell cycle; IMP:BHF-UCL.
DR   GO; GO:0051279; P:regulation of release of sequestered calcium ion into cytosol; IEA:Ensembl.
DR   GO; GO:0060338; P:regulation of type I interferon-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0031295; P:T cell costimulation; TAS:Reactome.
DR   Gene3D; 3.30.505.10; -; 2.
DR   Gene3D; 3.90.190.10; -; 1.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR000242; PTPase_domain.
DR   InterPro; IPR000980; SH2.
DR   InterPro; IPR036860; SH2_dom_sf.
DR   InterPro; IPR016130; Tyr_Pase_AS.
DR   InterPro; IPR003595; Tyr_Pase_cat.
DR   InterPro; IPR012152; Tyr_Pase_non-rcpt_typ-6/11.
DR   InterPro; IPR000387; TYR_PHOSPHATASE_dom.
DR   Pfam; PF00017; SH2; 2.
DR   Pfam; PF00102; Y_phosphatase; 1.
DR   PIRSF; PIRSF000929; Tyr-Ptase_nr_6; 1.
DR   PRINTS; PR00700; PRTYPHPHTASE.
DR   PRINTS; PR00401; SH2DOMAIN.
DR   SMART; SM00194; PTPc; 1.
DR   SMART; SM00404; PTPc_motif; 1.
DR   SMART; SM00252; SH2; 2.
DR   SUPFAM; SSF52799; SSF52799; 1.
DR   SUPFAM; SSF55550; SSF55550; 2.
DR   PROSITE; PS50001; SH2; 2.
DR   PROSITE; PS00383; TYR_PHOSPHATASE_1; 1.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 1.
DR   PROSITE; PS50055; TYR_PHOSPHATASE_PTP; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Cytoplasm;
KW   Hydrolase; Nucleus; Phosphoprotein; Protein phosphatase;
KW   Reference proteome; Repeat; SH2 domain.
FT   CHAIN         1    595       Tyrosine-protein phosphatase non-receptor
FT                                type 6.
FT                                /FTId=PRO_0000094758.
FT   DOMAIN        4    100       SH2 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00191}.
FT   DOMAIN      110    213       SH2 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00191}.
FT   DOMAIN      244    515       Tyrosine-protein phosphatase.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00160}.
FT   REGION      453    459       Substrate binding. {ECO:0000250}.
FT   ACT_SITE    453    453       Phosphocysteine intermediate.
FT   BINDING     419    419       Substrate. {ECO:0000250}.
FT   BINDING     500    500       Substrate. {ECO:0000250}.
FT   MOD_RES      10     10       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P81718}.
FT   MOD_RES      57     57       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P29351}.
FT   MOD_RES      64     64       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     377    377       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P29351}.
FT   MOD_RES     536    536       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P29351}.
FT   MOD_RES     564    564       Phosphotyrosine; by LYN.
FT                                {ECO:0000269|PubMed:10574931}.
FT   VAR_SEQ       1     39       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:1652101}.
FT                                /FTId=VSP_005129.
FT   VAR_SEQ       1      3       MVR -> MLSRG (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_007775.
FT   VAR_SEQ      40     44       SLSVR -> MLSRG (in isoform 3).
FT                                {ECO:0000303|PubMed:1652101}.
FT                                /FTId=VSP_005130.
FT   VAR_SEQ     559    595       HKEDVYENLHTKNKREEKVKKQRSADKEKSKGSLKRK ->
FT                                SLESSAGTVAASPVRRGGQRGLPVPGPPVLSPDLHQLPVLA
FT                                PLHPAADTRRMCMRTCTLRTRGRRK (in isoform 4).
FT                                {ECO:0000303|PubMed:10497187}.
FT                                /FTId=VSP_044447.
FT   CONFLICT      6      6       H -> L (in Ref. 5; AAA82880).
FT                                {ECO:0000305}.
FT   CONFLICT     86     86       L -> V (in Ref. 4; AAA36610 and 7;
FT                                AAD53317). {ECO:0000305}.
FT   CONFLICT    146    146       V -> E (in Ref. 5; AAA82880/AAA82879).
FT                                {ECO:0000305}.
FT   HELIX        11     21       {ECO:0000244|PDB:2B3O}.
FT   STRAND       26     31       {ECO:0000244|PDB:2B3O}.
FT   STRAND       33     45       {ECO:0000244|PDB:2B3O}.
FT   STRAND       48     55       {ECO:0000244|PDB:2B3O}.
FT   STRAND       57     59       {ECO:0000244|PDB:2B3O}.
FT   STRAND       61     63       {ECO:0000244|PDB:2B3O}.
FT   STRAND       68     70       {ECO:0000244|PDB:2B3O}.
FT   HELIX        72     80       {ECO:0000244|PDB:2B3O}.
FT   STRAND       89     91       {ECO:0000244|PDB:2B3O}.
FT   HELIX       105    107       {ECO:0000244|PDB:2B3O}.
FT   STRAND      111    114       {ECO:0000244|PDB:3PS5}.
FT   HELIX       117    127       {ECO:0000244|PDB:2B3O}.
FT   STRAND      132    137       {ECO:0000244|PDB:2B3O}.
FT   STRAND      139    141       {ECO:0000244|PDB:2B3O}.
FT   STRAND      145    154       {ECO:0000244|PDB:2B3O}.
FT   STRAND      155    157       {ECO:0000244|PDB:2RMX}.
FT   STRAND      162    170       {ECO:0000244|PDB:2B3O}.
FT   HELIX       172    174       {ECO:0000244|PDB:3PS5}.
FT   STRAND      175    181       {ECO:0000244|PDB:2B3O}.
FT   STRAND      184    186       {ECO:0000244|PDB:2B3O}.
FT   HELIX       187    197       {ECO:0000244|PDB:2B3O}.
FT   STRAND      199    201       {ECO:0000244|PDB:2RMX}.
FT   STRAND      202    204       {ECO:0000244|PDB:2B3O}.
FT   STRAND      205    207       {ECO:0000244|PDB:2RMX}.
FT   HELIX       221    223       {ECO:0000244|PDB:2B3O}.
FT   STRAND      236    238       {ECO:0000244|PDB:3PS5}.
FT   HELIX       244    256       {ECO:0000244|PDB:4GRZ}.
FT   TURN        257    259       {ECO:0000244|PDB:4HJP}.
FT   HELIX       263    266       {ECO:0000244|PDB:4GRZ}.
FT   HELIX       268    273       {ECO:0000244|PDB:4GRZ}.
FT   STRAND      275    278       {ECO:0000244|PDB:1GWZ}.
FT   TURN        283    285       {ECO:0000244|PDB:4GRZ}.
FT   STRAND      286    288       {ECO:0000244|PDB:4GRZ}.
FT   STRAND      290    292       {ECO:0000244|PDB:4GS0}.
FT   STRAND      294    296       {ECO:0000244|PDB:3PS5}.
FT   TURN        297    300       {ECO:0000244|PDB:4GRZ}.
FT   STRAND      301    307       {ECO:0000244|PDB:4GRZ}.
FT   STRAND      309    312       {ECO:0000244|PDB:1GWZ}.
FT   HELIX       314    316       {ECO:0000244|PDB:1FPR}.
FT   STRAND      321    324       {ECO:0000244|PDB:4GRZ}.
FT   HELIX       329    331       {ECO:0000244|PDB:4GRZ}.
FT   HELIX       332    341       {ECO:0000244|PDB:4GRZ}.
FT   STRAND      346    349       {ECO:0000244|PDB:4GRZ}.
FT   STRAND      353    355       {ECO:0000244|PDB:4GRZ}.
FT   STRAND      356    358       {ECO:0000244|PDB:1FPR}.
FT   STRAND      371    374       {ECO:0000244|PDB:4GRZ}.
FT   STRAND      377    386       {ECO:0000244|PDB:4GRZ}.
FT   STRAND      388    399       {ECO:0000244|PDB:4GRZ}.
FT   HELIX       400    402       {ECO:0000244|PDB:2B3O}.
FT   STRAND      403    405       {ECO:0000244|PDB:1FPR}.
FT   STRAND      407    414       {ECO:0000244|PDB:4GRZ}.
FT   STRAND      419    421       {ECO:0000244|PDB:2B3O}.
FT   STRAND      424    426       {ECO:0000244|PDB:4GRZ}.
FT   HELIX       427    442       {ECO:0000244|PDB:4GRZ}.
FT   STRAND      443    445       {ECO:0000244|PDB:4HJQ}.
FT   STRAND      449    452       {ECO:0000244|PDB:4GRZ}.
FT   STRAND      454    457       {ECO:0000244|PDB:4GRZ}.
FT   HELIX       458    476       {ECO:0000244|PDB:4GRZ}.
FT   HELIX       484    492       {ECO:0000244|PDB:4GRZ}.
FT   HELIX       502    523       {ECO:0000244|PDB:4GRZ}.
SQ   SEQUENCE   595 AA;  67561 MW;  4D7736C21D3542D2 CRC64;
     MVRWFHRDLS GLDAETLLKG RGVHGSFLAR PSRKNQGDFS LSVRVGDQVT HIRIQNSGDF
     YDLYGGEKFA TLTELVEYYT QQQGVLQDRD GTIIHLKYPL NCSDPTSERW YHGHMSGGQA
     ETLLQAKGEP WTFLVRESLS QPGDFVLSVL SDQPKAGPGS PLRVTHIKVM CEGGRYTVGG
     LETFDSLTDL VEHFKKTGIE EASGAFVYLR QPYYATRVNA ADIENRVLEL NKKQESEDTA
     KAGFWEEFES LQKQEVKNLH QRLEGQRPEN KGKNRYKNIL PFDHSRVILQ GRDSNIPGSD
     YINANYIKNQ LLGPDENAKT YIASQGCLEA TVNDFWQMAW QENSRVIVMT TREVEKGRNK
     CVPYWPEVGM QRAYGPYSVT NCGEHDTTEY KLRTLQVSPL DNGDLIREIW HYQYLSWPDH
     GVPSEPGGVL SFLDQINQRQ ESLPHAGPII VHCSAGIGRT GTIIVIDMLM ENISTKGLDC
     DIDIQKTIQM VRAQRSGMVQ TEAQYKFIYV AIAQFIETTK KKLEVLQSQK GQESEYGNIT
     YPPAMKNAHA KASRTSSKHK EDVYENLHTK NKREEKVKKQ RSADKEKSKG SLKRK
//
ID   Q53XS4_HUMAN            Unreviewed;       597 AA.
AC   Q53XS4;
DT   24-MAY-2005, integrated into UniProtKB/TrEMBL.
DT   24-MAY-2005, sequence version 1.
DT   13-FEB-2019, entry version 138.
DE   RecName: Full=Tyrosine-protein phosphatase non-receptor type {ECO:0000256|PIRNR:PIRNR000929};
DE            EC=3.1.3.48 {ECO:0000256|PIRNR:PIRNR000929};
GN   Name=PTPN6 {ECO:0000313|EMBL:EAW88702.1};
GN   ORFNames=hCG_25941 {ECO:0000313|EMBL:EAW88702.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAP36054.1};
RN   [1] {ECO:0000313|EMBL:EAW88702.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:AAP36054.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) System Donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:EAW88702.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:BAG36177.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Liver {ECO:0000313|EMBL:BAG36177.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Kaida T., Tsuchiya K., Iida Y.,
RA   Takayama Y., Murakawa K., Kanehori K., Andoh T., Kagawa N., Sato R.,
RA   Kawamura Y., Tanaka S., Kisu Y., Sugano S., Goshima N., Nomura N.,
RA   Isogai T.;
RT   "NEDO functional analysis of protein and research application
RT   project.";
RL   Submitted (JAN-2008) to the EMBL/GenBank/DDBJ databases.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + O-phospho-L-tyrosyl-[protein] = L-tyrosyl-[protein]
CC         + phosphate; Xref=Rhea:RHEA:10684, Rhea:RHEA-COMP:10136,
CC         Rhea:RHEA-COMP:10137, ChEBI:CHEBI:15377, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:46858, ChEBI:CHEBI:82620; EC=3.1.3.48;
CC         Evidence={ECO:0000256|PIRNR:PIRNR000929,
CC         ECO:0000256|SAAS:SAAS01128831};
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|PIRNR:PIRNR000929}.
CC   -!- SIMILARITY: Belongs to the protein-tyrosine phosphatase family.
CC       Non-receptor class 2 subfamily. {ECO:0000256|PIRNR:PIRNR000929}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; BT007390; AAP36054.1; -; mRNA.
DR   EMBL; AK313379; BAG36177.1; -; mRNA.
DR   EMBL; CH471116; EAW88702.1; -; Genomic_DNA.
DR   RefSeq; NP_536858.1; NM_080548.4.
DR   RefSeq; XP_011519290.1; XM_011520988.1.
DR   UniGene; Hs.63489; -.
DR   DNASU; 5777; -.
DR   GeneID; 5777; -.
DR   UCSC; uc001qsa.1; human.
DR   CTD; 5777; -.
DR   EuPathDB; HostDB:ENSG00000111679.16; -.
DR   PharmGKB; PA34002; -.
DR   eggNOG; KOG0790; Eukaryota.
DR   eggNOG; COG5599; LUCA.
DR   HOGENOM; HOG000273907; -.
DR   HOVERGEN; HBG000223; -.
DR   OrthoDB; 411281at2759; -.
DR   ChiTaRS; PTPN6; human.
DR   GenomeRNAi; 5777; -.
DR   Bgee; ENSG00000111679; Expressed in 217 organ(s), highest expression level in blood.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; IEA:UniProtKB-EC.
DR   Gene3D; 3.30.505.10; -; 2.
DR   Gene3D; 3.90.190.10; -; 1.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR000242; PTPase_domain.
DR   InterPro; IPR000980; SH2.
DR   InterPro; IPR036860; SH2_dom_sf.
DR   InterPro; IPR016130; Tyr_Pase_AS.
DR   InterPro; IPR003595; Tyr_Pase_cat.
DR   InterPro; IPR012152; Tyr_Pase_non-rcpt_typ-6/11.
DR   InterPro; IPR000387; TYR_PHOSPHATASE_dom.
DR   Pfam; PF00017; SH2; 2.
DR   Pfam; PF00102; Y_phosphatase; 1.
DR   PIRSF; PIRSF000929; Tyr-Ptase_nr_6; 1.
DR   PRINTS; PR00700; PRTYPHPHTASE.
DR   PRINTS; PR00401; SH2DOMAIN.
DR   SMART; SM00194; PTPc; 1.
DR   SMART; SM00404; PTPc_motif; 1.
DR   SMART; SM00252; SH2; 2.
DR   SUPFAM; SSF52799; SSF52799; 1.
DR   SUPFAM; SSF55550; SSF55550; 2.
DR   PROSITE; PS50001; SH2; 2.
DR   PROSITE; PS00383; TYR_PHOSPHATASE_1; 1.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 1.
DR   PROSITE; PS50055; TYR_PHOSPHATASE_PTP; 1.
PE   2: Evidence at transcript level;
KW   Cytoplasm {ECO:0000256|PIRNR:PIRNR000929};
KW   Hydrolase {ECO:0000256|PIRNR:PIRNR000929,
KW   ECO:0000256|SAAS:SAAS01031415};
KW   Protein phosphatase {ECO:0000256|PIRNR:PIRNR000929,
KW   ECO:0000256|SAAS:SAAS01031415};
KW   Receptor {ECO:0000313|EMBL:AAP36054.1};
KW   SH2 domain {ECO:0000256|PROSITE-ProRule:PRU00191}.
FT   DOMAIN        6    102       SH2. {ECO:0000259|PROSITE:PS50001}.
FT   DOMAIN      112    215       SH2. {ECO:0000259|PROSITE:PS50001}.
FT   DOMAIN      246    517       Tyrosine-protein phosphatase.
FT                                {ECO:0000259|PROSITE:PS50055}.
FT   DOMAIN      432    508       TYR_PHOSPHATASE_2.
FT                                {ECO:0000259|PROSITE:PS50056}.
FT   ACT_SITE    455    455       Phosphocysteine intermediate.
FT                                {ECO:0000256|PIRSR:PIRSR000929-1,
FT                                ECO:0000256|PROSITE-ProRule:PRU00160}.
FT   BINDING     421    421       Substrate.
FT                                {ECO:0000256|PIRSR:PIRSR000929-2}.
FT   BINDING     502    502       Substrate.
FT                                {ECO:0000256|PIRSR:PIRSR000929-2}.
SQ   SEQUENCE   597 AA;  67719 MW;  6A291A2860159389 CRC64;
     MLSRGWFHRD LSGLDAETLL KGRGVHGSFL ARPSRKNQGD FSLSVRVGDQ VTHIRIQNSG
     DFYDLYGGEK FATLTELVEY YTQQQGVLQD RDGTIIHLKY PLNCSDPTSE RWYHGHMSGG
     QAETLLQAKG EPWTFLVRES LSQPGDFVLS VLSDQPKAGP GSPLRVTHIK VMCEGGRYTV
     GGLETFDSLT DLVEHFKKTG IEEASGAFVY LRQPYYATRV NAADIENRVL ELNKKQESED
     TAKAGFWEEF ESLQKQEVKN LHQRLEGQRP ENKGKNRYKN ILPFDHSRVI LQGRDSNIPG
     SDYINANYIK NQLLGPDENA KTYIASQGCL EATVNDFWQM AWQENSRVIV MTTREVEKGR
     NKCVPYWPEV GMQRAYGPYS VTNCGEHDTT EYKLRTLQVS PLDNGDLIRE IWHYQYLSWP
     DHGVPSEPGG VLSFLDQINQ RQESLPHAGP IIVHCSAGIG RTGTIIVIDM LMENISTKGL
     DCDIDIQKTI QMVRAQRSGM VQTEAQYKFI YVAIAQFIET TKKKLEVLQS QKGQESEYGN
     ITYPPAMKNA HAKASRTSSK HKEDVYENLH TKNKREEKVK KQRSADKEKS KGSLKRK
//
ID   PTPRD_HUMAN             Reviewed;        1912 AA.
AC   P23468; B1ALA0; F5GWT7; Q3KPJ0; Q3KPJ1; Q3KPJ2;
DT   01-NOV-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 2.
DT   13-FEB-2019, entry version 201.
DE   RecName: Full=Receptor-type tyrosine-protein phosphatase delta;
DE            Short=Protein-tyrosine phosphatase delta;
DE            Short=R-PTP-delta;
DE            EC=3.1.3.48;
DE   Flags: Precursor;
GN   Name=PTPRD;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), CLEAVAGE SITE, AND MUTAGENESIS
RP   OF ARG-1178 AND ARG-1181.
RX   PubMed=7896816; DOI=10.1074/jbc.270.12.6722;
RA   Pulido R., Krueger N.X., Serra-Pages C., Saito H., Streuli M.;
RT   "Molecular characterization of the human transmembrane protein-
RT   tyrosine phosphatase delta. Evidence for tissue-specific expression of
RT   alternative human transmembrane protein-tyrosine phosphatase delta
RT   isoforms.";
RL   J. Biol. Chem. 270:6722-6728(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 4; 5 AND 6).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 390-1912.
RC   TISSUE=Placenta;
RX   PubMed=2170109;
RA   Krueger N.X., Streuli M., Saito H.;
RT   "Structural diversity and evolution of human receptor-like protein
RT   tyrosine phosphatases.";
RL   EMBO J. 9:3241-3252(1990).
RN   [5]
RP   INTERACTION WITH PPFIA1; PPFIA2 AND PPFIA3.
RX   PubMed=9624153; DOI=10.1074/jbc.273.25.15611;
RA   Serra-Pages C., Medley Q.G., Tang M., Hart A., Streuli M.;
RT   "Liprins, a family of LAR transmembrane protein-tyrosine phosphatase-
RT   interacting proteins.";
RL   J. Biol. Chem. 273:15611-15620(1998).
RN   [6]
RP   SPLICE ISOFORM(S) THAT ARE POTENTIAL NMD TARGET(S).
RX   PubMed=14759258; DOI=10.1186/gb-2004-5-2-r8;
RA   Hillman R.T., Green R.E., Brenner S.E.;
RT   "An unappreciated role for RNA surveillance.";
RL   Genome Biol. 5:R8.1-R8.16(2004).
RN   [7]
RP   STRUCTURE BY NMR OF 405-607.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the second and third FN3 domain of human
RT   receptor-type tyrosine-protein phosphatase delta.";
RL   Submitted (OCT-2006) to the PDB data bank.
RN   [8]
RP   VARIANTS [LARGE SCALE ANALYSIS] GLN-28; PRO-276 AND ALA-901.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Can bidirectionally induce pre- and post-synaptic
CC       differentiation of neurons by mediating interaction with IL1RAP
CC       and IL1RAPL1 trans-synaptically. Involved in pre-synaptic
CC       differentiation through interaction with SLITRK2.
CC       {ECO:0000250|UniProtKB:Q64487}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + O-phospho-L-tyrosyl-[protein] = L-tyrosyl-[protein]
CC         + phosphate; Xref=Rhea:RHEA:10684, Rhea:RHEA-COMP:10136,
CC         Rhea:RHEA-COMP:10137, ChEBI:CHEBI:15377, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:46858, ChEBI:CHEBI:82620; EC=3.1.3.48;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU10044};
CC   -!- SUBUNIT: Interacts with PPFIA1, PPFIA2 and PPFIA3
CC       (PubMed:9624153). Interacts (via extracellular domain) with
CC       SLITRK4 (via LRR 1 and 2 repeats). Interacts with SLITRK2; induces
CC       presynaptic differentiation. Interacts (via the second
CC       immunoglobilin domain) with IL1RAPL1 (via the first immunoglobilin
CC       domain); induces pre- and postsynaptic differentiation of neurons
CC       and synapse formation. Interacts (via the third immunoglobilin
CC       domain) with IL1RAP (via the first immunoglobilin domain); induces
CC       pre- and postsynaptic differentiation of neurons (By similarity).
CC       {ECO:0000250|UniProtKB:Q64487, ECO:0000269|PubMed:9624153}.
CC   -!- INTERACTION:
CC       O14965:AURKA; NbExp=2; IntAct=EBI-2682990, EBI-448680;
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=7;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1;
CC         IsoId=P23468-1; Sequence=Displayed;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay.;
CC       Name=2; Synonyms=Kidney;
CC         IsoId=P23468-2; Sequence=VSP_005147, VSP_005148, VSP_005149;
CC       Name=3; Synonyms=Fetal brain;
CC         IsoId=P23468-3; Sequence=VSP_005150;
CC       Name=4;
CC         IsoId=P23468-4; Sequence=VSP_043384, VSP_043385, VSP_043386,
CC                                  VSP_043387, VSP_043390;
CC         Note=No experimental confirmation available.;
CC       Name=5;
CC         IsoId=P23468-5; Sequence=VSP_043386, VSP_043387, VSP_043388;
CC         Note=No experimental confirmation available.;
CC       Name=6;
CC         IsoId=P23468-6; Sequence=VSP_043386, VSP_043387, VSP_043389;
CC         Note=No experimental confirmation available.;
CC       Name=7;
CC         IsoId=P23468-7; Sequence=VSP_054220, VSP_054221, VSP_043388;
CC   -!- PTM: A cleavage occurs, separating the extracellular domain from
CC       the transmembrane segment. This process called 'ectodomain
CC       shedding' is thought to be involved in receptor desensitization,
CC       signal transduction and/or membrane localization.
CC       {ECO:0000269|PubMed:7896816}.
CC   -!- SIMILARITY: Belongs to the protein-tyrosine phosphatase family.
CC       Receptor class 2A subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/PTPRDID41927ch9p23.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; L38929; AAC41749.1; -; mRNA.
DR   EMBL; AL137125; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL356584; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL445926; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL583805; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL590397; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL133479; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL135790; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL137069; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL137851; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL157826; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL353638; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL353733; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL354722; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL356054; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL390723; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL391864; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL441884; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL451130; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL513422; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL590307; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL591133; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL591622; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL596451; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL669908; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC106713; AAI06714.1; -; mRNA.
DR   EMBL; BC106714; AAI06715.1; -; mRNA.
DR   EMBL; BC106715; AAI06716.1; -; mRNA.
DR   EMBL; X54133; CAA38068.1; -; mRNA.
DR   CCDS; CCDS43786.1; -. [P23468-1]
DR   CCDS; CCDS55288.1; -. [P23468-7]
DR   CCDS; CCDS55289.1; -. [P23468-4]
DR   CCDS; CCDS55290.1; -. [P23468-6]
DR   CCDS; CCDS6472.2; -. [P23468-5]
DR   PIR; A56178; A56178.
DR   RefSeq; NP_001164496.1; NM_001171025.1. [P23468-4]
DR   RefSeq; NP_002830.1; NM_002839.3. [P23468-1]
DR   RefSeq; NP_569075.2; NM_130391.3. [P23468-5]
DR   RefSeq; NP_569076.2; NM_130392.3. [P23468-6]
DR   RefSeq; XP_006716895.1; XM_006716832.3. [P23468-4]
DR   RefSeq; XP_006716896.1; XM_006716833.3. [P23468-5]
DR   RefSeq; XP_006716898.1; XM_006716835.3. [P23468-7]
DR   RefSeq; XP_011516294.1; XM_011517992.2. [P23468-1]
DR   RefSeq; XP_016870480.1; XM_017014991.1. [P23468-6]
DR   UniGene; Hs.446083; -.
DR   PDB; 1X5Z; NMR; -; A=506-607.
DR   PDB; 2DLH; NMR; -; A=407-514.
DR   PDB; 2YD6; X-ray; 1.35 A; A=21-226.
DR   PDB; 2YD7; X-ray; 1.98 A; A/B=21-226.
DR   PDB; 4RCA; X-ray; 2.99 A; A=21-322.
DR   PDB; 5WY8; X-ray; 3.07 A; A=21-318.
DR   PDB; 5XNP; X-ray; 3.73 A; D/E=21-320.
DR   PDBsum; 1X5Z; -.
DR   PDBsum; 2DLH; -.
DR   PDBsum; 2YD6; -.
DR   PDBsum; 2YD7; -.
DR   PDBsum; 4RCA; -.
DR   PDBsum; 5WY8; -.
DR   PDBsum; 5XNP; -.
DR   ProteinModelPortal; P23468; -.
DR   SMR; P23468; -.
DR   BioGrid; 111753; 80.
DR   DIP; DIP-17023N; -.
DR   IntAct; P23468; 24.
DR   MINT; P23468; -.
DR   STRING; 9606.ENSP00000348812; -.
DR   DEPOD; P23468; -.
DR   iPTMnet; P23468; -.
DR   PhosphoSitePlus; P23468; -.
DR   BioMuta; PTPRD; -.
DR   DMDM; 1709906; -.
DR   EPD; P23468; -.
DR   jPOST; P23468; -.
DR   MaxQB; P23468; -.
DR   PaxDb; P23468; -.
DR   PeptideAtlas; P23468; -.
DR   PRIDE; P23468; -.
DR   ProteomicsDB; 54101; -.
DR   ProteomicsDB; 54102; -. [P23468-2]
DR   ProteomicsDB; 54103; -. [P23468-3]
DR   ProteomicsDB; 54104; -. [P23468-4]
DR   ProteomicsDB; 54105; -. [P23468-5]
DR   ProteomicsDB; 54106; -. [P23468-6]
DR   Ensembl; ENST00000355233; ENSP00000347373; ENSG00000153707. [P23468-6]
DR   Ensembl; ENST00000356435; ENSP00000348812; ENSG00000153707. [P23468-1]
DR   Ensembl; ENST00000381196; ENSP00000370593; ENSG00000153707. [P23468-1]
DR   Ensembl; ENST00000397606; ENSP00000380731; ENSG00000153707. [P23468-4]
DR   Ensembl; ENST00000397611; ENSP00000380735; ENSG00000153707. [P23468-7]
DR   Ensembl; ENST00000486161; ENSP00000417093; ENSG00000153707. [P23468-5]
DR   Ensembl; ENST00000540109; ENSP00000438164; ENSG00000153707. [P23468-1]
DR   Ensembl; ENST00000634556; ENSP00000489063; ENSG00000282932. [P23468-1]
DR   Ensembl; ENST00000634583; ENSP00000489509; ENSG00000282932. [P23468-5]
DR   Ensembl; ENST00000634608; ENSP00000489257; ENSG00000282932. [P23468-1]
DR   Ensembl; ENST00000635012; ENSP00000489439; ENSG00000282932. [P23468-1]
DR   Ensembl; ENST00000635279; ENSP00000488982; ENSG00000282932. [P23468-4]
DR   Ensembl; ENST00000635611; ENSP00000489155; ENSG00000282932. [P23468-7]
DR   Ensembl; ENST00000635613; ENSP00000489038; ENSG00000282932. [P23468-6]
DR   GeneID; 5789; -.
DR   KEGG; hsa:5789; -.
DR   UCSC; uc003zkp.4; human. [P23468-1]
DR   CTD; 5789; -.
DR   DisGeNET; 5789; -.
DR   EuPathDB; HostDB:ENSG00000153707.15; -.
DR   GeneCards; PTPRD; -.
DR   HGNC; HGNC:9668; PTPRD.
DR   HPA; HPA054829; -.
DR   MIM; 601598; gene.
DR   neXtProt; NX_P23468; -.
DR   OpenTargets; ENSG00000153707; -.
DR   PharmGKB; PA34013; -.
DR   eggNOG; KOG4228; Eukaryota.
DR   eggNOG; COG5599; LUCA.
DR   GeneTree; ENSGT00940000153617; -.
DR   HOGENOM; HOG000010250; -.
DR   HOVERGEN; HBG053758; -.
DR   InParanoid; P23468; -.
DR   KO; K06777; -.
DR   OMA; EVWWEPV; -.
DR   OrthoDB; 220353at2759; -.
DR   PhylomeDB; P23468; -.
DR   TreeFam; TF312900; -.
DR   BRENDA; 3.1.3.48; 2681.
DR   Reactome; R-HSA-388844; Receptor-type tyrosine-protein phosphatases.
DR   Reactome; R-HSA-8849932; Synaptic adhesion-like molecules.
DR   SignaLink; P23468; -.
DR   SIGNOR; P23468; -.
DR   ChiTaRS; PTPRD; human.
DR   EvolutionaryTrace; P23468; -.
DR   GeneWiki; PTPRD; -.
DR   GenomeRNAi; 5789; -.
DR   PRO; PR:P23468; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000153707; Expressed in 196 organ(s), highest expression level in forebrain.
DR   ExpressionAtlas; P23468; baseline and differential.
DR   Genevisible; P23468; HS.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0050839; F:cell adhesion molecule binding; ISS:BHF-UCL.
DR   GO; GO:0005102; F:signaling receptor binding; ISS:BHF-UCL.
DR   GO; GO:0005001; F:transmembrane receptor protein tyrosine phosphatase activity; TAS:ProtInc.
DR   GO; GO:0007157; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; ISS:BHF-UCL.
DR   GO; GO:0030182; P:neuron differentiation; ISS:BHF-UCL.
DR   GO; GO:0006796; P:phosphate-containing compound metabolic process; NAS:ProtInc.
DR   GO; GO:0050775; P:positive regulation of dendrite morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0051965; P:positive regulation of synapse assembly; ISS:UniProtKB.
DR   GO; GO:0097105; P:presynaptic membrane assembly; ISS:BHF-UCL.
DR   GO; GO:0006470; P:protein dephosphorylation; TAS:ProtInc.
DR   GO; GO:0099151; P:regulation of postsynaptic density assembly; IEA:Ensembl.
DR   GO; GO:1905606; P:regulation of presynapse assembly; IDA:SynGO.
DR   GO; GO:0099560; P:synaptic membrane adhesion; IDA:SynGO.
DR   GO; GO:0099545; P:trans-synaptic signaling by trans-synaptic complex; IDA:SynGO.
DR   GO; GO:0007185; P:transmembrane receptor protein tyrosine phosphatase signaling pathway; TAS:ProtInc.
DR   CDD; cd00063; FN3; 8.
DR   Gene3D; 2.60.40.10; -; 11.
DR   Gene3D; 3.90.190.10; -; 2.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR000242; PTPase_domain.
DR   InterPro; IPR016130; Tyr_Pase_AS.
DR   InterPro; IPR003595; Tyr_Pase_cat.
DR   InterPro; IPR000387; TYR_PHOSPHATASE_dom.
DR   Pfam; PF00041; fn3; 7.
DR   Pfam; PF07679; I-set; 2.
DR   Pfam; PF00102; Y_phosphatase; 2.
DR   PRINTS; PR00700; PRTYPHPHTASE.
DR   SMART; SM00060; FN3; 8.
DR   SMART; SM00409; IG; 4.
DR   SMART; SM00408; IGc2; 3.
DR   SMART; SM00194; PTPc; 2.
DR   SMART; SM00404; PTPc_motif; 2.
DR   SUPFAM; SSF48726; SSF48726; 3.
DR   SUPFAM; SSF49265; SSF49265; 5.
DR   SUPFAM; SSF52799; SSF52799; 2.
DR   PROSITE; PS50853; FN3; 8.
DR   PROSITE; PS50835; IG_LIKE; 3.
DR   PROSITE; PS00383; TYR_PHOSPHATASE_1; 2.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 2.
DR   PROSITE; PS50055; TYR_PHOSPHATASE_PTP; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Disulfide bond;
KW   Glycoprotein; Hydrolase; Immunoglobulin domain; Membrane;
KW   Polymorphism; Protein phosphatase; Receptor; Reference proteome;
KW   Repeat; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL        1     20       {ECO:0000255}.
FT   CHAIN        21   1912       Receptor-type tyrosine-protein
FT                                phosphatase delta.
FT                                /FTId=PRO_0000025437.
FT   TOPO_DOM     21   1265       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1266   1290       Helical. {ECO:0000255}.
FT   TOPO_DOM   1291   1912       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       24    114       Ig-like C2-type 1.
FT   DOMAIN      126    224       Ig-like C2-type 2.
FT   DOMAIN      236    318       Ig-like C2-type 3.
FT   DOMAIN      325    415       Fibronectin type-III 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      420    516       Fibronectin type-III 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      518    607       Fibronectin type-III 3.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      612    709       Fibronectin type-III 4.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      714    822       Fibronectin type-III 5.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      823    916       Fibronectin type-III 6.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      921   1016       Fibronectin type-III 7.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN     1020   1106       Fibronectin type-III 8.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN     1357   1612       Tyrosine-protein phosphatase 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00160}.
FT   DOMAIN     1644   1903       Tyrosine-protein phosphatase 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00160}.
FT   REGION      180    189       Interaction with IL1RAPL1. {ECO:0000250}.
FT   REGION      181    189       Mini-exon peptide A9; sufficient for
FT                                interaction with IL1RAPL1.
FT                                {ECO:0000250|UniProtKB:Q64487}.
FT   REGION      227    230       Mini-exon peptide B; required for
FT                                interaction with SLITRK2 and in the
FT                                function in pre-synaptic differentiation;
FT                                Acts as an adjustable linker to control
FT                                relative positions and orientations of
FT                                the PTPRD second and third immunoglobilin
FT                                domains for their simultaneous
FT                                interactions with the first
FT                                immunoglobilin domain of IL1RAPL1 and
FT                                IL1RAP; Modulates affinity for IL1RAPL1
FT                                and IL1RAP.
FT                                {ECO:0000250|UniProtKB:Q64487}.
FT   REGION     1553   1559       Substrate binding. {ECO:0000250}.
FT   ACT_SITE   1553   1553       Phosphocysteine intermediate.
FT                                {ECO:0000250}.
FT   ACT_SITE   1844   1844       Phosphocysteine intermediate.
FT                                {ECO:0000250}.
FT   BINDING    1521   1521       Substrate. {ECO:0000250}.
FT   BINDING    1597   1597       Substrate. {ECO:0000250}.
FT   SITE        266    266       Required for interaction with IL1RAP.
FT                                {ECO:0000250|UniProtKB:Q64487}.
FT   SITE       1181   1182       Cleavage. {ECO:0000305}.
FT   CARBOHYD    254    254       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    299    299       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    724    724       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    832    832       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     45     98       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   DISULFID    147    207       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   DISULFID    257    302       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   VAR_SEQ     181    189       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_005147.
FT   VAR_SEQ     181    183       Missing (in isoform 7). {ECO:0000305}.
FT                                /FTId=VSP_054220.
FT   VAR_SEQ     184    189       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_043384.
FT   VAR_SEQ     226    229       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_005148.
FT   VAR_SEQ     227    230       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_043385.
FT   VAR_SEQ     608   1019       KPSAPPQDISCTSPSSTSILVSWQPPPVEKQNGIITEYSIK
FT                                YTAVDGEDDKPHEILGIPSDTTKYLLEQLEKWTEYRITVTA
FT                                HTDVGPGPESLSVLIRTNEDVPSGPPRKVEVEAVNSTSVKV
FT                                SWRSPVPNKQHGQIRGYQVHYVRMENGEPKGQPMLKDVMLA
FT                                DAQWEFDDTTEHDMIISGLQPETSYSLTVTAYTTKGDGARS
FT                                KPKLVSTTGAVPGKPRLVINHTQMNTALIQWHPPVDTFGPL
FT                                QGYRLKFGRKDMEPLTTLEFSEKEDHFTATDIHKGASYVFR
FT                                LSARNKVGFGEEMVKEISIPEEVPTGFPQNLHSEGTTSTSV
FT                                QLSWQPPVLAERNGIITKYTLLYRDINIPLLPMEQLIVPAD
FT                                TTMTLTGLKPDTTYDVKVRAHTSKGPGPYSPSVQFRTLPVD
FT                                QV -> M (in isoform 7). {ECO:0000305}.
FT                                /FTId=VSP_054221.
FT   VAR_SEQ     608    608       K -> M (in isoform 4, isoform 5 and
FT                                isoform 6).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_043386.
FT   VAR_SEQ     609   1137       Missing (in isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_005150.
FT   VAR_SEQ     609   1019       Missing (in isoform 4, isoform 5 and
FT                                isoform 6).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_043387.
FT   VAR_SEQ     775    783       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_005149.
FT   VAR_SEQ    1291   1291       K -> KSKPD (in isoform 5 and isoform 7).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_043388.
FT   VAR_SEQ    1291   1291       K -> KSSKPD (in isoform 6).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_043389.
FT   VAR_SEQ    1330   1330       G -> GSDDSGYPGNLHSSS (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_043390.
FT   VARIANT      28     28       R -> Q (in a colorectal cancer sample;
FT                                somatic mutation; dbSNP:rs1353675904).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035645.
FT   VARIANT     276    276       L -> P (in a colorectal cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035646.
FT   VARIANT     447    447       Q -> E (in dbSNP:rs10977171).
FT                                /FTId=VAR_024581.
FT   VARIANT     901    901       V -> A (in a colorectal cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035647.
FT   VARIANT     995    995       R -> C (in dbSNP:rs35929428).
FT                                /FTId=VAR_061761.
FT   VARIANT    1078   1078       E -> D (in dbSNP:rs7869444).
FT                                /FTId=VAR_051761.
FT   MUTAGEN    1178   1178       R->A: 2.5-fold reduction in cleavage. 10-
FT                                fold reduction in cleavage; when
FT                                associated with A-1181.
FT                                {ECO:0000269|PubMed:7896816}.
FT   MUTAGEN    1181   1181       R->A: No reduction in cleavage. 10-fold
FT                                reduction in cleavage; when associated
FT                                with A-1178.
FT                                {ECO:0000269|PubMed:7896816}.
FT   STRAND       22     28       {ECO:0000244|PDB:2YD6}.
FT   STRAND       33     36       {ECO:0000244|PDB:2YD6}.
FT   STRAND       41     51       {ECO:0000244|PDB:2YD6}.
FT   STRAND       54     59       {ECO:0000244|PDB:2YD6}.
FT   STRAND       69     74       {ECO:0000244|PDB:2YD6}.
FT   HELIX        75     77       {ECO:0000244|PDB:2YD6}.
FT   STRAND       79     84       {ECO:0000244|PDB:2YD6}.
FT   TURN         89     92       {ECO:0000244|PDB:2YD6}.
FT   STRAND       94    102       {ECO:0000244|PDB:2YD6}.
FT   STRAND      105    116       {ECO:0000244|PDB:2YD6}.
FT   HELIX       118    120       {ECO:0000244|PDB:2YD6}.
FT   STRAND      127    130       {ECO:0000244|PDB:2YD6}.
FT   STRAND      135    138       {ECO:0000244|PDB:2YD6}.
FT   STRAND      143    150       {ECO:0000244|PDB:2YD6}.
FT   STRAND      156    161       {ECO:0000244|PDB:2YD6}.
FT   STRAND      170    172       {ECO:0000244|PDB:4RCA}.
FT   STRAND      175    180       {ECO:0000244|PDB:2YD6}.
FT   STRAND      184    186       {ECO:0000244|PDB:4RCA}.
FT   STRAND      190    194       {ECO:0000244|PDB:2YD6}.
FT   HELIX       199    201       {ECO:0000244|PDB:2YD6}.
FT   STRAND      203    211       {ECO:0000244|PDB:2YD6}.
FT   STRAND      214    217       {ECO:0000244|PDB:2YD6}.
FT   STRAND      221    226       {ECO:0000244|PDB:2YD6}.
FT   STRAND      234    240       {ECO:0000244|PDB:4RCA}.
FT   STRAND      245    247       {ECO:0000244|PDB:4RCA}.
FT   STRAND      251    263       {ECO:0000244|PDB:4RCA}.
FT   STRAND      266    271       {ECO:0000244|PDB:4RCA}.
FT   HELIX       279    281       {ECO:0000244|PDB:4RCA}.
FT   STRAND      284    294       {ECO:0000244|PDB:4RCA}.
FT   STRAND      298    306       {ECO:0000244|PDB:4RCA}.
FT   STRAND      309    319       {ECO:0000244|PDB:4RCA}.
FT   STRAND      422    426       {ECO:0000244|PDB:2DLH}.
FT   STRAND      430    433       {ECO:0000244|PDB:2DLH}.
FT   STRAND      436    439       {ECO:0000244|PDB:2DLH}.
FT   STRAND      448    454       {ECO:0000244|PDB:2DLH}.
FT   TURN        463    465       {ECO:0000244|PDB:2DLH}.
FT   STRAND      475    477       {ECO:0000244|PDB:2DLH}.
FT   STRAND      487    498       {ECO:0000244|PDB:2DLH}.
FT   STRAND      507    510       {ECO:0000244|PDB:2DLH}.
FT   STRAND      520    525       {ECO:0000244|PDB:1X5Z}.
FT   STRAND      527    537       {ECO:0000244|PDB:1X5Z}.
FT   STRAND      546    549       {ECO:0000244|PDB:1X5Z}.
FT   STRAND      551    556       {ECO:0000244|PDB:1X5Z}.
FT   STRAND      566    573       {ECO:0000244|PDB:1X5Z}.
FT   STRAND      580    583       {ECO:0000244|PDB:1X5Z}.
FT   STRAND      585    588       {ECO:0000244|PDB:1X5Z}.
FT   STRAND      593    596       {ECO:0000244|PDB:1X5Z}.
FT   STRAND      600    603       {ECO:0000244|PDB:1X5Z}.
SQ   SEQUENCE   1912 AA;  214760 MW;  3AE8CBCD32182E26 CRC64;
     MVHVARLLLL LLTFFLRTDA ETPPRFTRTP VDQTGVSGGV ASFICQATGD PRPKIVWNKK
     GKKVSNQRFE VIEFDDGSGS VLRIQPLRTP RDEAIYECVA SNNVGEISVS TRLTVLREDQ
     IPRGFPTIDM GPQLKVVERT RTATMLCAAS GNPDPEITWF KDFLPVDTSN NNGRIKQLRS
     ESIGGTPIRG ALQIEQSEES DQGKYECVAT NSAGTRYSAP ANLYVRELRE VRRVPPRFSI
     PPTNHEIMPG GSVNITCVAV GSPMPYVKWM LGAEDLTPED DMPIGRNVLE LNDVRQSANY
     TCVAMSTLGV IEAIAQITVK ALPKPPGTPV VTESTATSIT LTWDSGNPEP VSYYIIQHKP
     KNSEELYKEI DGVATTRYSV AGLSPYSDYE FRVVAVNNIG RGPPSEPVLT QTSEQAPSSA
     PRDVQARMLS STTILVQWKE PEEPNGQIQG YRVYYTMDPT QHVNNWMKHN VADSQITTIG
     NLVPQKTYSV KVLAFTSIGD GPLSSDIQVI TQTGVPGQPL NFKAEPESET SILLSWTPPR
     SDTIANYELV YKDGEHGEEQ RITIEPGTSY RLQGLKPNSL YYFRLAARSP QGLGASTAEI
     SARTMQSKPS APPQDISCTS PSSTSILVSW QPPPVEKQNG IITEYSIKYT AVDGEDDKPH
     EILGIPSDTT KYLLEQLEKW TEYRITVTAH TDVGPGPESL SVLIRTNEDV PSGPPRKVEV
     EAVNSTSVKV SWRSPVPNKQ HGQIRGYQVH YVRMENGEPK GQPMLKDVML ADAQWEFDDT
     TEHDMIISGL QPETSYSLTV TAYTTKGDGA RSKPKLVSTT GAVPGKPRLV INHTQMNTAL
     IQWHPPVDTF GPLQGYRLKF GRKDMEPLTT LEFSEKEDHF TATDIHKGAS YVFRLSARNK
     VGFGEEMVKE ISIPEEVPTG FPQNLHSEGT TSTSVQLSWQ PPVLAERNGI ITKYTLLYRD
     INIPLLPMEQ LIVPADTTMT LTGLKPDTTY DVKVRAHTSK GPGPYSPSVQ FRTLPVDQVF
     AKNFHVKAVM KTSVLLSWEI PENYNSAMPF KILYDDGKMV EEVDGRATQK LIVNLKPEKS
     YSFVLTNRGN SAGGLQHRVT AKTAPDVLRT KPAFIGKTNL DGMITVQLPE VPANENIKGY
     YIIIVPLKKS RGKFIKPWES PDEMELDELL KEISRKRRSI RYGREVELKP YIAAHFDVLP
     TEFTLGDDKH YGGFTNKQLQ SGQEYVFFVL AVMEHAESKM YATSPYSDPV VSMDLDPQPI
     TDEEEGLIWV VGPVLAVVFI ICIVIAILLY KRKRAESDSR KSSIPNNKEI PSHHPTDPVE
     LRRLNFQTPG MASHPPIPIL ELADHIERLK ANDNLKFSQE YESIDPGQQF TWEHSNLEVN
     KPKNRYANVI AYDHSRVLLS AIEGIPGSDY VNANYIDGYR KQNAYIATQG SLPETFGDFW
     RMIWEQRSAT VVMMTKLEER SRVKCDQYWP SRGTETHGLV QVTLLDTVEL ATYCVRTFAL
     YKNGSSEKRE VRQFQFTAWP DHGVPEHPTP FLAFLRRVKT CNPPDAGPMV VHCSAGVGRT
     GCFIVIDAML ERIKHEKTVD IYGHVTLMRA QRNYMVQTED QYIFIHDALL EAVTCGNTEV
     PARNLYAYIQ KLTQIETGEN VTGMELEFKR LASSKAHTSR FISANLPCNK FKNRLVNIMP
     YESTRVCLQP IRGVEGSDYI NASFIDGYRQ QKAYIATQGP LAETTEDFWR MLWEHNSTIV
     VMLTKLREMG REKCHQYWPA ERSARYQYFV VDPMAEYNMP QYILREFKVT DARDGQSRTV
     RQFQFTDWPE QGVPKSGEGF IDFIGQVHKT KEQFGQDGPI SVHCSAGVGR TGVFITLSIV
     LERMRYEGVV DIFQTVKMLR TQRPAMVQTE DQYQFSYRAA LEYLGSFDHY AT
//
ID   Q2HXI4_HUMAN            Unreviewed;      1912 AA.
AC   Q2HXI4;
DT   21-MAR-2006, integrated into UniProtKB/TrEMBL.
DT   21-MAR-2006, sequence version 1.
DT   13-FEB-2019, entry version 111.
DE   SubName: Full=Protein tyrosine phosphatase receptor type D {ECO:0000313|EMBL:BAE79816.1};
GN   Name=PTPRD {ECO:0000313|EMBL:BAE79816.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAE79816.1};
RN   [1] {ECO:0000313|EMBL:BAE79816.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Sato M., Kohno T., Yokota J.;
RT   "Identification of Chromosome Arm 9p as the Most Frequent Target of
RT   Homozygous Deletions in Lung Cancer.";
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + O-phospho-L-tyrosyl-[protein] = L-tyrosyl-[protein]
CC         + phosphate; Xref=Rhea:RHEA:10684, Rhea:RHEA-COMP:10136,
CC         Rhea:RHEA-COMP:10137, ChEBI:CHEBI:15377, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:46858, ChEBI:CHEBI:82620; EC=3.1.3.48;
CC         Evidence={ECO:0000256|SAAS:SAAS01128831};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AB211400; BAE79816.1; -; mRNA.
DR   RefSeq; NP_002830.1; NM_002839.3.
DR   UniGene; Hs.446083; -.
DR   ProteinModelPortal; Q2HXI4; -.
DR   PeptideAtlas; Q2HXI4; -.
DR   PRIDE; Q2HXI4; -.
DR   GeneID; 5789; -.
DR   KEGG; hsa:5789; -.
DR   CTD; 5789; -.
DR   PharmGKB; PA34013; -.
DR   eggNOG; KOG4228; Eukaryota.
DR   eggNOG; COG5599; LUCA.
DR   HOVERGEN; HBG053758; -.
DR   KO; K06777; -.
DR   OrthoDB; 220353at2759; -.
DR   ChiTaRS; PTPRD; human.
DR   GenomeRNAi; 5789; -.
DR   Genevisible; Q2HXI4; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; IEA:UniProtKB-EC.
DR   CDD; cd00063; FN3; 8.
DR   Gene3D; 2.60.40.10; -; 11.
DR   Gene3D; 3.90.190.10; -; 2.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR000242; PTPase_domain.
DR   InterPro; IPR016130; Tyr_Pase_AS.
DR   InterPro; IPR003595; Tyr_Pase_cat.
DR   InterPro; IPR000387; TYR_PHOSPHATASE_dom.
DR   Pfam; PF00041; fn3; 7.
DR   Pfam; PF07679; I-set; 2.
DR   Pfam; PF00102; Y_phosphatase; 2.
DR   PRINTS; PR00700; PRTYPHPHTASE.
DR   SMART; SM00060; FN3; 8.
DR   SMART; SM00409; IG; 4.
DR   SMART; SM00408; IGc2; 3.
DR   SMART; SM00194; PTPc; 2.
DR   SMART; SM00404; PTPc_motif; 2.
DR   SUPFAM; SSF48726; SSF48726; 3.
DR   SUPFAM; SSF49265; SSF49265; 5.
DR   SUPFAM; SSF52799; SSF52799; 2.
DR   PROSITE; PS50853; FN3; 8.
DR   PROSITE; PS50835; IG_LIKE; 3.
DR   PROSITE; PS00383; TYR_PHOSPHATASE_1; 2.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 2.
DR   PROSITE; PS50055; TYR_PHOSPHATASE_PTP; 2.
PE   2: Evidence at transcript level;
KW   Hydrolase {ECO:0000256|SAAS:SAAS01031415};
KW   Membrane {ECO:0000256|SAAS:SAAS00897767, ECO:0000256|SAM:Phobius};
KW   Protein phosphatase {ECO:0000256|SAAS:SAAS01031415};
KW   Receptor {ECO:0000313|EMBL:BAE79816.1};
KW   Repeat {ECO:0000256|SAAS:SAAS00923712};
KW   Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAAS:SAAS00897767,
KW   ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAAS:SAAS00897767,
KW   ECO:0000256|SAM:Phobius}.
FT   SIGNAL        1     20       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        21   1912       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5004209372.
FT   TRANSMEM   1267   1290       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN       24    114       Ig-like. {ECO:0000259|PROSITE:PS50835}.
FT   DOMAIN      126    224       Ig-like. {ECO:0000259|PROSITE:PS50835}.
FT   DOMAIN      236    318       Ig-like. {ECO:0000259|PROSITE:PS50835}.
FT   DOMAIN      325    415       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN      420    516       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN      518    607       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN      612    709       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN      714    822       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN      823    916       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN      921   1016       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN     1020   1106       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN     1357   1612       Tyrosine-protein phosphatase.
FT                                {ECO:0000259|PROSITE:PS50055}.
FT   DOMAIN     1532   1603       TYR_PHOSPHATASE_2.
FT                                {ECO:0000259|PROSITE:PS50056}.
FT   DOMAIN     1644   1903       Tyrosine-protein phosphatase.
FT                                {ECO:0000259|PROSITE:PS50055}.
FT   DOMAIN     1821   1894       TYR_PHOSPHATASE_2.
FT                                {ECO:0000259|PROSITE:PS50056}.
FT   ACT_SITE   1553   1553       Phosphocysteine intermediate.
FT                                {ECO:0000256|PROSITE-ProRule:PRU00160}.
FT   ACT_SITE   1844   1844       Phosphocysteine intermediate.
FT                                {ECO:0000256|PROSITE-ProRule:PRU00160}.
SQ   SEQUENCE   1912 AA;  214786 MW;  0889DDDA9AD62D2F CRC64;
     MVHVARLLLL LLTFFLRTDA ETPPRFTRTP VDQTGVSGGV ASFICQATGD PRPKIVWNKK
     GKKVSNQRFE VIEFDDGSGS VLRIQPLRTP RDEAIYECVA SNNVGEISVS TRLTVLREDQ
     IPRGFPTIDM GPQLKVVERT RTATMLCAAS GNPDPEITWF KDFLPVDTSN NNGRIKQLRS
     ESIGGTPIRG ALQIEQSEES DQGKYECVAT NSAGTRYSAP ANLYVRELRE VRRVPPRFSI
     PPTNHEIMPG GSVNITCVAV GSPMPYVKWM LGAEDLTPED DMPIGRNVLE LNDVRQSANY
     TCVAMSTLGV IEAIAQITVK PLPKPPGTPV VTESTATSIT LTWDSGNPEP VSYYIIQHKP
     KNSEELYKEI DGVATTRYSV AGLSPYSDYE FRVVAVNNIG RGPPSEPVLT QTSEQAPSSA
     PRDVQARMLS STTILVQWKE PEEPNGQIQG YRVYYTMDPT QHVNNWMKHN VADSQITTIG
     NLVPQKTYSV KVLAFTSIGD GPLSSDIQVI TQTGVPGQPL NFKAEPESET SILLSWTPPR
     SDTIANYELV YKDGEHGEEQ RITIEPGTSY RLQGLKPNSL YYFRLAARSP QGLGASTAEI
     SARTMQSKPS APPQDISCTS PSSTSILVSW QPPPVEKQNG IITEYSIKYT AVDGEDDKPH
     EILGIPSDTT KYLLEQLEKW TEYRITVTAH TDVGPGPESL SVLIRTNEDV PSGPPRKVEV
     EAVNSTSVKV SWRSPVPNKQ HGQIRGYQVH YVRMENGEPK GQPMLKDVML ADAQWEFDDT
     TEHDMIISGL QPETSYSLTV TAYTTKGDGA RSKPKLVSTT GAVPGKPRLV INHTQMNTAL
     IQWHPPVDTF GPLQGYRLKF GRKDMEPLTT LEFSEKEDHF TATDIHKGAS YVFRLSARNK
     VGFGEEMVKE ISIPEEVPTG FPQNLHSEGT TSTSVQLSWQ PPVLAERNGI ITKYTLLYRD
     INIPLLPMEQ LIVPADTTMT LTGLKPDTTY DVKVRAHTSK GPGPYSPSVQ FRTLPVDQVF
     AKNFHVKAVM KTSVLLSWEI PENYNSAMPF KILYDDGKMV EEVDGRATQK LIVNLKPEKS
     YSFVLTNRGN SAGGLQHRVT AKTAPDVLRT KPAFIGKTNL DGMITVQLPE VPANENIKGY
     YIIIVPLKKS RGKFIKPWES PDEMELDELL KEISRKRRSI RYGREVELKP YIAAHFDVLP
     TEFTLGDDKH YGGFTNKQLQ SGQEYVFFVL AVMEHAESKM YATSPYSDPV VSMDLDPQPI
     TDEEEGLIWV VGPVLAVVFI ICIVIAILLY KRKRAESDSR KSSIPNNKEI PSHHPTDPVE
     LRRLNFQTPG MASHPPIPIL ELADHIERLK ANDNLKFSQE YESIDPGQQF TWEHSNLEVN
     KPKNRYANVI AYDHSRVLLS AIEGIPGSDY VNANYIDGYR KQNAYIATQG SLPETFGDFW
     RMIWEQRSAT VVMMTKLEER SRVKCDQYWP SRGTETHGLV QVTLLDTVEL ATYCVRTFAL
     YKNGSSEKRE VRQFQFTAWP DHGVPEHPTP FLAFLRRVKT CNPPDAGPMV VHCSAGVGRT
     GCFIVIDAML ERIKHEKTVD IYGHVTLMRA QRNYMVQTED QYIFIHDALL EAVTCGNTEV
     PARNLYAYIQ KLTQIETGEN VTGMELEFKR LASSKAHTSR FISANLPCNK FKNRLVNIMP
     YESTRVCLQP IRGVEGSDYI NASFIDGYRQ QKAYIATQGP LAETTEDFWR MLWEHNSTIV
     VMLTKLREMG REKCHQYWPA ERSARYQYFV VDPMAEYNMP QYILREFKVT DARDGQSRTV
     RQFQFTDWPE QGVPKSGEGF IDFIGQVHKT KEQFGQDGPI SVHCSAGVGR TGVFITLSIV
     LERMRYEGVV DIFQTVKMLR TQRPAMVQTE DQYQFSYRAA LEYLGSFDHY AT
//
ID   Q3KPI9_HUMAN            Unreviewed;      1496 AA.
AC   Q3KPI9; F5GWY7;
DT   08-NOV-2005, integrated into UniProtKB/TrEMBL.
DT   08-NOV-2005, sequence version 1.
DT   13-FEB-2019, entry version 128.
DE   SubName: Full=PTPRD protein {ECO:0000313|EMBL:AAI06717.1};
DE   SubName: Full=Receptor-type tyrosine-protein phosphatase delta {ECO:0000313|Ensembl:ENSP00000440515};
GN   Name=PTPRD {ECO:0000313|EMBL:AAI06717.1,
GN   ECO:0000313|Ensembl:ENSP00000440515};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAI06717.1};
RN   [1] {ECO:0000313|EMBL:AAI06717.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M.,
RA   Peck A.M., Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S.,
RA   Feolo M., Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F.,
RA   Schaefer C.F., Buetow K., Bonner T.I., Haussler D., Kent J.,
RA   Kiekhaus M., Furey T., Brent M., Prange C., Schreiber K., Shapiro N.,
RA   Bhat N.K., Hopkins R.F., Hsie F., Driscoll T., Soares M.B.,
RA   Casavant T.L., Scheetz T.E., Brown-stein M.J., Usdin T.B.,
RA   Toshiyuki S., Carninci P., Piao Y., Dudekula D.B., Ko M.S.,
RA   Kawakami K., Suzuki Y., Sugano S., Gruber C.E., Smith M.R.,
RA   Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y., Wei C.L.,
RA   Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W., Fuh E.,
RA   Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D.,
RA   Granite S.J., Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G.,
RA   Blakesly R.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J.,
RA   Schmutz J., Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L.,
RA   Krzywinski M.I., Liao N., Morin R., Morrin R., Palmquist D.,
RA   Petrescu A.S., Skalska U., Smailus D.E., Stott J.M., Schnerch A.,
RA   Schein J.E., Jones S.J., Holt R.A., Baross A., Marra M.A., Clifton S.,
RA   Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [2] {ECO:0000313|Ensembl:ENSP00000440515, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [3] {ECO:0000313|Ensembl:ENSP00000440515}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
RN   [4] {ECO:0000313|Ensembl:ENSP00000489264}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (DEC-2015) to UniProtKB.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + O-phospho-L-tyrosyl-[protein] = L-tyrosyl-[protein]
CC         + phosphate; Xref=Rhea:RHEA:10684, Rhea:RHEA-COMP:10136,
CC         Rhea:RHEA-COMP:10137, ChEBI:CHEBI:15377, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:46858, ChEBI:CHEBI:82620; EC=3.1.3.48;
CC         Evidence={ECO:0000256|SAAS:SAAS01128831};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AC245202; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL137125; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL353638; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL356584; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL445926; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL451130; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL583805; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL590397; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL591133; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL596451; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL669908; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC106716; AAI06717.1; -; mRNA.
DR   RefSeq; NP_569077.2; NM_130393.3.
DR   RefSeq; XP_006716900.1; XM_006716837.3.
DR   UniGene; Hs.446083; -.
DR   Ensembl; ENST00000537002; ENSP00000440515; ENSG00000153707.
DR   Ensembl; ENST00000634498; ENSP00000489264; ENSG00000282932.
DR   GeneID; 5789; -.
DR   UCSC; uc003zkr.4; human.
DR   CTD; 5789; -.
DR   EuPathDB; HostDB:ENSG00000153707.15; -.
DR   HGNC; HGNC:9668; PTPRD.
DR   OpenTargets; ENSG00000153707; -.
DR   PharmGKB; PA34013; -.
DR   eggNOG; KOG4228; Eukaryota.
DR   eggNOG; COG5599; LUCA.
DR   GeneTree; ENSGT00940000153617; -.
DR   HOVERGEN; HBG053758; -.
DR   OrthoDB; 220353at2759; -.
DR   ChiTaRS; PTPRD; human.
DR   GenomeRNAi; 5789; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000153707; Expressed in 196 organ(s), highest expression level in forebrain.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; IEA:UniProtKB-EC.
DR   CDD; cd00063; FN3; 4.
DR   Gene3D; 2.60.40.10; -; 7.
DR   Gene3D; 3.90.190.10; -; 2.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR000242; PTPase_domain.
DR   InterPro; IPR016130; Tyr_Pase_AS.
DR   InterPro; IPR003595; Tyr_Pase_cat.
DR   InterPro; IPR000387; TYR_PHOSPHATASE_dom.
DR   Pfam; PF00041; fn3; 3.
DR   Pfam; PF07679; I-set; 2.
DR   Pfam; PF00102; Y_phosphatase; 2.
DR   PRINTS; PR00700; PRTYPHPHTASE.
DR   SMART; SM00060; FN3; 4.
DR   SMART; SM00409; IG; 4.
DR   SMART; SM00408; IGc2; 3.
DR   SMART; SM00194; PTPc; 2.
DR   SMART; SM00404; PTPc_motif; 2.
DR   SUPFAM; SSF48726; SSF48726; 3.
DR   SUPFAM; SSF49265; SSF49265; 3.
DR   SUPFAM; SSF52799; SSF52799; 2.
DR   PROSITE; PS50853; FN3; 4.
DR   PROSITE; PS50835; IG_LIKE; 3.
DR   PROSITE; PS00383; TYR_PHOSPHATASE_1; 2.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 2.
DR   PROSITE; PS50055; TYR_PHOSPHATASE_PTP; 2.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Hydrolase {ECO:0000256|SAAS:SAAS01031415};
KW   Membrane {ECO:0000256|SAAS:SAAS00897767, ECO:0000256|SAM:Phobius};
KW   Protein phosphatase {ECO:0000256|SAAS:SAAS01031415};
KW   Proteomics identification {ECO:0000213|MaxQB:Q3KPI9,
KW   ECO:0000213|PeptideAtlas:Q3KPI9};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Repeat {ECO:0000256|SAAS:SAAS00923712};
KW   Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAAS:SAAS00897767,
KW   ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAAS:SAAS00897767,
KW   ECO:0000256|SAM:Phobius}.
FT   SIGNAL        1     20       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        21   1496       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5014586318.
FT   TRANSMEM    851    874       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN       24    114       Ig-like. {ECO:0000259|PROSITE:PS50835}.
FT   DOMAIN      126    218       Ig-like. {ECO:0000259|PROSITE:PS50835}.
FT   DOMAIN      230    312       Ig-like. {ECO:0000259|PROSITE:PS50835}.
FT   DOMAIN      319    409       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN      414    510       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN      512    601       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN      604    690       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN      941   1196       Tyrosine-protein phosphatase.
FT                                {ECO:0000259|PROSITE:PS50055}.
FT   DOMAIN     1116   1187       TYR_PHOSPHATASE_2.
FT                                {ECO:0000259|PROSITE:PS50056}.
FT   DOMAIN     1228   1487       Tyrosine-protein phosphatase.
FT                                {ECO:0000259|PROSITE:PS50055}.
FT   DOMAIN     1405   1478       TYR_PHOSPHATASE_2.
FT                                {ECO:0000259|PROSITE:PS50056}.
FT   ACT_SITE   1137   1137       Phosphocysteine intermediate.
FT                                {ECO:0000256|PROSITE-ProRule:PRU00160}.
FT   ACT_SITE   1428   1428       Phosphocysteine intermediate.
FT                                {ECO:0000256|PROSITE-ProRule:PRU00160}.
SQ   SEQUENCE   1496 AA;  168666 MW;  BB9C92B895E91FE1 CRC64;
     MVHVARLLLL LLTFFLRTDA ETPPRFTRTP VDQTGVSGGV ASFICQATGD PRPKIVWNKK
     GKKVSNQRFE VIEFDDGSGS VLRIQPLRTP RDEAIYECVA SNNVGEISVS TRLTVLREDQ
     IPRGFPTIDM GPQLKVVERT RTATMLCAAS GNPDPEITWF KDFLPVDTSN NNGRIKQLRS
     ESIGALQIEQ SEESDQGKYE CVATNSAGTR YSAPANLYVR ELREVRRVPP RFSIPPTNHE
     IMPGGSVNIT CVAVGSPMPY VKWMLGAEDL TPEDDMPIGR NVLELNDVRQ SANYTCVAMS
     TLGVIEAIAQ ITVKALPKPP GTPVVTESTA TSITLTWDSG NPEPVSYYII QHKPKNSEEL
     YKEIDGVATT RYSVAGLSPY SDYEFRVVAV NNIGRGPPSE PVLTQTSEQA PSSAPRDVQA
     RMLSSTTILV QWKEPEEPNG QIQGYRVYYT MDPTQHVNNW MKHNVADSQI TTIGNLVPQK
     TYSVKVLAFT SIGDGPLSSD IQVITQTGVP GQPLNFKAEP ESETSILLSW TPPRSDTIAN
     YELVYKDGEH GEEQRITIEP GTSYRLQGLK PNSLYYFRLA ARSPQGLGAS TAEISARTMQ
     STVFAKNFHV KAVMKTSVLL SWEIPENYNS AMPFKILYDD GKMVEEVDGR ATQKLIVNLK
     PEKSYSFVLT NRGNSAGGLQ HRVTAKTAPD VLRTKPAFIG KTNLDGMITV QLPEVPANEN
     IKGYYIIIVP LKKSRGKFIK PWESPDEMEL DELLKEISRK RRSIRYGREV ELKPYIAAHF
     DVLPTEFTLG DDKHYGGFTN KQLQSGQEYV FFVLAVMEHA ESKMYATSPY SDPVVSMDLD
     PQPITDEEEG LIWVVGPVLA VVFIICIVIA ILLYKRKRAE SDSRKSSIPN NKEIPSHHPT
     DPVELRRLNF QTPGMASHPP IPILELADHI ERLKANDNLK FSQEYESIDP GQQFTWEHSN
     LEVNKPKNRY ANVIAYDHSR VLLSAIEGIP GSDYVNANYI DGYRKQNAYI ATQGSLPETF
     GDFWRMIWEQ RSATVVMMTK LEERSRVKCD QYWPSRGTET HGLVQVTLLD TVELATYCVR
     TFALYKNGSS EKREVRQFQF TAWPDHGVPE HPTPFLAFLR RVKTCNPPDA GPMVVHCSAG
     VGRTGCFIVI DAMLERIKHE KTVDIYGHVT LMRAQRNYMV QTEDQYIFIH DALLEAVTCG
     NTEVPARNLY AYIQKLTQIE TGENVTGMEL EFKRLASSKA HTSRFISANL PCNKFKNRLV
     NIMPYESTRV CLQPIRGVEG SDYINASFID GYRQQKAYIA TQGPLAETTE DFWRMLWEHN
     STIVVMLTKL REMGREKCHQ YWPAERSARY QYFVVDPMAE YNMPQYILRE FKVTDARDGQ
     SRTVRQFQFT DWPEQGVPKS GEGFIDFIGQ VHKTKEQFGQ DGPISVHCSA GVGRTGVFIT
     LSIVLERMRY EGVVDIFQTV KMLRTQRPAM VQTEDQYQFS YRAALEYLGS FDHYAT
//
ID   Q59H90_HUMAN            Unreviewed;      1478 AA.
AC   Q59H90;
DT   26-APR-2005, integrated into UniProtKB/TrEMBL.
DT   26-APR-2005, sequence version 1.
DT   16-JAN-2019, entry version 107.
DE   SubName: Full=Protein tyrosine phosphatase, receptor type, D isoform 4 variant {ECO:0000313|EMBL:BAD92106.1};
DE   Flags: Fragment;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAD92106.1};
RN   [1] {ECO:0000313|EMBL:BAD92106.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:BAD92106.1};
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RT   "Homo sapiens protein coding cDNA.";
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AB208869; BAD92106.1; -; mRNA.
DR   RefSeq; NP_001035802.1; NM_001040712.2.
DR   UniGene; Hs.446083; -.
DR   ProteinModelPortal; Q59H90; -.
DR   PeptideAtlas; Q59H90; -.
DR   PRIDE; Q59H90; -.
DR   GeneID; 5789; -.
DR   CTD; 5789; -.
DR   PharmGKB; PA34013; -.
DR   eggNOG; KOG4228; Eukaryota.
DR   eggNOG; COG5599; LUCA.
DR   HOVERGEN; HBG053758; -.
DR   OrthoDB; 220353at2759; -.
DR   GenomeRNAi; 5789; -.
DR   Genevisible; Q59H90; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; IEA:InterPro.
DR   CDD; cd00063; FN3; 4.
DR   Gene3D; 2.60.40.10; -; 7.
DR   Gene3D; 3.90.190.10; -; 2.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR000242; PTPase_domain.
DR   InterPro; IPR016130; Tyr_Pase_AS.
DR   InterPro; IPR003595; Tyr_Pase_cat.
DR   InterPro; IPR000387; TYR_PHOSPHATASE_dom.
DR   Pfam; PF00041; fn3; 3.
DR   Pfam; PF07679; I-set; 2.
DR   Pfam; PF00102; Y_phosphatase; 2.
DR   PRINTS; PR00700; PRTYPHPHTASE.
DR   SMART; SM00060; FN3; 4.
DR   SMART; SM00409; IG; 4.
DR   SMART; SM00408; IGc2; 3.
DR   SMART; SM00194; PTPc; 2.
DR   SMART; SM00404; PTPc_motif; 2.
DR   SUPFAM; SSF48726; SSF48726; 3.
DR   SUPFAM; SSF49265; SSF49265; 3.
DR   SUPFAM; SSF52799; SSF52799; 2.
DR   PROSITE; PS50853; FN3; 4.
DR   PROSITE; PS50835; IG_LIKE; 3.
DR   PROSITE; PS00383; TYR_PHOSPHATASE_1; 2.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 2.
DR   PROSITE; PS50055; TYR_PHOSPHATASE_PTP; 2.
PE   2: Evidence at transcript level;
KW   Hydrolase {ECO:0000256|PROSITE-ProRule:PRU00160};
KW   Membrane {ECO:0000256|SAAS:SAAS00897767, ECO:0000256|SAM:Phobius};
KW   Receptor {ECO:0000313|EMBL:BAD92106.1};
KW   Repeat {ECO:0000256|SAAS:SAAS00923712};
KW   Transmembrane {ECO:0000256|SAAS:SAAS00897767,
KW   ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAAS:SAAS00897767,
KW   ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    829    852       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN        1     90       Ig-like. {ECO:0000259|PROSITE:PS50835}.
FT   DOMAIN      102    197       Ig-like. {ECO:0000259|PROSITE:PS50835}.
FT   DOMAIN      209    291       Ig-like. {ECO:0000259|PROSITE:PS50835}.
FT   DOMAIN      298    388       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN      393    489       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN      491    580       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN      582    668       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN      923   1178       Tyrosine-protein phosphatase.
FT                                {ECO:0000259|PROSITE:PS50055}.
FT   DOMAIN     1098   1169       TYR_PHOSPHATASE_2.
FT                                {ECO:0000259|PROSITE:PS50056}.
FT   DOMAIN     1210   1469       Tyrosine-protein phosphatase.
FT                                {ECO:0000259|PROSITE:PS50055}.
FT   DOMAIN     1387   1460       TYR_PHOSPHATASE_2.
FT                                {ECO:0000259|PROSITE:PS50056}.
FT   ACT_SITE   1119   1119       Phosphocysteine intermediate.
FT                                {ECO:0000256|PROSITE-ProRule:PRU00160}.
FT   ACT_SITE   1410   1410       Phosphocysteine intermediate.
FT                                {ECO:0000256|PROSITE-ProRule:PRU00160}.
FT   NON_TER       1      1       {ECO:0000313|EMBL:BAD92106.1}.
SQ   SEQUENCE   1478 AA;  166527 MW;  7243A931A8CAF631 CRC64;
     RFTRTPVDQT GVSGGVASFI CQATGDPRPK IVWNKKGKKV SNQRFEVIEF DDGSGSVLRI
     QPLRTPRDEA IYECVASNNV GEISVSTRLT VLREDQIPRG FPTIDMGPQL KVVERTRTAT
     MLCAASGNPD PEITWFKDFL PVDTSNNNGR IKQLRSGGTP IRGALQIEQS EESDQGKYEC
     VATNSAGTRY SAPANLYVRE LREVRRVPPR FSIPPTNHEI MPGGSVNITC VAVGSPMPYV
     KWMLGAEDLT PEDDMPIGRN VLELNDVRQS ANYTCVAMST LGVIEAIAQI TVKALPKPPG
     TPVVTESTAT SITLTWDSGN PEPVSYYIIQ HKPKNSEELY KEIDGVATTR YSVAGLSPYS
     DYEFRVVAVN NIGRGPPSEP VLTQTSEQAP SSAPRDVQAR MLSSTTILVQ WKEPEEPNGQ
     IQGYRVYYTM DPTQHVNNWM KHNVADSQIT TIGNLVPQKT YSVKVLAFTS IGDGPLSSDI
     QVITQTGVPG QPLNFKAEPE SETSILLSWT PPRSDTIANY ELVYKDGEHG EEQRITIEPG
     TSYRLQGLKP NSLYYFRLAA RSPQGLGAST AEISARTMQS MFAKNFHVKA VMKTSVLLSW
     EIPENYNSAM PFKILYDDGK MVEEVDGRAT QKLIVNLKPE KSYSFVLTNR GNSAGGLQHR
     VTAKTAPDVL RTKPAFIGKT NLDGMITVQL PEVPANENIK GYYIIIVPLK KSRGKFIKPW
     ESPDEMELDE LLKEISRKRR SIRYGREVEL KPYIAAHFDV LPTEFTLGDD KHYGGFTNKQ
     LQSGQEYVFF VLAVMEHAES KMYATSPYSD PVVSMDLDPQ PITDEEEGLI WVVGPVLAVV
     FIICIVIAIL LYKSKPDRKR AESDSRKSSI PNNKEIPSHH PTDPVELRRL NFQTPGMASH
     PPIPILELAD HIERLKANDN LKFSQEYESI DPGQQFTWEH SNLEVNKPKN RYANVIAYDH
     SRVLLSAIEG IPGSDYVNAN YIDGYRKQNA YIATQGSLPE TFGDFWRMIW EQRSATVVMM
     TKLEERSRVK CDQYWPSRGT ETHGLVQVTL LDTVELATYC VRTFALYKNG SSEKREVRQF
     QFTAWPDHGV PEHPTPFLAF LRRVKTCNPP DAGPMVVHCS AGVGRTGCFI VIDAMLERIK
     HEKTVDIYGH VTLMRAQRNY MVQTEDQYIF IHDALLEAVT CGNTEVPARN LYAYIQKLTQ
     IETGENVTGM ELEFKRLASS KAHTSRFISA NLPCNKFKNR LVNIMPYEST RVCLQPIRGV
     EGSDYINASF IDGYRQQKAY IATQGPLAET TEDFWRMLWE HNSTIVVMLT KLREMGREKC
     HQYWPAERSA RYQYFVVDPM AEYNMPQYIL REFKVTDARD GQSRTVRQFQ FTDWPEQGVP
     KSGEGFIDFI GQVHKTKEQF GQDGPISVHC SAGVGRTGVF ITLSIVLERM RYEGVVDIFQ
     TVKMLRTQRP AMVQTEDQYQ FSYRAALEYL GSFDHYAT
//
ID   RAD17_HUMAN             Reviewed;         681 AA.
AC   O75943; A8K8X2; D3DWA5; O75714; Q7Z3S4; Q9UNK7; Q9UNR7; Q9UNR8;
AC   Q9UPF5;
DT   29-MAR-2005, integrated into UniProtKB/Swiss-Prot.
DT   29-MAR-2005, sequence version 2.
DT   13-FEB-2019, entry version 168.
DE   RecName: Full=Cell cycle checkpoint protein RAD17;
DE            Short=hRad17;
DE   AltName: Full=RF-C/activator 1 homolog;
GN   Name=RAD17; Synonyms=R24L;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=9878245; DOI=10.1006/geno.1998.5587;
RA   Dean F.B., Lian L., O'Donnell M.;
RT   "cDNA cloning and gene mapping of human homologs for
RT   Schizosaccharomyces pombe rad17, rad1, and hus1 and cloning of
RT   homologs from mouse, Caenorhabditis elegans, and Drosophila
RT   melanogaster.";
RL   Genomics 54:424-436(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), TISSUE SPECIFICITY, AND
RP   INTERACTION WITH RAD1.
RC   TISSUE=Neuroblastoma;
RX   PubMed=9660800; DOI=10.1074/jbc.273.29.18340;
RA   Parker A.E., Van de Weyer I., Laus M.C., Verhasselt P.,
RA   Luyten W.H.M.L.;
RT   "Identification of a human homologue of the Schizosaccharomyces pombe
RT   rad17+ checkpoint gene.";
RL   J. Biol. Chem. 273:18340-18346(1998).
RN   [3]
RP   ERRATUM.
RA   Parker A.E., Van de Weyer I., Laus M.C., Verhasselt P.,
RA   Luyten W.H.M.L.;
RL   J. Biol. Chem. 274:24438-24438(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), TISSUE SPECIFICITY,
RP   SUBCELLULAR LOCATION, AND VARIANT ARG-557.
RC   TISSUE=Fibroblast;
RX   PubMed=10232579;
RA   Bao S., Chang M.-S., Auclair D., Sun Y., Wang Y., Wong W.-K.,
RA   Zhang J., Liu Y., Qian X., Sutherland R., Magi-Galluzi C.,
RA   Weisberg E., Cheng E.Y.S., Hao L., Sasaki H., Campbell M.S.,
RA   Kraeft S.-K., Loda M., Lo K.-M., Chen L.B.;
RT   "HRad17, a human homologue of the Schizosaccharomyces pombe checkpoint
RT   gene rad17, is overexpressed in colon carcinoma.";
RL   Cancer Res. 59:2023-2028(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND ALTERNATIVE SPLICING.
RC   TISSUE=Thymus;
RX   PubMed=9933569; DOI=10.1006/geno.1998.5642;
RA   Bluyssen H.A.R., Naus N.C., van Os R.I., Jaspers I.,
RA   Hoeijmakers J.H.J., de Klein A.;
RT   "Human and mouse homologs of the Schizosaccharomyces pombe rad17+ cell
RT   cycle checkpoint control gene.";
RL   Genomics 55:219-228(1999).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 2), AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Fetal brain;
RX   PubMed=10480350; DOI=10.1007/s004399900067;
RA   von Deimling F., Scharf J.M., Liehr T., Rothe M., Kelter A.-R.,
RA   Albers P., Dietrich W.F., Kunkel L.M., Wernert N., Wirth B.;
RT   "Human and mouse RAD17 genes: identification, localization, genomic
RT   structure and histological expression pattern in normal testis and
RT   seminoma.";
RL   Hum. Genet. 105:17-27(1999).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), TISSUE SPECIFICITY, AND
RP   FUNCTION.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=10208430; DOI=10.1038/sj.onc.1202469;
RA   Li L., Peterson C.A., Kanter-Smoler G., Wei Y.-F., Ramagli L.S.,
RA   Sunnerhagen P., Siciliano M.J., Legerski R.J.;
RT   "hRAD17, a structural homolog of the Schizosaccharomyces pombe RAD17
RT   cell cycle checkpoint gene, stimulates p53 accumulation.";
RL   Oncogene 18:1689-1699(1999).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Liver;
RX   PubMed=11715513;
RA   Han Y., Zhu Y.;
RT   "Human hR24L gene is involved in DNA excision repair and recombination
RT   repair.";
RL   Zhonghua Yi Xue Za Zhi 79:941-943(1999).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3 AND 4), INDUCTION, AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Colon, and Fibroblast;
RX   PubMed=11602352; DOI=10.1016/S0378-1119(01)00692-8;
RA   Chen M.-S., Higashikubo R., Laszlo A., Roti Roti J.;
RT   "Multiple alternative splicing forms of human RAD17 and their
RT   differential response to ionizing radiation.";
RL   Gene 277:145-152(2001).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=11230166; DOI=10.1101/gr.GR1547R;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H.,
RA   Lauber J., Duesterhoeft A., Beyer A., Koehrer K., Strack N.,
RA   Mewes H.-W., Ottenwaelder B., Obermaier B., Tampe J., Heubner D.,
RA   Wambutt R., Korn B., Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and
RT   analysis of 500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Fetal brain;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS ILE-32; LEU-487;
RP   GLU-535 AND ARG-557.
RG   NIEHS SNPs program;
RL   Submitted (APR-2004) to the EMBL/GenBank/DDBJ databases.
RN   [14]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [15]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT
RP   ARG-557.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [16]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH SNU13.
RX   PubMed=10593953; DOI=10.1074/jbc.274.51.36544;
RA   Chang M.-S., Sasaki H., Campbell M.S., Kraeft S.-K., Sutherland R.,
RA   Yang C.-Y., Liu Y., Auclair D., Hao L., Sonoda H., Ferland L.H.,
RA   Chen L.B.;
RT   "HRad17 colocalizes with NHP2L1 in the nucleolus and redistributes
RT   after UV irradiation.";
RL   J. Biol. Chem. 274:36544-36549(1999).
RN   [17]
RP   INTERACTION WITH THE RAD1/RAD9/HUS1 COMPLEX AND RFC3, AND MUTAGENESIS
RP   OF LYS-143.
RX   PubMed=10884395; DOI=10.1074/jbc.M005782200;
RA   Rauen M., Burtelow M.A., Dufault V.M., Karnitz L.M.;
RT   "The human checkpoint protein hRad17 interacts with the PCNA-like
RT   proteins hRad1, hHus1, and hRad9.";
RL   J. Biol. Chem. 275:29767-29771(2000).
RN   [18]
RP   FUNCTION, INTERACTION WITH ATM; ATR AND RAD1, PHOSPHORYLATION AT
RP   SER-646 AND SER-656, AND MUTAGENESIS OF SER-646 AND SER-656.
RX   PubMed=11418864; DOI=10.1038/35082110;
RA   Bao S., Tibbetts R.S., Brumbaugh K.M., Fang Y., Richardson D.A.,
RA   Ali A., Chen S.M., Abraham R.T., Wang X.-F.;
RT   "ATR/ATM-mediated phosphorylation of human Rad17 is required for
RT   genotoxic stress responses.";
RL   Nature 411:969-974(2001).
RN   [19]
RP   IDENTIFICATION IN A COMPLEX WITH RFC2; RFC3; RFC4 AND RFC5.
RX   PubMed=11572977; DOI=10.1073/pnas.201373498;
RA   Lindsey-Boltz L.A., Bermudez V.P., Hurwitz J., Sancar A.;
RT   "Purification and characterization of human DNA damage checkpoint Rad
RT   complexes.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:11236-11241(2001).
RN   [20]
RP   FUNCTION, PHOSPHORYLATION AT SER-646 AND SER-656, INTERACTION WITH
RP   RFC4, AND MUTAGENESIS OF SER-191; SER-646 AND SER-656.
RX   PubMed=11687627; DOI=10.1073/pnas.231364598;
RA   Post S.M., Weng Y.-C., Cimprich K., Chen L.B., Xu Y., Lee E.Y.-H.P.;
RT   "Phosphorylation of serines 635 and 645 of human Rad17 is cell cycle
RT   regulated and is required for G(1)/S checkpoint activation in response
RT   to DNA damage.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:13102-13107(2001).
RN   [21]
RP   FUNCTION, PHOSPHORYLATION, MUTAGENESIS OF LYS-143, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=11799063; DOI=10.1101/gad.950302;
RA   Zou L., Cortez D., Elledge S.J.;
RT   "Regulation of ATR substrate selection by Rad17-dependent loading of
RT   Rad9 complexes onto chromatin.";
RL   Genes Dev. 16:198-208(2002).
RN   [22]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH RFC4.
RX   PubMed=12400013; DOI=10.1038/sj.onc.1205872;
RA   Dahm K., Huebscher U.;
RT   "Colocalization of human Rad17 and PCNA in late S phase of the cell
RT   cycle upon replication block.";
RL   Oncogene 21:7710-7719(2002).
RN   [23]
RP   FUNCTION.
RX   PubMed=12672690; DOI=10.1101/gad.1065103;
RA   Wang X., Zou L., Zheng H., Wei Q., Elledge S.J., Li L.;
RT   "Genomic instability and endoreduplication triggered by RAD17
RT   deletion.";
RL   Genes Dev. 17:965-970(2003).
RN   [24]
RP   INTERACTION WITH RAD9B.
RX   PubMed=14611806; DOI=10.1016/S0888-7543(03)00200-3;
RA   Dufault V.M., Oestreich A.J., Vroman B.T., Karnitz L.M.;
RT   "Identification and characterization of RAD9B, a paralog of the RAD9
RT   checkpoint gene.";
RL   Genomics 82:644-651(2003).
RN   [25]
RP   FUNCTION, PHOSPHORYLATION AT SER-646 AND SER-656, MUTAGENESIS OF
RP   SER-646 AND SER-656, AND INTERACTION WITH POLE.
RX   PubMed=14500819; DOI=10.1093/nar/gkg765;
RA   Post S.M., Tomkinson A.E., Lee E.Y.-H.P.;
RT   "The human checkpoint Rad protein Rad17 is chromatin-associated
RT   throughout the cell cycle, localizes to DNA replication sites, and
RT   interacts with DNA polymerase epsilon.";
RL   Nucleic Acids Res. 31:5568-5575(2003).
RN   [26]
RP   FUNCTION, INTERACTION WITH RFC2; RFC3; RFC4 AND RFC5, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=14624239; DOI=10.1371/journal.pbio.0000033;
RA   Ellison V., Stillman B.;
RT   "Biochemical characterization of DNA damage checkpoint complexes:
RT   clamp loader and clamp complexes with specificity for 5' recessed
RT   DNA.";
RL   PLoS Biol. 1:231-243(2003).
RN   [27]
RP   FUNCTION, AND INTERACTION WITH RAD1 AND RAD9.
RX   PubMed=12578958; DOI=10.1073/pnas.0437927100;
RA   Bermudez V.P., Lindsey-Boltz L.A., Cesare A.J., Maniwa Y.,
RA   Griffith J.D., Hurwitz J., Sancar A.;
RT   "Loading of the human 9-1-1 checkpoint complex onto DNA by the
RT   checkpoint clamp loader hRad17-replication factor C complex in
RT   vitro.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:1633-1638(2003).
RN   [28]
RP   INTERACTION WITH PPP5C, AND PHOSPHORYLATION AT SER-646.
RX   PubMed=14871926; DOI=10.1101/gad.1176004;
RA   Ali A., Zhang J., Bao S., Liu I., Otterness D., Dean N.M.,
RA   Abraham R.T., Wang X.F.;
RT   "Requirement of protein phosphatase 5 in DNA-damage-induced ATM
RT   activation.";
RL   Genes Dev. 18:249-254(2004).
RN   [29]
RP   FUNCTION, AND INTERACTION WITH MCM7.
RX   PubMed=15538388; DOI=10.1038/sj.emboj.7600463;
RA   Tsao C.-C., Geisen C., Abraham R.T.;
RT   "Interaction between human MCM7 and Rad17 proteins is required for
RT   replication checkpoint signaling.";
RL   EMBO J. 23:4660-4669(2004).
RN   [30]
RP   FUNCTION, AND MUTAGENESIS OF LYS-143; SER-646 AND SER-656.
RX   PubMed=15235112;
RA   Garg R., Callens S., Lim D.-S., Canman C.E., Kastan M.B., Xu B.;
RT   "Chromatin association of rad17 is required for an ataxia
RT   telangiectasia and rad-related kinase-mediated S-phase checkpoint in
RT   response to low-dose ultraviolet radiation.";
RL   Mol. Cancer Res. 2:362-369(2004).
RN   [31]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [32]
RP   FUNCTION.
RX   PubMed=21659603; DOI=10.1126/science.1203430;
RA   Cotta-Ramusino C., McDonald E.R. III, Hurov K., Sowa M.E.,
RA   Harper J.W., Elledge S.J.;
RT   "A DNA damage response screen identifies RHINO, a 9-1-1 and TopBP1
RT   interacting protein required for ATR signaling.";
RL   Science 332:1313-1317(2011).
RN   [33]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-71; SER-86 AND SER-359,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: Essential for sustained cell growth, maintenance of
CC       chromosomal stability, and ATR-dependent checkpoint activation
CC       upon DNA damage. Has a weak ATPase activity required for binding
CC       to chromatin. Participates in the recruitment of the RAD1-RAD9-
CC       HUS1 complex and RHNO1 onto chromatin, and in CHEK1 activation.
CC       May also serve as a sensor of DNA replication progression, and may
CC       be involved in homologous recombination.
CC       {ECO:0000269|PubMed:10208430, ECO:0000269|PubMed:11418864,
CC       ECO:0000269|PubMed:11687627, ECO:0000269|PubMed:11799063,
CC       ECO:0000269|PubMed:12578958, ECO:0000269|PubMed:12672690,
CC       ECO:0000269|PubMed:14500819, ECO:0000269|PubMed:14624239,
CC       ECO:0000269|PubMed:15235112, ECO:0000269|PubMed:15538388,
CC       ECO:0000269|PubMed:21659603}.
CC   -!- SUBUNIT: Part of a DNA-binding complex containing RFC2, RFC3, RFC4
CC       and RFC5. Interacts with RAD1 and RAD9 within the RAD1-RAD9-HUS1
CC       complex. Interacts with RAD9B, POLE, SNU13 and MCM7. DNA damage
CC       promotes interaction with ATR or ATM and disrupts interaction with
CC       the RAD1-RAD9-HUS1 complex. {ECO:0000269|PubMed:10593953,
CC       ECO:0000269|PubMed:10884395, ECO:0000269|PubMed:11418864,
CC       ECO:0000269|PubMed:11572977, ECO:0000269|PubMed:11687627,
CC       ECO:0000269|PubMed:12400013, ECO:0000269|PubMed:12578958,
CC       ECO:0000269|PubMed:14500819, ECO:0000269|PubMed:14611806,
CC       ECO:0000269|PubMed:14624239, ECO:0000269|PubMed:14871926,
CC       ECO:0000269|PubMed:15538388, ECO:0000269|PubMed:9660800}.
CC   -!- INTERACTION:
CC       Q9UM11:FZR1; NbExp=2; IntAct=EBI-968231, EBI-724997;
CC       P49959:MRE11; NbExp=2; IntAct=EBI-968231, EBI-396513;
CC       O60934:NBN; NbExp=5; IntAct=EBI-968231, EBI-494844;
CC       Q92878:RAD50; NbExp=2; IntAct=EBI-968231, EBI-495494;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10232579,
CC       ECO:0000269|PubMed:10593953, ECO:0000269|PubMed:11799063,
CC       ECO:0000269|PubMed:12400013}. Note=Phosphorylated form
CC       redistributes to discrete nuclear foci upon DNA damage.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=Rad17Sp, FM2;
CC         IsoId=O75943-1; Sequence=Displayed;
CC       Name=2; Synonyms=Rad17Sp2, FM1;
CC         IsoId=O75943-2; Sequence=VSP_013308;
CC       Name=3; Synonyms=FM3;
CC         IsoId=O75943-3; Sequence=VSP_013306;
CC       Name=4; Synonyms=FM4;
CC         IsoId=O75943-4; Sequence=VSP_013307, VSP_013309;
CC   -!- TISSUE SPECIFICITY: Overexpressed in various cancer cell lines and
CC       in colon carcinoma (at protein level). Isoform 2 and isoform 3 are
CC       the most abundant isoforms in non irradiated cells (at protein
CC       level). Ubiquitous at low levels. Highly expressed in testis,
CC       where it is expressed within the germinal epithelium of the
CC       seminiferous tubuli. Weakly expressed in seminomas (testicular
CC       tumors). {ECO:0000269|PubMed:10208430,
CC       ECO:0000269|PubMed:10232579, ECO:0000269|PubMed:10480350,
CC       ECO:0000269|PubMed:11602352, ECO:0000269|PubMed:9660800}.
CC   -!- INDUCTION: Isoform 1, isoform 3 and isoform 4 are induced by X-ray
CC       irradiation. {ECO:0000269|PubMed:11602352}.
CC   -!- PTM: Phosphorylated. Phosphorylation on Ser-646 and Ser-656 is
CC       cell cycle-regulated, enhanced by genotoxic stress, and required
CC       for activation of checkpoint signaling. Phosphorylation is
CC       mediated by ATR upon UV or replication arrest, whereas it may be
CC       mediated both by ATR and ATM upon ionizing radiation.
CC       Phosphorylation on both sites is required for interaction with
CC       RAD1 but dispensable for interaction with RFC3 or RFC4.
CC       {ECO:0000269|PubMed:11418864, ECO:0000269|PubMed:11687627,
CC       ECO:0000269|PubMed:11799063, ECO:0000269|PubMed:14500819,
CC       ECO:0000269|PubMed:14871926}.
CC   -!- SIMILARITY: Belongs to the rad17/RAD24 family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/rad17/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AF076838; AAC95520.1; -; mRNA.
DR   EMBL; AJ004977; CAA06251.1; -; mRNA.
DR   EMBL; AF112263; AAD38878.1; -; mRNA.
DR   EMBL; AF085736; AAC36334.1; -; mRNA.
DR   EMBL; AJ001642; CAA04894.1; -; mRNA.
DR   EMBL; AJ131296; CAB46364.1; -; Genomic_DNA.
DR   EMBL; AJ131297; CAB46364.1; JOINED; Genomic_DNA.
DR   EMBL; AJ131298; CAB46364.1; JOINED; Genomic_DNA.
DR   EMBL; AJ131299; CAB46364.1; JOINED; Genomic_DNA.
DR   EMBL; AJ131300; CAB46364.1; JOINED; Genomic_DNA.
DR   EMBL; AJ131301; CAB46364.1; JOINED; Genomic_DNA.
DR   EMBL; AJ131302; CAB46364.1; JOINED; Genomic_DNA.
DR   EMBL; AJ131303; CAB46364.1; JOINED; Genomic_DNA.
DR   EMBL; AJ131304; CAB46364.1; JOINED; Genomic_DNA.
DR   EMBL; AJ131305; CAB46364.1; JOINED; Genomic_DNA.
DR   EMBL; AJ131306; CAB46364.1; JOINED; Genomic_DNA.
DR   EMBL; AJ131307; CAB46364.1; JOINED; Genomic_DNA.
DR   EMBL; AJ131308; CAB46364.1; JOINED; Genomic_DNA.
DR   EMBL; AF017748; AAD01620.1; -; mRNA.
DR   EMBL; AF126424; AAD17334.1; -; mRNA.
DR   EMBL; AF098533; AAC97950.1; -; mRNA.
DR   EMBL; AF098534; AAC97951.1; -; mRNA.
DR   EMBL; AL122068; CAB59244.1; -; mRNA.
DR   EMBL; AK292487; BAF85176.1; -; mRNA.
DR   EMBL; BX537441; CAD97683.1; -; mRNA.
DR   EMBL; AY612854; AAT09763.1; -; Genomic_DNA.
DR   EMBL; CH471137; EAW51283.1; -; Genomic_DNA.
DR   EMBL; CH471137; EAW51284.1; -; Genomic_DNA.
DR   EMBL; CH471137; EAW51285.1; -; Genomic_DNA.
DR   EMBL; CH471137; EAW51286.1; -; Genomic_DNA.
DR   EMBL; CH471137; EAW51288.1; -; Genomic_DNA.
DR   EMBL; BC032304; AAH32304.1; -; mRNA.
DR   CCDS; CCDS4003.1; -. [O75943-1]
DR   CCDS; CCDS4004.1; -. [O75943-2]
DR   CCDS; CCDS4005.1; -. [O75943-4]
DR   CCDS; CCDS47226.1; -. [O75943-3]
DR   PIR; T34548; T34548.
DR   RefSeq; NP_001265551.1; NM_001278622.1. [O75943-2]
DR   RefSeq; NP_002864.1; NM_002873.1. [O75943-2]
DR   RefSeq; NP_579916.1; NM_133338.2. [O75943-2]
DR   RefSeq; NP_579917.1; NM_133339.2. [O75943-1]
DR   RefSeq; NP_579918.1; NM_133340.2. [O75943-3]
DR   RefSeq; NP_579919.1; NM_133341.2. [O75943-4]
DR   RefSeq; NP_579920.1; NM_133342.2. [O75943-2]
DR   RefSeq; NP_579921.1; NM_133343.1. [O75943-2]
DR   RefSeq; NP_579922.1; NM_133344.2. [O75943-2]
DR   RefSeq; XP_016865168.1; XM_017009679.1.
DR   RefSeq; XP_016865169.1; XM_017009680.1.
DR   RefSeq; XP_016865170.1; XM_017009681.1. [O75943-2]
DR   UniGene; Hs.16184; -.
DR   ProteinModelPortal; O75943; -.
DR   BioGrid; 111821; 33.
DR   CORUM; O75943; -.
DR   DIP; DIP-24254N; -.
DR   DIP; DIP-34896N; -.
DR   IntAct; O75943; 16.
DR   MINT; O75943; -.
DR   STRING; 9606.ENSP00000370151; -.
DR   iPTMnet; O75943; -.
DR   PhosphoSitePlus; O75943; -.
DR   BioMuta; RAD17; -.
DR   jPOST; O75943; -.
DR   MaxQB; O75943; -.
DR   PaxDb; O75943; -.
DR   PeptideAtlas; O75943; -.
DR   PRIDE; O75943; -.
DR   ProteomicsDB; 50304; -.
DR   ProteomicsDB; 50305; -. [O75943-2]
DR   ProteomicsDB; 50306; -. [O75943-3]
DR   ProteomicsDB; 50307; -. [O75943-4]
DR   DNASU; 5884; -.
DR   Ensembl; ENST00000282891; ENSP00000282891; ENSG00000152942. [O75943-4]
DR   Ensembl; ENST00000305138; ENSP00000303134; ENSG00000152942. [O75943-2]
DR   Ensembl; ENST00000345306; ENSP00000311227; ENSG00000152942. [O75943-2]
DR   Ensembl; ENST00000354312; ENSP00000346271; ENSG00000152942. [O75943-2]
DR   Ensembl; ENST00000354868; ENSP00000346938; ENSG00000152942. [O75943-2]
DR   Ensembl; ENST00000358030; ENSP00000350725; ENSG00000152942. [O75943-3]
DR   Ensembl; ENST00000361732; ENSP00000355226; ENSG00000152942. [O75943-2]
DR   Ensembl; ENST00000380774; ENSP00000370151; ENSG00000152942. [O75943-1]
DR   Ensembl; ENST00000509734; ENSP00000426191; ENSG00000152942. [O75943-1]
DR   Ensembl; ENST00000521422; ENSP00000427743; ENSG00000152942. [O75943-3]
DR   Ensembl; ENST00000610770; ENSP00000478167; ENSG00000276618.
DR   Ensembl; ENST00000611523; ENSP00000477962; ENSG00000276618.
DR   Ensembl; ENST00000612044; ENSP00000477996; ENSG00000276618.
DR   Ensembl; ENST00000616488; ENSP00000484854; ENSG00000276618.
DR   Ensembl; ENST00000616683; ENSP00000482775; ENSG00000152942. [O75943-2]
DR   Ensembl; ENST00000616759; ENSP00000479160; ENSG00000276618.
DR   Ensembl; ENST00000620889; ENSP00000482371; ENSG00000276618.
DR   GeneID; 5884; -.
DR   KEGG; hsa:5884; -.
DR   UCSC; uc003jwg.4; human. [O75943-1]
DR   CTD; 5884; -.
DR   DisGeNET; 5884; -.
DR   EuPathDB; HostDB:ENSG00000152942.18; -.
DR   GeneCards; RAD17; -.
DR   HGNC; HGNC:9807; RAD17.
DR   HPA; CAB004551; -.
DR   HPA; HPA005448; -.
DR   MIM; 603139; gene.
DR   neXtProt; NX_O75943; -.
DR   OpenTargets; ENSG00000152942; -.
DR   PharmGKB; PA34167; -.
DR   eggNOG; KOG1970; Eukaryota.
DR   eggNOG; COG0470; LUCA.
DR   GeneTree; ENSGT00440000039046; -.
DR   HOVERGEN; HBG059834; -.
DR   InParanoid; O75943; -.
DR   KO; K06662; -.
DR   OMA; AQIAFIQ; -.
DR   OrthoDB; 674169at2759; -.
DR   PhylomeDB; O75943; -.
DR   Reactome; R-HSA-176187; Activation of ATR in response to replication stress.
DR   Reactome; R-HSA-5685938; HDR through Single Strand Annealing (SSA).
DR   Reactome; R-HSA-5693607; Processing of DNA double-strand break ends.
DR   Reactome; R-HSA-5693616; Presynaptic phase of homologous DNA pairing and strand exchange.
DR   Reactome; R-HSA-6804756; Regulation of TP53 Activity through Phosphorylation.
DR   Reactome; R-HSA-69473; G2/M DNA damage checkpoint.
DR   SIGNOR; O75943; -.
DR   ChiTaRS; RAD17; human.
DR   GeneWiki; RAD17; -.
DR   GenomeRNAi; 5884; -.
DR   PRO; PR:O75943; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000152942; Expressed in 234 organ(s), highest expression level in testis.
DR   ExpressionAtlas; O75943; baseline and differential.
DR   Genevisible; O75943; HS.
DR   GO; GO:0000790; C:nuclear chromatin; IBA:GO_Central.
DR   GO; GO:0005730; C:nucleolus; IDA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; TAS:ProtInc.
DR   GO; GO:0031389; C:Rad17 RFC-like complex; IEA:InterPro.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003682; F:chromatin binding; IBA:GO_Central.
DR   GO; GO:0003689; F:DNA clamp loader activity; IEA:InterPro.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; IMP:UniProtKB.
DR   GO; GO:0000077; P:DNA damage checkpoint; IMP:UniProtKB.
DR   GO; GO:0006281; P:DNA repair; TAS:ProtInc.
DR   GO; GO:0006260; P:DNA replication; TAS:Reactome.
DR   GO; GO:0000076; P:DNA replication checkpoint; TAS:ProtInc.
DR   GO; GO:0007093; P:mitotic cell cycle checkpoint; IMP:UniProtKB.
DR   GO; GO:0033314; P:mitotic DNA replication checkpoint; IBA:GO_Central.
DR   GO; GO:0008156; P:negative regulation of DNA replication; IMP:UniProtKB.
DR   GO; GO:0042325; P:regulation of phosphorylation; IMP:UniProtKB.
DR   InterPro; IPR004582; Checkpoint_prot_Rad17_Rad24.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR018324; Rad17/Rad24_fun/met.
DR   PANTHER; PTHR12172; PTHR12172; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   TIGRFAMs; TIGR00602; rad24; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Cell cycle; Complete proteome;
KW   DNA damage; Nucleotide-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome.
FT   CHAIN         1    681       Cell cycle checkpoint protein RAD17.
FT                                /FTId=PRO_0000209948.
FT   NP_BIND     137    144       ATP. {ECO:0000255}.
FT   REGION      432    681       Interaction with MCM7.
FT                                {ECO:0000269|PubMed:15538388}.
FT   MOD_RES      55     55       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q9XT62}.
FT   MOD_RES      71     71       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      86     86       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     359    359       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     646    646       Phosphoserine; by ATR and ATM.
FT                                {ECO:0000269|PubMed:11418864,
FT                                ECO:0000269|PubMed:11687627,
FT                                ECO:0000269|PubMed:14500819,
FT                                ECO:0000269|PubMed:14871926}.
FT   MOD_RES     656    656       Phosphoserine; by ATR and ATM.
FT                                {ECO:0000269|PubMed:11418864,
FT                                ECO:0000269|PubMed:11687627,
FT                                ECO:0000269|PubMed:14500819}.
FT   VAR_SEQ       1    176       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:11602352}.
FT                                /FTId=VSP_013306.
FT   VAR_SEQ       1     97       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:11602352}.
FT                                /FTId=VSP_013307.
FT   VAR_SEQ       1     14       MSKTFLRPKVSSTK -> MNQ (in isoform 2).
FT                                {ECO:0000303|PubMed:10208430,
FT                                ECO:0000303|PubMed:10232579,
FT                                ECO:0000303|PubMed:10480350,
FT                                ECO:0000303|PubMed:11230166,
FT                                ECO:0000303|PubMed:11602352,
FT                                ECO:0000303|PubMed:11715513,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:17974005,
FT                                ECO:0000303|PubMed:9660800,
FT                                ECO:0000303|PubMed:9878245}.
FT                                /FTId=VSP_013308.
FT   VAR_SEQ      98     99       ET -> MN (in isoform 4).
FT                                {ECO:0000303|PubMed:11602352}.
FT                                /FTId=VSP_013309.
FT   VARIANT      32     32       V -> I (in dbSNP:rs17229831).
FT                                {ECO:0000269|Ref.13}.
FT                                /FTId=VAR_021574.
FT   VARIANT     487    487       R -> L (in dbSNP:rs17236478).
FT                                {ECO:0000269|Ref.13}.
FT                                /FTId=VAR_021575.
FT   VARIANT     535    535       K -> E (in dbSNP:rs17236485).
FT                                {ECO:0000269|Ref.13}.
FT                                /FTId=VAR_021576.
FT   VARIANT     557    557       L -> R (in dbSNP:rs1045051).
FT                                {ECO:0000269|PubMed:10232579,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|Ref.13}.
FT                                /FTId=VAR_021577.
FT   MUTAGEN     143    143       K->E: Impairs phosphorylation on S-656.
FT                                Abolishes interaction with the RAD1-RAD9-
FT                                HUS1 complex; does not affect interaction
FT                                with RFC3. {ECO:0000269|PubMed:10884395,
FT                                ECO:0000269|PubMed:11799063,
FT                                ECO:0000269|PubMed:15235112}.
FT   MUTAGEN     143    143       K->G: Impairs phosphorylation. Impairs
FT                                interaction with DNA and the RAD1-RAD9-
FT                                HUS1 complex; does not affect interaction
FT                                with RFC3. {ECO:0000269|PubMed:10884395,
FT                                ECO:0000269|PubMed:11799063,
FT                                ECO:0000269|PubMed:15235112}.
FT   MUTAGEN     191    191       S->A: No effect on phosphorylation by
FT                                ATR. {ECO:0000269|PubMed:11687627}.
FT   MUTAGEN     646    646       S->A: Reduces by 50% phosphorylation by
FT                                ATR, and abolishes interaction with RAD1.
FT                                Abolishes phosphorylation by ATR and
FT                                checkpoint activation without affecting
FT                                interaction with RFC3, RFC4, ATM or ATR;
FT                                when associated with A-656.
FT                                {ECO:0000269|PubMed:11418864,
FT                                ECO:0000269|PubMed:11687627,
FT                                ECO:0000269|PubMed:14500819,
FT                                ECO:0000269|PubMed:15235112}.
FT   MUTAGEN     646    646       S->D: Abolishes interaction with RAD1;
FT                                when associated with D-656.
FT                                {ECO:0000269|PubMed:11418864,
FT                                ECO:0000269|PubMed:11687627,
FT                                ECO:0000269|PubMed:14500819,
FT                                ECO:0000269|PubMed:15235112}.
FT   MUTAGEN     656    656       S->A: Reduces by 50% phosphorylation by
FT                                ATR, and abolishes interaction with RAD1.
FT                                Abolishes phosphorylation by ATR and
FT                                checkpoint activation without affecting
FT                                interaction with RFC3, RFC4, ATM or ATR;
FT                                when associated with A-646.
FT                                {ECO:0000269|PubMed:11418864,
FT                                ECO:0000269|PubMed:11687627,
FT                                ECO:0000269|PubMed:14500819,
FT                                ECO:0000269|PubMed:15235112}.
FT   MUTAGEN     656    656       S->D: Abolishes interaction with RAD1;
FT                                when associated with D-646.
FT                                {ECO:0000269|PubMed:11418864,
FT                                ECO:0000269|PubMed:11687627,
FT                                ECO:0000269|PubMed:14500819,
FT                                ECO:0000269|PubMed:15235112}.
FT   CONFLICT     75     75       I -> V (in Ref. 12; CAD97683).
FT                                {ECO:0000305}.
FT   CONFLICT    187    187       F -> L (in Ref. 5; AAC36334).
FT                                {ECO:0000305}.
FT   CONFLICT    194    194       A -> S (in Ref. 7; AAD01620).
FT                                {ECO:0000305}.
FT   CONFLICT    340    340       L -> P (in Ref. 5; AAC36334).
FT                                {ECO:0000305}.
FT   CONFLICT    445    445       P -> S (in Ref. 5; AAC36334).
FT                                {ECO:0000305}.
FT   CONFLICT    462    462       M -> T (in Ref. 5; AAC36334).
FT                                {ECO:0000305}.
FT   CONFLICT    648    648       N -> D (in Ref. 5; AAC36334).
FT                                {ECO:0000305}.
FT   CONFLICT    672    672       I -> M (in Ref. 5; AAC36334).
FT                                {ECO:0000305}.
SQ   SEQUENCE   681 AA;  77055 MW;  796C2BD48F7995A3 CRC64;
     MSKTFLRPKV SSTKVTDWVD PSFDDFLECS GVSTITATSL GVNNSSHRRK NGPSTLESSR
     FPARKRGNLS SLEQIYGLEN SKEYLSENEP WVDKYKPETQ HELAVHKKKI EEVETWLKAQ
     VLERQPKQGG SILLITGPPG CGKTTTLKIL SKEHGIQVQE WINPVLPDFQ KDDFKGMFNT
     ESSFHMFPYQ SQIAVFKEFL LRATKYNKLQ MLGDDLRTDK KIILVEDLPN QFYRDSHTLH
     EVLRKYVRIG RCPLIFIISD SLSGDNNQRL LFPKEIQEEC SISNISFNPV APTIMMKFLN
     RIVTIEANKN GGKITVPDKT SLELLCQGCS GDIRSAINSL QFSSSKGENN LRPRKKGMSL
     KSDAVLSKSK RRKKPDRVFE NQEVQAIGGK DVSLFLFRAL GKILYCKRAS LTELDSPRLP
     SHLSEYERDT LLVEPEEVVE MSHMPGDLFN LYLHQNYIDF FMEIDDIVRA SEFLSFADIL
     SGDWNTRSLL REYSTSIATR GVMHSNKARG YAHCQGGGSS FRPLHKPQWF LINKKYRENC
     LAAKALFPDF CLPALCLQTQ LLPYLALLTI PMRNQAQISF IQDIGRLPLK RHFGRLKMEA
     LTDREHGMID PDSGDEAQLN GGHSAEESLG EPTQATVPET WSLPLSQNSA SELPASQPQP
     FSAQGDMEEN IIIEDYESDG T
//
ID   RFWD3_HUMAN             Reviewed;         774 AA.
AC   Q6PCD5; A8K585; B2RE35; D3DUJ8; Q5XKR3; Q9H9Q3; Q9NVT4;
DT   20-FEB-2007, integrated into UniProtKB/Swiss-Prot.
DT   20-FEB-2007, sequence version 3.
DT   13-FEB-2019, entry version 145.
DE   RecName: Full=E3 ubiquitin-protein ligase RFWD3 {ECO:0000305};
DE            EC=2.3.2.27 {ECO:0000269|PubMed:26474068, ECO:0000269|PubMed:28575657, ECO:0000269|PubMed:28575658};
DE   AltName: Full=RING finger and WD repeat domain-containing protein 3;
DE   AltName: Full=RING finger protein 201;
GN   Name=RFWD3 {ECO:0000312|HGNC:HGNC:25539};
GN   Synonyms=RNF201 {ECO:0000312|HGNC:HGNC:25539};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Teratocarcinoma, and Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X.,
RA   Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A.,
RA   Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J.,
RA   Buckingham J.M., Callen D.F., Campbell C.S., Campbell M.L.,
RA   Campbell E.W., Caoile C., Challacombe J.F., Chasteen L.A.,
RA   Chertkov O., Chi H.C., Christensen M., Clark L.M., Cohn J.D.,
RA   Denys M., Detter J.C., Dickson M., Dimitrijevic-Bussod M., Escobar J.,
RA   Fawcett J.J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., Grigoriev I.,
RA   Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., Huang W.,
RA   Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., Kobayashi A.,
RA   Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., Lowry S.,
RA   Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L.,
RA   Rash S., Retterer J., Ricke D.O., Robinson D.L., Rodriguez A.,
RA   Salamov A., Saunders E.H., Scott D., Shough T., Stallings R.L.,
RA   Stalvey M., Sutherland R.D., Tapia R., Tesmer J.G., Thayer N.,
RA   Thompson L.S., Tice H., Torney D.C., Tran-Gyamfi M., Tsai M.,
RA   Ulanovsky L.E., Ustaszewska A., Vo N., White P.S., Williams A.L.,
RA   Wills P.L., Wu J.-R., Wu K., Yang J., DeJong P., Bruce D.,
RA   Doggett N.A., Deaven L., Schmutz J., Grimwood J., Richardson P.,
RA   Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., Myers R.M.,
RA   Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT VAL-564.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS LYS-392 AND
RP   THR-770.
RC   TISSUE=Brain, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [6]
RP   FUNCTION, INTERACTION WITH MDM2 AND TP53, SUBCELLULAR LOCATION,
RP   PHOSPHORYLATION AT SER-46 AND SER-63, AND MUTAGENESIS OF SER-46;
RP   SER-63 AND CYS-315.
RX   PubMed=20173098; DOI=10.1073/pnas.0912094107;
RA   Fu X., Yucer N., Liu S., Li M., Yi P., Mu J.J., Yang T., Chu J.,
RA   Jung S.Y., O'Malley B.W., Gu W., Qin J., Wang Y.;
RT   "RFWD3-Mdm2 ubiquitin ligase complex positively regulates p53
RT   stability in response to DNA damage.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:4579-4584(2010).
RN   [7]
RP   FUNCTION, INTERACTION WITH RPA2, AND SUBCELLULAR LOCATION.
RX   PubMed=21504906; DOI=10.1074/jbc.M111.222869;
RA   Gong Z., Chen J.;
RT   "E3 ligase RFWD3 participates in replication checkpoint control.";
RL   J. Biol. Chem. 286:22308-22313(2011).
RN   [8]
RP   FUNCTION, INTERACTION WITH RPA2, SUBCELLULAR LOCATION,
RP   PHOSPHORYLATION, DEVELOPMENTAL STAGE, AND MUTAGENESIS OF CYS-315.
RX   PubMed=21558276; DOI=10.1074/jbc.M111.222802;
RA   Liu S., Chu J., Yucer N., Leng M., Wang S.Y., Chen B.P.,
RA   Hittelman W.N., Wang Y.;
RT   "RING finger and WD repeat domain 3 (RFWD3) associates with
RT   replication protein A (RPA) and facilitates RPA-mediated DNA damage
RT   response.";
RL   J. Biol. Chem. 286:22314-22322(2011).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=26474068; DOI=10.1016/j.molcel.2015.09.011;
RA   Elia A.E., Wang D.C., Willis N.A., Boardman A.P., Hajdu I.,
RA   Adeyemi R.O., Lowry E., Gygi S.P., Scully R., Elledge S.J.;
RT   "RFWD3-dependent ubiquitination of RPA regulates repair at stalled
RT   replication forks.";
RL   Mol. Cell 60:280-293(2015).
RN   [11]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, PHOSPHORYLATION AT
RP   SER-46 AND SER-63, INVOLVEMENT IN FANCW, VARIANT FANCW LYS-639,
RP   CHARACTERIZATION OF VARIANT FANCW LYS-639, AND MUTAGENESIS OF CYS-315;
RP   GLN-499; LEU-518 AND TRP-543.
RX   PubMed=28575657; DOI=10.1016/j.molcel.2017.04.021;
RA   Feeney L., Munoz I.M., Lachaud C., Toth R., Appleton P.L.,
RA   Schindler D., Rouse J.;
RT   "RPA-mediated recruitment of the E3 ligase RFWD3 is vital for
RT   interstrand crosslink repair and human health.";
RL   Mol. Cell 66:610-621(2017).
RN   [12]
RP   FUNCTION, SUBCELLULAR LOCATION, INVOLVEMENT IN FANCW, VARIANT FANCW
RP   LYS-639, AND CHARACTERIZATION OF VARIANT FANCW LYS-639.
RX   PubMed=28691929; DOI=10.1172/JCI92069;
RA   Knies K., Inano S., Ramirez M.J., Ishiai M., Surralles J., Takata M.,
RA   Schindler D.;
RT   "Biallelic mutations in the ubiquitin ligase RFWD3 cause Fanconi
RT   anemia.";
RL   J. Clin. Invest. 127:3013-3027(2017).
RN   [13]
RP   FUNCTION, CATALYTIC ACTIVITY, PHOSPHORYLATION AT SER-46 AND SER-63,
RP   AND MUTAGENESIS OF 36-LEU--PRO-38; 53-LEU--PRO-55; 70-LEU--PRO-72 AND
RP   CYS-315.
RX   PubMed=28575658; DOI=10.1016/j.molcel.2017.04.022;
RA   Inano S., Sato K., Katsuki Y., Kobayashi W., Tanaka H., Nakajima K.,
RA   Nakada S., Miyoshi H., Knies K., Takaori-Kondo A., Schindler D.,
RA   Ishiai M., Kurumizaka H., Takata M.;
RT   "RFWD3-mediated ubiquitination promotes timely removal of both RPA and
RT   RAD51 from dna damage sites to facilitate homologous recombination.";
RL   Mol. Cell 66:622-634(2017).
CC   -!- FUNCTION: E3 ubiquitin-protein ligase required for the repair of
CC       DNA interstrand cross-links (ICL) in response to DNA damage
CC       (PubMed:21504906, PubMed:21558276, PubMed:26474068,
CC       PubMed:28575657, PubMed:28575658). Plays a key role in RPA-
CC       mediated DNA damage signaling and repair (PubMed:21504906,
CC       PubMed:21558276, PubMed:26474068, PubMed:28575657,
CC       PubMed:28575658, PubMed:28691929). Acts by mediating
CC       ubiquitination of the RPA complex (RPA1, RPA2 and RPA3 subunits)
CC       and RAD51 at stalled replication forks, leading to remove them
CC       from DNA damage sites and promote homologous recombination
CC       (PubMed:26474068, PubMed:28575657, PubMed:28575658). Also mediates
CC       the ubiquitination of p53/TP53 in the late response to DNA damage,
CC       and acts as a positive regulator of p53/TP53 stability, thereby
CC       regulating the G1/S DNA damage checkpoint (PubMed:20173098). May
CC       act by catalyzing the formation of short polyubiquitin chains on
CC       p53/TP53 that are not targeted to the proteasome
CC       (PubMed:20173098). In response to ionizing radiation, interacts
CC       with MDM2 and enhances p53/TP53 ubiquitination, possibly by
CC       restricting MDM2 from extending polyubiquitin chains on
CC       ubiquitinated p53/TP53 (PubMed:20173098).
CC       {ECO:0000269|PubMed:20173098, ECO:0000269|PubMed:21504906,
CC       ECO:0000269|PubMed:21558276, ECO:0000269|PubMed:26474068,
CC       ECO:0000269|PubMed:28575657, ECO:0000269|PubMed:28575658,
CC       ECO:0000269|PubMed:28691929}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-
CC         cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-
CC         conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor
CC         protein]-L-lysine.; EC=2.3.2.27;
CC         Evidence={ECO:0000269|PubMed:26474068,
CC         ECO:0000269|PubMed:28575657, ECO:0000269|PubMed:28575658};
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC       {ECO:0000269|PubMed:26474068, ECO:0000269|PubMed:28575657,
CC       ECO:0000269|PubMed:28575658}.
CC   -!- SUBUNIT: Interacts with MDM2 and p53/TP53 (PubMed:20173098). Binds
CC       to the RPA complex via direct interaction with RPA2
CC       (PubMed:21504906, PubMed:21558276, PubMed:26474068,
CC       PubMed:28575658). Interacts with RAD51 (PubMed:28575658).
CC       {ECO:0000269|PubMed:20173098, ECO:0000269|PubMed:21504906,
CC       ECO:0000269|PubMed:21558276, ECO:0000269|PubMed:26474068,
CC       ECO:0000269|PubMed:28575658}.
CC   -!- INTERACTION:
CC       Q00987:MDM2; NbExp=2; IntAct=EBI-2129159, EBI-389668;
CC       Q00987-11:MDM2; NbExp=5; IntAct=EBI-2129159, EBI-5279149;
CC       P04637:TP53; NbExp=5; IntAct=EBI-2129159, EBI-366083;
CC       P61088:UBE2N; NbExp=2; IntAct=EBI-2129159, EBI-1052908;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:20173098,
CC       ECO:0000269|PubMed:21504906, ECO:0000269|PubMed:21558276,
CC       ECO:0000269|PubMed:28575657, ECO:0000269|PubMed:28691929}.
CC       Nucleus, PML body {ECO:0000269|PubMed:21558276}. Cytoplasm
CC       {ECO:0000269|PubMed:21558276, ECO:0000269|PubMed:28691929}.
CC       Note=In undamaged cells, found both in the cytoplasm and in the
CC       nucleus, partially associated with PML nuclear bodies
CC       (PubMed:21558276). In response to replication block, such as that
CC       caused by hydroxyurea treatment, or to DNA damage caused by
CC       ionizing radiations or doxorubicin, recruited to the nucleus, to
CC       stalled replication forks or to sites of DNA repair
CC       (PubMed:21504906, PubMed:28575657). This recruitment depends upon
CC       RPA2 (PubMed:21504906). {ECO:0000269|PubMed:21504906,
CC       ECO:0000269|PubMed:28575657}.
CC   -!- DEVELOPMENTAL STAGE: Up-regulated in the S-G2 phase.
CC       {ECO:0000269|PubMed:21558276}.
CC   -!- DOMAIN: The coiled coil domain may be involved in RPA2-binding.
CC       {ECO:0000269|PubMed:21558276}.
CC   -!- PTM: Phosphorylated at Ser-46 and Ser-63 upon DNA damage by ATM or
CC       ATR. ATM phosphorylation occurs at early times upon DNA damage,
CC       while ATR is the major kinase at later times. Phosphorylation by
CC       ATM and ATR is required to stabilize p53/TP53. Part of the
CC       phosphorylation depends upon RPA2 presence.
CC       {ECO:0000269|PubMed:20173098, ECO:0000269|PubMed:21558276,
CC       ECO:0000269|PubMed:28575657, ECO:0000269|PubMed:28575658}.
CC   -!- DISEASE: Fanconi anemia, complementation group W (FANCW)
CC       [MIM:617784]: A form of Fanconi anemia, a disorder affecting all
CC       bone marrow elements and resulting in anemia, leukopenia and
CC       thrombopenia. It is associated with cardiac, renal and limb
CC       malformations, dermal pigmentary changes, and a predisposition to
CC       the development of malignancies. At the cellular level it is
CC       associated with hypersensitivity to DNA-damaging agents,
CC       chromosomal instability (increased chromosome breakage) and
CC       defective DNA repair. {ECO:0000269|PubMed:28575657,
CC       ECO:0000269|PubMed:28691929}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA91662.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAF83889.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAG38132.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AK001382; BAA91662.1; ALT_INIT; mRNA.
DR   EMBL; AK022673; BAB14169.1; -; mRNA.
DR   EMBL; AK291200; BAF83889.1; ALT_INIT; mRNA.
DR   EMBL; AK315786; BAG38132.1; ALT_INIT; mRNA.
DR   EMBL; AC109599; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471114; EAW95680.1; -; Genomic_DNA.
DR   EMBL; CH471114; EAW95681.1; -; Genomic_DNA.
DR   EMBL; BC002574; AAH02574.2; -; mRNA.
DR   EMBL; BC059371; AAH59371.2; -; mRNA.
DR   CCDS; CCDS32486.1; -.
DR   RefSeq; NP_060594.3; NM_018124.3.
DR   RefSeq; XP_005256078.1; XM_005256021.4.
DR   RefSeq; XP_005256079.1; XM_005256022.4.
DR   RefSeq; XP_011521493.1; XM_011523191.2.
DR   RefSeq; XP_016878880.1; XM_017023391.1.
DR   UniGene; Hs.567525; -.
DR   PDB; 6CVZ; X-ray; 1.80 A; A/B/C=425-774.
DR   PDBsum; 6CVZ; -.
DR   ProteinModelPortal; Q6PCD5; -.
DR   SMR; Q6PCD5; -.
DR   BioGrid; 120460; 58.
DR   DIP; DIP-52688N; -.
DR   IntAct; Q6PCD5; 42.
DR   MINT; Q6PCD5; -.
DR   STRING; 9606.ENSP00000354361; -.
DR   iPTMnet; Q6PCD5; -.
DR   PhosphoSitePlus; Q6PCD5; -.
DR   BioMuta; RFWD3; -.
DR   DMDM; 126253679; -.
DR   EPD; Q6PCD5; -.
DR   jPOST; Q6PCD5; -.
DR   MaxQB; Q6PCD5; -.
DR   PaxDb; Q6PCD5; -.
DR   PeptideAtlas; Q6PCD5; -.
DR   PRIDE; Q6PCD5; -.
DR   ProteomicsDB; 67062; -.
DR   Ensembl; ENST00000361070; ENSP00000354361; ENSG00000168411.
DR   Ensembl; ENST00000571750; ENSP00000460049; ENSG00000168411.
DR   GeneID; 55159; -.
DR   KEGG; hsa:55159; -.
DR   UCSC; uc002fda.4; human.
DR   CTD; 55159; -.
DR   DisGeNET; 55159; -.
DR   EuPathDB; HostDB:ENSG00000168411.13; -.
DR   GeneCards; RFWD3; -.
DR   GeneReviews; RFWD3; -.
DR   H-InvDB; HIX0013236; -.
DR   HGNC; HGNC:25539; RFWD3.
DR   HPA; HPA048258; -.
DR   HPA; HPA075649; -.
DR   MalaCards; RFWD3; -.
DR   MIM; 614151; gene.
DR   MIM; 617784; phenotype.
DR   neXtProt; NX_Q6PCD5; -.
DR   OpenTargets; ENSG00000168411; -.
DR   Orphanet; 84; Fanconi anemia.
DR   PharmGKB; PA134960063; -.
DR   eggNOG; KOG1645; Eukaryota.
DR   eggNOG; ENOG410XPPE; LUCA.
DR   GeneTree; ENSGT00390000008931; -.
DR   HOVERGEN; HBG093895; -.
DR   InParanoid; Q6PCD5; -.
DR   KO; K15691; -.
DR   OMA; WCLDENN; -.
DR   OrthoDB; 1451258at2759; -.
DR   PhylomeDB; Q6PCD5; -.
DR   TreeFam; TF323359; -.
DR   SignaLink; Q6PCD5; -.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; RFWD3; human.
DR   GenomeRNAi; 55159; -.
DR   PRO; PR:Q6PCD5; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000168411; Expressed in 176 organ(s), highest expression level in oocyte.
DR   ExpressionAtlas; Q6PCD5; baseline and differential.
DR   Genevisible; Q6PCD5; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0016605; C:PML body; IEA:UniProtKB-SubCell.
DR   GO; GO:0090734; C:site of DNA damage; IDA:UniProtKB.
DR   GO; GO:0097371; F:MDM2/MDM4 family protein binding; IPI:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0002039; F:p53 binding; IPI:UniProtKB.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IDA:UniProtKB.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB.
DR   GO; GO:0031052; P:chromosome breakage; ISS:UniProtKB.
DR   GO; GO:0000724; P:double-strand break repair via homologous recombination; IDA:UniProtKB.
DR   GO; GO:0036297; P:interstrand cross-link repair; IMP:UniProtKB.
DR   GO; GO:0031571; P:mitotic G1 DNA damage checkpoint; IMP:UniProtKB.
DR   GO; GO:0016567; P:protein ubiquitination; IDA:UniProtKB.
DR   GO; GO:2000001; P:regulation of DNA damage checkpoint; IMP:UniProtKB.
DR   GO; GO:0031297; P:replication fork processing; IDA:UniProtKB.
DR   GO; GO:0010212; P:response to ionizing radiation; IDA:UniProtKB.
DR   Gene3D; 2.130.10.10; -; 1.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR037381; RFWD3.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom_sf.
DR   InterPro; IPR001680; WD40_repeat.
DR   InterPro; IPR036322; WD40_repeat_dom_sf.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   PANTHER; PTHR16047; PTHR16047; 1.
DR   Pfam; PF13639; zf-RING_2; 1.
DR   SMART; SM00184; RING; 1.
DR   SMART; SM00320; WD40; 3.
DR   SUPFAM; SSF50978; SSF50978; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Coiled coil; Complete proteome; Cytoplasm;
KW   Disease mutation; DNA damage; DNA repair; Fanconi anemia;
KW   Metal-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repeat; Transferase; Ubl conjugation pathway;
KW   WD repeat; Zinc; Zinc-finger.
FT   CHAIN         1    774       E3 ubiquitin-protein ligase RFWD3.
FT                                /FTId=PRO_0000278234.
FT   REPEAT      495    537       WD 1.
FT   REPEAT      539    577       WD 2.
FT   REPEAT      583    628       WD 3.
FT   ZN_FING     287    331       RING-type; degenerate.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00175}.
FT   COILED      361    413       {ECO:0000255}.
FT   MOD_RES      46     46       Phosphoserine; by ATM and ATR.
FT                                {ECO:0000269|PubMed:20173098,
FT                                ECO:0000269|PubMed:28575657,
FT                                ECO:0000269|PubMed:28575658}.
FT   MOD_RES      63     63       Phosphoserine; by ATM and ATR.
FT                                {ECO:0000269|PubMed:20173098,
FT                                ECO:0000269|PubMed:28575657,
FT                                ECO:0000269|PubMed:28575658}.
FT   VARIANT      90     90       T -> N (in dbSNP:rs8058922).
FT                                /FTId=VAR_030700.
FT   VARIANT     392    392       R -> K (in dbSNP:rs17854997).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_030701.
FT   VARIANT     564    564       I -> V (in dbSNP:rs7193541).
FT                                {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_030702.
FT   VARIANT     639    639       I -> K (in FANCW; abolishes interaction
FT                                with the RPA complex and subsequent
FT                                recruitment of the protein at DNA damage
FT                                sites; decreased function in double-
FT                                strand break repair via homologous
FT                                recombination).
FT                                {ECO:0000269|PubMed:28575657,
FT                                ECO:0000269|PubMed:28691929}.
FT                                /FTId=VAR_078953.
FT   VARIANT     770    770       I -> T (in dbSNP:rs17854996).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_030703.
FT   MUTAGEN      36     38       LQP->AAA: Decreased interaction with
FT                                RAD51; when associated with 53-A--A-55
FT                                and 70-A--A-72.
FT                                {ECO:0000269|PubMed:28575658}.
FT   MUTAGEN      46     46       S->A: Markedly decreases phosphorylation
FT                                following ionizing radiation and
FT                                abolishes ability to stimulate p53/TP53
FT                                ubiquitination; when associated with A-
FT                                63. {ECO:0000269|PubMed:20173098}.
FT   MUTAGEN      53     55       LQP->AAA: Decreased interaction with
FT                                RAD51; when associated with 36-A--A-38
FT                                and 70-A--A-72.
FT                                {ECO:0000269|PubMed:28575658}.
FT   MUTAGEN      63     63       S->A: Markedly decreases phosphorylation
FT                                following ionizing radiation and
FT                                abolishes ability to stimulate p53/TP53
FT                                ubiquitination; when associated with A-
FT                                46. {ECO:0000269|PubMed:20173098}.
FT   MUTAGEN      70     72       LQP->AAA: Decreased interaction with
FT                                RAD51; when associated with 36-A--A-38
FT                                and 53-A--A-55.
FT                                {ECO:0000269|PubMed:28575658}.
FT   MUTAGEN     315    315       C->A: Abolishes ability to stimulate
FT                                p53/TP53 ubiquitination. No effect on
FT                                nuclear localization in response to DNA
FT                                damage. {ECO:0000269|PubMed:20173098,
FT                                ECO:0000269|PubMed:21558276,
FT                                ECO:0000269|PubMed:28575657,
FT                                ECO:0000269|PubMed:28575658}.
FT   MUTAGEN     499    499       Q->A: Does not affect interaction with
FT                                the RPA complex and subsequent
FT                                recruitment at DNA damage sites.
FT                                {ECO:0000269|PubMed:28575657}.
FT   MUTAGEN     518    518       L->A: Does not affect interaction with
FT                                the RPA complex and subsequent
FT                                recruitment at DNA damage sites.
FT                                {ECO:0000269|PubMed:28575657}.
FT   MUTAGEN     543    543       W->A: Abolishes interaction with the RPA
FT                                complex and subsequent recruitment at DNA
FT                                damage sites.
FT                                {ECO:0000269|PubMed:28575657}.
FT   CONFLICT    221    221       S -> P (in Ref. 1; BAF83889).
FT                                {ECO:0000305}.
FT   CONFLICT    552    552       A -> T (in Ref. 1; BAA91662).
FT                                {ECO:0000305}.
FT   CONFLICT    597    597       A -> V (in Ref. 1; BAA91662).
FT                                {ECO:0000305}.
FT   CONFLICT    741    741       Q -> R (in Ref. 1; BAB14169).
FT                                {ECO:0000305}.
FT   STRAND      435    443       {ECO:0000244|PDB:6CVZ}.
FT   STRAND      453    456       {ECO:0000244|PDB:6CVZ}.
FT   TURN        457    460       {ECO:0000244|PDB:6CVZ}.
FT   STRAND      461    467       {ECO:0000244|PDB:6CVZ}.
FT   TURN        470    472       {ECO:0000244|PDB:6CVZ}.
FT   STRAND      475    483       {ECO:0000244|PDB:6CVZ}.
FT   TURN        484    487       {ECO:0000244|PDB:6CVZ}.
FT   STRAND      491    498       {ECO:0000244|PDB:6CVZ}.
FT   STRAND      500    505       {ECO:0000244|PDB:6CVZ}.
FT   STRAND      507    509       {ECO:0000244|PDB:6CVZ}.
FT   STRAND      512    517       {ECO:0000244|PDB:6CVZ}.
FT   STRAND      520    526       {ECO:0000244|PDB:6CVZ}.
FT   TURN        527    530       {ECO:0000244|PDB:6CVZ}.
FT   STRAND      531    537       {ECO:0000244|PDB:6CVZ}.
FT   STRAND      542    547       {ECO:0000244|PDB:6CVZ}.
FT   STRAND      550    552       {ECO:0000244|PDB:6CVZ}.
FT   STRAND      554    559       {ECO:0000244|PDB:6CVZ}.
FT   STRAND      564    568       {ECO:0000244|PDB:6CVZ}.
FT   STRAND      572    574       {ECO:0000244|PDB:6CVZ}.
FT   STRAND      576    579       {ECO:0000244|PDB:6CVZ}.
FT   STRAND      588    594       {ECO:0000244|PDB:6CVZ}.
FT   STRAND      606    611       {ECO:0000244|PDB:6CVZ}.
FT   STRAND      614    620       {ECO:0000244|PDB:6CVZ}.
FT   STRAND      626    630       {ECO:0000244|PDB:6CVZ}.
FT   STRAND      635    644       {ECO:0000244|PDB:6CVZ}.
FT   TURN        645    648       {ECO:0000244|PDB:6CVZ}.
FT   STRAND      649    660       {ECO:0000244|PDB:6CVZ}.
FT   STRAND      664    674       {ECO:0000244|PDB:6CVZ}.
FT   STRAND      680    691       {ECO:0000244|PDB:6CVZ}.
FT   STRAND      703    706       {ECO:0000244|PDB:6CVZ}.
FT   STRAND      714    718       {ECO:0000244|PDB:6CVZ}.
FT   STRAND      725    730       {ECO:0000244|PDB:6CVZ}.
FT   TURN        731    733       {ECO:0000244|PDB:6CVZ}.
FT   STRAND      736    741       {ECO:0000244|PDB:6CVZ}.
FT   STRAND      748    754       {ECO:0000244|PDB:6CVZ}.
FT   STRAND      757    763       {ECO:0000244|PDB:6CVZ}.
FT   STRAND      765    774       {ECO:0000244|PDB:6CVZ}.
SQ   SEQUENCE   774 AA;  85094 MW;  EF6E0E186FD2E580 CRC64;
     MAHEAMEYDV QVQLNHAEQQ PAPAGMASSQ GGPALLQPVP ADVVSSQGVP SILQPAPAEV
     ISSQATPPLL QPAPQLSVDL TEVEVLGEDT VENINPRTSE QHRQGSDGNH TIPASSLHSM
     TNFISGLQRL HGMLEFLRPS SSNHSVGPMR TRRRVSASRR ARAGGSQRTD SARLRAPLDA
     YFQVSRTQPD LPATTYDSET RNPVSEELQV SSSSDSDSDS SAEYGGVVDQ AEESGAVILE
     EQLAGVSAEQ EVTCIDGGKT LPKQPSPQKS EPLLPSASMD EEEGDTCTIC LEQWTNAGDH
     RLSALRCGHL FGYRCISTWL KGQVRKCPQC NKKARHSDIV VLYARTLRAL DTSEQERMKS
     SLLKEQMLRK QAELESAQCR LQLQVLTDKC TRLQRRVQDL QKLTSHQSQN LQQPRGSQAW
     VLSCSPSSQG QHKHKYHFQK TFTVSQAGNC RIMAYCDALS CLVISQPSPQ ASFLPGFGVK
     MLSTANMKSS QYIPMHGKQI RGLAFSSYLR GLLLSASLDN TIKLTSLETN TVVQTYNAGR
     PVWSCCWCLD EANYIYAGLA NGSILVYDVR NTSSHVQELV AQKARCPLVS LSYMPRAASA
     AFPYGGVLAG TLEDASFWEQ KMDFSHWPHV LPLEPGGCID FQTENSSRHC LVTYRPDKNH
     TTIRSVLMEM SYRLDDTGNP ICSCQPVHTF FGGPTCKLLT KNAIFQSPEN DGNILVCTGD
     EAANSALLWD AASGSLLQDL QTDQPVLDIC PFEVNRNSYL ATLTEKMVHI YKWE
//
ID   ROBO2_HUMAN             Reviewed;        1378 AA.
AC   Q9HCK4; O43608; Q19AB4; Q19AB5;
DT   21-JUN-2004, integrated into UniProtKB/Swiss-Prot.
DT   21-JUN-2004, sequence version 2.
DT   13-FEB-2019, entry version 171.
DE   RecName: Full=Roundabout homolog 2;
DE   Flags: Precursor;
GN   Name=ROBO2; Synonyms=KIAA1568;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND ALTERNATIVE SPLICING.
RX   PubMed=16829019; DOI=10.1016/j.ygeno.2006.05.011;
RA   Yue Y., Grossmann B., Galetzka D., Zechner U., Haaf T.;
RT   "Isolation and differential expression of two isoforms of the
RT   ROBO2/Robo2 axon guidance receptor gene in humans and mice.";
RL   Genomics 88:772-778(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=10997877; DOI=10.1093/dnares/7.4.271;
RA   Nagase T., Kikuno R., Nakayama M., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes.
RT   XVIII. The complete sequences of 100 new cDNA clones from brain which
RT   code for large proteins in vitro.";
RL   DNA Res. 7:273-281(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RA   Yue Y., Grossmann B., Galetzka D., Zechner U., Haaf T.;
RL   Submitted (MAY-2006) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 845-1378 (ISOFORM 2).
RC   TISSUE=Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 323-607.
RX   PubMed=9458045; DOI=10.1016/S0092-8674(00)80915-0;
RA   Kidd T., Brose K., Mitchell K.J., Fetter R.D., Tessier-Lavigne M.,
RA   Goodman C.S., Tear G.;
RT   "Roundabout controls axon crossing of the CNS midline and defines a
RT   novel subfamily of evolutionarily conserved guidance receptors.";
RL   Cell 92:205-215(1998).
RN   [7]
RP   INTERACTION WITH SLIT2.
RX   PubMed=10102268; DOI=10.1016/S0092-8674(00)80590-5;
RA   Brose K., Bland K.S., Wang K.H., Arnott D., Henzel W., Goodman C.S.,
RA   Tessier-Lavigne M., Kidd T.;
RT   "Slit proteins bind Robo receptors and have an evolutionarily
RT   conserved role in repulsive axon guidance.";
RL   Cell 96:795-806(1999).
RN   [8]
RP   INTERACTION WITH SLIT2.
RX   PubMed=11404413;
RA   Nguyen-Ba-Charvet K.T., Brose K., Ma L., Wang K.H., Marillat V.,
RA   Sotelo C., Tessier-Lavigne M., Chedotal A.;
RT   "Diversity and specificity of actions of Slit2 proteolytic fragments
RT   in axon guidance.";
RL   J. Neurosci. 21:4281-4289(2001).
RN   [9]
RP   STRUCTURE BY NMR OF 417-734.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the fifth Ig-like domain and of first and
RT   second fibronectin type III domain from human roundabout homolog 2.";
RL   Submitted (AUG-2007) to the PDB data bank.
RN   [10]
RP   VARIANTS VUR2 THR-945 AND THR-1236, AND CHROMOSOMAL TRANSLOCATION WITH
RP   PCDH11Y.
RX   PubMed=17357069; DOI=10.1086/512735;
RA   Lu W., van Eerde A.M., Fan X., Quintero-Rivera F., Kulkarni S.,
RA   Ferguson H., Kim H.-G., Fan Y., Xi Q., Li Q.-G., Sanlaville D.,
RA   Andrews W., Sundaresan V., Bi W., Yan J., Giltay J.C., Wijmenga C.,
RA   de Jong T.P.V.M., Feather S.A., Woolf A.S., Rao Y., Lupski J.R.,
RA   Eccles M.R., Quade B.J., Gusella J.F., Morton C.C., Maas R.L.;
RT   "Disruption of ROBO2 is associated with urinary tract anomalies and
RT   confers risk of vesicoureteral reflux.";
RL   Am. J. Hum. Genet. 80:616-632(2007).
CC   -!- FUNCTION: Receptor for SLIT2, and probably SLIT1, which are
CC       thought to act as molecular guidance cue in cellular migration,
CC       including axonal navigation at the ventral midline of the neural
CC       tube and projection of axons to different regions during neuronal
CC       development.
CC   -!- SUBUNIT: Interacts with SLIT2. {ECO:0000269|PubMed:10102268,
CC       ECO:0000269|PubMed:11404413}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I
CC       membrane protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9HCK4-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9HCK4-2; Sequence=VSP_010647;
CC       Name=3;
CC         IsoId=Q9HCK4-3; Sequence=VSP_043394;
CC         Note=No experimental confirmation available.;
CC   -!- DISEASE: Vesicoureteral reflux 2 (VUR2) [MIM:610878]: A disease
CC       belonging to the group of congenital anomalies of the kidney and
CC       urinary tract. It is characterized by the reflux of urine from the
CC       bladder into the ureters and sometimes into the kidneys, and is a
CC       risk factor for urinary tract infections. Primary disease results
CC       from a developmental defect of the ureterovesical junction. In
CC       combination with intrarenal reflux, the resulting inflammatory
CC       reaction may result in renal injury or scarring, also called
CC       reflux nephropathy. Extensive renal scarring impairs renal
CC       function and may predispose patients to hypertension, proteinuria,
CC       renal insufficiency and end-stage renal disease.
CC       {ECO:0000269|PubMed:17357069}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Note=A chromosomal aberration involving ROBO2 is a cause
CC       of multiple congenital abnormalities, including severe bilateral
CC       VUR with ureterovesical junction defects. Translocation
CC       t(Y;3)(p11;p12) with PCDH11Y. This translocation disrupts ROBO2
CC       and produces dominant-negative ROBO2 proteins that abrogate SLIT-
CC       ROBO signaling in vitro.
CC   -!- SIMILARITY: Belongs to the immunoglobulin superfamily. ROBO
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC39576.1; Type=Frameshift; Positions=601; Evidence={ECO:0000305};
CC       Sequence=BAB13394.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; DQ533874; ABF83431.1; -; mRNA.
DR   EMBL; AB046788; BAB13394.1; ALT_INIT; mRNA.
DR   EMBL; DQ533873; ABF83430.1; -; mRNA.
DR   EMBL; AC016942; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC016952; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC024256; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC026877; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC067717; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC117514; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC117515; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC117516; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC126467; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC130004; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC131005; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC131154; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC133040; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC138974; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC064374; AAH64374.1; -; mRNA.
DR   EMBL; BC146772; AAI46773.1; -; mRNA.
DR   EMBL; AF040991; AAC39576.1; ALT_FRAME; mRNA.
DR   CCDS; CCDS43109.1; -. [Q9HCK4-1]
DR   CCDS; CCDS54609.1; -. [Q9HCK4-3]
DR   RefSeq; NP_001122401.1; NM_001128929.3. [Q9HCK4-3]
DR   RefSeq; NP_001276968.1; NM_001290039.1.
DR   RefSeq; NP_001276969.1; NM_001290040.1.
DR   RefSeq; NP_001276994.1; NM_001290065.1.
DR   RefSeq; NP_002933.1; NM_002942.4. [Q9HCK4-1]
DR   UniGene; Hs.13305; -.
DR   PDB; 1UEM; NMR; -; A=514-617.
DR   PDB; 1UJT; NMR; -; A=628-734.
DR   PDB; 2EDJ; NMR; -; A=417-509.
DR   PDB; 5NOI; X-ray; 2.40 A; A=311-509.
DR   PDBsum; 1UEM; -.
DR   PDBsum; 1UJT; -.
DR   PDBsum; 2EDJ; -.
DR   PDBsum; 5NOI; -.
DR   ProteinModelPortal; Q9HCK4; -.
DR   SMR; Q9HCK4; -.
DR   BioGrid; 112019; 20.
DR   IntAct; Q9HCK4; 29.
DR   MINT; Q9HCK4; -.
DR   STRING; 9606.ENSP00000417335; -.
DR   iPTMnet; Q9HCK4; -.
DR   PhosphoSitePlus; Q9HCK4; -.
DR   BioMuta; ROBO2; -.
DR   DMDM; 49036496; -.
DR   EPD; Q9HCK4; -.
DR   jPOST; Q9HCK4; -.
DR   MaxQB; Q9HCK4; -.
DR   PaxDb; Q9HCK4; -.
DR   PeptideAtlas; Q9HCK4; -.
DR   PRIDE; Q9HCK4; -.
DR   ProteomicsDB; 81744; -.
DR   ProteomicsDB; 81745; -. [Q9HCK4-2]
DR   ProteomicsDB; 81746; -. [Q9HCK4-3]
DR   Ensembl; ENST00000461745; ENSP00000417164; ENSG00000185008. [Q9HCK4-1]
DR   Ensembl; ENST00000487694; ENSP00000417335; ENSG00000185008. [Q9HCK4-3]
DR   GeneID; 6092; -.
DR   KEGG; hsa:6092; -.
DR   UCSC; uc003dpy.5; human. [Q9HCK4-1]
DR   CTD; 6092; -.
DR   DisGeNET; 6092; -.
DR   EuPathDB; HostDB:ENSG00000185008.17; -.
DR   GeneCards; ROBO2; -.
DR   HGNC; HGNC:10250; ROBO2.
DR   HPA; HPA013371; -.
DR   MalaCards; ROBO2; -.
DR   MIM; 602431; gene.
DR   MIM; 610878; phenotype.
DR   neXtProt; NX_Q9HCK4; -.
DR   OpenTargets; ENSG00000185008; -.
DR   Orphanet; 289365; Familial vesicoureteral reflux.
DR   PharmGKB; PA34621; -.
DR   eggNOG; KOG4222; Eukaryota.
DR   eggNOG; ENOG410XPQS; LUCA.
DR   GeneTree; ENSGT00940000156324; -.
DR   HOGENOM; HOG000010267; -.
DR   HOVERGEN; HBG073476; -.
DR   InParanoid; Q9HCK4; -.
DR   KO; K06754; -.
DR   OrthoDB; 45439at2759; -.
DR   PhylomeDB; Q9HCK4; -.
DR   TreeFam; TF351053; -.
DR   Reactome; R-HSA-376176; Signaling by ROBO receptors.
DR   Reactome; R-HSA-428542; Regulation of commissural axon pathfinding by SLIT and ROBO.
DR   Reactome; R-HSA-8985801; Regulation of cortical dendrite branching.
DR   Reactome; R-HSA-9010553; Regulation of expression of SLITs and ROBOs.
DR   Reactome; R-HSA-9010642; ROBO receptors bind AKAP5.
DR   ChiTaRS; ROBO2; human.
DR   EvolutionaryTrace; Q9HCK4; -.
DR   GeneWiki; ROBO2; -.
DR   GenomeRNAi; 6092; -.
DR   PRO; PR:Q9HCK4; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000185008; Expressed in 148 organ(s), highest expression level in forebrain.
DR   ExpressionAtlas; Q9HCK4; baseline and differential.
DR   Genevisible; Q9HCK4; HS.
DR   GO; GO:0030673; C:axolemma; ISS:UniProtKB.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0008046; F:axon guidance receptor activity; ISS:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IDA:UniProtKB.
DR   GO; GO:0035904; P:aorta development; ISS:BHF-UCL.
DR   GO; GO:0003180; P:aortic valve morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0061364; P:apoptotic process involved in luteolysis; IEP:UniProtKB.
DR   GO; GO:0007411; P:axon guidance; ISS:UniProtKB.
DR   GO; GO:0016199; P:axon midline choice point recognition; ISS:UniProtKB.
DR   GO; GO:0007420; P:brain development; IEP:UniProtKB.
DR   GO; GO:0032870; P:cellular response to hormone stimulus; IEP:UniProtKB.
DR   GO; GO:0007417; P:central nervous system development; NAS:UniProtKB.
DR   GO; GO:0003272; P:endocardial cushion formation; ISS:BHF-UCL.
DR   GO; GO:0007156; P:homophilic cell adhesion via plasma membrane adhesion molecules; IDA:UniProtKB.
DR   GO; GO:0001656; P:metanephros development; ISS:UniProtKB.
DR   GO; GO:0050925; P:negative regulation of negative chemotaxis; IDA:UniProtKB.
DR   GO; GO:0051964; P:negative regulation of synapse assembly; ISS:UniProtKB.
DR   GO; GO:0021891; P:olfactory bulb interneuron development; ISS:UniProtKB.
DR   GO; GO:0003148; P:outflow tract septum morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0050772; P:positive regulation of axonogenesis; IDA:UniProtKB.
DR   GO; GO:0035481; P:positive regulation of Notch signaling pathway involved in heart induction; ISS:BHF-UCL.
DR   GO; GO:0003184; P:pulmonary valve morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0031290; P:retinal ganglion cell axon guidance; ISS:UniProtKB.
DR   GO; GO:0035385; P:Roundabout signaling pathway; IEA:InterPro.
DR   GO; GO:0021510; P:spinal cord development; IEA:Ensembl.
DR   GO; GO:0001657; P:ureteric bud development; IMP:UniProtKB.
DR   GO; GO:0060412; P:ventricular septum morphogenesis; ISS:BHF-UCL.
DR   CDD; cd00063; FN3; 3.
DR   Gene3D; 2.60.40.10; -; 8.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR013106; Ig_V-set.
DR   InterPro; IPR032985; Robo2.
DR   PANTHER; PTHR44096:SF2; PTHR44096:SF2; 3.
DR   Pfam; PF00041; fn3; 3.
DR   Pfam; PF07679; I-set; 2.
DR   SMART; SM00060; FN3; 3.
DR   SMART; SM00409; IG; 5.
DR   SMART; SM00408; IGc2; 5.
DR   SMART; SM00406; IGv; 3.
DR   SUPFAM; SSF48726; SSF48726; 5.
DR   SUPFAM; SSF49265; SSF49265; 2.
DR   PROSITE; PS50853; FN3; 3.
DR   PROSITE; PS50835; IG_LIKE; 5.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Chemotaxis;
KW   Chromosomal rearrangement; Complete proteome; Developmental protein;
KW   Differentiation; Disease mutation; Disulfide bond; Glycoprotein;
KW   Immunoglobulin domain; Membrane; Neurogenesis; Phosphoprotein;
KW   Reference proteome; Repeat; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     21       {ECO:0000255}.
FT   CHAIN        22   1378       Roundabout homolog 2.
FT                                /FTId=PRO_0000031036.
FT   TOPO_DOM     22    859       Extracellular. {ECO:0000255}.
FT   TRANSMEM    860    880       Helical. {ECO:0000255}.
FT   TOPO_DOM    881   1378       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       31    127       Ig-like C2-type 1.
FT   DOMAIN      133    220       Ig-like C2-type 2.
FT   DOMAIN      225    309       Ig-like C2-type 3.
FT   DOMAIN      314    409       Ig-like C2-type 4.
FT   DOMAIN      418    504       Ig-like C2-type 5.
FT   DOMAIN      524    618       Fibronectin type-III 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      637    735       Fibronectin type-III 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      739    836       Fibronectin type-III 3.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   MOD_RES    1154   1154       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q7TPD3}.
FT   MOD_RES    1156   1156       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q7TPD3}.
FT   CARBOHYD    123    123       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    426    426       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    752    752       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    782    782       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    789    789       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    845    845       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     52    110       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   DISULFID    154    203       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   DISULFID    246    293       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   DISULFID    335    391       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   DISULFID    439    488       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   VAR_SEQ       1     20       MSLLMFTQLLLCGFLYVRVD -> MARRHERVTRRMWTWAP
FT                                GLLMMTVVFWGHQGNGQGQ (in isoform 3).
FT                                {ECO:0000303|Ref.3}.
FT                                /FTId=VSP_043394.
FT   VAR_SEQ    1186   1378       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_010647.
FT   VARIANT     945    945       I -> T (in VUR2; dbSNP:rs267607014).
FT                                {ECO:0000269|PubMed:17357069}.
FT                                /FTId=VAR_032960.
FT   VARIANT    1236   1236       A -> T (in VUR2; dbSNP:rs267607015).
FT                                {ECO:0000269|PubMed:17357069}.
FT                                /FTId=VAR_032961.
FT   CONFLICT    497    497       T -> A (in Ref. 5). {ECO:0000305}.
FT   STRAND      312    318       {ECO:0000244|PDB:5NOI}.
FT   STRAND      323    326       {ECO:0000244|PDB:5NOI}.
FT   STRAND      331    333       {ECO:0000244|PDB:5NOI}.
FT   STRAND      336    341       {ECO:0000244|PDB:5NOI}.
FT   STRAND      345    349       {ECO:0000244|PDB:5NOI}.
FT   STRAND      367    370       {ECO:0000244|PDB:5NOI}.
FT   STRAND      376    378       {ECO:0000244|PDB:5NOI}.
FT   HELIX       383    385       {ECO:0000244|PDB:5NOI}.
FT   STRAND      387    394       {ECO:0000244|PDB:5NOI}.
FT   STRAND      399    409       {ECO:0000244|PDB:5NOI}.
FT   STRAND      419    422       {ECO:0000244|PDB:5NOI}.
FT   STRAND      427    430       {ECO:0000244|PDB:5NOI}.
FT   STRAND      434    437       {ECO:0000244|PDB:5NOI}.
FT   STRAND      440    442       {ECO:0000244|PDB:5NOI}.
FT   STRAND      448    453       {ECO:0000244|PDB:5NOI}.
FT   STRAND      456    458       {ECO:0000244|PDB:5NOI}.
FT   STRAND      464    467       {ECO:0000244|PDB:5NOI}.
FT   STRAND      469    471       {ECO:0000244|PDB:5NOI}.
FT   STRAND      473    477       {ECO:0000244|PDB:5NOI}.
FT   HELIX       480    482       {ECO:0000244|PDB:5NOI}.
FT   STRAND      484    492       {ECO:0000244|PDB:5NOI}.
FT   STRAND      495    508       {ECO:0000244|PDB:5NOI}.
FT   STRAND      529    533       {ECO:0000244|PDB:1UEM}.
FT   STRAND      538    541       {ECO:0000244|PDB:1UEM}.
FT   STRAND      548    550       {ECO:0000244|PDB:1UEM}.
FT   STRAND      554    561       {ECO:0000244|PDB:1UEM}.
FT   TURN        562    564       {ECO:0000244|PDB:1UEM}.
FT   STRAND      565    575       {ECO:0000244|PDB:1UEM}.
FT   STRAND      577    582       {ECO:0000244|PDB:1UEM}.
FT   STRAND      590    599       {ECO:0000244|PDB:1UEM}.
FT   STRAND      602    606       {ECO:0000244|PDB:1UEM}.
FT   HELIX       630    636       {ECO:0000244|PDB:1UJT}.
FT   STRAND      639    641       {ECO:0000244|PDB:1UJT}.
FT   STRAND      651    660       {ECO:0000244|PDB:1UJT}.
FT   STRAND      667    679       {ECO:0000244|PDB:1UJT}.
FT   TURN        680    682       {ECO:0000244|PDB:1UJT}.
FT   STRAND      685    688       {ECO:0000244|PDB:1UJT}.
FT   STRAND      696    701       {ECO:0000244|PDB:1UJT}.
FT   STRAND      704    718       {ECO:0000244|PDB:1UJT}.
FT   STRAND      727    731       {ECO:0000244|PDB:1UJT}.
SQ   SEQUENCE   1378 AA;  151200 MW;  60F7CE3E53622B50 CRC64;
     MSLLMFTQLL LCGFLYVRVD GSRLRQEDFP PRIVEHPSDV IVSKGEPTTL NCKAEGRPTP
     TIEWYKDGER VETDKDDPRS HRMLLPSGSL FFLRIVHGRR SKPDEGSYVC VARNYLGEAV
     SRNASLEVAL LRDDFRQNPT DVVVAAGEPA ILECQPPRGH PEPTIYWKKD KVRIDDKEER
     ISIRGGKLMI SNTRKSDAGM YTCVGTNMVG ERDSDPAELT VFERPTFLRR PINQVVLEEE
     AVEFRCQVQG DPQPTVRWKK DDADLPRGRY DIKDDYTLRI KKTMSTDEGT YMCIAENRVG
     KMEASATLTV RAPPQFVVRP RDQIVAQGRT VTFPCETKGN PQPAVFWQKE GSQNLLFPNQ
     PQQPNSRCSV SPTGDLTITN IQRSDAGYYI CQALTVAGSI LAKAQLEVTD VLTDRPPPII
     LQGPANQTLA VDGTALLKCK ATGDPLPVIS WLKEGFTFPG RDPRATIQEQ GTLQIKNLRI
     SDTGTYTCVA TSSSGETSWS AVLDVTESGA TISKNYDLSD LPGPPSKPQV TDVTKNSVTL
     SWQPGTPGTL PASAYIIEAF SQSVSNSWQT VANHVKTTLY TVRGLRPNTI YLFMVRAINP
     QGLSDPSPMS DPVRTQDISP PAQGVDHRQV QKELGDVLVR LHNPVVLTPT TVQVTWTVDR
     QPQFIQGYRV MYRQTSGLQA TSSWQNLDAK VPTERSAVLV NLKKGVTYEI KVRPYFNEFQ
     GMDSESKTVR TTEEAPSAPP QSVTVLTVGS YNSTSISVSW DPPPPDHQNG IIQEYKIWCL
     GNETRFHINK TVDAAIRSVI IGGLFPGIQY RVEVAASTSA GVGVKSEPQP IIIGRRNEVV
     ITENNNSITE QITDVVKQPA FIAGIGGACW VILMGFSIWL YWRRKKRKGL SNYAVTFQRG
     DGGLMSNGSR PGLLNAGDPS YPWLADSWPA TSLPVNNSNS GPNEIGNFGR GDVLPPVPGQ
     GDKTATMLSD GAIYSSIDFT TKTSYNSSSQ ITQATPYATT QILHSNSIHE LAVDLPDPQW
     KSSIQQKTDL MGFGYSLPDQ NKGNNGGKGG KKKKNKNSSK PQKNNGSTWA NVPLPPPPVQ
     PLPGTELEHY AVEQQENGYD SDSWCPPLPV QTYLHQGLED ELEEDDDRVP TPPVRGVASS
     PAISFGQQST ATLTPSPREE MQPMLQAHLD ELTRAYQFDI AKQTWHIQSN NQPPQPPVPP
     LGYVSGALIS DLETDVADDD ADDEEEALEI PRPLRALDQT PGSSMDNLDS SVTGKAFTSS
     QRPRPTSPFS TDSNTSAALS QSQRPRPTKK HKGGRMDQQP ALPHRREGMT DEEALVPYSK
     PSFPSPGGHS SSGTASSKGS TGPRKTEVLR AGHQRNASDL LDIGYMGSNS QGQFTGEL
//
ID   SET1B_HUMAN             Reviewed;        1966 AA.
AC   Q9UPS6; F6MFW1;
DT   05-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   19-MAR-2014, sequence version 3.
DT   13-FEB-2019, entry version 139.
DE   RecName: Full=Histone-lysine N-methyltransferase SETD1B;
DE            EC=2.1.1.43;
DE   AltName: Full=Lysine N-methyltransferase 2G;
DE   AltName: Full=SET domain-containing protein 1B;
DE            Short=hSET1B;
GN   Name=SETD1B; Synonyms=KIAA1076, KMT2G, SET1B;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INTERACTION WITH RBM15, AND
RP   MUTAGENESIS OF LEU-577 AND ASP-579.
RX   PubMed=22927943; DOI=10.1371/journal.pone.0042965;
RA   Lee J.H., Skalnik D.G.;
RT   "Rbm15-Mkl1 interacts with the Setd1b histone H3-Lys4
RT   methyltransferase via a SPOC domain that is required for cytokine-
RT   independent proliferation.";
RL   PLoS ONE 7:E42965-E42965(2012).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1163-1966 (ISOFORM 1/2).
RC   TISSUE=Brain;
RX   PubMed=10470851; DOI=10.1093/dnares/6.3.197;
RA   Kikuno R., Nagase T., Ishikawa K., Hirosawa M., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XIV.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 6:197-205(1999).
RN   [4]
RP   ENZYME ACTIVITY, SUBCELLULAR LOCATION, AND IDENTIFICATION IN THE SET1
RP   COMPLEX.
RX   PubMed=17355966; DOI=10.1074/jbc.M609809200;
RA   Lee J.-H., Tate C.M., You J.-S., Skalnik D.G.;
RT   "Identification and characterization of the human Set1B histone H3-
RT   Lys4 methyltransferase complex.";
RL   J. Biol. Chem. 282:13419-13428(2007).
RN   [5]
RP   IDENTIFICATION IN SET1 COMPLEX, AND INTERACTION WITH WDR82; ASH2L AND
RP   POLR2A.
RX   PubMed=17998332; DOI=10.1128/MCB.01356-07;
RA   Lee J.H., Skalnik D.G.;
RT   "Wdr82 is a C-terminal domain-binding protein that recruits the Setd1A
RT   Histone H3-Lys4 methyltransferase complex to transcription start sites
RT   of transcribed human genes.";
RL   Mol. Cell. Biol. 28:609-618(2008).
RN   [6]
RP   IDENTIFICATION IN SET1 COMPLEX.
RX   PubMed=18838538; DOI=10.1128/MCB.00976-08;
RA   Wu M., Wang P.F., Lee J.S., Martin-Brown S., Florens L., Washburn M.,
RA   Shilatifard A.;
RT   "Molecular regulation of H3K4 trimethylation by Wdr82, a component of
RT   human Set1/COMPASS.";
RL   Mol. Cell. Biol. 28:7337-7344(2008).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1659, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-986; SER-994 AND
RP   SER-1031, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1335, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Histone methyltransferase that specifically methylates
CC       'Lys-4' of histone H3, when part of the SET1 histone
CC       methyltransferase (HMT) complex, but not if the neighboring 'Lys-
CC       9' residue is already methylated. H3 'Lys-4' methylation
CC       represents a specific tag for epigenetic transcriptional
CC       activation. The non-overlapping localization with SETD1A suggests
CC       that SETD1A and SETD1B make non-redundant contributions to the
CC       epigenetic control of chromatin structure and gene expression.
CC       Specifically tri-methylates 'Lys-4' of histone H3 in vitro.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-lysyl-[histone] + S-adenosyl-L-methionine = H(+) +
CC         N(6)-methyl-L-lysyl-[histone] + S-adenosyl-L-homocysteine;
CC         Xref=Rhea:RHEA:10024, Rhea:RHEA-COMP:9845, Rhea:RHEA-COMP:9846,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:29969, ChEBI:CHEBI:57856,
CC         ChEBI:CHEBI:59789, ChEBI:CHEBI:61929; EC=2.1.1.43;
CC         Evidence={ECO:0000269|PubMed:17355966};
CC   -!- SUBUNIT: Component of the SET1 complex, at least composed of the
CC       catalytic subunit (SETD1A or SETD1B), WDR5, WDR82, RBBP5,
CC       ASH2L/ASH2, CXXC1/CFP1, HCFC1 and DPY30. Interacts with HCFC1 and
CC       ASH2L/ASH2. Interacts (via the RRM domain) with WDR82. Interacts
CC       (via the RRM domain) with hyperphosphorylated C-terminal domain
CC       (CTD) of RNA polymerase II large subunit (POLR2A) only in the
CC       presence of WDR82. Binds specifically to CTD heptad repeats
CC       phosphorylated on 'Ser-5' of each heptad. Interacts with RBM15.
CC       {ECO:0000269|PubMed:17355966, ECO:0000269|PubMed:17998332,
CC       ECO:0000269|PubMed:18838538, ECO:0000269|PubMed:22927943}.
CC   -!- INTERACTION:
CC       Q9UBL3-3:ASH2L; NbExp=2; IntAct=EBI-16197836, EBI-16130425;
CC   -!- SUBCELLULAR LOCATION: Nucleus speckle
CC       {ECO:0000269|PubMed:17355966}. Chromosome
CC       {ECO:0000269|PubMed:17355966}. Note=Localizes to a largely non-
CC       overlapping set of euchromatic nuclear speckles with SETD1A,
CC       suggesting that SETD1A and SET1B each bind to a unique set of
CC       target genes.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9UPS6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UPS6-2; Sequence=VSP_053875, VSP_053876;
CC   -!- SIMILARITY: Belongs to the class V-like SAM-binding
CC       methyltransferase superfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00190}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; JF813787; AEG67286.1; -; mRNA.
DR   EMBL; AC079360; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC084018; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AB028999; BAA83028.1; -; mRNA.
DR   CCDS; CCDS86338.1; -. [Q9UPS6-1]
DR   RefSeq; NP_055863.1; NM_015048.1.
DR   RefSeq; XP_005253915.1; XM_005253858.4. [Q9UPS6-1]
DR   RefSeq; XP_006719359.1; XM_006719296.3. [Q9UPS6-1]
DR   UniGene; Hs.507122; -.
DR   PDB; 3UVO; X-ray; 2.20 A; B=1745-1755.
DR   PDB; 4ES0; X-ray; 1.82 A; C=1741-1754.
DR   PDBsum; 3UVO; -.
DR   PDBsum; 4ES0; -.
DR   ProteinModelPortal; Q9UPS6; -.
DR   SMR; Q9UPS6; -.
DR   BioGrid; 116702; 24.
DR   CORUM; Q9UPS6; -.
DR   DIP; DIP-61947N; -.
DR   ELM; Q9UPS6; -.
DR   IntAct; Q9UPS6; 15.
DR   STRING; 9606.ENSP00000267197; -.
DR   iPTMnet; Q9UPS6; -.
DR   PhosphoSitePlus; Q9UPS6; -.
DR   BioMuta; SETD1B; -.
DR   DMDM; 166977692; -.
DR   EPD; Q9UPS6; -.
DR   jPOST; Q9UPS6; -.
DR   PaxDb; Q9UPS6; -.
DR   PeptideAtlas; Q9UPS6; -.
DR   PRIDE; Q9UPS6; -.
DR   ProteomicsDB; 85430; -.
DR   Ensembl; ENST00000542440; ENSP00000442924; ENSG00000139718. [Q9UPS6-2]
DR   Ensembl; ENST00000604567; ENSP00000474253; ENSG00000139718. [Q9UPS6-1]
DR   Ensembl; ENST00000619791; ENSP00000481531; ENSG00000139718. [Q9UPS6-1]
DR   GeneID; 23067; -.
DR   UCSC; uc021rfg.2; human. [Q9UPS6-1]
DR   CTD; 23067; -.
DR   DisGeNET; 23067; -.
DR   EuPathDB; HostDB:ENSG00000139718.10; -.
DR   GeneCards; SETD1B; -.
DR   H-InvDB; HIX0011090; -.
DR   HGNC; HGNC:29187; SETD1B.
DR   HPA; HPA021667; -.
DR   HPA; HPA059412; -.
DR   MIM; 611055; gene.
DR   neXtProt; NX_Q9UPS6; -.
DR   OpenTargets; ENSG00000139718; -.
DR   PharmGKB; PA143485611; -.
DR   eggNOG; KOG1080; Eukaryota.
DR   eggNOG; COG2940; LUCA.
DR   GeneTree; ENSGT00940000154575; -.
DR   HOGENOM; HOG000168216; -.
DR   HOVERGEN; HBG055596; -.
DR   InParanoid; Q9UPS6; -.
DR   OMA; MLQQDNG; -.
DR   OrthoDB; 1234689at2759; -.
DR   TreeFam; TF106436; -.
DR   Reactome; R-HSA-3214841; PKMTs methylate histone lysines.
DR   Reactome; R-HSA-8936459; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function.
DR   GenomeRNAi; 23067; -.
DR   PRO; PR:Q9UPS6; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000139718; Expressed in 240 organ(s), highest expression level in endometrium.
DR   ExpressionAtlas; Q9UPS6; baseline and differential.
DR   Genevisible; Q9UPS6; HS.
DR   GO; GO:0005694; C:chromosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0035097; C:histone methyltransferase complex; IDA:UniProtKB.
DR   GO; GO:0016607; C:nuclear speck; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0048188; C:Set1C/COMPASS complex; IDA:UniProtKB.
DR   GO; GO:0018024; F:histone-lysine N-methyltransferase activity; TAS:Reactome.
DR   GO; GO:0003723; F:RNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0051568; P:histone H3-K4 methylation; IDA:UniProtKB.
DR   CDD; cd12549; RRM_Set1B; 1.
DR   Gene3D; 3.30.70.330; -; 1.
DR   InterPro; IPR024657; COMPASS_Set1_N-SET.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR003616; Post-SET_dom.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   InterPro; IPR034468; Set1B_RRM.
DR   InterPro; IPR001214; SET_dom.
DR   InterPro; IPR037842; SETD1B.
DR   PANTHER; PTHR22884:SF475; PTHR22884:SF475; 1.
DR   Pfam; PF11764; N-SET; 1.
DR   Pfam; PF00076; RRM_1; 1.
DR   Pfam; PF00856; SET; 1.
DR   SMART; SM01291; N-SET; 1.
DR   SMART; SM00508; PostSET; 1.
DR   SMART; SM00360; RRM; 1.
DR   SMART; SM00317; SET; 1.
DR   SUPFAM; SSF54928; SSF54928; 1.
DR   PROSITE; PS50868; POST_SET; 1.
DR   PROSITE; PS50102; RRM; 1.
DR   PROSITE; PS50280; SET; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; Alternative splicing; Chromatin regulator;
KW   Chromosome; Coiled coil; Complete proteome; Methyltransferase;
KW   Nucleus; Phosphoprotein; Reference proteome; RNA-binding;
KW   S-adenosyl-L-methionine; Transcription; Transcription regulation;
KW   Transferase.
FT   CHAIN         1   1966       Histone-lysine N-methyltransferase
FT                                SETD1B.
FT                                /FTId=PRO_0000316993.
FT   DOMAIN       93    181       RRM. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00176}.
FT   DOMAIN     1827   1944       SET. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00190}.
FT   DOMAIN     1950   1966       Post-SET. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00155}.
FT   COILED     1173   1204       {ECO:0000255}.
FT   COMPBIAS    366   1671       Pro-rich.
FT   COMPBIAS   1040   1175       Ser-rich.
FT   COMPBIAS   1068   1312       Glu-rich.
FT   COMPBIAS   1103   1138       Asp-rich.
FT   BINDING    1943   1943       S-adenosyl-L-methionine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00190}.
FT   MOD_RES     986    986       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     994    994       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1031   1031       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1265   1265       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8CFT2}.
FT   MOD_RES    1283   1283       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8CFT2}.
FT   MOD_RES    1335   1335       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES    1659   1659       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES    1663   1663       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8CFT2}.
FT   VAR_SEQ    1043   1068       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_053875.
FT   VAR_SEQ    1088   1104       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_053876.
FT   MUTAGEN     577    577       L->A: Abolishes interaction with RBM15.
FT                                {ECO:0000269|PubMed:22927943}.
FT   MUTAGEN     579    579       D->A: Abolishes interaction with RBM15.
FT                                {ECO:0000269|PubMed:22927943}.
FT   HELIX      1747   1750       {ECO:0000244|PDB:4ES0}.
SQ   SEQUENCE   1966 AA;  212803 MW;  164F81BC84EAD2C2 CRC64;
     MENSHPPHHH HQQPPPQPGP SGERRNHHWR SYKLMIDPAL KKGHHKLYRY DGQHFSLAMS
     SNRPVEIVED PRVVGIWTKN KELELSVPKF KIDEFYVGPV PPKQVTFAKL NDNIRENFLR
     DMCKKYGEVE EVEILYNPKT KKHLGIAKVV FATVRGAKDA VQHLHSTSVM GNIIHVELDT
     KGETRMRFYE LLVTGRYTPQ TLPVGELDAV SPIVNETLQL SDALKRLKDG GLSAGCGSGS
     SSVTPNSGGT PFSQDTAYSS CRLDTPNSYG QGTPLTPRLG TPFSQDSSYS SRQPTPSYLF
     SQDPAVTFKA RRHESKFTDA YNRRHEHHYV HNSPAVTAVA GATAAFRGSS DLPFGAVGGT
     GGSSGPPFKA QPQDSATFAH TPPPAQATPA PGFKSAFSPY QTPVAHFPPP PEEPTATAAF
     GARDSGEFRR APAPPPLPPA EPLAKEKPGT PPGPPPPDTN SMELGGRPTF GWSPEPCDSP
     GTPTLESSPA GPEKPHDSLD SRIEMLLKEQ RTKLLFLREP DSDTELQMEG SPISSSSSQL
     SPLAPFGTNS QPGFRGPTPP SSRPSSTGLE DISPTPLPDS DEDEELDLGL GPRPPPEPGP
     PDPAGLLSQT AEVALDLVGD RTPTSEKMDE GQQSSGEDME ISDDEMPSAP ITSADCPKPM
     VVTPGAAAVA APSVLAPTLP LPPPPGFPPL PPPPPPPPPQ PGFPMPPPLP PPPPPPPPAH
     PAVTVPPPPL PAPPGVPPPP ILPPLPPFPP GLFPVMQVDM SHVLGGQWGG MPMSFQMQTQ
     VLSRLMTGQG ACPYPPFMAA AAAAASAGLQ FVNLPPYRGP FSLSNSGPGR GQHWPPLPKF
     DPSVPPPGYM PRQEDPHKAT VDGVLLVVLK ELKAIMKRDL NRKMVEVVAF RAFDEWWDKK
     ERMAKASLTP VKSGEHKDED RPKPKDRIAS CLLESWGKGE GLGYEGLGLG IGLRGAIRLP
     SFKVKRKEPP DTTSSGDQKR LRPSTSVDEE DEESERERDR DMADTPCELA KRDPKGVGVR
     RRPARPLELD SGGEEDEKES LSASSSSSAS SSSGSSTTSP SSSASDKEEE QESTEEEEEA
     EEEEEEEVPR SQLSSSSTSS TSDKDDDDDD SDDRDESEND DEDTALSEAS EKDEGDSDEE
     ETVSIVTSKA EATSSSESSE SSEFESSSES SPSSSEDEEE VVAREEEEEE EEEEMVAEES
     MASAGPEDFE QDGEEAALAP GAPAVDSLGM EEEVDIETEA VAPEERPSML DEPPLPVGVE
     EPADSREPPE EPGLSQEGAM LLSPEPPAKE VEARPPLSPE RAPEHDLEVE PEPPMMLPLP
     LQPPLPPPRP PRPPSPPPEP ETTDASHPSV PPEPLAEDHP PHTPGLCGSL AKSQSTETVP
     ATPGGEPPLS GGSSGLSLSS PQVPGSPFSY PAPSPSLSSG GLPRTPGRDF SFTPTFSEPS
     GPLLLPVCPL PTGRRDERSG PLASPVLLET GLPLPLPLPL PLPLALPAVL RAQARAPTPL
     PPLLPAPLAS CPPPMKRKPG RPRRSPPSML SLDGPLVRPP AGAALGRELL LLPGQPQTPV
     FPSTHDPRTV TLDFRNAGIP APPPPLPPQP PPPPPPPPVE PTKLPFKELD NQWPSEAIPP
     GPRGRDEVTE EYMELAKSRG PWRRPPKKRH EDLVPPAGSP ELSPPQPLFR PRSEFEEMTI
     LYDIWNGGID EEDIRFLCVT YERLLQQDNG MDWLNDTLWV YHPSTSLSSA KKKKRDDGIR
     EHVTGCARSE GFYTIDKKDK LRYLNSSRAS TDEPPADTQG MSIPAQPHAS TRAGSERRSE
     QRRLLSSFTG SCDSDLLKFN QLKFRKKKLK FCKSHIHDWG LFAMEPIAAD EMVIEYVGQN
     IRQVIADMRE KRYEDEGIGS SYMFRVDHDT IIDATKCGNF ARFINHSCNP NCYAKVITVE
     SQKKIVIYSK QHINVNEEIT YDYKFPIEDV KIPCLCGSEN CRGTLN
//
ID   SHPS1_HUMAN             Reviewed;         504 AA.
AC   P78324; A2A2E1; A8K411; B2R6C3; O00683; O43799; Q8N517; Q8TAL8;
AC   Q9H0Z2; Q9UDX2; Q9UIJ6; Q9Y4U9;
DT   28-MAR-2003, integrated into UniProtKB/Swiss-Prot.
DT   05-APR-2011, sequence version 2.
DT   13-FEB-2019, entry version 194.
DE   RecName: Full=Tyrosine-protein phosphatase non-receptor type substrate 1;
DE            Short=SHP substrate 1;
DE            Short=SHPS-1;
DE   AltName: Full=Brain Ig-like molecule with tyrosine-based activation motifs;
DE            Short=Bit;
DE   AltName: Full=CD172 antigen-like family member A;
DE   AltName: Full=Inhibitory receptor SHPS-1;
DE   AltName: Full=Macrophage fusion receptor;
DE   AltName: Full=MyD-1 antigen;
DE   AltName: Full=Signal-regulatory protein alpha-1;
DE            Short=Sirp-alpha-1;
DE   AltName: Full=Signal-regulatory protein alpha-2;
DE            Short=Sirp-alpha-2;
DE   AltName: Full=Signal-regulatory protein alpha-3;
DE            Short=Sirp-alpha-3;
DE   AltName: Full=p84;
DE   AltName: CD_antigen=CD172a;
DE   Flags: Precursor;
GN   Name=SIRPA; Synonyms=BIT, MFR, MYD1, PTPNS1, SHPS1, SIRP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS SER-44; SER-50;
RP   ILE-52; HIS-54; VAL-57; ALA-75; GLU-95; SER-96; GLU-100; SER-107;
RP   SER-109 AND THR-132.
RC   TISSUE=Brain;
RX   PubMed=9070220; DOI=10.1006/bbrc.1996.6047;
RA   Yamao T., Matozaki T., Amano K., Matsuda Y., Takahashi N., Ochi F.,
RA   Fujioka Y., Kasuga M.;
RT   "Mouse and human SHPS-1: molecular cloning of cDNAs and chromosomal
RT   localization of genes.";
RL   Biochem. Biophys. Res. Commun. 231:61-67(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), POLYMORPHISM, PHOSPHORYLATION,
RP   GLYCOSYLATION, INTERACTION WITH PTPN11; PTPN6 AND GRB2, AND VARIANTS
RP   SER-44; SER-50; ILE-52; HIS-54; VAL-57; ALA-75; GLU-95; SER-96;
RP   GLU-100; SER-107; SER-109 AND THR-132.
RC   TISSUE=Placenta;
RX   PubMed=9062191; DOI=10.1038/386181a0;
RA   Kharitonenkov A., Chen Z., Sures I., Wang H., Schilling J.,
RA   Ullrich A.;
RT   "A family of proteins that inhibit signalling through tyrosine kinase
RT   receptors.";
RL   Nature 386:181-186(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=10585853; DOI=10.1042/bj3440667;
RA   Sano S., Ohnishi H., Kubota M.;
RT   "Gene structure of mouse BIT/SHPS-1.";
RL   Biochem. J. 344:667-675(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANTS
RP   SER-44; SER-50; ILE-52; HIS-54; VAL-57; ALA-75; GLU-95; SER-96;
RP   GLU-100; SER-107; SER-109 AND THR-132.
RC   TISSUE=Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND
RP   VARIANTS SER-44; SER-50; ILE-52; HIS-54; VAL-57; ALA-75; GLU-95;
RP   SER-96; GLU-100; SER-107; SER-109 AND THR-132.
RC   TISSUE=Brain, Kidney, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 76-504.
RC   TISSUE=Monocyte;
RX   PubMed=9485180;
RX   DOI=10.1002/(SICI)1521-4141(199801)28:01<1::AID-IMMU1>3.3.CO;2-M;
RA   Brooke G.P., Parsons K.R., Howard C.J.;
RT   "Cloning of two members of the SIRP alpha family of protein tyrosine
RT   phosphatase binding proteins in cattle that are expressed on monocytes
RT   and a subpopulation of dendritic cells and which mediate binding to
RT   CD4 T cells.";
RL   Eur. J. Immunol. 28:1-11(1998).
RN   [8]
RP   FUNCTION, AND INTERACTION WITH FYB1; SCAP2 AND PTK2B.
RX   PubMed=10469599; DOI=10.1016/S0960-9822(99)80401-1;
RA   Timms J.F., Swanson K.D., Marie-Cardine A., Raab M., Rudd C.E.,
RA   Schraven B., Neel B.G.;
RT   "SHPS-1 is a scaffold for assembling distinct adhesion-regulated
RT   multi-protein complexes in macrophages.";
RL   Curr. Biol. 9:927-930(1999).
RN   [9]
RP   PHOSPHORYLATION BY JAK2, AND INTERACTION WITH PTPN11 AND JAK2.
RX   PubMed=10842184; DOI=10.1074/jbc.M004238200;
RA   Stofega M.R., Argetsinger L.S., Wang H., Ullrich A., Carter-Su C.;
RT   "Negative regulation of growth hormone receptor/JAK2 signaling by
RT   signal regulatory protein alpha.";
RL   J. Biol. Chem. 275:28222-28229(2000).
RN   [10]
RP   FUNCTION, AND INTERACTION WITH CD47.
RX   PubMed=11509594; DOI=10.4049/jimmunol.167.5.2547;
RA   Latour S., Tanaka H., Demeure C., Mateo V., Rubio M., Brown E.J.,
RA   Maliszewski C., Lindberg F.P., Oldenborg A., Ullrich A.,
RA   Delespesse G., Sarfati M.;
RT   "Bidirectional negative regulation of human T and dendritic cells by
RT   CD47 and its cognate receptor signal-regulator protein-alpha: down-
RT   regulation of IL-12 responsiveness and inhibition of dendritic cell
RT   activation.";
RL   J. Immunol. 167:2547-2554(2001).
RN   [11]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-245.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,
RA   Moore R.J., Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [12]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-270 AND ASN-292.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-496, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 31-149, AND DISULFIDE BOND.
RX   PubMed=17369261; DOI=10.1074/jbc.M611511200;
RA   Hatherley D., Harlos K., Dunlop D.C., Stuart D.I., Barclay A.N.;
RT   "The structure of the macrophage signal regulatory protein alpha
RT   (SIRPalpha) inhibitory receptor reveals a binding face reminiscent of
RT   that used by T cell receptors.";
RL   J. Biol. Chem. 282:14567-14575(2007).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 31-149 IN COMPLEX WITH CD47,
RP   AND DISULFIDE BOND.
RX   PubMed=18657508; DOI=10.1016/j.molcel.2008.05.026;
RA   Hatherley D., Graham S.C., Turner J., Harlos K., Stuart D.I.,
RA   Barclay A.N.;
RT   "Paired receptor specificity explained by structures of signal
RT   regulatory proteins alone and complexed with CD47.";
RL   Mol. Cell 31:266-277(2008).
CC   -!- FUNCTION: Immunoglobulin-like cell surface receptor for CD47. Acts
CC       as docking protein and induces translocation of PTPN6, PTPN11 and
CC       other binding partners from the cytosol to the plasma membrane.
CC       Supports adhesion of cerebellar neurons, neurite outgrowth and
CC       glial cell attachment. May play a key role in intracellular
CC       signaling during synaptogenesis and in synaptic function (By
CC       similarity). Involved in the negative regulation of receptor
CC       tyrosine kinase-coupled cellular responses induced by cell
CC       adhesion, growth factors or insulin. Mediates negative regulation
CC       of phagocytosis, mast cell activation and dendritic cell
CC       activation. CD47 binding prevents maturation of immature dendritic
CC       cells and inhibits cytokine production by mature dendritic cells.
CC       {ECO:0000250, ECO:0000269|PubMed:10469599,
CC       ECO:0000269|PubMed:11509594}.
CC   -!- SUBUNIT: Binds PTPN11 when tyrosine-phosphorylated, except in
CC       macrophages, where it primarily binds PTPN6. Binds GRB2 in vitro.
CC       Binds FGR (By similarity). Binds JAK2 irrespective of its
CC       phosphorylation status and forms a stable complex. Binds SCAP1
CC       and/or SCAP2. The resulting complex recruits FYB1. Binds PTK2B.
CC       {ECO:0000250, ECO:0000269|PubMed:18657508}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P78324-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P78324-2; Sequence=VSP_007030;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=P78324-4; Sequence=VSP_040799;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Highly expressed in brain.
CC       Detected on myeloid cells, but not T-cells. Detected at lower
CC       levels in heart, placenta, lung, testis, ovary, colon, liver,
CC       small intestine, prostate, spleen, kidney, skeletal muscle and
CC       pancreas.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:16335952,
CC       ECO:0000269|PubMed:19159218, ECO:0000269|PubMed:9062191}.
CC   -!- PTM: Phosphorylated on tyrosine residues in response to
CC       stimulation with EGF, growth hormone, insulin and PDGF.
CC       Dephosphorylated by PTPN11. {ECO:0000269|PubMed:10842184,
CC       ECO:0000269|PubMed:9062191}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; D86043; BAA12974.1; -; mRNA.
DR   EMBL; Y10375; CAA71403.1; -; mRNA.
DR   EMBL; AB023430; BAA87929.1; -; mRNA.
DR   EMBL; AK290776; BAF83465.1; -; mRNA.
DR   EMBL; AK312521; BAG35420.1; -; mRNA.
DR   EMBL; AL034562; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL117335; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC026692; AAH26692.1; -; mRNA.
DR   EMBL; BC033092; AAH33092.1; -; mRNA.
DR   EMBL; BC038510; AAH38510.1; -; mRNA.
DR   EMBL; BC075849; AAH75849.1; -; mRNA.
DR   EMBL; Y11047; CAA71944.1; -; mRNA.
DR   CCDS; CCDS13022.1; -. [P78324-1]
DR   CCDS; CCDS82593.1; -. [P78324-2]
DR   PIR; JC5287; JC5287.
DR   RefSeq; NP_001035111.1; NM_001040022.1. [P78324-1]
DR   RefSeq; NP_001035112.1; NM_001040023.1. [P78324-1]
DR   RefSeq; NP_001317657.1; NM_001330728.1. [P78324-2]
DR   RefSeq; NP_542970.1; NM_080792.2. [P78324-1]
DR   RefSeq; XP_005260727.1; XM_005260670.3. [P78324-2]
DR   UniGene; Hs.581021; -.
DR   PDB; 2JJS; X-ray; 1.85 A; A/B=31-149.
DR   PDB; 2JJT; X-ray; 2.30 A; A/B=31-149.
DR   PDB; 2UV3; X-ray; 1.80 A; A/B=31-149.
DR   PDB; 2WNG; X-ray; 2.49 A; A=31-350.
DR   PDB; 4CMM; X-ray; 1.92 A; A=31-149.
DR   PDB; 6BIT; X-ray; 2.19 A; G/H=31-147.
DR   PDBsum; 2JJS; -.
DR   PDBsum; 2JJT; -.
DR   PDBsum; 2UV3; -.
DR   PDBsum; 2WNG; -.
DR   PDBsum; 4CMM; -.
DR   PDBsum; 6BIT; -.
DR   ProteinModelPortal; P78324; -.
DR   SMR; P78324; -.
DR   BioGrid; 126752; 17.
DR   IntAct; P78324; 7.
DR   STRING; 9606.ENSP00000348307; -.
DR   GlyConnect; 650; -.
DR   iPTMnet; P78324; -.
DR   PhosphoSitePlus; P78324; -.
DR   UniCarbKB; P78324; -.
DR   BioMuta; SIRPA; -.
DR   DMDM; 327478534; -.
DR   EPD; P78324; -.
DR   jPOST; P78324; -.
DR   MaxQB; P78324; -.
DR   PaxDb; P78324; -.
DR   PeptideAtlas; P78324; -.
DR   PRIDE; P78324; -.
DR   ProteomicsDB; 57564; -.
DR   ProteomicsDB; 57565; -. [P78324-2]
DR   ProteomicsDB; 57566; -. [P78324-4]
DR   DNASU; 140885; -.
DR   Ensembl; ENST00000356025; ENSP00000348307; ENSG00000198053. [P78324-1]
DR   Ensembl; ENST00000358771; ENSP00000351621; ENSG00000198053. [P78324-1]
DR   Ensembl; ENST00000400068; ENSP00000382941; ENSG00000198053. [P78324-1]
DR   Ensembl; ENST00000622179; ENSP00000478763; ENSG00000198053. [P78324-2]
DR   GeneID; 140885; -.
DR   KEGG; hsa:140885; -.
DR   UCSC; uc002wfq.3; human. [P78324-1]
DR   CTD; 140885; -.
DR   DisGeNET; 140885; -.
DR   EuPathDB; HostDB:ENSG00000198053.11; -.
DR   GeneCards; SIRPA; -.
DR   HGNC; HGNC:9662; SIRPA.
DR   HPA; CAB002776; -.
DR   HPA; CAB015122; -.
DR   HPA; HPA054437; -.
DR   HPA; HPA058511; -.
DR   MIM; 602461; gene.
DR   neXtProt; NX_P78324; -.
DR   OpenTargets; ENSG00000198053; -.
DR   PharmGKB; PA34006; -.
DR   eggNOG; ENOG410IKYM; Eukaryota.
DR   eggNOG; ENOG410YKK2; LUCA.
DR   GeneTree; ENSGT00940000163683; -.
DR   HOVERGEN; HBG056632; -.
DR   InParanoid; P78324; -.
DR   KO; K06551; -.
DR   OMA; RAAEPNN; -.
DR   OrthoDB; 962484at2759; -.
DR   PhylomeDB; P78324; -.
DR   TreeFam; TF341862; -.
DR   Reactome; R-HSA-202733; Cell surface interactions at the vascular wall.
DR   Reactome; R-HSA-391160; Signal regulatory protein family interactions.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   SignaLink; P78324; -.
DR   SIGNOR; P78324; -.
DR   ChiTaRS; SIRPA; human.
DR   EvolutionaryTrace; P78324; -.
DR   GeneWiki; Signal-regulatory_protein_alpha; -.
DR   GenomeRNAi; 140885; -.
DR   PRO; PR:P78324; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   Bgee; ENSG00000198053; Expressed in 217 organ(s), highest expression level in anterior cingulate cortex.
DR   Genevisible; P78324; HS.
DR   GO; GO:0009986; C:cell surface; IDA:ARUK-UCL.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0101003; C:ficolin-1-rich granule membrane; TAS:Reactome.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:ARUK-UCL.
DR   GO; GO:0016020; C:membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0070821; C:tertiary granule membrane; TAS:Reactome.
DR   GO; GO:0098632; F:cell-cell adhesion mediator activity; IPI:ARUK-UCL.
DR   GO; GO:0030695; F:GTPase regulator activity; ISS:ARUK-UCL.
DR   GO; GO:1990405; F:protein antigen binding; IPI:ARUK-UCL.
DR   GO; GO:0086080; F:protein binding involved in heterotypic cell-cell adhesion; ISS:ARUK-UCL.
DR   GO; GO:0019903; F:protein phosphatase binding; ISS:ARUK-UCL.
DR   GO; GO:1990782; F:protein tyrosine kinase binding; ISS:ARUK-UCL.
DR   GO; GO:0017124; F:SH3 domain binding; IEA:UniProtKB-KW.
DR   GO; GO:0007155; P:cell adhesion; TAS:ProtInc.
DR   GO; GO:0016477; P:cell migration; ISS:ARUK-UCL.
DR   GO; GO:0070301; P:cellular response to hydrogen peroxide; ISS:ARUK-UCL.
DR   GO; GO:0071346; P:cellular response to interferon-gamma; ISS:ARUK-UCL.
DR   GO; GO:0071347; P:cellular response to interleukin-1; ISS:ARUK-UCL.
DR   GO; GO:0071349; P:cellular response to interleukin-12; IMP:ARUK-UCL.
DR   GO; GO:0071222; P:cellular response to lipopolysaccharide; ISS:ARUK-UCL.
DR   GO; GO:0050900; P:leukocyte migration; TAS:Reactome.
DR   GO; GO:0035696; P:monocyte extravasation; ISS:ARUK-UCL.
DR   GO; GO:0071650; P:negative regulation of chemokine (C-C motif) ligand 5 production; ISS:ARUK-UCL.
DR   GO; GO:1900016; P:negative regulation of cytokine production involved in inflammatory response; ISS:ARUK-UCL.
DR   GO; GO:0070373; P:negative regulation of ERK1 and ERK2 cascade; ISS:ARUK-UCL.
DR   GO; GO:1903720; P:negative regulation of I-kappaB phosphorylation; ISS:ARUK-UCL.
DR   GO; GO:0050728; P:negative regulation of inflammatory response; IMP:ARUK-UCL.
DR   GO; GO:0032688; P:negative regulation of interferon-beta production; ISS:ARUK-UCL.
DR   GO; GO:0032715; P:negative regulation of interleukin-6 production; ISS:ARUK-UCL.
DR   GO; GO:0046329; P:negative regulation of JNK cascade; ISS:ARUK-UCL.
DR   GO; GO:0071641; P:negative regulation of macrophage inflammatory protein 1 alpha production; ISS:ARUK-UCL.
DR   GO; GO:0045019; P:negative regulation of nitric oxide biosynthetic process; ISS:ARUK-UCL.
DR   GO; GO:0050765; P:negative regulation of phagocytosis; ISS:ARUK-UCL.
DR   GO; GO:0001933; P:negative regulation of protein phosphorylation; ISS:ARUK-UCL.
DR   GO; GO:0032720; P:negative regulation of tumor necrosis factor production; ISS:ARUK-UCL.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0022409; P:positive regulation of cell-cell adhesion; IBA:GO_Central.
DR   GO; GO:0050766; P:positive regulation of phagocytosis; IBA:GO_Central.
DR   GO; GO:0050870; P:positive regulation of T cell activation; IBA:GO_Central.
DR   GO; GO:0010468; P:regulation of gene expression; IMP:ARUK-UCL.
DR   GO; GO:0032649; P:regulation of interferon-gamma production; IMP:ARUK-UCL.
DR   GO; GO:0032651; P:regulation of interleukin-1 beta production; ISS:ARUK-UCL.
DR   GO; GO:0032675; P:regulation of interleukin-6 production; ISS:ARUK-UCL.
DR   GO; GO:0045428; P:regulation of nitric oxide biosynthetic process; ISS:ARUK-UCL.
DR   GO; GO:0032680; P:regulation of tumor necrosis factor production; IGI:ARUK-UCL.
DR   Gene3D; 2.60.40.10; -; 3.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR013106; Ig_V-set.
DR   Pfam; PF07654; C1-set; 2.
DR   Pfam; PF07686; V-set; 1.
DR   SMART; SM00409; IG; 2.
DR   SMART; SM00407; IGc1; 2.
DR   SMART; SM00406; IGv; 1.
DR   SUPFAM; SSF48726; SSF48726; 3.
DR   PROSITE; PS50835; IG_LIKE; 3.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Disulfide bond;
KW   Glycoprotein; Immunoglobulin domain; Membrane; Phosphoprotein;
KW   Polymorphism; Reference proteome; Repeat; SH3-binding; Signal;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL        1     30       {ECO:0000255}.
FT   CHAIN        31    504       Tyrosine-protein phosphatase non-receptor
FT                                type substrate 1.
FT                                /FTId=PRO_0000014941.
FT   TOPO_DOM     31    373       Extracellular. {ECO:0000255}.
FT   TRANSMEM    374    394       Helical. {ECO:0000255}.
FT   TOPO_DOM    395    504       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       32    137       Ig-like V-type.
FT   DOMAIN      148    247       Ig-like C1-type 1.
FT   DOMAIN      254    348       Ig-like C1-type 2.
FT   MOTIF       429    432       SH2-binding. {ECO:0000255}.
FT   MOTIF       439    444       SH3-binding. {ECO:0000255}.
FT   MOTIF       453    456       SH2-binding. {ECO:0000255}.
FT   MOTIF       470    473       SH2-binding. {ECO:0000255}.
FT   MOTIF       496    499       SH2-binding. {ECO:0000255}.
FT   MOD_RES     429    429       Phosphotyrosine; by Tyr-kinases.
FT                                {ECO:0000255}.
FT   MOD_RES     453    453       Phosphotyrosine; by Tyr-kinases.
FT                                {ECO:0000255}.
FT   MOD_RES     470    470       Phosphotyrosine; by Tyr-kinases.
FT                                {ECO:0000250|UniProtKB:P97710}.
FT   MOD_RES     496    496       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   CARBOHYD    245    245       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:16335952}.
FT   CARBOHYD    270    270       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    292    292       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    319    319       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     55    121       {ECO:0000255|PROSITE-ProRule:PRU00114,
FT                                ECO:0000269|PubMed:17369261,
FT                                ECO:0000269|PubMed:18657508}.
FT   DISULFID    170    228       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   DISULFID    273    331       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   VAR_SEQ     130    130       Missing (in isoform 4). {ECO:0000305}.
FT                                /FTId=VSP_040799.
FT   VAR_SEQ     422    422       Q -> QVQSL (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_007030.
FT   VARIANT       6      7       PA -> RS.
FT                                /FTId=VAR_015462.
FT   VARIANT      20     20       A -> P.
FT                                /FTId=VAR_015463.
FT   VARIANT      40     40       D -> E (in dbSNP:rs1349896458).
FT                                /FTId=VAR_015464.
FT   VARIANT      44     44       L -> S (in dbSNP:rs143735290).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:9062191,
FT                                ECO:0000269|PubMed:9070220}.
FT                                /FTId=VAR_015465.
FT   VARIANT      50     50       T -> S (in dbSNP:rs17855609).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:9062191,
FT                                ECO:0000269|PubMed:9070220}.
FT                                /FTId=VAR_015466.
FT   VARIANT      52     52       T -> I (in dbSNP:rs17855610).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:9062191,
FT                                ECO:0000269|PubMed:9070220}.
FT                                /FTId=VAR_015468.
FT   VARIANT      54     54       R -> H (in dbSNP:rs17855611).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:9062191,
FT                                ECO:0000269|PubMed:9070220}.
FT                                /FTId=VAR_015470.
FT   VARIANT      57     57       A -> V (in dbSNP:rs17855612).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:9062191,
FT                                ECO:0000269|PubMed:9070220}.
FT                                /FTId=VAR_015471.
FT   VARIANT      61     61       I -> N (in dbSNP:rs1371837011).
FT                                /FTId=VAR_015472.
FT   VARIANT      68     68       W -> R.
FT                                /FTId=VAR_015473.
FT   VARIANT      75     75       G -> A (in dbSNP:rs1057114).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:9062191,
FT                                ECO:0000269|PubMed:9070220}.
FT                                /FTId=VAR_015474.
FT   VARIANT      77     77       E -> K (in dbSNP:rs1182420620).
FT                                /FTId=VAR_015475.
FT   VARIANT      81     81       N -> H.
FT                                /FTId=VAR_015477.
FT   VARIANT      95     95       D -> E (in dbSNP:rs138283486).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:9062191,
FT                                ECO:0000269|PubMed:9070220}.
FT                                /FTId=VAR_015478.
FT   VARIANT      96     96       L -> S. {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:9062191,
FT                                ECO:0000269|PubMed:9070220}.
FT                                /FTId=VAR_015479.
FT   VARIANT     100    100       N -> E (requires 2 nucleotide
FT                                substitutions; dbSNP:rs386811662).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:9062191,
FT                                ECO:0000269|PubMed:9070220}.
FT                                /FTId=VAR_015480.
FT   VARIANT     107    107       R -> S (in dbSNP:rs17855615).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:9062191,
FT                                ECO:0000269|PubMed:9070220}.
FT                                /FTId=VAR_015483.
FT   VARIANT     109    109       G -> S (in dbSNP:rs17855616).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:9062191,
FT                                ECO:0000269|PubMed:9070220}.
FT                                /FTId=VAR_015484.
FT   VARIANT     125    125       R -> Q (in dbSNP:rs767136065).
FT                                /FTId=VAR_015485.
FT   VARIANT     132    132       V -> T (requires 2 nucleotide
FT                                substitutions; dbSNP:rs386811663).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:9062191,
FT                                ECO:0000269|PubMed:9070220}.
FT                                /FTId=VAR_015486.
FT   VARIANT     134    134       F -> L.
FT                                /FTId=VAR_015487.
FT   VARIANT     163    163       Q -> D (requires 2 nucleotide
FT                                substitutions).
FT                                /FTId=VAR_015488.
FT   VARIANT     181    181       T -> S.
FT                                /FTId=VAR_015489.
FT   VARIANT     190    190       E -> Q.
FT                                /FTId=VAR_015490.
FT   VARIANT     201    202       VG -> AR.
FT                                /FTId=VAR_015491.
FT   VARIANT     214    214       K -> N.
FT                                /FTId=VAR_015492.
FT   VARIANT     220    220       E -> G.
FT                                /FTId=VAR_015493.
FT   VARIANT     222    222       V -> I (in dbSNP:rs143385810).
FT                                /FTId=VAR_015494.
FT   VARIANT     236    236       Q -> R.
FT                                /FTId=VAR_015495.
FT   VARIANT     239    240       PL -> SF.
FT                                /FTId=VAR_015496.
FT   VARIANT     251    251       R -> Q (in dbSNP:rs377448893).
FT                                /FTId=VAR_015497.
FT   VARIANT     261    261       Q -> L.
FT                                /FTId=VAR_015498.
FT   VARIANT     263    263       V -> M (in dbSNP:rs754806675).
FT                                /FTId=VAR_015499.
FT   VARIANT     271    271       V -> I.
FT                                /FTId=VAR_015500.
FT   VARIANT     276    276       R -> T.
FT                                /FTId=VAR_015501.
FT   VARIANT     302    302       V -> L (in dbSNP:rs2422666).
FT                                /FTId=VAR_015502.
FT   VARIANT     339    339       P -> S.
FT                                /FTId=VAR_015503.
FT   VARIANT     353    353       P -> L (in dbSNP:rs138876160).
FT                                /FTId=VAR_015504.
FT   VARIANT     357    357       G -> S (in dbSNP:rs1200233096).
FT                                /FTId=VAR_015505.
FT   VARIANT     367    367       S -> P.
FT                                /FTId=VAR_015506.
FT   VARIANT     370    370       R -> Q (in dbSNP:rs778218860).
FT                                /FTId=VAR_015507.
FT   VARIANT     389    389       A -> E.
FT                                /FTId=VAR_015508.
FT   VARIANT     443    443       Q -> R.
FT                                /FTId=VAR_015509.
FT   VARIANT     460    460       P -> L (in dbSNP:rs1168490568).
FT                                /FTId=VAR_015510.
FT   VARIANT     486    486       A -> L (requires 2 nucleotide
FT                                substitutions).
FT                                /FTId=VAR_015511.
FT   VARIANT     491    491       P -> L (in dbSNP:rs367629199).
FT                                /FTId=VAR_015512.
FT   CONFLICT    259    259       T -> I (in Ref. 7; CAA71944).
FT                                {ECO:0000305}.
FT   CONFLICT    503    503       R -> K (in Ref. 7; CAA71944).
FT                                {ECO:0000305}.
FT   STRAND       41     46       {ECO:0000244|PDB:2UV3}.
FT   STRAND       51     53       {ECO:0000244|PDB:2UV3}.
FT   STRAND       56     58       {ECO:0000244|PDB:2UV3}.
FT   STRAND       66     70       {ECO:0000244|PDB:2UV3}.
FT   STRAND       77     85       {ECO:0000244|PDB:2UV3}.
FT   STRAND       90     94       {ECO:0000244|PDB:2UV3}.
FT   STRAND      106    110       {ECO:0000244|PDB:2UV3}.
FT   HELIX       113    115       {ECO:0000244|PDB:2UV3}.
FT   STRAND      117    125       {ECO:0000244|PDB:2UV3}.
FT   STRAND      127    129       {ECO:0000244|PDB:2UV3}.
FT   STRAND      132    136       {ECO:0000244|PDB:2UV3}.
FT   STRAND      140    145       {ECO:0000244|PDB:2UV3}.
FT   STRAND      152    154       {ECO:0000244|PDB:2WNG}.
FT   STRAND      165    178       {ECO:0000244|PDB:2WNG}.
FT   STRAND      181    186       {ECO:0000244|PDB:2WNG}.
FT   STRAND      194    199       {ECO:0000244|PDB:2WNG}.
FT   STRAND      207    216       {ECO:0000244|PDB:2WNG}.
FT   HELIX       221    223       {ECO:0000244|PDB:2WNG}.
FT   STRAND      225    231       {ECO:0000244|PDB:2WNG}.
FT   STRAND      240    245       {ECO:0000244|PDB:2WNG}.
FT   HELIX       246    248       {ECO:0000244|PDB:2WNG}.
FT   STRAND      255    261       {ECO:0000244|PDB:2WNG}.
FT   STRAND      269    281       {ECO:0000244|PDB:2WNG}.
FT   STRAND      283    289       {ECO:0000244|PDB:2WNG}.
FT   STRAND      292    298       {ECO:0000244|PDB:2WNG}.
FT   STRAND      310    318       {ECO:0000244|PDB:2WNG}.
FT   STRAND      328    335       {ECO:0000244|PDB:2WNG}.
FT   STRAND      341    346       {ECO:0000244|PDB:2WNG}.
SQ   SEQUENCE   504 AA;  54967 MW;  18D2FD04F6182AD0 CRC64;
     MEPAGPAPGR LGPLLCLLLA ASCAWSGVAG EEELQVIQPD KSVLVAAGET ATLRCTATSL
     IPVGPIQWFR GAGPGRELIY NQKEGHFPRV TTVSDLTKRN NMDFSIRIGN ITPADAGTYY
     CVKFRKGSPD DVEFKSGAGT ELSVRAKPSA PVVSGPAARA TPQHTVSFTC ESHGFSPRDI
     TLKWFKNGNE LSDFQTNVDP VGESVSYSIH STAKVVLTRE DVHSQVICEV AHVTLQGDPL
     RGTANLSETI RVPPTLEVTQ QPVRAENQVN VTCQVRKFYP QRLQLTWLEN GNVSRTETAS
     TVTENKDGTY NWMSWLLVNV SAHRDDVKLT CQVEHDGQPA VSKSHDLKVS AHPKEQGSNT
     AAENTGSNER NIYIVVGVVC TLLVALLMAA LYLVRIRQKK AQGSTSSTRL HEPEKNAREI
     TQDTNDITYA DLNLPKGKKP APQAAEPNNH TEYASIQTSP QPASEDTLTY ADLDMVHLNR
     TPKQPAPKPE PSFSEYASVQ VPRK
//
ID   A0A384MR33_HUMAN        Unreviewed;      1233 AA.
AC   A0A384MR33;
DT   05-DEC-2018, integrated into UniProtKB/TrEMBL.
DT   05-DEC-2018, sequence version 1.
DT   13-FEB-2019, entry version 3.
DE   RecName: Full=Structural maintenance of chromosomes protein {ECO:0000256|PIRNR:PIRNR005719};
GN   Name=SMC1L1 {ECO:0000313|EMBL:EAW93150.1};
GN   ORFNames=hCG_18494 {ECO:0000313|EMBL:EAW93150.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ADO22411.1};
RN   [1] {ECO:0000313|EMBL:EAW93150.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW93150.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:ADO22411.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Hoernsten L., Su C., Osbourn A.E., Hellman U., Wernstedt C.,
RA   Oliw E.H.;
RL   Submitted (SEP-2009) to the EMBL/GenBank/DDBJ databases.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000256|PIRNR:PIRNR005719}.
CC   -!- SIMILARITY: Belongs to the SMC family.
CC       {ECO:0000256|PIRNR:PIRNR005719}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; GQ900894; ADO22411.1; -; mRNA.
DR   EMBL; CH471154; EAW93150.1; -; Genomic_DNA.
DR   RefSeq; NP_006297.2; NM_006306.3.
DR   GeneID; 8243; -.
DR   GO; GO:0008278; C:cohesin complex; IEA:InterPro.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0003682; F:chromatin binding; IEA:InterPro.
DR   GO; GO:0006281; P:DNA repair; IEA:InterPro.
DR   GO; GO:0007064; P:mitotic sister chromatid cohesion; IEA:InterPro.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR003395; RecF/RecN/SMC_N.
DR   InterPro; IPR024704; SMC.
DR   InterPro; IPR029683; SMC1A_metazoan.
DR   InterPro; IPR010935; SMC_hinge.
DR   InterPro; IPR036277; SMC_hinge_sf.
DR   PANTHER; PTHR18937:SF170; PTHR18937:SF170; 1.
DR   Pfam; PF06470; SMC_hinge; 1.
DR   Pfam; PF02463; SMC_N; 1.
DR   PIRSF; PIRSF005719; SMC; 1.
DR   SMART; SM00968; SMC_hinge; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   SUPFAM; SSF75553; SSF75553; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Nucleus {ECO:0000256|PIRNR:PIRNR005719}.
FT   DOMAIN      513    629       SMC hinge. {ECO:0000259|SMART:SM00968}.
FT   COILED      189    222       {ECO:0000256|SAM:Coils}.
FT   COILED      232    293       {ECO:0000256|SAM:Coils}.
FT   COILED      302    360       {ECO:0000256|SAM:Coils}.
FT   COILED      365    399       {ECO:0000256|SAM:Coils}.
FT   COILED      407    490       {ECO:0000256|SAM:Coils}.
FT   COILED      664    711       {ECO:0000256|SAM:Coils}.
FT   COILED      748    775       {ECO:0000256|SAM:Coils}.
FT   COILED      789    814       {ECO:0000256|SAM:Coils}.
FT   COILED      828    925       {ECO:0000256|SAM:Coils}.
FT   COILED      992   1016       {ECO:0000256|SAM:Coils}.
FT   COILED     1024   1065       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   1233 AA;  143233 MW;  E0A44CA7476C88A6 CRC64;
     MGFLKLIEIE NFKSYKGRQI IGPFQRFTAI IGPNGSGKSN LMDAISFVLG EKTSNLRVKT
     LRDLIHGAPV GKPAANRAFV SMVYSEEGAE DRTFARVIVG GSSEYKINNK VVQLHEYSEE
     LEKLGILIKA RNFLVFQGAV ESIAMKNPKE RTALFEEISR SGELAQEYDK RKKEMVKAEE
     DTQFNYHRKK NIAAERKEAK QEKEEADRYQ RLKDEVVRAQ VQLQLFKLYH NEVEIEKLNK
     ELASKNKEIE KDKKRMDKVE DELKEKKKEL GKMMREQQQI EKEIKEKDSE LNQKRPQYIK
     AKENTSHKIK KLEAAKKSLQ NAQKHYKKRK GDMDELEKEM LSVEKARQEF EERMEEESQS
     QGRDLTLEEN QVKKYHRLKE EASKRAATLA QELEKFNRDQ KADQDRLDLE ERKKVETEAK
     IKQKLREIEE NQKRIEKLEE YITTSKQSLE EQKKLEGELT EEVEMAKRRI DEINKELNQV
     MEQLGDARID RQESSRQQRK AEIMESIKRL YPGSVYGRLI DLCQPTQKKY QIAVTKVLGK
     NMDAIIVDSE KTGRDCIQYI KEQRGEPETF LPLDYLEVKP TDEKLRELKG AKLVIDVIRY
     EPPHIKKALQ YACGNALVCD NVEDARRIAF GGHQRHKTVA LDGTLFQKSG VISGGASDLK
     AKARRWDEKA VDKLKEKKER LTEELKEQMK AKRKEAELRQ VQSQAHGLQM RLKYSQSDLE
     QTKTRHLALN LQEKSKLESE LANFGPRIND IKRIIQSRER EMKDLKEKMN QVEDEVFEEF
     CREIGVRNIR EFEEEKVKRQ NEIAKKRLEF ENQKTRLGIQ LDFEKNQLKE DQDKVHMWEQ
     TVKKDENEIE KLKKEEQRHM KIIDETMAQL QDLKNQHLAK KSEVNDKNHE MEEIRKKLGG
     ANKEMTHLQK EVTAIETKLE QKRSDRHNLL QACKMQDIKL PLSKGTMDDI SQEEGSSQGE
     DSVSGSQRIS SIYAREALIE IDYGDLCEDL KDAQAEEEIK QEMNTLQQKL NEQQSVLQRI
     AAPNMKAMEK LESVRDKFQE TSDEFEAARK RAKKAKQAFE QIKKERFDRF NACFESVATN
     IDEIYKALSR NSSAQAFLGP ENPEEPYLDG INYNCVAPGK RFRPMDNLSG GEKTVAALAL
     LFAIHSYKPA PFFVLDEIDA ALDNTNIGKV ANYIKEQSTC NFQAIVISLK EEFYTKAESL
     IGVYPEQGDC VISKVLTFDL TKYPDANPNP NEQ
//
ID   G8JLG1_HUMAN            Unreviewed;      1211 AA.
AC   G8JLG1;
DT   25-JAN-2012, integrated into UniProtKB/TrEMBL.
DT   29-OCT-2014, sequence version 2.
DT   16-JAN-2019, entry version 62.
DE   RecName: Full=Structural maintenance of chromosomes protein {ECO:0000256|PIRNR:PIRNR005719};
GN   Name=SMC1A {ECO:0000313|Ensembl:ENSP00000364489};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000364489, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000364489, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [2] {ECO:0000213|PubMed:17525332}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R., Hurov K.E.,
RA   Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y.,
RA   Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [3] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [4] {ECO:0000213|PubMed:19690332}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:ra46-RA46(2009).
RN   [5] {ECO:0000213|PubMed:19608861}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [6] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:ra3-RA3(2010).
RN   [7] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [8] {ECO:0000213|PubMed:21406692}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:rs3-RS3(2011).
RN   [9] {ECO:0000313|Ensembl:ENSP00000364489}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (NOV-2011) to UniProtKB.
RN   [10] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000256|PIRNR:PIRNR005719}.
CC   -!- SIMILARITY: Belongs to the SMC family.
CC       {ECO:0000256|PIRNR:PIRNR005719}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AC233728; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001268392.1; NM_001281463.1.
DR   UniGene; Hs.211602; -.
DR   ProteinModelPortal; G8JLG1; -.
DR   EPD; G8JLG1; -.
DR   jPOST; G8JLG1; -.
DR   PeptideAtlas; G8JLG1; -.
DR   PRIDE; G8JLG1; -.
DR   Ensembl; ENST00000375340; ENSP00000364489; ENSG00000072501.
DR   GeneID; 8243; -.
DR   UCSC; uc011moe.3; human.
DR   CTD; 8243; -.
DR   EuPathDB; HostDB:ENSG00000072501.17; -.
DR   HGNC; HGNC:11111; SMC1A.
DR   OpenTargets; ENSG00000072501; -.
DR   eggNOG; KOG0018; Eukaryota.
DR   eggNOG; COG1196; LUCA.
DR   GeneTree; ENSGT00940000155614; -.
DR   OrthoDB; 326079at2759; -.
DR   ChiTaRS; SMC1A; human.
DR   GenomeRNAi; 8243; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000072501; Expressed in 234 organ(s), highest expression level in tendon of biceps brachii.
DR   ExpressionAtlas; G8JLG1; baseline and differential.
DR   GO; GO:0008278; C:cohesin complex; IEA:InterPro.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0003682; F:chromatin binding; IEA:InterPro.
DR   GO; GO:0006281; P:DNA repair; IEA:InterPro.
DR   GO; GO:0007064; P:mitotic sister chromatid cohesion; IEA:InterPro.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR003395; RecF/RecN/SMC_N.
DR   InterPro; IPR024704; SMC.
DR   InterPro; IPR029683; SMC1A_metazoan.
DR   InterPro; IPR010935; SMC_hinge.
DR   InterPro; IPR036277; SMC_hinge_sf.
DR   PANTHER; PTHR18937:SF170; PTHR18937:SF170; 1.
DR   Pfam; PF06470; SMC_hinge; 1.
DR   Pfam; PF02463; SMC_N; 1.
DR   PIRSF; PIRSF005719; SMC; 1.
DR   SMART; SM00968; SMC_hinge; 1.
DR   SUPFAM; SSF52540; SSF52540; 2.
DR   SUPFAM; SSF75553; SSF75553; 1.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Nucleus {ECO:0000256|PIRNR:PIRNR005719};
KW   Proteomics identification {ECO:0000213|EPD:G8JLG1,
KW   ECO:0000213|MaxQB:G8JLG1, ECO:0000213|PeptideAtlas:G8JLG1};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN      491    607       SMC hinge. {ECO:0000259|SMART:SM00968}.
FT   COILED      167    200       {ECO:0000256|SAM:Coils}.
FT   COILED      210    271       {ECO:0000256|SAM:Coils}.
FT   COILED      280    338       {ECO:0000256|SAM:Coils}.
FT   COILED      343    377       {ECO:0000256|SAM:Coils}.
FT   COILED      385    468       {ECO:0000256|SAM:Coils}.
FT   COILED      642    689       {ECO:0000256|SAM:Coils}.
FT   COILED      726    753       {ECO:0000256|SAM:Coils}.
FT   COILED      767    792       {ECO:0000256|SAM:Coils}.
FT   COILED      806    903       {ECO:0000256|SAM:Coils}.
FT   COILED      970    994       {ECO:0000256|SAM:Coils}.
FT   COILED     1002   1043       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   1211 AA;  140859 MW;  9E837EFEA36AD4D2 CRC64;
     MLEVSIPTPH RYVRGKSNLM DAISFVLGEK TSNLRVKTLR DLIHGAPVGK PAANRAFVSM
     VYSEEGAEDR TFARVIVGGS SEYKINNKVV QLHEYSEELE KLGILIKARN FLVFQGAVES
     IAMKNPKERT ALFEEISRSG ELAQEYDKRK KEMVKAEEDT QFNYHRKKNI AAERKEAKQE
     KEEADRYQRL KDEVVRAQVQ LQLFKLYHNE VEIEKLNKEL ASKNKEIEKD KKRMDKVEDE
     LKEKKKELGK MMREQQQIEK EIKEKDSELN QKRPQYIKAK ENTSHKIKKL EAAKKSLQNA
     QKHYKKRKGD MDELEKEMLS VEKARQEFEE RMEEESQSQG RDLTLEENQV KKYHRLKEEA
     SKRAATLAQE LEKFNRDQKA DQDRLDLEER KKVETEAKIK QKLREIEENQ KRIEKLEEYI
     TTSKQSLEEQ KKLEGELTEE VEMAKRRIDE INKELNQVME QLGDARIDRQ ESSRQQRKAE
     IMESIKRLYP GSVYGRLIDL CQPTQKKYQI AVTKVLGKNM DAIIVDSEKT GRDCIQYIKE
     QRGEPETFLP LDYLEVKPTD EKLRELKGAK LVIDVIRYEP PHIKKALQYA CGNALVCDNV
     EDARRIAFGG HQRHKTVALD GTLFQKSGVI SGGASDLKAK ARRWDEKAVD KLKEKKERLT
     EELKEQMKAK RKEAELRQVQ SQAHGLQMRL KYSQSDLEQT KTRHLALNLQ EKSKLESELA
     NFGPRINDIK RIIQSREREM KDLKEKMNQV EDEVFEEFCR EIGVRNIREF EEEKVKRQNE
     IAKKRLEFEN QKTRLGIQLD FEKNQLKEDQ DKVHMWEQTV KKDENEIEKL KKEEQRHMKI
     IDETMAQLQD LKNQHLAKKS EVNDKNHEME EIRKKLGGAN KEMTHLQKEV TAIETKLEQK
     RSDRHNLLQA CKMQDIKLPL SKGTMDDISQ EEGSSQGEDS VSGSQRISSI YAREALIEID
     YGDLCEDLKD AQAEEEIKQE MNTLQQKLNE QQSVLQRIAA PNMKAMEKLE SVRDKFQETS
     DEFEAARKRA KKAKQAFEQI KKERFDRFNA CFESVATNID EIYKALSRNS SAQAFLGPEN
     PEEPYLDGIN YNCVAPGKRF RPMDNLSGGE KTVAALALLF AIHSYKPAPF FVLDEIDAAL
     DNTNIGKVAN YIKEQSTCNF QAIVISLKEE FYTKAESLIG VYPEQGDCVI SKVLTFDLTK
     YPDANPNPNE Q
//
ID   SMC1A_HUMAN             Reviewed;        1233 AA.
AC   Q14683; O14995; Q16351; Q2M228;
DT   25-MAR-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 2.
DT   13-FEB-2019, entry version 201.
DE   RecName: Full=Structural maintenance of chromosomes protein 1A;
DE            Short=SMC protein 1A;
DE            Short=SMC-1-alpha;
DE            Short=SMC-1A;
DE   AltName: Full=Sb1.8;
GN   Name=SMC1A; Synonyms=DXS423E, KIAA0178, SB1.8, SMC1, SMC1L1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Fibroblast;
RX   PubMed=7757074; DOI=10.1093/hmg/4.2.243;
RA   Rocques P.J., Clark J., Ball S., Crew J., Gill S., Christodoulou Z.,
RA   Borts R.H., Louis E.J., Davies K.E., Cooper C.S.;
RT   "The human SB1.8 gene (DXS423E) encodes a putative chromosome
RT   segregation protein conserved in lower eukaryotes and prokaryotes.";
RL   Hum. Mol. Genet. 4:243-249(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Bone marrow;
RX   PubMed=8724849; DOI=10.1093/dnares/3.1.17;
RA   Nagase T., Seki N., Ishikawa K., Tanaka A., Nomura N.;
RT   "Prediction of the coding sequences of unidentified human genes. V.
RT   The coding sequences of 40 new genes (KIAA0161-KIAA0200) deduced by
RT   analysis of cDNA clones from human cell line KG-1.";
RL   DNA Res. 3:17-24(1996).
RN   [3]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 945-984, FUNCTION, INTERACTION WITH BRCA1,
RP   PHOSPHORYLATION AT SER-957 AND SER-966, AND MUTAGENESIS OF SER-957 AND
RP   SER-966.
RX   PubMed=11877377; DOI=10.1101/gad.970702;
RA   Yazdi P.T., Wang Y., Zhao S., Patel N., Lee E.Y.-H.P., Qin J.;
RT   "SMC1 is a downstream effector in the ATM/NBS1 branch of the human S-
RT   phase checkpoint.";
RL   Genes Dev. 16:571-582(2002).
RN   [7]
RP   INTERACTION WITH NDC80.
RX   PubMed=9295362; DOI=10.1074/jbc.272.38.24081;
RA   Chen Y., Sharp Z.D., Lee W.-H.;
RT   "HEC binds to the seventh regulatory subunit of the 26 S proteasome
RT   and modulates the proteolysis of mitotic cyclins.";
RL   J. Biol. Chem. 272:24081-24087(1997).
RN   [8]
RP   INTERACTION WITH NDC80.
RX   PubMed=10409732; DOI=10.1128/MCB.19.8.5417;
RA   Zheng L., Chen Y., Lee W.-H.;
RT   "Hec1p, an evolutionarily conserved coiled-coil protein, modulates
RT   chromosome segregation through interaction with SMC proteins.";
RL   Mol. Cell. Biol. 19:5417-5428(1999).
RN   [9]
RP   IDENTIFICATION IN A COHESIN COMPLEX WITH SMC3; STAG1 OR STAG2.
RX   PubMed=11076961; DOI=10.1083/jcb.151.4.749;
RA   Sumara I., Vorlaufer E., Gieffers C., Peters B.H., Peters J.-M.;
RT   "Characterization of vertebrate cohesin complexes and their regulation
RT   in prophase.";
RL   J. Cell Biol. 151:749-762(2000).
RN   [10]
RP   SUBCELLULAR LOCATION DURING CELL CYCLE.
RX   PubMed=12199140; DOI=10.1023/A:1016563523208;
RA   Gregson H.C., Van Hooser A.A., Ball A.R. Jr., Brinkley B.R.,
RA   Yokomori K.;
RT   "Localization of human SMC1 protein at kinetochores.";
RL   Chromosome Res. 10:267-277(2002).
RN   [11]
RP   PHOSPHORYLATION AT SER-966, AND MUTAGENESIS OF SER-966.
RX   PubMed=14657349; DOI=10.1073/pnas.2536810100;
RA   Wang Y., Qin J.;
RT   "MSH2 and ATR form a signaling module and regulate two branches of the
RT   damage response to DNA methylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:15387-15392(2003).
RN   [12]
RP   IDENTIFICATION IN A COMPLEX WITH CDCA5; SMC3; RAD21; PDS5A AND PDS5B.
RX   PubMed=15837422; DOI=10.1016/j.molcel.2005.03.017;
RA   Rankin S., Ayad N.G., Kirschner M.W.;
RT   "Sororin, a substrate of the anaphase-promoting complex, is required
RT   for sister chromatid cohesion in vertebrates.";
RL   Mol. Cell 18:185-200(2005).
RN   [13]
RP   ERRATUM.
RA   Rankin S., Ayad N.G., Kirschner M.W.;
RL   Mol. Cell 18:609-609(2005).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-358; SER-360 AND
RP   SER-966, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-360; SER-957 AND
RP   SER-970, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-957, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [17]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-648 AND LYS-713, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-360; SER-957 AND
RP   SER-966, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [20]
RP   INTERACTION WITH BRAT1, AND PHOSPHORYLATION AT SER-966.
RX   PubMed=22977523; DOI=10.3892/etm.2011.232;
RA   So E.Y., Ouchi T.;
RT   "Functional interaction of BRCA1/ATM-associated BAAT1 with the DNA-PK
RT   catalytic subunit.";
RL   Exp. Ther. Med. 2:443-447(2011).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [22]
RP   IDENTIFICATION IN A COHESIN COMPLEX WITH SMC3; STAG1 AND RAD21, AND
RP   INTERACTION WITH SMC3 AND HETERODIMER NIPB-MAU2.
RX   PubMed=22628566; DOI=10.1073/pnas.1206840109;
RA   Bermudez V.P., Farina A., Higashi T.L., Du F., Tappin I.,
RA   Takahashi T.S., Hurwitz J.;
RT   "In vitro loading of human cohesin on DNA by the human Scc2-Scc4
RT   loader complex.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:9366-9371(2012).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-360; SER-957 AND
RP   SER-962, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [24]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [25]
RP   VARIANTS CDLS2 ALA-493 AND GLN-832 DEL.
RX   PubMed=16604071; DOI=10.1038/ng1779;
RA   Musio A., Selicorni A., Focarelli M.L., Gervasini C., Milani D.,
RA   Russo S., Vezzoni P., Larizza L.;
RT   "X-linked Cornelia de Lange syndrome owing to SMC1L1 mutations.";
RL   Nat. Genet. 38:528-530(2006).
RN   [26]
RP   VARIANTS CDLS2 58-VAL--ARG-62 DEL; VAL-133; HIS-196; CYS-496; HIS-496;
RP   TRP-711; GLN-790 AND LEU-1122.
RX   PubMed=17273969; DOI=10.1086/511888;
RA   Deardorff M.A., Kaur M., Yaeger D., Rampuria A., Korolev S., Pie J.,
RA   Gil-Rodriguez C., Arnedo M., Loeys B., Kline A.D., Wilson M.,
RA   Lillquist K., Siu V., Ramos F.J., Musio A., Jackson L.S., Dorsett D.,
RA   Krantz I.D.;
RT   "Mutations in cohesin complex members SMC3 and SMC1A cause a mild
RT   variant of Cornelia de Lange syndrome with predominant mental
RT   retardation.";
RL   Am. J. Hum. Genet. 80:485-494(2007).
RN   [27]
RP   VARIANTS CDLS2 HIS-196 AND CYS-1085.
RX   PubMed=17221863; DOI=10.1002/humu.9478;
RA   Borck G., Zarhrate M., Bonnefont J.-P., Munnich A., Cormier-Daire V.,
RA   Colleaux L.;
RT   "Incidence and clinical features of X-linked Cornelia de Lange
RT   syndrome due to SMC1L1 mutations.";
RL   Hum. Mutat. 28:205-206(2007).
RN   [28]
RP   CHARACTERIZATION OF VARIANTS CDLS2 ALA-493; CYS-496 AND HIS-496, AND
RP   GENOMIC INSTABILITY OF CDLS CELL LINES TO IONIZING RADIATION.
RX   PubMed=18996922; DOI=10.1093/hmg/ddn369;
RA   Revenkova E., Focarelli M.L., Susani L., Paulis M., Bassi M.T.,
RA   Mannini L., Frattini A., Delia D., Krantz I., Vezzoni P.,
RA   Jessberger R., Musio A.;
RT   "Cornelia de Lange syndrome mutations in SMC1A or SMC3 affect binding
RT   to DNA.";
RL   Hum. Mol. Genet. 18:418-427(2009).
RN   [29]
RP   VARIANTS CDLS2 58-VAL--ARG-62 DEL; VAL-133; LYS-141; HIS-196; LYS-268
RP   DEL; SER-306 DEL; GLN-398; CYS-496; HIS-496; GLU-683 DEL; GLY-693;
RP   TRP-711; PHE-781; GLN-790; GLY-816; GLN-1049; LEU-1122 AND TRP-1123.
RX   PubMed=19701948; DOI=10.1002/humu.21095;
RA   Liu J., Feldman R., Zhang Z., Deardorff M.A., Haverfield E.V.,
RA   Kaur M., Li J.R., Clark D., Kline A.D., Waggoner D.J., Das S.,
RA   Jackson L.G., Krantz I.D.;
RT   "SMC1A expression and mechanism of pathogenicity in probands with X-
RT   Linked Cornelia de Lange syndrome.";
RL   Hum. Mutat. 30:1535-1542(2009).
RN   [30]
RP   VARIANTS CDLS2 HIS-196; LYS-268 DEL AND GLN-711.
RX   PubMed=20358602; DOI=10.1002/ajmg.a.33348;
RA   Pie J., Gil-Rodriguez M.C., Ciero M., Lopez-Vinas E., Ribate M.P.,
RA   Arnedo M., Deardorff M.A., Puisac B., Legarreta J., de Karam J.C.,
RA   Rubio E., Bueno I., Baldellou A., Calvo M.T., Casals N.,
RA   Olivares J.L., Losada A., Hegardt F.G., Krantz I.D., Gomez-Puertas P.,
RA   Ramos F.J.;
RT   "Mutations and variants in the cohesion factor genes NIPBL, SMC1A, and
RT   SMC3 in a cohort of 30 unrelated patients with Cornelia de Lange
RT   syndrome.";
RL   Am. J. Med. Genet. A 152:924-929(2010).
RN   [31]
RP   VARIANT CDLS2 THR-784.
RX   PubMed=20635401; DOI=10.1002/ajmg.a.33486;
RA   Limongelli G., Russo S., Digilio M.C., Masciadri M., Pacileo G.,
RA   Fratta F., Martone F., Maddaloni V., D'Alessandro R., Calabro P.,
RA   Russo M.G., Calabro R., Larizza L.;
RT   "Hypertrophic cardiomyopathy in a girl with Cornelia de Lange syndrome
RT   due to mutation in SMC1A.";
RL   Am. J. Med. Genet. A 152:2127-2129(2010).
RN   [32]
RP   VARIANTS CDLS2 58-VAL--ARG-62 DEL; GLY-398; MET-651; GLN-693; THR-784;
RP   GLN-790; THR-1166 AND PHE-1189.
RX   PubMed=24124034; DOI=10.1002/ajmg.a.36252;
RA   Gervasini C., Russo S., Cereda A., Parenti I., Masciadri M.,
RA   Azzollini J., Melis D., Aravena T., Doray B., Ferrarini A.,
RA   Garavelli L., Selicorni A., Larizza L.;
RT   "Cornelia de Lange individuals with new and recurrent SMC1A mutations
RT   enhance delineation of mutation repertoire and phenotypic spectrum.";
RL   Am. J. Med. Genet. A 161A:2909-2919(2013).
CC   -!- FUNCTION: Involved in chromosome cohesion during cell cycle and in
CC       DNA repair. Central component of cohesin complex. The cohesin
CC       complex is required for the cohesion of sister chromatids after
CC       DNA replication. The cohesin complex apparently forms a large
CC       proteinaceous ring within which sister chromatids can be trapped.
CC       At anaphase, the complex is cleaved and dissociates from
CC       chromatin, allowing sister chromatids to segregate. The cohesin
CC       complex may also play a role in spindle pole assembly during
CC       mitosis. Involved in DNA repair via its interaction with BRCA1 and
CC       its related phosphorylation by ATM, or via its phosphorylation by
CC       ATR. Works as a downstream effector both in the ATM/NBS1 branch
CC       and in the ATR/MSH2 branch of S-phase checkpoint.
CC       {ECO:0000269|PubMed:11877377}.
CC   -!- SUBUNIT: Forms a heterodimer with SMC3 in cohesin complexes
CC       (PubMed:22628566). Cohesin complexes are composed of the SMC1
CC       (SMC1A or SMC1B) and SMC3 heterodimer attached via their SMC hinge
CC       domain, RAD21 which link them, and one STAG protein (STAG1, STAG2
CC       or STAG3), which interacts with RAD21 (PubMed:11076961). In germ
CC       cell cohesin complexes, SMC1A is mutually exclusive with SMC1B (By
CC       similarity). Interacts with BRCA1 (PubMed:11877377). Found in a
CC       complex with CDCA5, SMC3 and RAD21, PDS5A/SCC-112 and PDS5B/APRIN
CC       (PubMed:15837422). Interacts with NDC80 (PubMed:9295362,
CC       PubMed:10409732,). Interacts with BRAT1 (PubMed:22977523). Found
CC       in a complex containing POLE and SMC3. Interacts with RPGR, STAG3
CC       and SYCP2 (By similarity). Found in a cohesin complex with SMC3,
CC       STAG1 and RAD21 (PubMed:22628566). The SMC1A-SMC3 heterodimer
CC       interacts with the NIPBL-MAU2 heterodimer (PubMed:22628566).
CC       {ECO:0000250|UniProtKB:O97593, ECO:0000250|UniProtKB:Q9CU62,
CC       ECO:0000250|UniProtKB:Q9Z1M9, ECO:0000269|PubMed:10409732,
CC       ECO:0000269|PubMed:11076961, ECO:0000269|PubMed:11877377,
CC       ECO:0000269|PubMed:15837422, ECO:0000269|PubMed:22628566,
CC       ECO:0000269|PubMed:22977523, ECO:0000269|PubMed:9295362}.
CC   -!- INTERACTION:
CC       Q99IB8:- (xeno); NbExp=3; IntAct=EBI-80690, EBI-6927928;
CC       Q96FF9:CDCA5; NbExp=6; IntAct=EBI-80690, EBI-718805;
CC       P33993:MCM7; NbExp=8; IntAct=EBI-80690, EBI-355924;
CC       O60216:RAD21; NbExp=14; IntAct=EBI-80690, EBI-80739;
CC       P78406:RAE1; NbExp=5; IntAct=EBI-80690, EBI-724495;
CC       Q5FBB7:SGO1; NbExp=9; IntAct=EBI-80690, EBI-989069;
CC       Q9UQE7:SMC3; NbExp=14; IntAct=EBI-80690, EBI-80718;
CC       Q8N3U4:STAG2; NbExp=8; IntAct=EBI-80690, EBI-1057252;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12199140}.
CC       Chromosome {ECO:0000269|PubMed:12199140}. Chromosome, centromere,
CC       kinetochore {ECO:0000269|PubMed:12199140}. Note=Associates with
CC       chromatin. Before prophase it is scattered along chromosome arms.
CC       During prophase, most of cohesin complexes dissociate from
CC       chromatin probably because of phosphorylation by PLK, except at
CC       centromeres, where cohesin complexes remain. At anaphase, the
CC       RAD21 subunit of the cohesin complex is cleaved, leading to the
CC       dissociation of the complex from chromosomes, allowing chromosome
CC       separation. In germ cells, cohesin complex dissociates from
CC       chromatin at prophase I, and may be replaced by a meiosis-specific
CC       cohesin complex. The phosphorylated form on Ser-957 and Ser-966
CC       associates with chromatin during G1/S/G2 phases but not during M
CC       phase, suggesting that phosphorylation does not regulate cohesin
CC       function. Integral component of the functional centromere-
CC       kinetochore complex at the kinetochore region during mitosis.
CC   -!- DOMAIN: The flexible SMC hinge domain, which separates the large
CC       intramolecular coiled coil regions, allows the heterotypic
CC       interaction with the corresponding domain of SMC3, forming a V-
CC       shaped heterodimer. The two heads of the heterodimer are then
CC       connected by different ends of the cleavable RAD21 protein,
CC       forming a ring structure (By similarity). {ECO:0000250}.
CC   -!- PTM: Phosphorylated by ATM upon ionizing radiation in a NBS1-
CC       dependent manner. Phosphorylated by ATR upon DNA methylation in a
CC       MSH2/MSH6-dependent manner. Phosphorylation of Ser-957 and Ser-966
CC       activates it and is required for S-phase checkpoint activation.
CC       {ECO:0000269|PubMed:11877377, ECO:0000269|PubMed:14657349}.
CC   -!- DISEASE: Cornelia de Lange syndrome 2 (CDLS2) [MIM:300590]: A form
CC       of Cornelia de Lange syndrome, a clinically heterogeneous
CC       developmental disorder associated with malformations affecting
CC       multiple systems. Characterized by facial dysmorphisms, abnormal
CC       hands and feet, growth delay, cognitive retardation, hirsutism,
CC       gastroesophageal dysfunction and cardiac, ophthalmologic and
CC       genitourinary anomalies. {ECO:0000269|PubMed:16604071,
CC       ECO:0000269|PubMed:17221863, ECO:0000269|PubMed:17273969,
CC       ECO:0000269|PubMed:18996922, ECO:0000269|PubMed:19701948,
CC       ECO:0000269|PubMed:20358602, ECO:0000269|PubMed:20635401,
CC       ECO:0000269|PubMed:24124034}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: Mutated Cornelia de Lange cell lines display
CC       genomic instability and sensitivity to ionizing radiation and
CC       interstrand cross-linking agents.
CC   -!- SIMILARITY: Belongs to the SMC family. SMC1 subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; S78271; AAB34405.1; -; mRNA.
DR   EMBL; D80000; BAA11495.2; -; mRNA.
DR   EMBL; AL161779; CAI42089.1; -; Genomic_DNA.
DR   EMBL; Z97054; CAI42089.1; JOINED; Genomic_DNA.
DR   EMBL; Z97054; CAI42646.1; -; Genomic_DNA.
DR   EMBL; AL161779; CAI42646.1; JOINED; Genomic_DNA.
DR   EMBL; BC112127; AAI12128.1; -; mRNA.
DR   CCDS; CCDS14352.1; -.
DR   PIR; I54383; I54383.
DR   RefSeq; NP_006297.2; NM_006306.3.
DR   UniGene; Hs.211602; -.
DR   ProteinModelPortal; Q14683; -.
DR   SMR; Q14683; -.
DR   BioGrid; 113871; 159.
DR   CORUM; Q14683; -.
DR   DIP; DIP-30911N; -.
DR   IntAct; Q14683; 109.
DR   MINT; Q14683; -.
DR   STRING; 9606.ENSP00000323421; -.
DR   iPTMnet; Q14683; -.
DR   PhosphoSitePlus; Q14683; -.
DR   SwissPalm; Q14683; -.
DR   BioMuta; SMC1A; -.
DR   DMDM; 29336622; -.
DR   EPD; Q14683; -.
DR   jPOST; Q14683; -.
DR   MaxQB; Q14683; -.
DR   PaxDb; Q14683; -.
DR   PeptideAtlas; Q14683; -.
DR   PRIDE; Q14683; -.
DR   ProteomicsDB; 60117; -.
DR   Ensembl; ENST00000322213; ENSP00000323421; ENSG00000072501.
DR   GeneID; 8243; -.
DR   KEGG; hsa:8243; -.
DR   UCSC; uc004dsg.4; human.
DR   CTD; 8243; -.
DR   DisGeNET; 8243; -.
DR   EuPathDB; HostDB:ENSG00000072501.17; -.
DR   GeneCards; SMC1A; -.
DR   GeneReviews; SMC1A; -.
DR   HGNC; HGNC:11111; SMC1A.
DR   HPA; CAB025404; -.
DR   HPA; HPA005499; -.
DR   MalaCards; SMC1A; -.
DR   MIM; 300040; gene.
DR   MIM; 300590; phenotype.
DR   neXtProt; NX_Q14683; -.
DR   OpenTargets; ENSG00000072501; -.
DR   Orphanet; 199; Cornelia de Lange syndrome.
DR   Orphanet; 319182; Wiedemann-Steiner syndrome.
DR   PharmGKB; PA35961; -.
DR   eggNOG; KOG0018; Eukaryota.
DR   eggNOG; COG1196; LUCA.
DR   GeneTree; ENSGT00940000155614; -.
DR   HOGENOM; HOG000195481; -.
DR   HOVERGEN; HBG039593; -.
DR   InParanoid; Q14683; -.
DR   KO; K06636; -.
DR   OMA; YMEAIVV; -.
DR   OrthoDB; 1557466at2759; -.
DR   PhylomeDB; Q14683; -.
DR   TreeFam; TF101156; -.
DR   Reactome; R-HSA-1221632; Meiotic synapsis.
DR   Reactome; R-HSA-2467813; Separation of Sister Chromatids.
DR   Reactome; R-HSA-2468052; Establishment of Sister Chromatid Cohesion.
DR   Reactome; R-HSA-2470946; Cohesin Loading onto Chromatin.
DR   Reactome; R-HSA-2500257; Resolution of Sister Chromatid Cohesion.
DR   Reactome; R-HSA-3108214; SUMOylation of DNA damage response and repair proteins.
DR   Reactome; R-HSA-9018519; Estrogen-dependent gene expression.
DR   SignaLink; Q14683; -.
DR   SIGNOR; Q14683; -.
DR   ChiTaRS; SMC1A; human.
DR   GeneWiki; SMC1A; -.
DR   GenomeRNAi; 8243; -.
DR   PRO; PR:Q14683; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000072501; Expressed in 234 organ(s), highest expression level in tendon of biceps brachii.
DR   ExpressionAtlas; Q14683; baseline and differential.
DR   Genevisible; Q14683; HS.
DR   GO; GO:0005694; C:chromosome; TAS:Reactome.
DR   GO; GO:0000775; C:chromosome, centromeric region; TAS:Reactome.
DR   GO; GO:0008278; C:cohesin complex; IDA:UniProtKB.
DR   GO; GO:0000777; C:condensed chromosome kinetochore; IEA:UniProtKB-SubCell.
DR   GO; GO:0000794; C:condensed nuclear chromosome; TAS:ProtInc.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0000776; C:kinetochore; IDA:UniProtKB.
DR   GO; GO:0030893; C:meiotic cohesin complex; IDA:UniProtKB.
DR   GO; GO:0097431; C:mitotic spindle pole; IDA:UniProtKB.
DR   GO; GO:0016363; C:nuclear matrix; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003682; F:chromatin binding; IDA:UniProtKB.
DR   GO; GO:0036033; F:mediator complex binding; IEA:Ensembl.
DR   GO; GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0006281; P:DNA repair; TAS:UniProtKB.
DR   GO; GO:0051321; P:meiotic cell cycle; ISS:UniProtKB.
DR   GO; GO:0007064; P:mitotic sister chromatid cohesion; TAS:UniProtKB.
DR   GO; GO:0000070; P:mitotic sister chromatid segregation; TAS:UniProtKB.
DR   GO; GO:0032876; P:negative regulation of DNA endoreduplication; IMP:BHF-UCL.
DR   GO; GO:1901673; P:regulation of mitotic spindle assembly; IMP:UniProtKB.
DR   GO; GO:0072423; P:response to DNA damage checkpoint signaling; IDA:UniProtKB.
DR   GO; GO:0009314; P:response to radiation; IEP:UniProtKB.
DR   GO; GO:0007062; P:sister chromatid cohesion; IMP:BHF-UCL.
DR   GO; GO:0019827; P:stem cell population maintenance; IEA:Ensembl.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR003395; RecF/RecN/SMC_N.
DR   InterPro; IPR024704; SMC.
DR   InterPro; IPR029683; SMC1A_metazoan.
DR   InterPro; IPR010935; SMC_hinge.
DR   InterPro; IPR036277; SMC_hinge_sf.
DR   PANTHER; PTHR18937:SF170; PTHR18937:SF170; 1.
DR   Pfam; PF06470; SMC_hinge; 1.
DR   Pfam; PF02463; SMC_N; 1.
DR   PIRSF; PIRSF005719; SMC; 1.
DR   SMART; SM00968; SMC_hinge; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   SUPFAM; SSF75553; SSF75553; 1.
PE   1: Evidence at protein level;
KW   Acetylation; ATP-binding; Cell cycle; Cell division; Centromere;
KW   Chromosome; Coiled coil; Complete proteome; Direct protein sequencing;
KW   Disease mutation; DNA damage; DNA repair; Kinetochore; Meiosis;
KW   Mental retardation; Mitosis; Nucleotide-binding; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome.
FT   CHAIN         1   1233       Structural maintenance of chromosomes
FT                                protein 1A.
FT                                /FTId=PRO_0000118989.
FT   DOMAIN      515    629       SMC hinge.
FT   NP_BIND      32     39       ATP. {ECO:0000255}.
FT   COILED      104    124       {ECO:0000255}.
FT   COILED      163    503       {ECO:0000255}.
FT   COILED      660    935       {ECO:0000255}.
FT   COILED      991   1068       {ECO:0000255}.
FT   COMPBIAS   1128   1163       Ala/Asp-rich (DA-box).
FT   MOD_RES     358    358       Phosphoserine.
FT                                {ECO:0000244|PubMed:17525332}.
FT   MOD_RES     360    360       Phosphoserine.
FT                                {ECO:0000244|PubMed:17525332,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     648    648       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     713    713       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     957    957       Phosphoserine; by ATM.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:11877377}.
FT   MOD_RES     962    962       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     966    966       Phosphoserine; by ATM and ATR.
FT                                {ECO:0000244|PubMed:17525332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000269|PubMed:11877377,
FT                                ECO:0000269|PubMed:14657349,
FT                                ECO:0000269|PubMed:22977523}.
FT   MOD_RES     970    970       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES    1037   1037       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q9CU62}.
FT   VARIANT      28     28       T -> P (in dbSNP:rs34530151).
FT                                /FTId=VAR_052438.
FT   VARIANT      58     62       Missing (in CDLS2).
FT                                {ECO:0000269|PubMed:17273969,
FT                                ECO:0000269|PubMed:19701948,
FT                                ECO:0000269|PubMed:24124034}.
FT                                /FTId=VAR_062785.
FT   VARIANT     133    133       F -> V (in CDLS2).
FT                                {ECO:0000269|PubMed:17273969,
FT                                ECO:0000269|PubMed:19701948}.
FT                                /FTId=VAR_062786.
FT   VARIANT     141    141       E -> K (in CDLS2; dbSNP:rs587784420).
FT                                {ECO:0000269|PubMed:19701948}.
FT                                /FTId=VAR_062787.
FT   VARIANT     196    196       R -> H (in CDLS2).
FT                                {ECO:0000269|PubMed:17221863,
FT                                ECO:0000269|PubMed:17273969,
FT                                ECO:0000269|PubMed:19701948,
FT                                ECO:0000269|PubMed:20358602}.
FT                                /FTId=VAR_062788.
FT   VARIANT     268    268       Missing (in CDLS2).
FT                                {ECO:0000269|PubMed:19701948,
FT                                ECO:0000269|PubMed:20358602}.
FT                                /FTId=VAR_062789.
FT   VARIANT     306    306       Missing (in CDLS2).
FT                                {ECO:0000269|PubMed:19701948}.
FT                                /FTId=VAR_062790.
FT   VARIANT     398    398       R -> G (in CDLS2).
FT                                {ECO:0000269|PubMed:24124034}.
FT                                /FTId=VAR_078274.
FT   VARIANT     398    398       R -> Q (in CDLS2; dbSNP:rs587784403).
FT                                {ECO:0000269|PubMed:19701948}.
FT                                /FTId=VAR_062791.
FT   VARIANT     493    493       E -> A (in CDLS2; affects the affinity of
FT                                SMC hinge dimers for DNA; mutated hinge
FT                                dimers bind DNA with higher affinity than
FT                                wild-type proteins; dbSNP:rs122454122).
FT                                {ECO:0000269|PubMed:16604071,
FT                                ECO:0000269|PubMed:18996922}.
FT                                /FTId=VAR_026529.
FT   VARIANT     496    496       R -> C (in CDLS2; affects the affinity of
FT                                SMC hinge dimers for DNA; mutated hinge
FT                                dimers bind DNA with higher affinity than
FT                                wild-type proteins).
FT                                {ECO:0000269|PubMed:17273969,
FT                                ECO:0000269|PubMed:18996922,
FT                                ECO:0000269|PubMed:19701948}.
FT                                /FTId=VAR_062792.
FT   VARIANT     496    496       R -> H (in CDLS2; affects the affinity of
FT                                SMC hinge dimers for DNA; mutated hinge
FT                                dimers bind DNA with higher affinity than
FT                                wild-type proteins; dbSNP:rs122454123).
FT                                {ECO:0000269|PubMed:17273969,
FT                                ECO:0000269|PubMed:18996922,
FT                                ECO:0000269|PubMed:19701948}.
FT                                /FTId=VAR_062793.
FT   VARIANT     651    651       V -> M (in CDLS2; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:24124034}.
FT                                /FTId=VAR_078275.
FT   VARIANT     683    683       Missing (in CDLS2).
FT                                {ECO:0000269|PubMed:19701948}.
FT                                /FTId=VAR_062794.
FT   VARIANT     693    693       R -> G (in CDLS2).
FT                                {ECO:0000269|PubMed:19701948}.
FT                                /FTId=VAR_062795.
FT   VARIANT     693    693       R -> Q (in CDLS2; dbSNP:rs587784408).
FT                                {ECO:0000269|PubMed:24124034}.
FT                                /FTId=VAR_078276.
FT   VARIANT     711    711       R -> Q (in CDLS2; dbSNP:rs782176647).
FT                                {ECO:0000269|PubMed:20358602}.
FT                                /FTId=VAR_064542.
FT   VARIANT     711    711       R -> W (in CDLS2; dbSNP:rs587784409).
FT                                {ECO:0000269|PubMed:17273969,
FT                                ECO:0000269|PubMed:19701948}.
FT                                /FTId=VAR_062796.
FT   VARIANT     781    781       C -> F (in CDLS2).
FT                                {ECO:0000269|PubMed:19701948}.
FT                                /FTId=VAR_062797.
FT   VARIANT     784    784       I -> T (in CDLS2; dbSNP:rs387906702).
FT                                {ECO:0000269|PubMed:20635401,
FT                                ECO:0000269|PubMed:24124034}.
FT                                /FTId=VAR_064543.
FT   VARIANT     790    790       R -> Q (in CDLS2; dbSNP:rs797045993).
FT                                {ECO:0000269|PubMed:17273969,
FT                                ECO:0000269|PubMed:19701948,
FT                                ECO:0000269|PubMed:24124034}.
FT                                /FTId=VAR_062798.
FT   VARIANT     816    816       R -> G (in CDLS2).
FT                                {ECO:0000269|PubMed:19701948}.
FT                                /FTId=VAR_062799.
FT   VARIANT     832    832       Missing (in CDLS2).
FT                                {ECO:0000269|PubMed:16604071}.
FT                                /FTId=VAR_026530.
FT   VARIANT    1049   1049       R -> Q (in CDLS2; dbSNP:rs587784416).
FT                                {ECO:0000269|PubMed:19701948}.
FT                                /FTId=VAR_062800.
FT   VARIANT    1085   1085       Y -> C (in CDLS2; dbSNP:rs587784418).
FT                                {ECO:0000269|PubMed:17221863}.
FT                                /FTId=VAR_062801.
FT   VARIANT    1122   1122       F -> L (in CDLS2).
FT                                {ECO:0000269|PubMed:17273969,
FT                                ECO:0000269|PubMed:19701948}.
FT                                /FTId=VAR_062802.
FT   VARIANT    1123   1123       R -> W (in CDLS2).
FT                                {ECO:0000269|PubMed:19701948}.
FT                                /FTId=VAR_062803.
FT   VARIANT    1166   1166       N -> T (in CDLS2; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:24124034}.
FT                                /FTId=VAR_078277.
FT   VARIANT    1189   1189       L -> F (in CDLS2; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:24124034}.
FT                                /FTId=VAR_078278.
FT   MUTAGEN     957    957       S->A: Reduces phosphorylation and the S-
FT                                phase checkpoint activation. Abolishes S-
FT                                phase activation; when associated with A-
FT                                966. {ECO:0000269|PubMed:11877377}.
FT   MUTAGEN     966    966       S->A: Reduces phosphorylation and the S-
FT                                phase checkpoint activation. Increases
FT                                sensitivity to DNA methylation. Abolishes
FT                                S-phase activation; when associated with
FT                                A-957. {ECO:0000269|PubMed:11877377,
FT                                ECO:0000269|PubMed:14657349}.
FT   CONFLICT    163    164       EL -> DV (in Ref. 1; AAB34405).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1233 AA;  143233 MW;  E0A44CA7476C88A6 CRC64;
     MGFLKLIEIE NFKSYKGRQI IGPFQRFTAI IGPNGSGKSN LMDAISFVLG EKTSNLRVKT
     LRDLIHGAPV GKPAANRAFV SMVYSEEGAE DRTFARVIVG GSSEYKINNK VVQLHEYSEE
     LEKLGILIKA RNFLVFQGAV ESIAMKNPKE RTALFEEISR SGELAQEYDK RKKEMVKAEE
     DTQFNYHRKK NIAAERKEAK QEKEEADRYQ RLKDEVVRAQ VQLQLFKLYH NEVEIEKLNK
     ELASKNKEIE KDKKRMDKVE DELKEKKKEL GKMMREQQQI EKEIKEKDSE LNQKRPQYIK
     AKENTSHKIK KLEAAKKSLQ NAQKHYKKRK GDMDELEKEM LSVEKARQEF EERMEEESQS
     QGRDLTLEEN QVKKYHRLKE EASKRAATLA QELEKFNRDQ KADQDRLDLE ERKKVETEAK
     IKQKLREIEE NQKRIEKLEE YITTSKQSLE EQKKLEGELT EEVEMAKRRI DEINKELNQV
     MEQLGDARID RQESSRQQRK AEIMESIKRL YPGSVYGRLI DLCQPTQKKY QIAVTKVLGK
     NMDAIIVDSE KTGRDCIQYI KEQRGEPETF LPLDYLEVKP TDEKLRELKG AKLVIDVIRY
     EPPHIKKALQ YACGNALVCD NVEDARRIAF GGHQRHKTVA LDGTLFQKSG VISGGASDLK
     AKARRWDEKA VDKLKEKKER LTEELKEQMK AKRKEAELRQ VQSQAHGLQM RLKYSQSDLE
     QTKTRHLALN LQEKSKLESE LANFGPRIND IKRIIQSRER EMKDLKEKMN QVEDEVFEEF
     CREIGVRNIR EFEEEKVKRQ NEIAKKRLEF ENQKTRLGIQ LDFEKNQLKE DQDKVHMWEQ
     TVKKDENEIE KLKKEEQRHM KIIDETMAQL QDLKNQHLAK KSEVNDKNHE MEEIRKKLGG
     ANKEMTHLQK EVTAIETKLE QKRSDRHNLL QACKMQDIKL PLSKGTMDDI SQEEGSSQGE
     DSVSGSQRIS SIYAREALIE IDYGDLCEDL KDAQAEEEIK QEMNTLQQKL NEQQSVLQRI
     AAPNMKAMEK LESVRDKFQE TSDEFEAARK RAKKAKQAFE QIKKERFDRF NACFESVATN
     IDEIYKALSR NSSAQAFLGP ENPEEPYLDG INYNCVAPGK RFRPMDNLSG GEKTVAALAL
     LFAIHSYKPA PFFVLDEIDA ALDNTNIGKV ANYIKEQSTC NFQAIVISLK EEFYTKAESL
     IGVYPEQGDC VISKVLTFDL TKYPDANPNP NEQ
//
ID   Q68EN4_HUMAN            Unreviewed;       417 AA.
AC   Q68EN4;
DT   11-OCT-2004, integrated into UniProtKB/TrEMBL.
DT   11-OCT-2004, sequence version 1.
DT   16-JAN-2019, entry version 80.
DE   SubName: Full=SMC1A protein {ECO:0000313|EMBL:AAH80185.1};
DE   Flags: Fragment;
GN   Name=SMC1A {ECO:0000313|EMBL:AAH80185.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH80185.1};
RN   [1] {ECO:0000313|EMBL:AAH80185.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis {ECO:0000313|EMBL:AAH80185.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M.,
RA   Peck A.M., Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S.,
RA   Feolo M., Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F.,
RA   Schaefer C.F., Buetow K., Bonner T.I., Haussler D., Kent J.,
RA   Kiekhaus M., Furey T., Brent M., Prange C., Schreiber K., Shapiro N.,
RA   Bhat N.K., Hopkins R.F., Hsie F., Driscoll T., Soares M.B.,
RA   Casavant T.L., Scheetz T.E., Brown-stein M.J., Usdin T.B.,
RA   Toshiyuki S., Carninci P., Piao Y., Dudekula D.B., Ko M.S.,
RA   Kawakami K., Suzuki Y., Sugano S., Gruber C.E., Smith M.R.,
RA   Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y., Wei C.L.,
RA   Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W., Fuh E.,
RA   Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D.,
RA   Granite S.J., Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G.,
RA   Blakesly R.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J.,
RA   Schmutz J., Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L.,
RA   Krzywinski M.I., Liao N., Morin R., Morrin R., Palmquist D.,
RA   Petrescu A.S., Skalska U., Smailus D.E., Stott J.M., Schnerch A.,
RA   Schein J.E., Jones S.J., Holt R.A., Baross A., Marra M.A., Clifton S.,
RA   Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; BC080185; AAH80185.1; -; mRNA.
DR   RefSeq; NP_006297.2; NM_006306.3.
DR   UniGene; Hs.211602; -.
DR   ProteinModelPortal; Q68EN4; -.
DR   PeptideAtlas; Q68EN4; -.
DR   PRIDE; Q68EN4; -.
DR   GeneID; 8243; -.
DR   KEGG; hsa:8243; -.
DR   CTD; 8243; -.
DR   eggNOG; KOG0018; Eukaryota.
DR   eggNOG; COG1196; LUCA.
DR   HOVERGEN; HBG062260; -.
DR   KO; K06636; -.
DR   OrthoDB; 326079at2759; -.
DR   ChiTaRS; SMC1A; human.
DR   GenomeRNAi; 8243; -.
DR   GO; GO:0008278; C:cohesin complex; IEA:InterPro.
DR   GO; GO:0003682; F:chromatin binding; IEA:InterPro.
DR   GO; GO:0006281; P:DNA repair; IEA:InterPro.
DR   GO; GO:0007064; P:mitotic sister chromatid cohesion; IEA:InterPro.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR003395; RecF/RecN/SMC_N.
DR   InterPro; IPR029683; SMC1A_metazoan.
DR   PANTHER; PTHR18937:SF170; PTHR18937:SF170; 1.
DR   Pfam; PF02463; SMC_N; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   DOMAIN        3    129       SMC_N. {ECO:0000259|Pfam:PF02463}.
FT   COILED      189    222       {ECO:0000256|SAM:Coils}.
FT   COILED      232    293       {ECO:0000256|SAM:Coils}.
FT   COILED      302    360       {ECO:0000256|SAM:Coils}.
FT   COILED      365    399       {ECO:0000256|SAM:Coils}.
FT   NON_TER     417    417       {ECO:0000313|EMBL:AAH80185.1}.
SQ   SEQUENCE   417 AA;  48888 MW;  EA7302053D16FD4A CRC64;
     MGFLKLIEIE NFKSYKGRQI IGPFQRFTAI IGPNGSGKSN LMDAISFVLG EKTSNLRVKT
     LRDLIHGAPV GKPAANRAFV SMVYSEEGAE DRTFARVIVG GSSEYKINNK VVQLHEYSEE
     LEKLGILIKA RNFLVFQGAV ESIAMKNPKE RTALFEEISR SGELAQEYDK RKKEMVKAEE
     DTQFNYHRKK NIAAERKEAK QEKEEADRYQ RLKDEVVRAQ VQLQLFKLYH NEVEIEKLNK
     ELASKNKEIE KDKKRMDKVE DELKEKKKEL GKMMREQQQI EKEIKEKDSE LNQKRPQYIK
     AKENTSHKIK KLEAAKKSLQ NAQKHYKKRK GDMDELEKEM LSVEKARQEF EERMEEESQS
     QGRDLTLEEN QVKKYHRLKE EASKRAATLA QELEKFNRDQ KADQDRLDLE ERKKKKK
//
ID   SOX21_HUMAN             Reviewed;         276 AA.
AC   Q9Y651; P35715; Q15504; Q5TBS1;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   13-FEB-2019, entry version 149.
DE   RecName: Full=Transcription factor SOX-21;
DE   AltName: Full=SOX-A;
GN   Name=SOX21; Synonyms=SOX25, SOXA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10441749; DOI=10.1007/s003359901118;
RA   Malas S., Duthie S., Deloukas P., Episkopou V.;
RT   "The isolation and high-resolution chromosomal mapping of human SOX14
RT   and SOX21; two members of the SOX gene family related to SOX1, SOX2,
RT   and SOX3.";
RL   Mamm. Genome 10:934-937(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E.,
RA   Griffiths-Jones S., Jones M.C., Keenan S.J., Oliver K., Scott C.E.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Andrews D.T.,
RA   Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J., Bannerjee R.,
RA   Barlow K.F., Bates K., Beasley H., Bird C.P., Bray-Allen S.,
RA   Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M.,
RA   Clegg S.C., Cobley V., Collins J.E., Corby N., Coville G.J.,
RA   Deloukas P., Dhami P., Dunham I., Dunn M., Earthrowl M.E.,
RA   Ellington A.G., Faulkner L., Frankish A.G., Frankland J., French L.,
RA   Garner P., Garnett J., Gilbert J.G.R., Gilson C.J., Ghori J.,
RA   Grafham D.V., Gribble S.M., Griffiths C., Hall R.E., Hammond S.,
RA   Harley J.L., Hart E.A., Heath P.D., Howden P.J., Huckle E.J.,
RA   Hunt P.J., Hunt A.R., Johnson C., Johnson D., Kay M., Kimberley A.M.,
RA   King A., Laird G.K., Langford C.J., Lawlor S., Leongamornlert D.A.,
RA   Lloyd D.M., Lloyd C., Loveland J.E., Lovell J., Martin S.,
RA   Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K.M., Rice C.M., Searle S.,
RA   Sehra H.K., Shownkeen R., Skuce C.D., Smith M., Steward C.A.,
RA   Sycamore N., Tester J., Thomas D.W., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., Whitehead S.L., Willey D.L.,
RA   Wilming L., Wray P.W., Wright M.W., Young L., Coulson A., Durbin R.M.,
RA   Hubbard T., Sulston J.E., Beck S., Bentley D.R., Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 12-87.
RC   TISSUE=Spinal cord;
RA   Stevanovic M.;
RL   Submitted (APR-1993) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 19-72.
RX   PubMed=1614875; DOI=10.1093/nar/20.11.2887;
RA   Denny P., Swift S., Brand N., Dabhade N., Barton P., Ashworth A.;
RT   "A conserved family of genes related to the testis determining gene,
RT   SRY.";
RL   Nucleic Acids Res. 20:2887-2887(1992).
CC   -!- FUNCTION: May play a role as an activator of transcription of
CC       OPRM1. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00267}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AF107044; AAC95381.1; -; Genomic_DNA.
DR   EMBL; AL137061; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471085; EAX08946.1; -; Genomic_DNA.
DR   EMBL; X71136; CAA50466.1; -; mRNA.
DR   EMBL; X65666; CAA46617.1; -; mRNA.
DR   CCDS; CCDS9473.1; -.
DR   PIR; I38238; I38238.
DR   PIR; S22937; S22937.
DR   RefSeq; NP_009015.1; NM_007084.3.
DR   UniGene; Hs.187577; -.
DR   ProteinModelPortal; Q9Y651; -.
DR   SMR; Q9Y651; -.
DR   BioGrid; 116337; 3.
DR   STRING; 9606.ENSP00000366144; -.
DR   iPTMnet; Q9Y651; -.
DR   PhosphoSitePlus; Q9Y651; -.
DR   BioMuta; SOX21; -.
DR   DMDM; 6831690; -.
DR   EPD; Q9Y651; -.
DR   jPOST; Q9Y651; -.
DR   MaxQB; Q9Y651; -.
DR   PaxDb; Q9Y651; -.
DR   PeptideAtlas; Q9Y651; -.
DR   PRIDE; Q9Y651; -.
DR   ProteomicsDB; 86600; -.
DR   DNASU; 11166; -.
DR   Ensembl; ENST00000376945; ENSP00000366144; ENSG00000125285.
DR   GeneID; 11166; -.
DR   KEGG; hsa:11166; -.
DR   UCSC; uc001vma.4; human.
DR   CTD; 11166; -.
DR   DisGeNET; 11166; -.
DR   EuPathDB; HostDB:ENSG00000125285.5; -.
DR   GeneCards; SOX21; -.
DR   H-InvDB; HIX0037360; -.
DR   HGNC; HGNC:11197; SOX21.
DR   HPA; HPA048337; -.
DR   HPA; HPA064084; -.
DR   MIM; 604974; gene.
DR   neXtProt; NX_Q9Y651; -.
DR   OpenTargets; ENSG00000125285; -.
DR   PharmGKB; PA36034; -.
DR   eggNOG; ENOG410IPZA; Eukaryota.
DR   eggNOG; ENOG4110UF6; LUCA.
DR   GeneTree; ENSGT00940000162795; -.
DR   HOGENOM; HOG000231647; -.
DR   HOVERGEN; HBG105618; -.
DR   InParanoid; Q9Y651; -.
DR   KO; K09267; -.
DR   OMA; KPQLEPY; -.
DR   OrthoDB; 1335452at2759; -.
DR   PhylomeDB; Q9Y651; -.
DR   TreeFam; TF351735; -.
DR   GeneWiki; SOX21; -.
DR   GenomeRNAi; 11166; -.
DR   PRO; PR:Q9Y651; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   Bgee; ENSG00000125285; Expressed in 44 organ(s), highest expression level in amygdala.
DR   Genevisible; Q9Y651; HS.
DR   GO; GO:0044798; C:nuclear transcription factor complex; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0003677; F:DNA binding; ISS:UniProtKB.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; IEA:Ensembl.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; ISS:UniProtKB.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISA:NTNU_SB.
DR   GO; GO:0000978; F:RNA polymerase II proximal promoter sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0007417; P:central nervous system development; IBA:GO_Central.
DR   GO; GO:0001942; P:hair follicle development; IEA:Ensembl.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0030182; P:neuron differentiation; IBA:GO_Central.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; NAS:UniProtKB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; ISS:UniProtKB.
DR   GO; GO:0048863; P:stem cell differentiation; IDA:UniProtKB.
DR   Gene3D; 1.10.30.10; -; 1.
DR   InterPro; IPR009071; HMG_box_dom.
DR   InterPro; IPR036910; HMG_box_dom_sf.
DR   InterPro; IPR022097; SOX_fam.
DR   Pfam; PF00505; HMG_box; 1.
DR   Pfam; PF12336; SOXp; 1.
DR   SMART; SM00398; HMG; 1.
DR   SUPFAM; SSF47095; SSF47095; 1.
DR   PROSITE; PS50118; HMG_BOX_2; 1.
PE   2: Evidence at transcript level;
KW   Activator; Complete proteome; DNA-binding; Nucleus; Polymorphism;
KW   Reference proteome; Transcription; Transcription regulation.
FT   CHAIN         1    276       Transcription factor SOX-21.
FT                                /FTId=PRO_0000048770.
FT   DNA_BIND      8     76       HMG box. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00267}.
FT   VARIANT     230    230       G -> R (in dbSNP:rs6492735).
FT                                /FTId=VAR_049562.
FT   CONFLICT     41     41       R -> P (in Ref. 4; CAA50466).
FT                                {ECO:0000305}.
FT   CONFLICT     83     83       P -> T (in Ref. 4; CAA50466).
FT                                {ECO:0000305}.
SQ   SEQUENCE   276 AA;  28580 MW;  99DC899B7EC9A96B CRC64;
     MSKPVDHVKR PMNAFMVWSR AQRRKMAQEN PKMHNSEISK RLGAEWKLLT ESEKRPFIDE
     AKRLRAMHMK EHPDYKYRPR RKPKTLLKKD KFAFPVPYGL GGVADAEHPA LKAGAGLHAG
     AGGGLVPESL LANPEKAAAA AAAAAARVFF PQSAAAAAAA AAAAAAGSPY SLLDLGSKMA
     EISSSSSGLP YASSLGYPTA GAGAFHGAAA AAAAAAAAAG GHTHSHPSPG NPGYMIPCNC
     SAWPSPGLQP PLAYILLPGM GKPQLDPYPA AYAAAL
//
ID   Q4LE48_HUMAN            Unreviewed;      1275 AA.
AC   Q4LE48;
DT   02-AUG-2005, integrated into UniProtKB/TrEMBL.
DT   02-AUG-2005, sequence version 1.
DT   16-JAN-2019, entry version 74.
DE   SubName: Full=STAG1 variant protein {ECO:0000313|EMBL:BAE06105.1};
DE   Flags: Fragment;
GN   Name=STAG1 variant protein {ECO:0000313|EMBL:BAE06105.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAE06105.1};
RN   [1] {ECO:0000313|EMBL:BAE06105.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Nakajima D., Saito K., Yamakawa H., Kikuno R.F., Nakayama M.,
RA   Ohara R., Okazaki N., Koga H., Nagase T., Ohara O.;
RT   "Preparation of a set of expression-ready clones of mammalian long
RT   cDNAs encoding large proteins by the ORF trap cloning method.";
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AB210023; BAE06105.1; -; mRNA.
DR   RefSeq; NP_005853.2; NM_005862.2.
DR   UniGene; Hs.412586; -.
DR   PRIDE; Q4LE48; -.
DR   GeneID; 10274; -.
DR   KEGG; hsa:10274; -.
DR   CTD; 10274; -.
DR   eggNOG; KOG2011; Eukaryota.
DR   eggNOG; COG5537; LUCA.
DR   HOGENOM; HOG000231375; -.
DR   HOVERGEN; HBG057636; -.
DR   KO; K06671; -.
DR   OrthoDB; 167826at2759; -.
DR   ChiTaRS; STAG1; human.
DR   GenomeRNAi; 10274; -.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR039662; Cohesin_Scc3/SA.
DR   InterPro; IPR020839; SCD.
DR   InterPro; IPR013721; STAG.
DR   PANTHER; PTHR11199; PTHR11199; 1.
DR   Pfam; PF08514; STAG; 1.
DR   SUPFAM; SSF48371; SSF48371; 1.
DR   PROSITE; PS51425; SCD; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   DOMAIN      313    398       SCD. {ECO:0000259|PROSITE:PS51425}.
FT   COILED      277    307       {ECO:0000256|SAM:Coils}.
FT   NON_TER       1      1       {ECO:0000313|EMBL:BAE06105.1}.
SQ   SEQUENCE   1275 AA;  146339 MW;  670E3573E6ACBE74 CRC64;
     VVQHLIILLH CERTSPAMIT SELPVLQDST NETTAHSDAG SELEETEVKG KRKRGRPGRP
     PSTNKKPRKS PGEKSRIEAG IRGAGRGRAN GHPQQNGEGE PVTLFEVVKL GKSAMQSVVD
     DWIESYKQDR DIALLDLINF FIQCSGCRGT VRIEMFRNMQ NAEIIRKMTE EFDEDSGDYP
     LTMPGPQWKK FRSNFCEFIG VLIRQCQYSI IYDEYMMDTV ISLLTGLSDS QVRAFRHTST
     LAAMKLMTAL VNVALNLSIH QDNTQRQYEA ERNKMIGKRA NERLELLLQK RKELQENQDE
     IENMMNSIFK GIFVHRYRDA IAEIRAICIE EIGVWMKMYS DAFLNDSYLK YVGWTLHDRQ
     GEVRLKCLKA LQSLYTNREL FPKLELFTNR FKDRIVSMTL DKEYDVAVEA IRLVTLILHG
     SEEALSNEDC ENVYHLVYSA HRPVAVAAGE FLHKKLFSRH DPQAEEALAK RRGRNSPNGN
     LIRMLVLFFL ESELHEHAAY LVDSLWESSQ ELLKDWECMT ELLLEEPVQG EEAMSDRQES
     ALIELMVCTI RQAAEAHPPV GRGTGKRVLT AKERKTQIDD RNKLTEHFII TLPMLLSKYS
     ADAEKVANLL QIPQYFDLEI YSTGRMEKHL DALLKQIKFV VEKHVESDVL EACSKTYSIL
     CSEEYTIQNR VDIARSQLID EFVDRFNHSV EDLLQEGEEA DDDDIYNVLS TLKRLTSFHN
     AHDLTKWDLF GNCYRLLKTG IEHGAMPEQI VVQALQCSHY SILWQLVKIT DGSPSKEDLL
     VLRKTVKSFL AVCQQCLSNV NTPVKEQAFM LLCDLLMIFS HQLMTGGREG LQPLVFNPDT
     GLQSELLSFV MDHVFIDQDE ENQSMEGDEE DEANKIEALH KRRNLLAAFS KLIIYDIVDM
     HAAADIFKHY MKYYNDYGDI IKETLSKTRQ IDKIQCAKTL ILSLQQLFNE LVQEQGPNLD
     RTSAHVSGIK ELARRFALTF GLDQIKTREA VATLHKDGIE FAFKYQNQKG QEYPPPNLAF
     LEVLSEFSSK LLRQDKKTVH SYLEKFLTEQ MMERREDVWL PLISYRNSLV TGGEDDRMSV
     NSGSSSSKTS SVRNKKGRPP LHKKRVEDES LDNTWLNRTD TMIQTPGPLP APQLTSTVLR
     ENSRPMGDQI QEPESEHGSE PDFLHNPQMQ ISWLGQPKLE DLNRKDRTGM NYMKVRTGVR
     HAVRGLMEED AEPIFEDVMM SSRSQLEDMN EEFEDTMVID LPPSRNRRER AELRPDFFDS
     AAIIEDDSGF GMPMF
//
ID   STAG1_HUMAN             Reviewed;        1258 AA.
AC   Q8WVM7; O00539; Q6P275;
DT   25-MAR-2003, integrated into UniProtKB/Swiss-Prot.
DT   14-OCT-2008, sequence version 3.
DT   13-FEB-2019, entry version 159.
DE   RecName: Full=Cohesin subunit SA-1;
DE   AltName: Full=SCC3 homolog 1;
DE   AltName: Full=Stromal antigen 1;
GN   Name=STAG1; Synonyms=SA1, SCC3 {ECO:0000303|PubMed:22628566};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Thymus;
RX   PubMed=9305759; DOI=10.1016/S0378-1119(97)00121-2;
RA   Carramolino L., Lee B.C., Zaballos A., Peled A., Barthelemy I.,
RA   Shav-Tal Y., Prieto I., Carmi P., Gothelf Y., Gonzalez de Buitrago G.,
RA   Aracil M., Marquez G., Barbero J.L., Zipori D.;
RT   "SA-1, a nuclear protein encoded by one member of a novel gene family:
RT   molecular cloning and detection in hemopoietic organs.";
RL   Gene 195:151-159(1997).
RN   [2]
RP   ERRATUM.
RA   Carramolino L., Lee B.C., Zaballos A., Peled A., Barthelemy I.,
RA   Shav-Tal Y., Prieto I., Carmi P., Gothelf Y., Gonzalez de Buitrago G.,
RA   Aracil M., Marquez G., Barbero J.L., Zipori D.;
RL   Gene 206:283-286(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 787-1258 (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   IDENTIFICATION IN A COHESIN COMPLEX WITH SMC1A AND SMC3.
RX   PubMed=11076961; DOI=10.1083/jcb.151.4.749;
RA   Sumara I., Vorlaufer E., Gieffers C., Peters B.H., Peters J.-M.;
RT   "Characterization of vertebrate cohesin complexes and their regulation
RT   in prophase.";
RL   J. Cell Biol. 151:749-762(2000).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1062, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-24, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   IDENTIFICATION IN A COHESIN COMPLEX WITH SMC1A; SMC3 AND RAD21.
RX   PubMed=22628566; DOI=10.1073/pnas.1206840109;
RA   Bermudez V.P., Farina A., Higashi T.L., Du F., Tappin I.,
RA   Takahashi T.S., Hurwitz J.;
RT   "In vitro loading of human cohesin on DNA by the human Scc2-Scc4
RT   loader complex.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:9366-9371(2012).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-756 AND SER-1093, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11]
RP   INVOLVEMENT IN MRD47, AND VARIANTS MRD47 ARG-214; GLY-216; ARG-220;
RP   GLN-333; TRP-351; GLN-373; PRO-478 AND ARG-979.
RX   PubMed=28119487; DOI=10.1136/jmedgenet-2016-104468;
RA   Lehalle D., Mosca-Boidron A.L., Begtrup A., Boute-Benejean O.,
RA   Charles P., Cho M.T., Clarkson A., Devinsky O., Duffourd Y.,
RA   Duplomb-Jego L., Gerard B., Jacquette A., Kuentz P.,
RA   Masurel-Paulet A., McDougall C., Moutton S., Olivie H., Park S.M.,
RA   Rauch A., Revencu N., Riviere J.B., Rubin K., Simonic I., Shears D.J.,
RA   Smol T., Taylor Tavares A.L., Terhal P., Thevenon J., Van Gassen K.,
RA   Vincent-Delorme C., Willemsen M.H., Wilson G.N., Zackai E., Zweier C.,
RA   Callier P., Thauvin-Robinet C., Faivre L.;
RT   "STAG1 mutations cause a novel cohesinopathy characterised by
RT   unspecific syndromic intellectual disability.";
RL   J. Med. Genet. 54:479-488(2017).
RN   [12]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-1161, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: Component of cohesin complex, a complex required for the
CC       cohesion of sister chromatids after DNA replication. The cohesin
CC       complex apparently forms a large proteinaceous ring within which
CC       sister chromatids can be trapped. At anaphase, the complex is
CC       cleaved and dissociates from chromatin, allowing sister chromatids
CC       to segregate. The cohesin complex may also play a role in spindle
CC       pole assembly during mitosis.
CC   -!- SUBUNIT: Cohesin complexes are composed of a heterodimer between a
CC       SMC1 protein (SMC1A or SMC1B) and SMC3, which are attached via
CC       their hinge domain, and RAD21 which link them at their heads, and
CC       one STAG protein (STAG1, STAG2 or STAG3). In cohesin complexes,
CC       STAG1 is mutually exclusive with STAG2 and STAG3
CC       (PubMed:11076961). Interacts directly with RAD21 in cohesin
CC       complex (By similarity). Found in a cohesin complex with SMC1A,
CC       SMC3 and RAD21 (PubMed:22628566). {ECO:0000250|UniProtKB:Q9DGN1,
CC       ECO:0000269|PubMed:11076961, ECO:0000269|PubMed:22628566}.
CC   -!- INTERACTION:
CC       Q29RF7:PDS5A; NbExp=3; IntAct=EBI-1175097, EBI-1175454;
CC       Q9NTI5:PDS5B; NbExp=3; IntAct=EBI-1175097, EBI-1175604;
CC       Q9UQE7:SMC3; NbExp=12; IntAct=EBI-1175097, EBI-80718;
CC       Q8N3U4:STAG2; NbExp=2; IntAct=EBI-1175097, EBI-1057252;
CC       P54274:TERF1; NbExp=4; IntAct=EBI-1175097, EBI-710997;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Chromosome. Chromosome, centromere.
CC       Note=Associates with chromatin. Before prophase it is scattered
CC       along chromosome arms. During prophase, most of cohesin complexes
CC       dissociate from chromatin probably because of phosphorylation by
CC       PLK1, except at centromeres, where cohesin complexes remain. At
CC       anaphase, the RAD21 subunit of cohesin is cleaved, leading to the
CC       dissociation of the complex from chromosomes, allowing chromosome
CC       separation.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8WVM7-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8WVM7-2; Sequence=VSP_054496;
CC         Note=No experimental confirmation available.;
CC   -!- PTM: Phosphorylated by PLK1. The large dissociation of cohesin
CC       from chromosome arms during prophase is partly due to its
CC       phosphorylation (By similarity). {ECO:0000250}.
CC   -!- DISEASE: Mental retardation, autosomal dominant 47 (MRD47)
CC       [MIM:617635]: A form of mental retardation, a disorder
CC       characterized by significantly below average general intellectual
CC       functioning associated with impairments in adaptive behavior and
CC       manifested during the developmental period. MRD47 patients
CC       manifest developmental delay and mild to moderate intellectual
CC       disability, usually with delayed speech.
CC       {ECO:0000269|PubMed:28119487}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the SCC3 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; Z75330; CAA99731.1; -; mRNA.
DR   EMBL; AC069514; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC069524; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC107425; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC117382; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC128712; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC017735; AAH17735.1; -; mRNA.
DR   EMBL; BC064699; AAH64699.1; -; mRNA.
DR   CCDS; CCDS3090.1; -. [Q8WVM7-1]
DR   RefSeq; NP_005853.2; NM_005862.2. [Q8WVM7-1]
DR   UniGene; Hs.412586; -.
DR   ProteinModelPortal; Q8WVM7; -.
DR   SMR; Q8WVM7; -.
DR   BioGrid; 115564; 35.
DR   CORUM; Q8WVM7; -.
DR   DIP; DIP-35421N; -.
DR   IntAct; Q8WVM7; 22.
DR   MINT; Q8WVM7; -.
DR   STRING; 9606.ENSP00000372689; -.
DR   iPTMnet; Q8WVM7; -.
DR   PhosphoSitePlus; Q8WVM7; -.
DR   BioMuta; STAG1; -.
DR   DMDM; 209572720; -.
DR   EPD; Q8WVM7; -.
DR   jPOST; Q8WVM7; -.
DR   MaxQB; Q8WVM7; -.
DR   PaxDb; Q8WVM7; -.
DR   PeptideAtlas; Q8WVM7; -.
DR   PRIDE; Q8WVM7; -.
DR   ProteomicsDB; 74804; -.
DR   Ensembl; ENST00000236698; ENSP00000236698; ENSG00000118007. [Q8WVM7-2]
DR   Ensembl; ENST00000383202; ENSP00000372689; ENSG00000118007. [Q8WVM7-1]
DR   GeneID; 10274; -.
DR   KEGG; hsa:10274; -.
DR   UCSC; uc003era.2; human. [Q8WVM7-1]
DR   CTD; 10274; -.
DR   DisGeNET; 10274; -.
DR   EuPathDB; HostDB:ENSG00000118007.12; -.
DR   GeneCards; STAG1; -.
DR   H-InvDB; HIX0030898; -.
DR   HGNC; HGNC:11354; STAG1.
DR   HPA; HPA035015; -.
DR   HPA; HPA058653; -.
DR   MalaCards; STAG1; -.
DR   MIM; 604358; gene.
DR   MIM; 617635; phenotype.
DR   neXtProt; NX_Q8WVM7; -.
DR   OpenTargets; ENSG00000118007; -.
DR   Orphanet; 502434; STAG1-related intellectual disability-facial dysmorphism-gastroesophageal reflux syndrome.
DR   PharmGKB; PA36176; -.
DR   eggNOG; KOG2011; Eukaryota.
DR   eggNOG; COG5537; LUCA.
DR   GeneTree; ENSGT00940000153619; -.
DR   HOGENOM; HOG000231375; -.
DR   HOVERGEN; HBG057636; -.
DR   InParanoid; Q8WVM7; -.
DR   KO; K06671; -.
DR   OMA; RWDLFGN; -.
DR   OrthoDB; 167826at2759; -.
DR   PhylomeDB; Q8WVM7; -.
DR   TreeFam; TF314604; -.
DR   Reactome; R-HSA-1221632; Meiotic synapsis.
DR   Reactome; R-HSA-2467813; Separation of Sister Chromatids.
DR   Reactome; R-HSA-2468052; Establishment of Sister Chromatid Cohesion.
DR   Reactome; R-HSA-2470946; Cohesin Loading onto Chromatin.
DR   Reactome; R-HSA-2500257; Resolution of Sister Chromatid Cohesion.
DR   Reactome; R-HSA-3108214; SUMOylation of DNA damage response and repair proteins.
DR   Reactome; R-HSA-9018519; Estrogen-dependent gene expression.
DR   ChiTaRS; STAG1; human.
DR   GeneWiki; STAG1; -.
DR   GenomeRNAi; 10274; -.
DR   PRO; PR:Q8WVM7; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000118007; Expressed in 232 organ(s), highest expression level in intestine.
DR   ExpressionAtlas; Q8WVM7; baseline and differential.
DR   Genevisible; Q8WVM7; HS.
DR   GO; GO:0000785; C:chromatin; IDA:UniProtKB.
DR   GO; GO:0005694; C:chromosome; TAS:Reactome.
DR   GO; GO:0000775; C:chromosome, centromeric region; TAS:Reactome.
DR   GO; GO:0008278; C:cohesin complex; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0097431; C:mitotic spindle pole; IDA:UniProtKB.
DR   GO; GO:0016604; C:nuclear body; IDA:HPA.
DR   GO; GO:0016363; C:nuclear matrix; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0003682; F:chromatin binding; IBA:GO_Central.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; IEA:Ensembl.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:1901673; P:regulation of mitotic spindle assembly; IMP:UniProtKB.
DR   GO; GO:0007062; P:sister chromatid cohesion; IBA:GO_Central.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR039662; Cohesin_Scc3/SA.
DR   InterPro; IPR020839; SCD.
DR   InterPro; IPR013721; STAG.
DR   PANTHER; PTHR11199; PTHR11199; 1.
DR   Pfam; PF08514; STAG; 1.
DR   SUPFAM; SSF48371; SSF48371; 1.
DR   PROSITE; PS51425; SCD; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell cycle; Cell division; Centromere;
KW   Chromosome; Chromosome partition; Complete proteome; Disease mutation;
KW   Isopeptide bond; Mental retardation; Mitosis; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome; Ubl conjugation.
FT   CHAIN         1   1258       Cohesin subunit SA-1.
FT                                /FTId=PRO_0000120182.
FT   DOMAIN      296    381       SCD. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00750}.
FT   COMPBIAS    684    687       Poly-Asp.
FT   COMPBIAS   1065   1070       Poly-Ser.
FT   MOD_RES      24     24       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     756    756       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1062   1062       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES    1065   1065       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9D3E6}.
FT   MOD_RES    1093   1093       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   CROSSLNK   1161   1161       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   VAR_SEQ    1150   1186       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_054496.
FT   VARIANT     214    214       Q -> R (in MRD47).
FT                                {ECO:0000269|PubMed:28119487}.
FT                                /FTId=VAR_079487.
FT   VARIANT     216    216       R -> G (in MRD47).
FT                                {ECO:0000269|PubMed:28119487}.
FT                                /FTId=VAR_079488.
FT   VARIANT     220    220       H -> R (in MRD47; dbSNP:rs1057519153).
FT                                {ECO:0000269|PubMed:28119487}.
FT                                /FTId=VAR_079489.
FT   VARIANT     333    333       K -> Q (in MRD47).
FT                                {ECO:0000269|PubMed:28119487}.
FT                                /FTId=VAR_079490.
FT   VARIANT     351    351       L -> W (in MRD47).
FT                                {ECO:0000269|PubMed:28119487}.
FT                                /FTId=VAR_079491.
FT   VARIANT     373    373       R -> Q (in MRD47; dbSNP:rs1376334317).
FT                                {ECO:0000269|PubMed:28119487}.
FT                                /FTId=VAR_079492.
FT   VARIANT     478    478       H -> P (in MRD47).
FT                                {ECO:0000269|PubMed:28119487}.
FT                                /FTId=VAR_079493.
FT   VARIANT     979    979       K -> R (in MRD47).
FT                                {ECO:0000269|PubMed:28119487}.
FT                                /FTId=VAR_079494.
FT   VARIANT    1132   1132       Q -> H (in dbSNP:rs34149860).
FT                                /FTId=VAR_046968.
FT   CONFLICT    645    645       S -> N (in Ref. 1; CAA99731).
FT                                {ECO:0000305}.
FT   CONFLICT    702    702       H -> Q (in Ref. 1; CAA99731).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1258 AA;  144427 MW;  FAF911998EC52179 CRC64;
     MITSELPVLQ DSTNETTAHS DAGSELEETE VKGKRKRGRP GRPPSTNKKP RKSPGEKSRI
     EAGIRGAGRG RANGHPQQNG EGEPVTLFEV VKLGKSAMQS VVDDWIESYK QDRDIALLDL
     INFFIQCSGC RGTVRIEMFR NMQNAEIIRK MTEEFDEDSG DYPLTMPGPQ WKKFRSNFCE
     FIGVLIRQCQ YSIIYDEYMM DTVISLLTGL SDSQVRAFRH TSTLAAMKLM TALVNVALNL
     SIHQDNTQRQ YEAERNKMIG KRANERLELL LQKRKELQEN QDEIENMMNS IFKGIFVHRY
     RDAIAEIRAI CIEEIGVWMK MYSDAFLNDS YLKYVGWTLH DRQGEVRLKC LKALQSLYTN
     RELFPKLELF TNRFKDRIVS MTLDKEYDVA VEAIRLVTLI LHGSEEALSN EDCENVYHLV
     YSAHRPVAVA AGEFLHKKLF SRHDPQAEEA LAKRRGRNSP NGNLIRMLVL FFLESELHEH
     AAYLVDSLWE SSQELLKDWE CMTELLLEEP VQGEEAMSDR QESALIELMV CTIRQAAEAH
     PPVGRGTGKR VLTAKERKTQ IDDRNKLTEH FIITLPMLLS KYSADAEKVA NLLQIPQYFD
     LEIYSTGRME KHLDALLKQI KFVVEKHVES DVLEACSKTY SILCSEEYTI QNRVDIARSQ
     LIDEFVDRFN HSVEDLLQEG EEADDDDIYN VLSTLKRLTS FHNAHDLTKW DLFGNCYRLL
     KTGIEHGAMP EQIVVQALQC SHYSILWQLV KITDGSPSKE DLLVLRKTVK SFLAVCQQCL
     SNVNTPVKEQ AFMLLCDLLM IFSHQLMTGG REGLQPLVFN PDTGLQSELL SFVMDHVFID
     QDEENQSMEG DEEDEANKIE ALHKRRNLLA AFSKLIIYDI VDMHAAADIF KHYMKYYNDY
     GDIIKETLSK TRQIDKIQCA KTLILSLQQL FNELVQEQGP NLDRTSAHVS GIKELARRFA
     LTFGLDQIKT REAVATLHKD GIEFAFKYQN QKGQEYPPPN LAFLEVLSEF SSKLLRQDKK
     TVHSYLEKFL TEQMMERRED VWLPLISYRN SLVTGGEDDR MSVNSGSSSS KTSSVRNKKG
     RPPLHKKRVE DESLDNTWLN RTDTMIQTPG PLPAPQLTST VLRENSRPMG DQIQEPESEH
     GSEPDFLHNP QMQISWLGQP KLEDLNRKDR TGMNYMKVRT GVRHAVRGLM EEDAEPIFED
     VMMSSRSQLE DMNEEFEDTM VIDLPPSRNR RERAELRPDF FDSAAIIEDD SGFGMPMF
//
ID   A0A024RBD7_HUMAN        Unreviewed;       712 AA.
AC   A0A024RBD7;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   13-FEB-2019, entry version 50.
DE   RecName: Full=Ubiquitinyl hydrolase 1 {ECO:0000256|SAAS:SAAS01044305};
DE            EC=3.4.19.12 {ECO:0000256|SAAS:SAAS01044305};
GN   Name=USP44 {ECO:0000313|EMBL:EAW97542.1};
GN   ORFNames=hCG_1642341 {ECO:0000313|EMBL:EAW97542.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW97542.1};
RN   [1] {ECO:0000313|EMBL:EAW97542.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW97542.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Thiol-dependent hydrolysis of ester, thioester, amide,
CC         peptide and isopeptide bonds formed by the C-terminal Gly of
CC         ubiquitin (a 76-residue protein attached to proteins as an
CC         intracellular targeting signal).; EC=3.4.19.12;
CC         Evidence={ECO:0000256|SAAS:SAAS01117307};
CC   -!- SIMILARITY: Belongs to the peptidase C19 family.
CC       {ECO:0000256|SAAS:SAAS01045498}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471054; EAW97540.1; -; Genomic_DNA.
DR   EMBL; CH471054; EAW97541.1; -; Genomic_DNA.
DR   EMBL; CH471054; EAW97542.1; -; Genomic_DNA.
DR   RefSeq; NP_001035862.1; NM_001042403.2.
DR   RefSeq; NP_001265322.1; NM_001278393.1.
DR   RefSeq; NP_001334865.1; NM_001347936.1.
DR   RefSeq; NP_001334866.1; NM_001347937.1.
DR   RefSeq; NP_115523.2; NM_032147.4.
DR   RefSeq; XP_016875499.1; XM_017020010.1.
DR   UniGene; Hs.646421; -.
DR   UniGene; Hs.710121; -.
DR   GeneID; 84101; -.
DR   KEGG; hsa:84101; -.
DR   CTD; 84101; -.
DR   EuPathDB; HostDB:ENSG00000136014.11; -.
DR   eggNOG; KOG1867; Eukaryota.
DR   eggNOG; ENOG410XQQ0; LUCA.
DR   KO; K11834; -.
DR   OMA; KQLMICH; -.
DR   OrthoDB; 1230415at2759; -.
DR   ChiTaRS; USP44; human.
DR   GenomeRNAi; 84101; -.
DR   Bgee; ENSG00000136014; Expressed in 102 organ(s), highest expression level in secondary oocyte.
DR   GO; GO:0005634; C:nucleus; IEA:Ensembl.
DR   GO; GO:0036459; F:thiol-dependent ubiquitinyl hydrolase activity; IEA:UniProtKB-EC.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0007059; P:chromosome segregation; IEA:Ensembl.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IEA:Ensembl.
DR   GO; GO:0016579; P:protein deubiquitination; IEA:InterPro.
DR   GO; GO:0090266; P:regulation of mitotic cell cycle spindle assembly checkpoint; IEA:Ensembl.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR038765; Papain_like_cys_pep_sf.
DR   InterPro; IPR001394; Peptidase_C19_UCH.
DR   InterPro; IPR018200; USP_CS.
DR   InterPro; IPR028889; USP_dom.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR001607; Znf_UBP.
DR   Pfam; PF00443; UCH; 1.
DR   Pfam; PF02148; zf-UBP; 1.
DR   SMART; SM00290; ZnF_UBP; 1.
DR   SUPFAM; SSF54001; SSF54001; 1.
DR   PROSITE; PS00972; USP_1; 1.
DR   PROSITE; PS00973; USP_2; 1.
DR   PROSITE; PS50235; USP_3; 1.
DR   PROSITE; PS50271; ZF_UBP; 1.
PE   3: Inferred from homology;
KW   Hydrolase {ECO:0000256|SAAS:SAAS01044269};
KW   Metal-binding {ECO:0000256|SAAS:SAAS01044352};
KW   Protease {ECO:0000256|SAAS:SAAS01044269};
KW   Thiol protease {ECO:0000256|SAAS:SAAS01044269};
KW   Ubl conjugation pathway {ECO:0000256|SAAS:SAAS01044331};
KW   Zinc {ECO:0000256|SAAS:SAAS01044352};
KW   Zinc-finger {ECO:0000256|SAAS:SAAS01044352}.
FT   DOMAIN       27     88       UBP-type. {ECO:0000259|PROSITE:PS50271}.
FT   DOMAIN      273    678       USP. {ECO:0000259|PROSITE:PS50235}.
FT   ZN_FING      27     88       UBP-type. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00502}.
SQ   SEQUENCE   712 AA;  81185 MW;  A8211DFAD78EE731 CRC64;
     MLAMDTCKHV GQLQLAQDHS SLNPQKWHCV DCNTTESIWA CLSCSHVACG RYIEEHALKH
     FQESSHPVAL EVNEMYVFCY LCDDYVLNDN TTGDLKLLRR TLSAIKSQNY HCTTRSGRFL
     RSMGTGDDSY FLHDGAQSLL QSEDQLYTAL WHRRRILMGK IFRTWFEQSP IGRKKQEEPF
     QEKIVVKREV KKRRQELEYQ VKAELESMPP RKSLRLQGLA QSTIIEIVSV QVPAQTPASP
     AKDKVLSTSE NEISQKVSDS SVKRRPIVTP GVTGLRNLGN TCYMNSVLQV LSHLLIFRQC
     FLKLDLNQWL AMTASEKTRS CKHPPVTDTV VYQMNECQEK DTGFVCSRQS SLSSGLSGGA
     SKGRKMELIQ PKEPTSQYIS LCHELHTLFQ VMWSGKWALV SPFAMLHSVW RLIPAFRGYA
     QQDAQEFLCE LLDKIQRELE TTGTSLPALI PTSQRKLIKQ VLNVVNNIFH GQLLSQVTCL
     ACDNKSNTIE PFWDLSLEFP ERYQCSGKDI ASQPCLVTEM LAKFTETEAL EGKIYVCDQC
     NSKRRRFSSK PVVLTEAQKQ LMICHLPQVL RLHLKRFRWS GRNNREKIGV HVGFEEILNM
     EPYCCRETLK SLRPECFIYD LSAVVMHHGK GFGSGHYTAY CYNSEGGFWV HCNDSKLSMC
     TMDEVCKAQA YILFYTQRVT ENGHSKLLPP ELLLGSQHPN EDADTSSNEI LS
//
ID   UBP44_HUMAN             Reviewed;         712 AA.
AC   Q9H0E7; B2RDW3;
DT   10-OCT-2003, integrated into UniProtKB/Swiss-Prot.
DT   13-JUL-2010, sequence version 2.
DT   13-FEB-2019, entry version 152.
DE   RecName: Full=Ubiquitin carboxyl-terminal hydrolase 44;
DE            EC=3.4.19.12;
DE   AltName: Full=Deubiquitinating enzyme 44;
DE   AltName: Full=Ubiquitin thioesterase 44;
DE   AltName: Full=Ubiquitin-specific-processing protease 44;
GN   Name=USP44;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ALA-91.
RC   TISSUE=Testis;
RX   PubMed=11230166; DOI=10.1101/gr.GR1547R;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H.,
RA   Lauber J., Duesterhoeft A., Beyer A., Koehrer K., Strack N.,
RA   Mewes H.-W., Ottenwaelder B., Obermaier B., Tampe J., Heubner D.,
RA   Wambutt R., Korn B., Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and
RT   analysis of 500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ALA-91.
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ALA-91.
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   TISSUE SPECIFICITY, AND ENZYME ACTIVITY.
RX   PubMed=14715245; DOI=10.1016/j.bbrc.2003.12.050;
RA   Quesada V., Diaz-Perales A., Gutierrez-Fernandez A., Garabaya C.,
RA   Cal S., Lopez-Otin C.;
RT   "Cloning and enzymatic analysis of 22 novel human ubiquitin-specific
RT   proteases.";
RL   Biochem. Biophys. Res. Commun. 314:54-62(2004).
RN   [6]
RP   FUNCTION, CATALYTIC ACTIVITY, PHOSPHORYLATION, DEVELOPMENTAL STAGE,
RP   AND MUTAGENESIS OF CYS-282.
RX   PubMed=17443180; DOI=10.1038/nature05694;
RA   Stegmeier F., Rape M., Draviam V.M., Nalepa G., Sowa M.E., Ang X.L.,
RA   McDonald E.R. III, Li M.Z., Hannon G.J., Sorger P.K., Kirschner M.W.,
RA   Harper J.W., Elledge S.J.;
RT   "Anaphase initiation is regulated by antagonistic ubiquitination and
RT   deubiquitination activities.";
RL   Nature 446:876-881(2007).
RN   [7]
RP   CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, UBIQUITINATION, AND
RP   MUTAGENESIS OF CYS-282.
RX   PubMed=20402667; DOI=10.1042/CBI20090144;
RA   Suresh B., Ramakrishna S., Lee H.J., Choi J.H., Kim J.Y., Ahn W.S.,
RA   Baek K.H.;
RT   "K48- and K63-linked polyubiquitination of deubiquitinating enzyme
RT   USP44.";
RL   Cell Biol. Int. 34:799-808(2010).
RN   [8]
RP   INDUCTION.
RX   PubMed=20505756; DOI=10.1371/journal.pone.0010709;
RA   Jung M., Peterson H., Chavez L., Kahlem P., Lehrach H., Vilo J.,
RA   Adjaye J.;
RT   "A data integration approach to mapping OCT4 gene regulatory networks
RT   operative in embryonic stem cells and embryonal carcinoma cells.";
RL   PLoS ONE 5:E10709-E10709(2010).
RN   [9]
RP   TISSUE SPECIFICITY.
RX   PubMed=21853124; DOI=10.1371/journal.pone.0023389;
RA   Zhang Y., van Deursen J., Galardy P.J.;
RT   "Overexpression of ubiquitin specific protease 44 (USP44) induces
RT   chromosomal instability and is frequently observed in human T-cell
RT   leukemia.";
RL   PLoS ONE 6:E23389-E23389(2011).
RN   [10]
RP   FUNCTION.
RX   PubMed=22681888; DOI=10.1016/j.molcel.2012.05.023;
RA   Fuchs G., Shema E., Vesterman R., Kotler E., Wolchinsky Z., Wilder S.,
RA   Golomb L., Pribluda A., Zhang F., Haj-Yahya M., Feldmesser E.,
RA   Brik A., Yu X., Hanna J., Aberdam D., Domany E., Oren M.;
RT   "RNF20 and USP44 regulate stem cell differentiation by modulating H2B
RT   monoubiquitylation.";
RL   Mol. Cell 46:662-673(2012).
RN   [11]
RP   PHOSPHORYLATION AT SER-169; SER-239; THR-269 AND SER-401, AND
RP   DEPHOSPHORYLATION.
RX   PubMed=22692537; DOI=10.1038/ncomms1886;
RA   Visconti R., Palazzo L., Della Monica R., Grieco D.;
RT   "Fcp1-dependent dephosphorylation is required for M-phase-promoting
RT   factor inactivation at mitosis exit.";
RL   Nat. Commun. 3:894-894(2012).
CC   -!- FUNCTION: Deubiquitinase that plays a key regulatory role in the
CC       spindle assembly checkpoint or mitotic checkpoint by preventing
CC       premature anaphase onset. Acts by specifically mediating
CC       deubiquitination of CDC20, a negative regulator of the anaphase
CC       promoting complex/cyclosome (APC/C). Deubiquitination of CDC20
CC       leads to stabilize the MAD2L1-CDC20-APC/C ternary complex (also
CC       named mitotic checkpoint complex), thereby preventing premature
CC       activation of the APC/C. Promotes association of MAD2L1 with CDC20
CC       and reinforces the spindle assembly checkpoint. Acts as a negative
CC       regulator of histone H2B (H2BK120ub1) ubiquitination.
CC       {ECO:0000269|PubMed:17443180, ECO:0000269|PubMed:22681888}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Thiol-dependent hydrolysis of ester, thioester, amide,
CC         peptide and isopeptide bonds formed by the C-terminal Gly of
CC         ubiquitin (a 76-residue protein attached to proteins as an
CC         intracellular targeting signal).; EC=3.4.19.12;
CC         Evidence={ECO:0000269|PubMed:14715245,
CC         ECO:0000269|PubMed:17443180, ECO:0000269|PubMed:20402667};
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:20402667}.
CC       Note=Peaks in interphase, with relatively low levels maintained
CC       throughout mitosis. {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Expressed in testis. Expressed at high levels
CC       in T-cell acute lymphoblastic leukemia.
CC       {ECO:0000269|PubMed:14715245, ECO:0000269|PubMed:21853124}.
CC   -!- DEVELOPMENTAL STAGE: Elevated in mitosis; levels increase in
CC       mitotic cells and rapidly decrease once cells have completed
CC       chromosome attachment and exit from mitosis.
CC       {ECO:0000269|PubMed:17443180}.
CC   -!- INDUCTION: Transcriptionally regulated by POU5F1/OCT4 in embryonic
CC       stem cells and embryonal carcinoma cells.
CC       {ECO:0000269|PubMed:20505756}.
CC   -!- PTM: Dephosphorylated by CTDP1.
CC   -!- PTM: Ubiquitinated; undergoes both 'Lys-48'- and 'Lys-63'-linked
CC       polyubiquitination and is degraded by the proteasome.
CC       {ECO:0000269|PubMed:20402667}.
CC   -!- SIMILARITY: Belongs to the peptidase C19 family. USP44 subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AL136825; CAB66759.1; -; mRNA.
DR   EMBL; AK315697; BAG38060.1; -; mRNA.
DR   EMBL; AC018475; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC030704; AAH30704.1; -; mRNA.
DR   CCDS; CCDS9053.1; -.
DR   RefSeq; NP_001035862.1; NM_001042403.2.
DR   RefSeq; NP_001265322.1; NM_001278393.1.
DR   RefSeq; NP_001334865.1; NM_001347936.1.
DR   RefSeq; NP_001334866.1; NM_001347937.1.
DR   RefSeq; NP_115523.2; NM_032147.4.
DR   RefSeq; XP_016875499.1; XM_017020010.1.
DR   UniGene; Hs.646421; -.
DR   UniGene; Hs.710121; -.
DR   ProteinModelPortal; Q9H0E7; -.
DR   SMR; Q9H0E7; -.
DR   BioGrid; 123890; 23.
DR   IntAct; Q9H0E7; 11.
DR   STRING; 9606.ENSP00000258499; -.
DR   MEROPS; C19.057; -.
DR   iPTMnet; Q9H0E7; -.
DR   PhosphoSitePlus; Q9H0E7; -.
DR   BioMuta; USP44; -.
DR   DMDM; 300669621; -.
DR   EPD; Q9H0E7; -.
DR   PaxDb; Q9H0E7; -.
DR   PeptideAtlas; Q9H0E7; -.
DR   PRIDE; Q9H0E7; -.
DR   ProteomicsDB; 80264; -.
DR   DNASU; 84101; -.
DR   Ensembl; ENST00000258499; ENSP00000258499; ENSG00000136014.
DR   Ensembl; ENST00000393091; ENSP00000376806; ENSG00000136014.
DR   Ensembl; ENST00000537435; ENSP00000442629; ENSG00000136014.
DR   GeneID; 84101; -.
DR   KEGG; hsa:84101; -.
DR   UCSC; uc001teg.5; human.
DR   CTD; 84101; -.
DR   DisGeNET; 84101; -.
DR   EuPathDB; HostDB:ENSG00000136014.11; -.
DR   GeneCards; USP44; -.
DR   H-InvDB; HIX0010895; -.
DR   HGNC; HGNC:20064; USP44.
DR   HPA; HPA026543; -.
DR   MIM; 610993; gene.
DR   neXtProt; NX_Q9H0E7; -.
DR   OpenTargets; ENSG00000136014; -.
DR   PharmGKB; PA134931457; -.
DR   eggNOG; KOG1867; Eukaryota.
DR   eggNOG; ENOG410XQQ0; LUCA.
DR   GeneTree; ENSGT00940000160526; -.
DR   HOGENOM; HOG000015084; -.
DR   HOVERGEN; HBG018027; -.
DR   InParanoid; Q9H0E7; -.
DR   KO; K11834; -.
DR   OMA; KQLMICH; -.
DR   OrthoDB; 1230415at2759; -.
DR   PhylomeDB; Q9H0E7; -.
DR   TreeFam; TF315281; -.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   ChiTaRS; USP44; human.
DR   GeneWiki; USP44; -.
DR   GenomeRNAi; 84101; -.
DR   PRO; PR:Q9H0E7; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000136014; Expressed in 102 organ(s), highest expression level in secondary oocyte.
DR   ExpressionAtlas; Q9H0E7; baseline and differential.
DR   Genevisible; Q9H0E7; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0004843; F:thiol-dependent ubiquitin-specific protease activity; IDA:UniProtKB.
DR   GO; GO:0036459; F:thiol-dependent ubiquitinyl hydrolase activity; IMP:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0007059; P:chromosome segregation; IEA:Ensembl.
DR   GO; GO:1904667; P:negative regulation of ubiquitin protein ligase activity; IMP:UniProtKB.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; ISS:UniProtKB.
DR   GO; GO:0016579; P:protein deubiquitination; IDA:UniProtKB.
DR   GO; GO:0090266; P:regulation of mitotic cell cycle spindle assembly checkpoint; ISS:UniProtKB.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR038765; Papain_like_cys_pep_sf.
DR   InterPro; IPR001394; Peptidase_C19_UCH.
DR   InterPro; IPR018200; USP_CS.
DR   InterPro; IPR028889; USP_dom.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR001607; Znf_UBP.
DR   Pfam; PF00443; UCH; 1.
DR   Pfam; PF02148; zf-UBP; 1.
DR   SMART; SM00290; ZnF_UBP; 1.
DR   SUPFAM; SSF54001; SSF54001; 1.
DR   PROSITE; PS00972; USP_1; 1.
DR   PROSITE; PS00973; USP_2; 1.
DR   PROSITE; PS50235; USP_3; 1.
DR   PROSITE; PS50271; ZF_UBP; 1.
PE   1: Evidence at protein level;
KW   Cell cycle; Cell division; Complete proteome; Hydrolase;
KW   Metal-binding; Mitosis; Nucleus; Phosphoprotein; Polymorphism;
KW   Protease; Reference proteome; Thiol protease; Ubl conjugation;
KW   Ubl conjugation pathway; Zinc; Zinc-finger.
FT   CHAIN         1    712       Ubiquitin carboxyl-terminal hydrolase 44.
FT                                /FTId=PRO_0000080673.
FT   DOMAIN      273    678       USP.
FT   ZN_FING      27     88       UBP-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00502}.
FT   ACT_SITE    282    282       Nucleophile.
FT   ACT_SITE    636    636       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10092, ECO:0000255|PROSITE-
FT                                ProRule:PRU10093}.
FT   MOD_RES     169    169       Phosphoserine.
FT                                {ECO:0000305|PubMed:22692537}.
FT   MOD_RES     239    239       Phosphoserine.
FT                                {ECO:0000305|PubMed:22692537}.
FT   MOD_RES     269    269       Phosphothreonine.
FT                                {ECO:0000305|PubMed:22692537}.
FT   MOD_RES     401    401       Phosphoserine.
FT                                {ECO:0000305|PubMed:22692537}.
FT   VARIANT      91     91       T -> A (in dbSNP:rs3812813).
FT                                {ECO:0000269|PubMed:11230166,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_017125.
FT   VARIANT     316    316       E -> Q (in dbSNP:rs7305024).
FT                                /FTId=VAR_057043.
FT   VARIANT     348    348       R -> G (in dbSNP:rs7135642).
FT                                /FTId=VAR_057044.
FT   MUTAGEN     282    282       C->S,A: Abolishes deubiquitinase
FT                                activity. {ECO:0000269|PubMed:17443180,
FT                                ECO:0000269|PubMed:20402667}.
SQ   SEQUENCE   712 AA;  81185 MW;  A8211DFAD78EE731 CRC64;
     MLAMDTCKHV GQLQLAQDHS SLNPQKWHCV DCNTTESIWA CLSCSHVACG RYIEEHALKH
     FQESSHPVAL EVNEMYVFCY LCDDYVLNDN TTGDLKLLRR TLSAIKSQNY HCTTRSGRFL
     RSMGTGDDSY FLHDGAQSLL QSEDQLYTAL WHRRRILMGK IFRTWFEQSP IGRKKQEEPF
     QEKIVVKREV KKRRQELEYQ VKAELESMPP RKSLRLQGLA QSTIIEIVSV QVPAQTPASP
     AKDKVLSTSE NEISQKVSDS SVKRRPIVTP GVTGLRNLGN TCYMNSVLQV LSHLLIFRQC
     FLKLDLNQWL AMTASEKTRS CKHPPVTDTV VYQMNECQEK DTGFVCSRQS SLSSGLSGGA
     SKGRKMELIQ PKEPTSQYIS LCHELHTLFQ VMWSGKWALV SPFAMLHSVW RLIPAFRGYA
     QQDAQEFLCE LLDKIQRELE TTGTSLPALI PTSQRKLIKQ VLNVVNNIFH GQLLSQVTCL
     ACDNKSNTIE PFWDLSLEFP ERYQCSGKDI ASQPCLVTEM LAKFTETEAL EGKIYVCDQC
     NSKRRRFSSK PVVLTEAQKQ LMICHLPQVL RLHLKRFRWS GRNNREKIGV HVGFEEILNM
     EPYCCRETLK SLRPECFIYD LSAVVMHHGK GFGSGHYTAY CYNSEGGFWV HCNDSKLSMC
     TMDEVCKAQA YILFYTQRVT ENGHSKLLPP ELLLGSQHPN EDADTSSNEI LS
//
ID   F8W9F9_HUMAN            Unreviewed;      2217 AA.
AC   F8W9F9;
DT   21-SEP-2011, integrated into UniProtKB/TrEMBL.
DT   21-SEP-2011, sequence version 1.
DT   16-JAN-2019, entry version 63.
DE   SubName: Full=Serine/threonine-protein kinase WNK2 {ECO:0000313|Ensembl:ENSP00000378860};
GN   Name=WNK2 {ECO:0000313|Ensembl:ENSP00000378860};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000378860, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000378860, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [2] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [3] {ECO:0000213|PubMed:19413330}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [4] {ECO:0000213|PubMed:19690332}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:ra46-RA46(2009).
RN   [5] {ECO:0000213|PubMed:21406692}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:rs3-RS3(2011).
RN   [6] {ECO:0000313|Ensembl:ENSP00000378860}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AL354991; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL390760; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL583839; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_006639.3; NM_006648.3.
DR   RefSeq; XP_005252198.1; XM_005252141.2.
DR   UniGene; Hs.654856; -.
DR   ProteinModelPortal; F8W9F9; -.
DR   iPTMnet; F8W9F9; -.
DR   jPOST; F8W9F9; -.
DR   MaxQB; F8W9F9; -.
DR   PeptideAtlas; F8W9F9; -.
DR   PRIDE; F8W9F9; -.
DR   Ensembl; ENST00000395477; ENSP00000378860; ENSG00000165238.
DR   GeneID; 65268; -.
DR   UCSC; uc004atj.3; human.
DR   CTD; 65268; -.
DR   EuPathDB; HostDB:ENSG00000165238.16; -.
DR   HGNC; HGNC:14542; WNK2.
DR   OpenTargets; ENSG00000165238; -.
DR   eggNOG; KOG0584; Eukaryota.
DR   eggNOG; ENOG410XQWZ; LUCA.
DR   GeneTree; ENSGT00940000157161; -.
DR   OrthoDB; 27514at2759; -.
DR   SignaLink; F8W9F9; -.
DR   ChiTaRS; WNK2; human.
DR   GenomeRNAi; 65268; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000165238; Expressed in 181 organ(s), highest expression level in apex of heart.
DR   ExpressionAtlas; F8W9F9; baseline and differential.
DR   Genevisible; F8W9F9; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:InterPro.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR024678; Kinase_OSR1/WNK_CCT.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF12202; OSR1_C; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|MaxQB:F8W9F9,
KW   ECO:0000213|PeptideAtlas:F8W9F9};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN      195    453       Protein kinase.
FT                                {ECO:0000259|PROSITE:PS50011}.
FT   COILED     1247   1267       {ECO:0000256|SAM:Coils}.
FT   COILED     1894   1925       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   2217 AA;  234380 MW;  60E5F2982D5235A1 CRC64;
     MDGDGGRRDV PGTLMEPGRG AGPAGMAEPR AKAARPGPQR FLRRSVVESD QEEPPGLEAA
     EAPGPQPPQP LQRRVLLLCK TRRLIAERAR GRPAAPAPAA LVAQPGAPGA PADAGPEPVG
     TQEPGPDPIA AAVETAPAPD GGPREEAAAT VRKEDEGAAE AKPEPGRTRR DEPEEEEDDE
     DDLKAVATSL DGRFLKFDIE LGRGSFKTVY KGLDTETWVE VAWCELQDRK LTKLERQRFK
     EEAEMLKGLQ HPNIVRFYDF WESSAKGKRC IVLVTELMTS GTLKTYLKRF KVMKPKVLRS
     WCRQILKGLL FLHTRTPPII HRDLKCDNIF ITGPTGSVKI GDLGLATLKR ASFAKSVIGT
     PEFMAPEMYE EHYDESVDVY AFGMCMLEMA TSEYPYSECQ NAAQIYRKVT CGIKPASFEK
     VHDPEIKEII GECICKNKEE RYEIKDLLSH AFFAEDTGVR VELAEEDHGR KSTIALRLWV
     EDPKKLKGKP KDNGAIEFTF DLEKETPDEV AQEMIESGFF HESDVKIVAK SIRDRVALIQ
     WRRERIWPAL QPKEQQDVGS PDKARGPPVP LQVQVTYHAQ AGQPGPPEPE EPEADQHLLP
     PTLPTSATSL ASDSTFDSGQ GSTVYSDSQS SQQSVMLGSL ADAAPSPAQC VCSPPVSEGP
     VLPQSLPSLG AYQQPTAAPG LPVGSVPAPA CPPSLQQHFP DPAMSFAPVL PPPSTPMPTG
     PGQPAPPGQQ PPPLAQPTPL PQVLAPQPVV PLQPVPPHLP PYLAPASQVG APAQLKPLQM
     PQAPLQPLAQ VPPQMPPIPV VPPITPLAGI DGLPPALPDL PTATVPPVPP PQYFSPAVIL
     PSLAAPLPPA SPALPLQAVK LPHPPGAPLA MPCRTIVPNA PATIPLLAVA PPGVAALSIH
     SAVAQLPGQP VYPAAFPQMA PTDVPPSPHH TVQNMRATPP QPALPPQPTL PPQPVLPPQP
     TLPPQPVLPP QPTRPPQPVL PPQPMLPPQP VLPPQPALPV RPEPLQPHLP EQAAPAATPG
     SQILLGHPAP YAVDVAAQVP TVPVPPAAVL SPPLPEVLLP AAPELLPQFP SSLATVSASV
     QSVPTQTATL LPPANPPLPG GPGIASPCPT VQLTVEPVQE EQASQDKPPG LPQSCESYGG
     SDVTSGKELS DSCEGAFGGG RLEGRAARKH HRRSTRARSR QERASRPRLT ILNVCNTGDK
     MVECQLETHN HKMVTFKFDL DGDAPDEIAT YMVEHDFILQ AERETFIEQM KDVMDKAEDM
     LSEDTDADRG SDPGTSPPHL STCGLGTGEE SRQSQANAPV YQQNVLHTGK RWFIICPVAE
     HPAPEAPESS PPLPLSSLPP EASQDSAPYK DQLSSKEQPS FLASQQLLSQ AGPSNPPGAP
     PAPLAPSSPP VTALPQDGAA PATSTMPEPA SGTASQAGGP GTPQGLTSEL ETSQPLAETH
     EAPLAVQPLV VGLAPCTPAP EAASTRDASA PREPLPPPAP EPSPHSGTPQ PALGQPAPLL
     PAAVGAVSLA TSQLPSPPLG PTVPPQPPSA LESDGEGPPP RVGFVDSTIK SLDEKLRTLL
     YQEHVPTSSA SAGTPVEVGD RDFTLEPLRG DQPRSEVCGG DLALPPVPKE AVSGRVQLPQ
     PLVEKSELAP TRGAVMEQGT SSSMTAESSP RSMLGYDRDG RQVASDSHVV PSVPQDVPAF
     VRPARVEPTD RDGGEAGESS AEPPPSDMGT VGGQASHPQT LGARALGSPR KRPEQQDVSS
     PAKTVGRFSV VSTQDEWTLA SPHSLRYSAP PDVYLDEAPS SPDVKLAVRR AQTASSIEVG
     VGEPVSSDSG DEGPRARPPV QKQASLPVSG SVAGDFVKKA TAFLQRPSRA GSLGPETPSR
     VGMKVPTISV TSFHSQSSYI SSDNDSELED ADIKKELQSL REKHLKEISE LQSQQKQEIE
     ALYRRLGKPL PPNVGFFHTA PPTGRRRKTS KSKLKAGKLL NPLVRQLKVV ASSTGHLADS
     SRGPPAKDPA QASVGLTADS TGLSGKAVQT QQPCSVRASL SSDICSGLAS DGGGARGQGW
     TVYHPTSERV TYKSSSKPRA RFLSGPVSVS IWSALKRLCL GKEHSSRSST SSLAPGPEPG
     PQPALHVQAQ VNNSNNKKGT FTDDLHKLVD EWTSKTVGAA QLKPTLNQLK QTQKLQDMEA
     QAGWAAPGEA RAMTAPRAGV GMPRLPPAPG PLSTTVIPGA APTLSVPTPD PESEKPD
//
ID   WNK2_HUMAN              Reviewed;        2297 AA.
AC   Q9Y3S1; Q5VWF1; Q5VWF2; Q8IY36; Q9C0A3; Q9H3P4;
DT   02-FEB-2004, integrated into UniProtKB/Swiss-Prot.
DT   02-FEB-2004, sequence version 4.
DT   13-FEB-2019, entry version 169.
DE   RecName: Full=Serine/threonine-protein kinase WNK2 {ECO:0000305};
DE            EC=2.7.11.1 {ECO:0000250|UniProtKB:Q9H4A3};
DE   AltName: Full=Antigen NY-CO-43;
DE   AltName: Full=Protein kinase lysine-deficient 2 {ECO:0000312|HGNC:HGNC:14542};
DE   AltName: Full=Protein kinase with no lysine 2 {ECO:0000303|PubMed:11571656};
DE   AltName: Full=Serologically defined colon cancer antigen 43;
GN   Name=WNK2 {ECO:0000312|HGNC:HGNC:14542};
GN   Synonyms=KIAA1760 {ECO:0000312|EMBL:BAB21851.2},
GN   PRKWNK2 {ECO:0000312|HGNC:HGNC:14542},
GN   SDCCAG43 {ECO:0000312|HGNC:HGNC:14542}; ORFNames=P/OKcl.13;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND
RP   CHROMOSOMAL LOCATION.
RC   TISSUE=Colon epithelium {ECO:0000269|PubMed:11571656};
RX   PubMed=11571656; DOI=10.1038/sj.onc.1204726;
RA   Verissimo F., Jordan P.;
RT   "WNK kinases, a novel protein kinase subfamily in multi-cellular
RT   organisms.";
RL   Oncogene 20:5562-5569(2001).
RN   [2] {ECO:0000305}
RP   SEQUENCE REVISION.
RA   Jordan P.;
RL   Submitted (JAN-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [4] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-845 (ISOFORM 3).
RC   TISSUE=Pancreatic cancer {ECO:0000269|PubMed:11280764};
RX   PubMed=11280764;
RA   Ito M., Shichijo S., Tsuda N., Ochi M., Harashima N., Saito N.,
RA   Itoh K.;
RT   "Molecular basis of T cell-mediated recognition of pancreatic cancer
RT   cells.";
RL   Cancer Res. 61:2038-2046(2001).
RN   [5] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 6-2297 (ISOFORM 2).
RC   TISSUE=Brain {ECO:0000312|EMBL:BAB21851.2};
RX   PubMed=11214970; DOI=10.1093/dnares/7.6.347;
RA   Nagase T., Kikuno R., Hattori A., Kondo Y., Okumura K., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XIX.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 7:347-355(2000).
RN   [6] {ECO:0000305}
RP   SEQUENCE REVISION.
RA   Ohara O., Nagase T., Kikuno R.;
RL   Submitted (NOV-2000) to the EMBL/GenBank/DDBJ databases.
RN   [7] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1609-2297 (ISOFORM 4).
RC   TISSUE=Lung {ECO:0000269|PubMed:15489334};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND
RP   AUTOPHOSPHORYLATION.
RX   PubMed=17667937; DOI=10.1038/sj.onc.1210706;
RA   Moniz S., Verissimo F., Matos P., Brazao R., Silva E., Kotelevets L.,
RA   Kotevelets L., Chastre E., Gespach C., Jordan P.;
RT   "Protein kinase WNK2 inhibits cell proliferation by negatively
RT   modulating the activation of MEK1/ERK1/2.";
RL   Oncogene 26:6071-6081(2007).
RN   [9]
RP   ERRATUM.
RA   Moniz S., Verissimo F., Matos P., Brazao R., Silva E., Kotelevets L.,
RA   Kotevelets L., Chastre E., Gespach C., Jordan P.;
RL   Oncogene 27:155-155(2008).
RN   [10]
RP   FUNCTION, SUBCELLULAR LOCATION, AND PHOSPHORYLATION.
RX   PubMed=18593598; DOI=10.1016/j.cellsig.2008.06.002;
RA   Moniz S., Matos P., Jordan P.;
RT   "WNK2 modulates MEK1 activity through the Rho GTPase pathway.";
RL   Cell. Signal. 20:1762-1768(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1817 AND SER-1818, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1817 AND SER-1818, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [14]
RP   FUNCTION, TISSUE SPECIFICITY, AND PHOSPHORYLATION AT SER-45; SER-560;
RP   SER-1150; SER-1262; SER-1588; SER-1685; SER-1736; SER-1817; SER-1818;
RP   SER-1862 AND SER-2067.
RX   PubMed=21733846; DOI=10.1074/jbc.M111.222893;
RA   Rinehart J., Vazquez N., Kahle K.T., Hodson C.A., Ring A.M.,
RA   Gulcicek E.E., Louvi A., Bobadilla N.A., Gamba G., Lifton R.P.;
RT   "WNK2 is a novel regulator of essential neuronal cation-chloride
RT   cotransporters.";
RL   J. Biol. Chem. 286:30171-30180(2011).
CC   -!- FUNCTION: Serine/threonine kinase which plays an important role in
CC       the regulation of electrolyte homeostasis, cell signaling,
CC       survival, and proliferation. Acts as an activator and inhibitor of
CC       sodium-coupled chloride cotransporters and potassium-coupled
CC       chloride cotransporters respectively. Activates SLC12A2, SCNN1A,
CC       SCNN1B, SCNN1D and SGK1 and inhibits SLC12A5. Negatively regulates
CC       the EGF-induced activation of the ERK/MAPK-pathway and the
CC       downstream cell cycle progression. Affects MAPK3/MAPK1 activity by
CC       modulating the activity of MAP2K1 and this modulation depends on
CC       phosphorylation of MAP2K1 by PAK1. WNK2 acts by interfering with
CC       the activity of PAK1 by controlling the balance of the activity of
CC       upstream regulators of PAK1 activity, RHOA and RAC1, which display
CC       reciprocal activity. {ECO:0000269|PubMed:17667937,
CC       ECO:0000269|PubMed:18593598, ECO:0000269|PubMed:21733846}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1; Evidence={ECO:0000250|UniProtKB:Q9H4A3};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1; Evidence={ECO:0000250|UniProtKB:Q9H4A3};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:Q9H4A3};
CC   -!- ACTIVITY REGULATION: Activation requires autophosphorylation of
CC       Ser-356. Phosphorylation of Ser-352 also promotes increased
CC       activity (By similarity). {ECO:0000250|UniProtKB:Q9JIH7}.
CC   -!- SUBUNIT: Forms a complex with the phosphorylated form of STK39.
CC       {ECO:0000250|UniProtKB:Q3UH66}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17667937,
CC       ECO:0000269|PubMed:18593598}. Cell membrane
CC       {ECO:0000269|PubMed:18593598}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1 {ECO:0000269|PubMed:11571656};
CC         IsoId=Q9Y3S1-1; Sequence=Displayed;
CC       Name=2 {ECO:0000303|PubMed:11214970};
CC         IsoId=Q9Y3S1-2; Sequence=VSP_050643, VSP_050644, VSP_050647;
CC         Note=No experimental confirmation available. {ECO:0000305};
CC       Name=3 {ECO:0000269|PubMed:11280764};
CC         IsoId=Q9Y3S1-3; Sequence=VSP_050639, VSP_050640, VSP_050641,
CC                                  VSP_050642;
CC         Note=Incomplete sequence. {ECO:0000269|PubMed:11280764};
CC       Name=4 {ECO:0000303|PubMed:15489334};
CC         IsoId=Q9Y3S1-4; Sequence=VSP_050645, VSP_050646;
CC         Note=No experimental confirmation available. {ECO:0000305};
CC   -!- TISSUE SPECIFICITY: Expressed in various cancer cell lines (at
CC       protein level). Predominantly expressed in heart, brain, skeletal
CC       muscle and colon. {ECO:0000269|PubMed:11571656,
CC       ECO:0000269|PubMed:17667937, ECO:0000269|PubMed:21733846}.
CC   -!- PTM: Autophosphorylated. {ECO:0000269|PubMed:18593598,
CC       ECO:0000269|PubMed:21733846}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr
CC       protein kinase family. WNK subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00159}.
CC   -!- CAUTION: Was named WNK/'with no lysine(K)' because key residues
CC       for catalysis, including the lysine involved in ATP binding, are
CC       either not conserved or differ compared to the residues described
CC       in other kinase family proteins. {ECO:0000250|UniProtKB:Q9H4A3}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH37965.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/WNK2ID41867ch9q22.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ242724; CAB44308.5; -; mRNA.
DR   EMBL; AL354991; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL390760; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL583839; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AB044546; BAB18648.1; -; mRNA.
DR   EMBL; AB051547; BAB21851.2; -; mRNA.
DR   EMBL; BC037965; AAH37965.1; ALT_INIT; mRNA.
DR   CCDS; CCDS75858.1; -. [Q9Y3S1-1]
DR   RefSeq; NP_001269323.1; NM_001282394.1. [Q9Y3S1-1]
DR   RefSeq; XP_005252197.1; XM_005252140.2. [Q9Y3S1-2]
DR   UniGene; Hs.654856; -.
DR   PDB; 6ELM; X-ray; 1.14 A; A=454-549.
DR   PDB; 6FBK; X-ray; 1.74 A; A=454-549.
DR   PDBsum; 6ELM; -.
DR   PDBsum; 6FBK; -.
DR   ProteinModelPortal; Q9Y3S1; -.
DR   SMR; Q9Y3S1; -.
DR   BioGrid; 122423; 13.
DR   ELM; Q9Y3S1; -.
DR   IntAct; Q9Y3S1; 11.
DR   STRING; 9606.ENSP00000297954; -.
DR   BindingDB; Q9Y3S1; -.
DR   ChEMBL; CHEMBL5639; -.
DR   GuidetoPHARMACOLOGY; 2281; -.
DR   iPTMnet; Q9Y3S1; -.
DR   PhosphoSitePlus; Q9Y3S1; -.
DR   BioMuta; WNK2; -.
DR   DMDM; 41688799; -.
DR   EPD; Q9Y3S1; -.
DR   jPOST; Q9Y3S1; -.
DR   PaxDb; Q9Y3S1; -.
DR   PeptideAtlas; Q9Y3S1; -.
DR   PRIDE; Q9Y3S1; -.
DR   ProteomicsDB; 86071; -.
DR   ProteomicsDB; 86072; -. [Q9Y3S1-2]
DR   ProteomicsDB; 86073; -. [Q9Y3S1-3]
DR   ProteomicsDB; 86074; -. [Q9Y3S1-4]
DR   Ensembl; ENST00000297954; ENSP00000297954; ENSG00000165238. [Q9Y3S1-1]
DR   GeneID; 65268; -.
DR   KEGG; hsa:65268; -.
DR   UCSC; uc004ati.3; human. [Q9Y3S1-1]
DR   CTD; 65268; -.
DR   DisGeNET; 65268; -.
DR   EuPathDB; HostDB:ENSG00000165238.16; -.
DR   GeneCards; WNK2; -.
DR   HGNC; HGNC:14542; WNK2.
DR   HPA; CAB017813; -.
DR   HPA; HPA015555; -.
DR   HPA; HPA016519; -.
DR   MIM; 606249; gene.
DR   neXtProt; NX_Q9Y3S1; -.
DR   OpenTargets; ENSG00000165238; -.
DR   PharmGKB; PA33783; -.
DR   eggNOG; KOG0584; Eukaryota.
DR   eggNOG; ENOG410XQWZ; LUCA.
DR   GeneTree; ENSGT00940000157161; -.
DR   HOGENOM; HOG000139922; -.
DR   HOVERGEN; HBG050345; -.
DR   InParanoid; Q9Y3S1; -.
DR   KO; K08867; -.
DR   OMA; YDFWESC; -.
DR   OrthoDB; 27514at2759; -.
DR   PhylomeDB; Q9Y3S1; -.
DR   TreeFam; TF315363; -.
DR   Reactome; R-HSA-2672351; Stimuli-sensing channels.
DR   SignaLink; Q9Y3S1; -.
DR   ChiTaRS; WNK2; human.
DR   GeneWiki; WNK2; -.
DR   GenomeRNAi; 65268; -.
DR   PRO; PR:Q9Y3S1; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000165238; Expressed in 181 organ(s), highest expression level in apex of heart.
DR   ExpressionAtlas; Q9Y3S1; baseline and differential.
DR   Genevisible; Q9Y3S1; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; ISS:UniProtKB.
DR   GO; GO:0019869; F:chloride channel inhibitor activity; IBA:GO_Central.
DR   GO; GO:0019870; F:potassium channel inhibitor activity; IBA:GO_Central.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; ISS:UniProtKB.
DR   GO; GO:0035556; P:intracellular signal transduction; ISS:UniProtKB.
DR   GO; GO:0050801; P:ion homeostasis; IMP:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; IMP:UniProtKB.
DR   GO; GO:0070373; P:negative regulation of ERK1 and ERK2 cascade; IMP:UniProtKB.
DR   GO; GO:0010766; P:negative regulation of sodium ion transport; IBA:GO_Central.
DR   GO; GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IMP:FlyBase.
DR   GO; GO:0032414; P:positive regulation of ion transmembrane transporter activity; IBA:GO_Central.
DR   GO; GO:1903288; P:positive regulation of potassium ion import across plasma membrane; IBA:GO_Central.
DR   GO; GO:2000651; P:positive regulation of sodium ion transmembrane transporter activity; IMP:UniProtKB.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR024678; Kinase_OSR1/WNK_CCT.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF12202; OSR1_C; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Cell membrane;
KW   Complete proteome; Cytoplasm; Kinase; Membrane; Methylation;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1   2297       Serine/threonine-protein kinase WNK2.
FT                                /FTId=PRO_0000086822.
FT   DOMAIN      195    453       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     275    278       ATP. {ECO:0000250|UniProtKB:Q9H4A3}.
FT   ACT_SITE    342    342       Proton acceptor.
FT                                {ECO:0000250|UniProtKB:Q9JIH7}.
FT   BINDING     205    205       ATP; via amide nitrogen.
FT                                {ECO:0000250|UniProtKB:Q9H4A3}.
FT   BINDING     325    325       ATP. {ECO:0000250|UniProtKB:Q9H4A3}.
FT   MOD_RES      19     19       Omega-N-methylarginine.
FT                                {ECO:0000250|UniProtKB:Q3UH66}.
FT   MOD_RES      30     30       Omega-N-methylarginine.
FT                                {ECO:0000250|UniProtKB:Q3UH66}.
FT   MOD_RES      45     45       Phosphoserine.
FT                                {ECO:0000269|PubMed:21733846}.
FT   MOD_RES     352    352       Phosphoserine; by autocatalysis.
FT                                {ECO:0000250|UniProtKB:Q9JIH7}.
FT   MOD_RES     356    356       Phosphoserine; by autocatalysis.
FT                                {ECO:0000250|UniProtKB:Q9JIH7}.
FT   MOD_RES     560    560       Phosphoserine.
FT                                {ECO:0000269|PubMed:21733846}.
FT   MOD_RES    1150   1150       Phosphoserine.
FT                                {ECO:0000269|PubMed:21733846}.
FT   MOD_RES    1262   1262       Phosphoserine.
FT                                {ECO:0000269|PubMed:21733846}.
FT   MOD_RES    1588   1588       Phosphoserine.
FT                                {ECO:0000269|PubMed:21733846}.
FT   MOD_RES    1685   1685       Phosphoserine.
FT                                {ECO:0000269|PubMed:21733846}.
FT   MOD_RES    1736   1736       Phosphoserine.
FT                                {ECO:0000269|PubMed:21733846}.
FT   MOD_RES    1817   1817       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000269|PubMed:21733846}.
FT   MOD_RES    1818   1818       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000269|PubMed:21733846}.
FT   MOD_RES    1862   1862       Phosphoserine.
FT                                {ECO:0000269|PubMed:21733846}.
FT   MOD_RES    1889   1889       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q3UH66}.
FT   MOD_RES    2067   2067       Phosphoserine.
FT                                {ECO:0000269|PubMed:21733846}.
FT   VAR_SEQ       1     14       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:11280764}.
FT                                /FTId=VSP_050639.
FT   VAR_SEQ     680    731       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:11280764}.
FT                                /FTId=VSP_050640.
FT   VAR_SEQ     843    845       LAA -> RTR (in isoform 3).
FT                                {ECO:0000303|PubMed:11280764}.
FT                                /FTId=VSP_050641.
FT   VAR_SEQ     846   2297       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:11280764}.
FT                                /FTId=VSP_050642.
FT   VAR_SEQ    1345   1381       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:11214970}.
FT                                /FTId=VSP_050643.
FT   VAR_SEQ    2247   2261       DGALGTARRNQVWFG -> GSCGPRAVSTPTSYT (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:11214970}.
FT                                /FTId=VSP_050644.
FT   VAR_SEQ    2248   2254       GALGTAR -> PESEKPD (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_050645.
FT   VAR_SEQ    2255   2297       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_050646.
FT   VAR_SEQ    2262   2297       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:11214970}.
FT                                /FTId=VSP_050647.
FT   VARIANT     828    828       V -> M (in dbSNP:rs10761203).
FT                                /FTId=VAR_057114.
FT   VARIANT     974    974       R -> L (in dbSNP:rs10114908).
FT                                /FTId=VAR_059773.
FT   STRAND      458    465       {ECO:0000244|PDB:6ELM}.
FT   STRAND      469    481       {ECO:0000244|PDB:6ELM}.
FT   HELIX       483    485       {ECO:0000244|PDB:6ELM}.
FT   STRAND      496    501       {ECO:0000244|PDB:6ELM}.
FT   TURN        502    504       {ECO:0000244|PDB:6ELM}.
FT   HELIX       507    516       {ECO:0000244|PDB:6ELM}.
FT   HELIX       522    524       {ECO:0000244|PDB:6ELM}.
FT   HELIX       525    545       {ECO:0000244|PDB:6ELM}.
SQ   SEQUENCE   2297 AA;  242676 MW;  33D2EF2BFA6A1BD2 CRC64;
     MDGDGGRRDV PGTLMEPGRG AGPAGMAEPR AKAARPGPQR FLRRSVVESD QEEPPGLEAA
     EAPGPQPPQP LQRRVLLLCK TRRLIAERAR GRPAAPAPAA LVAQPGAPGA PADAGPEPVG
     TQEPGPDPIA AAVETAPAPD GGPREEAAAT VRKEDEGAAE AKPEPGRTRR DEPEEEEDDE
     DDLKAVATSL DGRFLKFDIE LGRGSFKTVY KGLDTETWVE VAWCELQDRK LTKLERQRFK
     EEAEMLKGLQ HPNIVRFYDF WESSAKGKRC IVLVTELMTS GTLKTYLKRF KVMKPKVLRS
     WCRQILKGLL FLHTRTPPII HRDLKCDNIF ITGPTGSVKI GDLGLATLKR ASFAKSVIGT
     PEFMAPEMYE EHYDESVDVY AFGMCMLEMA TSEYPYSECQ NAAQIYRKVT CGIKPASFEK
     VHDPEIKEII GECICKNKEE RYEIKDLLSH AFFAEDTGVR VELAEEDHGR KSTIALRLWV
     EDPKKLKGKP KDNGAIEFTF DLEKETPDEV AQEMIESGFF HESDVKIVAK SIRDRVALIQ
     WRRERIWPAL QPKEQQDVGS PDKARGPPVP LQVQVTYHAQ AGQPGPPEPE EPEADQHLLP
     PTLPTSATSL ASDSTFDSGQ GSTVYSDSQS SQQSVMLGSL ADAAPSPAQC VCSPPVSEGP
     VLPQSLPSLG AYQQPTAAPG LPVGSVPAPA CPPSLQQHFP DPAMSFAPVL PPPSTPMPTG
     PGQPAPPGQQ PPPLAQPTPL PQVLAPQPVV PLQPVPPHLP PYLAPASQVG APAQLKPLQM
     PQAPLQPLAQ VPPQMPPIPV VPPITPLAGI DGLPPALPDL PTATVPPVPP PQYFSPAVIL
     PSLAAPLPPA SPALPLQAVK LPHPPGAPLA MPCRTIVPNA PATIPLLAVA PPGVAALSIH
     SAVAQLPGQP VYPAAFPQMA PTDVPPSPHH TVQNMRATPP QPALPPQPTL PPQPVLPPQP
     TLPPQPVLPP QPTRPPQPVL PPQPMLPPQP VLPPQPALPV RPEPLQPHLP EQAAPAATPG
     SQILLGHPAP YAVDVAAQVP TVPVPPAAVL SPPLPEVLLP AAPELLPQFP SSLATVSASV
     QSVPTQTATL LPPANPPLPG GPGIASPCPT VQLTVEPVQE EQASQDKPPG LPQSCESYGG
     SDVTSGKELS DSCEGAFGGG RLEGRAARKH HRRSTRARSR QERASRPRLT ILNVCNTGDK
     MVECQLETHN HKMVTFKFDL DGDAPDEIAT YMVEHDFILQ AERETFIEQM KDVMDKAEDM
     LSEDTDADRG SDPGTSPPHL STCGLGTGEE SRQSQANAPV YQQNVLHTGK RWFIICPVAE
     HPAPEAPESS PPLPLSSLPP EASQGPCRGL TLPCLPWRRA ACGAVFLSLF SAESAQSKQP
     PDSAPYKDQL SSKEQPSFLA SQQLLSQAGP SNPPGAPPAP LAPSSPPVTA LPQDGAAPAT
     STMPEPASGT ASQAGGPGTP QGLTSELETS QPLAETHEAP LAVQPLVVGL APCTPAPEAA
     STRDASAPRE PLPPPAPEPS PHSGTPQPAL GQPAPLLPAA VGAVSLATSQ LPSPPLGPTV
     PPQPPSALES DGEGPPPRVG FVDSTIKSLD EKLRTLLYQE HVPTSSASAG TPVEVGDRDF
     TLEPLRGDQP RSEVCGGDLA LPPVPKEAVS GRVQLPQPLV EKSELAPTRG AVMEQGTSSS
     MTAESSPRSM LGYDRDGRQV ASDSHVVPSV PQDVPAFVRP ARVEPTDRDG GEAGESSAEP
     PPSDMGTVGG QASHPQTLGA RALGSPRKRP EQQDVSSPAK TVGRFSVVST QDEWTLASPH
     SLRYSAPPDV YLDEAPSSPD VKLAVRRAQT ASSIEVGVGE PVSSDSGDEG PRARPPVQKQ
     ASLPVSGSVA GDFVKKATAF LQRPSRAGSL GPETPSRVGM KVPTISVTSF HSQSSYISSD
     NDSELEDADI KKELQSLREK HLKEISELQS QQKQEIEALY RRLGKPLPPN VGFFHTAPPT
     GRRRKTSKSK LKAGKLLNPL VRQLKVVASS TGHLADSSRG PPAKDPAQAS VGLTADSTGL
     SGKAVQTQQP CSVRASLSSD ICSGLASDGG GARGQGWTVY HPTSERVTYK SSSKPRARFL
     SGPVSVSIWS ALKRLCLGKE HSSRSSTSSL APGPEPGPQP ALHVQAQVNN SNNKKGTFTD
     DLHKLVDEWT SKTVGAAQLK PTLNQLKQTQ KLQDMEAQAG WAAPGEARAM TAPRAGVGMP
     RLPPAPGPLS TTVIPGAAPT LSVPTPDGAL GTARRNQVWF GLRVPPTACC GHSTQPRGGQ
     RVGSKTASFA ASDPVRS
//
ID   A8K3Z7_HUMAN            Unreviewed;       495 AA.
AC   A8K3Z7;
DT   04-DEC-2007, integrated into UniProtKB/TrEMBL.
DT   04-DEC-2007, sequence version 1.
DT   16-JAN-2019, entry version 49.
DE   SubName: Full=cDNA FLJ77082, highly similar to Homo sapiens zinc finger, MYM-type 3, mRNA {ECO:0000313|EMBL:BAF83451.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAF83451.1};
RN   [1] {ECO:0000313|EMBL:BAF83451.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AK290762; BAF83451.1; -; mRNA.
DR   RefSeq; NP_001164634.1; NM_001171163.1.
DR   RefSeq; NP_005087.1; NM_005096.3.
DR   UniGene; Hs.522684; -.
DR   PeptideAtlas; A8K3Z7; -.
DR   PRIDE; A8K3Z7; -.
DR   DNASU; 9203; -.
DR   GeneID; 9203; -.
DR   KEGG; hsa:9203; -.
DR   CTD; 9203; -.
DR   PharmGKB; PA37632; -.
DR   eggNOG; ENOG410IE8I; Eukaryota.
DR   eggNOG; ENOG410XQR6; LUCA.
DR   HOGENOM; HOG000293143; -.
DR   HOVERGEN; HBG071046; -.
DR   OrthoDB; 587724at2759; -.
DR   GenomeRNAi; 9203; -.
DR   Genevisible; A8K3Z7; HS.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   InterPro; IPR026625; TFII-I-rel.
DR   InterPro; IPR011017; TRASH_dom.
DR   InterPro; IPR010507; Znf_MYM.
DR   PANTHER; PTHR11697; PTHR11697; 1.
DR   Pfam; PF06467; zf-FCS; 3.
DR   SMART; SM00746; TRASH; 4.
PE   2: Evidence at transcript level;
FT   DOMAIN      311    347       TRASH. {ECO:0000259|SMART:SM00746}.
FT   DOMAIN      353    393       TRASH. {ECO:0000259|SMART:SM00746}.
FT   DOMAIN      409    444       TRASH. {ECO:0000259|SMART:SM00746}.
FT   DOMAIN      451    492       TRASH. {ECO:0000259|SMART:SM00746}.
SQ   SEQUENCE   495 AA;  52527 MW;  D0C0BE49CA296D53 CRC64;
     MDPSDFPSPF DPLTLPEKPL AGDLPVDMEF GEDLLESQTA PTRGWAPPGP SPSSGALDLL
     DTPAGLEKDP GVPDGATELL GLGGLLYKAP SPPEVDHDPE GTLAWDAGDQ TLEPGPGGQT
     PEVVPPDPGA GANSCSPEGL LEPLAPDSPI TLQSPHIEEE ETTSIATARR GSPGQEEELP
     QGQPQSPNAP PSPSVGETLG DGINSSQTKP GGSSPPAHPS LPGDGLTAKA SEKPPERKRS
     ERVRRAEPPK PEVVDSTESI PVSDEDSDAM VDDPNDEDFV PFRPRRSPRM SLRSSVSQRA
     GRSAVGTKMT CAHCRTPLQK GQTAYQRKGL PQLFCSSSCL TTFSKKPSGK KTCTFCKKEI
     WNTKDSVVAQ TGSGGSFHEF CTSVCLSLYE AQQQRPIPQS GDPADATRCS ICQKTGEVLH
     EVSNGSVVHR LCSDSCFSKF RANKGLKTNC CDQCGAYIYT KTGSPGPELL FHEGQQKRFC
     NTTCLGAYKK VGPRE
//
ID   ZMYM3_HUMAN             Reviewed;        1370 AA.
AC   Q14202; D3DVV3; O15089; Q96E26;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2000, sequence version 2.
DT   13-FEB-2019, entry version 157.
DE   RecName: Full=Zinc finger MYM-type protein 3;
DE   AltName: Full=Zinc finger protein 261;
GN   Name=ZMYM3; Synonyms=DXS6673E, KIAA0385, ZNF261;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Fetal brain;
RX   PubMed=8817323; DOI=10.1093/hmg/5.7.887;
RA   van der Maarel S.M., Scholten I.H.G.M., Huber I., Phillippe C.,
RA   Suijkerbuijk R.F., Gilgenkrantz S., Kere J., Cremers F.P.M.,
RA   Ropers H.-H.;
RT   "Cloning and characterization of DXS6673E, a candidate gene for X-
RT   linked mental retardation in Xq13.1.";
RL   Hum. Mol. Genet. 5:887-897(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=9205841; DOI=10.1093/dnares/4.2.141;
RA   Nagase T., Ishikawa K., Nakajima D., Ohira M., Seki N., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. VII.
RT   The complete sequences of 100 new cDNA clones from brain which can
RT   code for large proteins in vitro.";
RL   DNA Res. 4:141-150(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Lymph, and Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   IDENTIFICATION IN THE BHC COMPLEX WITH GSE1; GTF2I; HDAC1; HDAC2;
RP   HMG20B; KDM1A; RCOR1; PHF21A; ZNF217 AND ZMYM2.
RX   PubMed=12493763; DOI=10.1074/jbc.M208992200;
RA   Hakimi M.-A., Dong Y., Lane W.S., Speicher D.W., Shiekhattar R.;
RT   "A candidate X-linked mental retardation gene is a component of a new
RT   family of histone deacetylase-containing complexes.";
RL   J. Biol. Chem. 278:7234-7239(2003).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-263 AND SER-267, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-263; SER-267 AND
RP   SER-464, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   FUNCTION.
RX   PubMed=21834987; DOI=10.1186/1741-7007-9-54;
RA   Bai S.W., Herrera-Abreu M.T., Rohn J.L., Racine V., Tajadura V.,
RA   Suryavanshi N., Bechtel S., Wiemann S., Baum B., Ridley A.J.;
RT   "Identification and characterization of a set of conserved and new
RT   regulators of cytoskeletal organisation, cell morphology and
RT   migration.";
RL   BMC Biol. 9:54-54(2011).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-464; THR-795; THR-817
RP   AND THR-826, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-817, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [16]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-308; LYS-320; LYS-328;
RP   LYS-778; LYS-786; LYS-804; LYS-847; LYS-861; LYS-920 AND LYS-1275,
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-786 (ISOFORM 2), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: Plays a role in the regulation of cell morphology and
CC       cytoskeletal organization. {ECO:0000269|PubMed:21834987}.
CC   -!- SUBUNIT: May be a component of a BHC histone deacetylase complex
CC       that contains HDAC1, HDAC2, HMG20B/BRAF35, KDM1A, RCOR1/CoREST,
CC       PHF21A/BHC80, ZMYM2, ZNF217, ZMYM3, GSE1 and GTF2I.
CC       {ECO:0000269|PubMed:12493763}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q14202-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q14202-2; Sequence=VSP_004492;
CC         Note=No experimental confirmation available. Contains a glycyl
CC         lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2) at
CC         position 786. {ECO:0000244|PubMed:28112733};
CC       Name=3;
CC         IsoId=Q14202-3; Sequence=VSP_043262, VSP_043263;
CC   -!- TISSUE SPECIFICITY: Most abundant in brain, moderate in muscle and
CC       heart, low in other tissues except placenta.
CC   -!- DISEASE: Note=A chromosomal aberration involving ZMYM3 may be a
CC       cause of X-linked mental retardation in Xq13.1. Translocation
CC       t(X;13)(q13.1;?). {ECO:0000269|PubMed:8817323}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA20839.2; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; X95808; CAA65075.1; -; mRNA.
DR   EMBL; AB002383; BAA20839.2; ALT_INIT; mRNA.
DR   EMBL; BT007095; AAP35759.1; -; mRNA.
DR   EMBL; AL590762; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471132; EAX05302.1; -; Genomic_DNA.
DR   EMBL; CH471132; EAX05303.1; -; Genomic_DNA.
DR   EMBL; BC069057; AAH69057.1; -; mRNA.
DR   EMBL; BC013009; AAH13009.1; -; mRNA.
DR   CCDS; CCDS14409.1; -. [Q14202-1]
DR   CCDS; CCDS55443.1; -. [Q14202-3]
DR   CCDS; CCDS55444.1; -. [Q14202-2]
DR   RefSeq; NP_001164633.1; NM_001171162.1. [Q14202-2]
DR   RefSeq; NP_001164634.1; NM_001171163.1. [Q14202-3]
DR   RefSeq; NP_005087.1; NM_005096.3. [Q14202-1]
DR   RefSeq; NP_963893.1; NM_201599.2. [Q14202-1]
DR   RefSeq; XP_005262366.1; XM_005262309.3. [Q14202-1]
DR   RefSeq; XP_005262367.1; XM_005262310.2. [Q14202-2]
DR   RefSeq; XP_011529364.1; XM_011531062.2. [Q14202-1]
DR   UniGene; Hs.522684; -.
DR   ProteinModelPortal; Q14202; -.
DR   SMR; Q14202; -.
DR   BioGrid; 114637; 52.
DR   CORUM; Q14202; -.
DR   IntAct; Q14202; 28.
DR   MINT; Q14202; -.
DR   STRING; 9606.ENSP00000322845; -.
DR   iPTMnet; Q14202; -.
DR   PhosphoSitePlus; Q14202; -.
DR   BioMuta; ZMYM3; -.
DR   DMDM; 12644413; -.
DR   EPD; Q14202; -.
DR   jPOST; Q14202; -.
DR   MaxQB; Q14202; -.
DR   PaxDb; Q14202; -.
DR   PeptideAtlas; Q14202; -.
DR   PRIDE; Q14202; -.
DR   ProteomicsDB; 59922; -.
DR   ProteomicsDB; 59923; -. [Q14202-2]
DR   ProteomicsDB; 59924; -. [Q14202-3]
DR   DNASU; 9203; -.
DR   Ensembl; ENST00000314425; ENSP00000322845; ENSG00000147130. [Q14202-1]
DR   Ensembl; ENST00000373981; ENSP00000363093; ENSG00000147130. [Q14202-3]
DR   Ensembl; ENST00000373998; ENSP00000363110; ENSG00000147130. [Q14202-2]
DR   GeneID; 9203; -.
DR   KEGG; hsa:9203; -.
DR   UCSC; uc004dzh.3; human. [Q14202-1]
DR   CTD; 9203; -.
DR   DisGeNET; 9203; -.
DR   EuPathDB; HostDB:ENSG00000147130.14; -.
DR   GeneCards; ZMYM3; -.
DR   HGNC; HGNC:13054; ZMYM3.
DR   HPA; HPA003211; -.
DR   HPA; HPA075255; -.
DR   MIM; 300061; gene.
DR   neXtProt; NX_Q14202; -.
DR   OpenTargets; ENSG00000147130; -.
DR   PharmGKB; PA37632; -.
DR   eggNOG; ENOG410IE8I; Eukaryota.
DR   eggNOG; ENOG410XQR6; LUCA.
DR   GeneTree; ENSGT00940000160693; -.
DR   HOGENOM; HOG000293258; -.
DR   HOVERGEN; HBG071046; -.
DR   InParanoid; Q14202; -.
DR   OrthoDB; 587724at2759; -.
DR   PhylomeDB; Q14202; -.
DR   TreeFam; TF336988; -.
DR   ChiTaRS; ZMYM3; human.
DR   GeneWiki; ZMYM3; -.
DR   GenomeRNAi; 9203; -.
DR   PRO; PR:Q14202; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000147130; Expressed in 225 organ(s), highest expression level in left ovary.
DR   ExpressionAtlas; Q14202; baseline and differential.
DR   Genevisible; Q14202; HS.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0003677; F:DNA binding; TAS:ProtInc.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IBA:GO_Central.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0007010; P:cytoskeleton organization; IMP:UniProtKB.
DR   GO; GO:0007275; P:multicellular organism development; TAS:ProtInc.
DR   GO; GO:0022604; P:regulation of cell morphogenesis; IMP:UniProtKB.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   InterPro; IPR021893; DUF3504.
DR   InterPro; IPR026625; TFII-I-rel.
DR   InterPro; IPR011017; TRASH_dom.
DR   InterPro; IPR010507; Znf_MYM.
DR   PANTHER; PTHR11697; PTHR11697; 1.
DR   Pfam; PF12012; DUF3504; 1.
DR   Pfam; PF06467; zf-FCS; 8.
DR   SMART; SM00746; TRASH; 10.
PE   1: Evidence at protein level;
KW   Alternative splicing; Chromosomal rearrangement; Complete proteome;
KW   Isopeptide bond; Metal-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Repeat; Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN         1   1370       Zinc finger MYM-type protein 3.
FT                                /FTId=PRO_0000191378.
FT   ZN_FING     332    366       MYM-type 1.
FT   ZN_FING     378    422       MYM-type 2.
FT   ZN_FING     429    464       MYM-type 3.
FT   ZN_FING     477    511       MYM-type 4.
FT   ZN_FING     521    559       MYM-type 5.
FT   ZN_FING     567    604       MYM-type 6.
FT   ZN_FING     612    646       MYM-type 7.
FT   ZN_FING     653    692       MYM-type 8.
FT   ZN_FING     699    733       MYM-type 9.
FT   MOD_RES     263    263       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648}.
FT   MOD_RES     267    267       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648}.
FT   MOD_RES     464    464       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     795    795       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     817    817       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     826    826       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   CROSSLNK    308    308       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    320    320       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    328    328       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    778    778       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    786    786       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    804    804       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    847    847       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    861    861       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    920    920       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK   1275   1275       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   VAR_SEQ     491    495       KNTRV -> VGPRE (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.3}.
FT                                /FTId=VSP_043262.
FT   VAR_SEQ     496   1370       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.3}.
FT                                /FTId=VSP_043263.
FT   VAR_SEQ     793    804       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:8817323}.
FT                                /FTId=VSP_004492.
SQ   SEQUENCE   1370 AA;  152379 MW;  088B5E01E7EE9C30 CRC64;
     MDPSDFPSPF DPLTLPEKPL AGDLPVDMEF GEDLLESQTA PTRGWAPPGP SPSSGALDLL
     DTPAGLEKDP GVLDGATELL GLGGLLYKAP SPPEVDHGPE GTLAWDAGDQ TLEPGPGGQT
     PEVVPPDPGA GANSCSPEGL LEPLAPDSPI TLQSPHIEEE ETTSIATARR GSPGQEEELP
     QGQPQSPNAP PSPSVGETLG DGINSSQTKP GGSSPPAHPS LPGDGLTAKA SEKPPERKRS
     ERVRRAEPPK PEVVDSTESI PVSDEDSDAM VDDPNDEDFV PFRPRRSPRM SLRSSVSQRA
     GRSAVGTKMT CAHCRTPLQK GQTAYQRKGL PQLFCSSSCL TTFSKKPSGK KTCTFCKKEI
     WNTKDSVVAQ TGSGGSFHEF CTSVCLSLYE AQQQRPIPQS GDPADATRCS ICQKTGEVLH
     EVSNGSVVHR LCSDSCFSKF RANKGLKTNC CDQCGAYIYT KTGSPGPELL FHEGQQKRFC
     NTTCLGAYKK KNTRVYPCVW CKTLCKNFEM LSHVDRNGKT SLFCSLCCTT SYKVKQAGLT
     GPPRPCSFCR RSLSDPCYYN KVDRTVYQFC SPSCWTKFQR TSPEGGIHLS CHYCHSLFSG
     KPEVLDWQDQ VFQFCCRDCC EDFKRLRGVV SQCEHCRQEK LLHEKLRFSG VEKSFCSEGC
     VLLYKQDFTK KLGLCCITCT YCSQTCQRGV TEQLDGSTWD FCSEDCKSKY LLWYCKAARC
     HACKRQGKLL ETIHWRGQIR HFCNQQCLLR FYSQQNQPNL DTQSGPESLL NSQSPESKPQ
     TPSQTKVENS NTVRTPEENG NLGKIPVKTR SAPTAPTPPP PPPPATPRKN KAAMCKPLMQ
     NRGVSCKVEM KSKGSQTEEW KPQVIVLPIP VPIFVPVPMH LYCQKVPVPF SMPIPVPVPM
     FLPTTLESTD KIVETIEELK VKIPSNPLEA DILAMAEMIA EAEELDKASS DLCDLVSNQS
     AEGLLEDCDL FGPARDDVLA MAVKMANVLD EPGQDLEADF PKNPLDINPS VDFLFDCGLV
     GPEDVSTEQD LPRTMRKGQK RLVLSESCSR DSMSSQPSCT GLNYSYGVNA WKCWVQSKYA
     NGETSKGDEL RFGPKPMRIK EDILACSAAE LNYGLAQFVR EITRPNGERY EPDSIYYLCL
     GIQQYLLENN RMVNIFTDLY YLTFVQELNK SLSTWQPTLL PNNTVFSRVE EEHLWECKQL
     GVYSPFVLLN TLMFFNTKFF GLQTAEEHMQ LSFTNVVRQS RKCTTPRGTT KVVSIRYYAP
     VRQRKGRDTG PGKRKREDEA PILEQRENRM NPLRCPVKFY EFYLSKCPES LRTRNDVFYL
     QPERSCIAES PLWYSVIPMD RSMLESMLNR ILAVREIYEE LGRPGEEDLD
//
ID   A0A024R1J1_HUMAN        Unreviewed;       936 AA.
AC   A0A024R1J1;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   13-FEB-2019, entry version 39.
DE   SubName: Full=HCG40978, isoform CRA_b {ECO:0000313|EMBL:EAW59769.1};
GN   ORFNames=hCG_40978 {ECO:0000313|EMBL:EAW59769.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW59769.1};
RN   [1] {ECO:0000313|EMBL:EAW59769.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW59769.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471095; EAW59768.1; -; Genomic_DNA.
DR   EMBL; CH471095; EAW59769.1; -; Genomic_DNA.
DR   RefSeq; NP_001193927.1; NM_001206998.1.
DR   UniGene; Hs.604200; -.
DR   UniGene; Hs.655242; -.
DR   UniGene; Hs.732114; -.
DR   GeneID; 84133; -.
DR   KEGG; hsa:84133; -.
DR   CTD; 84133; -.
DR   EuPathDB; HostDB:ENSG00000183579.15; -.
DR   eggNOG; KOG0800; Eukaryota.
DR   eggNOG; ENOG41121N2; LUCA.
DR   KO; K16273; -.
DR   OMA; PHRCGLE; -.
DR   OrthoDB; 1487241at2759; -.
DR   GenomeRNAi; 84133; -.
DR   Bgee; ENSG00000183579; Expressed in 196 organ(s), highest expression level in caput epididymis.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0030178; P:negative regulation of Wnt signaling pathway; IEA:Ensembl.
DR   GO; GO:0060828; P:regulation of canonical Wnt signaling pathway; IEA:Ensembl.
DR   GO; GO:2000095; P:regulation of Wnt signaling pathway, planar cell polarity pathway; IEA:Ensembl.
DR   GO; GO:0072089; P:stem cell proliferation; IEA:Ensembl.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR040700; ZNRF-3_ecto.
DR   Pfam; PF13639; zf-RING_2; 1.
DR   Pfam; PF18212; ZNRF_3_ecto; 1.
DR   SMART; SM00184; RING; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   4: Predicted;
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00175};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00175};
KW   Zinc-finger {ECO:0000256|PROSITE-ProRule:PRU00175}.
FT   TRANSMEM    216    238       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN      293    334       RING-type. {ECO:0000259|PROSITE:PS50089}.
SQ   SEQUENCE   936 AA;  100574 MW;  EE68B810BD3C9C74 CRC64;
     MRPRSGGRPG ATGRRRRRLR RRPRGLRCSR LPPPPPLPLL LGLLLAAAGP GAARAKETAF
     VEVVLFESSP SGDYTTYTTG LTGRFSRAGA TLSAEGEIVQ MHPLGLCNNN DEEDLYEYGW
     VGVVKLEQPE LDPKPCLTVL GKAKRAVQRG ATAVIFDVSE NPEAIDQLNQ GSEDPLKRPV
     VYVKGADAIK LMNIVNKQKV ARARIQHRPP RQPTEYFDMG IFLAFFVVVS LVCLILLVKI
     KLKQRRSQNS MNRLAVQALE KMETRKFNSK SKGRREGSCG ALDTLSSSST SDCAICLEKY
     IDGEELRVIP CTHRFHRKCV DPWLLQHHTC PHCRHNIIEQ KGNPSAVCVE TSNLSRGRQQ
     RVTLPVHYPG RVHRTNAIPA YPTRTSMDSH GNPVTLLTMD RHGEQSLYSP QTPAYIRSYP
     PLHLDHSLAA HRCGLEHRAY SPAHPFRRPK LSGRSFSKAA CFSQYETMYQ HYYFQGLSYP
     EQEGQSPPSL APRGPARAFP PSGSGSLLFP TVVHVAPPSH LESGSTSSFS CYHGHRSVCS
     GYLADCPGSD SSSSSSSGQC HCSSSDSVVD CTEVSNQGVY GSCSTFRSSL SSDYDPFIYR
     SRSPCRASEA GGSGSSGRGP ALCFEGSPPP EELPAVHSHG AGRGEPWPGP ASPSGDQVST
     CSLEMNYSSN SSLEHRGPNS STSEVGLEAS PGAAPDLRRT WKGGHELPSC ACCCEPQPSP
     AGPSAGAAGS STLFLGPHLY EGSGPAGGEP QSGSSQGLYG LHPDHLPRTD GVKYEGLPCC
     FYEEKQVARG GGGGSGCYTE DYSVSVQYTL TEEPPPGCYP GARDLSQRIP IIPEDVDCDL
     GLPSDCQGTH SLGSWGGTRG PDTPRPHRGL GATREEERAL CCQARALLRP GCPPEEAGAV
     RANFPSALQD TQESSTTATE AAGPRSHSAD SSSPGA
//
ID   ZNRF3_HUMAN             Reviewed;         936 AA.
AC   Q9ULT6; B3KU18; Q6ICH1; Q6NTF8; Q8WU18;
DT   20-FEB-2007, integrated into UniProtKB/Swiss-Prot.
DT   20-FEB-2007, sequence version 3.
DT   13-FEB-2019, entry version 139.
DE   RecName: Full=E3 ubiquitin-protein ligase ZNRF3;
DE            EC=2.3.2.27;
DE   AltName: Full=RING finger protein 203;
DE   AltName: Full=RING-type E3 ubiquitin transferase ZNRF3;
DE   AltName: Full=Zinc/RING finger protein 3;
DE   Flags: Precursor;
GN   Name=ZNRF3; Synonyms=KIAA1133, RNF203;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M.,
RA   Clamp M., Smink L.J., Ainscough R., Almeida J.P., Babbage A.K.,
RA   Bagguley C., Bailey J., Barlow K.F., Bates K.N., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Buck D., Burgess J.,
RA   Burrill W.D., Burton J., Carder C., Carter N.P., Chen Y., Clark G.,
RA   Clegg S.M., Cobley V.E., Cole C.G., Collier R.E., Connor R.,
RA   Conroy D., Corby N.R., Coville G.J., Cox A.V., Davis J., Dawson E.,
RA   Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M., Ellington A.G.,
RA   Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S.,
RA   Hunt S.E., Jones M.C., Kershaw J., Kimberley A.M., King A.,
RA   Laird G.K., Langford C.F., Leversha M.A., Lloyd C., Lloyd D.M.,
RA   Martyn I.D., Mashreghi-Mohammadi M., Matthews L.H., Mccann O.T.,
RA   Mcclay J., Mclaren S., McMurray A.A., Milne S.A., Mortimore B.J.,
RA   Odell C.N., Pavitt R., Pearce A.V., Pearson D., Phillimore B.J.C.T.,
RA   Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y., Rogers L., Ross M.T.,
RA   Scott C.E., Sehra H.K., Skuce C.D., Smalley S., Smith M.L.,
RA   Soderlund C., Spragon L., Steward C.A., Sulston J.E., Swann R.M.,
RA   Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J.,
RA   Shintani A., Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S.,
RA   Roe B.A., Chen F., Chu L., Crabtree J., Deschamps S., Do A., Do T.,
RA   Dorman A., Fang F., Fu Y., Hu P., Hua A., Kenton S., Lai H., Lao H.I.,
RA   Lewis J., Lewis S., Lin S.-P., Loh P., Malaj E., Nguyen T., Pan H.,
RA   Phan S., Qi S., Qian Y., Ray L., Ren Q., Shaull S., Sloan D., Song L.,
RA   Wang Q., Wang Y., Wang Z., White J., Willingham D., Wu H., Yao Z.,
RA   Zhan M., Zhang G., Chissoe S., Murray J., Miller N., Minx P.,
RA   Fulton R., Johnson D., Bemis G., Bentley D., Bradshaw H., Bourne S.,
RA   Cordes M., Du Z., Fulton L., Goela D., Graves T., Hawkins J.,
RA   Hinds K., Kemp K., Latreille P., Layman D., Ozersky P., Rohlfing T.,
RA   Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K., Nelson J.,
RA   Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S.,
RA   Budarf M.L., McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E.,
RA   Edelmann L., Kim U.J., Shizuya H., Simon M.I., Dumanski J.P.,
RA   Peyrard M., Kedra D., Seroussi E., Fransson I., Tapia I., Bruder C.E.,
RA   O'Brien K.P., Wilkinson P., Bodenteich A., Hartman K., Hu X.,
RA   Khan A.S., Lane L., Tilahun Y., Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 46-936 (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=10574461; DOI=10.1093/dnares/6.5.329;
RA   Hirosawa M., Nagase T., Ishikawa K., Kikuno R., Nomura N., Ohara O.;
RT   "Characterization of cDNA clones selected by the GeneMark analysis
RT   from size-fractionated cDNA libraries from human brain.";
RL   DNA Res. 6:329-336(1999).
RN   [4]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 77-936 (ISOFORM 1).
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:R84.1-R84.11(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 284-936.
RC   TISSUE=Brain, and Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION, SUBCELLULAR LOCATION, ACTIVITY REGULATION, INTERACTION WITH
RP   FZD4; FZD5; FZD6; FZD8; LRP6 AND RSPO1, AND MUTAGENESIS OF PRO-103.
RX   PubMed=22575959; DOI=10.1038/nature11019;
RA   Hao H.X., Xie Y., Zhang Y., Charlat O., Oster E., Avello M., Lei H.,
RA   Mickanin C., Liu D., Ruffner H., Mao X., Ma Q., Zamponi R.,
RA   Bouwmeester T., Finan P.M., Kirschner M.W., Porter J.A., Serluca F.C.,
RA   Cong F.;
RT   "ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive
RT   manner.";
RL   Nature 485:195-200(2012).
RN   [8]
RP   INTERACTION WITH RSPO2.
RX   PubMed=29769720; DOI=10.1038/s41586-018-0118-y;
RA   Szenker-Ravi E., Altunoglu U., Leushacke M., Bosso-Lefevre C.,
RA   Khatoo M., Thi Tran H., Naert T., Noelanders R., Hajamohideen A.,
RA   Beneteau C., de Sousa S.B., Karaman B., Latypova X., Basaran S.,
RA   Yuecel E.B., Tan T.T., Vlaminck L., Nayak S.S., Shukla A.,
RA   Girisha K.M., Le Caignec C., Soshnikova N., Uyguner Z.O.,
RA   Vleminckx K., Barker N., Kayserili H., Reversade B.;
RT   "RSPO2 inhibition of RNF43 and ZNRF3 governs limb development
RT   independently of LGR4/5/6.";
RL   Nature 557:564-569(2018).
CC   -!- FUNCTION: E3 ubiquitin-protein ligase that acts as a negative
CC       regulator of the Wnt signaling pathway by mediating the
CC       ubiquitination and subsequent degradation of Wnt receptor complex
CC       components Frizzled and LRP6. Acts on both canonical and non-
CC       canonical Wnt signaling pathway. Acts as a tumor suppressor in the
CC       intestinal stem cell zone by inhibiting the Wnt signaling pathway,
CC       thereby resticting the size of the intestinal stem cell zone
CC       (PubMed:22575959). Along with RSPO2 and RNF43, constitutes a
CC       master switch that governs limb specification (By similarity).
CC       {ECO:0000250|UniProtKB:Q08D68, ECO:0000269|PubMed:22575959}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-
CC         cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-
CC         conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor
CC         protein]-L-lysine.; EC=2.3.2.27;
CC   -!- ACTIVITY REGULATION: Negatively regulated by R-spondin proteins
CC       such as RSPO1: interaction with RSPO1 induces the indirect
CC       association between ZNRF3 and LGR4, promoting membrane clearance
CC       of ZNRF3. {ECO:0000269|PubMed:22575959}.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Interacts with LRP6, FZD4, FZD5, FZD6 and FZD8
CC       (PubMed:22575959). Interacts with RSPO1; interaction promotes
CC       indirect interaction with LGR4 and membrane clearance of ZNRF3
CC       (PubMed:22575959). Also interacts with RSPO2 (PubMed:29769720).
CC       {ECO:0000269|PubMed:22575959, ECO:0000269|PubMed:29769720}.
CC   -!- INTERACTION:
CC       O60353:FZD6; NbExp=2; IntAct=EBI-949772, EBI-8754490;
CC       Q9BXB1:LGR4; NbExp=2; IntAct=EBI-949772, EBI-10965764;
CC       O75581:LRP6; NbExp=2; IntAct=EBI-949772, EBI-910915;
CC       Q2MKA7:RSPO1; NbExp=6; IntAct=EBI-949772, EBI-10045219;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:22575959};
CC       Single-pass type I membrane protein {ECO:0000269|PubMed:22575959}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9ULT6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9ULT6-2; Sequence=VSP_044043;
CC         Note=No experimental confirmation available.;
CC   -!- SIMILARITY: Belongs to the ZNRF3 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAG30283.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AK096397; BAG53280.1; -; mRNA.
DR   EMBL; Z95113; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL021393; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL031596; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AB051436; BAB33319.1; -; mRNA.
DR   EMBL; CR456397; CAG30283.1; ALT_INIT; mRNA.
DR   EMBL; BC021570; AAH21570.1; -; mRNA.
DR   EMBL; BC069019; AAH69019.1; -; mRNA.
DR   EMBL; BC094857; AAH94857.1; -; mRNA.
DR   CCDS; CCDS42999.1; -. [Q9ULT6-2]
DR   CCDS; CCDS56225.1; -. [Q9ULT6-1]
DR   RefSeq; NP_001193927.1; NM_001206998.1. [Q9ULT6-1]
DR   RefSeq; NP_115549.2; NM_032173.3. [Q9ULT6-2]
DR   UniGene; Hs.604200; -.
DR   UniGene; Hs.655242; -.
DR   UniGene; Hs.732114; -.
DR   ProteinModelPortal; Q9ULT6; -.
DR   SMR; Q9ULT6; -.
DR   BioGrid; 123905; 14.
DR   DIP; DIP-50030N; -.
DR   IntAct; Q9ULT6; 8.
DR   MINT; Q9ULT6; -.
DR   STRING; 9606.ENSP00000443824; -.
DR   iPTMnet; Q9ULT6; -.
DR   PhosphoSitePlus; Q9ULT6; -.
DR   BioMuta; ZNRF3; -.
DR   DMDM; 126253847; -.
DR   EPD; Q9ULT6; -.
DR   jPOST; Q9ULT6; -.
DR   PaxDb; Q9ULT6; -.
DR   PeptideAtlas; Q9ULT6; -.
DR   PRIDE; Q9ULT6; -.
DR   ProteomicsDB; 85106; -.
DR   ProteomicsDB; 85107; -. [Q9ULT6-2]
DR   DNASU; 84133; -.
DR   Ensembl; ENST00000402174; ENSP00000384456; ENSG00000183579. [Q9ULT6-2]
DR   Ensembl; ENST00000406323; ENSP00000384553; ENSG00000183579. [Q9ULT6-2]
DR   Ensembl; ENST00000544604; ENSP00000443824; ENSG00000183579. [Q9ULT6-1]
DR   GeneID; 84133; -.
DR   KEGG; hsa:84133; -.
DR   UCSC; uc003aeg.4; human. [Q9ULT6-1]
DR   CTD; 84133; -.
DR   DisGeNET; 84133; -.
DR   EuPathDB; HostDB:ENSG00000183579.15; -.
DR   GeneCards; ZNRF3; -.
DR   HGNC; HGNC:18126; ZNRF3.
DR   HPA; HPA036702; -.
DR   HPA; HPA036703; -.
DR   MIM; 612062; gene.
DR   neXtProt; NX_Q9ULT6; -.
DR   OpenTargets; ENSG00000183579; -.
DR   PharmGKB; PA134983897; -.
DR   eggNOG; KOG0800; Eukaryota.
DR   eggNOG; ENOG41121N2; LUCA.
DR   GeneTree; ENSGT00940000154006; -.
DR   HOGENOM; HOG000155811; -.
DR   HOVERGEN; HBG082538; -.
DR   InParanoid; Q9ULT6; -.
DR   KO; K16273; -.
DR   OMA; PHRCGLE; -.
DR   OrthoDB; 1487241at2759; -.
DR   PhylomeDB; Q9ULT6; -.
DR   TreeFam; TF317074; -.
DR   Reactome; R-HSA-4641263; Regulation of FZD by ubiquitination.
DR   SIGNOR; Q9ULT6; -.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; ZNRF3; human.
DR   GenomeRNAi; 84133; -.
DR   PRO; PR:Q9ULT6; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   Bgee; ENSG00000183579; Expressed in 196 organ(s), highest expression level in caput epididymis.
DR   ExpressionAtlas; Q9ULT6; baseline and differential.
DR   Genevisible; Q9ULT6; HS.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005109; F:frizzled binding; IPI:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IBA:GO_Central.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IDA:UniProtKB.
DR   GO; GO:0060173; P:limb development; ISS:UniProtKB.
DR   GO; GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IMP:UniProtKB.
DR   GO; GO:2000051; P:negative regulation of non-canonical Wnt signaling pathway; IMP:UniProtKB.
DR   GO; GO:0016567; P:protein ubiquitination; IDA:UniProtKB.
DR   GO; GO:2000095; P:regulation of Wnt signaling pathway, planar cell polarity pathway; IEA:Ensembl.
DR   GO; GO:0072089; P:stem cell proliferation; ISS:UniProtKB.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IMP:UniProtKB.
DR   GO; GO:0038018; P:Wnt receptor catabolic process; IMP:UniProtKB.
DR   GO; GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR040700; ZNRF-3_ecto.
DR   Pfam; PF13639; zf-RING_2; 1.
DR   Pfam; PF18212; ZNRF_3_ecto; 1.
DR   SMART; SM00184; RING; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Complete proteome;
KW   Developmental protein; Membrane; Metal-binding; Reference proteome;
KW   Signal; Transferase; Transmembrane; Transmembrane helix;
KW   Ubl conjugation pathway; Wnt signaling pathway; Zinc; Zinc-finger.
FT   SIGNAL        1     55       {ECO:0000255}.
FT   CHAIN        56    936       E3 ubiquitin-protein ligase ZNRF3.
FT                                /FTId=PRO_0000277806.
FT   TOPO_DOM     56    219       Extracellular. {ECO:0000255}.
FT   TRANSMEM    220    240       Helical. {ECO:0000255}.
FT   TOPO_DOM    241    936       Cytoplasmic. {ECO:0000255}.
FT   ZN_FING     293    334       RING-type; atypical.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00175}.
FT   VAR_SEQ       1    100       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_044043.
FT   MUTAGEN     103    103       P->A: Abolishes interaction with RSPO1
FT                                and prevents subsequent membrane
FT                                clearance. {ECO:0000269|PubMed:22575959}.
SQ   SEQUENCE   936 AA;  100574 MW;  EE68B810BD3C9C74 CRC64;
     MRPRSGGRPG ATGRRRRRLR RRPRGLRCSR LPPPPPLPLL LGLLLAAAGP GAARAKETAF
     VEVVLFESSP SGDYTTYTTG LTGRFSRAGA TLSAEGEIVQ MHPLGLCNNN DEEDLYEYGW
     VGVVKLEQPE LDPKPCLTVL GKAKRAVQRG ATAVIFDVSE NPEAIDQLNQ GSEDPLKRPV
     VYVKGADAIK LMNIVNKQKV ARARIQHRPP RQPTEYFDMG IFLAFFVVVS LVCLILLVKI
     KLKQRRSQNS MNRLAVQALE KMETRKFNSK SKGRREGSCG ALDTLSSSST SDCAICLEKY
     IDGEELRVIP CTHRFHRKCV DPWLLQHHTC PHCRHNIIEQ KGNPSAVCVE TSNLSRGRQQ
     RVTLPVHYPG RVHRTNAIPA YPTRTSMDSH GNPVTLLTMD RHGEQSLYSP QTPAYIRSYP
     PLHLDHSLAA HRCGLEHRAY SPAHPFRRPK LSGRSFSKAA CFSQYETMYQ HYYFQGLSYP
     EQEGQSPPSL APRGPARAFP PSGSGSLLFP TVVHVAPPSH LESGSTSSFS CYHGHRSVCS
     GYLADCPGSD SSSSSSSGQC HCSSSDSVVD CTEVSNQGVY GSCSTFRSSL SSDYDPFIYR
     SRSPCRASEA GGSGSSGRGP ALCFEGSPPP EELPAVHSHG AGRGEPWPGP ASPSGDQVST
     CSLEMNYSSN SSLEHRGPNS STSEVGLEAS PGAAPDLRRT WKGGHELPSC ACCCEPQPSP
     AGPSAGAAGS STLFLGPHLY EGSGPAGGEP QSGSSQGLYG LHPDHLPRTD GVKYEGLPCC
     FYEEKQVARG GGGGSGCYTE DYSVSVQYTL TEEPPPGCYP GARDLSQRIP IIPEDVDCDL
     GLPSDCQGTH SLGSWGGTRG PDTPRPHRGL GATREEERAL CCQARALLRP GCPPEEAGAV
     RANFPSALQD TQESSTTATE AAGPRSHSAD SSSPGA
//
